cell_line_id,drug_id,response,predictions
DMS 273,9952709,2.373087309160908,1.8594267642584574
NCI-H522,613000,2.2856040748624347,1.8594267642584574
YAPC,16038120,1.926562361021756,1.8594267642584574
NCI-H292,9935249,3.8808310590786,1.8594267642584574
SNU-449,navitoclax-gemcitabine (1-1 mol-mol),5.117951975418846,1.8594267642584574
NCI-H522,9908783,5.043768225694569,1.8594267642584574
JM-1,11175137,0.9157477453434189,1.8594267642584574
NCI-H522,5287620,-2.19230412457559,1.8594267642584574
MDA-MB-453,4917,2.8920757434762203,1.8594267642584574
DMS 273,135421197,2.3407622077730035,1.8594267642584574
SNU-449,BRD-K55473186,5.1406225681359174,1.8594267642584574
SNU-61,4521392,3.90812104829802,1.8594267642584574
G-401,9549297,1.736191202159007,1.8594267642584574
NCI-H146,89183176,1.451528120959232,1.8594267642584574
LOU-NH91,5287620,-1.52867963951729,1.8594267642584574
FTC-133,123631,3.8044847524269865,1.8594267642584574
KMRC-1,5291,3.811670367299954,1.8594267642584574
A-673,9823820,4.6435125645675095,1.8594267642584574
FU-OV-1,168313047,2.3973799381416208,1.8594267642584574
Panc 04.03,44462760,4.978463894781355,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],7326481,3.471788060157272,1.8594267642584574
OPM-2,445091,3.996829176942573,1.8594267642584574
ONS-76,5746,1.4703359849180313,1.8594267642584574
NCI-H661,3025944,3.908905198351104,1.8594267642584574
A4/Fukuda,107970,1.5574682195612295,1.8594267642584574
CAL-51,49850262,3.6300011952383584,1.8594267642584574
NCI-H460,2858523,3.1665522277325575,1.8594267642584574
G-401,6184667,2.5094508901292487,1.8594267642584574
NCI-H661,44607531,1.139733733680255,1.8594267642584574
SNU-81,6917907,-6.2756065511253185,1.8594267642584574
MSTO-211H,54678924,1.5146991125566602,1.8594267642584574
FTC-133,10127622,5.496386107928154,1.8594267642584574
EFO-27,11977753,-1.8189065225127747,1.8594267642584574
SNU-61,selumetinib-decitabine (4-1 mol-mol),0.7791363138333649,1.8594267642584574
MSTO-211H,19582717,3.17062921236116,1.8594267642584574
KMRC-1,53392493,3.2185750963739026,1.8594267642584574
OPM-2,2749,1.7313419667612246,1.8594267642584574
NCI-H460,5351362,3.0809857123464037,1.8594267642584574
SNU-449,56949517,4.374997906660537,1.8594267642584574
NCI-H146,1716436,1.8968095332546364,1.8594267642584574
MSTO-211H,9884685,-1.5007126123703023,1.8594267642584574
CA46,46926350,-5.311040218420036,1.8594267642584574
BxPC-3,72193861,-0.2425633398981322,1.8594267642584574
NCI-H522,24180719,4.104291025168841,1.8594267642584574
NCI-H292,16038120,0.8772093711483475,1.8594267642584574
NCI-H2171,11364421,-5.769988570724398,1.8594267642584574
LOU-NH91,71304818,3.9209078908272703,1.8594267642584574
NCI-H2009,71466380,3.950405172838994,1.8594267642584574
EFO-27,44607530,2.237032971856772,1.8594267642584574
CAL-51,3136844,4.799885860604426,1.8594267642584574
MSTO-211H,9936388,-4.464575449065994,1.8594267642584574
A2780,66577038,2.715796351675557,1.8594267642584574
G-401,24779724,6.361263224396382,1.8594267642584574
OPM-2,5470400,-0.1217933569770787,1.8594267642584574
HCC1143,36314,1.6197332159913502,1.8594267642584574
SW1463,54143018,1.6932952952144893,1.8594267642584574
JM-1,1317464,3.8125649173872938,1.8594267642584574
DMS 273,46907787,0.4735517334159472,1.8594267642584574
MDA-MB-453,46843906,1.4379824902109608,1.8594267642584574
YAPC,6252,1.451992868069142,1.8594267642584574
MDA-MB-157,navitoclax-sorafenib (1-1 mol-mol),-1.4384143120917083,1.8594267642584574
CA46,46943432,1.2105530921386296,1.8594267642584574
NCI-H292,24785538,2.1095024536235374,1.8594267642584574
NCI-H292,3038522,3.811290582208577,1.8594267642584574
NCI-H460,54454,2.7807551042334935,1.8594267642584574
NCI-H661,9911463,3.595935737335879,1.8594267642584574
BT-549,4261,1.9217340769001163,1.8594267642584574
FTC-133,16013152,4.199465293191842,1.8594267642584574
MDA-MB-453,54618305,5.448966988850886,1.8594267642584574
LOU-NH91,56946209,-2.032751224257796,1.8594267642584574
KMRC-1,16659841,4.161446951047465,1.8594267642584574
LXF 289,66577038,2.7615792990535937,1.8594267642584574
A-673,2871966,-2.1375369153988597,1.8594267642584574
EFO-27,4788,6.204062284318603,1.8594267642584574
FTC-133,5281321,-2.4880366458953196,1.8594267642584574
JM-1,613753,2.4959303189076376,1.8594267642584574
CAL-51,168312962,1.4117577594763937,1.8594267642584574
OPM-2,6450551,0.7106995413225735,1.8594267642584574
ONS-76,selumetinib-decitabine (4-1 mol-mol),-0.8020302824426914,1.8594267642584574
EFO-27,26596,4.577324640946523,1.8594267642584574
LoVo,656346,0.766025679375412,1.8594267642584574
NCI-H522,4477,0.4448521837298123,1.8594267642584574
NCI-H727,9936388,1.6432072244848812,1.8594267642584574
FTC-133,104842,-5.8581546696404,1.8594267642584574
EFO-27,7326481,5.957065585898912,1.8594267642584574
NCI-H460,11222830,2.8861636193629323,1.8594267642584574
OPM-2,selumetinib-BRD-A02303741 (4-1 mol-mol),2.0894009030955245,1.8594267642584574
NCI-H460,54618771,1.6853262233131374,1.8594267642584574
JM-1,52947716,1.780956269613054,1.8594267642584574
OPM-2,9444,2.5095115053941557,1.8594267642584574
NCI-H146,60700,-4.723399126949256,1.8594267642584574
BxPC-3,9911830,2.611582201474507,1.8594267642584574
NCI-H146,16038120,1.7989248875403512,1.8594267642584574
LXF 289,51037431,5.679407317259089,1.8594267642584574
HCC1143,44589607,1.260451666530297,1.8594267642584574
CA46,5281321,-3.5082232289526663,1.8594267642584574
BxPC-3,3815108,3.682439325637505,1.8594267642584574
BT-549,ISOX-bortezomib (250-1 mol-mol),0.1826356805695565,1.8594267642584574
BxPC-3,3552672,2.73628551508051,1.8594267642584574
SCC-9,3081361,1.719146178558617,1.8594267642584574
SCC-9,135875424,4.9754653396039314,1.8594267642584574
LoVo,1716436,2.86184708699294,1.8594267642584574
MDA-MB-157,9884685,1.398372779004129,1.8594267642584574
NCI-H292,9911463,4.207043029649759,1.8594267642584574
G-401,54626689,4.421186382617726,1.8594267642584574
NCI-H460,6917907,-4.956095121428261,1.8594267642584574
CA46,25062766,1.483751377697603,1.8594267642584574
LXF 289,44241473,4.688676931788039,1.8594267642584574
EFO-27,71680916,4.9682795090816185,1.8594267642584574
SW1463,11152667,-0.1903484351781526,1.8594267642584574
NCI-H292,73707398,0.96137499748578,1.8594267642584574
NCI-H2009,16725315,3.943728055015544,1.8594267642584574
SNU-61,135440466,2.760100648324382,1.8594267642584574
A2780,451668,4.676838081876032,1.8594267642584574
JM-1,46191454,-0.7072965876905944,1.8594267642584574
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725,1.8594267642584574
SNU-449,2733526,4.280379959685792,1.8594267642584574
JM-1,10302451,3.097435274235228,1.8594267642584574
DMS 273,tanespimycin-gemcitabine (1-1 mol-mol),-1.669434491650497,1.8594267642584574
EFO-27,vorinostat-carboplatin (1-1 mol-mol),2.7861871023454077,1.8594267642584574
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324,1.8594267642584574
NCI-H460,vorinostat-navitoclax (4-1 mol-mol),2.672492910118056,1.8594267642584574
OPM-2,52912189,-3.1407059889083424,1.8594267642584574
SCC-9,9549297,5.273243325738832,1.8594267642584574
A-673,375860,-0.5094320760358009,1.8594267642584574
SNU-449,15983966,0.8926749279922188,1.8594267642584574
SNU-449,135440466,2.7536019754154375,1.8594267642584574
CA46,serdemetan-SCH-529074 (1-1 mol-mol),1.5485076626446956,1.8594267642584574
NCI-H522,73707398,0.7434005611154502,1.8594267642584574
NCI-H1623,72376,-0.6301176586270604,1.8594267642584574
SCC-9,24901704,4.548877009949327,1.8594267642584574
HSC-4,448949,2.25928901468022,1.8594267642584574
SCC-9,25102847,2.571358625043281,1.8594267642584574
FTC-133,135411,0.6572104898559208,1.8594267642584574
DMS 273,445643,4.452334519038606,1.8594267642584574
HSC-4,24771867,2.9499855440491243,1.8594267642584574
BxPC-3,2841722,6.186043735824486,1.8594267642584574
MDA-MB-157,52947716,2.709287320485668,1.8594267642584574
HSC-4,46224516,3.389129888163455,1.8594267642584574
NCI-H146,400769,-1.4971487301951925,1.8594267642584574
LOU-NH91,387447,-3.4249375140388247,1.8594267642584574
CA46,6610216,4.017162804005507,1.8594267642584574
LoVo,375860,-0.1162329718395109,1.8594267642584574
FU-OV-1,9911830,2.8434321082933773,1.8594267642584574
LoVo,9840324,5.061772266378942,1.8594267642584574
MSTO-211H,56649450,2.845391743702004,1.8594267642584574
HSC-4,9935249,3.700870290975298,1.8594267642584574
BT-549,44486219,4.179253703467884,1.8594267642584574
SNU-449,24901704,3.9093934632949616,1.8594267642584574
FTC-133,44589607,3.1305768616958085,1.8594267642584574
LOU-NH91,42642645,0.5799169530603235,1.8594267642584574
KYSE-70,51037431,6.2873914521382765,1.8594267642584574
KMRC-1,1566236,3.0378094444517645,1.8594267642584574
Panc 04.03,42642645,1.6619965718360328,1.8594267642584574
CAL-51,3689413,0.5709426612715743,1.8594267642584574
NCI-H522,44487872,5.4176039717063915,1.8594267642584574
NCI-H2009,16722836,0.9347693241342916,1.8594267642584574
NCI-H522,11222830,1.4433136379668847,1.8594267642584574
CA46,72193861,0.1338517787347367,1.8594267642584574
NCI-H146,sirolimus-bortezomib (250-1 mol-mol),-0.0099585964665403,1.8594267642584574
LoVo,119607,4.4096130331744865,1.8594267642584574
MDA-MB-453,1566236,2.5975650319928434,1.8594267642584574
ONS-76,11152667,-0.1692604119623072,1.8594267642584574
G-401,24748573,1.6686206591324024,1.8594267642584574
A2780,176870,3.0464675702719655,1.8594267642584574
NCI-H727,vorinostat-navitoclax (4-1 mol-mol),3.0192408076128823,1.8594267642584574
OPM-2,3385,3.5898560550490837,1.8594267642584574
NCI-H460,doxorubicin-navitoclax (2-1 mol-mol),-0.1987090661532434,1.8594267642584574
NOMO-1,53495165,-0.0338576092201104,1.8594267642584574
LoVo,46191454,2.275591949439888,1.8594267642584574
A4/Fukuda,4096211,1.2598455852625392,1.8594267642584574
NCI-H522,25126798,3.91575296607237,1.8594267642584574
FU-OV-1,135411,0.8541212220651947,1.8594267642584574
KYSE-70,10113978,1.960067513789881,1.8594267642584574
FU-OV-1,24856436,0.8416503079264269,1.8594267642584574
A-498,10026128,4.231838396167064,1.8594267642584574
JM-1,11626560,-0.1801568688824005,1.8594267642584574
NCI-H460,9911830,3.1326305509826824,1.8594267642584574
A-673,9911830,1.9751375507094395,1.8594267642584574
Panc 04.03,71751553,4.683117627568525,1.8594267642584574
LXF 289,6450551,1.9915066986525345,1.8594267642584574
NCI-H522,156414,0.937566519659893,1.8594267642584574
MDA-MB-453,6610355,3.820285868995436,1.8594267642584574
FU-OV-1,46843906,0.6915308493256752,1.8594267642584574
NCI-H522,42642645,1.4297074042386375,1.8594267642584574
SCC-9,4917,3.683292695011318,1.8594267642584574
NCI-H460,navitoclax-MST-312 (1-1 mol-mol),2.434638176735655,1.8594267642584574
SBC-5,54649381,4.189343649803657,1.8594267642584574
NCI-H1623,6918837,-3.3974396350468674,1.8594267642584574
KMRC-1,10184653,1.755388017214173,1.8594267642584574
LXF 289,9967941,3.6599941581067057,1.8594267642584574
FTC-133,57519531,1.7209799050566308,1.8594267642584574
NCI-H661,19582717,3.3132894226769056,1.8594267642584574
MSTO-211H,selumetinib-PLX-4032 (8-1 mol-mol),2.4533429181840307,1.8594267642584574
LoVo,71466578,1.8530080227063717,1.8594267642584574
NCI-H2009,46907787,0.5680124512944033,1.8594267642584574
DMS 273,49793307,-3.720971975288363,1.8594267642584574
NCI-H522,135659046,3.4944475458884012,1.8594267642584574
FTC-133,5351362,2.946320615286136,1.8594267642584574
JM-1,208908,1.8689748302954872,1.8594267642584574
Panc 04.03,216239,3.3806837686851923,1.8594267642584574
NOMO-1,71466445,1.8310961714544176,1.8594267642584574
NCI-H522,71680916,3.6078643166976896,1.8594267642584574
EFO-27,2126,5.846579140474247,1.8594267642584574
ONS-76,5284616,3.539643222518188,1.8594267642584574
SCC-9,16736978,3.1048488109971664,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],46926350,-4.0983765968922485,1.8594267642584574
A4/Fukuda,23582824,-0.7377224087572002,1.8594267642584574
NCI-H661,53325874,4.390083123893945,1.8594267642584574
SNU-61,4096211,1.05462843518756,1.8594267642584574
CAL-51,675434,4.354107922133551,1.8594267642584574
NOMO-1,11175137,1.3676050257567425,1.8594267642584574
NCI-H2171,5335621,4.282845813975702,1.8594267642584574
SNU-449,11647372,1.9881649315547345,1.8594267642584574
NCI-H522,3503,2.0960599148243557,1.8594267642584574
NCI-H2171,52947716,1.4567314464455066,1.8594267642584574
NOMO-1,5291,3.5817896511091862,1.8594267642584574
NCI-H522,46843906,2.3044802452603967,1.8594267642584574
OPM-2,11494412,0.3054873199299708,1.8594267642584574
A-673,53495165,-1.305348317827654,1.8594267642584574
KYSE-70,54618771,1.1170424016733127,1.8594267642584574
CAL-51,vorinostat-carboplatin (1-1 mol-mol),3.249812174722343,1.8594267642584574
SCC-9,3062316,1.318086870144001,1.8594267642584574
LoVo,387447,-3.727342469020989,1.8594267642584574
MSTO-211H,73707386,2.8647689708389943,1.8594267642584574
FTC-133,54613361,1.5430217136639572,1.8594267642584574
SNU-61,12001922,2.043150446887516,1.8594267642584574
DMS 273,374536,2.442253811681885,1.8594267642584574
LXF 289,10302451,1.735451917587997,1.8594267642584574
CAL-51,2858523,3.1959449804225524,1.8594267642584574
Panc 04.03,23582824,1.118403221753994,1.8594267642584574
KMRC-1,6505803,1.455434702084088,1.8594267642584574
CAL-51,4261,2.4552246887350417,1.8594267642584574
SCC-9,5746,1.774962232755205,1.8594267642584574
NCI-H661,71466578,3.739107690689307,1.8594267642584574
ONS-76,54619267,4.0364090976663,1.8594267642584574
NCI-H522,100016,6.692385014202011,1.8594267642584574
G-401,11719255,3.853695059500007,1.8594267642584574
HSC-4,3815108,3.178044313970192,1.8594267642584574
NCI-H2171,5287620,-0.0573950216422359,1.8594267642584574
A4/Fukuda,5311,-0.1264358008137528,1.8594267642584574
NCI-H292,387447,-4.003442188855186,1.8594267642584574
OPM-2,148124,-6.3849256320012575,1.8594267642584574
MDA-MB-453,alisertib-navitoclax (2-1 mol-mol),3.3277558601146215,1.8594267642584574
DMS 273,salermide-PLX-4032 (12-1 mol-mol),5.306834954267239,1.8594267642584574
CA46,9967941,3.699441503938977,1.8594267642584574
SNU-61,JQ-1-navitoclax (2-1 mol-mol),0.8164075639499123,1.8594267642584574
LXF 289,387447,-4.093727880786265,1.8594267642584574
CAL-51,5113032,4.55807021159329,1.8594267642584574
NCI-H727,serdemetan-SCH-529074 (1-1 mol-mol),2.331809225876462,1.8594267642584574
OPM-2,241158,1.7102591321182437,1.8594267642584574
ONS-76,16741245,1.9308546797770672,1.8594267642584574
Panc 04.03,322968,5.075488138121087,1.8594267642584574
BT-549,135875424,3.804392758634582,1.8594267642584574
A-673,54626689,4.6393725921997415,1.8594267642584574
SNU-449,navitoclax-birinapant (1-1 mol-mol),3.571225842715355,1.8594267642584574
HCC1143,3543504,4.280043771428645,1.8594267642584574
BxPC-3,107970,2.2592769610294448,1.8594267642584574
ONS-76,51037431,1.0002101292366832,1.8594267642584574
G-401,24785538,-1.0602782345595374,1.8594267642584574
MDA-MB-453,SNX-2112-bortezomib (250-1 mol-mol),-2.8558068979293383,1.8594267642584574
FTC-133,676352,3.9949531967924297,1.8594267642584574
NOMO-1,53232,3.2414615649348772,1.8594267642584574
LoVo,11625818,2.0848313295223844,1.8594267642584574
A4/Fukuda,702558,5.147225783500614,1.8594267642584574
NOMO-1,11455910,0.2303469505827257,1.8594267642584574
SNU-81,4096211,1.97800800333133,1.8594267642584574
NCI-H522,676352,1.6559488811299496,1.8594267642584574
YAPC,60750,-4.781219880342373,1.8594267642584574
Panc 04.03,11612883,3.751429287253437,1.8594267642584574
NCI-H661,67156097,-3.370555704228358,1.8594267642584574
SNU-449,4705,3.898593282840832,1.8594267642584574
MDA-MB-157,9952709,2.6586157499418444,1.8594267642584574
NCI-H522,16038120,0.9671280612186928,1.8594267642584574
A4/Fukuda,4259181,-0.5702867723998835,1.8594267642584574
LoVo,135398744,6.330186357549225,1.8594267642584574
OPM-2,637858,0.8070227403937857,1.8594267642584574
SCC-9,3038522,1.9571402343301385,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],navitoclax-gemcitabine (1-1 mol-mol),1.5505113720092498,1.8594267642584574
A4/Fukuda,10127622,0.8035335483112384,1.8594267642584574
Panc 04.03,4378219,5.53220646065493,1.8594267642584574
EFO-27,JQ-1-vorinostat (2-1 mol-mol),1.2489296683546294,1.8594267642584574
LOU-NH91,navitoclax-piperlongumine (1-1 mol-mol),-1.482580438049138,1.8594267642584574
EFO-27,11396600,3.826824277303455,1.8594267642584574
LoVo,JQ-1-MK-0752 (1-1 mol-mol),1.4055408884057283,1.8594267642584574
NCI-H2171,7251185,0.8673768610035957,1.8594267642584574
NCI-H1623,5311281,4.903104817913162,1.8594267642584574
OPM-2,11317348,2.0151792351474755,1.8594267642584574
OPM-2,100016,3.804278037815123,1.8594267642584574
LoVo,46224516,4.94892102130723,1.8594267642584574
A4/Fukuda,9826308,-1.4955537783248567,1.8594267642584574
LoVo,15547703,1.4569683263207862,1.8594267642584574
LoVo,227681,3.064150517180394,1.8594267642584574
NCI-H727,5460769,4.510942150258337,1.8594267642584574
NCI-H292,6918837,-2.538558148903755,1.8594267642584574
A2780,132971,2.947129832610188,1.8594267642584574
FTC-133,4788,5.605324981437421,1.8594267642584574
A-498,selumetinib-decitabine (4-1 mol-mol),2.586259947527723,1.8594267642584574
A-498,23582824,2.0595934555669886,1.8594267642584574
SNU-61,8515,5.6731171982359365,1.8594267642584574
MDA-MB-453,23582824,0.0198148722876335,1.8594267642584574
DMS 273,5329102,2.038563375095403,1.8594267642584574
NCI-H460,72193861,2.1658883750752844,1.8594267642584574
MDA-MB-157,6610355,3.680589360872168,1.8594267642584574
Panc 04.03,56649450,4.182465283011193,1.8594267642584574
NCI-H727,124202324,2.79148434895864,1.8594267642584574
MSTO-211H,24772860,-3.3585393605141824,1.8594267642584574
ONS-76,selumetinib-GDC-0941 (4-1 mol-mol),-1.205136839893776,1.8594267642584574
CAL-51,20959075,-3.1196535578382987,1.8594267642584574
OPM-2,322968,0.7466819505545055,1.8594267642584574
CA46,984333,-2.431082434536014,1.8594267642584574
JM-1,1242560,2.356943306915098,1.8594267642584574
NOMO-1,25126798,3.9519848152055848,1.8594267642584574
MDA-MB-453,5738263,2.9414099779046934,1.8594267642584574
OVISE,10074640,3.3556303567674064,1.8594267642584574
SNU-81,JQ-1-MK-0752 (1-1 mol-mol),4.555770786077887,1.8594267642584574
MSTO-211H,159324,-0.971759723426381,1.8594267642584574
Panc 04.03,46191454,2.0071895522726377,1.8594267642584574
SBC-5,9826308,0.1778598819423294,1.8594267642584574
BxPC-3,1641662,3.0109567862503654,1.8594267642584574
NCI-H460,2708,4.613368759945332,1.8594267642584574
MDA-MB-453,2746,1.6853152695376463,1.8594267642584574
NCI-H292,2858523,3.0406792249868633,1.8594267642584574
LoVo,52912189,0.3784309245329977,1.8594267642584574
BxPC-3,navitoclax-gemcitabine (1-1 mol-mol),-2.057283602704844,1.8594267642584574
NCI-H460,9936388,2.3098343611543415,1.8594267642584574
A4/Fukuda,176870,1.9874765150136215,1.8594267642584574
LOU-NH91,49793307,0.2442451207819767,1.8594267642584574
MDA-MB-453,2945648,2.145365576847094,1.8594267642584574
SNU-449,54596490,5.440438718305218,1.8594267642584574
NCI-H2171,9927531,3.1501077196413783,1.8594267642584574
CAL-51,25150857,2.2346870378683934,1.8594267642584574
YAPC,navitoclax-sorafenib (1-1 mol-mol),5.55182899322967,1.8594267642584574
NCI-H727,9444,4.415864627267573,1.8594267642584574
CA46,71466578,1.7711352492213497,1.8594267642584574
CAL-51,selumetinib-UNC0638 (4-1 mol-mol),4.646662024517227,1.8594267642584574
G-401,11507802,0.4930201538787991,1.8594267642584574
OVISE,11214940,-0.1911189695405239,1.8594267642584574
MDA-MB-453,135999136,4.2113637134750395,1.8594267642584574
CA46,445455,4.357290874085763,1.8594267642584574
KMRC-1,5335621,6.052276706579308,1.8594267642584574
Panc 04.03,36462,3.526332093717117,1.8594267642584574
SBC-5,56963564,-0.838635946263744,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],107970,2.147130016699997,1.8594267642584574
NCI-H727,46224516,2.477743379244975,1.8594267642584574
NCI-H292,11222830,1.205012148013641,1.8594267642584574
MDA-MB-453,24771867,4.091824937074987,1.8594267642584574
NCI-H460,72376,-0.5460239014371263,1.8594267642584574
SBC-5,selumetinib-GDC-0941 (4-1 mol-mol),2.377221196755023,1.8594267642584574
LXF 289,9911830,2.045852319971143,1.8594267642584574
LoVo,1242560,3.2639930925900305,1.8594267642584574
NCI-H292,6918736,3.734181331597608,1.8594267642584574
G-401,11717001,3.7897150646045863,1.8594267642584574
ONS-76,46398810,2.9642978938134004,1.8594267642584574
NCI-H522,1242560,4.210520049105227,1.8594267642584574
EFO-27,3081361,2.362036241237279,1.8594267642584574
SBC-5,11222830,1.4112085967579189,1.8594267642584574
CAL-51,serdemetan-SCH-529074 (1-1 mol-mol),1.9102886426753127,1.8594267642584574
CA46,11213558,2.4131379110887496,1.8594267642584574
FU-OV-1,6918837,-4.1157354170673495,1.8594267642584574
A4/Fukuda,56946209,-6.395954164738885,1.8594267642584574
NCI-H2171,tanespimycin-gemcitabine (1-1 mol-mol),-2.6967474652224745,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],JQ-1-vorinostat (2-1 mol-mol),0.912398125341492,1.8594267642584574
OVISE,vorinostat-navitoclax (4-1 mol-mol),1.48951856204489,1.8594267642584574
MDA-MB-453,navitoclax-birinapant (1-1 mol-mol),3.002333269444996,1.8594267642584574
A4/Fukuda,216239,1.5760740052804734,1.8594267642584574
FTC-133,4578,5.173307644971936,1.8594267642584574
NCI-H146,selumetinib-JQ-1 (4-1 mol-mol),0.7874306910270304,1.8594267642584574
NCI-H460,54618164,4.49670945938676,1.8594267642584574
CAL-51,42642645,0.4324607401831485,1.8594267642584574
BxPC-3,24771867,1.9124988819938955,1.8594267642584574
LXF 289,JQ-1-MK-0752 (1-1 mol-mol),0.1352273684724335,1.8594267642584574
NCI-H460,15953870,5.00315267734786,1.8594267642584574
A2780,24964624,-0.4628922796959323,1.8594267642584574
CAL-51,654092,0.82886283906252,1.8594267642584574
G-401,5281321,-2.57337969869382,1.8594267642584574
MDA-MB-157,3634881,2.7842407118999852,1.8594267642584574
MDA-MB-453,42642645,1.5292302084545462,1.8594267642584574
BT-549,54618164,4.423974096662665,1.8594267642584574
A4/Fukuda,16741245,4.963846947143099,1.8594267642584574
BxPC-3,44632017,0.4026385498906549,1.8594267642584574
ONS-76,9911830,2.941904202808556,1.8594267642584574
NCI-H146,navitoclax-birinapant (1-1 mol-mol),-2.693365824422348,1.8594267642584574
ONS-76,4477,-0.2351585842599584,1.8594267642584574
JM-1,44493528,3.997956862382446,1.8594267642584574
NCI-H146,5702613,3.149923076768629,1.8594267642584574
NOMO-1,25150857,2.063048355345986,1.8594267642584574
LoVo,24856436,-0.7244956111709783,1.8594267642584574
OPM-2,53481919,3.0492738202957206,1.8594267642584574
BxPC-3,44507138,1.658490789748868,1.8594267642584574
FU-OV-1,2113511,4.466585490981426,1.8594267642584574
NCI-H661,2749,0.7713739826565964,1.8594267642584574
NCI-H1623,53495165,-0.5563852526996439,1.8594267642584574
NCI-H522,6610216,4.154510920860766,1.8594267642584574
BxPC-3,148198,-2.171424706341701,1.8594267642584574
MSTO-211H,4788,5.119342350142264,1.8594267642584574
A-498,1750826,-1.7479882416802337,1.8594267642584574
HSC-4,136227924,4.2199200707906845,1.8594267642584574
Panc 04.03,selumetinib-UNC0638 (4-1 mol-mol),4.963542223842957,1.8594267642584574
LoVo,54618771,0.7060685526757626,1.8594267642584574
DMS 273,10322450,3.6367733537116167,1.8594267642584574
ONS-76,1750826,-1.6505794475434372,1.8594267642584574
MDA-MB-157,135440466,3.174924928897617,1.8594267642584574
NCI-H727,241158,6.115461447477091,1.8594267642584574
HCC1143,46398810,2.1694021244377333,1.8594267642584574
A4/Fukuda,decitabine-carboplatin (1-1 mol-mol),0.1179398036962416,1.8594267642584574
SNU-449,3062316,-1.3612378425924234,1.8594267642584574
SNU-449,11977753,-2.005546044599541,1.8594267642584574
JM-1,24771867,-4.48997165682624,1.8594267642584574
NCI-H2009,11507802,1.1556617167312242,1.8594267642584574
HSC-4,11964036,1.64347500999081,1.8594267642584574
Panc 04.03,5479543,4.112837907412102,1.8594267642584574
ONS-76,439501,-2.2755976390662163,1.8594267642584574
JM-1,54639126,4.392955654749798,1.8594267642584574
CA46,11167602,1.6890466560929325,1.8594267642584574
CA46,135411,0.0331424760277949,1.8594267642584574
MDA-MB-453,tretinoin-navitoclax (4-1 mol-mol),3.844804044479517,1.8594267642584574
Panc 04.03,11625818,5.081289492721679,1.8594267642584574
NCI-H292,12001922,1.805770236255338,1.8594267642584574
NCI-H460,crizotinib-PLX-4032 (2-1 mol-mol),2.8016371489501593,1.8594267642584574
MDA-MB-453,5278396,3.602107220771141,1.8594267642584574
NCI-H522,6438330,2.681865372615506,1.8594267642584574
A-673,71466445,2.638210082463498,1.8594267642584574
MDA-MB-453,25105715,3.2581724710849778,1.8594267642584574
A2780,17759555,2.3500586644289165,1.8594267642584574
YAPC,124202324,3.68667481758741,1.8594267642584574
NCI-H522,25227462,-0.4562280137645088,1.8594267642584574
KYSE-70,10074640,3.109810551584267,1.8594267642584574
HCC1143,5278396,2.995823973274505,1.8594267642584574
HSC-4,5479543,4.052409111099337,1.8594267642584574
NCI-H661,446155,0.1985182541705634,1.8594267642584574
YAPC,53495165,-1.0203233667221312,1.8594267642584574
FU-OV-1,11719255,3.4823701199113097,1.8594267642584574
NCI-H2171,5278396,3.2627520221828115,1.8594267642584574
MDA-MB-157,9911830,0.0801478348660684,1.8594267642584574
OPM-2,9911463,3.091122447781221,1.8594267642584574
LoVo,25126798,3.7423562181337338,1.8594267642584574
EFO-27,9911463,4.361076045114702,1.8594267642584574
HSC-4,docetaxel-tanespimycin (2-1 mol-mol),1.367923691324148,1.8594267642584574
A2780,5280436,2.9198027340920434,1.8594267642584574
SCC-9,5311037,3.6943722712183007,1.8594267642584574
ONS-76,5978,-2.168221630618191,1.8594267642584574
A-673,44819697,-3.745571155852308,1.8594267642584574
CA46,24785538,1.2011715151517115,1.8594267642584574
HSC-4,9936388,2.361545024779824,1.8594267642584574
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591,1.8594267642584574
NCI-H460,49793307,0.4479933662320887,1.8594267642584574
A2780,64971,1.607646338152048,1.8594267642584574
JM-1,72193861,0.5763432020354632,1.8594267642584574
NOMO-1,11625818,1.7683333213472852,1.8594267642584574
NCI-H522,navitoclax-PLX-4032 (1-1 mol-mol),3.539669986895116,1.8594267642584574
MSTO-211H,11507802,-2.113337212450165,1.8594267642584574
NCI-H661,53232,0.4849867031297817,1.8594267642584574
YAPC,16720766,-1.1916244870670316,1.8594267642584574
NCI-H522,208908,1.8410391152152548,1.8594267642584574
MDA-MB-157,5284616,2.798393493195082,1.8594267642584574
MSTO-211H,6505803,-0.0669493563910609,1.8594267642584574
NOMO-1,56649450,3.0749194455734012,1.8594267642584574
NCI-H727,9967941,3.73486297967426,1.8594267642584574
SW1463,15547703,3.1824451623977312,1.8594267642584574
FTC-133,24951314,1.987520160616717,1.8594267642584574
MDA-MB-157,24772860,-2.2599749907314175,1.8594267642584574
G-401,2749,1.3663456978729704,1.8594267642584574
BT-549,16065773,1.5788570773866877,1.8594267642584574
OPM-2,11955716,-2.9191891869850015,1.8594267642584574
NCI-H661,176870,2.3474624932942207,1.8594267642584574
NCI-H292,66577038,2.9683700205355765,1.8594267642584574
MSTO-211H,54143018,-0.309857947329572,1.8594267642584574
OPM-2,3634881,2.0291765129520467,1.8594267642584574
LOU-NH91,navitoclax-birinapant (1-1 mol-mol),-1.5910791983061243,1.8594267642584574
A-498,44607531,1.7098722083353044,1.8594267642584574
KMRC-1,2749,2.412459730094544,1.8594267642584574
NCI-H292,57519531,1.7489075965122454,1.8594267642584574
NCI-H727,11404337,0.8145711342672778,1.8594267642584574
CA46,salermide-PLX-4032 (12-1 mol-mol),5.07380877764379,1.8594267642584574
SNU-81,107985,-4.076050447844214,1.8594267642584574
SNU-61,24785538,1.5668080683488936,1.8594267642584574
SNU-449,56946209,-2.472995255165521,1.8594267642584574
KYSE-70,452548,2.3575041584151637,1.8594267642584574
BxPC-3,5280436,3.644569175052812,1.8594267642584574
JM-1,409805,3.649428990507172,1.8594267642584574
SNU-81,17755052,-1.02795410661762,1.8594267642584574
DMS 273,SNX-2112-bortezomib (250-1 mol-mol),0.148208176798338,1.8594267642584574
MSTO-211H,BRD-K27188169-navitoclax (2-1 mol-mol),1.2533198226261906,1.8594267642584574
G-401,54618771,0.8582285882331511,1.8594267642584574
LoVo,4788,4.577300245187766,1.8594267642584574
A2780,24771867,-2.9740519428749055,1.8594267642584574
NCI-H292,4261,1.3935441456482582,1.8594267642584574
SCC-9,vorinostat-navitoclax (4-1 mol-mol),1.1894462341904075,1.8594267642584574
NCI-H522,2729026,3.0595997973682043,1.8594267642584574
MSTO-211H,448949,1.6774063902575909,1.8594267642584574
BxPC-3,9825149,2.348819386499172,1.8594267642584574
NCI-H522,44607531,1.4505766804532754,1.8594267642584574
NCI-H292,ISOX-bortezomib (250-1 mol-mol),0.5542499080925709,1.8594267642584574
A-498,1285940,4.242355519484504,1.8594267642584574
BT-549,selumetinib-BRD-A02303741 (4-1 mol-mol),5.411757040622344,1.8594267642584574
NCI-H661,44543605,4.030509034099432,1.8594267642584574
CAL-51,12003241,-1.2189714227076325,1.8594267642584574
A4/Fukuda,135411,0.1560078623072997,1.8594267642584574
HCC1143,675434,4.285446752444937,1.8594267642584574
CA46,11719255,3.04595311036835,1.8594267642584574
BxPC-3,654092,-0.3546902897816355,1.8594267642584574
NCI-H292,11238147,1.7384499640365698,1.8594267642584574
LoVo,285033,-2.045623665035502,1.8594267642584574
NCI-H1623,136227924,2.959018127447204,1.8594267642584574
OPM-2,5329102,0.9197947820907424,1.8594267642584574
OPM-2,208908,1.37961789198716,1.8594267642584574
MSTO-211H,124202324,2.766151060695559,1.8594267642584574
LOU-NH91,piperlongumine-MST-312 (1-1 mol-mol),1.9465172211690425,1.8594267642584574
SBC-5,selumetinib-piperlongumine (8-1 mol-mol),5.086049517752745,1.8594267642584574
SNU-81,55508,3.0035688840672767,1.8594267642584574
CAL-51,JQ-1-navitoclax (2-1 mol-mol),3.0806992030623053,1.8594267642584574
A-498,24821094,3.8657770123239574,1.8594267642584574
DMS 273,6918736,-3.620580414510608,1.8594267642584574
JM-1,3062316,-0.5573937765637444,1.8594267642584574
JM-1,56649450,3.7062904943567263,1.8594267642584574
SBC-5,24856436,0.2896075356546521,1.8594267642584574
BT-549,285033,-1.3520552126123144,1.8594267642584574
OPM-2,5746,0.8583790934138843,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],135398738,5.665186147666449,1.8594267642584574
G-401,6914657,-5.660532663542792,1.8594267642584574
NCI-H460,navitoclax-gemcitabine (1-1 mol-mol),-0.7753344502406821,1.8594267642584574
HSC-4,2858523,3.1192513569149245,1.8594267642584574
NCI-H522,675434,4.236381328267226,1.8594267642584574
CAL-51,25183872,-0.1080661998677032,1.8594267642584574
BT-549,4259181,2.4625999028961743,1.8594267642584574
NCI-H522,11455910,0.4156799864056491,1.8594267642584574
A4/Fukuda,decitabine-navitoclax (2-1 mol-mol),-0.552282956789893,1.8594267642584574
EFO-27,JQ-1-UNC0638 (2-1 mol-mol),3.1988831496339536,1.8594267642584574
NCI-H460,3543504,4.388423548450019,1.8594267642584574
LOU-NH91,11626560,1.802766880846386,1.8594267642584574
NCI-H522,2871966,1.782445654343025,1.8594267642584574
G-401,135440466,1.822823734742602,1.8594267642584574
A-673,10172275,4.325815901444083,1.8594267642584574
LoVo,3385,1.4948122184820352,1.8594267642584574
OVISE,BRD-K27188169-navitoclax (2-1 mol-mol),1.3102218056663513,1.8594267642584574
SNU-61,tanespimycin-bortezomib (250-1 mol-mol),-0.3977146693406259,1.8594267642584574
A-673,637858,0.7164978632133837,1.8594267642584574
OPM-2,4915,5.457147549775398,1.8594267642584574
CAL-51,11626560,0.7349282975065881,1.8594267642584574
NCI-H661,2729026,2.3445725854556696,1.8594267642584574
KMRC-1,25126798,3.86147373401716,1.8594267642584574
KMRC-1,107970,3.035071998795665,1.8594267642584574
MDA-MB-157,16219061,1.3123257474603047,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],44202524,4.374181896011121,1.8594267642584574
NCI-H292,erlotinib-PLX-4032 (2-1 mol-mol),3.1994790670479,1.8594267642584574
NCI-H2009,24964624,2.271229049936602,1.8594267642584574
NCI-H522,7251185,1.2190943442977031,1.8594267642584574
CAL-51,carboplatin-UNC0638 (2-1 mol-mol),3.3460163341878726,1.8594267642584574
G-401,52912189,0.0594470173160698,1.8594267642584574
OPM-2,vorinostat-carboplatin (1-1 mol-mol),1.8335119611994213,1.8594267642584574
OVISE,702558,5.699669356311473,1.8594267642584574
BxPC-3,selumetinib-navitoclax (8-1 mol-mol),-0.6113329982147029,1.8594267642584574
EFO-27,54678924,2.818156902929417,1.8594267642584574
LOU-NH91,44607530,2.1348137775706646,1.8594267642584574
EFO-27,24180125,3.663788732934096,1.8594267642584574
NCI-H661,135421197,1.0600684669241136,1.8594267642584574
MDA-MB-157,56963564,-0.5852778857487072,1.8594267642584574
OVISE,navitoclax-pluripotin (1-1 mol-mol),-0.9390281108513666,1.8594267642584574
LXF 289,6505803,-2.367756082461904,1.8594267642584574
SCC-9,navitoclax-gemcitabine (1-1 mol-mol),1.7873613384947808,1.8594267642584574
A-673,5278396,3.572368012209165,1.8594267642584574
MDA-MB-453,135421197,0.8806711164351635,1.8594267642584574
NCI-H661,11396600,4.301216087095742,1.8594267642584574
G-401,148124,-6.018913106580182,1.8594267642584574
NCI-H661,selumetinib-vorinostat (8-1 mol-mol),2.6116020455446884,1.8594267642584574
SNU-61,208908,2.000237947522829,1.8594267642584574
NCI-H661,5329102,2.676948448482624,1.8594267642584574
NCI-H146,148124,-0.9007997951548676,1.8594267642584574
HSC-4,446155,4.1145986724492865,1.8594267642584574
NCI-H661,3825829,3.711058317012711,1.8594267642584574
OPM-2,135411,1.0006691045824918,1.8594267642584574
CAL-51,3815108,3.0623029951861396,1.8594267642584574
NCI-H522,2858523,2.9817407099898676,1.8594267642584574
YAPC,2708,5.2324194580289065,1.8594267642584574
Panc 04.03,4917,3.7974030923782274,1.8594267642584574
KMRC-1,51039095,3.0507646213845008,1.8594267642584574
MDA-MB-157,44632017,-0.0621812067979977,1.8594267642584574
KYSE-70,613753,3.646356391333843,1.8594267642584574
OPM-2,11364421,-7.162542415885671,1.8594267642584574
KYSE-70,11964036,0.6479741930424838,1.8594267642584574
EFO-27,9915743,1.432055126276498,1.8594267642584574
LoVo,selumetinib-piperlongumine (8-1 mol-mol),1.883455735434258,1.8594267642584574
A2780,9935249,1.4583070792637778,1.8594267642584574
NCI-H292,25105715,3.507158893285561,1.8594267642584574
JM-1,5566,2.903571956440186,1.8594267642584574
NCI-H460,16722836,2.818869820371906,1.8594267642584574
MDA-MB-453,71466380,3.4268898477848784,1.8594267642584574
MSTO-211H,24753719,3.2448003358152286,1.8594267642584574
JM-1,637858,0.5231851777275447,1.8594267642584574
MDA-MB-453,11152667,-1.4808178636693017,1.8594267642584574
HCC1143,44185566,2.5224843451498273,1.8594267642584574
SBC-5,53481919,4.872311947173971,1.8594267642584574
LXF 289,crizotinib-PLX-4032 (2-1 mol-mol),1.666725560868834,1.8594267642584574
LoVo,3038522,4.270533501697307,1.8594267642584574
OPM-2,5280436,1.5288125622159816,1.8594267642584574
A-673,71680916,4.0499723530429295,1.8594267642584574
LOU-NH91,6610355,5.077923698507978,1.8594267642584574
SW1463,10127622,-0.1211197806374188,1.8594267642584574
ONS-76,2126,3.999900921085769,1.8594267642584574
NCI-H522,53301938,4.938312106360689,1.8594267642584574
NCI-H2171,3552672,1.63504499488054,1.8594267642584574
SNU-449,375860,2.655390537146391,1.8594267642584574
MDA-MB-157,54626689,4.568687551235484,1.8594267642584574
KMRC-1,5746,2.0919022066371484,1.8594267642584574
CAL-51,24964624,1.6704816041215405,1.8594267642584574
EFO-27,46199207,3.7203826311454096,1.8594267642584574
A2780,439501,-2.4090624878410316,1.8594267642584574
LoVo,89183176,4.107889784939482,1.8594267642584574
NCI-H661,24772860,-4.399665014096174,1.8594267642584574
NOMO-1,46224516,2.27353152393119,1.8594267642584574
NCI-H460,5281672,4.99885948312363,1.8594267642584574
NCI-H2171,selumetinib-GDC-0941 (4-1 mol-mol),2.15287144597935,1.8594267642584574
OVISE,navitoclax-birinapant (1-1 mol-mol),0.2692297316447783,1.8594267642584574
NCI-H460,9967941,4.030885542149613,1.8594267642584574
NCI-H292,44819697,-0.5623825720804246,1.8594267642584574
OPM-2,216468,0.7655721379939343,1.8594267642584574
ONS-76,60700,0.0915142349819345,1.8594267642584574
YAPC,17755052,3.2330221121257874,1.8594267642584574
EFO-27,444795,5.488221670965637,1.8594267642584574
YAPC,24797083,1.6153709299916277,1.8594267642584574
NCI-H661,51039095,3.3700376717556315,1.8594267642584574
MDA-MB-453,25154868,3.2796937080857296,1.8594267642584574
A2780,decitabine-navitoclax (2-1 mol-mol),1.762746087507787,1.8594267642584574
KMRC-1,9911463,4.4126092990485395,1.8594267642584574
NCI-H727,JQ-1-vorinostat (2-1 mol-mol),2.062672486797119,1.8594267642584574
G-401,107970,2.0352708529532824,1.8594267642584574
FU-OV-1,25195348,3.3767609447508846,1.8594267642584574
NCI-H1623,11234052,4.315313421055944,1.8594267642584574
MDA-MB-157,151289,0.3130009139891556,1.8594267642584574
EFO-27,56973724,4.318199286965652,1.8594267642584574
NCI-H460,5328940,3.322075361136407,1.8594267642584574
NCI-H2171,11964036,0.8555185627034467,1.8594267642584574
Panc 04.03,24821094,4.144896314615952,1.8594267642584574
CAL-51,selumetinib-piperlongumine (8-1 mol-mol),4.057759894730394,1.8594267642584574
Panc 04.03,selumetinib-MK-2206 (8-1 mol-mol),2.306008489562984,1.8594267642584574
FTC-133,5280436,3.005172717589714,1.8594267642584574
NCI-H292,49766530,5.348764781206105,1.8594267642584574
NCI-H661,selumetinib-decitabine (4-1 mol-mol),5.0553831746033815,1.8594267642584574
FTC-133,219104,4.114698267906641,1.8594267642584574
A-498,BRD-A02303741-navitoclax (2-1 mol-mol),1.0685247130671895,1.8594267642584574
ONS-76,6918736,-1.0728340962982743,1.8594267642584574
A4/Fukuda,16065773,1.900447949816596,1.8594267642584574
FU-OV-1,25126798,3.715640842708804,1.8594267642584574
NCI-H460,6505803,-0.4074860596498978,1.8594267642584574
ONS-76,44491742,4.314760532803232,1.8594267642584574
MSTO-211H,6914657,-1.9341273237470331,1.8594267642584574
G-401,136227924,2.3105932180874365,1.8594267642584574
Panc 04.03,148198,-3.912302089259141,1.8594267642584574
CAL-51,23725625,3.781531245600544,1.8594267642584574
NCI-H1623,7251185,3.63742147878688,1.8594267642584574
A2780,44589607,1.4452328541597397,1.8594267642584574
A-673,675434,3.949120496105267,1.8594267642584574
KMRC-1,25227462,1.6145893273286742,1.8594267642584574
BxPC-3,selumetinib-BRD-A02303741 (4-1 mol-mol),1.732263513385207,1.8594267642584574
HSC-4,2749,1.8453067540575636,1.8594267642584574
DMS 273,6438330,2.6669951536881182,1.8594267642584574
KMRC-1,44491742,6.09620831621162,1.8594267642584574
MDA-MB-453,3465537,1.8912554302439897,1.8594267642584574
SNU-61,156414,1.6812768260110038,1.8594267642584574
YAPC,11625818,4.8006567630911094,1.8594267642584574
CAL-51,9911463,4.251278022142156,1.8594267642584574
MSTO-211H,68056272,2.8034566103574825,1.8594267642584574
OVISE,9911830,4.830872688345326,1.8594267642584574
MDA-MB-453,6917907,3.1299164846836796,1.8594267642584574
SNU-449,9444,4.238096768887569,1.8594267642584574
SNU-61,3062316,1.255261088163193,1.8594267642584574
A2780,11178236,-3.658526043242797,1.8594267642584574
MSTO-211H,219104,2.9811404214526136,1.8594267642584574
CA46,11364421,-6.636542851208846,1.8594267642584574
NCI-H1623,3689413,0.664737487618683,1.8594267642584574
YAPC,9907093,4.959151627500645,1.8594267642584574
ONS-76,19582717,4.438276624405871,1.8594267642584574
LoVo,446155,3.732759169917468,1.8594267642584574
G-401,5566,2.967754959970698,1.8594267642584574
JM-1,navitoclax-PLX-4032 (1-1 mol-mol),0.5328133860295355,1.8594267642584574
HSC-4,9884685,0.6492053944574516,1.8594267642584574
CA46,4788,4.772802977698259,1.8594267642584574
SBC-5,selumetinib-PLX-4032 (8-1 mol-mol),4.703781138829708,1.8594267642584574
CAL-51,decitabine-navitoclax (2-1 mol-mol),4.2164288882213,1.8594267642584574
Panc 04.03,6918837,-2.8853122799888085,1.8594267642584574
NCI-H460,71466380,4.4879606530616725,1.8594267642584574
CA46,25183872,-1.226882585953409,1.8594267642584574
NCI-H146,12001922,1.0892970499924846,1.8594267642584574
SBC-5,11625818,4.225517908096314,1.8594267642584574
JM-1,vorinostat-navitoclax (4-1 mol-mol),-0.3924776625427159,1.8594267642584574
LoVo,2708,4.2308362163689415,1.8594267642584574
OVISE,72193861,4.281646205908775,1.8594267642584574
NCI-H460,16720766,0.8258921674033131,1.8594267642584574
LoVo,4378219,2.040258922351895,1.8594267642584574
MSTO-211H,24901704,1.657456360567008,1.8594267642584574
A4/Fukuda,4477,0.5783674149898913,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],vorinostat-carboplatin (1-1 mol-mol),3.4124582914647026,1.8594267642584574
CA46,107985,-3.181693098398671,1.8594267642584574
DMS 273,JQ-1-MK-0752 (1-1 mol-mol),0.7328961203568959,1.8594267642584574
EFO-27,19582717,3.374407024388894,1.8594267642584574
NCI-H1623,15953870,1.9962949386047493,1.8594267642584574
FU-OV-1,46199207,3.737847668041784,1.8594267642584574
A2780,11213558,0.737897067491707,1.8594267642584574
NCI-H460,9926054,2.081701465030928,1.8594267642584574
NCI-H460,11404337,1.7201854837770862,1.8594267642584574
NCI-H2171,2749,1.9442537074322577,1.8594267642584574
HSC-4,49846579,1.975916395804951,1.8594267642584574
NCI-H2009,56963564,-0.2763231945711286,1.8594267642584574
Panc 04.03,3825829,5.002168928220905,1.8594267642584574
HSC-4,5738263,3.918173826320675,1.8594267642584574
MDA-MB-157,9926054,2.0716850398098368,1.8594267642584574
OPM-2,50905018,4.056598853615348,1.8594267642584574
BxPC-3,9915743,0.4274244099837221,1.8594267642584574
HSC-4,16725315,4.164866459292326,1.8594267642584574
SCC-9,11175137,3.431057653368815,1.8594267642584574
A-673,BRD-A02303741-carboplatin (1-1 mol-mol),5.048794854025553,1.8594267642584574
NCI-H146,107985,-3.379993708562796,1.8594267642584574
SNU-61,3689413,-2.128463404187725,1.8594267642584574
KMRC-1,9903786,4.024109374851969,1.8594267642584574
JM-1,BRD-A02303741-navitoclax (2-1 mol-mol),0.7492754152668983,1.8594267642584574
SNU-61,73707386,3.625444775073466,1.8594267642584574
ONS-76,11238147,3.0900457426442864,1.8594267642584574
KMRC-1,selumetinib-UNC0638 (4-1 mol-mol),3.730844045001738,1.8594267642584574
SBC-5,JQ-1-vorinostat (2-1 mol-mol),1.350348201689009,1.8594267642584574
MDA-MB-157,piperlongumine-MST-312 (1-1 mol-mol),0.2909221181293618,1.8594267642584574
OPM-2,44607531,0.9426576866563848,1.8594267642584574
BT-549,409805,3.826135579342285,1.8594267642584574
G-401,6505803,-2.085126737120111,1.8594267642584574
ONS-76,9866186,2.0020907987509657,1.8594267642584574
BT-549,1641662,3.5282995747020514,1.8594267642584574
MSTO-211H,3384730,2.0695323326007387,1.8594267642584574
NCI-H292,439501,-2.469830491210978,1.8594267642584574
NCI-H2009,11964036,0.3874991337590915,1.8594267642584574
Panc 04.03,9840324,5.85151623174837,1.8594267642584574
NCI-H522,5311,1.356899837189567,1.8594267642584574
ONS-76,5311,1.4287655491580966,1.8594267642584574
NCI-H146,JQ-1-navitoclax (2-1 mol-mol),-2.878043275810858,1.8594267642584574
EFO-27,24775005,4.127014722833266,1.8594267642584574
NCI-H460,5278396,3.885794996406102,1.8594267642584574
NCI-H2009,23725625,3.8804106674125713,1.8594267642584574
NCI-H146,25102847,3.053262776547781,1.8594267642584574
JM-1,11396600,1.6173586604508372,1.8594267642584574
SBC-5,168312962,-2.5718885882949896,1.8594267642584574
DMS 273,46215462,1.755765775691153,1.8594267642584574
YAPC,107985,-3.02393363080246,1.8594267642584574
KYSE-70,5566,3.0340425256076813,1.8594267642584574
G-401,BRD-A02303741-carboplatin (1-1 mol-mol),4.945197636740216,1.8594267642584574
NCI-H292,selumetinib-GDC-0941 (4-1 mol-mol),-0.4502449233555984,1.8594267642584574
NOMO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2771882035135704,1.8594267642584574
CAL-51,11404337,-1.4033364127444676,1.8594267642584574
A4/Fukuda,25183872,-2.565081518812491,1.8594267642584574
SNU-61,3815108,2.973673139417603,1.8594267642584574
KYSE-70,11507802,1.463595053056406,1.8594267642584574
A2780,10296883,3.5268945611299927,1.8594267642584574
FTC-133,24797083,1.5806228477994335,1.8594267642584574
MDA-MB-157,122327,5.563359607134461,1.8594267642584574
NCI-H2009,ISOX-bortezomib (250-1 mol-mol),0.5557935848602048,1.8594267642584574
NCI-H146,4378219,1.8118272794434884,1.8594267642584574
SNU-81,54143018,-0.9079963072010888,1.8594267642584574
NCI-H2009,49850262,3.4451640543988233,1.8594267642584574
KMRC-1,54143018,1.481383467839363,1.8594267642584574
NCI-H522,11507802,0.900021964921284,1.8594267642584574
A2780,6438330,0.9178294762259074,1.8594267642584574
A-673,selumetinib-piperlongumine (8-1 mol-mol),2.5365769801397,1.8594267642584574
SW1463,82146,3.98984472956996,1.8594267642584574
BxPC-3,135984461,1.8776729747018608,1.8594267642584574
NCI-H2171,56946209,-6.55665845628197,1.8594267642584574
KMRC-1,selumetinib-MK-2206 (8-1 mol-mol),2.4382383240498244,1.8594267642584574
HCC1143,54619267,5.25191473393144,1.8594267642584574
NCI-H2171,46907787,0.7633638606493435,1.8594267642584574
NCI-H1623,216468,3.833399887526913,1.8594267642584574
MDA-MB-453,9803433,3.6839578739817935,1.8594267642584574
SCC-9,11955716,-2.333323067647372,1.8594267642584574
A4/Fukuda,54619267,3.184419267966046,1.8594267642584574
KYSE-70,387447,-2.8804562370412765,1.8594267642584574
FTC-133,135398744,6.510037604259866,1.8594267642584574
CA46,2842253,3.7037662444842696,1.8594267642584574
BT-549,12001922,2.460799936977109,1.8594267642584574
LoVo,107970,2.0597080136849795,1.8594267642584574
CAL-51,BRD-A02303741-carboplatin (1-1 mol-mol),6.00849408957599,1.8594267642584574
CAL-51,3385,3.064238699960593,1.8594267642584574
CAL-51,375860,-0.3577134594482877,1.8594267642584574
OPM-2,3025944,3.8735985412418943,1.8594267642584574
NCI-H522,53325874,4.347038439567835,1.8594267642584574
MSTO-211H,216239,0.7405720543436254,1.8594267642584574
CAL-51,9868037,3.5441777448678615,1.8594267642584574
A-673,49836020,4.096681472773702,1.8594267642584574
SNU-61,erlotinib-PLX-4032 (2-1 mol-mol),3.033607579022277,1.8594267642584574
LoVo,49836020,1.6927786584323,1.8594267642584574
OPM-2,5291,3.3293230980723254,1.8594267642584574
LOU-NH91,9884685,4.047485572984955,1.8594267642584574
HSC-4,36462,0.7755986988683452,1.8594267642584574
SNU-61,46907787,2.0753699666277936,1.8594267642584574
NCI-H522,5951923,5.621144710124551,1.8594267642584574
SBC-5,445091,4.3721050746953845,1.8594267642584574
MSTO-211H,6252,0.7966303392140095,1.8594267642584574
MSTO-211H,6610355,3.5448971464264507,1.8594267642584574
DMS 273,selumetinib-MK-2206 (8-1 mol-mol),1.7350778472906083,1.8594267642584574
CAL-51,15953870,3.220977372988981,1.8594267642584574
NCI-H460,25150857,3.536831166282903,1.8594267642584574
DMS 273,3854666,0.530051590236263,1.8594267642584574
LXF 289,9825149,1.6285560242869113,1.8594267642584574
NCI-H522,67156097,-2.1513446238308656,1.8594267642584574
MSTO-211H,3062316,0.3213577633457804,1.8594267642584574
LXF 289,11485656,2.2610473771175847,1.8594267642584574
BT-549,4477,0.6326595549350394,1.8594267642584574
NCI-H2009,54454,1.843451372115344,1.8594267642584574
SNU-449,16013152,4.866412327860677,1.8594267642584574
SBC-5,16115403,-4.662279180425711,1.8594267642584574
A2780,2842253,3.957240977141399,1.8594267642584574
MSTO-211H,135398516,-0.6247457561994184,1.8594267642584574
NCI-H146,navitoclax-pluripotin (1-1 mol-mol),-2.9432727760472326,1.8594267642584574
YAPC,702558,5.05880400043124,1.8594267642584574
MDA-MB-453,409805,5.496183153122164,1.8594267642584574
G-401,25161177,2.410029759496817,1.8594267642584574
A4/Fukuda,3025944,3.254701794903189,1.8594267642584574
NOMO-1,126941,-2.339513844414448,1.8594267642584574
FU-OV-1,159324,3.7929038817112746,1.8594267642584574
MSTO-211H,2113511,3.4014041807223228,1.8594267642584574
A4/Fukuda,1242560,1.4412010240031818,1.8594267642584574
OPM-2,327653,2.4944005218311984,1.8594267642584574
HCC1143,navitoclax-pluripotin (1-1 mol-mol),0.3469367515592647,1.8594267642584574
KYSE-70,46398810,2.5990171625416916,1.8594267642584574
MSTO-211H,44486219,3.5621328730435216,1.8594267642584574
MDA-MB-453,6450551,2.407686053683273,1.8594267642584574
A4/Fukuda,24180719,2.900503133545593,1.8594267642584574
NCI-H661,selumetinib-GDC-0941 (4-1 mol-mol),1.8607941121872416,1.8594267642584574
A4/Fukuda,11234052,3.83864189929063,1.8594267642584574
ONS-76,10231331,-2.145918525616272,1.8594267642584574
JM-1,11656518,1.5501827619920003,1.8594267642584574
SNU-61,ISOX-bortezomib (250-1 mol-mol),1.4968983788663748,1.8594267642584574
EFO-27,16741245,5.191473652546265,1.8594267642584574
DMS 273,216468,1.1199955960897896,1.8594267642584574
MSTO-211H,3689413,-2.1873545800685865,1.8594267642584574
NCI-H727,10074640,3.0722260002613697,1.8594267642584574
BxPC-3,66577038,2.7392816080167117,1.8594267642584574
OPM-2,44489675,4.196628172603179,1.8594267642584574
A-673,1239801,2.654695998337671,1.8594267642584574
G-401,9444,5.739332402240228,1.8594267642584574
NCI-H661,SNX-2112-bortezomib (250-1 mol-mol),0.017075608398325,1.8594267642584574
KYSE-70,71466380,5.08916461895765,1.8594267642584574
NCI-H460,3025944,5.476008686130055,1.8594267642584574
OPM-2,375860,-0.7230228450862618,1.8594267642584574
G-401,262093,2.911602765721858,1.8594267642584574
OPM-2,12001922,1.1641343868089369,1.8594267642584574
SCC-9,9903786,2.6448761987997917,1.8594267642584574
YAPC,1750826,2.252131937951327,1.8594267642584574
JM-1,9840324,5.823306366003189,1.8594267642584574
SNU-61,4705,2.600761934037586,1.8594267642584574
HCC1143,24821094,3.095995819095247,1.8594267642584574
A-673,JQ-1-vorinostat (2-1 mol-mol),0.4793000681263289,1.8594267642584574
HSC-4,15983966,0.1445652725334258,1.8594267642584574
MDA-MB-157,9887053,3.277628039368057,1.8594267642584574
KYSE-70,969516,2.5944329315988552,1.8594267642584574
CAL-51,135421197,1.6266864976107616,1.8594267642584574
LOU-NH91,11175137,1.9157928307161511,1.8594267642584574
NCI-H661,168313047,3.0111797961595523,1.8594267642584574
Panc 04.03,16659841,4.736684370351261,1.8594267642584574
KYSE-70,16720766,1.38091635176305,1.8594267642584574
SNU-449,BRD-A02303741-navitoclax (2-1 mol-mol),3.897294679895557,1.8594267642584574
NCI-H2009,9911463,4.220122302208283,1.8594267642584574
HCC1143,selumetinib-navitoclax (8-1 mol-mol),3.081871684463836,1.8594267642584574
MDA-MB-157,44491742,3.772080854170876,1.8594267642584574
A-673,216239,1.7434495050319987,1.8594267642584574
MSTO-211H,9967941,1.8027522151796112,1.8594267642584574
YAPC,3815108,3.3369752363492315,1.8594267642584574
MSTO-211H,73707398,0.6990065379334892,1.8594267642584574
NCI-H727,4788,5.448581481072406,1.8594267642584574
A2780,9911830,1.8386970616579583,1.8594267642584574
JM-1,3038522,1.6953465924304043,1.8594267642584574
FTC-133,107985,-2.14591043360211,1.8594267642584574
NCI-H727,3503,3.7902677592538265,1.8594267642584574
ONS-76,selumetinib-navitoclax (8-1 mol-mol),-1.4029292063040089,1.8594267642584574
KMRC-1,24771867,5.5206603877823275,1.8594267642584574
KYSE-70,3634881,3.4536977245329363,1.8594267642584574
SBC-5,119607,3.910029744126627,1.8594267642584574
NCI-H292,serdemetan-SCH-529074 (1-1 mol-mol),2.3213297405207083,1.8594267642584574
Panc 04.03,5329102,2.9853977590279075,1.8594267642584574
SNU-449,selumetinib-JQ-1 (4-1 mol-mol),3.9590560352886457,1.8594267642584574
A2780,9826308,-0.0101157672837292,1.8594267642584574
HSC-4,135440466,2.2202939224472655,1.8594267642584574
NCI-H727,6917907,-5.56846167215282,1.8594267642584574
MDA-MB-157,123631,3.9412563374531864,1.8594267642584574
MSTO-211H,11640390,2.078497045728262,1.8594267642584574
OVISE,54649381,4.33420809644373,1.8594267642584574
MDA-MB-157,9868037,3.2071579521245823,1.8594267642584574
A4/Fukuda,67291369,-0.3870993856905487,1.8594267642584574
A4/Fukuda,10113978,1.900139268592958,1.8594267642584574
KMRC-1,doxorubicin-navitoclax (2-1 mol-mol),-0.3990728174038296,1.8594267642584574
A2780,46199207,2.4758344041689093,1.8594267642584574
NCI-H2009,151289,0.8401149520435854,1.8594267642584574
DMS 273,4477,0.2378478748071137,1.8594267642584574
HCC1143,6852167,2.667487538311212,1.8594267642584574
NCI-H460,5335621,5.645903220513178,1.8594267642584574
NCI-H460,54613361,2.8642714411834502,1.8594267642584574
A2780,6852167,1.374383856311773,1.8594267642584574
SCC-9,11707110,2.5707994933885736,1.8594267642584574
LXF 289,piperlongumine-MST-312 (1-1 mol-mol),1.396630605927831,1.8594267642584574
MDA-MB-453,BRD9876-MK-1775 (4-1 mol-mol),0.1986827293321165,1.8594267642584574
EFO-27,6610355,3.735872349212987,1.8594267642584574
ONS-76,navitoclax-piperlongumine (1-1 mol-mol),2.7557969357291476,1.8594267642584574
OPM-2,16038120,-1.581922980476964,1.8594267642584574
KYSE-70,serdemetan-SCH-529074 (1-1 mol-mol),2.076858890087622,1.8594267642584574
HCC1143,10410894,4.771687149558392,1.8594267642584574
YAPC,54454,3.200830039856186,1.8594267642584574
DMS 273,6252,1.7538621935564394,1.8594267642584574
SCC-9,doxorubicin-navitoclax (2-1 mol-mol),-1.5026968555435367,1.8594267642584574
G-401,44491742,3.951665256591854,1.8594267642584574
DMS 273,11625818,4.382645377089847,1.8594267642584574
LOU-NH91,3503,2.9647844947930397,1.8594267642584574
G-401,446155,3.2535633304842144,1.8594267642584574
DMS 273,675434,4.24768091674901,1.8594267642584574
Panc 04.03,erlotinib-PLX-4032 (2-1 mol-mol),4.205995552769646,1.8594267642584574
YAPC,ISOX-bortezomib (250-1 mol-mol),1.2420544087730638,1.8594267642584574
Panc 04.03,168313016,6.087789512449841,1.8594267642584574
NCI-H1623,24856436,0.944997546799197,1.8594267642584574
ONS-76,ISOX-bortezomib (250-1 mol-mol),0.2723721998746015,1.8594267642584574
LoVo,3025986,-0.1762115912359206,1.8594267642584574
A-673,10184653,1.446453264453446,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],637858,2.624063294513633,1.8594267642584574
LoVo,66577038,2.852951614414874,1.8594267642584574
NCI-H522,3136844,3.3827652175643577,1.8594267642584574
A-673,3676137,4.749608800479587,1.8594267642584574
SCC-9,409805,5.497565328609373,1.8594267642584574
DMS 273,6918328,-1.955094157059326,1.8594267642584574
LXF 289,4259181,0.8555931132792622,1.8594267642584574
OVISE,448949,2.233154508177948,1.8594267642584574
JM-1,675434,3.7844228868956296,1.8594267642584574
NCI-H292,5566,3.044146869319611,1.8594267642584574
EFO-27,227681,1.958013080406725,1.8594267642584574
EFO-27,65064,5.385038331959097,1.8594267642584574
A-498,9907093,3.786767310891997,1.8594267642584574
SNU-61,676352,2.4274144006766893,1.8594267642584574
MDA-MB-157,135421197,1.265960780615991,1.8594267642584574
NCI-H460,10074640,3.83137833519258,1.8594267642584574
BxPC-3,46199207,2.8626203608628416,1.8594267642584574
CAL-51,387447,-3.720200693098244,1.8594267642584574
NCI-H146,56946209,-6.937271673290349,1.8594267642584574
EFO-27,46907787,4.067144836646944,1.8594267642584574
NCI-H292,2729026,2.9142630754738037,1.8594267642584574
LOU-NH91,1716436,1.3649900096390022,1.8594267642584574
KMRC-1,8515,4.713762602344707,1.8594267642584574
MDA-MB-453,crizotinib-PLX-4032 (2-1 mol-mol),2.6505270517489596,1.8594267642584574
SNU-449,448949,1.5810053045793695,1.8594267642584574
SBC-5,4096211,1.588189246491771,1.8594267642584574
NCI-H661,26596,-0.5563822784391794,1.8594267642584574
A4/Fukuda,51037431,0.9928208538339424,1.8594267642584574
HCC1143,doxorubicin-navitoclax (2-1 mol-mol),-0.0488581620418106,1.8594267642584574
OVISE,5311,2.608797421965248,1.8594267642584574
A2780,11238147,1.47132390494783,1.8594267642584574
NCI-H1623,676352,1.987229853680802,1.8594267642584574
Panc 04.03,126941,-1.1535511280443094,1.8594267642584574
NCI-H727,9926054,2.0492739470784445,1.8594267642584574
LoVo,65064,4.389937632551182,1.8594267642584574
SNU-449,52947716,1.9936156354056855,1.8594267642584574
Panc 04.03,5351362,1.307383541492636,1.8594267642584574
HSC-4,vorinostat-navitoclax (4-1 mol-mol),1.9548576859286355,1.8594267642584574
NOMO-1,44493952,3.580250185381126,1.8594267642584574
A-498,676352,1.77005199556574,1.8594267642584574
Panc 04.03,5280436,1.6844699655115762,1.8594267642584574
CAL-51,16736978,0.375988055286384,1.8594267642584574
MDA-MB-157,54618771,3.1146330047846877,1.8594267642584574
NOMO-1,6450551,1.2307950565416117,1.8594267642584574
MDA-MB-157,tretinoin-carboplatin (2-1 mol-mol),3.238516076449109,1.8594267642584574
G-401,25105715,3.9034348367564258,1.8594267642584574
BxPC-3,151289,0.5689607060021993,1.8594267642584574
NCI-H727,44543605,4.300237824274415,1.8594267642584574
SNU-81,2907,6.641268536629272,1.8594267642584574
SNU-81,613753,2.2388707005796507,1.8594267642584574
JM-1,168312962,1.22629450044224,1.8594267642584574
LOU-NH91,168313200,3.810508485111527,1.8594267642584574
NCI-H146,3854666,1.3221451848305394,1.8594267642584574
KYSE-70,322968,3.381611542483835,1.8594267642584574
ONS-76,241158,4.846225597872182,1.8594267642584574
SNU-61,selumetinib-PLX-4032 (8-1 mol-mol),1.220990708913243,1.8594267642584574
KMRC-1,JQ-1-vorinostat (2-1 mol-mol),1.4567711420543266,1.8594267642584574
CAL-51,5291,4.8235616489491635,1.8594267642584574
SNU-61,SNX-2112-bortezomib (250-1 mol-mol),-2.113975984395572,1.8594267642584574
MDA-MB-453,168313016,4.163913885489913,1.8594267642584574
A-498,60700,2.2087582051541257,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],65064,5.283352652805609,1.8594267642584574
HSC-4,6918878,5.2813290465493505,1.8594267642584574
MDA-MB-453,9884685,-1.4419247946131482,1.8594267642584574
A2780,2746,1.939184711313242,1.8594267642584574
NCI-H661,148198,-4.235070372495308,1.8594267642584574
HSC-4,54678924,3.092091974621669,1.8594267642584574
A-673,2113511,4.0082027727586,1.8594267642584574
A4/Fukuda,5287620,-3.30087759062066,1.8594267642584574
SNU-449,selumetinib-MK-2206 (8-1 mol-mol),3.758556004242712,1.8594267642584574
LOU-NH91,6918328,0.1478473020386815,1.8594267642584574
BxPC-3,3385,3.820290029267426,1.8594267642584574
MDA-MB-453,44185566,2.487729821066063,1.8594267642584574
LXF 289,46907787,-0.1426698074457199,1.8594267642584574
EFO-27,piperlongumine-MST-312 (1-1 mol-mol),1.300459178940563,1.8594267642584574
EFO-27,9887053,4.025142225668377,1.8594267642584574
BxPC-3,4259181,0.1397018777458316,1.8594267642584574
SCC-9,10184653,-0.319006591471168,1.8594267642584574
SNU-449,53232,1.6560937312011326,1.8594267642584574
BxPC-3,53232,2.859321527409702,1.8594267642584574
NCI-H460,71304818,2.359856693071434,1.8594267642584574
NCI-H2009,11178236,-2.605718631753464,1.8594267642584574
FU-OV-1,400769,0.1189863997269066,1.8594267642584574
NCI-H292,vorinostat-carboplatin (1-1 mol-mol),3.668554918362719,1.8594267642584574
FTC-133,72376,-0.3430893294901544,1.8594267642584574
LOU-NH91,2858523,2.98680776080117,1.8594267642584574
LoVo,6918837,-3.586713596901602,1.8594267642584574
SNU-449,erlotinib-PLX-4032 (2-1 mol-mol),3.286095103916852,1.8594267642584574
CAL-51,6918837,-3.0563476396929703,1.8594267642584574
NCI-H292,676352,2.616071543582294,1.8594267642584574
NCI-H522,11626560,2.464867345362881,1.8594267642584574
HSC-4,SNX-2112-bortezomib (250-1 mol-mol),-1.2345732834782526,1.8594267642584574
A-673,11167602,2.442600782118551,1.8594267642584574
OPM-2,11222830,0.0961911151739945,1.8594267642584574
A4/Fukuda,7251185,1.076285820033946,1.8594267642584574
OPM-2,24978538,1.9225155298388676,1.8594267642584574
CAL-51,135411,0.595745817277345,1.8594267642584574
NCI-H2009,selumetinib-tretinoin (2-1 mol-mol),-1.112372565869968,1.8594267642584574
HSC-4,3025986,-1.9523671858491285,1.8594267642584574
BT-549,54618771,1.4883156908959423,1.8594267642584574
DMS 273,1239801,5.369367906855259,1.8594267642584574
SNU-449,374536,4.370390285639732,1.8594267642584574
MDA-MB-157,168313016,4.249309770188466,1.8594267642584574
NCI-H522,446155,3.2752737209903504,1.8594267642584574
BxPC-3,9935249,3.9268263105803727,1.8594267642584574
A2780,16725315,3.2354385253964253,1.8594267642584574
NCI-H522,11647372,2.460433695225771,1.8594267642584574
MDA-MB-157,3689413,-1.567220624306923,1.8594267642584574
NOMO-1,36314,1.6795260413615891,1.8594267642584574
CAL-51,alisertib-navitoclax (2-1 mol-mol),0.1244503961193178,1.8594267642584574
ONS-76,46199207,3.062888044588984,1.8594267642584574
HSC-4,2746,3.845189406581069,1.8594267642584574
A-673,126941,-4.88778992999732,1.8594267642584574
A4/Fukuda,2874250,4.0164309105299685,1.8594267642584574
DMS 273,navitoclax-piperlongumine (1-1 mol-mol),2.7902567268334786,1.8594267642584574
Panc 04.03,3136844,4.698465140769799,1.8594267642584574
KYSE-70,53232,3.7067207893488017,1.8594267642584574
CAL-51,24180125,2.8082301472193203,1.8594267642584574
Panc 04.03,9884685,1.6842032304446288,1.8594267642584574
NCI-H460,11626560,2.497647926194901,1.8594267642584574
SNU-449,168312962,3.745202246753347,1.8594267642584574
HCC1143,9935249,3.8757786370374303,1.8594267642584574
SNU-449,613753,3.229445182846538,1.8594267642584574
OPM-2,44491742,3.727542800888903,1.8594267642584574
KYSE-70,9936388,-4.915846401119174,1.8594267642584574
CAL-51,654092,0.82886283906252,1.8594267642584574
SBC-5,448949,2.9920694717704204,1.8594267642584574
OPM-2,46843906,-0.5330027912440064,1.8594267642584574
CAL-51,5566,3.271951139375183,1.8594267642584574
KMRC-1,53232,3.79650380515527,1.8594267642584574
CAL-51,11228183,3.6770505489909007,1.8594267642584574
SW1463,24785538,0.6322996420886741,1.8594267642584574
A4/Fukuda,119182,-4.160589878424858,1.8594267642584574
A-498,107970,3.0044685679861054,1.8594267642584574
CAL-51,11612883,1.9359641259018452,1.8594267642584574
A-498,11317348,4.2355090436144875,1.8594267642584574
LoVo,67291369,1.4516021942624118,1.8594267642584574
A2780,11222830,0.6433638933511314,1.8594267642584574
BxPC-3,241158,3.755569293331497,1.8594267642584574
SCC-9,6610216,4.4695629784882795,1.8594267642584574
CAL-51,374536,3.1977545561189347,1.8594267642584574
LXF 289,selumetinib-MK-2206 (8-1 mol-mol),2.3074669489760296,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],25183872,-1.7223948932282942,1.8594267642584574
SNU-449,72376,1.1438392823146497,1.8594267642584574
A-673,4259181,-0.6373852614685119,1.8594267642584574
DMS 273,168313200,2.725135044490621,1.8594267642584574
NCI-H460,9911463,4.421747687015995,1.8594267642584574
JM-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.988694058348957,1.8594267642584574
YAPC,119182,-1.6155541294016968,1.8594267642584574
SBC-5,6184667,2.5027552360756946,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],89928392,1.6489632684947326,1.8594267642584574
G-401,2858523,3.0226653633513,1.8594267642584574
MDA-MB-157,10184653,0.5581112583171038,1.8594267642584574
A4/Fukuda,19582717,0.7629696429231957,1.8594267642584574
NCI-H460,53392493,4.733063337287369,1.8594267642584574
OPM-2,72193861,0.7906161175639799,1.8594267642584574
NCI-H146,44491742,2.6808030102351323,1.8594267642584574
NOMO-1,46398810,2.1682472320454504,1.8594267642584574
DMS 273,16736978,0.9096800466601204,1.8594267642584574
NCI-H292,navitoclax-piperlongumine (1-1 mol-mol),2.359221869060842,1.8594267642584574
CAL-51,16741245,4.222373420591208,1.8594267642584574
MDA-MB-157,10074640,3.629475203970288,1.8594267642584574
SNU-449,2828334,6.138780539354761,1.8594267642584574
HSC-4,9823820,4.434899642824078,1.8594267642584574
A-673,11238147,1.6374380314183412,1.8594267642584574
EFO-27,selumetinib-PLX-4032 (8-1 mol-mol),5.056777545277596,1.8594267642584574
A4/Fukuda,4915,4.811112690158961,1.8594267642584574
JM-1,42642645,-0.9084434189288264,1.8594267642584574
MDA-MB-157,3854666,0.668628762558335,1.8594267642584574
SBC-5,2841722,4.592516057239796,1.8594267642584574
BxPC-3,2742550,6.208235416241253,1.8594267642584574
NCI-H2171,168313200,1.615164123973231,1.8594267642584574
LOU-NH91,46843906,2.60442098689998,1.8594267642584574
DMS 273,54619267,3.628421853226673,1.8594267642584574
CAL-51,16725315,3.2794500362302,1.8594267642584574
MDA-MB-157,10127622,3.2546864424502076,1.8594267642584574
NCI-H2171,16725315,3.053630151756443,1.8594267642584574
SCC-9,9935249,4.690276947265519,1.8594267642584574
NCI-H460,44507138,4.578042897326484,1.8594267642584574
NCI-H1623,5282054,3.865413044747809,1.8594267642584574
HCC1143,984333,-0.0539665216618622,1.8594267642584574
CA46,selumetinib-PLX-4032 (8-1 mol-mol),4.812160149058309,1.8594267642584574
MDA-MB-453,9840324,6.873328025428986,1.8594267642584574
Panc 04.03,176870,4.897846724128431,1.8594267642584574
NOMO-1,11640390,1.5691640408186416,1.8594267642584574
Panc 04.03,409805,5.536204895331733,1.8594267642584574
MSTO-211H,71466445,2.2675767772231024,1.8594267642584574
NCI-H2171,9915743,0.832341910278816,1.8594267642584574
A4/Fukuda,5281672,3.917758560865086,1.8594267642584574
LXF 289,11427553,2.4541082171467368,1.8594267642584574
Panc 04.03,7251185,3.2944683029692237,1.8594267642584574
NCI-H522,9933475,1.020852520604034,1.8594267642584574
JM-1,24180719,3.5833576580940005,1.8594267642584574
SCC-9,15953870,4.1491811794097995,1.8594267642584574
Panc 04.03,56946209,-4.443392589569815,1.8594267642584574
BT-549,6918837,-1.3661230802503712,1.8594267642584574
ONS-76,56946209,-3.559106939272703,1.8594267642584574
OVISE,44507138,4.185704551553473,1.8594267642584574
NCI-H292,441298,3.4530013870499037,1.8594267642584574
EFO-27,374536,3.468329704237433,1.8594267642584574
NCI-H292,568763,1.0095796953036382,1.8594267642584574
NCI-H522,122327,3.7548997428021904,1.8594267642584574
FTC-133,409805,6.0297974484260655,1.8594267642584574
KMRC-1,3384730,3.706671423221143,1.8594267642584574
HSC-4,5351362,1.6988999536887646,1.8594267642584574
BT-549,448949,1.6914375683866394,1.8594267642584574
JM-1,753704,3.307600856766594,1.8594267642584574
CAL-51,25195348,5.6667768045179905,1.8594267642584574
CAL-51,3025986,-1.0834382414923172,1.8594267642584574
HCC1143,15547703,3.062266000318877,1.8594267642584574
EFO-27,navitoclax-PLX-4032 (1-1 mol-mol),3.1574015935029083,1.8594267642584574
CAL-51,135999136,4.2132345103647015,1.8594267642584574
ONS-76,55283,0.3588409196586273,1.8594267642584574
CAL-51,doxorubicin-navitoclax (2-1 mol-mol),-2.632738790580408,1.8594267642584574
MDA-MB-453,selumetinib-vorinostat (8-1 mol-mol),2.0806958823850485,1.8594267642584574
SW1463,25262965,-1.5690747748042335,1.8594267642584574
FTC-133,241158,4.091507154193835,1.8594267642584574
KMRC-1,23582824,0.9449566223543509,1.8594267642584574
A4/Fukuda,selumetinib-GDC-0941 (4-1 mol-mol),-1.0916711617769086,1.8594267642584574
FU-OV-1,16013152,4.2048953133679765,1.8594267642584574
MDA-MB-453,613000,0.0740651651217389,1.8594267642584574
MDA-MB-157,24797083,0.6098010922803769,1.8594267642584574
NCI-H460,10074640,3.83137833519258,1.8594267642584574
CAL-51,16722836,0.8083581946159574,1.8594267642584574
NCI-H146,tretinoin-navitoclax (4-1 mol-mol),-1.851053903762128,1.8594267642584574
G-401,BRD-A02303741-navitoclax (2-1 mol-mol),3.4869097822802915,1.8594267642584574
G-401,10322450,4.220475308231234,1.8594267642584574
G-401,15983966,-4.354524639754001,1.8594267642584574
CA46,9887053,1.048475441216289,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11625818,4.3229587777026035,1.8594267642584574
NCI-H1623,11152667,-0.7587975819891684,1.8594267642584574
HSC-4,11609586,5.018303752842559,1.8594267642584574
OPM-2,67156097,-3.031514601372161,1.8594267642584574
G-401,984333,0.0612358592539302,1.8594267642584574
LXF 289,9908783,5.689655754809611,1.8594267642584574
SCC-9,5329102,2.2394800798474677,1.8594267642584574
NCI-H661,17759555,2.3282310316349935,1.8594267642584574
LXF 289,24856436,0.8419130403195528,1.8594267642584574
SBC-5,159324,3.4028835437957112,1.8594267642584574
JM-1,6184667,1.7187669889057045,1.8594267642584574
MDA-MB-157,11396600,3.7386973485738424,1.8594267642584574
BxPC-3,216239,2.4917493719892274,1.8594267642584574
MDA-MB-453,72193861,1.6700607918257404,1.8594267642584574
CA46,selumetinib-tretinoin (2-1 mol-mol),4.988677002369049,1.8594267642584574
KMRC-1,9915743,1.4003501061845525,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],5351362,2.343495237192863,1.8594267642584574
A-673,12001922,0.9671300191794728,1.8594267642584574
A-673,1323703,5.495685082034704,1.8594267642584574
SCC-9,2729026,3.0647326637868573,1.8594267642584574
HCC1143,navitoclax-piperlongumine (1-1 mol-mol),1.8457079169425925,1.8594267642584574
NCI-H2171,3503,1.152076889590999,1.8594267642584574
JM-1,252682,6.042634536055517,1.8594267642584574
CA46,44137675,2.206940954689562,1.8594267642584574
CAL-51,11152667,-1.203722258692511,1.8594267642584574
LXF 289,135984461,4.539632657840611,1.8594267642584574
EFO-27,docetaxel-tanespimycin (2-1 mol-mol),2.492630012164076,1.8594267642584574
SW1463,11507802,1.438199099446833,1.8594267642584574
BxPC-3,25062766,1.590701824067561,1.8594267642584574
EFO-27,45279963,4.232301991437958,1.8594267642584574
G-401,selumetinib-MK-2206 (8-1 mol-mol),1.699600486285741,1.8594267642584574
NCI-H2009,42642645,0.1491359953679814,1.8594267642584574
FTC-133,53495165,1.6157050027500164,1.8594267642584574
NCI-H292,11640390,3.2514062698758015,1.8594267642584574
A-673,135423438,2.29660224903782,1.8594267642584574
SBC-5,9911830,3.21689826570876,1.8594267642584574
MDA-MB-157,36314,-4.695989096441824,1.8594267642584574
NCI-H1623,5328940,1.639592653942716,1.8594267642584574
SNU-61,135999136,5.618921387112628,1.8594267642584574
CAL-51,25102847,1.94226811064499,1.8594267642584574
MSTO-211H,selumetinib-vorinostat (8-1 mol-mol),2.5507506919352037,1.8594267642584574
A2780,68056272,2.2410901197134923,1.8594267642584574
NCI-H2009,selumetinib-JQ-1 (4-1 mol-mol),-2.491953444120814,1.8594267642584574
KYSE-70,24856436,0.5719980221753466,1.8594267642584574
CAL-51,46398810,2.084696284876613,1.8594267642584574
NCI-H661,16720766,3.873672796747104,1.8594267642584574
LXF 289,11234052,4.719623128458786,1.8594267642584574
NCI-H146,selumetinib-PLX-4032 (8-1 mol-mol),4.7955071162055,1.8594267642584574
MSTO-211H,107970,1.929708493397844,1.8594267642584574
MDA-MB-453,9929138,5.862527790185705,1.8594267642584574
G-401,285033,-4.902412101243927,1.8594267642584574
OPM-2,6852167,1.7172653102666242,1.8594267642584574
EFO-27,11228183,3.371245966973651,1.8594267642584574
CAL-51,17759555,3.5733302595078182,1.8594267642584574
SCC-9,24785538,2.4612574042553432,1.8594267642584574
KMRC-1,11364421,1.724167601186248,1.8594267642584574
MDA-MB-453,24748573,1.9919110400088051,1.8594267642584574
EFO-27,5460769,4.47484627366887,1.8594267642584574
HCC1143,49850262,3.2153342375189533,1.8594267642584574
Panc 04.03,66577038,3.1738099516277667,1.8594267642584574
NCI-H661,11238147,3.129195095759777,1.8594267642584574
SNU-61,6623618,1.73773822434396,1.8594267642584574
EFO-27,16720766,3.656433318818957,1.8594267642584574
BxPC-3,969516,1.4378873066513898,1.8594267642584574
JM-1,54596558,3.768195826371459,1.8594267642584574
LOU-NH91,5738263,3.7277759973822726,1.8594267642584574
JM-1,25183872,-4.29494207596009,1.8594267642584574
NCI-H292,89928392,1.456532385863884,1.8594267642584574
NCI-H460,119607,4.735621464768821,1.8594267642584574
NCI-H460,322968,5.369771337760045,1.8594267642584574
MSTO-211H,navitoclax-sorafenib (1-1 mol-mol),-1.757065878159517,1.8594267642584574
CAL-51,9907093,3.7886359098281783,1.8594267642584574
CAL-51,tretinoin-carboplatin (2-1 mol-mol),4.904159369397283,1.8594267642584574
LoVo,123631,1.2882244486240189,1.8594267642584574
NCI-H661,crizotinib-PLX-4032 (2-1 mol-mol),2.1767708357401188,1.8594267642584574
MDA-MB-453,15983966,1.8434310309669164,1.8594267642584574
A-673,selumetinib-PLX-4032 (8-1 mol-mol),5.680938960321501,1.8594267642584574
HCC1143,135440466,2.588436572703006,1.8594267642584574
NCI-H146,9926054,1.7480459470636802,1.8594267642584574
KMRC-1,5278396,3.6212610119500783,1.8594267642584574
A2780,46191454,-1.192769752942619,1.8594267642584574
A4/Fukuda,25062766,1.3929374396347198,1.8594267642584574
NCI-H292,53232,1.814131755875953,1.8594267642584574
ONS-76,24771867,4.286887453999452,1.8594267642584574
FU-OV-1,31703,-1.7023718917237094,1.8594267642584574
A4/Fukuda,66577038,2.118562328013949,1.8594267642584574
NOMO-1,445455,4.303833401854377,1.8594267642584574
NCI-H2009,12003241,-1.6852069192913937,1.8594267642584574
LXF 289,42642645,0.485507292149712,1.8594267642584574
NOMO-1,46199207,2.5514936314753434,1.8594267642584574
NCI-H460,322968,5.369771337760045,1.8594267642584574
Panc 04.03,5328940,2.517395347800957,1.8594267642584574
SNU-61,9936388,-6.308071034865157,1.8594267642584574
LoVo,4261,-0.8211989197292223,1.8594267642584574
A2780,136227924,2.141563547945887,1.8594267642584574
DMS 273,11175137,1.5448586489611442,1.8594267642584574
LoVo,44202524,1.5416570481285088,1.8594267642584574
HCC1143,9907093,3.794716934303189,1.8594267642584574
NCI-H292,6610216,4.846288432835765,1.8594267642584574
BxPC-3,11178236,-3.5754762678880567,1.8594267642584574
MDA-MB-453,5978,-2.563797038396111,1.8594267642584574
NCI-H146,5460769,1.8747395178404,1.8594267642584574
CA46,11238147,1.5462987380530164,1.8594267642584574
A2780,selumetinib-vorinostat (8-1 mol-mol),1.1370776925514063,1.8594267642584574
LoVo,2828334,5.515630519838643,1.8594267642584574
KMRC-1,5287969,-1.8174868244268352,1.8594267642584574
NCI-H460,676352,2.985829219207002,1.8594267642584574
SNU-61,23635314,-2.2430318809352556,1.8594267642584574
NCI-H460,11612883,2.88158995470921,1.8594267642584574
HCC1143,24951314,0.9489239510798212,1.8594267642584574
OVISE,387447,-4.037756707187744,1.8594267642584574
JM-1,568763,-0.4685251193741573,1.8594267642584574
SNU-449,9907093,4.078651849005814,1.8594267642584574
BT-549,53392493,1.9491955503491856,1.8594267642584574
MSTO-211H,24180719,1.9210037149309027,1.8594267642584574
NCI-H1623,23635314,-3.504391783968502,1.8594267642584574
MDA-MB-157,135875424,2.7117106005077276,1.8594267642584574
NCI-H661,54678924,1.9600004323573317,1.8594267642584574
DMS 273,25105715,3.6490952941772496,1.8594267642584574
NCI-H1623,216345,4.517328735854535,1.8594267642584574
SNU-61,5282054,3.0015154117441996,1.8594267642584574
SNU-61,10302451,2.848073588995495,1.8594267642584574
CAL-51,16720766,0.5416929462446769,1.8594267642584574
ONS-76,BRD-A02303741-navitoclax (2-1 mol-mol),3.993242759783489,1.8594267642584574
OPM-2,selumetinib-decitabine (4-1 mol-mol),0.7585781361547917,1.8594267642584574
NCI-H522,46398810,2.2314734558486053,1.8594267642584574
JM-1,67156097,-2.627968736143573,1.8594267642584574
LXF 289,60700,2.2902498510351528,1.8594267642584574
BxPC-3,2945648,3.219283504871713,1.8594267642584574
A4/Fukuda,65064,3.1077716650538707,1.8594267642584574
NCI-H292,tanespimycin-gemcitabine (1-1 mol-mol),0.0441766051027791,1.8594267642584574
BxPC-3,10077130,4.243605425717339,1.8594267642584574
DMS 273,JQ-1-carboplatin (1-1 mol-mol),0.4682254596147815,1.8594267642584574
NCI-H2171,tretinoin-navitoclax (4-1 mol-mol),-0.4442650177645615,1.8594267642584574
NCI-H292,carboplatin-UNC0638 (2-1 mol-mol),3.385304428653225,1.8594267642584574
LoVo,168312962,0.7059894109575258,1.8594267642584574
G-401,65064,5.209946412003188,1.8594267642584574
NCI-H146,148198,-5.323171419653744,1.8594267642584574
EFO-27,tanespimycin-bortezomib (250-1 mol-mol),1.741135148136739,1.8594267642584574
A-673,UNC0638-navitoclax (1-1 mol-mol),0.924898873011094,1.8594267642584574
HCC1143,2746,1.9419289545652112,1.8594267642584574
NCI-H2009,erlotinib-PLX-4032 (2-1 mol-mol),3.949302222933775,1.8594267642584574
JM-1,decitabine-navitoclax (2-1 mol-mol),-3.5626840909623234,1.8594267642584574
NCI-H2009,10385095,0.2451756361843044,1.8594267642584574
OPM-2,11167602,1.1745103577473592,1.8594267642584574
CAL-51,26596,-1.4638590943230956,1.8594267642584574
NCI-H460,1716436,4.318712917611328,1.8594267642584574
ONS-76,71304818,2.469307822454373,1.8594267642584574
BxPC-3,11626560,1.2674200020854305,1.8594267642584574
CAL-51,104842,-3.020036586723177,1.8594267642584574
NCI-H460,49793307,0.4479933662320887,1.8594267642584574
FTC-133,5284373,3.681008384459256,1.8594267642584574
SBC-5,11455910,0.8715920005264659,1.8594267642584574
MSTO-211H,49850262,3.597717946429448,1.8594267642584574
DMS 273,2871966,0.6484564569530932,1.8594267642584574
OPM-2,2729026,2.502425703285658,1.8594267642584574
KMRC-1,JQ-1-navitoclax (2-1 mol-mol),1.5220385393532236,1.8594267642584574
NCI-H292,9840324,5.8141064790381884,1.8594267642584574
NCI-H661,375860,0.2037463104187888,1.8594267642584574
NOMO-1,6918328,-2.206625897840938,1.8594267642584574
NCI-H522,54143018,0.2801073306793095,1.8594267642584574
OPM-2,23635314,-4.85335222903722,1.8594267642584574
NCI-H1623,1716436,2.729344651836522,1.8594267642584574
CA46,60700,-1.6899904219212585,1.8594267642584574
SNU-81,10077130,-1.1742608263747976,1.8594267642584574
MSTO-211H,9907093,3.5779290533064856,1.8594267642584574
CA46,2126,3.4622152695614767,1.8594267642584574
CAL-51,49766530,0.4609697007955676,1.8594267642584574
CAL-51,6438330,3.884194225982375,1.8594267642584574
KYSE-70,68056272,3.571583007543391,1.8594267642584574
LOU-NH91,vorinostat-navitoclax (4-1 mol-mol),-1.0050592172430175,1.8594267642584574
EFO-27,68056272,3.9995237189063784,1.8594267642584574
SCC-9,241158,3.962823581088113,1.8594267642584574
NOMO-1,5746,1.3002002606442051,1.8594267642584574
MSTO-211H,44202524,1.4972222665959742,1.8594267642584574
NCI-H727,49793307,-2.322611372156632,1.8594267642584574
NCI-H146,4578,4.154543455900732,1.8594267642584574
NCI-H522,JQ-1-vorinostat (2-1 mol-mol),-0.7689256810946783,1.8594267642584574
LoVo,107985,-3.583734032756361,1.8594267642584574
YAPC,984333,0.9591784056691972,1.8594267642584574
SW1463,1750826,-6.63000221324875,1.8594267642584574
NCI-H1623,crizotinib-PLX-4032 (2-1 mol-mol),2.4308697458394652,1.8594267642584574
HSC-4,9866186,0.7177643600632182,1.8594267642584574
G-401,navitoclax-pluripotin (1-1 mol-mol),-1.0942323522272883,1.8594267642584574
ONS-76,135398516,1.9151603507117831,1.8594267642584574
LoVo,11964036,-0.4950100771581299,1.8594267642584574
KMRC-1,crizotinib-PLX-4032 (2-1 mol-mol),1.7808089870084007,1.8594267642584574
CAL-51,11964036,0.7531640395115359,1.8594267642584574
SBC-5,5328940,3.016318294707136,1.8594267642584574
SNU-61,9444,4.091366887299019,1.8594267642584574
A4/Fukuda,selumetinib-UNC0638 (4-1 mol-mol),0.1859137838774149,1.8594267642584574
A2780,676352,1.788840905955693,1.8594267642584574
FTC-133,JQ-1-vorinostat (2-1 mol-mol),2.666931641938378,1.8594267642584574
JM-1,7251185,0.7253388444333596,1.8594267642584574
Panc 04.03,JQ-1-navitoclax (2-1 mol-mol),4.611253227928805,1.8594267642584574
NCI-H460,52947716,-4.997624319891589,1.8594267642584574
NCI-H2009,6505803,-0.1719772058921901,1.8594267642584574
OVISE,25126798,4.262747569123806,1.8594267642584574
G-401,54678924,1.6253720221899297,1.8594267642584574
Panc 04.03,tretinoin-navitoclax (4-1 mol-mol),4.366288248143094,1.8594267642584574
A2780,135421197,1.3895584306244824,1.8594267642584574
EFO-27,25126798,3.692256603979053,1.8594267642584574
DMS 273,73707398,1.2764695344106731,1.8594267642584574
MSTO-211H,10296883,3.6762481855456985,1.8594267642584574
LOU-NH91,60700,-0.2604526525302556,1.8594267642584574
Panc 04.03,8515,4.900392472396633,1.8594267642584574
A4/Fukuda,216345,2.739557201577506,1.8594267642584574
A-673,24978538,2.0217931845087596,1.8594267642584574
SBC-5,11152667,-0.3838978082878119,1.8594267642584574
NCI-H460,15983966,-0.5601417251503862,1.8594267642584574
EFO-27,400769,-0.0834796845468066,1.8594267642584574
YAPC,2858523,3.168058012530131,1.8594267642584574
LOU-NH91,navitoclax-sorafenib (1-1 mol-mol),-0.9074262006529596,1.8594267642584574
NCI-H2171,227681,1.8296199533038344,1.8594267642584574
NCI-H460,11455910,1.4134750909778395,1.8594267642584574
G-401,44566777,-0.9568944013200004,1.8594267642584574
NCI-H292,5328940,1.2067364026743148,1.8594267642584574
G-401,navitoclax-sorafenib (1-1 mol-mol),1.5806960178530294,1.8594267642584574
NCI-H460,docetaxel-tanespimycin (2-1 mol-mol),-0.9537223333522225,1.8594267642584574
JM-1,25154868,2.919888649987432,1.8594267642584574
LoVo,44185566,1.1715497148164364,1.8594267642584574
ONS-76,54618164,4.167815792355048,1.8594267642584574
NOMO-1,151289,1.0922355572005962,1.8594267642584574
G-401,44493528,4.310857122389352,1.8594267642584574
KYSE-70,89928392,5.113782206339635,1.8594267642584574
NCI-H661,89928392,1.5970967591597882,1.8594267642584574
SCC-9,docetaxel-tanespimycin (2-1 mol-mol),-3.608220129301709,1.8594267642584574
KMRC-1,3503,2.6706031423305845,1.8594267642584574
G-401,11455910,1.3171347053017213,1.8594267642584574
SNU-449,208908,2.01293579360495,1.8594267642584574
G-401,57519531,1.5783303012871783,1.8594267642584574
MDA-MB-453,11427553,2.8599395215861567,1.8594267642584574
LOU-NH91,241158,4.097895358021133,1.8594267642584574
G-401,24951314,0.7541386929645643,1.8594267642584574
MDA-MB-453,208908,1.869724740513474,1.8594267642584574
YAPC,46398810,3.0625661294812216,1.8594267642584574
LOU-NH91,1750826,-0.8784962447018205,1.8594267642584574
FTC-133,ISOX-bortezomib (250-1 mol-mol),0.3351331605659957,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],24771867,4.508296832673209,1.8594267642584574
MDA-MB-157,100016,3.517936084480814,1.8594267642584574
HCC1143,60750,-4.413462787403808,1.8594267642584574
NCI-H661,selumetinib-BRD-A02303741 (4-1 mol-mol),5.5299727991020555,1.8594267642584574
HCC1143,159324,3.533344711636858,1.8594267642584574
JM-1,1750826,-4.271139507623605,1.8594267642584574
CA46,selumetinib-JQ-1 (4-1 mol-mol),0.1147444107016205,1.8594267642584574
A-673,11396600,2.723776149104898,1.8594267642584574
NCI-H1623,24964624,2.070631930148384,1.8594267642584574
MDA-MB-453,104842,-3.389911854354977,1.8594267642584574
SNU-81,49793307,-4.215972202332142,1.8594267642584574
A4/Fukuda,54618164,3.3817410387547575,1.8594267642584574
NCI-H2171,26596,-1.7584148860978708,1.8594267642584574
MDA-MB-157,selumetinib-GDC-0941 (4-1 mol-mol),2.2510493382113155,1.8594267642584574
ONS-76,676352,2.5309673509494535,1.8594267642584574
SCC-9,4378219,1.9931327421657885,1.8594267642584574
CAL-51,613753,3.3238399640193177,1.8594267642584574
Panc 04.03,49867926,4.237506736984018,1.8594267642584574
NCI-H292,salermide-PLX-4032 (12-1 mol-mol),5.437042614590839,1.8594267642584574
NCI-H727,selumetinib-navitoclax (8-1 mol-mol),-2.0021206675207885,1.8594267642584574
MSTO-211H,3543504,4.118160915221066,1.8594267642584574
NCI-H460,6252,1.4342703041264255,1.8594267642584574
OVISE,navitoclax-gemcitabine (1-1 mol-mol),-0.8912301406187855,1.8594267642584574
NCI-H727,3825829,4.725008182252989,1.8594267642584574
OPM-2,119182,-0.8289962289267476,1.8594267642584574
LoVo,54613361,-1.4267659732177436,1.8594267642584574
HSC-4,navitoclax-PLX-4032 (1-1 mol-mol),2.8756909366575023,1.8594267642584574
A4/Fukuda,126941,-4.18863393868508,1.8594267642584574
NCI-H2171,SNX-2112-bortezomib (250-1 mol-mol),-3.076194221484089,1.8594267642584574
NCI-H460,136227924,3.925006850615035,1.8594267642584574
NCI-H727,3136844,6.195563862298742,1.8594267642584574
MDA-MB-453,136227924,2.410345496671846,1.8594267642584574
SNU-61,51037431,3.7250627983577513,1.8594267642584574
SNU-61,3384730,2.3184170398790154,1.8594267642584574
Panc 04.03,24753719,4.39873379823384,1.8594267642584574
SNU-81,5978,-4.726956734092058,1.8594267642584574
SNU-61,9967941,2.1294940171884043,1.8594267642584574
SNU-81,selumetinib-piperlongumine (8-1 mol-mol),-0.9226947877098262,1.8594267642584574
ONS-76,5470400,1.68546701619173,1.8594267642584574
JM-1,52912189,-1.1165299764243126,1.8594267642584574
NOMO-1,52947716,-3.339302012338735,1.8594267642584574
JM-1,26596,-2.491901301923365,1.8594267642584574
NCI-H661,445455,5.2176896422295025,1.8594267642584574
SBC-5,216468,3.330480208625043,1.8594267642584574
NCI-H292,5311,1.7806932533505695,1.8594267642584574
Panc 04.03,9935249,3.3873751996630177,1.8594267642584574
NCI-H2009,doxorubicin-navitoclax (2-1 mol-mol),-0.756296183538871,1.8594267642584574
CA46,25262965,-5.196703638661911,1.8594267642584574
NCI-H460,11626560,2.497647926194901,1.8594267642584574
CAL-51,54686904,4.850424917483252,1.8594267642584574
KYSE-70,vorinostat-navitoclax (4-1 mol-mol),1.6518262185005994,1.8594267642584574
NCI-H2171,6918328,-2.9240080597430813,1.8594267642584574
CAL-51,3825829,3.9510679995615257,1.8594267642584574
SNU-61,65064,4.771880102821997,1.8594267642584574
CAL-51,124202324,2.033990287468598,1.8594267642584574
NCI-H1623,11494412,1.2552972437851018,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],67156097,4.4289502620646415,1.8594267642584574
JM-1,135398516,1.8505892369708832,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],10296883,4.143855024915708,1.8594267642584574
HSC-4,BRD-K27188169-navitoclax (2-1 mol-mol),3.591026933435327,1.8594267642584574
LoVo,1641662,3.111662868893329,1.8594267642584574
BxPC-3,selumetinib-GDC-0941 (4-1 mol-mol),-1.450319129285142,1.8594267642584574
HCC1143,24856436,0.4052757500096688,1.8594267642584574
YAPC,73707398,1.1307339717786768,1.8594267642584574
FU-OV-1,24771867,2.3744516407985485,1.8594267642584574
NCI-H727,piperlongumine-MST-312 (1-1 mol-mol),1.950169428347768,1.8594267642584574
SNU-61,2749,1.958913212534665,1.8594267642584574
CAL-51,20959075,-3.1196535578382987,1.8594267642584574
A-673,6918878,1.2344260030899934,1.8594267642584574
LOU-NH91,73707398,1.1540810865513749,1.8594267642584574
NCI-H2171,107985,-3.896160678794096,1.8594267642584574
KYSE-70,12003241,-1.4257688129039825,1.8594267642584574
MDA-MB-453,10296883,4.2989687155614735,1.8594267642584574
NCI-H2009,JQ-1-carboplatin (1-1 mol-mol),0.1059252519818266,1.8594267642584574
A4/Fukuda,crizotinib-PLX-4032 (2-1 mol-mol),-0.0418615820710858,1.8594267642584574
NCI-H727,selumetinib-JQ-1 (4-1 mol-mol),-0.7236905390047186,1.8594267642584574
NCI-H661,4259181,-1.4326329693308524,1.8594267642584574
JM-1,salermide-PLX-4032 (12-1 mol-mol),5.264877641383212,1.8594267642584574
A4/Fukuda,JQ-1-MK-0752 (1-1 mol-mol),-0.933197038878086,1.8594267642584574
SCC-9,25183872,-1.5689686359020558,1.8594267642584574
NCI-H727,6438394,3.7246032061112553,1.8594267642584574
NCI-H1623,selumetinib-navitoclax (8-1 mol-mol),2.5972184822142004,1.8594267642584574
Panc 04.03,9911463,4.4327726522455855,1.8594267642584574
ONS-76,2733487,6.718347537986806,1.8594267642584574
MDA-MB-453,25062766,1.9156877669914651,1.8594267642584574
NCI-H1623,36314,1.7259264714185265,1.8594267642584574
SCC-9,selumetinib-piperlongumine (8-1 mol-mol),4.590174164336879,1.8594267642584574
MDA-MB-453,11234052,3.3366002038414493,1.8594267642584574
NCI-H661,54143018,-0.94518686271758,1.8594267642584574
NOMO-1,72376,-3.881755374018637,1.8594267642584574
NCI-H1623,104842,-3.8091356035642434,1.8594267642584574
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324,1.8594267642584574
JM-1,71466445,1.831003524042788,1.8594267642584574
EFO-27,49766530,-2.657964166176686,1.8594267642584574
NCI-H661,753704,5.093119647973415,1.8594267642584574
OPM-2,11175137,1.4890519960627426,1.8594267642584574
G-401,carboplatin-etoposide (40-17 mol-mol),0.9786260223785996,1.8594267642584574
A4/Fukuda,5746,-1.1009867615741116,1.8594267642584574
SNU-449,44489675,3.6193477306301927,1.8594267642584574
NCI-H661,12001922,2.629031416850278,1.8594267642584574
DMS 273,11640390,3.3173332454053717,1.8594267642584574
SNU-449,4259181,0.6587440570439733,1.8594267642584574
EFO-27,24964624,2.939505532014586,1.8594267642584574
LoVo,4096211,0.5868958804653562,1.8594267642584574
A2780,2841722,4.258280317113099,1.8594267642584574
CAL-51,24771867,-0.5018492111736887,1.8594267642584574
G-401,46907787,-0.0293884143124787,1.8594267642584574
JM-1,24772860,-4.004711239665373,1.8594267642584574
MDA-MB-453,71680916,4.8348560692055695,1.8594267642584574
JM-1,11507802,0.223918960474334,1.8594267642584574
A-673,462382,-0.040658639847304,1.8594267642584574
NCI-H661,216345,4.176204855685743,1.8594267642584574
BxPC-3,9907093,4.5613416209155755,1.8594267642584574
HSC-4,216468,2.5769925673594227,1.8594267642584574
NOMO-1,60700,-1.0021705320646457,1.8594267642584574
YAPC,11455910,1.8317787914833017,1.8594267642584574
SNU-449,11175137,3.183352091664916,1.8594267642584574
A2780,2113511,4.588817591987419,1.8594267642584574
NCI-H146,613753,2.6314812615131222,1.8594267642584574
SNU-81,10231331,-2.370371712203436,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],387447,-5.081876711684109,1.8594267642584574
NCI-H661,168313016,5.326553105852446,1.8594267642584574
CAL-51,25126798,3.926975819986009,1.8594267642584574
Panc 04.03,1716436,3.048029385411991,1.8594267642584574
EFO-27,11625818,4.615590718074381,1.8594267642584574
A-498,44495899,4.223152889477574,1.8594267642584574
A2780,3825829,2.5427924978442467,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],675434,4.441344472745021,1.8594267642584574
NCI-H1623,2858523,3.2758661507497115,1.8594267642584574
A-673,49793307,-5.444897343264971,1.8594267642584574
MDA-MB-453,9935249,2.561550169446695,1.8594267642584574
MSTO-211H,navitoclax-gemcitabine (1-1 mol-mol),0.5051490037024954,1.8594267642584574
LXF 289,3062316,-3.851151802003845,1.8594267642584574
MDA-MB-157,2874250,4.29768331905581,1.8594267642584574
HSC-4,4521392,4.744801099229743,1.8594267642584574
EFO-27,23725625,5.484413053531449,1.8594267642584574
MDA-MB-157,navitoclax-MST-312 (1-1 mol-mol),-3.237142139083902,1.8594267642584574
NCI-H2009,5460769,1.3316086312624285,1.8594267642584574
LOU-NH91,654092,0.641619390442256,1.8594267642584574
NCI-H460,decitabine-carboplatin (1-1 mol-mol),5.711922209034068,1.8594267642584574
SNU-449,9887053,4.621717664819675,1.8594267642584574
LOU-NH91,54618164,4.244208934703923,1.8594267642584574
MDA-MB-157,24951314,0.2652102931153908,1.8594267642584574
SCC-9,4261,1.568262163612179,1.8594267642584574
CAL-51,262093,2.862241975448649,1.8594267642584574
DMS 273,100016,5.677769516399485,1.8594267642584574
A2780,44137675,1.3252793631369038,1.8594267642584574
DMS 273,71466578,4.37241227128359,1.8594267642584574
A4/Fukuda,1566236,1.4071330472860828,1.8594267642584574
SNU-61,navitoclax-gemcitabine (1-1 mol-mol),2.2784859242088062,1.8594267642584574
NCI-H2171,25102847,1.8897460049958847,1.8594267642584574
MDA-MB-453,60700,-1.6006047446684224,1.8594267642584574
A-498,11404337,2.25955984981305,1.8594267642584574
NCI-H2171,10302451,3.986494326049399,1.8594267642584574
YAPC,10184653,0.1561987566095487,1.8594267642584574
NCI-H661,9967941,4.170813203069281,1.8594267642584574
BT-549,24901704,3.7794480452342,1.8594267642584574
A2780,3038522,3.0311112283818864,1.8594267642584574
NCI-H522,67291369,2.1338291538877514,1.8594267642584574
HSC-4,753704,4.983094182740762,1.8594267642584574
G-401,44607530,1.0217800111575093,1.8594267642584574
OPM-2,19582717,1.9960397366001383,1.8594267642584574
NCI-H2009,104741,-5.941055510927969,1.8594267642584574
OVISE,9936388,2.6758567859836826,1.8594267642584574
NCI-H1623,11178236,-2.2917099582879144,1.8594267642584574
CAL-51,5746,-0.6872762444946757,1.8594267642584574
JM-1,3503,1.2397121319894746,1.8594267642584574
LoVo,26596,-4.043483931746528,1.8594267642584574
ONS-76,44486219,4.293725912166159,1.8594267642584574
SNU-81,vorinostat-navitoclax (4-1 mol-mol),1.2655278546702862,1.8594267642584574
NCI-H460,24964624,3.5490884182562565,1.8594267642584574
A2780,448949,1.9574027813966313,1.8594267642584574
G-401,6918878,1.5849207586223315,1.8594267642584574
EFO-27,123631,3.2705036111065957,1.8594267642584574
NCI-H460,71466380,4.4879606530616725,1.8594267642584574
NCI-H146,126941,0.4535750644224253,1.8594267642584574
SCC-9,JQ-1-vorinostat (2-1 mol-mol),0.3641375851810363,1.8594267642584574
JM-1,25062766,0.7257031347370316,1.8594267642584574
BxPC-3,44819697,-0.5900667288519075,1.8594267642584574
DMS 273,49766530,-1.3487399530522592,1.8594267642584574
G-401,6918837,-4.518653911968971,1.8594267642584574
FTC-133,25195348,4.144583358862902,1.8594267642584574
BT-549,5281321,-3.0037540013163433,1.8594267642584574
Panc 04.03,44241473,4.425072929332434,1.8594267642584574
YAPC,5278396,4.010893890545004,1.8594267642584574
ONS-76,5287620,-2.6985711183159573,1.8594267642584574
SBC-5,11612883,3.4240653421197877,1.8594267642584574
SNU-81,doxorubicin-navitoclax (2-1 mol-mol),-2.5154002454653277,1.8594267642584574
A-673,tretinoin-navitoclax (4-1 mol-mol),2.75284038442573,1.8594267642584574
SBC-5,219104,3.745930190487188,1.8594267642584574
SNU-61,176870,2.732721688120773,1.8594267642584574
CAL-51,36314,1.3238047725901672,1.8594267642584574
SNU-81,carboplatin-UNC0638 (2-1 mol-mol),2.7350455316868416,1.8594267642584574
DMS 273,71751553,4.31191978803821,1.8594267642584574
NCI-H2171,400769,-1.2297634018381476,1.8594267642584574
MSTO-211H,salermide-PLX-4032 (12-1 mol-mol),5.150950565200891,1.8594267642584574
NCI-H727,71304818,2.536891878991305,1.8594267642584574
G-401,JQ-1-carboplatin (1-1 mol-mol),0.2473733960236567,1.8594267642584574
CA46,135398516,0.7680931483587626,1.8594267642584574
MSTO-211H,100016,4.243846732059744,1.8594267642584574
NCI-H522,selumetinib-MK-2206 (8-1 mol-mol),3.9815155524182337,1.8594267642584574
NCI-H2171,carboplatin-UNC0638 (2-1 mol-mol),3.641096967492651,1.8594267642584574
SW1463,25183872,-1.2446986167158185,1.8594267642584574
EFO-27,122327,4.8281000238128,1.8594267642584574
MDA-MB-157,11222830,0.6776847499576403,1.8594267642584574
NCI-H2009,25150857,2.992056775880064,1.8594267642584574
NOMO-1,216468,1.212023833941809,1.8594267642584574
JM-1,11152667,-1.617053586455527,1.8594267642584574
CAL-51,selumetinib-navitoclax (8-1 mol-mol),4.759192445659263,1.8594267642584574
A-673,25126798,3.569829443135804,1.8594267642584574
DMS 273,148198,-4.27913692458833,1.8594267642584574
LXF 289,selumetinib-tretinoin (2-1 mol-mol),2.6390813886621203,1.8594267642584574
LXF 289,5329102,1.6667075021580833,1.8594267642584574
HSC-4,53495165,1.6708694504220498,1.8594267642584574
CAL-51,969516,2.948027689121256,1.8594267642584574
NCI-H661,5746,2.052034109930783,1.8594267642584574
A4/Fukuda,9967941,2.4411204768161983,1.8594267642584574
MDA-MB-157,89928392,-0.9485630303355488,1.8594267642584574
NCI-H460,12001922,2.3574763109101253,1.8594267642584574
SNU-81,327653,3.5323829695882267,1.8594267642584574
NCI-H661,124202324,2.0891928025286943,1.8594267642584574
BxPC-3,42642645,0.6313588777440967,1.8594267642584574
NCI-H2009,24772860,-3.0306018162615342,1.8594267642584574
A-673,6610355,3.502413574243847,1.8594267642584574
SNU-61,57330099,3.603690788773508,1.8594267642584574
NCI-H522,2749,2.969505400884835,1.8594267642584574
NCI-H661,57519531,4.09429699672183,1.8594267642584574
MSTO-211H,2126,4.496176254172968,1.8594267642584574
KMRC-1,10410894,3.4812991400934585,1.8594267642584574
EFO-27,44237094,3.2066908421034332,1.8594267642584574
LoVo,16725315,3.2447595903434627,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],5291,3.9145533177301552,1.8594267642584574
MDA-MB-453,2842253,6.29942483998937,1.8594267642584574
A-498,135875424,4.978423270774445,1.8594267642584574
Panc 04.03,9903786,4.611047286699123,1.8594267642584574
SCC-9,54639665,4.512228528266098,1.8594267642584574
JM-1,24856436,-2.211637583066154,1.8594267642584574
A4/Fukuda,5311037,4.577970147235868,1.8594267642584574
NCI-H522,66577038,3.0388231599187017,1.8594267642584574
BT-549,25154868,5.818557590138654,1.8594267642584574
KYSE-70,6505803,-1.025033993677824,1.8594267642584574
LXF 289,11396600,4.152956454399736,1.8594267642584574
SNU-61,navitoclax-MST-312 (1-1 mol-mol),3.0006796747399394,1.8594267642584574
SBC-5,126941,-0.8684780314881991,1.8594267642584574
MSTO-211H,tanespimycin-bortezomib (250-1 mol-mol),-0.4503897657817667,1.8594267642584574
OPM-2,9933475,-1.3895511853659537,1.8594267642584574
YAPC,11214940,1.707662344700129,1.8594267642584574
EFO-27,4259181,1.8274060730963064,1.8594267642584574
NCI-H460,446155,3.79922347841428,1.8594267642584574
NCI-H1623,carboplatin-etoposide (40-17 mol-mol),1.5186330340389391,1.8594267642584574
A4/Fukuda,3634881,2.7004024711225596,1.8594267642584574
NCI-H661,1566236,3.2299922345410006,1.8594267642584574
MDA-MB-157,6450551,1.4635370045174534,1.8594267642584574
NCI-H146,vorinostat-carboplatin (1-1 mol-mol),1.5707903367584717,1.8594267642584574
BT-549,6918328,0.6487197523295809,1.8594267642584574
NCI-H727,11175137,3.085433657363398,1.8594267642584574
NCI-H460,3854666,3.1385110084048065,1.8594267642584574
LoVo,44241473,4.10673515965005,1.8594267642584574
G-401,10074640,2.6430496317806957,1.8594267642584574
EFO-27,sirolimus-bortezomib (250-1 mol-mol),2.1280256093524264,1.8594267642584574
SBC-5,2126,4.14698296213378,1.8594267642584574
ONS-76,3503,2.5109588721491938,1.8594267642584574
SNU-61,5470400,-1.745187092277687,1.8594267642584574
NCI-H661,36314,-4.592945905020296,1.8594267642584574
JM-1,451668,-4.255879556837535,1.8594267642584574
NCI-H1623,5978,-1.0298747552622975,1.8594267642584574
DMS 273,136227924,2.538513279360657,1.8594267642584574
SBC-5,selumetinib-navitoclax (8-1 mol-mol),4.706526584593769,1.8594267642584574
A4/Fukuda,6918638,-1.9449982869755031,1.8594267642584574
HCC1143,16038120,0.5509172721588973,1.8594267642584574
BxPC-3,44185566,1.4327209520395616,1.8594267642584574
ONS-76,2858523,2.9452513130208975,1.8594267642584574
NOMO-1,46191454,0.6880471005756411,1.8594267642584574
NCI-H292,216239,2.858200088172953,1.8594267642584574
DMS 273,11178236,-4.200581603954177,1.8594267642584574
OPM-2,10074640,2.1693178922200813,1.8594267642584574
ONS-76,5566,3.1751487050742804,1.8594267642584574
BxPC-3,10385095,1.8732992891777025,1.8594267642584574
A-673,crizotinib-PLX-4032 (2-1 mol-mol),0.1365223010669094,1.8594267642584574
MDA-MB-453,675434,4.221225816741011,1.8594267642584574
SCC-9,navitoclax-pluripotin (1-1 mol-mol),-0.0123473768643266,1.8594267642584574
CA46,9825149,2.310107059064329,1.8594267642584574
MDA-MB-453,12003241,-0.9610578830621354,1.8594267642584574
A-673,613753,2.7839803669097134,1.8594267642584574
A4/Fukuda,erlotinib-PLX-4032 (2-1 mol-mol),1.6869811830916113,1.8594267642584574
NCI-H460,3062316,3.704520183651484,1.8594267642584574
CA46,carboplatin-etoposide (40-17 mol-mol),0.8336753262316364,1.8594267642584574
A2780,11427553,1.40474333506403,1.8594267642584574
CAL-51,5287620,-2.338247824560234,1.8594267642584574
KMRC-1,11640390,3.901360175468555,1.8594267642584574
EFO-27,16219061,3.8100949831762296,1.8594267642584574
A2780,31703,-4.480868228272363,1.8594267642584574
Panc 04.03,135440466,2.8713092707831116,1.8594267642584574
SCC-9,16065773,3.2014379284662864,1.8594267642584574
SNU-449,148198,-4.785889264279132,1.8594267642584574
OPM-2,2949965,2.476405976050771,1.8594267642584574
ONS-76,44489367,4.840464292002439,1.8594267642584574
NCI-H146,navitoclax-piperlongumine (1-1 mol-mol),-3.055255187933708,1.8594267642584574
NCI-H522,vorinostat-navitoclax (4-1 mol-mol),1.5182214624562833,1.8594267642584574
MDA-MB-453,135411,0.2962177293375728,1.8594267642584574
DMS 273,123631,3.074313122611396,1.8594267642584574
CA46,19582717,2.2741322004032716,1.8594267642584574
A2780,3676137,3.624330330130062,1.8594267642584574
BxPC-3,11964036,0.7144816609502266,1.8594267642584574
G-401,71466445,3.182548969694367,1.8594267642584574
YAPC,navitoclax-piperlongumine (1-1 mol-mol),3.667001325655349,1.8594267642584574
A-673,49766530,-3.0139632371957705,1.8594267642584574
JM-1,JQ-1-UNC0638 (2-1 mol-mol),-2.068621419812743,1.8594267642584574
SNU-449,11609586,3.2368097564340546,1.8594267642584574
G-401,46199207,3.084348249789013,1.8594267642584574
A2780,11612883,1.284093973133662,1.8594267642584574
KMRC-1,2708,5.927603665606935,1.8594267642584574
EFO-27,SNX-2112-bortezomib (250-1 mol-mol),1.0533662240531856,1.8594267642584574
DMS 273,135875424,3.231864587804135,1.8594267642584574
Panc 04.03,2749,3.2242301239764184,1.8594267642584574
G-401,675434,4.2282934242266235,1.8594267642584574
G-401,72734382,4.843742106159305,1.8594267642584574
SNU-81,72376,-4.141271855112041,1.8594267642584574
LXF 289,208908,1.975389940693236,1.8594267642584574
EFO-27,11175137,3.0704812268942296,1.8594267642584574
HCC1143,16736978,2.2332113551174415,1.8594267642584574
LoVo,24821094,2.523288695365458,1.8594267642584574
A4/Fukuda,10322450,2.3588003127389277,1.8594267642584574
EFO-27,11152667,1.7712187839859168,1.8594267642584574
A2780,6918736,-1.942572837589071,1.8594267642584574
FU-OV-1,285033,0.0377877938075082,1.8594267642584574
KYSE-70,11626560,2.028097573065789,1.8594267642584574
CAL-51,400769,-0.1641693790968544,1.8594267642584574
A-673,selumetinib-GDC-0941 (4-1 mol-mol),0.7594316863977323,1.8594267642584574
CA46,11507802,0.4399982092061076,1.8594267642584574
SBC-5,tretinoin-navitoclax (4-1 mol-mol),3.0928632602038575,1.8594267642584574
SNU-61,44607531,1.8838139804325664,1.8594267642584574
MDA-MB-157,135984461,1.8807242402896556,1.8594267642584574
YAPC,68056272,3.685228443179594,1.8594267642584574
KMRC-1,3025986,0.2913922358554936,1.8594267642584574
G-401,11656518,0.9589948119457968,1.8594267642584574
CAL-51,25262965,-2.904292987251918,1.8594267642584574
NCI-H727,31703,0.5895859224805655,1.8594267642584574
FTC-133,3025986,2.6500554516402515,1.8594267642584574
OPM-2,11404337,-1.9830798838769188,1.8594267642584574
NOMO-1,54649381,4.1030759428324455,1.8594267642584574
OPM-2,45279963,2.6394525890823335,1.8594267642584574
G-401,54619267,3.6389956680017495,1.8594267642584574
SCC-9,613753,3.4469207135602904,1.8594267642584574
FTC-133,3825829,4.910712910753543,1.8594267642584574
NCI-H727,6918328,2.020699769993763,1.8594267642584574
JM-1,3384730,1.783412153965406,1.8594267642584574
OPM-2,5335621,3.731372916139424,1.8594267642584574
NCI-H727,46199207,3.049846279584177,1.8594267642584574
NCI-H2009,100016,6.24887408197215,1.8594267642584574
OPM-2,2742550,2.8639715022070713,1.8594267642584574
A-673,56649450,2.339222019664337,1.8594267642584574
LoVo,135928012,4.12079355273469,1.8594267642584574
SNU-449,46215462,1.6240369462021291,1.8594267642584574
EFO-27,10385095,0.896347771716858,1.8594267642584574
BT-549,6917907,-5.828237871920148,1.8594267642584574
A-673,262093,2.1198375376891705,1.8594267642584574
SCC-9,crizotinib-PLX-4032 (2-1 mol-mol),2.600413424515517,1.8594267642584574
G-401,2871966,-1.4998546935779766,1.8594267642584574
NCI-H460,6610355,4.949206869720499,1.8594267642584574
NCI-H292,56946209,-3.439063202171596,1.8594267642584574
MDA-MB-453,46907787,-0.524764523127372,1.8594267642584574
NCI-H661,9935249,3.279757521015836,1.8594267642584574
Panc 04.03,5311281,5.064761813982229,1.8594267642584574
EFO-27,54765302,4.904683382842226,1.8594267642584574
OVISE,24964624,2.347879134584806,1.8594267642584574
MSTO-211H,6918878,2.3677965777112653,1.8594267642584574
KMRC-1,1641662,3.91383049133015,1.8594267642584574
NOMO-1,3025944,3.969971169930392,1.8594267642584574
MDA-MB-453,10322450,5.853812101119735,1.8594267642584574
A-498,675434,6.195396019607132,1.8594267642584574
JM-1,16736978,2.465148690257062,1.8594267642584574
HCC1143,400769,-0.895432113907658,1.8594267642584574
JM-1,5328940,0.4457439228433418,1.8594267642584574
NCI-H522,156422,4.012108454967305,1.8594267642584574
DMS 273,135999136,4.8097980755766505,1.8594267642584574
A2780,44607530,1.3884091000724437,1.8594267642584574
KMRC-1,10302451,2.629362111325239,1.8594267642584574
SNU-61,6918736,-1.624439463390885,1.8594267642584574
BT-549,135999136,1.9798336492119424,1.8594267642584574
NCI-H1623,9926054,1.7409203229588674,1.8594267642584574
JM-1,16722836,0.523497579231149,1.8594267642584574
MSTO-211H,613753,2.697490548990984,1.8594267642584574
NOMO-1,16725315,4.952538276899841,1.8594267642584574
KMRC-1,16736978,2.1404631421072975,1.8594267642584574
A-498,123631,3.2458168084526564,1.8594267642584574
MDA-MB-157,decitabine-carboplatin (1-1 mol-mol),3.837030982901149,1.8594267642584574
NCI-H1623,24951314,1.0133274480783143,1.8594267642584574
NCI-H661,11228183,4.275001578251326,1.8594267642584574
FTC-133,5479543,4.4305420476204205,1.8594267642584574
NCI-H292,136227924,3.1886204590132654,1.8594267642584574
A2780,6184667,2.4201329833494705,1.8594267642584574
SCC-9,5278396,3.934746070394729,1.8594267642584574
OPM-2,5743,-3.6176009576451142,1.8594267642584574
DMS 273,66577038,3.0260629384717443,1.8594267642584574
SBC-5,151289,0.3068057764327633,1.8594267642584574
A4/Fukuda,44491742,3.3943913096556444,1.8594267642584574
MDA-MB-453,135928012,3.1518499848728534,1.8594267642584574
A-673,2828334,5.945698490544337,1.8594267642584574
OVISE,44185566,3.1371413376940724,1.8594267642584574
FTC-133,tanespimycin-bortezomib (250-1 mol-mol),2.589157052333849,1.8594267642584574
KYSE-70,5460769,2.831605222646697,1.8594267642584574
EFO-27,60700,0.0275300045157078,1.8594267642584574
SNU-449,2871966,0.0642629453363792,1.8594267642584574
A-498,135411,0.9450284346401692,1.8594267642584574
CAL-51,151289,0.6583498849401344,1.8594267642584574
CAL-51,piperlongumine-MST-312 (1-1 mol-mol),2.124506315707809,1.8594267642584574
NCI-H292,54454,1.5363763322568371,1.8594267642584574
MDA-MB-453,984333,1.2010378495759917,1.8594267642584574
A2780,1242560,2.8030380184252346,1.8594267642584574
G-401,11625818,3.256149300060542,1.8594267642584574
EFO-27,2729026,3.178460421270277,1.8594267642584574
CAL-51,54454,2.240351559744082,1.8594267642584574
SNU-81,5470400,-5.232383325772668,1.8594267642584574
JM-1,selumetinib-tretinoin (2-1 mol-mol),2.58796154707147,1.8594267642584574
MDA-MB-453,tanespimycin-bortezomib (250-1 mol-mol),-3.425148302168821,1.8594267642584574
LoVo,51037431,2.9518330914759043,1.8594267642584574
NCI-H1623,57519531,2.253772853853667,1.8594267642584574
BxPC-3,6918837,-2.8801990347910045,1.8594267642584574
SNU-81,452548,-0.1759999006209261,1.8594267642584574
BT-549,327653,2.9888914918454854,1.8594267642584574
CA46,46199207,1.8825158344658808,1.8594267642584574
MDA-MB-157,10410894,1.6628456414259642,1.8594267642584574
SCC-9,66577038,2.999012470787333,1.8594267642584574
NOMO-1,6918878,0.4522523514749809,1.8594267642584574
SNU-61,5281321,-1.743716860572046,1.8594267642584574
SBC-5,decitabine-navitoclax (2-1 mol-mol),2.675632395894592,1.8594267642584574
HCC1143,9840324,5.44269474449066,1.8594267642584574
CA46,11234052,2.4794836109026077,1.8594267642584574
CA46,11609586,1.0102139081655188,1.8594267642584574
NCI-H460,10385095,2.2920897819597896,1.8594267642584574
BT-549,11625818,5.0921701677816875,1.8594267642584574
SW1463,400769,-0.5224692496950973,1.8594267642584574
Panc 04.03,10113978,5.097338218314276,1.8594267642584574
JM-1,9907093,3.962832886035932,1.8594267642584574
CAL-51,23582824,1.0413279539794644,1.8594267642584574
Panc 04.03,135398738,4.347297256699442,1.8594267642584574
G-401,3038522,2.1905688095022215,1.8594267642584574
HSC-4,selumetinib-vorinostat (8-1 mol-mol),2.2215922063973648,1.8594267642584574
NCI-H146,4261,-1.8051480987265105,1.8594267642584574
DMS 273,2729026,2.67706862921606,1.8594267642584574
SNU-81,1750826,0.9975547695410114,1.8594267642584574
CA46,168313200,1.9493207867170304,1.8594267642584574
OVISE,vorinostat-carboplatin (1-1 mol-mol),3.460247929578718,1.8594267642584574
A2780,57519531,1.3251208810116586,1.8594267642584574
OPM-2,navitoclax-sorafenib (1-1 mol-mol),1.274845961219173,1.8594267642584574
A4/Fukuda,11717001,3.8123333180630103,1.8594267642584574
LOU-NH91,3634881,3.4323223488487593,1.8594267642584574
JM-1,11485656,1.6613246077420758,1.8594267642584574
SNU-61,107985,-3.1587785808489297,1.8594267642584574
FTC-133,2729026,3.353273516564875,1.8594267642584574
ONS-76,159324,2.5690437216419677,1.8594267642584574
CAL-51,crizotinib-PLX-4032 (2-1 mol-mol),1.2740742707449055,1.8594267642584574
G-401,9927531,4.9703255494446035,1.8594267642584574
LOU-NH91,25105715,3.511519280721543,1.8594267642584574
SNU-61,15953870,3.2687219409332657,1.8594267642584574
NCI-H2009,navitoclax-gemcitabine (1-1 mol-mol),0.4354090663504973,1.8594267642584574
EFO-27,24951314,0.9989426715403756,1.8594267642584574
MSTO-211H,5311,0.950405781568164,1.8594267642584574
A-673,9444,4.054770941664931,1.8594267642584574
MDA-MB-453,6852167,1.219966928776707,1.8594267642584574
DMS 273,3384730,2.794672653243152,1.8594267642584574
NCI-H522,24964624,3.0091798278143003,1.8594267642584574
DMS 273,6918878,0.6913807013381441,1.8594267642584574
CAL-51,selumetinib-BRD-A02303741 (4-1 mol-mol),6.310844826141485,1.8594267642584574
CAL-51,5311,1.4183219405835503,1.8594267642584574
SNU-449,3136844,4.333259755823753,1.8594267642584574
SNU-61,10074640,3.0465009012673923,1.8594267642584574
NCI-H292,5738263,3.605646843776872,1.8594267642584574
NCI-H2009,135440466,0.1778924686528867,1.8594267642584574
SBC-5,387447,-4.42204631831661,1.8594267642584574
HSC-4,60700,-2.3901041148359,1.8594267642584574
Panc 04.03,navitoclax-PLX-4032 (1-1 mol-mol),3.364460655624257,1.8594267642584574
BxPC-3,322968,4.585795478380971,1.8594267642584574
CA46,24821094,1.9467424475066963,1.8594267642584574
SNU-449,5282054,4.57557530009064,1.8594267642584574
CAL-51,11625818,4.1129054868405905,1.8594267642584574
A2780,16038120,0.4203115446628392,1.8594267642584574
MDA-MB-453,44484893,4.218904183145372,1.8594267642584574
YAPC,969516,2.7207948170212894,1.8594267642584574
SCC-9,6914657,-2.6898440352771704,1.8594267642584574
BT-549,156414,4.402880659642667,1.8594267642584574
A2780,10410894,2.69442494781606,1.8594267642584574
HSC-4,1566236,1.9723291328750472,1.8594267642584574
CAL-51,53232,2.8018516258833395,1.8594267642584574
NCI-H522,73707371,4.918377506073214,1.8594267642584574
FTC-133,2858523,3.137647378022636,1.8594267642584574
NCI-H146,2949965,2.1998257096859235,1.8594267642584574
A2780,5291,3.6974106280730767,1.8594267642584574
A-673,11317348,1.5484644948233677,1.8594267642584574
CA46,5284616,-8.167802056045408,1.8594267642584574
FU-OV-1,9840324,7.491199941931371,1.8594267642584574
NCI-H292,17759555,3.476208496969499,1.8594267642584574
NCI-H2009,6918837,-3.78935135271195,1.8594267642584574
NCI-H460,216345,3.827300936034388,1.8594267642584574
BxPC-3,54143018,-0.804639103071218,1.8594267642584574
SNU-449,11612883,3.957753067546404,1.8594267642584574
DMS 273,49867930,4.404291499076759,1.8594267642584574
FTC-133,15953870,4.441911294632587,1.8594267642584574
NCI-H522,11612883,3.3366707819202666,1.8594267642584574
A2780,9444,3.815396075990075,1.8594267642584574
NCI-H460,54619267,4.901891634717457,1.8594267642584574
SNU-449,salermide-PLX-4032 (12-1 mol-mol),5.474676464487576,1.8594267642584574
LXF 289,doxorubicin-navitoclax (2-1 mol-mol),0.6583204224583108,1.8594267642584574
A4/Fukuda,4521392,3.820585335578038,1.8594267642584574
CA46,5328940,1.1838617633473132,1.8594267642584574
NCI-H460,452548,0.6919333948360032,1.8594267642584574
YAPC,25126798,3.983335704988987,1.8594267642584574
SNU-449,322968,4.603056923598163,1.8594267642584574
SNU-61,54618164,4.021673833793196,1.8594267642584574
NCI-H661,400769,-1.492892337104586,1.8594267642584574
G-401,24964624,1.4880998129973728,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],702558,5.773616649362023,1.8594267642584574
OVISE,2945648,2.8352179600513367,1.8594267642584574
FU-OV-1,JQ-1-UNC0638 (2-1 mol-mol),1.6948403130228156,1.8594267642584574
BxPC-3,984333,0.8836461068661873,1.8594267642584574
NCI-H1623,42642645,0.9313727170286358,1.8594267642584574
BxPC-3,71466445,4.819923879864087,1.8594267642584574
MSTO-211H,126941,-2.2791548116201987,1.8594267642584574
MSTO-211H,20959075,-3.222615813929693,1.8594267642584574
BxPC-3,16741245,5.048799679028713,1.8594267642584574
OVISE,12001922,2.261742632923514,1.8594267642584574
NCI-H2171,135440466,1.9220793929810305,1.8594267642584574
BT-549,119182,-0.6766164524597643,1.8594267642584574
KMRC-1,65064,5.386842832596526,1.8594267642584574
ONS-76,16725315,4.104726960292652,1.8594267642584574
ONS-76,6505803,1.3937943977095182,1.8594267642584574
MDA-MB-453,JQ-1-navitoclax (2-1 mol-mol),-0.5308919352690735,1.8594267642584574
FU-OV-1,25062766,2.359728819743937,1.8594267642584574
KMRC-1,5566,3.18269246163038,1.8594267642584574
NCI-H460,6438330,3.783082395235063,1.8594267642584574
CAL-51,135440466,2.9511327404143755,1.8594267642584574
DMS 273,23582824,1.3511796414129456,1.8594267642584574
CAL-51,56946209,-4.496983035262223,1.8594267642584574
OVISE,176870,4.342841287056181,1.8594267642584574
KMRC-1,11494412,2.978505743964039,1.8594267642584574
A4/Fukuda,54454,2.014078017992857,1.8594267642584574
MDA-MB-453,2733526,2.894784526555574,1.8594267642584574
HSC-4,11625818,4.485436042124793,1.8594267642584574
NCI-H727,2733487,6.440431233061491,1.8594267642584574
HSC-4,54618771,2.9865797342969564,1.8594267642584574
CAL-51,12003241,-1.2189714227076325,1.8594267642584574
A4/Fukuda,52912189,-0.8285591911559074,1.8594267642584574
NCI-H460,SNX-2112-bortezomib (250-1 mol-mol),-0.7287978777704803,1.8594267642584574
CAL-51,6610355,4.388066889778601,1.8594267642584574
SNU-81,sirolimus-bortezomib (250-1 mol-mol),1.681791395416448,1.8594267642584574
NCI-H1623,56649450,-0.2540238687607088,1.8594267642584574
A4/Fukuda,9444,3.1818692272898423,1.8594267642584574
NCI-H2171,55508,1.786136919471965,1.8594267642584574
NCI-H522,9840324,6.2981118504366735,1.8594267642584574
DMS 273,409805,3.6932334728164826,1.8594267642584574
SNU-81,selumetinib-UNC0638 (4-1 mol-mol),-1.1313432157917445,1.8594267642584574
NCI-H727,16722836,1.5817712487099789,1.8594267642584574
HSC-4,selumetinib-decitabine (4-1 mol-mol),5.3885261906416275,1.8594267642584574
G-401,5281672,4.259815588040996,1.8594267642584574
FTC-133,4917,3.819256860929221,1.8594267642584574
YAPC,selumetinib-UNC0638 (4-1 mol-mol),2.613021216315863,1.8594267642584574
JM-1,10113978,2.290370569955518,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],6917907,-5.490132832786946,1.8594267642584574
EFO-27,675434,4.38679148408465,1.8594267642584574
SNU-81,5460769,-2.0941921209529575,1.8594267642584574
BxPC-3,5282054,3.885649252328735,1.8594267642584574
OVISE,6184667,4.390472676016808,1.8594267642584574
G-401,16659841,2.2879294183156396,1.8594267642584574
HSC-4,19582717,4.479728463380205,1.8594267642584574
KYSE-70,1750826,1.0050628158627442,1.8594267642584574
LOU-NH91,135659046,3.4412725013745336,1.8594267642584574
HSC-4,11396600,3.0766488056466104,1.8594267642584574
KMRC-1,11964036,1.816670768699429,1.8594267642584574
MDA-MB-157,decitabine-navitoclax (2-1 mol-mol),-2.3403643839095607,1.8594267642584574
HCC1143,54618771,1.714955024233068,1.8594267642584574
A2780,8515,1.754639935244518,1.8594267642584574
FU-OV-1,36462,2.321134275550796,1.8594267642584574
OVISE,selumetinib-UNC0638 (4-1 mol-mol),4.700379518419309,1.8594267642584574
YAPC,216345,4.822006863531136,1.8594267642584574
ONS-76,tretinoin-navitoclax (4-1 mol-mol),3.585528237924169,1.8594267642584574
LOU-NH91,72193861,1.0473212139197163,1.8594267642584574
NCI-H2009,piperlongumine-MST-312 (1-1 mol-mol),1.2420237661253426,1.8594267642584574
CA46,54618164,3.845436645537388,1.8594267642584574
NCI-H292,446155,1.4424758906582096,1.8594267642584574
HCC1143,9936388,-6.988875343339418,1.8594267642584574
NCI-H727,9907093,4.262034183201205,1.8594267642584574
ONS-76,126941,-2.856353430413947,1.8594267642584574
A2780,11455910,-0.8495199814745813,1.8594267642584574
A2780,73707398,0.6651600447827565,1.8594267642584574
NCI-H2009,tanespimycin-bortezomib (250-1 mol-mol),-0.207724504276561,1.8594267642584574
MDA-MB-157,24856436,-0.6830375019554852,1.8594267642584574
LoVo,1750826,-1.736017877496402,1.8594267642584574
NCI-H146,49766530,4.81095512251176,1.8594267642584574
HCC1143,409805,4.31745443409651,1.8594267642584574
OVISE,159324,4.206537691518507,1.8594267642584574
SNU-81,10302451,3.60256279960024,1.8594267642584574
EFO-27,5282054,3.999430083075576,1.8594267642584574
LOU-NH91,4917,3.4124252266322297,1.8594267642584574
SCC-9,5328940,1.568072217369216,1.8594267642584574
OVISE,637858,1.8122421616924396,1.8594267642584574
NCI-H2171,44607531,0.7654225162387793,1.8594267642584574
SBC-5,7326481,1.449700392659346,1.8594267642584574
LXF 289,9907093,2.975231625485398,1.8594267642584574
G-401,SNX-2112-bortezomib (250-1 mol-mol),-1.620175957239239,1.8594267642584574
NCI-H522,navitoclax-MST-312 (1-1 mol-mol),0.9315063640095164,1.8594267642584574
KYSE-70,159324,1.7590392520862297,1.8594267642584574
NCI-H2009,3025944,4.548991530576528,1.8594267642584574
SNU-81,135398516,1.5373988209241822,1.8594267642584574
A-673,9911463,3.7053308577681583,1.8594267642584574
CAL-51,9826308,0.5677925602140103,1.8594267642584574
SNU-449,10074640,3.65403010435808,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],216468,3.6601371592015273,1.8594267642584574
A4/Fukuda,doxorubicin-navitoclax (2-1 mol-mol),-2.572338922039687,1.8594267642584574
JM-1,11213558,1.11781575024048,1.8594267642584574
FTC-133,navitoclax-MST-312 (1-1 mol-mol),0.3680672721218185,1.8594267642584574
DMS 273,11396600,2.9821670224503025,1.8594267642584574
CAL-51,2742550,4.689941422286605,1.8594267642584574
SCC-9,salermide-PLX-4032 (12-1 mol-mol),5.953204050581384,1.8594267642584574
NOMO-1,24856436,-0.4465471145990737,1.8594267642584574
BxPC-3,54454,2.2110977916594945,1.8594267642584574
NCI-H2009,selumetinib-decitabine (4-1 mol-mol),-0.75536294855302,1.8594267642584574
A4/Fukuda,selumetinib-BRD-A02303741 (4-1 mol-mol),0.8807124285351838,1.8594267642584574
LoVo,54678924,0.9602640778132784,1.8594267642584574
MDA-MB-157,JQ-1-carboplatin (1-1 mol-mol),3.3337524262441853,1.8594267642584574
NCI-H460,9911463,4.421747687015995,1.8594267642584574
CAL-51,3062316,-2.5625958708444205,1.8594267642584574
G-401,11404337,0.5096427987118028,1.8594267642584574
A4/Fukuda,107985,-4.34456564276242,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],25262965,2.4523456450078323,1.8594267642584574
SNU-61,9956119,3.7156714580567063,1.8594267642584574
FU-OV-1,navitoclax-gemcitabine (1-1 mol-mol),3.0788972572820597,1.8594267642584574
EFO-27,53301938,6.290465616373669,1.8594267642584574
NCI-H727,17759555,3.180616959518291,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],3503,2.644951314615224,1.8594267642584574
SNU-61,44819697,3.53302657640718,1.8594267642584574
FTC-133,16065773,0.3113531910395277,1.8594267642584574
G-401,tretinoin-navitoclax (4-1 mol-mol),3.928321185847307,1.8594267642584574
HSC-4,navitoclax-pluripotin (1-1 mol-mol),0.2476370471109345,1.8594267642584574
NCI-H2009,107985,-3.3237358160703843,1.8594267642584574
NCI-H146,3676137,4.978597159303883,1.8594267642584574
NCI-H146,16065773,1.505871551892472,1.8594267642584574
CAL-51,selumetinib-PLX-4032 (8-1 mol-mol),4.984071600611491,1.8594267642584574
NCI-H661,60700,0.4833445990508663,1.8594267642584574
A-673,selumetinib-tretinoin (2-1 mol-mol),4.294042915691989,1.8594267642584574
MDA-MB-453,44491742,4.088527945953042,1.8594267642584574
NCI-H661,2945648,2.4705894827529984,1.8594267642584574
FU-OV-1,12001922,2.2107336164209586,1.8594267642584574
SNU-81,serdemetan-SCH-529074 (1-1 mol-mol),1.2075198291977594,1.8594267642584574
FTC-133,168312962,3.97521401805193,1.8594267642584574
NCI-H2009,24951314,0.5822698862930126,1.8594267642584574
Panc 04.03,3552672,4.635312487107652,1.8594267642584574
HCC1143,16725315,4.684699585721338,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11626560,1.948909455015208,1.8594267642584574
A4/Fukuda,67156097,-3.3575882698535526,1.8594267642584574
NCI-H460,44507138,4.578042897326484,1.8594267642584574
BT-549,262093,3.1295246575488354,1.8594267642584574
A-673,BRD-A02303741-navitoclax (2-1 mol-mol),2.626339202884455,1.8594267642584574
LOU-NH91,23635314,-2.2216361010230545,1.8594267642584574
HSC-4,11485656,2.41592786996926,1.8594267642584574
Panc 04.03,2858523,3.1704472292667245,1.8594267642584574
CAL-51,31703,-2.726607914110417,1.8594267642584574
SCC-9,11485656,3.6663619913543446,1.8594267642584574
EFO-27,11234052,4.354926990140025,1.8594267642584574
NOMO-1,11977753,-1.9426292333262003,1.8594267642584574
NCI-H146,5280436,1.6778415991784894,1.8594267642584574
SCC-9,44589607,3.476138487776652,1.8594267642584574
YAPC,1716436,3.308380745751715,1.8594267642584574
MSTO-211H,72376,-3.945669301292739,1.8594267642584574
CA46,6438330,0.8057128440407828,1.8594267642584574
SNU-81,46907787,-1.0582449369350613,1.8594267642584574
ONS-76,53232,1.9476307600046912,1.8594267642584574
SCC-9,51037431,5.108150298111964,1.8594267642584574
SNU-61,11719255,3.5581483316812275,1.8594267642584574
BxPC-3,serdemetan-SCH-529074 (1-1 mol-mol),1.9726746361730008,1.8594267642584574
NCI-H522,8515,4.67214972936148,1.8594267642584574
A2780,104842,-8.58016789938804,1.8594267642584574
KYSE-70,56946209,-4.444419695204879,1.8594267642584574
NCI-H2171,46191454,1.782184086758524,1.8594267642584574
NCI-H292,54618305,4.4370648491662195,1.8594267642584574
A-498,16725315,5.296109915632034,1.8594267642584574
A-498,11494412,3.741733086313002,1.8594267642584574
JM-1,36314,-7.745176622378906,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],17755052,4.178055403408082,1.8594267642584574
LOU-NH91,JQ-1-UNC0638 (2-1 mol-mol),1.6963345544096158,1.8594267642584574
A-673,erlotinib-PLX-4032 (2-1 mol-mol),2.801712278221697,1.8594267642584574
BxPC-3,72734382,5.457836982387995,1.8594267642584574
NCI-H2009,72734382,3.739945681050146,1.8594267642584574
CAL-51,65064,3.306239750209062,1.8594267642584574
A4/Fukuda,6252,-3.645065834912594,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],6914657,-2.702554466691394,1.8594267642584574
A-673,36462,-0.225010248526114,1.8594267642584574
BT-549,25195348,2.629764497852918,1.8594267642584574
ONS-76,3385,3.2517912405561784,1.8594267642584574
A-498,73707398,1.745059470984177,1.8594267642584574
A-673,56963564,0.0212663307031236,1.8594267642584574
NCI-H522,984333,-0.7488997443424653,1.8594267642584574
NCI-H292,452548,1.0483210578903834,1.8594267642584574
NCI-H661,57330099,4.147264508988866,1.8594267642584574
KMRC-1,11167602,5.704956856257104,1.8594267642584574
YAPC,25150857,2.3485140693919178,1.8594267642584574
LoVo,6918878,0.5506920931363443,1.8594267642584574
LoVo,5282054,3.3404837473565077,1.8594267642584574
G-401,445643,3.8388087856424,1.8594267642584574
Panc 04.03,31703,0.9238663549391216,1.8594267642584574
KMRC-1,25150857,2.932634990579502,1.8594267642584574
LXF 289,9903786,1.8485652979864533,1.8594267642584574
MDA-MB-157,navitoclax-pluripotin (1-1 mol-mol),-3.540221681232844,1.8594267642584574
Panc 04.03,25227462,1.6849134644206611,1.8594267642584574
LoVo,5328940,0.1711764774474706,1.8594267642584574
SNU-81,49850262,-1.5447601433950633,1.8594267642584574
CA46,46215462,1.3062506059575565,1.8594267642584574
MDA-MB-157,219104,2.454471278072077,1.8594267642584574
MSTO-211H,168313047,1.6297190097298295,1.8594267642584574
NCI-H522,16722836,1.5816295407965617,1.8594267642584574
OPM-2,54626689,3.88605573030338,1.8594267642584574
DMS 273,60700,-0.3389173956036069,1.8594267642584574
OPM-2,crizotinib-PLX-4032 (2-1 mol-mol),0.9302198277032876,1.8594267642584574
SNU-81,9826308,-1.744878476856413,1.8594267642584574
NCI-H661,selumetinib-PLX-4032 (8-1 mol-mol),2.9532845148669495,1.8594267642584574
NCI-H292,72734382,4.432039940054941,1.8594267642584574
NCI-H661,11507802,0.3336368123539006,1.8594267642584574
Panc 04.03,676352,2.180457258433582,1.8594267642584574
FTC-133,322968,4.798855030018761,1.8594267642584574
G-401,16720766,1.0481135004094,1.8594267642584574
G-401,462382,0.38796721763981,1.8594267642584574
MSTO-211H,25062766,2.0532887481804605,1.8594267642584574
A2780,16736978,-0.7643928517553599,1.8594267642584574
NCI-H727,2729026,3.015864992302643,1.8594267642584574
CAL-51,135440466,2.9511327404143755,1.8594267642584574
A-498,selumetinib-MK-2206 (8-1 mol-mol),1.8815723158535835,1.8594267642584574
BT-549,72376,-0.6560931555152002,1.8594267642584574
A-673,9933475,1.583729012108943,1.8594267642584574
ONS-76,navitoclax-gemcitabine (1-1 mol-mol),0.9931716655175384,1.8594267642584574
EFO-27,135875424,4.6207788215281465,1.8594267642584574
A-673,24785538,-1.1944412082957694,1.8594267642584574
CA46,135659046,2.986085914123542,1.8594267642584574
CA46,3038522,1.2076902647573031,1.8594267642584574
MSTO-211H,54626689,2.3486455994654767,1.8594267642584574
SNU-61,44241473,4.262106100814371,1.8594267642584574
MDA-MB-157,25126798,2.9199314308838327,1.8594267642584574
SNU-449,10410894,3.985550363358928,1.8594267642584574
LXF 289,53232,1.5859701947912777,1.8594267642584574
ONS-76,JQ-1-vorinostat (2-1 mol-mol),1.13707340055611,1.8594267642584574
DMS 273,11234052,4.3748762471871725,1.8594267642584574
A2780,107985,-4.859396565896689,1.8594267642584574
Panc 04.03,44202524,4.489701680422056,1.8594267642584574
LOU-NH91,44185566,3.062522771292805,1.8594267642584574
NCI-H727,selumetinib-vorinostat (8-1 mol-mol),-1.6328295941141144,1.8594267642584574
EFO-27,36462,3.079082429258617,1.8594267642584574
JM-1,24821094,1.723225199642946,1.8594267642584574
KMRC-1,216345,4.164305633353381,1.8594267642584574
NOMO-1,168313047,1.7455342513633885,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],carboplatin-etoposide (40-17 mol-mol),3.7784194640429822,1.8594267642584574
NCI-H522,5282054,2.516149277526254,1.8594267642584574
SNU-81,26596,-2.2143193215677925,1.8594267642584574
LOU-NH91,135875424,2.9424536382603215,1.8594267642584574
HCC1143,446155,3.993343592958968,1.8594267642584574
NCI-H1623,selumetinib-piperlongumine (8-1 mol-mol),4.451549095180413,1.8594267642584574
LXF 289,3081361,2.235375481166719,1.8594267642584574
Panc 04.03,6918638,0.956445062850862,1.8594267642584574
ONS-76,46907787,2.0367347893242247,1.8594267642584574
FTC-133,5470400,2.075616738071143,1.8594267642584574
SNU-449,9884685,0.40134732620175,1.8594267642584574
FTC-133,44566777,0.1715240988601806,1.8594267642584574
KMRC-1,9911830,2.7576147713752532,1.8594267642584574
LoVo,navitoclax-pluripotin (1-1 mol-mol),-2.104287475086767,1.8594267642584574
SNU-61,119607,4.552023022199627,1.8594267642584574
FU-OV-1,2945648,2.6612648927829348,1.8594267642584574
CAL-51,5282054,3.552468823116285,1.8594267642584574
A-673,1750826,-4.326827801164573,1.8594267642584574
NCI-H661,23582824,0.4459994130921247,1.8594267642584574
A4/Fukuda,208908,1.6750686900112284,1.8594267642584574
LXF 289,24180719,2.719444673565486,1.8594267642584574
MDA-MB-453,11647372,0.3935032395331521,1.8594267642584574
NOMO-1,54454,3.4949720971193083,1.8594267642584574
SBC-5,1750826,-0.5333690682178334,1.8594267642584574
SNU-449,11234052,5.346874708028275,1.8594267642584574
LXF 289,159324,2.685439807189008,1.8594267642584574
A-498,11964036,1.806054574855834,1.8594267642584574
CA46,SNX-2112-bortezomib (250-1 mol-mol),-3.5188600200549507,1.8594267642584574
NCI-H460,piperlongumine-MST-312 (1-1 mol-mol),2.8290325142840036,1.8594267642584574
NOMO-1,11178236,-2.492998231075174,1.8594267642584574
BxPC-3,3503,1.5238678808710824,1.8594267642584574
A2780,5281672,4.494440141018236,1.8594267642584574
NCI-H460,57519531,1.7606196796007008,1.8594267642584574
NCI-H146,3038522,1.5824622735127496,1.8594267642584574
NCI-H146,alisertib-navitoclax (2-1 mol-mol),-3.5747410805145425,1.8594267642584574
A2780,7251185,3.0282253021168835,1.8594267642584574
NCI-H2009,54143018,-0.2798924220132643,1.8594267642584574
NCI-H661,navitoclax-pluripotin (1-1 mol-mol),-0.6328260588885871,1.8594267642584574
A-673,50905018,4.224820228350104,1.8594267642584574
SBC-5,sirolimus-bortezomib (250-1 mol-mol),0.8879652697006557,1.8594267642584574
A2780,11640390,3.511086163886132,1.8594267642584574
NOMO-1,984333,-1.7512214516120577,1.8594267642584574
NCI-H292,3062316,0.0480521305272509,1.8594267642584574
NCI-H1623,25183872,0.2518729007636168,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],46907787,1.929794927586623,1.8594267642584574
DMS 273,11647372,0.2469617170644157,1.8594267642584574
KMRC-1,12001922,2.9414276180440884,1.8594267642584574
A2780,54143018,-1.3409986451592475,1.8594267642584574
YAPC,49793307,-4.348408449857898,1.8594267642584574
CA46,1716436,3.005257864158129,1.8594267642584574
HSC-4,676352,2.328446260179327,1.8594267642584574
LoVo,erlotinib-PLX-4032 (2-1 mol-mol),1.656921727064621,1.8594267642584574
YAPC,12001922,1.7591466639310227,1.8594267642584574
MSTO-211H,5460769,-2.0887143253822615,1.8594267642584574
CA46,3384730,2.283076300956678,1.8594267642584574
JM-1,9911830,1.0886367976495992,1.8594267642584574
BxPC-3,1242560,2.823718248478356,1.8594267642584574
G-401,44237094,3.2290132612915325,1.8594267642584574
BxPC-3,16736978,1.696086021540879,1.8594267642584574
SNU-61,46191454,1.739312628335972,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.948451755079763,1.8594267642584574
NCI-H460,5329102,3.240160570329804,1.8594267642584574
NCI-H460,serdemetan-SCH-529074 (1-1 mol-mol),2.824761318038116,1.8594267642584574
LXF 289,216468,2.2889797638929683,1.8594267642584574
SCC-9,44819697,0.1293575980749295,1.8594267642584574
Panc 04.03,675434,5.243078667682196,1.8594267642584574
HCC1143,135398516,2.188515967576281,1.8594267642584574
ONS-76,25262965,-0.7369683376858831,1.8594267642584574
A4/Fukuda,53392493,1.8640822641046917,1.8594267642584574
A-673,2130404,3.217416760546526,1.8594267642584574
NCI-H661,72193861,0.3965882674238952,1.8594267642584574
CA46,119607,3.9558807366301374,1.8594267642584574
CAL-51,24856436,-0.3083697359271743,1.8594267642584574
NCI-H2009,2828334,6.796615650463657,1.8594267642584574
JM-1,135398738,1.1596934849395544,1.8594267642584574
CAL-51,49793307,-3.2015156477281193,1.8594267642584574
HSC-4,10410894,2.7401570440851155,1.8594267642584574
KYSE-70,46843906,3.5210263801871498,1.8594267642584574
KYSE-70,11178236,-1.2639965798928303,1.8594267642584574
EFO-27,6610216,4.772563131438148,1.8594267642584574
JM-1,135659046,3.550517545140938,1.8594267642584574
A4/Fukuda,3136844,3.333855932915555,1.8594267642584574
KYSE-70,53495165,0.5494520653774981,1.8594267642584574
EFO-27,9926054,1.857839666788878,1.8594267642584574
NCI-H460,16741245,2.175171044948558,1.8594267642584574
NCI-H727,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.2513080779268564,1.8594267642584574
MSTO-211H,SNX-2112-bortezomib (250-1 mol-mol),-1.2312117350271496,1.8594267642584574
NCI-H661,107970,2.2398777867932473,1.8594267642584574
LoVo,selumetinib-decitabine (4-1 mol-mol),1.6918156459461149,1.8594267642584574
SNU-61,51039095,2.128467827492616,1.8594267642584574
YAPC,104842,-2.4249346234244302,1.8594267642584574
EFO-27,11364421,0.0539420857608272,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],71304818,3.0028368617128485,1.8594267642584574
HSC-4,5284616,2.67117659303102,1.8594267642584574
NCI-H146,UNC0638-navitoclax (1-1 mol-mol),-1.9432589760731351,1.8594267642584574
KMRC-1,100016,6.458679548763862,1.8594267642584574
A2780,JQ-1-MK-0752 (1-1 mol-mol),0.9266829250462012,1.8594267642584574
SNU-81,UNC0638-navitoclax (1-1 mol-mol),0.5211429629753735,1.8594267642584574
LXF 289,10184653,0.2846387514020494,1.8594267642584574
G-401,docetaxel-tanespimycin (2-1 mol-mol),-6.677172451643826,1.8594267642584574
ONS-76,73707438,3.6763163562039103,1.8594267642584574
CA46,10113978,2.0547387812543425,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],216345,4.578948480850923,1.8594267642584574
MDA-MB-453,9444,3.890114397090033,1.8594267642584574
DMS 273,462382,0.1050500144131629,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],selumetinib-MK-2206 (8-1 mol-mol),1.8238867716534872,1.8594267642584574
SNU-449,327653,3.836895463512291,1.8594267642584574
JM-1,4917,2.618606210388543,1.8594267642584574
A-673,7326481,2.3948672158707027,1.8594267642584574
LoVo,3543504,4.109477120593384,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],439501,-1.003670618583837,1.8594267642584574
FU-OV-1,322968,2.943455676205593,1.8594267642584574
CAL-51,selumetinib-decitabine (4-1 mol-mol),5.605446855061176,1.8594267642584574
NCI-H522,10172275,5.332939953657848,1.8594267642584574
FU-OV-1,11175137,4.687876560675478,1.8594267642584574
NCI-H292,702558,5.809534673466565,1.8594267642584574
JM-1,UNC0638-navitoclax (1-1 mol-mol),0.2019375485573805,1.8594267642584574
FTC-133,4378219,2.0024564120700874,1.8594267642584574
A-673,322968,2.685664332943325,1.8594267642584574
A4/Fukuda,11175137,1.0544671313881684,1.8594267642584574
NCI-H522,9907093,4.234502914187168,1.8594267642584574
NCI-H460,73707398,3.251551904382877,1.8594267642584574
NCI-H1623,11625818,3.770410958253076,1.8594267642584574
NCI-H2171,3384730,2.17478810564445,1.8594267642584574
EFO-27,navitoclax-gemcitabine (1-1 mol-mol),2.157503731341055,1.8594267642584574
BxPC-3,135398516,1.0474106677719497,1.8594267642584574
YAPC,6852167,3.757016833172803,1.8594267642584574
HCC1143,11178236,-3.0622306456236728,1.8594267642584574
LoVo,168313047,1.791039731088859,1.8594267642584574
CA46,9915743,0.7447060154867644,1.8594267642584574
CA46,16065773,1.8844207098737984,1.8594267642584574
DMS 273,2749,1.7681499736943271,1.8594267642584574
OPM-2,9549297,1.1861201303789202,1.8594267642584574
MDA-MB-157,selumetinib-PLX-4032 (8-1 mol-mol),5.042710602125305,1.8594267642584574
G-401,3136844,3.887156631896907,1.8594267642584574
NCI-H727,24901704,2.771852034083143,1.8594267642584574
LOU-NH91,serdemetan-SCH-529074 (1-1 mol-mol),2.4104201077494913,1.8594267642584574
ONS-76,36314,-4.67770988102335,1.8594267642584574
A4/Fukuda,navitoclax-piperlongumine (1-1 mol-mol),0.9145762959476356,1.8594267642584574
LXF 289,navitoclax-gemcitabine (1-1 mol-mol),-0.2472011757618401,1.8594267642584574
NCI-H146,54618771,0.1782763900918093,1.8594267642584574
LXF 289,navitoclax-pluripotin (1-1 mol-mol),-1.4421954677948514,1.8594267642584574
BT-549,1750826,-1.15792790160721,1.8594267642584574
A-673,4521392,3.83212246390289,1.8594267642584574
A-498,10127622,2.6897842830613934,1.8594267642584574
NCI-H146,24951314,0.0243539025761212,1.8594267642584574
LXF 289,11404337,0.1273620702572638,1.8594267642584574
CAL-51,72376,-2.938334648898351,1.8594267642584574
HSC-4,56946209,-4.10163917558625,1.8594267642584574
OPM-2,11719255,1.0053781432887028,1.8594267642584574
EFO-27,selumetinib-vorinostat (8-1 mol-mol),2.529072801083276,1.8594267642584574
OPM-2,54765302,3.66991118627716,1.8594267642584574
YAPC,107970,2.510985201601563,1.8594267642584574
A4/Fukuda,6505803,0.0348674492980193,1.8594267642584574
NCI-H146,421610,3.280213272702812,1.8594267642584574
CA46,10427712,3.800630662833656,1.8594267642584574
Panc 04.03,42611257,4.903884607697216,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],24785538,2.5999055228125254,1.8594267642584574
SBC-5,54618771,0.9612938071948806,1.8594267642584574
NOMO-1,44819697,-3.3724853213010895,1.8594267642584574
SNU-449,46843906,3.9850337221839074,1.8594267642584574
A-673,2733526,4.173930306540303,1.8594267642584574
Panc 04.03,387447,-4.060832381569581,1.8594267642584574
ONS-76,16038120,1.944596111088229,1.8594267642584574
Panc 04.03,12001922,2.0215480430072588,1.8594267642584574
EFO-27,56946209,-4.24663912291577,1.8594267642584574
A4/Fukuda,15983966,4.102938700353478,1.8594267642584574
NCI-H522,10322450,3.5945001970925787,1.8594267642584574
CAL-51,SNX-2112-bortezomib (250-1 mol-mol),-1.7705274817452763,1.8594267642584574
BT-549,16038120,1.0292862217749383,1.8594267642584574
JM-1,selumetinib-JQ-1 (4-1 mol-mol),0.3812013730118292,1.8594267642584574
FU-OV-1,selumetinib-navitoclax (8-1 mol-mol),1.6329291252143736,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],9936388,1.970083737001912,1.8594267642584574
OPM-2,10302451,3.176323712036339,1.8594267642584574
BT-549,5291,3.9626748190842167,1.8594267642584574
A4/Fukuda,54143018,0.5698360241890451,1.8594267642584574
CAL-51,5113032,4.55807021159329,1.8594267642584574
A-673,navitoclax-sorafenib (1-1 mol-mol),1.9636796155178384,1.8594267642584574
KMRC-1,15983966,1.4470823508624893,1.8594267642584574
SBC-5,409805,5.881004535625117,1.8594267642584574
MSTO-211H,11717001,4.186640197436745,1.8594267642584574
MSTO-211H,5351362,0.1292531164344693,1.8594267642584574
BxPC-3,navitoclax-MST-312 (1-1 mol-mol),1.414454953268366,1.8594267642584574
A-673,135398738,4.1394757023123505,1.8594267642584574
NCI-H2009,navitoclax-pluripotin (1-1 mol-mol),-1.5280134971991166,1.8594267642584574
NCI-H2009,12001922,2.0619007134450524,1.8594267642584574
CAL-51,3634881,3.319714226315486,1.8594267642584574
SCC-9,5282054,4.577178009511458,1.8594267642584574
SNU-449,6610355,5.42598000328545,1.8594267642584574
JM-1,100016,5.094244415703564,1.8594267642584574
DMS 273,16720766,1.3424969772091375,1.8594267642584574
MDA-MB-453,82146,5.197355724890258,1.8594267642584574
NCI-H727,219104,4.385991256377306,1.8594267642584574
G-401,387447,-4.890417311710873,1.8594267642584574
SNU-61,445643,4.910443238015828,1.8594267642584574
G-401,445091,4.490925944707375,1.8594267642584574
Panc 04.03,10074640,3.644812120140466,1.8594267642584574
KYSE-70,3038522,4.319477989558539,1.8594267642584574
NCI-H727,5311281,4.417954223041409,1.8594267642584574
OPM-2,24889392,2.046562304125139,1.8594267642584574
OPM-2,9866186,1.7779199456036283,1.8594267642584574
NCI-H292,65628,4.3235700442832625,1.8594267642584574
JM-1,5284329,3.614100674193798,1.8594267642584574
LoVo,49850262,2.4887252685350227,1.8594267642584574
BxPC-3,24785538,1.143761767664292,1.8594267642584574
LoVo,176870,1.1282563754131285,1.8594267642584574
OVISE,selumetinib-GDC-0941 (4-1 mol-mol),0.6038813555942163,1.8594267642584574
EFO-27,73707398,1.1269975883077623,1.8594267642584574
CAL-51,49850262,3.6300011952383584,1.8594267642584574
NCI-H2009,1750826,0.0733322198534379,1.8594267642584574
LOU-NH91,9903786,3.184012464559237,1.8594267642584574
NOMO-1,9911463,3.1879476164010243,1.8594267642584574
A2780,16722836,0.6661441985838381,1.8594267642584574
MDA-MB-453,11238147,2.2482376857817856,1.8594267642584574
NCI-H2009,11626560,0.9059448501577204,1.8594267642584574
LoVo,2746,2.3133613771451524,1.8594267642584574
NCI-H661,9840324,5.7754199175322825,1.8594267642584574
SNU-61,10385095,2.7560205308704044,1.8594267642584574
A4/Fukuda,24771867,-3.7385177445932585,1.8594267642584574
NCI-H727,654092,0.4388886539996767,1.8594267642584574
NCI-H661,44507138,1.7319125686737762,1.8594267642584574
EFO-27,16013152,4.523705738143722,1.8594267642584574
CAL-51,4259181,-0.5132501801478601,1.8594267642584574
A4/Fukuda,2746,1.0000278581130588,1.8594267642584574
NOMO-1,10184653,1.080224838410231,1.8594267642584574
Panc 04.03,135398516,3.776050709281408,1.8594267642584574
YAPC,3038522,4.3203914817087234,1.8594267642584574
NCI-H292,9926054,1.8794077191249725,1.8594267642584574
NCI-H661,5278396,2.727600530538007,1.8594267642584574
BxPC-3,JQ-1-carboplatin (1-1 mol-mol),1.4385682837687654,1.8594267642584574
A2780,9803433,4.475774001896097,1.8594267642584574
MDA-MB-157,11178236,-4.597953573249134,1.8594267642584574
ONS-76,44137675,3.612845962454732,1.8594267642584574
LoVo,51039095,1.8047028032602028,1.8594267642584574
NCI-H522,tanespimycin-gemcitabine (1-1 mol-mol),-2.467840431866496,1.8594267642584574
SNU-61,25183872,0.0265852822027559,1.8594267642584574
NCI-H661,10410894,2.079430431888453,1.8594267642584574
NCI-H1623,11497983,5.112351206162292,1.8594267642584574
FTC-133,navitoclax-gemcitabine (1-1 mol-mol),-2.9541403252647744,1.8594267642584574
NCI-H522,6184667,2.532079714436212,1.8594267642584574
MDA-MB-157,selumetinib-navitoclax (8-1 mol-mol),-0.2333098537360622,1.8594267642584574
NCI-H2009,44589607,3.679148722712513,1.8594267642584574
EFO-27,44137675,3.925812188621705,1.8594267642584574
FTC-133,5328940,3.204514542529291,1.8594267642584574
FTC-133,2708,3.4116435244290773,1.8594267642584574
NCI-H661,24901704,2.3315866691701395,1.8594267642584574
MSTO-211H,11719255,2.56955632094912,1.8594267642584574
OVISE,11626560,2.348997135596899,1.8594267642584574
OPM-2,ISOX-bortezomib (250-1 mol-mol),-0.1945134958657626,1.8594267642584574
CAL-51,9868037,3.5441777448678615,1.8594267642584574
MDA-MB-157,5328940,1.5742504795877947,1.8594267642584574
BxPC-3,19582717,4.685369750995796,1.8594267642584574
MSTO-211H,6852167,2.890925130180435,1.8594267642584574
CAL-51,5746,-0.6872762444946757,1.8594267642584574
OVISE,17759555,4.197708618199663,1.8594267642584574
EFO-27,6918638,-0.5643283195590469,1.8594267642584574
JM-1,439501,-5.872076466297635,1.8594267642584574
NCI-H522,44486219,4.336787525166091,1.8594267642584574
SNU-449,11167602,2.762483283064935,1.8594267642584574
NCI-H661,11640390,3.9877189690607993,1.8594267642584574
SNU-449,216239,2.7953722371364473,1.8594267642584574
NOMO-1,17755052,-0.2814114025249274,1.8594267642584574
EFO-27,UNC0638-navitoclax (1-1 mol-mol),3.21943648938414,1.8594267642584574
A-498,54618771,1.1394352833671273,1.8594267642584574
CAL-51,176870,2.9999818119422175,1.8594267642584574
NCI-H292,11404337,-1.5117614396305947,1.8594267642584574
HSC-4,9911463,3.832706037448295,1.8594267642584574
DMS 273,5470400,-1.1243568241206934,1.8594267642584574
OPM-2,25183872,-4.3499490255982085,1.8594267642584574
CA46,tanespimycin-bortezomib (250-1 mol-mol),0.4718837425399894,1.8594267642584574
LOU-NH91,31703,0.5806868540812907,1.8594267642584574
NCI-H661,44493528,5.823125515558819,1.8594267642584574
SCC-9,10074640,3.673307032160535,1.8594267642584574
A4/Fukuda,11427553,0.0702382308883879,1.8594267642584574
SBC-5,568763,0.2965266090010964,1.8594267642584574
BT-549,25126798,3.990115132251306,1.8594267642584574
SNU-449,9933475,1.8242814161965168,1.8594267642584574
BT-549,2113511,7.745487386721322,1.8594267642584574
SCC-9,969516,2.533129063350548,1.8594267642584574
A-498,11178236,-0.0767055613398424,1.8594267642584574
YAPC,1242560,3.336355906074855,1.8594267642584574
YAPC,54626689,5.597039319211252,1.8594267642584574
SBC-5,BRD-A02303741-navitoclax (2-1 mol-mol),3.4496626470660807,1.8594267642584574
NCI-H522,JQ-1-carboplatin (1-1 mol-mol),0.3092817510850776,1.8594267642584574
HSC-4,6918837,-1.8301723200742368,1.8594267642584574
YAPC,656346,3.528875898488543,1.8594267642584574
LXF 289,5470400,3.745756378340341,1.8594267642584574
NCI-H2171,168312962,2.801787293375821,1.8594267642584574
MDA-MB-453,6918638,-1.2403270134347248,1.8594267642584574
NCI-H522,1566236,1.6835491869847783,1.8594267642584574
NCI-H661,24964624,2.8216778680067836,1.8594267642584574
NCI-H2009,5281672,4.642324044569225,1.8594267642584574
Panc 04.03,navitoclax-gemcitabine (1-1 mol-mol),1.3720951008161577,1.8594267642584574
NCI-H1623,16065773,2.4078381094703456,1.8594267642584574
CAL-51,46398810,2.084696284876613,1.8594267642584574
OPM-2,54143018,-0.7196855693728514,1.8594267642584574
SCC-9,15547703,2.91115041464476,1.8594267642584574
DMS 273,6914657,-3.971712341208325,1.8594267642584574
OPM-2,3676137,3.169610101166173,1.8594267642584574
OVISE,3025944,5.5857056433387235,1.8594267642584574
Panc 04.03,4259181,1.0934261994249337,1.8594267642584574
A2780,11683005,3.0394905793504963,1.8594267642584574
HCC1143,5328940,1.7305674649682683,1.8594267642584574
NCI-H2009,72193861,0.2482611586799762,1.8594267642584574
NCI-H292,6914657,-3.659053204598075,1.8594267642584574
NCI-H522,46199207,1.8719788650663136,1.8594267642584574
CA46,53481919,3.755788894439918,1.8594267642584574
LoVo,444795,4.8141558651213145,1.8594267642584574
FTC-133,9823820,4.816748988305079,1.8594267642584574
KMRC-1,6918837,-1.4377118656295438,1.8594267642584574
HSC-4,44486219,5.375029781512573,1.8594267642584574
NCI-H292,54613361,2.8419740491204957,1.8594267642584574
A4/Fukuda,alisertib-navitoclax (2-1 mol-mol),-3.158247130795727,1.8594267642584574
CAL-51,11234052,5.18044926966805,1.8594267642584574
SNU-449,387447,-3.8386512960067862,1.8594267642584574
SNU-61,53232,3.65751057839411,1.8594267642584574
LoVo,16038120,0.8839921956645777,1.8594267642584574
BxPC-3,219104,3.7528053800812615,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],sirolimus-bortezomib (250-1 mol-mol),0.4278853760712148,1.8594267642584574
SNU-81,24748573,1.8214275246808207,1.8594267642584574
MSTO-211H,16725315,3.290115596802182,1.8594267642584574
SNU-61,25154868,4.341936394973705,1.8594267642584574
MDA-MB-453,1716436,1.6727209102312437,1.8594267642584574
G-401,5329102,1.4807949874052762,1.8594267642584574
BxPC-3,6610216,4.298723179439111,1.8594267642584574
ONS-76,5738263,4.146346761655981,1.8594267642584574
A2780,51037431,1.9184867581168112,1.8594267642584574
CA46,46398810,1.9636985074186508,1.8594267642584574
BxPC-3,9936388,-5.112429278661846,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],10385095,1.0940876839597544,1.8594267642584574
MSTO-211H,637858,1.3984482263345202,1.8594267642584574
A-673,5284373,2.9730764803314496,1.8594267642584574
JM-1,5284616,2.861882362083186,1.8594267642584574
A-673,64971,3.704564654457452,1.8594267642584574
ONS-76,6918289,2.669224964930956,1.8594267642584574
HSC-4,11167602,1.6360881716966182,1.8594267642584574
NCI-H661,3689413,0.5447440822016135,1.8594267642584574
A4/Fukuda,12003241,-4.192136354440014,1.8594267642584574
LoVo,10231331,-0.6826574775964468,1.8594267642584574
NCI-H292,219104,4.068792108053485,1.8594267642584574
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353,1.8594267642584574
NCI-H460,216468,4.763843832635099,1.8594267642584574
SBC-5,322968,4.849411960208385,1.8594267642584574
MDA-MB-157,135411,-1.5273896245850724,1.8594267642584574
A-498,6918837,-1.461997313484149,1.8594267642584574
MSTO-211H,decitabine-navitoclax (2-1 mol-mol),0.593652289859318,1.8594267642584574
MDA-MB-157,doxorubicin-navitoclax (2-1 mol-mol),-3.2378494218759637,1.8594267642584574
FTC-133,36314,-6.239918298117373,1.8594267642584574
CAL-51,23635314,-2.261837237964324,1.8594267642584574
NCI-H292,126941,-3.055153146808903,1.8594267642584574
A4/Fukuda,23725625,4.971593284778653,1.8594267642584574
A2780,25105715,3.052833826388835,1.8594267642584574
JM-1,9903786,1.587415218469425,1.8594267642584574
NCI-H460,5566,3.3663694984335533,1.8594267642584574
OVISE,262093,2.7343448368987597,1.8594267642584574
CAL-51,25262965,-2.904292987251918,1.8594267642584574
SNU-61,448949,2.574317813231787,1.8594267642584574
SCC-9,24180125,3.671852734769843,1.8594267642584574
HSC-4,42611257,3.4394582921614933,1.8594267642584574
EFO-27,46174525,4.9061854461465435,1.8594267642584574
G-401,3384730,2.1525913455039474,1.8594267642584574
G-401,3825829,3.962498358217521,1.8594267642584574
A2780,53232,-0.3956468617212337,1.8594267642584574
YAPC,54618164,4.31457100114165,1.8594267642584574
SNU-449,54765302,4.743565917095417,1.8594267642584574
NCI-H460,24951314,1.96669984187411,1.8594267642584574
FTC-133,11364421,1.174405518858428,1.8594267642584574
MDA-MB-453,carboplatin-etoposide (40-17 mol-mol),3.9287174119504225,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],16038120,1.1652003457864657,1.8594267642584574
NCI-H2171,24771867,-2.6220866978549444,1.8594267642584574
A-498,11427553,3.7697046176741185,1.8594267642584574
MDA-MB-157,5394,4.303334925677516,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],44589607,3.248085405337134,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],10184653,2.2395944761831372,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.3016699371514477,1.8594267642584574
SNU-61,15983966,-2.103596771317332,1.8594267642584574
A2780,9927531,3.2712332494904226,1.8594267642584574
MDA-MB-157,UNC0638-navitoclax (1-1 mol-mol),-2.9600993667864275,1.8594267642584574
NCI-H661,168312962,0.9705864877614524,1.8594267642584574
OPM-2,135440466,0.016624870652288,1.8594267642584574
NCI-H727,44486219,4.75896405378265,1.8594267642584574
NOMO-1,637858,1.0893367728071195,1.8594267642584574
NCI-H727,23725625,5.500914308976136,1.8594267642584574
NCI-H661,444795,4.831383676329662,1.8594267642584574
NCI-H1623,10427712,4.824592613381889,1.8594267642584574
CAL-51,11507802,1.2528060552922216,1.8594267642584574
SNU-81,tanespimycin-gemcitabine (1-1 mol-mol),-5.141011099555512,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],5328940,2.0329581384082944,1.8594267642584574
A-673,2949965,2.43157797191215,1.8594267642584574
FTC-133,46907787,3.491897677971775,1.8594267642584574
BxPC-3,JQ-1-MK-0752 (1-1 mol-mol),0.0240612102256537,1.8594267642584574
JM-1,12003241,0.2073989775302392,1.8594267642584574
DMS 273,72376,-2.307681046282287,1.8594267642584574
A-673,3025986,-4.4852998426095985,1.8594267642584574
A2780,9823820,2.6289512031423836,1.8594267642584574
HCC1143,11152667,-1.9901975183751028,1.8594267642584574
A2780,119607,4.019563194528792,1.8594267642584574
MSTO-211H,136227924,2.717505566177341,1.8594267642584574
A-673,3025944,3.970835118137527,1.8594267642584574
NCI-H146,11222830,0.9953145616857674,1.8594267642584574
NCI-H146,1750826,0.7822669653178473,1.8594267642584574
JM-1,selumetinib-PLX-4032 (8-1 mol-mol),4.727165716436182,1.8594267642584574
BxPC-3,1750826,-1.1292189334445044,1.8594267642584574
CA46,6450551,1.1375422858810305,1.8594267642584574
NCI-H1623,46191454,1.8980276717062192,1.8594267642584574
CAL-51,24797083,1.5666479073716466,1.8594267642584574
CA46,448949,1.4123991312197492,1.8594267642584574
OVISE,135999136,4.426271635938179,1.8594267642584574
HSC-4,2742550,4.46855499399167,1.8594267642584574
NCI-H460,168313200,3.91056508525232,1.8594267642584574
NCI-H292,1750826,1.4118366921158176,1.8594267642584574
HCC1143,452548,1.7974899966046338,1.8594267642584574
SCC-9,53325874,4.533787552290022,1.8594267642584574
CA46,24771867,-0.8036362931877258,1.8594267642584574
A2780,72199292,-0.0351373222218005,1.8594267642584574
MDA-MB-157,216468,1.0474678727125786,1.8594267642584574
SNU-449,65064,5.2463646910054536,1.8594267642584574
NCI-H292,9952709,2.799114874088216,1.8594267642584574
LOU-NH91,24964624,2.935669445800335,1.8594267642584574
MSTO-211H,5566,3.048712391825719,1.8594267642584574
MDA-MB-157,3384730,2.532514051685687,1.8594267642584574
BxPC-3,753704,5.46289082133378,1.8594267642584574
A2780,SNX-2112-bortezomib (250-1 mol-mol),-3.4792243011702957,1.8594267642584574
SCC-9,12003241,-1.125345709331217,1.8594267642584574
HCC1143,285033,-0.1452813325821209,1.8594267642584574
CAL-51,docetaxel-tanespimycin (2-1 mol-mol),-4.362144159711312,1.8594267642584574
FTC-133,9956119,4.526890245155382,1.8594267642584574
SNU-61,3854666,2.8565665342705735,1.8594267642584574
G-401,16065773,1.1067048318222386,1.8594267642584574
G-401,11214940,0.8244141998238856,1.8594267642584574
HCC1143,54618164,3.885707225557291,1.8594267642584574
MDA-MB-453,16013152,4.031304285322853,1.8594267642584574
SBC-5,24951314,1.1707148737631825,1.8594267642584574
FTC-133,135398516,3.4482633492568913,1.8594267642584574
KYSE-70,11625818,4.1356453826336965,1.8594267642584574
BT-549,16722836,2.2023880033470893,1.8594267642584574
MDA-MB-157,54678924,0.1283777680712135,1.8594267642584574
SNU-81,10410894,4.450607476297739,1.8594267642584574
KYSE-70,9926054,2.326174845830733,1.8594267642584574
KYSE-70,SNX-2112-bortezomib (250-1 mol-mol),-1.0131042472486071,1.8594267642584574
EFO-27,25102847,3.020723568572887,1.8594267642584574
MDA-MB-453,5351362,1.2969167061447922,1.8594267642584574
LoVo,9926054,1.9069881185353632,1.8594267642584574
NCI-H1623,46926350,-4.300601402935136,1.8594267642584574
SNU-61,16065773,0.792903808301444,1.8594267642584574
A-673,5287620,-2.2582011832849824,1.8594267642584574
NCI-H727,9903786,3.725485605999375,1.8594267642584574
KMRC-1,72376,-0.8386976675707333,1.8594267642584574
JM-1,11640390,2.558073354039076,1.8594267642584574
A-498,104842,-1.4921326822698753,1.8594267642584574
LoVo,10127622,2.21220618035224,1.8594267642584574
LoVo,11364421,-3.7348040522268624,1.8594267642584574
FU-OV-1,57519531,3.042184872303348,1.8594267642584574
MDA-MB-453,serdemetan-SCH-529074 (1-1 mol-mol),1.825240779322759,1.8594267642584574
DMS 273,6917907,-5.615473283892677,1.8594267642584574
MDA-MB-453,2828334,5.6655606940020755,1.8594267642584574
HSC-4,navitoclax-piperlongumine (1-1 mol-mol),2.6552743905338905,1.8594267642584574
A2780,3025944,3.330273751246369,1.8594267642584574
MSTO-211H,vorinostat-navitoclax (4-1 mol-mol),-1.2418766725750991,1.8594267642584574
Panc 04.03,11152667,-0.1106415062306802,1.8594267642584574
SNU-449,selumetinib-decitabine (4-1 mol-mol),5.489476406274314,1.8594267642584574
SBC-5,374536,0.1871414147839566,1.8594267642584574
NCI-H661,11222830,1.6760341955617937,1.8594267642584574
BxPC-3,89183176,5.843393871566337,1.8594267642584574
JM-1,135999136,3.9281924738089016,1.8594267642584574
BxPC-3,selumetinib-UNC0638 (4-1 mol-mol),1.3922516322535516,1.8594267642584574
CAL-51,navitoclax-birinapant (1-1 mol-mol),5.691707887303523,1.8594267642584574
SBC-5,navitoclax-MST-312 (1-1 mol-mol),1.562622268083127,1.8594267642584574
SBC-5,56946209,0.800516243447007,1.8594267642584574
NCI-H2009,5328940,1.7426808664178373,1.8594267642584574
NCI-H2171,navitoclax-pluripotin (1-1 mol-mol),-1.0064664066659004,1.8594267642584574
LOU-NH91,decitabine-navitoclax (2-1 mol-mol),-0.8280147922678951,1.8594267642584574
SNU-449,9911463,3.778924364931394,1.8594267642584574
HCC1143,3025944,4.170847171640537,1.8594267642584574
JM-1,969516,2.095061675415332,1.8594267642584574
NCI-H460,3384730,3.247736649900264,1.8594267642584574
LOU-NH91,135411,2.1671070624345674,1.8594267642584574
FTC-133,44607531,1.7603587928522244,1.8594267642584574
NCI-H146,decitabine-navitoclax (2-1 mol-mol),-2.2755638944126644,1.8594267642584574
MDA-MB-157,445091,2.3343110617588785,1.8594267642584574
HSC-4,16013152,3.4985623845199956,1.8594267642584574
Panc 04.03,11427553,3.7212087866143433,1.8594267642584574
KMRC-1,10113978,4.2388531684480615,1.8594267642584574
A2780,10127622,1.5174517910950884,1.8594267642584574
JM-1,navitoclax-gemcitabine (1-1 mol-mol),-5.563041913768145,1.8594267642584574
NCI-H2171,89183176,2.3651641452605747,1.8594267642584574
Panc 04.03,54618771,1.7180394725494992,1.8594267642584574
NCI-H292,11485656,2.2579953762585725,1.8594267642584574
LXF 289,322968,3.971478433961818,1.8594267642584574
SBC-5,vorinostat-carboplatin (1-1 mol-mol),1.8980945585311684,1.8594267642584574
YAPC,10385095,1.3302689043535871,1.8594267642584574
LOU-NH91,5329102,1.7122787452562382,1.8594267642584574
SNU-61,19582717,4.214212535444011,1.8594267642584574
HSC-4,49850262,4.158516161733518,1.8594267642584574
FU-OV-1,selumetinib-UNC0638 (4-1 mol-mol),1.7956327688699871,1.8594267642584574
NCI-H661,123631,1.2265867761007856,1.8594267642584574
KMRC-1,3062316,-0.7612421720697753,1.8594267642584574
BT-549,9936388,-4.888200161073446,1.8594267642584574
HSC-4,24951314,1.4348411807415282,1.8594267642584574
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353,1.8594267642584574
A2780,navitoclax-pluripotin (1-1 mol-mol),-1.8595742905962285,1.8594267642584574
SCC-9,9933475,1.8547363245124415,1.8594267642584574
CAL-51,9936388,-5.638746232401389,1.8594267642584574
KMRC-1,ISOX-bortezomib (250-1 mol-mol),0.316621545277449,1.8594267642584574
CA46,72734382,3.577472012209052,1.8594267642584574
NCI-H661,16741245,3.244500107466936,1.8594267642584574
SNU-81,docetaxel-tanespimycin (2-1 mol-mol),-6.596466940190321,1.8594267642584574
HCC1143,11964036,1.1986784595252613,1.8594267642584574
NCI-H661,selumetinib-UNC0638 (4-1 mol-mol),3.9317627584077695,1.8594267642584574
A2780,126941,-2.3178428604154746,1.8594267642584574
A2780,navitoclax-PLX-4032 (1-1 mol-mol),1.492192553915411,1.8594267642584574
NCI-H661,24753719,3.905315348750775,1.8594267642584574
SBC-5,25126798,4.2020115243555285,1.8594267642584574
NCI-H146,6917907,-6.190181636892531,1.8594267642584574
NCI-H661,1750826,-0.2904028146963975,1.8594267642584574
Panc 04.03,navitoclax-birinapant (1-1 mol-mol),3.2417464009141845,1.8594267642584574
ONS-76,613753,4.08215787211526,1.8594267642584574
SBC-5,3689413,-0.1482568941323282,1.8594267642584574
FU-OV-1,446155,2.635089718837861,1.8594267642584574
SNU-449,216345,4.054978999003172,1.8594267642584574
CA46,6918328,-3.721989268042841,1.8594267642584574
CAL-51,5978,-2.6819752982341463,1.8594267642584574
MDA-MB-157,57519531,1.1252399396652772,1.8594267642584574
NCI-H1623,51037431,4.287686451446288,1.8594267642584574
A4/Fukuda,5394,2.6676913787283305,1.8594267642584574
MSTO-211H,151289,1.1545674452198869,1.8594267642584574
HCC1143,3825829,3.893715702367038,1.8594267642584574
MSTO-211H,374536,3.2477584475462904,1.8594267642584574
NCI-H460,6610216,4.838717363885395,1.8594267642584574
CAL-51,54618771,0.0049145289548569,1.8594267642584574
CA46,1239801,3.4142476342729817,1.8594267642584574
A-673,9956119,3.229119212963112,1.8594267642584574
NCI-H460,73707438,4.549718141383013,1.8594267642584574
YAPC,9936388,2.1810367621372095,1.8594267642584574
LXF 289,4705,5.10311909598278,1.8594267642584574
CAL-51,54454,2.240351559744082,1.8594267642584574
JM-1,4788,5.493172342149484,1.8594267642584574
SNU-449,262093,3.0394524195162766,1.8594267642584574
EFO-27,46926350,-4.056205960361391,1.8594267642584574
SNU-61,5566,2.945300560810773,1.8594267642584574
Panc 04.03,6610355,5.365295116093154,1.8594267642584574
NCI-H727,navitoclax-piperlongumine (1-1 mol-mol),2.3472848325526448,1.8594267642584574
NCI-H1623,56963564,0.7315466561739135,1.8594267642584574
HCC1143,10113978,4.851592729588868,1.8594267642584574
NCI-H2009,navitoclax-piperlongumine (1-1 mol-mol),2.538490249667484,1.8594267642584574
LOU-NH91,5311281,1.0411900413843744,1.8594267642584574
KMRC-1,24856436,1.3740575733249207,1.8594267642584574
SBC-5,400769,-0.0932857286492618,1.8594267642584574
OVISE,11964036,1.5054845636014844,1.8594267642584574
JM-1,1716436,2.291915875842717,1.8594267642584574
SW1463,6505803,0.5252870082270547,1.8594267642584574
A-673,navitoclax-pluripotin (1-1 mol-mol),-1.5806846608606773,1.8594267642584574
CAL-51,119182,-1.323881847361974,1.8594267642584574
A4/Fukuda,4788,3.9402862208503753,1.8594267642584574
SBC-5,9926054,3.0567796435466628,1.8594267642584574
EFO-27,vorinostat-navitoclax (4-1 mol-mol),0.8763520950927793,1.8594267642584574
G-401,3634881,2.5006119442923938,1.8594267642584574
NCI-H727,9911830,2.860892848593743,1.8594267642584574
G-401,9911463,2.712760379614347,1.8594267642584574
NCI-H460,15983966,-0.5601417251503862,1.8594267642584574
BT-549,serdemetan-SCH-529074 (1-1 mol-mol),2.72716237465292,1.8594267642584574
NCI-H292,31703,-1.868725819699569,1.8594267642584574
NCI-H292,11175137,3.5103695935197328,1.8594267642584574
NCI-H2009,3543504,4.270240870629309,1.8594267642584574
EFO-27,702558,4.734643042503988,1.8594267642584574
NCI-H292,107985,-2.5053359043606043,1.8594267642584574
HSC-4,25154868,3.1331848354363063,1.8594267642584574
KYSE-70,docetaxel-tanespimycin (2-1 mol-mol),-4.718411789937545,1.8594267642584574
SBC-5,doxorubicin-navitoclax (2-1 mol-mol),-2.1214883367160113,1.8594267642584574
MSTO-211H,11364421,-5.484172518994792,1.8594267642584574
NCI-H460,11238147,4.460003386993959,1.8594267642584574
NCI-H2171,60700,-0.3771090207819011,1.8594267642584574
LXF 289,1641662,3.640483694902119,1.8594267642584574
MDA-MB-157,49793307,-3.250396628323611,1.8594267642584574
A-673,3503,1.5343061624145853,1.8594267642584574
LoVo,10296883,3.831816674357036,1.8594267642584574
HCC1143,6917907,-6.676374133945339,1.8594267642584574
NCI-H661,44185566,2.810411867420033,1.8594267642584574
NCI-H522,23725625,7.287275637495971,1.8594267642584574
BT-549,11175137,0.9532540120968724,1.8594267642584574
BT-549,9840324,5.7680719211185005,1.8594267642584574
DMS 273,42642645,-0.2214891751848421,1.8594267642584574
LXF 289,24797083,1.462636821965973,1.8594267642584574
A2780,9887053,0.4462184617201571,1.8594267642584574
G-401,3689413,-2.428789331956376,1.8594267642584574
NCI-H460,65064,5.803776096144955,1.8594267642584574
MDA-MB-453,JQ-1-carboplatin (1-1 mol-mol),-0.0296980532629666,1.8594267642584574
CAL-51,452548,-0.9080095532304931,1.8594267642584574
NCI-H460,54613361,2.8642714411834502,1.8594267642584574
YAPC,675434,4.582728256156342,1.8594267642584574
KMRC-1,4578,4.295676817145532,1.8594267642584574
BT-549,387447,-4.9509675804959,1.8594267642584574
MDA-MB-453,selumetinib-JQ-1 (4-1 mol-mol),1.824440496752652,1.8594267642584574
EFO-27,11719255,3.4932821683662865,1.8594267642584574
OPM-2,219104,1.446566622432128,1.8594267642584574
NCI-H1623,6610216,4.306736710776884,1.8594267642584574
NOMO-1,23582824,0.0799476906959343,1.8594267642584574
NCI-H292,6610355,4.982353204264952,1.8594267642584574
NCI-H2009,46191454,2.1369399253900347,1.8594267642584574
NOMO-1,3062316,2.517026306117631,1.8594267642584574
NOMO-1,119182,-3.695250738066314,1.8594267642584574
SNU-61,decitabine-carboplatin (1-1 mol-mol),5.043967029141517,1.8594267642584574
FU-OV-1,11364421,-3.956792545928709,1.8594267642584574
OPM-2,17755052,0.9533058757913144,1.8594267642584574
SNU-449,doxorubicin-navitoclax (2-1 mol-mol),1.3165597718985669,1.8594267642584574
DMS 273,46199207,3.605640907411319,1.8594267642584574
NCI-H522,55508,2.4640988254574356,1.8594267642584574
NCI-H292,10385095,1.2562128411100733,1.8594267642584574
SNU-61,piperlongumine-MST-312 (1-1 mol-mol),2.3794490551959107,1.8594267642584574
CA46,107970,1.651382626144423,1.8594267642584574
EFO-27,5746,1.7615281276545924,1.8594267642584574
OPM-2,24856436,-0.767009816479034,1.8594267642584574
CA46,25126798,3.582571225160254,1.8594267642584574
YAPC,89928392,2.607647468641453,1.8594267642584574
MDA-MB-453,3062316,2.3886014193927285,1.8594267642584574
MDA-MB-453,387447,-4.667010811634082,1.8594267642584574
G-401,107985,-4.394015959361378,1.8594267642584574
A2780,decitabine-carboplatin (1-1 mol-mol),3.747400322321459,1.8594267642584574
SBC-5,135875424,3.947045576812926,1.8594267642584574
KYSE-70,24785538,1.5800117539652696,1.8594267642584574
BT-549,25262965,-2.559107571112332,1.8594267642584574
G-401,selumetinib-PLX-4032 (8-1 mol-mol),2.777074550060763,1.8594267642584574
BxPC-3,2828334,6.44946379786602,1.8594267642584574
NCI-H460,3025986,0.3909368316008428,1.8594267642584574
DMS 273,11656518,1.6608448179793895,1.8594267642584574
EFO-27,3825829,4.213579429540561,1.8594267642584574
NCI-H146,44493528,1.3818057906729433,1.8594267642584574
CAL-51,73707398,0.7053044464230985,1.8594267642584574
NCI-H292,148198,-2.0841293800573446,1.8594267642584574
NCI-H460,2828334,6.134119597935603,1.8594267642584574
CAL-51,439501,-2.444412450902406,1.8594267642584574
SNU-449,73707398,1.8238531786702632,1.8594267642584574
A-673,10322450,2.1969870036583323,1.8594267642584574
NCI-H2171,71466380,3.3392440967630797,1.8594267642584574
HSC-4,53392493,2.986961827224748,1.8594267642584574
OPM-2,1239801,3.3443313732590543,1.8594267642584574
LoVo,9935249,1.1872155844887071,1.8594267642584574
G-401,1566236,1.5621622205700352,1.8594267642584574
HSC-4,9907093,5.592562690426939,1.8594267642584574
MDA-MB-453,445091,4.203535883394564,1.8594267642584574
EFO-27,24821094,3.745327872256005,1.8594267642584574
KMRC-1,3038522,2.3225128068669676,1.8594267642584574
NCI-H2009,11427553,1.9586555200212517,1.8594267642584574
SNU-449,25227462,3.4571199035251565,1.8594267642584574
CAL-51,136227924,2.079284078064279,1.8594267642584574
ONS-76,452548,1.1046001555889895,1.8594267642584574
SNU-449,25105715,3.5056666677867625,1.8594267642584574
CA46,156414,1.2808873732328336,1.8594267642584574
SNU-449,400769,-0.6000208096132458,1.8594267642584574
HSC-4,tretinoin-navitoclax (4-1 mol-mol),4.058213789004076,1.8594267642584574
NCI-H146,462382,-0.5302162316770459,1.8594267642584574
NCI-H460,613753,5.368273372553464,1.8594267642584574
MDA-MB-453,3136844,3.6967063162994114,1.8594267642584574
A-673,5281672,3.4533278359325323,1.8594267642584574
A2780,salermide-PLX-4032 (12-1 mol-mol),4.80403055299543,1.8594267642584574
EFO-27,1716436,3.5844471141038823,1.8594267642584574
SNU-449,3825829,4.613153689576251,1.8594267642584574
NOMO-1,73707398,0.2786764614411772,1.8594267642584574
A2780,568763,-1.431759576680003,1.8594267642584574
HCC1143,6918878,5.533567107436573,1.8594267642584574
LoVo,11455910,2.8170443999319574,1.8594267642584574
EFO-27,23582824,2.0177544133250187,1.8594267642584574
DMS 273,crizotinib-PLX-4032 (2-1 mol-mol),1.107090848194829,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],3854666,3.226193389725711,1.8594267642584574
MDA-MB-453,44819697,-2.6195477020037696,1.8594267642584574
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076,1.8594267642584574
A4/Fukuda,7326481,2.3355820774301206,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],3689413,0.4564681386605935,1.8594267642584574
DMS 273,5566,3.001039957404815,1.8594267642584574
MDA-MB-157,148124,-6.016678597172854,1.8594267642584574
LoVo,11507802,0.9778049572121082,1.8594267642584574
NCI-H522,9444,4.166279980928258,1.8594267642584574
SNU-61,crizotinib-PLX-4032 (2-1 mol-mol),2.112541337520524,1.8594267642584574
MDA-MB-157,9549297,2.7932032986762008,1.8594267642584574
YAPC,3689413,3.09003195173071,1.8594267642584574
KYSE-70,10385095,0.9665013844498838,1.8594267642584574
ONS-76,11222830,1.7336224967240552,1.8594267642584574
JM-1,11625818,3.7613008305210727,1.8594267642584574
LoVo,16736978,-0.2277330125842315,1.8594267642584574
NCI-H2009,10074640,3.329342225437922,1.8594267642584574
MDA-MB-157,selumetinib-piperlongumine (8-1 mol-mol),2.303505265933228,1.8594267642584574
NCI-H460,9866186,0.4176494313944011,1.8594267642584574
DMS 273,piperlongumine-MST-312 (1-1 mol-mol),1.0735064497414797,1.8594267642584574
A2780,60750,-0.3844759756013921,1.8594267642584574
MSTO-211H,5329102,1.1990183253858175,1.8594267642584574
NCI-H292,60700,-1.1983388185725197,1.8594267642584574
OPM-2,16659841,1.643311806599576,1.8594267642584574
NCI-H661,11427553,3.4193847918785782,1.8594267642584574
DMS 273,445455,4.9732665628078045,1.8594267642584574
NCI-H460,9967941,4.030885542149613,1.8594267642584574
NCI-H460,5281321,2.142807178276493,1.8594267642584574
HSC-4,44137675,2.9134227764609735,1.8594267642584574
HCC1143,2729026,2.66692124656069,1.8594267642584574
LoVo,1566236,1.5203890875485482,1.8594267642584574
NCI-H146,2842253,3.419228107779433,1.8594267642584574
BxPC-3,crizotinib-PLX-4032 (2-1 mol-mol),1.1893497843020568,1.8594267642584574
G-401,navitoclax-birinapant (1-1 mol-mol),1.830641570341204,1.8594267642584574
NCI-H522,5311281,2.6748920868920125,1.8594267642584574
NCI-H2171,2945648,2.4840683519833835,1.8594267642584574
OVISE,9840324,5.37005208850368,1.8594267642584574
NCI-H522,11485656,1.866098793785005,1.8594267642584574
LoVo,5280436,3.7935840263164984,1.8594267642584574
SNU-61,11152667,-1.0116802565381595,1.8594267642584574
NCI-H460,2708,4.613368759945332,1.8594267642584574
JM-1,6918328,-3.1408711543116854,1.8594267642584574
ONS-76,1716436,4.404636467874722,1.8594267642584574
A-673,vorinostat-carboplatin (1-1 mol-mol),1.8302271851347216,1.8594267642584574
EFO-27,241158,4.165561573655071,1.8594267642584574
A2780,7326481,2.2466116261364215,1.8594267642584574
SNU-61,11507802,1.2021022137126776,1.8594267642584574
MDA-MB-157,11404337,0.0143481506183785,1.8594267642584574
CA46,71466445,1.6737757590775906,1.8594267642584574
NCI-H727,5329102,2.005304296489746,1.8594267642584574
HSC-4,51039095,3.5449735354798,1.8594267642584574
SNU-61,135411,1.4786327368897634,1.8594267642584574
KYSE-70,23635314,-2.258343718513796,1.8594267642584574
LoVo,54619267,3.1603381625719,1.8594267642584574
A4/Fukuda,71751553,4.0599050322296995,1.8594267642584574
MSTO-211H,156414,0.8242215144670997,1.8594267642584574
OPM-2,salermide-PLX-4032 (12-1 mol-mol),5.221268337510566,1.8594267642584574
FTC-133,44185566,3.3632936032593403,1.8594267642584574
DMS 273,448949,2.08082767357287,1.8594267642584574
NCI-H2009,71466578,3.1093531088855797,1.8594267642584574
G-401,44632017,0.8985354611426208,1.8594267642584574
BT-549,selumetinib-MK-2206 (8-1 mol-mol),3.7435094380917793,1.8594267642584574
HCC1143,107970,2.31840177997234,1.8594267642584574
NCI-H661,156414,0.2928474479064595,1.8594267642584574
OVISE,216345,4.54917324344274,1.8594267642584574
SCC-9,25227462,0.3695734481821194,1.8594267642584574
FTC-133,46199207,4.2182762440826576,1.8594267642584574
Panc 04.03,9926054,1.9560696374821285,1.8594267642584574
G-401,6918736,-2.2327850291733577,1.8594267642584574
SCC-9,44607531,1.3853072214617428,1.8594267642584574
NCI-H146,serdemetan-SCH-529074 (1-1 mol-mol),0.832618254010713,1.8594267642584574
HSC-4,171352865,4.360447231593142,1.8594267642584574
OVISE,613753,2.681502253258482,1.8594267642584574
A-673,5282054,2.3452018577417166,1.8594267642584574
CAL-51,5328940,1.595278406971918,1.8594267642584574
G-401,426756,4.944025345893246,1.8594267642584574
BxPC-3,selumetinib-PLX-4032 (8-1 mol-mol),0.9505923867338788,1.8594267642584574
FTC-133,73707398,1.7335394908123083,1.8594267642584574
LoVo,20959075,-3.964629838563966,1.8594267642584574
LoVo,46907787,0.5340804086119918,1.8594267642584574
FU-OV-1,9907093,3.428205270837273,1.8594267642584574
NCI-H146,5470400,-3.389889619220011,1.8594267642584574
FTC-133,60750,-2.331663889988264,1.8594267642584574
NCI-H661,637858,2.3544841299222927,1.8594267642584574
NCI-H460,24772860,-0.596461213785507,1.8594267642584574
FTC-133,135999136,5.800253145127344,1.8594267642584574
SNU-61,2945648,3.4316222719918903,1.8594267642584574
SBC-5,52947716,-5.148190181120178,1.8594267642584574
G-401,5311,0.6627378317361174,1.8594267642584574
SNU-449,25183872,-0.2769192593247403,1.8594267642584574
NCI-H460,selumetinib-MK-2206 (8-1 mol-mol),3.864749533949913,1.8594267642584574
A2780,444795,1.1255727490438436,1.8594267642584574
HCC1143,11404337,-0.7051632820466462,1.8594267642584574
LOU-NH91,23582824,0.7266398713670753,1.8594267642584574
JM-1,24964624,1.3785887120991174,1.8594267642584574
SCC-9,6918328,0.8244293983868239,1.8594267642584574
SBC-5,44507138,1.9527307391432291,1.8594267642584574
OVISE,tanespimycin-bortezomib (250-1 mol-mol),0.9202514572514084,1.8594267642584574
HSC-4,3081361,1.976322212956416,1.8594267642584574
MDA-MB-453,navitoclax-piperlongumine (1-1 mol-mol),1.490500263606314,1.8594267642584574
A4/Fukuda,73707398,-0.4328093310020208,1.8594267642584574
NCI-H146,2130404,3.7873290414593983,1.8594267642584574
NCI-H522,11656518,2.6059049947054533,1.8594267642584574
A-498,11626560,2.3564203123568648,1.8594267642584574
A2780,17755052,-1.4995675278651837,1.8594267642584574
HSC-4,2841722,4.578140166849417,1.8594267642584574
JM-1,44462760,2.3346005220819785,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11455910,0.3019920512168372,1.8594267642584574
FTC-133,4261,1.6400921135700228,1.8594267642584574
LOU-NH91,54618771,2.8270991446030593,1.8594267642584574
NCI-H1623,16720766,0.9555863303424396,1.8594267642584574
BT-549,44632017,1.021144372127497,1.8594267642584574
NCI-H292,107970,2.31632347859771,1.8594267642584574
SCC-9,24753719,4.411411644196846,1.8594267642584574
KMRC-1,4917,3.6746853329943248,1.8594267642584574
NCI-H661,72734382,5.266471995298585,1.8594267642584574
SNU-449,4578,4.5704959764236675,1.8594267642584574
KYSE-70,9887053,4.5630363901990565,1.8594267642584574
NCI-H460,81146,4.483282466350705,1.8594267642584574
G-401,637858,0.5800115670130345,1.8594267642584574
BT-549,5280436,2.325988989460079,1.8594267642584574
HSC-4,107970,2.304506496588027,1.8594267642584574
NCI-H292,421610,4.310067764922952,1.8594267642584574
MSTO-211H,11175137,1.4320314455831638,1.8594267642584574
BxPC-3,11175137,2.81920931641519,1.8594267642584574
G-401,vorinostat-navitoclax (4-1 mol-mol),0.632092146955943,1.8594267642584574
NCI-H292,11625818,5.668815438823822,1.8594267642584574
BxPC-3,3025986,-1.3024282207469429,1.8594267642584574
NCI-H460,11364421,0.3566052665939138,1.8594267642584574
MDA-MB-157,3385,-0.6145392702282009,1.8594267642584574
DMS 273,44589607,2.105355871894398,1.8594267642584574
SCC-9,107970,3.0149180037966095,1.8594267642584574
Panc 04.03,17755052,3.2992451395509503,1.8594267642584574
LoVo,10427712,4.119455144779727,1.8594267642584574
MDA-MB-453,ISOX-bortezomib (250-1 mol-mol),-0.3200221310037367,1.8594267642584574
OVISE,9825149,2.776616936788869,1.8594267642584574
DMS 273,44185566,2.401025824688418,1.8594267642584574
SBC-5,selumetinib-MK-2206 (8-1 mol-mol),4.137952563186265,1.8594267642584574
EFO-27,5329102,3.2209933806874926,1.8594267642584574
NCI-H2009,3503,2.6223022737526085,1.8594267642584574
SNU-449,66577038,3.1506640300230075,1.8594267642584574
SNU-449,135999136,4.264029635041134,1.8594267642584574
MDA-MB-453,16725315,3.1590887754383847,1.8594267642584574
SNU-61,6505803,-0.8091898598550518,1.8594267642584574
Panc 04.03,6438330,3.1739512088269968,1.8594267642584574
SNU-81,124202324,-1.5604837877349913,1.8594267642584574
Panc 04.03,navitoclax-piperlongumine (1-1 mol-mol),2.817487895898936,1.8594267642584574
FU-OV-1,49850262,3.0107305406398206,1.8594267642584574
FU-OV-1,selumetinib-MK-2206 (8-1 mol-mol),-0.4869777969309855,1.8594267642584574
ONS-76,54618771,0.5276024038238057,1.8594267642584574
SNU-61,5311,1.5459052759872411,1.8594267642584574
CA46,11612883,1.866301185217262,1.8594267642584574
A4/Fukuda,selumetinib-MK-2206 (8-1 mol-mol),0.2592073552888009,1.8594267642584574
A-673,11960529,3.1772019850221054,1.8594267642584574
YAPC,400769,-0.4056066486406303,1.8594267642584574
KYSE-70,107970,2.5727619321994353,1.8594267642584574
JM-1,5291,3.241129374385646,1.8594267642584574
KMRC-1,9444,4.31479767249553,1.8594267642584574
NCI-H727,44819697,-0.26094531007839,1.8594267642584574
NCI-H2009,5351362,1.2372754831617516,1.8594267642584574
LXF 289,53495165,1.0389398894889437,1.8594267642584574
ONS-76,vorinostat-carboplatin (1-1 mol-mol),3.120131426487973,1.8594267642584574
NCI-H727,123631,2.758434269009812,1.8594267642584574
NCI-H2009,5311,0.3641463076187463,1.8594267642584574
MDA-MB-157,241158,1.407364121620741,1.8594267642584574
LXF 289,24785538,0.6202102990423739,1.8594267642584574
BxPC-3,10074640,2.675443562621253,1.8594267642584574
G-401,4378219,4.593157039926137,1.8594267642584574
CAL-51,445643,4.334473435217703,1.8594267642584574
OPM-2,2858523,3.124441680057984,1.8594267642584574
NCI-H522,tretinoin-navitoclax (4-1 mol-mol),4.26592131531013,1.8594267642584574
HSC-4,11175137,3.5997845208099797,1.8594267642584574
MDA-MB-453,25126798,3.9955340419002057,1.8594267642584574
SNU-81,159324,-2.5700546068481502,1.8594267642584574
SNU-61,3552672,2.025857953798933,1.8594267642584574
FTC-133,246676,4.92384525208296,1.8594267642584574
MDA-MB-453,11364421,-1.677319267600166,1.8594267642584574
CA46,122327,3.963727711050333,1.8594267642584574
LXF 289,262093,3.4150141342974605,1.8594267642584574
NCI-H292,6918289,2.42392533304279,1.8594267642584574
NCI-H661,25154868,3.681430006213129,1.8594267642584574
NCI-H522,327653,3.011425661783578,1.8594267642584574
KYSE-70,44202524,1.884457998669868,1.8594267642584574
A-673,8515,3.2253171108003023,1.8594267642584574
SNU-449,6505803,1.2866498789511422,1.8594267642584574
FTC-133,10074640,3.79174067417729,1.8594267642584574
NCI-H522,72734382,6.037966635177564,1.8594267642584574
NCI-H460,navitoclax-gemcitabine (1-1 mol-mol),-0.7753344502406821,1.8594267642584574
NOMO-1,46943432,0.592792127892358,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],2828334,6.287208595728056,1.8594267642584574
MSTO-211H,15953870,2.3250629767102273,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],5281321,1.2119883175444373,1.8594267642584574
NOMO-1,24951314,-0.0494287054100275,1.8594267642584574
NCI-H292,6918328,0.4467511585294103,1.8594267642584574
SNU-81,72193861,-0.4444993909438327,1.8594267642584574
SCC-9,9956119,4.352516606884389,1.8594267642584574
CAL-51,66577038,4.134711160885491,1.8594267642584574
MSTO-211H,44489675,3.600660518296678,1.8594267642584574
SNU-449,11494412,2.814472666417892,1.8594267642584574
OPM-2,navitoclax-MST-312 (1-1 mol-mol),0.8084377370546902,1.8594267642584574
NCI-H522,11364421,-6.31463288554187,1.8594267642584574
OVISE,11222830,0.6942836946088363,1.8594267642584574
LoVo,135398516,0.8347424818537327,1.8594267642584574
MSTO-211H,409805,4.793476239157615,1.8594267642584574
SNU-449,selumetinib-piperlongumine (8-1 mol-mol),4.611443902148163,1.8594267642584574
MSTO-211H,9926054,1.9546831701161536,1.8594267642584574
NCI-H292,2749,1.484796478537434,1.8594267642584574
OPM-2,702558,4.8466631372101725,1.8594267642584574
LoVo,71466445,2.646256567071358,1.8594267642584574
BT-549,16659841,4.205377629414311,1.8594267642584574
KYSE-70,3025986,-0.3454993097331295,1.8594267642584574
NCI-H2171,15953870,3.344319567560605,1.8594267642584574
Panc 04.03,11640390,3.824707626147026,1.8594267642584574
NCI-H292,5278396,3.8202006656128735,1.8594267642584574
NCI-H460,5311,2.161812802665503,1.8594267642584574
CA46,54596558,4.227379600712383,1.8594267642584574
NCI-H522,50905018,5.2003053075185734,1.8594267642584574
JM-1,54596490,4.858476490911798,1.8594267642584574
KMRC-1,5281672,4.43646792139098,1.8594267642584574
SBC-5,46199207,3.436092011920994,1.8594267642584574
NCI-H661,46907787,3.1119891404607083,1.8594267642584574
NCI-H1623,11222830,2.056201659978474,1.8594267642584574
SBC-5,3038522,3.9213361824350024,1.8594267642584574
NCI-H661,9926054,1.7811448977738318,1.8594267642584574
LOU-NH91,969516,2.9922565120136944,1.8594267642584574
MDA-MB-157,5329102,3.39801486229995,1.8594267642584574
SNU-449,445643,4.11461116511151,1.8594267642584574
NCI-H522,9887053,3.177768808520637,1.8594267642584574
NOMO-1,16065773,2.6012917178973405,1.8594267642584574
G-401,67291369,1.7656191364648908,1.8594267642584574
HSC-4,crizotinib-PLX-4032 (2-1 mol-mol),2.8141472051881076,1.8594267642584574
MSTO-211H,11609586,2.648073114002603,1.8594267642584574
A4/Fukuda,25195348,0.8993846970771071,1.8594267642584574
NCI-H2009,54649381,3.659944396907473,1.8594267642584574
CAL-51,3025986,-1.0834382414923172,1.8594267642584574
EFO-27,52912189,5.780518526906142,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],104842,-3.5875650629821942,1.8594267642584574
A-673,123631,1.860693828866879,1.8594267642584574
A2780,44632017,0.0856486258730489,1.8594267642584574
A-673,24901704,3.0162186042420966,1.8594267642584574
OPM-2,168312962,0.8773607091058507,1.8594267642584574
NCI-H292,46398810,2.6001901820453166,1.8594267642584574
SNU-449,53495165,1.8844225218094013,1.8594267642584574
YAPC,2749,2.2394739682848512,1.8594267642584574
NCI-H460,4788,5.894567383019075,1.8594267642584574
LOU-NH91,637858,2.168731257760998,1.8594267642584574
NCI-H727,11427553,2.8726920198872397,1.8594267642584574
NCI-H2171,5978,-3.1305615418900468,1.8594267642584574
EFO-27,969516,2.57565712333896,1.8594267642584574
SNU-81,11152667,-1.3658791794225291,1.8594267642584574
LoVo,2858523,2.923658201852042,1.8594267642584574
FU-OV-1,56946209,-4.492733112758285,1.8594267642584574
CA46,9549297,1.0960598621603344,1.8594267642584574
ONS-76,6917907,-5.751164378556486,1.8594267642584574
NCI-H460,51037431,2.104101453867928,1.8594267642584574
CA46,68056272,3.136594245199668,1.8594267642584574
CAL-51,54143018,-0.6388505972102335,1.8594267642584574
SNU-449,5284329,2.300938885216567,1.8594267642584574
A4/Fukuda,11609586,0.4485915276425587,1.8594267642584574
NCI-H146,9933475,1.6402256772331771,1.8594267642584574
NOMO-1,9927531,5.049638663441057,1.8594267642584574
A-673,148198,-7.755828732328633,1.8594267642584574
SNU-449,2113511,6.338115821615388,1.8594267642584574
NCI-H522,49793307,-5.2014711504438,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],135398744,7.791771320405332,1.8594267642584574
FU-OV-1,44493952,2.9850522959236883,1.8594267642584574
NCI-H661,5328940,0.9675290055268168,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],241158,4.470658456064693,1.8594267642584574
NCI-H727,60700,1.7894131654495464,1.8594267642584574
MDA-MB-157,10385095,0.7848337329764868,1.8594267642584574
DMS 273,46224516,2.6849968878024297,1.8594267642584574
G-401,1641662,3.2482177517563766,1.8594267642584574
NCI-H292,448949,2.3471350598248795,1.8594267642584574
ONS-76,3038522,3.87205505246704,1.8594267642584574
G-401,216468,0.7704979015554879,1.8594267642584574
NCI-H727,10127622,-2.4732053445147333,1.8594267642584574
JM-1,erlotinib-PLX-4032 (2-1 mol-mol),3.366484807659052,1.8594267642584574
LXF 289,16722836,0.8079280065417594,1.8594267642584574
FTC-133,11167602,2.051836472120041,1.8594267642584574
LXF 289,3825829,3.6707575370566534,1.8594267642584574
CA46,25150857,1.719157108492683,1.8594267642584574
NCI-H727,3025986,0.1020219293656271,1.8594267642584574
MDA-MB-453,107985,-4.386344018126506,1.8594267642584574
NCI-H1623,72193861,2.1993190803521423,1.8594267642584574
MDA-MB-453,decitabine-navitoclax (2-1 mol-mol),3.3987025983008468,1.8594267642584574
ONS-76,12001922,1.7268373273866384,1.8594267642584574
LXF 289,5460769,3.06478422280727,1.8594267642584574
MDA-MB-453,doxorubicin-navitoclax (2-1 mol-mol),-1.00600213948852,1.8594267642584574
LoVo,9967941,3.621110602900207,1.8594267642584574
HSC-4,navitoclax-MST-312 (1-1 mol-mol),0.8559820038991849,1.8594267642584574
NCI-H727,5113032,6.018394893069797,1.8594267642584574
MDA-MB-157,5351362,0.7984725267524495,1.8594267642584574
JM-1,1641662,2.861679408031504,1.8594267642584574
A-673,JQ-1-navitoclax (2-1 mol-mol),0.2328293171340499,1.8594267642584574
MSTO-211H,445091,2.4700472101717312,1.8594267642584574
NCI-H146,11404337,-1.5914515878545687,1.8594267642584574
CAL-51,11364421,-3.809863778172731,1.8594267642584574
A2780,4096211,0.5297517602102724,1.8594267642584574
SW1463,23635314,0.7077124425294024,1.8594267642584574
EFO-27,9933475,2.2279721994416364,1.8594267642584574
CAL-51,135875424,4.33643967165441,1.8594267642584574
NCI-H1623,15983966,2.013058792543676,1.8594267642584574
SNU-449,3038522,2.1807259662851735,1.8594267642584574
SNU-81,969516,2.098687325749346,1.8594267642584574
SNU-449,9935249,2.650976699885872,1.8594267642584574
LoVo,10385095,1.3603816893768768,1.8594267642584574
ONS-76,322968,4.979501026393853,1.8594267642584574
DMS 273,9933475,2.0005654751864865,1.8594267642584574
CAL-51,71466578,5.340961831553399,1.8594267642584574
Panc 04.03,selumetinib-PLX-4032 (8-1 mol-mol),4.2289817394660805,1.8594267642584574
MDA-MB-157,1750826,-3.091616753079083,1.8594267642584574
G-401,salermide-PLX-4032 (12-1 mol-mol),5.25337589730296,1.8594267642584574
NOMO-1,702558,2.777027807122979,1.8594267642584574
YAPC,60700,-0.2763967023007928,1.8594267642584574
CA46,5287969,-2.5448622649608925,1.8594267642584574
CA46,15953870,3.0438117584706164,1.8594267642584574
A2780,selumetinib-UNC0638 (4-1 mol-mol),2.0119949051388493,1.8594267642584574
YAPC,6610355,5.243598963135711,1.8594267642584574
SNU-449,4477,0.3396527753410003,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],selumetinib-vorinostat (8-1 mol-mol),2.2938712073349152,1.8594267642584574
SCC-9,168312962,1.0708744032070256,1.8594267642584574
SNU-449,119607,5.345576432951938,1.8594267642584574
LoVo,135999136,5.7154474843469565,1.8594267642584574
NCI-H146,984333,-0.904410626141992,1.8594267642584574
KMRC-1,54619267,4.117989845600413,1.8594267642584574
A4/Fukuda,11485656,1.5130746228374388,1.8594267642584574
BxPC-3,5311,1.3160685062040935,1.8594267642584574
NCI-H522,3038522,2.4524519125835473,1.8594267642584574
SNU-61,89928392,1.2163192063780537,1.8594267642584574
FTC-133,5287969,-0.5047683720981219,1.8594267642584574
ONS-76,25062766,2.430053801867403,1.8594267642584574
NCI-H2009,44486219,4.368704582532332,1.8594267642584574
NCI-H522,637858,0.9732265340904396,1.8594267642584574
NCI-H522,44632017,0.530418286591973,1.8594267642584574
SW1463,11485656,1.9271812519349985,1.8594267642584574
SCC-9,46843906,3.309522412048413,1.8594267642584574
A4/Fukuda,6914657,-5.308594861321554,1.8594267642584574
LOU-NH91,36462,3.2256365983613677,1.8594267642584574
NCI-H1623,3825829,4.488518875119825,1.8594267642584574
MSTO-211H,56946209,-4.75779739938848,1.8594267642584574
YAPC,11427553,3.397606686380644,1.8594267642584574
JM-1,426756,3.661156723786521,1.8594267642584574
JM-1,10184653,1.3269176228991806,1.8594267642584574
NOMO-1,11497983,-3.443590431300748,1.8594267642584574
JM-1,JQ-1-carboplatin (1-1 mol-mol),-0.8945850233452926,1.8594267642584574
A2780,9952709,2.339079626269582,1.8594267642584574
MDA-MB-157,9866186,-1.7048510464532898,1.8594267642584574
CA46,216239,1.3191761483145148,1.8594267642584574
MSTO-211H,176870,1.3974668510804569,1.8594267642584574
LoVo,vorinostat-navitoclax (4-1 mol-mol),1.8172554757062631,1.8594267642584574
OPM-2,135928012,2.8826672527394956,1.8594267642584574
BT-549,9915743,2.34179420613382,1.8594267642584574
LXF 289,71304818,2.1201305139291033,1.8594267642584574
HCC1143,11214940,2.1301365232114144,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],2871966,0.2370033726564668,1.8594267642584574
KYSE-70,11404337,0.2060464556058333,1.8594267642584574
NCI-H2171,11152667,-0.915095731247344,1.8594267642584574
HCC1143,46191454,1.52291312584366,1.8594267642584574
SNU-449,71680916,5.959793136995753,1.8594267642584574
YAPC,219104,4.027438046449075,1.8594267642584574
JM-1,446155,2.7706022090916793,1.8594267642584574
BxPC-3,46398810,2.2883583084835126,1.8594267642584574
OPM-2,2828334,5.82639787583413,1.8594267642584574
A-673,44137675,3.4578104481213905,1.8594267642584574
FTC-133,7251185,3.0292037228467628,1.8594267642584574
KMRC-1,676352,1.883475825529446,1.8594267642584574
EFO-27,1641662,3.8267974599371417,1.8594267642584574
G-401,168312962,3.2015141434031547,1.8594267642584574
CAL-51,2945648,2.7250935788350064,1.8594267642584574
CAL-51,71466445,4.7818956768695715,1.8594267642584574
JM-1,5113032,4.766616079684312,1.8594267642584574
SCC-9,24821094,2.906183993814488,1.8594267642584574
NCI-H661,piperlongumine-MST-312 (1-1 mol-mol),1.6507934598054954,1.8594267642584574
NCI-H292,216345,3.474677020151061,1.8594267642584574
MSTO-211H,JQ-1-MK-0752 (1-1 mol-mol),2.3232645118005015,1.8594267642584574
SBC-5,9549297,3.510799485826288,1.8594267642584574
CA46,156422,3.7635879578153126,1.8594267642584574
MDA-MB-453,71466445,1.9167870178623896,1.8594267642584574
A-673,54596558,3.847043372257958,1.8594267642584574
OPM-2,10231331,0.6444733525039235,1.8594267642584574
HSC-4,5335621,5.235604448739508,1.8594267642584574
CAL-51,11719255,2.5837610433465588,1.8594267642584574
Panc 04.03,44493528,4.362737332857046,1.8594267642584574
SBC-5,carboplatin-etoposide (40-17 mol-mol),1.335045540127449,1.8594267642584574
NCI-H522,24821094,2.425713290484283,1.8594267642584574
CAL-51,6610355,4.388066889778601,1.8594267642584574
MDA-MB-453,6438330,2.0150251794967655,1.8594267642584574
Panc 04.03,46199207,3.759856924739056,1.8594267642584574
SNU-61,9866186,1.5207851909017442,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],10427712,4.591789634520137,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],72193861,4.277039631190645,1.8594267642584574
Panc 04.03,71466578,5.726073349824824,1.8594267642584574
NCI-H727,107970,3.133468251114326,1.8594267642584574
BT-549,60700,-0.4810674620852896,1.8594267642584574
OPM-2,51037431,4.229346700902662,1.8594267642584574
MDA-MB-453,56946209,-4.730570165381635,1.8594267642584574
NCI-H460,72376,-0.5460239014371263,1.8594267642584574
BT-549,44241473,4.976602861760902,1.8594267642584574
A2780,24748573,1.2286507677110594,1.8594267642584574
NOMO-1,5311,-0.031303965270056,1.8594267642584574
A-673,9927531,4.216692000672551,1.8594267642584574
NCI-H1623,46199207,3.747077477678168,1.8594267642584574
NCI-H292,71304818,2.830949431838268,1.8594267642584574
NCI-H1623,9911463,3.95788841498078,1.8594267642584574
SBC-5,9825149,2.9056064620320896,1.8594267642584574
NCI-H460,11612883,2.88158995470921,1.8594267642584574
OVISE,6918878,5.066606594706477,1.8594267642584574
FTC-133,5278396,3.726623182659884,1.8594267642584574
Panc 04.03,24775005,4.54660450697204,1.8594267642584574
CA46,1641662,3.144498035259472,1.8594267642584574
MDA-MB-453,16722836,1.2443221263797826,1.8594267642584574
CA46,54618771,1.203400154931592,1.8594267642584574
HCC1143,613753,3.4353326628352714,1.8594267642584574
A-673,60750,-4.61356677624384,1.8594267642584574
A4/Fukuda,1641662,2.3667755294261297,1.8594267642584574
OVISE,navitoclax-piperlongumine (1-1 mol-mol),0.5165659112827317,1.8594267642584574
MSTO-211H,375860,0.0606650448750636,1.8594267642584574
BxPC-3,6184667,3.26727461265582,1.8594267642584574
CA46,227681,1.829365253324193,1.8594267642584574
SW1463,11964036,0.627645429671571,1.8594267642584574
NCI-H2009,vorinostat-navitoclax (4-1 mol-mol),0.5355412888346941,1.8594267642584574
FTC-133,49766530,-1.1381086002707512,1.8594267642584574
SNU-449,selumetinib-BRD-A02303741 (4-1 mol-mol),5.2718140952083585,1.8594267642584574
NCI-H292,11364421,1.76762986564817,1.8594267642584574
KMRC-1,44819697,1.235264283084374,1.8594267642584574
NCI-H661,9907093,3.834837743900246,1.8594267642584574
DMS 273,17755052,0.9609599247674856,1.8594267642584574
SCC-9,11364421,-0.952029021799848,1.8594267642584574
FTC-133,135984461,4.350998124633342,1.8594267642584574
JM-1,11497983,-3.7280544169699192,1.8594267642584574
MDA-MB-453,24753719,4.38597739181452,1.8594267642584574
ONS-76,168313047,2.901208476511606,1.8594267642584574
NCI-H460,67156097,3.7191617083219097,1.8594267642584574
SNU-81,selumetinib-decitabine (4-1 mol-mol),-2.7455044109926168,1.8594267642584574
A2780,9866186,0.3046354439957303,1.8594267642584574
HSC-4,219104,4.150323587810277,1.8594267642584574
SBC-5,168313047,3.954131669958023,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],19582717,3.1254677854052333,1.8594267642584574
NCI-H292,15953870,3.631273190289841,1.8594267642584574
SNU-449,5281321,-2.557888043471457,1.8594267642584574
HCC1143,702558,5.703077608026742,1.8594267642584574
EFO-27,644241,3.241988529302909,1.8594267642584574
Panc 04.03,9911830,2.4999304852863404,1.8594267642584574
NCI-H522,9967941,3.44539283334302,1.8594267642584574
BT-549,44607531,1.5480457992975702,1.8594267642584574
BxPC-3,44607531,1.3275313586220698,1.8594267642584574
KMRC-1,24951314,2.7376925539969927,1.8594267642584574
JM-1,10231331,5.343116821873739,1.8594267642584574
A-673,25262965,-3.9892118887375303,1.8594267642584574
FTC-133,1716436,3.3698315146098015,1.8594267642584574
OPM-2,2733526,4.066729211955922,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],168312962,3.7277757368773345,1.8594267642584574
DMS 273,3825829,3.788583241717048,1.8594267642584574
KYSE-70,3825829,3.6022414485207452,1.8594267642584574
BxPC-3,5351362,0.9304368738373464,1.8594267642584574
NOMO-1,6918736,-3.755126975181922,1.8594267642584574
A4/Fukuda,11977753,-3.131569873612884,1.8594267642584574
SBC-5,navitoclax-pluripotin (1-1 mol-mol),2.5594903061856744,1.8594267642584574
MDA-MB-157,navitoclax-piperlongumine (1-1 mol-mol),-2.7470196870152894,1.8594267642584574
A2780,73707386,2.710080958425795,1.8594267642584574
SW1463,44819697,-0.8614164905769626,1.8594267642584574
YAPC,24180125,3.806846010722946,1.8594267642584574
NCI-H727,54649381,3.660865770056845,1.8594267642584574
SNU-449,2708,5.735631765174737,1.8594267642584574
CAL-51,54143018,-0.6388505972102335,1.8594267642584574
LXF 289,753704,4.962227230589067,1.8594267642584574
NCI-H2009,9907093,4.391694288558607,1.8594267642584574
EFO-27,387447,-3.111228692284437,1.8594267642584574
NCI-H661,65064,3.46809117241053,1.8594267642584574
SNU-61,5278396,3.627128978826316,1.8594267642584574
NCI-H727,452548,3.7056139041011034,1.8594267642584574
NCI-H292,16720766,0.3451831901206211,1.8594267642584574
SBC-5,serdemetan-SCH-529074 (1-1 mol-mol),2.482890846632963,1.8594267642584574
A4/Fukuda,100016,4.8831896191852096,1.8594267642584574
G-401,25126798,3.708942608188802,1.8594267642584574
SNU-61,24951314,1.416243399270427,1.8594267642584574
CA46,89183176,2.547561715641907,1.8594267642584574
Panc 04.03,2746,3.3610494767062513,1.8594267642584574
FTC-133,107970,3.2744864550719126,1.8594267642584574
NCI-H661,6918878,1.4921814323330362,1.8594267642584574
YAPC,24951314,2.2257819926279243,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11485656,1.8807064812530925,1.8594267642584574
LXF 289,216345,3.67485776854348,1.8594267642584574
G-401,5287969,-2.352936827953192,1.8594267642584574
LXF 289,5566,2.9960878643930218,1.8594267642584574
JM-1,71680916,3.747509118270568,1.8594267642584574
LoVo,16741245,3.141864677583783,1.8594267642584574
NCI-H661,54649381,3.920223147571483,1.8594267642584574
EFO-27,25154868,5.200143123549252,1.8594267642584574
SCC-9,25126798,4.663845786250664,1.8594267642584574
A4/Fukuda,24964624,-0.76967256635286,1.8594267642584574
A-673,11178236,-6.344930978772708,1.8594267642584574
SNU-81,3825829,3.873341985908314,1.8594267642584574
KMRC-1,36462,3.0698954920529324,1.8594267642584574
NCI-H661,262093,3.4983141095274126,1.8594267642584574
LXF 289,JQ-1-navitoclax (2-1 mol-mol),-0.1811537886614743,1.8594267642584574
G-401,676352,1.5550652369933835,1.8594267642584574
SNU-81,11228183,0.0397441918833689,1.8594267642584574
MDA-MB-453,10385095,0.8735195901829151,1.8594267642584574
KMRC-1,16065773,3.457331493974802,1.8594267642584574
CAL-51,5328940,1.595278406971918,1.8594267642584574
CAL-51,56946209,-4.496983035262223,1.8594267642584574
FU-OV-1,5329102,1.609553320034118,1.8594267642584574
YAPC,3062316,1.4892918633711576,1.8594267642584574
NCI-H661,11609586,3.2377833862635206,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],5329102,2.5793782122473985,1.8594267642584574
NCI-H661,serdemetan-SCH-529074 (1-1 mol-mol),2.3260585064542014,1.8594267642584574
JM-1,36462,-2.702351282209385,1.8594267642584574
EFO-27,55508,5.431657737658487,1.8594267642584574
CAL-51,10296883,4.0377332681132305,1.8594267642584574
CAL-51,123631,2.4616591372530605,1.8594267642584574
A-673,53481919,3.7180877845578073,1.8594267642584574
JM-1,107970,1.4704012549786991,1.8594267642584574
CAL-51,5278396,3.885366261927898,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],44819697,-0.1720631569254475,1.8594267642584574
KYSE-70,4096211,2.254549645630953,1.8594267642584574
DMS 273,11609586,1.9163652577621844,1.8594267642584574
EFO-27,9903786,4.039986452778869,1.8594267642584574
CAL-51,6917907,-8.395782425589301,1.8594267642584574
A-498,54454,2.893611310147977,1.8594267642584574
A4/Fukuda,49793307,-5.572580515048152,1.8594267642584574
NOMO-1,4259181,0.2459758371125145,1.8594267642584574
SNU-449,107985,-3.1392486992039235,1.8594267642584574
FU-OV-1,5278396,3.713343254157872,1.8594267642584574
SCC-9,selumetinib-decitabine (4-1 mol-mol),6.773727258865908,1.8594267642584574
A-673,5460769,1.3883868162718005,1.8594267642584574
SCC-9,568763,0.9120329628896908,1.8594267642584574
CAL-51,72199292,1.0008292341873897,1.8594267642584574
MDA-MB-157,8515,2.4995790404865983,1.8594267642584574
NCI-H661,374536,3.546483103952357,1.8594267642584574
KYSE-70,selumetinib-navitoclax (8-1 mol-mol),3.975968679943077,1.8594267642584574
FTC-133,53392493,3.195209876090235,1.8594267642584574
SBC-5,selumetinib-tretinoin (2-1 mol-mol),5.430491518611957,1.8594267642584574
SNU-61,selumetinib-BRD-A02303741 (4-1 mol-mol),0.6699368728217061,1.8594267642584574
BxPC-3,selumetinib-MK-2206 (8-1 mol-mol),0.2275715298784707,1.8594267642584574
NCI-H2009,3825829,4.333180881174198,1.8594267642584574
A-673,6610216,4.190818336865809,1.8594267642584574
LXF 289,1750826,-0.5305094201812034,1.8594267642584574
MDA-MB-453,44543605,3.7347256504274418,1.8594267642584574
BT-549,24964624,2.3327253679943696,1.8594267642584574
DMS 273,24797083,1.0969779553781829,1.8594267642584574
NCI-H2009,24856436,-1.037334288977755,1.8594267642584574
ONS-76,73707440,4.1934861569389845,1.8594267642584574
NCI-H2009,1242560,3.090706196906407,1.8594267642584574
NCI-H2009,6610355,3.511475006316147,1.8594267642584574
CAL-51,51039095,2.1842093640891416,1.8594267642584574
CA46,11404337,-2.4021967063511434,1.8594267642584574
A-673,decitabine-navitoclax (2-1 mol-mol),0.9419890820834614,1.8594267642584574
NCI-H292,11152667,0.5464898224488388,1.8594267642584574
CAL-51,25154868,4.656760297450745,1.8594267642584574
NCI-H727,doxorubicin-navitoclax (2-1 mol-mol),0.353164953880874,1.8594267642584574
HSC-4,66577038,3.591157601556467,1.8594267642584574
LoVo,11175137,1.7419612548831422,1.8594267642584574
Panc 04.03,46215462,2.9027075063139804,1.8594267642584574
G-401,1750826,-3.031444880989549,1.8594267642584574
SCC-9,462382,0.912003027061621,1.8594267642584574
NCI-H2171,71304818,1.9125624841179896,1.8594267642584574
NCI-H2171,6252,2.1051572182795,1.8594267642584574
G-401,51037431,3.9974576184013726,1.8594267642584574
SNU-61,219104,3.1068483513637033,1.8594267642584574
SBC-5,60750,-3.858196401702703,1.8594267642584574
JM-1,72734382,2.7239851923699443,1.8594267642584574
EFO-27,2733526,4.707486415914075,1.8594267642584574
A4/Fukuda,71466445,1.4546499284121797,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],54454,4.0573540170920355,1.8594267642584574
NCI-H460,24797083,0.9153025805785596,1.8594267642584574
A4/Fukuda,54596558,4.022693113590735,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],15983966,2.238460019878405,1.8594267642584574
NCI-H2009,serdemetan-SCH-529074 (1-1 mol-mol),2.304731385362492,1.8594267642584574
HSC-4,44202524,5.184990397771561,1.8594267642584574
MSTO-211H,erlotinib-PLX-4032 (2-1 mol-mol),1.1572104860425592,1.8594267642584574
SNU-61,selumetinib-piperlongumine (8-1 mol-mol),1.4116770683714617,1.8594267642584574
OPM-2,9915743,0.7579871544404475,1.8594267642584574
CA46,56949517,4.303265452215328,1.8594267642584574
HSC-4,tanespimycin-gemcitabine (1-1 mol-mol),-4.488052486534361,1.8594267642584574
CAL-51,24785538,0.7720267524795773,1.8594267642584574
EFO-27,navitoclax-piperlongumine (1-1 mol-mol),2.507192070148125,1.8594267642584574
CAL-51,10322450,3.881825194853649,1.8594267642584574
A2780,241158,1.61479428578643,1.8594267642584574
CA46,JQ-1-UNC0638 (2-1 mol-mol),-0.7861923396287928,1.8594267642584574
LXF 289,10074640,2.806214579062189,1.8594267642584574
NOMO-1,sirolimus-bortezomib (250-1 mol-mol),-0.7938299836559928,1.8594267642584574
NCI-H522,119607,5.115168095819997,1.8594267642584574
A-498,6918638,1.620608219340894,1.8594267642584574
CA46,10302451,0.2515382956842912,1.8594267642584574
NCI-H727,11152667,-1.354343634557878,1.8594267642584574
NCI-H292,135999136,4.360218039072087,1.8594267642584574
NCI-H292,322968,4.489137987914782,1.8594267642584574
KMRC-1,11238147,2.6910045327617422,1.8594267642584574
LoVo,selumetinib-GDC-0941 (4-1 mol-mol),0.7605582392782264,1.8594267642584574
NCI-H522,9911463,3.273817127322074,1.8594267642584574
A4/Fukuda,26596,-3.7061252239164553,1.8594267642584574
CAL-51,2945648,2.7250935788350064,1.8594267642584574
FTC-133,10113978,5.149340897630058,1.8594267642584574
G-401,25227462,-4.354739504605027,1.8594267642584574
CAL-51,3634881,3.319714226315486,1.8594267642584574
NCI-H522,5280436,1.9285860105900432,1.8594267642584574
LOU-NH91,JQ-1-MK-0752 (1-1 mol-mol),2.239144963977278,1.8594267642584574
A-673,285033,-3.783680268063714,1.8594267642584574
KYSE-70,11497983,4.3699696445826035,1.8594267642584574
EFO-27,135423438,3.7049046399150134,1.8594267642584574
CA46,26596,-3.5845712744961324,1.8594267642584574
A2780,24785538,0.5365701421591345,1.8594267642584574
NCI-H2009,8515,4.894015987740437,1.8594267642584574
DMS 273,carboplatin-etoposide (40-17 mol-mol),3.245479848916456,1.8594267642584574
JM-1,387447,-6.033292615187937,1.8594267642584574
DMS 273,9956119,4.190734481617164,1.8594267642584574
A2780,navitoclax-birinapant (1-1 mol-mol),-1.2503932555480053,1.8594267642584574
NCI-H146,36462,-0.9223549938225544,1.8594267642584574
NCI-H1623,11485656,1.644044907667622,1.8594267642584574
NCI-H1623,24821094,-0.2323488781711246,1.8594267642584574
HSC-4,53301938,4.738168418112686,1.8594267642584574
LOU-NH91,676352,2.464978676736505,1.8594267642584574
NCI-H146,46926350,-6.324766796143129,1.8594267642584574
ONS-76,16722836,1.7132123007700326,1.8594267642584574
YAPC,327653,3.117178905090827,1.8594267642584574
OVISE,24901704,4.2849421736627615,1.8594267642584574
JM-1,54618164,3.458143614246244,1.8594267642584574
A-673,445091,4.1466370846962075,1.8594267642584574
OVISE,5329102,2.956482132219437,1.8594267642584574
HCC1143,5470400,2.3870928447001867,1.8594267642584574
BxPC-3,salermide-PLX-4032 (12-1 mol-mol),4.912455807166081,1.8594267642584574
SNU-61,3503,2.986460298481687,1.8594267642584574
DMS 273,11455910,0.4737958394902512,1.8594267642584574
NCI-H460,46907787,4.3372157131836255,1.8594267642584574
CAL-51,216345,2.9520334452605637,1.8594267642584574
A2780,6450551,0.1349302943593443,1.8594267642584574
LoVo,46398810,1.578557668618055,1.8594267642584574
SNU-81,15953870,1.3050219745867302,1.8594267642584574
A-673,54613361,-0.6759826855411176,1.8594267642584574
SBC-5,11234052,4.136817608168693,1.8594267642584574
NCI-H460,36462,3.103581216464206,1.8594267642584574
MDA-MB-157,selumetinib-JQ-1 (4-1 mol-mol),4.112916907677963,1.8594267642584574
A-673,168313200,1.7801049656035806,1.8594267642584574
A4/Fukuda,vorinostat-carboplatin (1-1 mol-mol),1.5546210220419645,1.8594267642584574
A2780,100016,4.757543521992015,1.8594267642584574
NCI-H727,selumetinib-tretinoin (2-1 mol-mol),0.6638203077807998,1.8594267642584574
CA46,25105715,3.628482142858773,1.8594267642584574
HCC1143,9911463,3.749174224015704,1.8594267642584574
LOU-NH91,4477,1.3512747052000795,1.8594267642584574
A2780,UNC0638-navitoclax (1-1 mol-mol),1.9262711606440108,1.8594267642584574
FU-OV-1,25154868,3.6525772823030502,1.8594267642584574
A2780,168313016,3.896841135664639,1.8594267642584574
MDA-MB-453,JQ-1-UNC0638 (2-1 mol-mol),-0.1830175507337199,1.8594267642584574
FU-OV-1,selumetinib-piperlongumine (8-1 mol-mol),2.8006116127321463,1.8594267642584574
NCI-H292,15547703,3.23498204624142,1.8594267642584574
JM-1,5329102,1.4301495534996294,1.8594267642584574
NCI-H522,3384730,2.8239588226941104,1.8594267642584574
A2780,9911463,2.7303797257759235,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],5746,1.2509488539194744,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],327653,3.480028492466642,1.8594267642584574
YAPC,9887053,4.707664045043398,1.8594267642584574
HCC1143,10074640,2.8253679093766104,1.8594267642584574
LXF 289,11178236,-2.9660816129263297,1.8594267642584574
A2780,ISOX-bortezomib (250-1 mol-mol),0.49630436037141,1.8594267642584574
KYSE-70,135398516,2.3739819683449697,1.8594267642584574
A-498,57519531,4.461574036812888,1.8594267642584574
NOMO-1,9840324,6.741383080584752,1.8594267642584574
BxPC-3,10427712,4.346184062898943,1.8594267642584574
NCI-H292,selumetinib-decitabine (4-1 mol-mol),4.672876887029793,1.8594267642584574
LoVo,25062766,1.8850615394111836,1.8594267642584574
FTC-133,262093,3.024825063724614,1.8594267642584574
HCC1143,44819697,-2.8669414823386115,1.8594267642584574
BT-549,5351362,2.1022372489581227,1.8594267642584574
FTC-133,selumetinib-navitoclax (8-1 mol-mol),3.0170288782836163,1.8594267642584574
MSTO-211H,53325874,5.432400358349695,1.8594267642584574
NCI-H460,serdemetan-SCH-529074 (1-1 mol-mol),2.824761318038116,1.8594267642584574
DMS 273,7326481,3.48743847164077,1.8594267642584574
JM-1,11955716,-2.692308040243548,1.8594267642584574
SNU-61,JQ-1-vorinostat (2-1 mol-mol),1.221813874955551,1.8594267642584574
MDA-MB-157,2842253,6.170125707570699,1.8594267642584574
SNU-61,54454,3.789888893365768,1.8594267642584574
NOMO-1,5460769,4.769752092364765,1.8594267642584574
A2780,285033,-3.502152061737446,1.8594267642584574
HCC1143,44495899,4.517503920361928,1.8594267642584574
NCI-H661,31703,-1.814857416200904,1.8594267642584574
A-498,piperlongumine-MST-312 (1-1 mol-mol),3.2083615282552853,1.8594267642584574
YAPC,navitoclax-pluripotin (1-1 mol-mol),-0.110540489139909,1.8594267642584574
A2780,2729026,1.9590477988732768,1.8594267642584574
JM-1,89928392,-1.0810313065311572,1.8594267642584574
JM-1,10410894,1.2527004533251185,1.8594267642584574
NCI-H661,16038120,1.553795977052523,1.8594267642584574
LoVo,135421197,2.0078610802467307,1.8594267642584574
HSC-4,24901704,4.088081803824046,1.8594267642584574
HSC-4,135411,-0.261300177061483,1.8594267642584574
NCI-H522,4917,2.9130794248329392,1.8594267642584574
JM-1,11364421,-7.32386861469755,1.8594267642584574
NCI-H2009,10127622,-1.471627480680591,1.8594267642584574
DMS 273,4917,3.103248515982538,1.8594267642584574
OPM-2,44462760,2.3304413416808463,1.8594267642584574
YAPC,9956119,3.92905072911681,1.8594267642584574
A4/Fukuda,5113032,4.450145517718883,1.8594267642584574
NCI-H1623,49793307,-1.4788317062169576,1.8594267642584574
BxPC-3,637858,2.219072546092823,1.8594267642584574
NCI-H1623,1566236,4.077529389730835,1.8594267642584574
G-401,23725625,4.115882586635449,1.8594267642584574
SNU-81,crizotinib-PLX-4032 (2-1 mol-mol),1.4380831221683867,1.8594267642584574
DMS 273,252682,6.321322886147215,1.8594267642584574
KYSE-70,135411,1.9014599224142343,1.8594267642584574
NCI-H2171,49867930,3.814749813399888,1.8594267642584574
SW1463,10302451,2.197754569420114,1.8594267642584574
Panc 04.03,salermide-PLX-4032 (12-1 mol-mol),5.297407479315669,1.8594267642584574
NCI-H522,71466445,4.480637973076106,1.8594267642584574
NCI-H727,6610355,5.167779637611195,1.8594267642584574
A4/Fukuda,613753,2.966875582154842,1.8594267642584574
ONS-76,4261,2.2909626551681757,1.8594267642584574
YAPC,serdemetan-SCH-529074 (1-1 mol-mol),2.033605312871709,1.8594267642584574
KMRC-1,31703,0.3325905755235477,1.8594267642584574
SNU-449,445455,4.484776409201516,1.8594267642584574
A-498,6918878,4.306638073301365,1.8594267642584574
SCC-9,selumetinib-tretinoin (2-1 mol-mol),3.7791942672746974,1.8594267642584574
OPM-2,1750826,-5.079410714013139,1.8594267642584574
NCI-H1623,9915743,-1.6977137550638366,1.8594267642584574
CAL-51,crizotinib-PLX-4032 (2-1 mol-mol),1.2740742707449055,1.8594267642584574
SNU-449,7251185,2.777592648573664,1.8594267642584574
NCI-H522,2733526,4.089503686239825,1.8594267642584574
LoVo,24180719,2.381979820549913,1.8594267642584574
A-498,49793307,2.582548635431232,1.8594267642584574
FU-OV-1,selumetinib-PLX-4032 (8-1 mol-mol),1.0793153404708502,1.8594267642584574
NCI-H522,4788,5.8756804910396925,1.8594267642584574
G-401,374536,1.448879337840406,1.8594267642584574
SBC-5,135440466,3.787084066930897,1.8594267642584574
BxPC-3,36314,4.043064497836865,1.8594267642584574
SBC-5,11626560,2.9533832336239985,1.8594267642584574
OPM-2,613753,2.6904302784099845,1.8594267642584574
G-401,71466380,4.3225707153388,1.8594267642584574
G-401,45279963,3.527434868311602,1.8594267642584574
MDA-MB-453,1239801,4.069717893467032,1.8594267642584574
A2780,11719255,1.8256962189728296,1.8594267642584574
KMRC-1,navitoclax-gemcitabine (1-1 mol-mol),-4.218093403904549,1.8594267642584574
HSC-4,11404337,-0.2351979780524762,1.8594267642584574
A2780,crizotinib-PLX-4032 (2-1 mol-mol),0.8552062968209889,1.8594267642584574
JM-1,5978,-5.097158196512326,1.8594267642584574
BxPC-3,6917907,-5.822397614063261,1.8594267642584574
NCI-H2009,52912189,1.2519346625881922,1.8594267642584574
KMRC-1,6917907,2.5901706443444477,1.8594267642584574
YAPC,selumetinib-JQ-1 (4-1 mol-mol),3.639146337556592,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],135875424,4.234717543087367,1.8594267642584574
KYSE-70,2746,2.8005709054024224,1.8594267642584574
BxPC-3,638278,3.0042450495358923,1.8594267642584574
CAL-51,navitoclax-pluripotin (1-1 mol-mol),-0.5264654943286647,1.8594267642584574
HSC-4,31703,-2.446577735650292,1.8594267642584574
NCI-H661,11152667,-1.7022631730770723,1.8594267642584574
SCC-9,73707398,1.5896934234406246,1.8594267642584574
FU-OV-1,148198,-3.302287500778492,1.8594267642584574
MDA-MB-157,5287969,-2.775456728988527,1.8594267642584574
OVISE,6918289,3.317561176891493,1.8594267642584574
CAL-51,JQ-1-navitoclax (2-1 mol-mol),3.0806992030623053,1.8594267642584574
HCC1143,10296883,4.463772522749199,1.8594267642584574
FU-OV-1,25150857,2.264135178575504,1.8594267642584574
LOU-NH91,ISOX-bortezomib (250-1 mol-mol),1.5845315088477396,1.8594267642584574
BxPC-3,16725315,4.1100247270568815,1.8594267642584574
EFO-27,11707110,4.483747329636401,1.8594267642584574
A-673,2858523,3.068752318729834,1.8594267642584574
OVISE,5280436,4.204860612632051,1.8594267642584574
NCI-H727,122327,5.896927010318378,1.8594267642584574
CAL-51,448949,2.479839067238928,1.8594267642584574
NCI-H2171,serdemetan-SCH-529074 (1-1 mol-mol),1.0572285020282108,1.8594267642584574
HSC-4,72199292,2.0552941548988506,1.8594267642584574
NCI-H2009,36462,0.0033291412741449,1.8594267642584574
Panc 04.03,JQ-1-vorinostat (2-1 mol-mol),1.3014737329174946,1.8594267642584574
JM-1,71466578,1.9829041072742877,1.8594267642584574
A2780,JQ-1-vorinostat (2-1 mol-mol),0.2041997396935529,1.8594267642584574
LXF 289,67291369,3.4412292386368746,1.8594267642584574
NOMO-1,5281321,-2.1390969134868656,1.8594267642584574
NCI-H661,387447,-3.746079371333459,1.8594267642584574
NCI-H460,10385095,2.2920897819597896,1.8594267642584574
EFO-27,3543504,5.270070957864149,1.8594267642584574
NCI-H2009,11497983,-2.437134563400756,1.8594267642584574
NCI-H2171,4917,1.7834364774656617,1.8594267642584574
MDA-MB-157,4578,4.4846224734546025,1.8594267642584574
A-673,9935249,0.595201632659186,1.8594267642584574
NCI-H146,4096211,2.4692816884948856,1.8594267642584574
NOMO-1,60750,-2.6028640292275567,1.8594267642584574
NOMO-1,676352,2.3647709516043336,1.8594267642584574
SNU-81,168312962,1.078666024421789,1.8594267642584574
A-673,3081361,1.7117642477526505,1.8594267642584574
NCI-H460,46398810,3.30325787352206,1.8594267642584574
FTC-133,24771867,3.849205905915908,1.8594267642584574
KMRC-1,409805,5.852991634240623,1.8594267642584574
LXF 289,2708,6.094251503540483,1.8594267642584574
A4/Fukuda,11647372,-0.68075141177871,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],25195348,3.936962209730735,1.8594267642584574
NCI-H522,3025944,4.039653719751215,1.8594267642584574
HSC-4,6918289,2.856015155241233,1.8594267642584574
MDA-MB-453,erlotinib-PLX-4032 (2-1 mol-mol),2.999832239704596,1.8594267642584574
MDA-MB-453,67291369,1.3466484853812946,1.8594267642584574
A4/Fukuda,11178236,-5.149024442366163,1.8594267642584574
NCI-H661,168313200,3.81404568417466,1.8594267642584574
EFO-27,219104,4.121088157278177,1.8594267642584574
KYSE-70,46191454,2.1451937437577575,1.8594267642584574
SCC-9,9927531,5.254709651648818,1.8594267642584574
A-673,navitoclax-piperlongumine (1-1 mol-mol),0.5796855962539734,1.8594267642584574
CAL-51,16038120,-0.248771562775031,1.8594267642584574
JM-1,3634881,1.559410928505107,1.8594267642584574
SCC-9,5113032,4.570528604758655,1.8594267642584574
CAL-51,68056272,3.9955701948507247,1.8594267642584574
CAL-51,4521392,4.667802355757324,1.8594267642584574
BxPC-3,navitoclax-piperlongumine (1-1 mol-mol),1.3224342280969303,1.8594267642584574
Panc 04.03,BRD-A02303741-navitoclax (2-1 mol-mol),3.819752111817625,1.8594267642584574
A-673,serdemetan-SCH-529074 (1-1 mol-mol),0.8484968738221454,1.8594267642584574
SNU-61,9887053,4.377899885829067,1.8594267642584574
NCI-H2009,25102847,2.121570289721804,1.8594267642584574
NCI-H661,54454,0.5886754914082402,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],24901704,4.114962911798603,1.8594267642584574
MDA-MB-157,46174525,4.215722898807237,1.8594267642584574
LoVo,5978,-0.9838296745754056,1.8594267642584574
NOMO-1,44137675,1.7607667559168472,1.8594267642584574
JM-1,ISOX-bortezomib (250-1 mol-mol),-0.4363685688396392,1.8594267642584574
FTC-133,216468,3.7386330008080018,1.8594267642584574
NCI-H522,5284616,3.1429047752915036,1.8594267642584574
A-673,6450551,1.2504532759531255,1.8594267642584574
MDA-MB-453,2126,4.599537631708682,1.8594267642584574
FTC-133,12001922,3.1425787892022656,1.8594267642584574
BxPC-3,6610355,3.939463034432562,1.8594267642584574
Panc 04.03,72193861,4.339971647759762,1.8594267642584574
DMS 273,984333,0.9143511576606916,1.8594267642584574
NCI-H460,126941,-2.220790788147435,1.8594267642584574
SBC-5,11178236,-5.106449128542812,1.8594267642584574
A2780,11497983,-3.587231584220661,1.8594267642584574
EFO-27,5278396,3.98166727080577,1.8594267642584574
NCI-H460,40482356,5.06381124686115,1.8594267642584574
OVISE,51039095,3.497583622307714,1.8594267642584574
HCC1143,56946209,-4.25120546555742,1.8594267642584574
NCI-H2009,3025986,-0.6988289053859157,1.8594267642584574
DMS 273,44543605,5.15097132829554,1.8594267642584574
HSC-4,23635314,4.118860430098142,1.8594267642584574
FU-OV-1,107970,2.0514231206369686,1.8594267642584574
HSC-4,selumetinib-JQ-1 (4-1 mol-mol),3.950475054879744,1.8594267642584574
A-498,5284329,4.906845392884974,1.8594267642584574
NCI-H522,selumetinib-piperlongumine (8-1 mol-mol),2.5567872657123307,1.8594267642584574
A-673,11612883,1.6900414301434703,1.8594267642584574
DMS 273,11507802,0.7884214749573938,1.8594267642584574
NCI-H661,44486219,4.876697308801278,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],51037431,4.999864104870178,1.8594267642584574
CA46,selumetinib-BRD-A02303741 (4-1 mol-mol),5.304542005494123,1.8594267642584574
LOU-NH91,JQ-1-navitoclax (2-1 mol-mol),-0.9494893938719444,1.8594267642584574
SNU-449,135875424,4.841371934548395,1.8594267642584574
HSC-4,carboplatin-etoposide (40-17 mol-mol),1.986163410800157,1.8594267642584574
NCI-H292,72376,-2.1951743702669573,1.8594267642584574
CA46,36462,0.0715644321871689,1.8594267642584574
A2780,54678924,1.3135335490837166,1.8594267642584574
JM-1,9926054,1.6867956204893688,1.8594267642584574
LOU-NH91,4788,5.956614254075031,1.8594267642584574
G-401,navitoclax-piperlongumine (1-1 mol-mol),0.8522562027001119,1.8594267642584574
YAPC,9929138,5.651296587688524,1.8594267642584574
CA46,613753,2.777360120502711,1.8594267642584574
BxPC-3,159324,1.5239234886257875,1.8594267642584574
DMS 273,9911830,2.0619640796568848,1.8594267642584574
LOU-NH91,selumetinib-navitoclax (8-1 mol-mol),0.0322992078492161,1.8594267642584574
ONS-76,17755052,2.9613727126940126,1.8594267642584574
Panc 04.03,navitoclax-MST-312 (1-1 mol-mol),2.2985193388482177,1.8594267642584574
DMS 273,serdemetan-SCH-529074 (1-1 mol-mol),2.0860866366199584,1.8594267642584574
BT-549,56963564,0.7590937126260752,1.8594267642584574
A4/Fukuda,135398738,0.2588260022635366,1.8594267642584574
FU-OV-1,6918328,-0.3184221939986219,1.8594267642584574
NCI-H2171,119182,5.854927706564024,1.8594267642584574
LXF 289,46224516,3.632609368126253,1.8594267642584574
BT-549,66577038,3.347380186099457,1.8594267642584574
LXF 289,navitoclax-MST-312 (1-1 mol-mol),0.8889120523673528,1.8594267642584574
NCI-H460,25183872,2.110783783288614,1.8594267642584574
CAL-51,17759555,3.5733302595078182,1.8594267642584574
HCC1143,4788,5.8180322078124265,1.8594267642584574
NCI-H727,selumetinib-PLX-4032 (8-1 mol-mol),-1.7195859584086806,1.8594267642584574
LOU-NH91,selumetinib-JQ-1 (4-1 mol-mol),1.3495947131381103,1.8594267642584574
A-673,11656518,-0.6930464248114873,1.8594267642584574
NCI-H522,12003241,-1.5672925136718587,1.8594267642584574
NCI-H2009,19582717,2.816304614086765,1.8594267642584574
LXF 289,9911463,2.935801973679381,1.8594267642584574
NCI-H1623,44202524,1.6623127043604982,1.8594267642584574
NCI-H522,9952709,3.5153076410238477,1.8594267642584574
EFO-27,4378219,5.419366677908557,1.8594267642584574
FU-OV-1,11404337,-0.2130364442314083,1.8594267642584574
FU-OV-1,119607,4.651010364988691,1.8594267642584574
NCI-H146,135875424,2.9115600315347057,1.8594267642584574
LOU-NH91,11152667,-0.304989451834292,1.8594267642584574
SW1463,439501,-0.3046644173954531,1.8594267642584574
LoVo,25022340,4.929882293123705,1.8594267642584574
NCI-H1623,23725625,5.633484297207613,1.8594267642584574
KMRC-1,439501,-2.7889227637684773,1.8594267642584574
A4/Fukuda,9907093,3.513986602103764,1.8594267642584574
A2780,969516,2.2684147801302155,1.8594267642584574
HCC1143,24753719,5.247680835091332,1.8594267642584574
DMS 273,25183872,-1.4455230978287994,1.8594267642584574
SNU-81,3854666,0.9917295007006844,1.8594267642584574
NCI-H522,57330099,4.380671698756577,1.8594267642584574
A-673,135421197,0.3124298336996849,1.8594267642584574
NCI-H460,46398810,3.30325787352206,1.8594267642584574
NCI-H661,52947716,-6.022145864838143,1.8594267642584574
CAL-51,9907093,3.7886359098281783,1.8594267642584574
FTC-133,erlotinib-PLX-4032 (2-1 mol-mol),4.762605584233989,1.8594267642584574
SCC-9,11640390,4.170413196512925,1.8594267642584574
SW1463,56973724,0.8689023909239705,1.8594267642584574
HCC1143,24180719,4.266131781804432,1.8594267642584574
KMRC-1,135398738,5.381791034510906,1.8594267642584574
BxPC-3,36462,3.4182720226712457,1.8594267642584574
MDA-MB-157,4261,1.9483424687424111,1.8594267642584574
NOMO-1,2708,4.2098167660909525,1.8594267642584574
A4/Fukuda,10410894,1.64506751408979,1.8594267642584574
A2780,3384730,1.1479192192658911,1.8594267642584574
SNU-449,439501,-4.772752939359215,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],SNX-2112-bortezomib (250-1 mol-mol),-0.995249621859288,1.8594267642584574
DMS 273,51037431,4.4079331684726775,1.8594267642584574
A2780,16741245,2.3123767413084786,1.8594267642584574
SNU-81,42642645,1.3921275935464503,1.8594267642584574
CA46,44632017,0.5480853683486498,1.8594267642584574
A-673,71304818,1.350808371963784,1.8594267642584574
SNU-449,6914657,-4.967870149056919,1.8594267642584574
MSTO-211H,25150857,2.632878402859221,1.8594267642584574
MDA-MB-157,26596,-2.8480155125253623,1.8594267642584574
LXF 289,9929138,7.38651684018349,1.8594267642584574
G-401,25183872,-1.5190566583165497,1.8594267642584574
A-673,241158,1.6738540084680422,1.8594267642584574
SNU-61,25195348,2.878615726844662,1.8594267642584574
MDA-MB-157,53392493,1.7008245883035995,1.8594267642584574
LoVo,68056272,4.365145786196869,1.8594267642584574
NCI-H2171,6918837,-5.273009588122425,1.8594267642584574
NCI-H460,168312962,-1.8333752522095308,1.8594267642584574
CAL-51,44259,0.1826439745217317,1.8594267642584574
HSC-4,285033,-0.8602386046724618,1.8594267642584574
EFO-27,25105715,3.778793980481446,1.8594267642584574
A-673,1641662,3.2069303925294625,1.8594267642584574
KMRC-1,3854666,2.659759078644905,1.8594267642584574
DMS 273,375860,-0.4468381354972334,1.8594267642584574
NCI-H661,10231331,4.850159308010921,1.8594267642584574
DMS 273,16725315,5.248612259787856,1.8594267642584574
NCI-H292,crizotinib-PLX-4032 (2-1 mol-mol),2.353099722482166,1.8594267642584574
NCI-H661,73707398,1.1965083244926786,1.8594267642584574
OPM-2,JQ-1-vorinostat (2-1 mol-mol),-2.42287599285764,1.8594267642584574
NCI-H1623,135421197,3.7764453326534855,1.8594267642584574
BxPC-3,24951314,1.2340413323146109,1.8594267642584574
MSTO-211H,navitoclax-birinapant (1-1 mol-mol),-0.9866972359238844,1.8594267642584574
NCI-H146,119182,2.1823445512420308,1.8594267642584574
G-401,4578,4.054730999265937,1.8594267642584574
MDA-MB-157,6918837,-2.759774975538005,1.8594267642584574
EFO-27,9907093,4.474758252228614,1.8594267642584574
HCC1143,navitoclax-gemcitabine (1-1 mol-mol),1.7090792961792267,1.8594267642584574
NCI-H727,navitoclax-MST-312 (1-1 mol-mol),1.3064491848942938,1.8594267642584574
FU-OV-1,carboplatin-etoposide (40-17 mol-mol),3.4615233575458992,1.8594267642584574
HSC-4,tanespimycin-bortezomib (250-1 mol-mol),0.4907221930959023,1.8594267642584574
NCI-H460,3025944,5.476008686130055,1.8594267642584574
LXF 289,selumetinib-GDC-0941 (4-1 mol-mol),2.154352876327122,1.8594267642584574
NCI-H292,9915743,-0.4817131806939655,1.8594267642584574
LXF 289,44202524,1.498501439362416,1.8594267642584574
OVISE,135411,0.7729741022965545,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],46174525,4.230350619821445,1.8594267642584574
NCI-H2009,5746,1.7505534195957702,1.8594267642584574
A4/Fukuda,10184653,1.3612642262853822,1.8594267642584574
SNU-61,selumetinib-vorinostat (8-1 mol-mol),-0.9807970774294382,1.8594267642584574
BxPC-3,ISOX-bortezomib (250-1 mol-mol),0.0666490306431122,1.8594267642584574
JM-1,375860,-0.4977027167273706,1.8594267642584574
SNU-61,46943432,3.2717403410494397,1.8594267642584574
NCI-H146,168313200,1.5894074456272884,1.8594267642584574
HCC1143,piperlongumine-MST-312 (1-1 mol-mol),2.011691576039941,1.8594267642584574
NCI-H2171,6184667,1.4164127707768046,1.8594267642584574
DMS 273,10184653,1.3805891581139824,1.8594267642584574
HSC-4,JQ-1-navitoclax (2-1 mol-mol),3.2016872805134025,1.8594267642584574
SNU-81,24856436,-0.0712468901893707,1.8594267642584574
LXF 289,71680916,5.339150924844951,1.8594267642584574
CA46,5291,2.960224941202677,1.8594267642584574
NCI-H2009,5329102,2.1297157842750756,1.8594267642584574
HCC1143,49793307,-2.279288310815399,1.8594267642584574
HCC1143,15953870,6.0969880807250085,1.8594267642584574
BxPC-3,2749,2.8971498792709784,1.8594267642584574
SNU-449,12003241,0.2005365129445947,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.1552329187196393,1.8594267642584574
MDA-MB-157,2733487,0.3711294020076626,1.8594267642584574
NCI-H292,3025944,4.3344233170115185,1.8594267642584574
FTC-133,637858,3.731185140297224,1.8594267642584574
NCI-H1623,387447,-3.670338978810225,1.8594267642584574
JM-1,5394,4.3191880254190425,1.8594267642584574
NCI-H292,alisertib-navitoclax (2-1 mol-mol),2.7354640490460724,1.8594267642584574
MDA-MB-453,24964624,0.7400526464517642,1.8594267642584574
SBC-5,637858,3.033148612268187,1.8594267642584574
HSC-4,3825829,4.330540788358233,1.8594267642584574
LOU-NH91,26596,-0.8372049149458933,1.8594267642584574
Panc 04.03,24180719,4.502790622897018,1.8594267642584574
MDA-MB-453,44486219,3.97168660448306,1.8594267642584574
ONS-76,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.0736426571342059,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],9915743,2.171200504833566,1.8594267642584574
G-401,selumetinib-GDC-0941 (4-1 mol-mol),0.5111362666668609,1.8594267642584574
MDA-MB-453,carboplatin-UNC0638 (2-1 mol-mol),3.2412925949460223,1.8594267642584574
A2780,46398810,1.6945681809511193,1.8594267642584574
ONS-76,44493528,4.396938069944904,1.8594267642584574
HSC-4,3854666,2.969420021692798,1.8594267642584574
SNU-449,5291,3.951163668523845,1.8594267642584574
MDA-MB-453,216345,3.4613524333124337,1.8594267642584574
NCI-H727,71680916,5.541731669631066,1.8594267642584574
NCI-H460,4261,3.676509117184606,1.8594267642584574
NCI-H2171,10184653,0.99528741531969,1.8594267642584574
FTC-133,54626689,4.834884112239084,1.8594267642584574
A2780,55283,0.78738067747292,1.8594267642584574
OPM-2,753704,3.6202062566191984,1.8594267642584574
NCI-H522,53392493,1.8355339375888644,1.8594267642584574
DMS 273,10127622,5.766745520319409,1.8594267642584574
ONS-76,BRD-K58730230,4.314454311755605,1.8594267642584574
MDA-MB-453,49766530,3.3081056054922064,1.8594267642584574
A2780,16065773,0.67384212990199,1.8594267642584574
JM-1,241158,1.7269305863155773,1.8594267642584574
A4/Fukuda,71466380,2.851115718652883,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],227681,1.7640901700531322,1.8594267642584574
MDA-MB-157,16722836,1.792866712111087,1.8594267642584574
NCI-H460,6852167,4.590065962834362,1.8594267642584574
SCC-9,375860,0.1694000381305893,1.8594267642584574
CAL-51,54649381,3.902782783768603,1.8594267642584574
EFO-27,2708,5.128228617584202,1.8594267642584574
G-401,6450551,1.2745400494425214,1.8594267642584574
SNU-449,168313016,5.914877518762689,1.8594267642584574
NCI-H661,654092,0.3537062860674825,1.8594267642584574
SNU-61,5284616,3.808934677012338,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],selumetinib-JQ-1 (4-1 mol-mol),0.8519093027045113,1.8594267642584574
KYSE-70,25195348,5.534160735777195,1.8594267642584574
NCI-H2171,135421197,2.0026019926205185,1.8594267642584574
NCI-H460,4261,3.676509117184606,1.8594267642584574
DMS 273,1641662,3.247845954250749,1.8594267642584574
BxPC-3,6914657,-4.023901786471393,1.8594267642584574
CAL-51,9936388,-5.638746232401389,1.8594267642584574
A4/Fukuda,25161177,3.5710974046751804,1.8594267642584574
NOMO-1,24821094,3.1222382635594967,1.8594267642584574
A4/Fukuda,53232,1.4709221708336295,1.8594267642584574
A-673,9840324,5.96119566119886,1.8594267642584574
LoVo,613753,3.444351424595812,1.8594267642584574
FTC-133,4477,0.2258553638980791,1.8594267642584574
MDA-MB-453,11214940,4.455338804672604,1.8594267642584574
A2780,56649450,-0.3009304069219352,1.8594267642584574
HCC1143,89928392,0.2924123173203115,1.8594267642584574
BT-549,6852167,2.654575121453327,1.8594267642584574
G-401,375860,-0.2910974790080222,1.8594267642584574
NCI-H661,613753,3.3170674343428708,1.8594267642584574
YAPC,71304818,2.728620236586343,1.8594267642584574
NCI-H292,3503,2.756562172316919,1.8594267642584574
OPM-2,44819697,-1.6539436611429392,1.8594267642584574
HCC1143,60700,1.3373007617879429,1.8594267642584574
MSTO-211H,446155,-0.2868964860821164,1.8594267642584574
A4/Fukuda,2708,3.0461577581065007,1.8594267642584574
SNU-61,126941,2.173772773827979,1.8594267642584574
DMS 273,selumetinib-piperlongumine (8-1 mol-mol),4.661418163963333,1.8594267642584574
HCC1143,444795,4.803024181226615,1.8594267642584574
JM-1,441298,2.4952150007247393,1.8594267642584574
DMS 273,44507138,4.08877163590395,1.8594267642584574
Panc 04.03,5291,3.9842309161066063,1.8594267642584574
BxPC-3,3062316,-1.891072672499,1.8594267642584574
KYSE-70,15983966,-0.1847866067827735,1.8594267642584574
LoVo,doxorubicin-navitoclax (2-1 mol-mol),-1.249111657931932,1.8594267642584574
DMS 273,44607531,1.5313743675110545,1.8594267642584574
NCI-H292,5746,0.9253562515034884,1.8594267642584574
NCI-H146,6914657,-5.6838858588772245,1.8594267642584574
EFO-27,25150857,3.1416161415552173,1.8594267642584574
SNU-61,54618771,-0.470226071786205,1.8594267642584574
BT-549,1716436,2.964006130486385,1.8594267642584574
BxPC-3,4521392,4.6952932183187,1.8594267642584574
BxPC-3,5328940,0.9544734009845622,1.8594267642584574
LoVo,vorinostat-carboplatin (1-1 mol-mol),2.43633518664014,1.8594267642584574
Panc 04.03,16013152,4.359497957481629,1.8594267642584574
A4/Fukuda,3062316,0.4248767517614322,1.8594267642584574
A-673,11609586,1.032418246609784,1.8594267642584574
SW1463,322968,1.9625017896764745,1.8594267642584574
JM-1,11427553,0.2949480151387566,1.8594267642584574
CAL-51,11497983,2.6322425573174213,1.8594267642584574
Panc 04.03,12003241,0.3752932920389255,1.8594267642584574
FU-OV-1,216345,4.02478525181321,1.8594267642584574
NCI-H522,89928392,1.1479343378844449,1.8594267642584574
NCI-H460,11485656,2.6212830818798065,1.8594267642584574
LOU-NH91,6438330,3.480541802748286,1.8594267642584574
MDA-MB-157,11228183,0.9797898244038654,1.8594267642584574
A4/Fukuda,10385095,0.4549399411675465,1.8594267642584574
G-401,241158,1.9889661714459972,1.8594267642584574
MDA-MB-157,5282054,1.4096594950320644,1.8594267642584574
NCI-H522,11404337,-1.4542746262182442,1.8594267642584574
NCI-H661,322968,4.732962604670861,1.8594267642584574
NOMO-1,65064,5.083490310509571,1.8594267642584574
NCI-H522,tanespimycin-bortezomib (250-1 mol-mol),-2.8316369576725284,1.8594267642584574
BxPC-3,1716436,3.6064873492654943,1.8594267642584574
NCI-H2009,24753719,4.192950544032197,1.8594267642584574
BxPC-3,136227924,2.62858882862477,1.8594267642584574
OPM-2,alisertib-navitoclax (2-1 mol-mol),-2.0231135401510967,1.8594267642584574
SBC-5,3854666,0.5257720708282073,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],6918328,0.3348856135951876,1.8594267642584574
NCI-H460,1750826,3.3189287492303197,1.8594267642584574
A4/Fukuda,4705,2.104501352907832,1.8594267642584574
BT-549,24821094,3.680768028115557,1.8594267642584574
NCI-H727,vorinostat-carboplatin (1-1 mol-mol),4.5535915499208,1.8594267642584574
A4/Fukuda,46398810,1.5683404384737003,1.8594267642584574
NCI-H292,sirolimus-bortezomib (250-1 mol-mol),1.4329016074897702,1.8594267642584574
MDA-MB-157,3062316,3.257879214731084,1.8594267642584574
NCI-H727,71466380,5.170266193783112,1.8594267642584574
OPM-2,selumetinib-tretinoin (2-1 mol-mol),2.843446228896377,1.8594267642584574
HSC-4,16038120,1.7232268235274473,1.8594267642584574
FU-OV-1,53392493,2.412509849766808,1.8594267642584574
NCI-H2171,3634881,2.317126021520602,1.8594267642584574
DMS 273,54618305,4.272082763698834,1.8594267642584574
LoVo,docetaxel-tanespimycin (2-1 mol-mol),-4.329942307031701,1.8594267642584574
SNU-61,9926054,1.8929452670989917,1.8594267642584574
MDA-MB-453,216239,1.9202357593604051,1.8594267642584574
A4/Fukuda,252682,6.117343290485243,1.8594267642584574
Panc 04.03,11455910,2.454958233695195,1.8594267642584574
MSTO-211H,24951314,-1.1401244239295247,1.8594267642584574
A2780,navitoclax-sorafenib (1-1 mol-mol),1.0762822607268765,1.8594267642584574
NCI-H146,67156097,-2.3396756899377595,1.8594267642584574
NCI-H727,alisertib-navitoclax (2-1 mol-mol),5.700791179880255,1.8594267642584574
FTC-133,25150857,3.5794152247995004,1.8594267642584574
KMRC-1,24797083,0.8876318381449373,1.8594267642584574
KMRC-1,5282054,4.624285853166485,1.8594267642584574
MDA-MB-157,36462,0.1516360669313773,1.8594267642584574
SNU-61,11609586,2.423992088951442,1.8594267642584574
MDA-MB-157,4378219,2.6716514190617104,1.8594267642584574
NCI-H2171,navitoclax-PLX-4032 (1-1 mol-mol),-0.7537972454626107,1.8594267642584574
A4/Fukuda,57519531,1.5811593813701257,1.8594267642584574
EFO-27,136227331,4.702115323060179,1.8594267642584574
MDA-MB-453,9952709,3.2945084007394616,1.8594267642584574
G-401,54143018,0.971383874427432,1.8594267642584574
EFO-27,9927531,5.387402639259967,1.8594267642584574
DMS 273,3025986,-1.574939205922683,1.8594267642584574
NCI-H522,26596,-2.5500947066960276,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],676352,2.484571523504373,1.8594267642584574
CAL-51,5280436,3.749440064194485,1.8594267642584574
SNU-449,25150857,3.008716268425874,1.8594267642584574
KYSE-70,23582824,2.6933165956875964,1.8594267642584574
OVISE,54454,2.25285494204451,1.8594267642584574
A4/Fukuda,selumetinib-tretinoin (2-1 mol-mol),0.1306282538246569,1.8594267642584574
MSTO-211H,5282054,2.057664237493602,1.8594267642584574
CAL-51,16720766,0.5416929462446769,1.8594267642584574
HCC1143,selumetinib-JQ-1 (4-1 mol-mol),2.450816568945253,1.8594267642584574
EFO-27,navitoclax-pluripotin (1-1 mol-mol),-0.1072190892754552,1.8594267642584574
SNU-449,446155,0.8119451390236352,1.8594267642584574
NCI-H146,375860,0.4213004900992469,1.8594267642584574
CAL-51,5281321,-0.4656602142962174,1.8594267642584574
SNU-449,navitoclax-piperlongumine (1-1 mol-mol),2.97767132898613,1.8594267642584574
NCI-H2171,44462760,3.915746717375186,1.8594267642584574
SNU-61,151289,1.0402759766313254,1.8594267642584574
DMS 273,24856436,0.3584417497554937,1.8594267642584574
CAL-51,71466578,5.340961831553399,1.8594267642584574
HCC1143,44607530,2.3193328073886628,1.8594267642584574
SCC-9,3136844,4.895725881728452,1.8594267642584574
CAL-51,148198,-3.728190383000159,1.8594267642584574
DMS 273,25126798,4.049346019168164,1.8594267642584574
A2780,JQ-1-navitoclax (2-1 mol-mol),-0.0889318851591051,1.8594267642584574
A2780,9825149,2.396834344892177,1.8594267642584574
CAL-51,104842,-3.020036586723177,1.8594267642584574
A-673,676352,1.522059533133182,1.8594267642584574
FTC-133,9967941,5.123707260677636,1.8594267642584574
NCI-H2171,56963564,-0.0417490265139498,1.8594267642584574
DMS 273,753704,5.000496745911757,1.8594267642584574
JM-1,6918837,-6.173851145057706,1.8594267642584574
KMRC-1,285033,-1.948983558292048,1.8594267642584574
FU-OV-1,54454,4.96368280899624,1.8594267642584574
LoVo,11152667,-3.1828514843907967,1.8594267642584574
A2780,3081361,2.3669572433114663,1.8594267642584574
CA46,11497983,3.715862022418827,1.8594267642584574
EFO-27,9952709,3.7128554087131658,1.8594267642584574
SCC-9,3503,2.580691900576731,1.8594267642584574
CAL-51,42642645,0.4324607401831485,1.8594267642584574
NCI-H522,462382,-0.0152056919239,1.8594267642584574
NCI-H661,44632017,0.8459474985730225,1.8594267642584574
LXF 289,44137675,2.0502885463252665,1.8594267642584574
SNU-61,11404337,-0.7844361329588494,1.8594267642584574
FTC-133,15983966,2.5675405254421113,1.8594267642584574
KMRC-1,56946209,-5.003023698532595,1.8594267642584574
CA46,9866186,-0.3275085520058725,1.8594267642584574
DMS 273,23635314,-4.293922540672693,1.8594267642584574
LOU-NH91,4259181,1.0248896787271708,1.8594267642584574
SCC-9,46224516,2.803045033456012,1.8594267642584574
SCC-9,6918837,-2.658799999554452,1.8594267642584574
FU-OV-1,tanespimycin-gemcitabine (1-1 mol-mol),2.043943445508653,1.8594267642584574
LOU-NH91,15983966,2.104720476479653,1.8594267642584574
NCI-H661,285033,-2.1039671806681985,1.8594267642584574
G-401,16722836,1.0452487365316014,1.8594267642584574
SNU-61,11964036,1.5202881054490238,1.8594267642584574
MDA-MB-157,374536,-0.5698586384338129,1.8594267642584574
OVISE,168313047,2.139797955827927,1.8594267642584574
LXF 289,400769,-1.8947060859446272,1.8594267642584574
BxPC-3,10302451,2.105262518783424,1.8594267642584574
KMRC-1,446155,2.327207673229407,1.8594267642584574
KMRC-1,selumetinib-decitabine (4-1 mol-mol),7.0489920004822855,1.8594267642584574
MDA-MB-453,421610,2.7771188964172664,1.8594267642584574
SBC-5,navitoclax-gemcitabine (1-1 mol-mol),-2.8520173060125296,1.8594267642584574
OPM-2,2113511,3.5660346238413565,1.8594267642584574
ONS-76,31703,-1.5971524717515937,1.8594267642584574
CA46,100016,3.773189878640827,1.8594267642584574
MSTO-211H,tretinoin-navitoclax (4-1 mol-mol),1.3222230725566817,1.8594267642584574
EFO-27,11167602,3.5204241483481686,1.8594267642584574
SNU-81,6505803,-0.5044882096333503,1.8594267642584574
NCI-H727,1716436,2.7605133955676178,1.8594267642584574
OVISE,10302451,2.747913318530857,1.8594267642584574
NCI-H292,24772860,-1.7688616980402292,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],135398516,4.64558268257279,1.8594267642584574
Panc 04.03,702558,5.6133476434957,1.8594267642584574
NCI-H727,24964624,2.2819429425827984,1.8594267642584574
MDA-MB-157,2828334,5.757584300180036,1.8594267642584574
NCI-H2009,67291369,0.975633217461442,1.8594267642584574
EFO-27,421610,3.836140121936173,1.8594267642584574
G-401,vorinostat-carboplatin (1-1 mol-mol),1.81058220615163,1.8594267642584574
LXF 289,11626560,1.452143156792952,1.8594267642584574
LoVo,carboplatin-etoposide (40-17 mol-mol),1.7816353489464614,1.8594267642584574
NOMO-1,9444,3.521396869825756,1.8594267642584574
KYSE-70,24821094,5.190593902676824,1.8594267642584574
NCI-H292,104842,-3.713576042756873,1.8594267642584574
CAL-51,23725625,3.781531245600544,1.8594267642584574
MDA-MB-453,11175137,2.676203543730399,1.8594267642584574
LXF 289,SNX-2112-bortezomib (250-1 mol-mol),-1.375165167974982,1.8594267642584574
OPM-2,3038522,1.4393753112244685,1.8594267642584574
KMRC-1,107985,-3.501321688193531,1.8594267642584574
G-401,selumetinib-piperlongumine (8-1 mol-mol),2.3292817687818768,1.8594267642584574
FTC-133,9549297,5.410509835078823,1.8594267642584574
HCC1143,66577038,3.1905565845946993,1.8594267642584574
A-673,73707438,5.240927680887528,1.8594267642584574
LoVo,44137675,-1.419079349485425,1.8594267642584574
SNU-449,3503,2.7484718807665396,1.8594267642584574
JM-1,11960529,4.3881984442046384,1.8594267642584574
FTC-133,5460769,4.281031552964228,1.8594267642584574
LoVo,3025944,2.9449078290251256,1.8594267642584574
A2780,613753,3.052273906836147,1.8594267642584574
NCI-H661,navitoclax-MST-312 (1-1 mol-mol),1.292744867259036,1.8594267642584574
NCI-H2171,navitoclax-piperlongumine (1-1 mol-mol),-0.1756857272470243,1.8594267642584574
NCI-H727,119607,4.980733327072692,1.8594267642584574
A2780,15983966,-5.363621110890126,1.8594267642584574
LOU-NH91,52912189,2.021653283813576,1.8594267642584574
NCI-H2171,46926350,-4.867098709680934,1.8594267642584574
JM-1,11222830,1.159649219525665,1.8594267642584574
Panc 04.03,9887053,4.247469701197239,1.8594267642584574
MDA-MB-157,6918878,0.7604288199483474,1.8594267642584574
DMS 273,25150857,2.151062266440261,1.8594267642584574
NCI-H2009,637858,2.463099291034241,1.8594267642584574
A-673,89928392,0.0772153864579325,1.8594267642584574
OPM-2,56646779,4.429673228200906,1.8594267642584574
CA46,selumetinib-MK-2206 (8-1 mol-mol),2.416379770776117,1.8594267642584574
MDA-MB-157,104842,-7.463907387011825,1.8594267642584574
ONS-76,tanespimycin-gemcitabine (1-1 mol-mol),1.9345282385200928,1.8594267642584574
CAL-51,selumetinib-navitoclax (8-1 mol-mol),4.759192445659263,1.8594267642584574
SBC-5,23725625,4.5493880465204235,1.8594267642584574
CA46,16736978,0.453820731366511,1.8594267642584574
SNU-81,5287620,-3.371703836172312,1.8594267642584574
OPM-2,9929138,4.40255967212205,1.8594267642584574
CAL-51,107985,-4.126908547019261,1.8594267642584574
SNU-61,4261,1.9153687598051303,1.8594267642584574
KYSE-70,5311,1.3049127753558711,1.8594267642584574
A2780,2874250,4.6617329815359545,1.8594267642584574
A2780,46843906,2.4977538844634637,1.8594267642584574
FTC-133,11234052,5.0298463189452445,1.8594267642584574
LXF 289,serdemetan-SCH-529074 (1-1 mol-mol),1.9875604335847448,1.8594267642584574
OVISE,5282054,4.4060399380094415,1.8594267642584574
HCC1143,4096211,1.556998125169598,1.8594267642584574
NCI-H661,11364421,-5.690348879388773,1.8594267642584574
MDA-MB-453,docetaxel-tanespimycin (2-1 mol-mol),-3.838890117483947,1.8594267642584574
A-673,11427553,0.6536689467636717,1.8594267642584574
JM-1,6917907,-6.147483124234289,1.8594267642584574
A4/Fukuda,9926054,1.7963505717751411,1.8594267642584574
Panc 04.03,65064,5.203402541242721,1.8594267642584574
MDA-MB-157,25154868,5.338832763625219,1.8594267642584574
A2780,3689413,0.5219259729031659,1.8594267642584574
NOMO-1,2828334,5.727397129817869,1.8594267642584574
NCI-H292,selumetinib-PLX-4032 (8-1 mol-mol),2.9334189816499476,1.8594267642584574
JM-1,carboplatin-etoposide (40-17 mol-mol),-1.4071886446096369,1.8594267642584574
A-498,10385095,3.0502652475567347,1.8594267642584574
NCI-H460,5280436,4.847067650781305,1.8594267642584574
NCI-H146,71304818,1.6140243095299662,1.8594267642584574
SNU-61,135398516,5.118120351018792,1.8594267642584574
HCC1143,9967941,5.23006520077408,1.8594267642584574
SBC-5,51039095,3.807088636542375,1.8594267642584574
NCI-H460,docetaxel-tanespimycin (2-1 mol-mol),-0.9537223333522225,1.8594267642584574
NCI-H1623,vorinostat-navitoclax (4-1 mol-mol),1.3203635672750993,1.8594267642584574
HCC1143,44137675,2.963488174732173,1.8594267642584574
EFO-27,15983966,2.453959425588555,1.8594267642584574
NCI-H1623,10184653,-1.536462891864862,1.8594267642584574
JM-1,216468,0.5768131010636649,1.8594267642584574
KYSE-70,5278396,3.1929088159597656,1.8594267642584574
SW1463,216345,4.078496637973622,1.8594267642584574
MDA-MB-157,54619267,4.18775168816921,1.8594267642584574
LXF 289,16065773,1.584092119185821,1.8594267642584574
Panc 04.03,107985,-4.416167995938274,1.8594267642584574
SNU-449,11238147,4.105269625362408,1.8594267642584574
ONS-76,66577038,3.2799369572038977,1.8594267642584574
NCI-H1623,156414,-2.396664487331107,1.8594267642584574
DMS 273,4578,4.680938801431088,1.8594267642584574
NCI-H2009,selumetinib-piperlongumine (8-1 mol-mol),-1.1472655544324035,1.8594267642584574
OVISE,73707398,1.6715872061037895,1.8594267642584574
SCC-9,JQ-1-carboplatin (1-1 mol-mol),3.612051093214818,1.8594267642584574
MSTO-211H,navitoclax-PLX-4032 (1-1 mol-mol),-0.7263097826113902,1.8594267642584574
G-401,2945648,2.835527608429738,1.8594267642584574
BT-549,89928392,1.2423762488932544,1.8594267642584574
NCI-H146,107970,1.621489555747201,1.8594267642584574
OPM-2,71466380,2.758760560312852,1.8594267642584574
HSC-4,15547703,3.6362413258054063,1.8594267642584574
JM-1,crizotinib-PLX-4032 (2-1 mol-mol),0.7552309582979843,1.8594267642584574
EFO-27,navitoclax-sorafenib (1-1 mol-mol),3.3507850442139024,1.8594267642584574
MDA-MB-453,navitoclax-MST-312 (1-1 mol-mol),1.1594914654574615,1.8594267642584574
HSC-4,17759555,2.4253306074953978,1.8594267642584574
FTC-133,2945648,3.116487231281591,1.8594267642584574
BxPC-3,3825829,3.4267099071969738,1.8594267642584574
NCI-H2171,selumetinib-BRD-A02303741 (4-1 mol-mol),6.130541879028699,1.8594267642584574
NCI-H1623,3025986,-1.391492623029173,1.8594267642584574
BT-549,3025986,-1.1986125704978905,1.8594267642584574
JM-1,25227462,-4.63830716322272,1.8594267642584574
EFO-27,4477,1.1283660363220671,1.8594267642584574
LOU-NH91,52947716,2.984350097195249,1.8594267642584574
CAL-51,44489367,4.725330666921359,1.8594267642584574
DMS 273,2949965,2.5486766063035056,1.8594267642584574
MSTO-211H,36462,1.134601353001676,1.8594267642584574
BxPC-3,4917,2.980696163243889,1.8594267642584574
CA46,9903786,1.650432742323398,1.8594267642584574
CAL-51,156414,1.13799157004995,1.8594267642584574
OPM-2,6610355,3.590135914900994,1.8594267642584574
FTC-133,doxorubicin-navitoclax (2-1 mol-mol),-1.6634242865770594,1.8594267642584574
NCI-H661,439501,-2.903837615768139,1.8594267642584574
Panc 04.03,9952709,3.610885547265169,1.8594267642584574
BT-549,navitoclax-birinapant (1-1 mol-mol),-2.097754918128948,1.8594267642584574
CAL-51,selumetinib-PLX-4032 (8-1 mol-mol),4.984071600611491,1.8594267642584574
NCI-H460,navitoclax-pluripotin (1-1 mol-mol),0.2287186529333839,1.8594267642584574
OPM-2,2708,4.148168261065231,1.8594267642584574
NCI-H661,10385095,0.8549868667974337,1.8594267642584574
JM-1,24785538,-0.4888535449792195,1.8594267642584574
FTC-133,6610216,5.488595178062795,1.8594267642584574
MSTO-211H,216468,0.7149646325927866,1.8594267642584574
LoVo,selumetinib-MK-2206 (8-1 mol-mol),-1.1472378913456864,1.8594267642584574
NOMO-1,5978,-2.430694050184869,1.8594267642584574
DMS 273,216345,4.389361768667068,1.8594267642584574
MDA-MB-157,selumetinib-vorinostat (8-1 mol-mol),2.3136990091285883,1.8594267642584574
LoVo,676352,2.5317553470156646,1.8594267642584574
Panc 04.03,107970,2.70125557955606,1.8594267642584574
HCC1143,11427553,3.376761154443363,1.8594267642584574
BxPC-3,piperlongumine-MST-312 (1-1 mol-mol),2.334096835358741,1.8594267642584574
FTC-133,salermide-PLX-4032 (12-1 mol-mol),5.419117653198884,1.8594267642584574
NCI-H2171,vorinostat-navitoclax (4-1 mol-mol),-0.1406498808904326,1.8594267642584574
NCI-H292,11626560,1.446983052748098,1.8594267642584574
EFO-27,3062316,-1.351094232476051,1.8594267642584574
MDA-MB-157,2746,2.873003215594031,1.8594267642584574
LOU-NH91,24180125,2.532676427085935,1.8594267642584574
JM-1,135411,-1.048960589681706,1.8594267642584574
NCI-H146,644241,1.2089846023639548,1.8594267642584574
A4/Fukuda,72199292,-0.4044306818473915,1.8594267642584574
SBC-5,135421197,2.079587314097717,1.8594267642584574
SNU-81,6918837,-2.735310336273069,1.8594267642584574
JM-1,7326481,2.606242200480973,1.8594267642584574
LXF 289,67156097,-1.7104573080698593,1.8594267642584574
CAL-51,89928392,1.068329558331595,1.8594267642584574
A-673,6505803,0.2745970276233078,1.8594267642584574
FTC-133,carboplatin-etoposide (40-17 mol-mol),1.440649023013039,1.8594267642584574
SNU-61,15547703,3.101064478021952,1.8594267642584574
LoVo,JQ-1-carboplatin (1-1 mol-mol),1.9010825713651585,1.8594267642584574
SNU-449,16065773,2.84526561612217,1.8594267642584574
MDA-MB-453,53392493,1.7017875748321412,1.8594267642584574
SW1463,11317348,3.510696959395443,1.8594267642584574
MDA-MB-157,11214940,-0.245291289631715,1.8594267642584574
ONS-76,navitoclax-pluripotin (1-1 mol-mol),-0.9678858040482444,1.8594267642584574
OVISE,44202524,4.183655897410181,1.8594267642584574
A-673,11964036,0.9382905451812168,1.8594267642584574
LXF 289,3503,2.5386473527097837,1.8594267642584574
MDA-MB-453,54678924,1.5140521677167769,1.8594267642584574
SCC-9,2749,3.600343159035071,1.8594267642584574
CA46,9840324,5.575806842573594,1.8594267642584574
DMS 273,54143018,0.522600880214995,1.8594267642584574
KMRC-1,selumetinib-PLX-4032 (8-1 mol-mol),3.77714123562175,1.8594267642584574
FU-OV-1,25102847,2.696211974787464,1.8594267642584574
KMRC-1,73707398,1.5458693028147192,1.8594267642584574
A2780,5287620,-3.13264442622338,1.8594267642584574
NCI-H460,54619267,4.901891634717457,1.8594267642584574
EFO-27,2945648,3.241602940948522,1.8594267642584574
NCI-H522,25105715,3.4847863866008755,1.8594267642584574
SBC-5,638278,3.4285441526954687,1.8594267642584574
KMRC-1,piperlongumine-MST-312 (1-1 mol-mol),2.0343376342805906,1.8594267642584574
CAL-51,6918328,0.3807555589851347,1.8594267642584574
NCI-H727,11497983,4.370504456176288,1.8594267642584574
NCI-H460,4259181,-0.2054535095090753,1.8594267642584574
FU-OV-1,16741245,4.362196150231273,1.8594267642584574
SNU-449,9911830,2.1326623866395487,1.8594267642584574
NCI-H727,5278396,3.8599732465447247,1.8594267642584574
MDA-MB-157,44566777,-1.1276584651283623,1.8594267642584574
LXF 289,656346,1.157307128170796,1.8594267642584574
CAL-51,176870,2.9999818119422175,1.8594267642584574
NCI-H661,JQ-1-vorinostat (2-1 mol-mol),1.2466897580827978,1.8594267642584574
SNU-61,10184653,-0.5580603125211917,1.8594267642584574
OPM-2,25126798,3.830489811395835,1.8594267642584574
SNU-449,49793307,-2.0136733678876335,1.8594267642584574
NCI-H2009,60750,0.952457111724262,1.8594267642584574
MDA-MB-157,60750,-2.031758614917575,1.8594267642584574
Panc 04.03,selumetinib-tretinoin (2-1 mol-mol),5.031160903281955,1.8594267642584574
MDA-MB-453,44137675,2.41330993625909,1.8594267642584574
DMS 273,5287969,-2.213452126148289,1.8594267642584574
LOU-NH91,11609586,3.3390226168587716,1.8594267642584574
NCI-H661,24951314,0.8780582238506052,1.8594267642584574
A4/Fukuda,6852167,0.513003696591474,1.8594267642584574
CA46,5311281,1.0891225881142432,1.8594267642584574
A2780,11625818,1.819164792403796,1.8594267642584574
LOU-NH91,51039095,2.9779244840652295,1.8594267642584574
NCI-H661,4096211,1.4698398043308702,1.8594267642584574
LoVo,4705,1.5085236639058903,1.8594267642584574
MDA-MB-453,46926350,-4.337117227146235,1.8594267642584574
SCC-9,5738263,4.330654025732234,1.8594267642584574
YAPC,46199207,3.321634350680955,1.8594267642584574
A-673,71466578,4.1904953682389,1.8594267642584574
G-401,10127622,3.1466102465201793,1.8594267642584574
A-673,5311281,0.6354511881397967,1.8594267642584574
Panc 04.03,6917907,-5.49357619863333,1.8594267642584574
OPM-2,216239,1.2934585013066655,1.8594267642584574
KYSE-70,1716436,3.404085131889099,1.8594267642584574
NCI-H727,9887053,6.41036176282966,1.8594267642584574
NCI-H460,11404337,1.7201854837770862,1.8594267642584574
CA46,24901704,2.114836921018661,1.8594267642584574
NCI-H292,9903786,2.498172259524573,1.8594267642584574
A4/Fukuda,9927531,3.7257201794253776,1.8594267642584574
CAL-51,2113511,6.39897875596168,1.8594267642584574
OVISE,409805,6.403340651497087,1.8594267642584574
HCC1143,11626560,1.5863706836040057,1.8594267642584574
CAL-51,26596,-1.4638590943230956,1.8594267642584574
A-673,23725625,2.0065405091728272,1.8594267642584574
DMS 273,6610355,5.006954006570411,1.8594267642584574
A2780,24901704,1.9524214470888757,1.8594267642584574
SCC-9,11494412,1.4365999648395638,1.8594267642584574
DMS 273,4788,5.897035505528926,1.8594267642584574
NOMO-1,46907787,-1.215006340822028,1.8594267642584574
EFO-27,676352,2.5978940444924703,1.8594267642584574
A-673,44607530,1.766367479354274,1.8594267642584574
SW1463,9887053,1.032433665952219,1.8594267642584574
EFO-27,54619267,4.322845534804342,1.8594267642584574
G-401,9907093,3.2734126555601506,1.8594267642584574
NCI-H460,24772860,-0.596461213785507,1.8594267642584574
NCI-H292,JQ-1-vorinostat (2-1 mol-mol),-1.255345642631911,1.8594267642584574
FTC-133,119607,5.542629368531396,1.8594267642584574
SBC-5,11364421,-4.061592659681506,1.8594267642584574
Panc 04.03,5566,3.3462548914340204,1.8594267642584574
NOMO-1,6505803,0.1224616163714439,1.8594267642584574
NCI-H146,24772860,-4.237473750878659,1.8594267642584574
NCI-H1623,11609586,3.053283731487635,1.8594267642584574
CA46,208908,1.4900061271350116,1.8594267642584574
BxPC-3,9956119,3.6276214672042975,1.8594267642584574
SBC-5,BRD-K27188169-navitoclax (2-1 mol-mol),2.901601885739978,1.8594267642584574
CAL-51,10410894,3.3356149928792513,1.8594267642584574
JM-1,9927531,4.0230036766634125,1.8594267642584574
FTC-133,9866186,-0.0573555179634338,1.8594267642584574
OPM-2,3136844,3.3377711403827783,1.8594267642584574
FU-OV-1,3815108,2.287889788505342,1.8594267642584574
CAL-51,10410894,3.3356149928792513,1.8594267642584574
FTC-133,selumetinib-piperlongumine (8-1 mol-mol),4.667559315189104,1.8594267642584574
LoVo,5329102,1.3429054297502294,1.8594267642584574
A2780,168313047,2.060680306449853,1.8594267642584574
HCC1143,104842,-3.076711821193911,1.8594267642584574
NCI-H2171,JQ-1-MK-0752 (1-1 mol-mol),0.9706610774505884,1.8594267642584574
LOU-NH91,6918736,-0.749268328982244,1.8594267642584574
LXF 289,11625818,3.3628594045115805,1.8594267642584574
LXF 289,5311281,0.8902308213691446,1.8594267642584574
SNU-449,5351362,1.2849200933546208,1.8594267642584574
NCI-H522,135875424,3.5456342124976445,1.8594267642584574
MSTO-211H,44185566,1.3875680654995235,1.8594267642584574
BxPC-3,24964624,2.317613094015834,1.8594267642584574
HSC-4,6852167,2.6632521076475446,1.8594267642584574
NCI-H661,409805,4.01937565581764,1.8594267642584574
NCI-H2009,16038120,-1.1539994385349277,1.8594267642584574
NCI-H2009,5978,-2.257242885332271,1.8594267642584574
EFO-27,56649450,4.209581770525167,1.8594267642584574
DMS 273,5287620,-2.166812480100597,1.8594267642584574
LOU-NH91,613753,3.2819891552194327,1.8594267642584574
NCI-H460,73707438,4.549718141383013,1.8594267642584574
LOU-NH91,24785538,0.7950573935003075,1.8594267642584574
KMRC-1,71304818,3.217910603872335,1.8594267642584574
MDA-MB-157,carboplatin-etoposide (40-17 mol-mol),-0.0660482957905645,1.8594267642584574
LOU-NH91,15953870,3.547895487506012,1.8594267642584574
SNU-81,3384730,-0.4505726212948157,1.8594267642584574
SNU-61,1750826,-4.373387519590766,1.8594267642584574
MDA-MB-453,753704,5.23059705064669,1.8594267642584574
A-673,119607,5.020937738944074,1.8594267642584574
KMRC-1,9907093,4.272059047954712,1.8594267642584574
CA46,11640390,3.3312213559791397,1.8594267642584574
SCC-9,24771867,5.065268858490301,1.8594267642584574
ONS-76,5280436,3.697781558026248,1.8594267642584574
JM-1,10427712,3.737784417116883,1.8594267642584574
FTC-133,3081361,3.8958462184451697,1.8594267642584574
KMRC-1,56649450,3.8757723452520136,1.8594267642584574
A4/Fukuda,navitoclax-gemcitabine (1-1 mol-mol),-5.146642660406073,1.8594267642584574
LoVo,159324,-0.9516179858777442,1.8594267642584574
ONS-76,2841722,4.548555296080543,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],148198,-3.91492317301152,1.8594267642584574
SNU-449,5460769,0.9117409452183444,1.8594267642584574
NCI-H460,6852167,4.590065962834362,1.8594267642584574
OPM-2,tanespimycin-gemcitabine (1-1 mol-mol),-0.8527630037012235,1.8594267642584574
KYSE-70,176870,5.518340217914711,1.8594267642584574
HSC-4,alisertib-navitoclax (2-1 mol-mol),1.936953944798388,1.8594267642584574
JM-1,vorinostat-carboplatin (1-1 mol-mol),1.5414150367145687,1.8594267642584574
FU-OV-1,15953870,3.743404981829692,1.8594267642584574
CAL-51,navitoclax-MST-312 (1-1 mol-mol),1.7959249408216948,1.8594267642584574
SCC-9,navitoclax-MST-312 (1-1 mol-mol),0.9061907565004998,1.8594267642584574
LXF 289,654092,-0.8888310934038361,1.8594267642584574
BxPC-3,9826308,0.5055656835854033,1.8594267642584574
LOU-NH91,25150857,3.1116403082593096,1.8594267642584574
LoVo,JQ-1-vorinostat (2-1 mol-mol),0.1759239316074218,1.8594267642584574
A2780,375860,-0.912616297645574,1.8594267642584574
LOU-NH91,6852167,3.2671273023515934,1.8594267642584574
CA46,24753719,4.040239779097469,1.8594267642584574
HCC1143,135999136,4.602247958833588,1.8594267642584574
SNU-61,selumetinib-MK-2206 (8-1 mol-mol),0.3339128925553656,1.8594267642584574
CAL-51,11960529,3.662834723962616,1.8594267642584574
SNU-81,20959075,-6.025577396301825,1.8594267642584574
NCI-H522,57519531,3.3673050119485555,1.8594267642584574
HCC1143,135421197,0.8918606552263807,1.8594267642584574
SW1463,24978538,1.1634359901262634,1.8594267642584574
HSC-4,445091,4.370395830414555,1.8594267642584574
SNU-61,5329102,2.445912447276521,1.8594267642584574
G-401,23582824,-0.1091259215243222,1.8594267642584574
MDA-MB-157,11485656,1.3019788320898549,1.8594267642584574
NCI-H1623,11964036,0.5644570453188236,1.8594267642584574
MSTO-211H,1242560,2.686361074048806,1.8594267642584574
A-673,65064,3.1048319417370775,1.8594267642584574
KYSE-70,208908,2.5295165235288004,1.8594267642584574
SBC-5,2733526,3.427490731511537,1.8594267642584574
ONS-76,6184667,3.7303112000686256,1.8594267642584574
A2780,23939,3.9158411595028046,1.8594267642584574
JM-1,1566236,0.6280103536338946,1.8594267642584574
CAL-51,navitoclax-piperlongumine (1-1 mol-mol),2.2643943730886944,1.8594267642584574
NCI-H727,ISOX-bortezomib (250-1 mol-mol),1.608281700069038,1.8594267642584574
CA46,11396600,2.515122226404857,1.8594267642584574
BxPC-3,262093,3.443903516481154,1.8594267642584574
CAL-51,1566236,2.769525954778687,1.8594267642584574
JM-1,3025944,3.553601432401545,1.8594267642584574
CA46,31703,-2.2435350155349023,1.8594267642584574
FTC-133,25105715,3.757366730830659,1.8594267642584574
LOU-NH91,54649381,2.7277802519486514,1.8594267642584574
A4/Fukuda,11364421,-5.769651092108399,1.8594267642584574
A4/Fukuda,5978,-3.163562671527086,1.8594267642584574
NCI-H1623,969516,3.836806795163693,1.8594267642584574
NCI-H2009,5113032,6.328717344861362,1.8594267642584574
HSC-4,7326481,1.9301811465772087,1.8594267642584574
DMS 273,54639665,4.46621146803559,1.8594267642584574
YAPC,9926054,1.8358643335634888,1.8594267642584574
NCI-H460,11238147,4.460003386993959,1.8594267642584574
OPM-2,9887053,1.8393709016316329,1.8594267642584574
JM-1,168313016,3.8541200519849017,1.8594267642584574
NCI-H1623,285033,-2.516722374910668,1.8594267642584574
KYSE-70,5351362,2.601126509135012,1.8594267642584574
NOMO-1,10113978,3.435868796737405,1.8594267642584574
HCC1143,17759555,3.749709067386792,1.8594267642584574
NCI-H292,11964036,1.1514824488888922,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],54618164,4.275813843135039,1.8594267642584574
FU-OV-1,46943432,0.7627718951481175,1.8594267642584574
NCI-H292,4917,3.248446822462735,1.8594267642584574
FU-OV-1,452548,0.3745426606957432,1.8594267642584574
A2780,24180125,2.723679145549484,1.8594267642584574
SNU-61,9911830,2.7749851076050187,1.8594267642584574
DMS 273,6918837,-4.776469138555483,1.8594267642584574
NCI-H460,54454,2.7807551042334935,1.8594267642584574
SNU-61,5978,-3.491631614089224,1.8594267642584574
G-401,5287620,-2.7219963273379766,1.8594267642584574
ONS-76,9884685,2.079600161824297,1.8594267642584574
NCI-H460,6610216,4.838717363885395,1.8594267642584574
CAL-51,51039095,2.1842093640891416,1.8594267642584574
MDA-MB-157,2871966,-0.7905554969861216,1.8594267642584574
G-401,46926350,-4.213486210672068,1.8594267642584574
LOU-NH91,navitoclax-PLX-4032 (1-1 mol-mol),-1.9251020200365585,1.8594267642584574
OVISE,10184653,1.818458167845024,1.8594267642584574
A-498,6918328,1.134294475717993,1.8594267642584574
A-498,10302451,3.720340150939392,1.8594267642584574
CAL-51,9935249,3.84795648434564,1.8594267642584574
NCI-H292,24856436,1.0729923244387796,1.8594267642584574
A-498,409805,6.12415200666612,1.8594267642584574
EFO-27,24889392,4.405449300162506,1.8594267642584574
NCI-H1623,navitoclax-piperlongumine (1-1 mol-mol),2.7839098581302366,1.8594267642584574
NCI-H460,159324,4.0462841352482855,1.8594267642584574
LXF 289,16720766,0.4842655504206017,1.8594267642584574
LXF 289,54649381,3.6309892426510406,1.8594267642584574
G-401,decitabine-navitoclax (2-1 mol-mol),2.109547843543789,1.8594267642584574
JM-1,71751553,4.311473922741218,1.8594267642584574
MDA-MB-157,2945648,2.730573332542116,1.8594267642584574
SCC-9,navitoclax-birinapant (1-1 mol-mol),1.9538462590257963,1.8594267642584574
SNU-449,67156097,3.7845495552330024,1.8594267642584574
NCI-H2171,24951314,0.4758147687646419,1.8594267642584574
A2780,24180719,2.9021439553303026,1.8594267642584574
OPM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.6034498457254175,1.8594267642584574
A2780,54454,-0.2144211598876236,1.8594267642584574
A4/Fukuda,16659841,2.2699989015311437,1.8594267642584574
Panc 04.03,44137675,4.02019355498934,1.8594267642584574
HCC1143,25150857,2.69660437037969,1.8594267642584574
BT-549,104842,-3.414515083122074,1.8594267642584574
NCI-H146,11960529,3.5646000180725146,1.8594267642584574
MDA-MB-157,11238147,1.748896698587814,1.8594267642584574
SCC-9,72376,-1.0275629780171365,1.8594267642584574
MSTO-211H,57330099,2.804758704858228,1.8594267642584574
MSTO-211H,135999136,4.2061059176098645,1.8594267642584574
LOU-NH91,46907787,1.567116016960845,1.8594267642584574
G-401,navitoclax-MST-312 (1-1 mol-mol),0.8926313701991264,1.8594267642584574
NCI-H2009,71466445,2.5164920571758036,1.8594267642584574
OPM-2,54618771,0.7318105179081044,1.8594267642584574
A-673,1716436,1.8403672814357532,1.8594267642584574
LoVo,crizotinib-PLX-4032 (2-1 mol-mol),1.6425571440672022,1.8594267642584574
SNU-449,selumetinib-tretinoin (2-1 mol-mol),6.057400941930893,1.8594267642584574
FU-OV-1,327653,2.5930307991109784,1.8594267642584574
KYSE-70,JQ-1-vorinostat (2-1 mol-mol),1.448223728209247,1.8594267642584574
NCI-H522,56973724,3.7409361942384183,1.8594267642584574
NCI-H146,25262965,-1.0264838155868825,1.8594267642584574
CAL-51,2749,1.4482754145936665,1.8594267642584574
MSTO-211H,4477,1.290064962685197,1.8594267642584574
NCI-H292,637858,2.5198155256882813,1.8594267642584574
DMS 273,3136844,4.133948633698644,1.8594267642584574
HCC1143,654092,-0.1725481204081408,1.8594267642584574
NCI-H727,72734382,4.575159301501077,1.8594267642584574
NCI-H1623,ISOX-bortezomib (250-1 mol-mol),0.4701818373659249,1.8594267642584574
NCI-H522,6918837,-4.666914399076351,1.8594267642584574
HSC-4,11228183,2.0585180361700313,1.8594267642584574
NCI-H1623,107970,2.966658693868389,1.8594267642584574
A4/Fukuda,5278396,2.678829799859676,1.8594267642584574
SNU-61,25062766,2.174077685737065,1.8594267642584574
HSC-4,JQ-1-vorinostat (2-1 mol-mol),2.1995872566354864,1.8594267642584574
ONS-76,5460769,1.8809234095271896,1.8594267642584574
BxPC-3,448949,1.967823553768285,1.8594267642584574
FTC-133,42642645,4.559192948180462,1.8594267642584574
MDA-MB-453,4705,2.8938913201458583,1.8594267642584574
NCI-H727,54454,4.237398664855094,1.8594267642584574
SCC-9,selumetinib-MK-2206 (8-1 mol-mol),2.3963375706124967,1.8594267642584574
MDA-MB-453,tanespimycin-gemcitabine (1-1 mol-mol),-3.3001321684488825,1.8594267642584574
NOMO-1,19582717,2.563142509513499,1.8594267642584574
A2780,445643,3.2119323974162786,1.8594267642584574
MDA-MB-453,6918837,-5.413037386455184,1.8594267642584574
BT-549,72193861,1.0619418160757952,1.8594267642584574
HSC-4,44607530,1.7156299328297433,1.8594267642584574
A-673,11455910,-0.0977898825280259,1.8594267642584574
SCC-9,262093,3.396257832039873,1.8594267642584574
JM-1,148198,-6.864264453079388,1.8594267642584574
LoVo,selumetinib-JQ-1 (4-1 mol-mol),-1.8361098312254576,1.8594267642584574
CAL-51,8515,3.5852991976047863,1.8594267642584574
NCI-H292,49793307,-2.523289852336332,1.8594267642584574
NCI-H1623,2708,5.67986318014104,1.8594267642584574
SCC-9,3025944,4.376039606027409,1.8594267642584574
LXF 289,24772860,-1.828128181459349,1.8594267642584574
NCI-H1623,5287969,-1.6741359655835943,1.8594267642584574
A-673,54454,2.1191092291244877,1.8594267642584574
HCC1143,10302451,1.8641137803790455,1.8594267642584574
NCI-H292,54649381,3.811841265663476,1.8594267642584574
FU-OV-1,44607530,1.1358438423183184,1.8594267642584574
OPM-2,5702613,2.283159730657738,1.8594267642584574
LOU-NH91,11612883,2.793800542696417,1.8594267642584574
DMS 273,11214940,1.0513565801549722,1.8594267642584574
FU-OV-1,65064,4.9743661807936235,1.8594267642584574
A4/Fukuda,23635314,-5.004930640559638,1.8594267642584574
NCI-H146,44137675,3.928890295501361,1.8594267642584574
NCI-H727,carboplatin-UNC0638 (2-1 mol-mol),3.50410186086625,1.8594267642584574
YAPC,navitoclax-gemcitabine (1-1 mol-mol),-2.531110642636913,1.8594267642584574
SCC-9,25105715,3.642638215460893,1.8594267642584574
HCC1143,219104,3.69834662828724,1.8594267642584574
CAL-51,46215462,0.9657515518660452,1.8594267642584574
FU-OV-1,9936388,1.7648084748519457,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],54619267,4.6297481177667725,1.8594267642584574
A2780,65628,0.1843862993724733,1.8594267642584574
SNU-81,11647372,-4.046967337474091,1.8594267642584574
NCI-H460,44589607,4.73035444754351,1.8594267642584574
SNU-449,9549297,4.8793656902716345,1.8594267642584574
SCC-9,11625818,5.698343618019975,1.8594267642584574
LOU-NH91,54619267,4.2625648850210665,1.8594267642584574
SNU-81,676352,1.7899908822518449,1.8594267642584574
CA46,4096211,0.9281979530192106,1.8594267642584574
FTC-133,6918638,0.7173410835371117,1.8594267642584574
A-673,10074640,2.0498537136670696,1.8594267642584574
FTC-133,9907093,5.562055210260789,1.8594267642584574
HSC-4,24775005,4.677905847548428,1.8594267642584574
A-498,selumetinib-PLX-4032 (8-1 mol-mol),2.57044020856199,1.8594267642584574
CAL-51,11964036,0.7531640395115359,1.8594267642584574
NCI-H146,16736978,0.7510083752799234,1.8594267642584574
YAPC,15547703,3.1542356669454055,1.8594267642584574
NCI-H1623,25195348,2.589072393428722,1.8594267642584574
JM-1,5311281,0.5908340552261697,1.8594267642584574
SNU-61,9840324,5.730394861191507,1.8594267642584574
CAL-51,322968,3.332930006684798,1.8594267642584574
BxPC-3,613753,3.1887459622848935,1.8594267642584574
A4/Fukuda,9887053,3.945623871756388,1.8594267642584574
ONS-76,119607,5.207716304164231,1.8594267642584574
G-401,11955716,-2.313708507563708,1.8594267642584574
EFO-27,9840324,6.098788849131883,1.8594267642584574
Panc 04.03,219104,4.644038290885272,1.8594267642584574
HCC1143,25262965,-0.487374364701845,1.8594267642584574
EFO-27,25227462,1.7048102531951876,1.8594267642584574
HSC-4,10074640,3.187745953835862,1.8594267642584574
SNU-449,5287969,-1.7501228923890362,1.8594267642584574
BT-549,49836020,-1.94641857460656,1.8594267642584574
BT-549,36462,2.0708174288882075,1.8594267642584574
SNU-449,135421197,1.7191553190938056,1.8594267642584574
EFO-27,49867926,4.359647239344765,1.8594267642584574
NCI-H727,568763,0.1873556014231215,1.8594267642584574
SCC-9,5287620,-3.0509576220001953,1.8594267642584574
SNU-449,3543504,4.913571994290616,1.8594267642584574
BxPC-3,12001922,2.0478076671218317,1.8594267642584574
Panc 04.03,selumetinib-vorinostat (8-1 mol-mol),2.824320658243333,1.8594267642584574
NCI-H661,54618164,4.023349318575714,1.8594267642584574
ONS-76,JQ-1-UNC0638 (2-1 mol-mol),1.9548647661287404,1.8594267642584574
OPM-2,5287620,-2.918074250075414,1.8594267642584574
SBC-5,71304818,1.011143162310159,1.8594267642584574
NCI-H522,navitoclax-sorafenib (1-1 mol-mol),2.7725846762531856,1.8594267642584574
CAL-51,216468,1.370586512271769,1.8594267642584574
MDA-MB-157,25150857,3.068531629493821,1.8594267642584574
ONS-76,10074640,3.173150149140259,1.8594267642584574
NCI-H2009,5470400,0.3791383114910072,1.8594267642584574
CAL-51,54619267,4.1828818787298765,1.8594267642584574
A4/Fukuda,5738263,2.3624425097256676,1.8594267642584574
SCC-9,1239801,5.7667211168431205,1.8594267642584574
CA46,11152667,-1.1506421067609531,1.8594267642584574
LXF 289,9444,4.020808033871241,1.8594267642584574
Panc 04.03,25062766,2.3535958479396166,1.8594267642584574
MDA-MB-157,71466445,-0.8161407888171323,1.8594267642584574
NCI-H661,10302451,1.6315200392387812,1.8594267642584574
NCI-H522,10385095,0.7404415633977295,1.8594267642584574
LoVo,53495165,-1.2075385636979648,1.8594267642584574
NCI-H1623,613753,3.253043904005535,1.8594267642584574
SNU-81,49836020,-3.195484765979539,1.8594267642584574
A-673,73707371,5.345141037142936,1.8594267642584574
JM-1,71466380,3.0146886034862885,1.8594267642584574
MDA-MB-453,135659046,3.699316020945489,1.8594267642584574
LXF 289,72193861,1.9781400147016948,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],25150857,2.2320644525888165,1.8594267642584574
Panc 04.03,46843906,4.199928797005276,1.8594267642584574
NCI-H460,16725315,5.407057101640495,1.8594267642584574
SNU-61,375860,-0.3575080218905608,1.8594267642584574
SNU-61,216345,4.373705885149758,1.8594267642584574
CAL-51,25154868,4.656760297450745,1.8594267642584574
NCI-H146,10172275,4.247153556222009,1.8594267642584574
SBC-5,122327,4.539216274618647,1.8594267642584574
A4/Fukuda,24785538,-4.18833617701787,1.8594267642584574
NCI-H727,54618305,5.896457883643312,1.8594267642584574
A4/Fukuda,tretinoin-navitoclax (4-1 mol-mol),2.572216751068698,1.8594267642584574
NCI-H727,6918736,5.488213607701973,1.8594267642584574
NCI-H522,168313200,1.7984937800694238,1.8594267642584574
OVISE,11396600,4.241731433198166,1.8594267642584574
ONS-76,25154868,3.0856348617246048,1.8594267642584574
LXF 289,135398516,1.6034740470130215,1.8594267642584574
G-401,9967941,2.755238424074781,1.8594267642584574
NCI-H2171,44493528,3.677120674941258,1.8594267642584574
DMS 273,135398516,0.9081791710880508,1.8594267642584574
CAL-51,219104,3.260140555917495,1.8594267642584574
SNU-449,9927531,4.924705078398161,1.8594267642584574
A4/Fukuda,9840324,5.782088483619631,1.8594267642584574
DMS 273,11404337,-1.7233190830375906,1.8594267642584574
MDA-MB-157,24964624,3.531877357122639,1.8594267642584574
CAL-51,44486219,4.943814728636009,1.8594267642584574
LOU-NH91,216345,4.715464564049095,1.8594267642584574
LXF 289,124202324,2.1762748500922657,1.8594267642584574
HSC-4,23582824,-0.585849233367442,1.8594267642584574
LXF 289,25126798,3.2757893610597923,1.8594267642584574
SBC-5,4788,5.245695847909484,1.8594267642584574
ONS-76,24856436,1.9295271968291927,1.8594267642584574
SNU-61,24753719,3.71513491278392,1.8594267642584574
MDA-MB-157,vorinostat-carboplatin (1-1 mol-mol),2.089611871642824,1.8594267642584574
LXF 289,54618305,4.64176895308047,1.8594267642584574
CAL-51,9926054,2.2227862000004577,1.8594267642584574
DMS 273,11427553,3.72076353850383,1.8594267642584574
NCI-H460,25126798,4.092385726400508,1.8594267642584574
SNU-81,1716436,3.163180638308135,1.8594267642584574
SW1463,426756,2.2352578961733967,1.8594267642584574
NCI-H1623,6918638,-0.0742651507067239,1.8594267642584574
NCI-H522,46191454,1.7170402718959707,1.8594267642584574
SCC-9,JQ-1-UNC0638 (2-1 mol-mol),1.0836659373023885,1.8594267642584574
MSTO-211H,49766530,-4.866552298919663,1.8594267642584574
NCI-H2171,11228183,-0.0614644470988351,1.8594267642584574
HCC1143,5311281,1.3434544130633397,1.8594267642584574
ONS-76,10410894,3.505250871213463,1.8594267642584574
LoVo,navitoclax-piperlongumine (1-1 mol-mol),1.788433807521411,1.8594267642584574
SCC-9,46398810,2.8303032541075455,1.8594267642584574
OVISE,5351362,2.5456705040985708,1.8594267642584574
CA46,navitoclax-birinapant (1-1 mol-mol),3.397408717118992,1.8594267642584574
NCI-H522,5287969,-0.7039868347543177,1.8594267642584574
KYSE-70,9840324,6.215387239369238,1.8594267642584574
G-401,2708,4.061322582720861,1.8594267642584574
MDA-MB-453,selumetinib-PLX-4032 (8-1 mol-mol),5.5493324312500825,1.8594267642584574
SNU-81,selumetinib-MK-2206 (8-1 mol-mol),-1.5641952931996328,1.8594267642584574
A2780,9868037,1.6123332444026346,1.8594267642584574
EFO-27,selumetinib-MK-2206 (8-1 mol-mol),3.7293539227770824,1.8594267642584574
NCI-H292,2708,4.789540620747355,1.8594267642584574
HSC-4,11238147,3.6589845000918504,1.8594267642584574
NCI-H2009,168313047,3.1000323585702083,1.8594267642584574
OVISE,3689413,-2.3316050545360136,1.8594267642584574
NCI-H522,71751553,5.137300136027492,1.8594267642584574
NCI-H661,9444,4.500292949687679,1.8594267642584574
BxPC-3,54649381,3.6406106092590007,1.8594267642584574
KMRC-1,selumetinib-piperlongumine (8-1 mol-mol),4.604012019572112,1.8594267642584574
KYSE-70,ISOX-bortezomib (250-1 mol-mol),1.0092839144289247,1.8594267642584574
KMRC-1,10427712,4.418169957842134,1.8594267642584574
FTC-133,9935249,4.194644265855045,1.8594267642584574
LOU-NH91,alisertib-navitoclax (2-1 mol-mol),-1.2312433531350488,1.8594267642584574
SBC-5,5280436,3.662085558148715,1.8594267642584574
JM-1,JQ-1-MK-0752 (1-1 mol-mol),-0.97629163512536,1.8594267642584574
BT-549,462382,0.0307570083617302,1.8594267642584574
Panc 04.03,445091,5.978315194185719,1.8594267642584574
A4/Fukuda,3011155,4.269088750580724,1.8594267642584574
G-401,selumetinib-tretinoin (2-1 mol-mol),2.678729484296938,1.8594267642584574
A-673,57519531,1.198988142705803,1.8594267642584574
SNU-61,3025944,3.777150750907422,1.8594267642584574
CAL-51,11497983,2.6322425573174213,1.8594267642584574
JM-1,12001922,1.1772658700026328,1.8594267642584574
A4/Fukuda,375860,-1.1918610484687095,1.8594267642584574
LXF 289,5978,0.6093029371771528,1.8594267642584574
FTC-133,5329102,4.217502606235289,1.8594267642584574
LOU-NH91,erlotinib-PLX-4032 (2-1 mol-mol),3.00809922416846,1.8594267642584574
OPM-2,10296883,2.7550650350156474,1.8594267642584574
FU-OV-1,4259181,1.2776952629591818,1.8594267642584574
BxPC-3,100016,6.453363473458683,1.8594267642584574
YAPC,168313047,2.3481335437424957,1.8594267642584574
NCI-H460,10184653,3.574651577310896,1.8594267642584574
OPM-2,3062316,1.3077504545650411,1.8594267642584574
NCI-H460,9956119,4.485375019847723,1.8594267642584574
ONS-76,3815108,3.0019527232257555,1.8594267642584574
NCI-H2009,6918878,-0.4863456687538305,1.8594267642584574
NCI-H727,10302451,3.178772538514987,1.8594267642584574
NCI-H727,2945648,2.622160220955332,1.8594267642584574
SCC-9,71751553,4.89059631642312,1.8594267642584574
SBC-5,36462,0.3494520767872783,1.8594267642584574
G-401,4477,0.236688812816839,1.8594267642584574
DMS 273,9926054,1.8030373867492464,1.8594267642584574
MSTO-211H,2828334,5.714930690846282,1.8594267642584574
A2780,24797083,0.8113195258872324,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],984333,1.0265914359647546,1.8594267642584574
FTC-133,44486219,4.933137185021197,1.8594267642584574
CAL-51,6918736,-2.0480142356294637,1.8594267642584574
NCI-H522,72193861,-0.7243330419144597,1.8594267642584574
BxPC-3,JQ-1-navitoclax (2-1 mol-mol),-0.3389644558379706,1.8594267642584574
ONS-76,25102847,3.483061373005376,1.8594267642584574
NCI-H727,168313016,5.705554517808247,1.8594267642584574
SNU-81,selumetinib-vorinostat (8-1 mol-mol),-1.2319110423527484,1.8594267642584574
OPM-2,25161177,3.2493247866394497,1.8594267642584574
NCI-H292,374536,1.098561227965989,1.8594267642584574
NCI-H522,54618771,1.252244709003548,1.8594267642584574
KYSE-70,44486219,3.9722791166403657,1.8594267642584574
FU-OV-1,72193861,4.196952295232924,1.8594267642584574
CA46,56973724,2.349278499068081,1.8594267642584574
A4/Fukuda,2729026,2.569130626356953,1.8594267642584574
YAPC,148198,-3.117185181322903,1.8594267642584574
A-673,24753719,3.397650756866718,1.8594267642584574
NCI-H1623,16659841,4.138965758514941,1.8594267642584574
NCI-H727,637858,2.2360670355510086,1.8594267642584574
NOMO-1,31703,-1.8429032714500968,1.8594267642584574
LoVo,65628,4.171555925906434,1.8594267642584574
EFO-27,322968,2.5694057659070264,1.8594267642584574
NCI-H2009,216345,4.438201480917741,1.8594267642584574
BT-549,5282054,2.5925054001589976,1.8594267642584574
FTC-133,6918837,-2.2077574090678307,1.8594267642584574
DMS 273,54626689,4.997985813086497,1.8594267642584574
HSC-4,16741245,1.7716610997683242,1.8594267642584574
SNU-61,6438330,3.4216884605560085,1.8594267642584574
FTC-133,9936388,3.0046059879710363,1.8594267642584574
OVISE,3815108,2.0996140723315913,1.8594267642584574
NCI-H522,navitoclax-piperlongumine (1-1 mol-mol),1.629477440849753,1.8594267642584574
NCI-H292,5281321,-0.9498489394799606,1.8594267642584574
BxPC-3,25126798,3.172026591671247,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],6610216,4.434175859871968,1.8594267642584574
BxPC-3,11213558,1.5061777503093252,1.8594267642584574
BT-549,3503,1.5652779265398058,1.8594267642584574
FU-OV-1,1716436,3.524722071533676,1.8594267642584574
MSTO-211H,15547703,3.049193057044517,1.8594267642584574
KMRC-1,11427553,3.2258060185151343,1.8594267642584574
NCI-H292,46191454,0.9903655583180804,1.8594267642584574
CAL-51,135928012,4.192641653546412,1.8594267642584574
NCI-H2009,44202524,1.444691297679544,1.8594267642584574
HSC-4,erlotinib-PLX-4032 (2-1 mol-mol),2.314385393540324,1.8594267642584574
SCC-9,2858523,3.190510944053216,1.8594267642584574
BxPC-3,15953870,2.831569416015373,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],49793307,-2.331301981492291,1.8594267642584574
SNU-449,135398516,1.5851782119809552,1.8594267642584574
SNU-81,9843750,-0.6437789188002867,1.8594267642584574
SNU-449,11427553,2.8197595076352564,1.8594267642584574
OPM-2,11656518,2.629079922396914,1.8594267642584574
BT-549,135398516,2.1186047788766085,1.8594267642584574
OPM-2,176870,3.9257377377060383,1.8594267642584574
OPM-2,46926350,-5.934740852723627,1.8594267642584574
HSC-4,2729026,2.4603123985812276,1.8594267642584574
KYSE-70,9444,4.1582482593031145,1.8594267642584574
FTC-133,9933475,4.176811369298493,1.8594267642584574
MDA-MB-157,51037431,2.1321019948022046,1.8594267642584574
NCI-H522,carboplatin-UNC0638 (2-1 mol-mol),3.513501660159428,1.8594267642584574
FTC-133,44493528,6.31419839504633,1.8594267642584574
ONS-76,tanespimycin-bortezomib (250-1 mol-mol),1.246384835528882,1.8594267642584574
KMRC-1,11507802,3.5140789318254426,1.8594267642584574
KMRC-1,25183872,-1.331773303463366,1.8594267642584574
OPM-2,16219061,1.6139038412518538,1.8594267642584574
LoVo,25183872,-1.0423877479811554,1.8594267642584574
NCI-H460,navitoclax-pluripotin (1-1 mol-mol),0.2287186529333839,1.8594267642584574
FU-OV-1,6623618,4.441105176868704,1.8594267642584574
DMS 273,4259181,0.4383145170351891,1.8594267642584574
A-673,docetaxel-tanespimycin (2-1 mol-mol),-8.62633538117336,1.8594267642584574
KMRC-1,89183176,5.996613867274686,1.8594267642584574
MDA-MB-453,9825149,2.3540085594050204,1.8594267642584574
Panc 04.03,decitabine-navitoclax (2-1 mol-mol),3.786860225423862,1.8594267642584574
G-401,4788,4.978954455161412,1.8594267642584574
MDA-MB-453,52947716,-7.0217551266009375,1.8594267642584574
SBC-5,6918328,-0.0891350348900322,1.8594267642584574
HCC1143,49836020,2.702530837822698,1.8594267642584574
MDA-MB-453,9956119,4.182542041452956,1.8594267642584574
A-673,136227924,1.815433973878695,1.8594267642584574
HCC1143,9956119,3.9159046092458785,1.8594267642584574
OVISE,ISOX-bortezomib (250-1 mol-mol),-0.1243058727191033,1.8594267642584574
BxPC-3,11234052,5.706263551465742,1.8594267642584574
NCI-H727,44259,1.5490626006331412,1.8594267642584574
SNU-449,24964624,2.993830455857875,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],42642645,1.367998127032919,1.8594267642584574
LXF 289,3025944,3.4981276099044134,1.8594267642584574
A-498,24964624,2.395732501339878,1.8594267642584574
DMS 273,4096211,1.7794100041919845,1.8594267642584574
NCI-H146,SNX-2112-bortezomib (250-1 mol-mol),-4.105126294975654,1.8594267642584574
SCC-9,16722836,2.261290441734353,1.8594267642584574
LOU-NH91,452548,2.191181432305291,1.8594267642584574
KYSE-70,2828334,5.886367586734188,1.8594267642584574
EFO-27,6450551,4.042476340029328,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],66577038,3.167694948675542,1.8594267642584574
SCC-9,1716436,3.7585685406918783,1.8594267642584574
NCI-H2009,409805,3.859994247591149,1.8594267642584574
Panc 04.03,SNX-2112-bortezomib (250-1 mol-mol),-2.269720015649412,1.8594267642584574
SCC-9,54618164,4.4493976732458576,1.8594267642584574
OVISE,5470400,-1.924229347102114,1.8594267642584574
EFO-27,44607531,1.7985046151445,1.8594267642584574
KYSE-70,439501,-1.7979650249976522,1.8594267642584574
FU-OV-1,JQ-1-navitoclax (2-1 mol-mol),0.4181206302825215,1.8594267642584574
NCI-H460,11175137,3.7005840280640374,1.8594267642584574
ONS-76,71680916,4.956248935312428,1.8594267642584574
NCI-H1623,10410894,1.736668634267143,1.8594267642584574
KMRC-1,6918736,4.048742051120841,1.8594267642584574
CA46,25161177,3.91788686206549,1.8594267642584574
MDA-MB-157,6852167,3.8998726158787007,1.8594267642584574
HSC-4,11364421,-0.0916399418549534,1.8594267642584574
CAL-51,2746,3.539110169106334,1.8594267642584574
SNU-449,24748573,1.9316038598597545,1.8594267642584574
EFO-27,selumetinib-GDC-0941 (4-1 mol-mol),2.701249599183188,1.8594267642584574
KMRC-1,9926054,1.768451409600443,1.8594267642584574
SNU-61,4917,3.0491510397841015,1.8594267642584574
FU-OV-1,5335621,4.183078950789895,1.8594267642584574
LXF 289,44607531,1.6515112206427849,1.8594267642584574
A-673,11640390,1.6795118149646189,1.8594267642584574
DMS 273,51039095,3.4577395537233526,1.8594267642584574
NCI-H460,126941,-2.220790788147435,1.8594267642584574
NOMO-1,5281672,5.39154363605107,1.8594267642584574
SW1463,11214940,-1.9875595606860448,1.8594267642584574
SW1463,72376,-4.419423024557842,1.8594267642584574
OPM-2,613000,1.2483941007528057,1.8594267642584574
NCI-H292,445091,4.263425815338472,1.8594267642584574
MDA-MB-157,46926350,-4.132103643787292,1.8594267642584574
Panc 04.03,10296883,4.422301293811254,1.8594267642584574
SCC-9,11964036,1.807051006133268,1.8594267642584574
YAPC,11626560,1.7222365359336271,1.8594267642584574
LOU-NH91,375860,-0.2088041582630222,1.8594267642584574
MSTO-211H,JQ-1-vorinostat (2-1 mol-mol),0.928346567061831,1.8594267642584574
A2780,374536,0.6453837370733745,1.8594267642584574
LoVo,5351362,1.2957137522113673,1.8594267642584574
DMS 273,navitoclax-PLX-4032 (1-1 mol-mol),3.5987731605667284,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],148124,4.246203808599277,1.8594267642584574
LOU-NH91,322968,3.304915281144932,1.8594267642584574
OPM-2,54596558,4.064764759335406,1.8594267642584574
LOU-NH91,selumetinib-GDC-0941 (4-1 mol-mol),3.122551145262448,1.8594267642584574
A-498,UNC0638-navitoclax (1-1 mol-mol),0.9874220571731112,1.8594267642584574
MSTO-211H,44137675,1.9879298255329003,1.8594267642584574
NCI-H2171,42642645,-0.8345775302937554,1.8594267642584574
A-673,5287969,-3.109107778120567,1.8594267642584574
HSC-4,5566,3.1631957469062684,1.8594267642584574
NCI-H146,5284616,1.616711114994892,1.8594267642584574
FTC-133,10184653,4.443025626482117,1.8594267642584574
BT-549,241158,3.5488750117076484,1.8594267642584574
CA46,25195348,1.4184238486273535,1.8594267642584574
BxPC-3,11497983,5.307904838671978,1.8594267642584574
MSTO-211H,4096211,1.4030307395810702,1.8594267642584574
CA46,11175137,1.918070959510412,1.8594267642584574
NCI-H460,doxorubicin-navitoclax (2-1 mol-mol),-0.1987090661532434,1.8594267642584574
NCI-H1623,5566,3.3003894636357565,1.8594267642584574
SNU-449,25262965,-2.560427276701697,1.8594267642584574
FU-OV-1,16038120,1.1817724128349547,1.8594267642584574
NCI-H460,6438330,3.783082395235063,1.8594267642584574
SNU-449,selumetinib-navitoclax (8-1 mol-mol),4.616443457041138,1.8594267642584574
LOU-NH91,12003241,-1.4006618643370652,1.8594267642584574
NCI-H2009,89928392,1.462956527326012,1.8594267642584574
OPM-2,selumetinib-MK-2206 (8-1 mol-mol),1.6316326577463918,1.8594267642584574
NCI-H661,53495165,0.322884771008066,1.8594267642584574
FTC-133,16659841,4.779782303247626,1.8594267642584574
FU-OV-1,176870,2.993075468358777,1.8594267642584574
MDA-MB-157,24771867,-2.9284017086321197,1.8594267642584574
MSTO-211H,5328940,-0.7344582610548551,1.8594267642584574
A-498,25126798,4.108305960475203,1.8594267642584574
HSC-4,piperlongumine-MST-312 (1-1 mol-mol),1.1147970090966637,1.8594267642584574
HSC-4,5460769,1.9290612526481368,1.8594267642584574
JM-1,9826308,-1.254578223347674,1.8594267642584574
ONS-76,124202324,3.376244033970937,1.8594267642584574
YAPC,135984461,4.395865755985396,1.8594267642584574
DMS 273,5746,-0.0149388723107023,1.8594267642584574
FU-OV-1,4917,3.642085139957623,1.8594267642584574
LXF 289,49793307,-1.960491877422628,1.8594267642584574
OVISE,107970,3.0608588072726444,1.8594267642584574
BxPC-3,446155,2.3080345350315015,1.8594267642584574
OPM-2,65064,2.528451354351822,1.8594267642584574
SNU-81,5278396,1.9031243607798085,1.8594267642584574
NOMO-1,5351362,2.08054014163225,1.8594267642584574
A4/Fukuda,675434,3.712142385749843,1.8594267642584574
ONS-76,44241473,4.684511997660941,1.8594267642584574
NCI-H292,54619267,4.1033140795833445,1.8594267642584574
NOMO-1,5470400,0.2862684612003833,1.8594267642584574
LXF 289,1716436,2.59582131383783,1.8594267642584574
OPM-2,71680916,3.9051822114426025,1.8594267642584574
YAPC,72193861,3.178335780336401,1.8594267642584574
HSC-4,148198,-2.795908666323494,1.8594267642584574
Panc 04.03,piperlongumine-MST-312 (1-1 mol-mol),2.325884658046027,1.8594267642584574
A-673,25161177,3.4603475867806788,1.8594267642584574
NCI-H522,9866186,0.2313673592680447,1.8594267642584574
CAL-51,24772860,-2.425084956958233,1.8594267642584574
KYSE-70,72734382,4.428008981499565,1.8594267642584574
EFO-27,44491742,4.311239061696844,1.8594267642584574
CAL-51,322968,3.332930006684798,1.8594267642584574
OPM-2,68056272,3.036834126647856,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],selumetinib-decitabine (4-1 mol-mol),3.6407543671140417,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],1716436,2.8487797947795226,1.8594267642584574
LoVo,11485656,1.8604760547282393,1.8594267642584574
LOU-NH91,selumetinib-MK-2206 (8-1 mol-mol),3.1932369628338195,1.8594267642584574
CAL-51,10074640,3.192334769578339,1.8594267642584574
CA46,piperlongumine-MST-312 (1-1 mol-mol),1.0820043516957718,1.8594267642584574
SNU-61,452548,0.6134547199912214,1.8594267642584574
MDA-MB-453,5311,-0.5257883568365231,1.8594267642584574
HCC1143,23582824,-0.3689859010226292,1.8594267642584574
SBC-5,7251185,3.120445126947185,1.8594267642584574
NCI-H292,24901704,3.391496569820259,1.8594267642584574
NCI-H522,10410894,2.9293088965189553,1.8594267642584574
SNU-61,23582824,2.5643180100002225,1.8594267642584574
HCC1143,16065773,2.712611567173667,1.8594267642584574
MSTO-211H,46191454,1.2859626841233986,1.8594267642584574
DMS 273,72199292,5.337691921623293,1.8594267642584574
LOU-NH91,46398810,3.045211454343731,1.8594267642584574
HSC-4,135928012,4.241462346184107,1.8594267642584574
NCI-H727,3384730,3.6794289647639737,1.8594267642584574
SNU-61,4788,5.909414847709577,1.8594267642584574
A2780,5329102,1.3737092942346336,1.8594267642584574
MDA-MB-453,444795,4.759998515464953,1.8594267642584574
CAL-51,BRD-A02303741-carboplatin (1-1 mol-mol),6.00849408957599,1.8594267642584574
BxPC-3,11507802,0.9945684314547258,1.8594267642584574
Panc 04.03,24889392,4.270107644861146,1.8594267642584574
MSTO-211H,46215462,0.9168806818627014,1.8594267642584574
MDA-MB-453,11167602,2.244240898320102,1.8594267642584574
A2780,400769,-2.1774855243121425,1.8594267642584574
ONS-76,52912189,4.881284158574923,1.8594267642584574
BxPC-3,44137675,2.990010873447489,1.8594267642584574
HCC1143,753704,4.831564496260181,1.8594267642584574
SNU-61,9915743,-0.5579526190142376,1.8594267642584574
OVISE,1242560,3.5076159129293956,1.8594267642584574
CAL-51,6914657,-5.067352950634086,1.8594267642584574
LoVo,selumetinib-UNC0638 (4-1 mol-mol),1.1151231376311057,1.8594267642584574
NCI-H292,9907093,4.58058164849987,1.8594267642584574
CA46,selumetinib-GDC-0941 (4-1 mol-mol),2.557872196645032,1.8594267642584574
Panc 04.03,vorinostat-navitoclax (4-1 mol-mol),1.7756869415630383,1.8594267642584574
EFO-27,6852167,4.289895730200754,1.8594267642584574
A4/Fukuda,148124,-6.6912736941139865,1.8594267642584574
MSTO-211H,24785538,0.8010437121318222,1.8594267642584574
NCI-H661,49850262,3.557667726590132,1.8594267642584574
BxPC-3,navitoclax-PLX-4032 (1-1 mol-mol),1.642487970123168,1.8594267642584574
EFO-27,4521392,4.521895501485345,1.8594267642584574
A-673,65628,3.827084992759042,1.8594267642584574
SCC-9,11427553,3.060791645335887,1.8594267642584574
A4/Fukuda,BRD-A02303741-navitoclax (2-1 mol-mol),4.161880654149954,1.8594267642584574
NCI-H661,36462,2.012090600363037,1.8594267642584574
CAL-51,11625818,4.1129054868405905,1.8594267642584574
SNU-449,252682,6.455952915446744,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],5311,1.6255593512960202,1.8594267642584574
HSC-4,2828334,6.111197262680893,1.8594267642584574
MSTO-211H,selumetinib-navitoclax (8-1 mol-mol),0.5648552965523568,1.8594267642584574
A-673,753704,3.1138845387287657,1.8594267642584574
NCI-H292,409805,3.708436738901026,1.8594267642584574
NCI-H2009,72376,-1.9106633783650309,1.8594267642584574
OPM-2,24753719,4.370940438199297,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],15547703,3.173985625992098,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],2746,2.384271625154073,1.8594267642584574
LoVo,9915743,-0.8819018227786422,1.8594267642584574
BT-549,4788,5.920199401047736,1.8594267642584574
CAL-51,2858523,3.1959449804225524,1.8594267642584574
OVISE,2742550,5.280611289386831,1.8594267642584574
HSC-4,5470400,-1.775367561967962,1.8594267642584574
FTC-133,3503,1.9089172693495084,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],ISOX-bortezomib (250-1 mol-mol),0.2714695446270951,1.8594267642584574
MDA-MB-453,4578,4.4862028800041545,1.8594267642584574
EFO-27,16038120,2.346094356536249,1.8594267642584574
SNU-61,66577038,2.989851386241242,1.8594267642584574
CAL-51,4259181,-0.5132501801478601,1.8594267642584574
CA46,decitabine-carboplatin (1-1 mol-mol),2.864981631125043,1.8594267642584574
LoVo,SNX-2112-bortezomib (250-1 mol-mol),-2.7337701225380786,1.8594267642584574
SNU-449,3552672,3.5064135830435563,1.8594267642584574
SNU-61,44589607,2.748444545219875,1.8594267642584574
ONS-76,2945648,2.901632251679741,1.8594267642584574
ONS-76,44607531,1.762572438348297,1.8594267642584574
DMS 273,2874250,4.3291006423311025,1.8594267642584574
SNU-449,9840324,5.822936489993131,1.8594267642584574
NCI-H460,6610355,4.949206869720499,1.8594267642584574
HSC-4,11612883,3.5946567658341197,1.8594267642584574
NCI-H522,11175137,2.853962760117135,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],selumetinib-BRD-A02303741 (4-1 mol-mol),2.266377175881345,1.8594267642584574
A-498,5281321,-0.4472251536664238,1.8594267642584574
OVISE,25154868,4.508600245054991,1.8594267642584574
Panc 04.03,44185566,3.115745823738928,1.8594267642584574
SNU-61,49793307,-2.3504304765085573,1.8594267642584574
CA46,44607530,1.320133740199814,1.8594267642584574
SCC-9,10385095,1.4052834583911455,1.8594267642584574
HSC-4,675434,4.235689784331333,1.8594267642584574
NCI-H522,16725315,3.2253372097194752,1.8594267642584574
FU-OV-1,1750826,-4.024957616345245,1.8594267642584574
HSC-4,57519531,1.2769425534379089,1.8594267642584574
NCI-H292,9868037,4.01216306257403,1.8594267642584574
G-401,52947716,-7.497954818853376,1.8594267642584574
EFO-27,5280436,2.3763113561475997,1.8594267642584574
SNU-449,11625818,4.573588862325648,1.8594267642584574
CAL-51,135999136,4.2132345103647015,1.8594267642584574
NCI-H146,19582717,2.457603508665216,1.8594267642584574
HCC1143,1716436,2.8430583337953284,1.8594267642584574
DMS 273,9911463,3.7655644930376257,1.8594267642584574
NCI-H460,54649381,4.173104904963283,1.8594267642584574
NCI-H727,6918837,-1.02939028052569,1.8594267642584574
BxPC-3,6852167,2.5268139587107754,1.8594267642584574
MSTO-211H,168312962,-1.9489367550084584,1.8594267642584574
CA46,17755052,1.7120394846678155,1.8594267642584574
ONS-76,3676137,5.654292431942107,1.8594267642584574
A2780,11175137,0.1901581111291173,1.8594267642584574
NCI-H727,10427712,4.338841626329874,1.8594267642584574
LoVo,241158,4.012317425862525,1.8594267642584574
Panc 04.03,3062316,3.5966054915380647,1.8594267642584574
SNU-81,54454,2.7601348658589,1.8594267642584574
SBC-5,3136844,4.085952663076754,1.8594267642584574
BxPC-3,4261,1.8613797726144792,1.8594267642584574
YAPC,11364421,2.3126725462898508,1.8594267642584574
NCI-H727,387447,-3.6268426938273457,1.8594267642584574
A-673,11955716,-2.8120675934907107,1.8594267642584574
Panc 04.03,selumetinib-decitabine (4-1 mol-mol),4.200719534788661,1.8594267642584574
FU-OV-1,135440466,0.9480137026796296,1.8594267642584574
NCI-H146,25150857,0.3973439930915976,1.8594267642584574
SNU-449,46926350,-1.1609870247475182,1.8594267642584574
MSTO-211H,9840324,5.369584805162093,1.8594267642584574
G-401,5460769,-1.872739736028161,1.8594267642584574
CAL-51,568763,0.0917223714484538,1.8594267642584574
MDA-MB-453,5951923,4.303369563038856,1.8594267642584574
KYSE-70,66577038,3.0162273972396005,1.8594267642584574
LOU-NH91,16722836,1.148829534310261,1.8594267642584574
FU-OV-1,613753,3.071481920375854,1.8594267642584574
KYSE-70,doxorubicin-navitoclax (2-1 mol-mol),1.6680875974880454,1.8594267642584574
CA46,49766530,-5.499020578204802,1.8594267642584574
SNU-61,11175137,3.4257878627613505,1.8594267642584574
HSC-4,969516,2.6364274978390703,1.8594267642584574
A2780,10074640,2.580771204793581,1.8594267642584574
EFO-27,10410894,3.5790791622635907,1.8594267642584574
SNU-81,8515,4.116210915577815,1.8594267642584574
KMRC-1,322968,4.639571189041566,1.8594267642584574
EFO-27,54626689,4.866384531477491,1.8594267642584574
LOU-NH91,9911830,2.650870613913377,1.8594267642584574
OPM-2,135659046,2.7260896342727396,1.8594267642584574
OPM-2,6917907,-6.048813777211379,1.8594267642584574
SCC-9,151289,2.789872420286255,1.8594267642584574
NCI-H661,4705,2.5155315968978127,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],15953870,5.063824663341904,1.8594267642584574
LOU-NH91,25154868,5.6992218929630205,1.8594267642584574
NCI-H522,54619267,4.072629967998864,1.8594267642584574
BT-549,11222830,1.721965279957128,1.8594267642584574
NCI-H146,53301938,3.7804038583893504,1.8594267642584574
FU-OV-1,selumetinib-JQ-1 (4-1 mol-mol),-0.403195367038434,1.8594267642584574
NCI-H727,selumetinib-MK-2206 (8-1 mol-mol),-1.8356480928534216,1.8594267642584574
MDA-MB-453,7326481,2.376694251985227,1.8594267642584574
HSC-4,6914657,-3.070952064512468,1.8594267642584574
MDA-MB-453,72376,-2.4391350280385033,1.8594267642584574
SCC-9,selumetinib-JQ-1 (4-1 mol-mol),2.082538789678548,1.8594267642584574
CA46,2130404,5.640885888744477,1.8594267642584574
G-401,216345,1.83916726924219,1.8594267642584574
LXF 289,54143018,0.7636513295056184,1.8594267642584574
MDA-MB-453,246676,1.942789144720036,1.8594267642584574
A-498,19582717,5.689025629434131,1.8594267642584574
MSTO-211H,11964036,1.836732040985672,1.8594267642584574
A-673,3552672,1.3462933778606576,1.8594267642584574
CAL-51,11152667,-1.203722258692511,1.8594267642584574
CAL-51,67156097,-2.385254348530768,1.8594267642584574
CAL-51,65064,3.306239750209062,1.8594267642584574
A-673,piperlongumine-MST-312 (1-1 mol-mol),1.0809583866306374,1.8594267642584574
KYSE-70,navitoclax-pluripotin (1-1 mol-mol),-0.6013562023885967,1.8594267642584574
MDA-MB-157,6917907,-6.62909111977728,1.8594267642584574
HSC-4,64971,1.7199562834608897,1.8594267642584574
NCI-H460,135440466,3.295247648571462,1.8594267642584574
MSTO-211H,57519531,1.3086690033484818,1.8594267642584574
G-401,9926054,1.744192331951833,1.8594267642584574
OPM-2,24821094,1.5161257655930716,1.8594267642584574
NCI-H727,1641662,3.969866081416476,1.8594267642584574
YAPC,66577038,3.3954554117120224,1.8594267642584574
A4/Fukuda,36462,-0.7730347482869518,1.8594267642584574
DMS 273,135440466,3.3485559592244214,1.8594267642584574
FTC-133,445455,5.178470647326205,1.8594267642584574
Panc 04.03,72376,-2.048199615123948,1.8594267642584574
CAL-51,10302451,1.350542324147247,1.8594267642584574
JM-1,11214940,0.7147440273172748,1.8594267642584574
A-498,25183872,-0.6220750954527926,1.8594267642584574
OVISE,44607531,3.0758971794813093,1.8594267642584574
A-673,53392493,1.8369213613876785,1.8594267642584574
LoVo,11719255,3.552916809155198,1.8594267642584574
SNU-61,439501,-1.3808373898758073,1.8594267642584574
NCI-H460,104842,-2.7771726159534773,1.8594267642584574
CAL-51,11364421,-3.809863778172731,1.8594267642584574
BxPC-3,71466578,5.509660254732227,1.8594267642584574
NCI-H522,12001922,1.5621076115514363,1.8594267642584574
KMRC-1,11626560,2.283484204530191,1.8594267642584574
MDA-MB-453,5329102,2.150481946774112,1.8594267642584574
DMS 273,navitoclax-gemcitabine (1-1 mol-mol),-2.068576653592491,1.8594267642584574
NCI-H460,tanespimycin-gemcitabine (1-1 mol-mol),0.0048174492306964,1.8594267642584574
ONS-76,16720766,0.8880370259188662,1.8594267642584574
EFO-27,56949517,4.565823410262603,1.8594267642584574
DMS 273,11222830,1.4389641717758948,1.8594267642584574
LoVo,36462,0.97058855741136,1.8594267642584574
OVISE,SNX-2112-bortezomib (250-1 mol-mol),-0.8591608441303084,1.8594267642584574
Panc 04.03,16038120,1.7157321990683845,1.8594267642584574
LOU-NH91,3062316,-1.7568876367320156,1.8594267642584574
A2780,9903786,1.372407357095215,1.8594267642584574
OVISE,49766530,-2.0570642495309004,1.8594267642584574
G-401,doxorubicin-navitoclax (2-1 mol-mol),-2.722419727945218,1.8594267642584574
SNU-61,11427553,3.286064968901604,1.8594267642584574
A-673,72193861,0.2228627716233472,1.8594267642584574
Panc 04.03,tanespimycin-gemcitabine (1-1 mol-mol),-1.7855747696836677,1.8594267642584574
NCI-H2009,3815108,3.061482559784255,1.8594267642584574
A-673,2126,5.190382873813306,1.8594267642584574
ONS-76,10302451,3.399700001459874,1.8594267642584574
G-401,9825149,1.4427851681991832,1.8594267642584574
NCI-H522,44202524,1.1337498661514331,1.8594267642584574
SNU-61,52947716,-2.831948664567002,1.8594267642584574
A4/Fukuda,2945648,2.3216808345706035,1.8594267642584574
A-673,25105715,3.2161270828318207,1.8594267642584574
NCI-H522,11178236,-5.864645603629742,1.8594267642584574
JM-1,216239,1.5816975151035817,1.8594267642584574
CAL-51,9903786,2.1849161121493847,1.8594267642584574
SNU-449,9936388,0.4589950900054629,1.8594267642584574
NCI-H292,9927531,4.942242070848643,1.8594267642584574
NCI-H2171,25262965,-0.9052216234257174,1.8594267642584574
OVISE,selumetinib-MK-2206 (8-1 mol-mol),3.824616242676661,1.8594267642584574
JM-1,24901704,1.786623485766962,1.8594267642584574
SBC-5,656346,0.6270929807498155,1.8594267642584574
KMRC-1,89928392,3.173061856078121,1.8594267642584574
NCI-H292,156414,1.4083938325335852,1.8594267642584574
LXF 289,135875424,3.2815298243266553,1.8594267642584574
A-673,11494412,0.2373053627626316,1.8594267642584574
A-673,5746,-2.085801833901771,1.8594267642584574
DMS 273,9935249,1.448801275140577,1.8594267642584574
FTC-133,11404337,1.1811341910019733,1.8594267642584574
MDA-MB-453,57519531,4.708696705883037,1.8594267642584574
FU-OV-1,11152667,-0.9879051128837576,1.8594267642584574
A-673,44493528,4.641329710074662,1.8594267642584574
NCI-H460,2828334,6.134119597935603,1.8594267642584574
NCI-H2171,16659841,2.989016667138281,1.8594267642584574
FU-OV-1,73707386,2.8924737769549633,1.8594267642584574
FU-OV-1,24901704,3.02942514713799,1.8594267642584574
NCI-H727,4259181,-0.7375001764594127,1.8594267642584574
LOU-NH91,tretinoin-navitoclax (4-1 mol-mol),-1.081702007915755,1.8594267642584574
KMRC-1,navitoclax-PLX-4032 (1-1 mol-mol),3.702338136233157,1.8594267642584574
G-401,sirolimus-bortezomib (250-1 mol-mol),0.0501690880033574,1.8594267642584574
MDA-MB-453,17755052,-0.3952702915340721,1.8594267642584574
DMS 273,46398810,2.5474695176149527,1.8594267642584574
G-401,5278396,3.0023073980849424,1.8594267642584574
NCI-H661,24821094,2.278259467148376,1.8594267642584574
NCI-H146,11364421,-6.559818289293388,1.8594267642584574
JM-1,24797083,0.8026470280931975,1.8594267642584574
NCI-H522,168312962,3.69802370811012,1.8594267642584574
ONS-76,sirolimus-bortezomib (250-1 mol-mol),0.9944674218020764,1.8594267642584574
BT-549,16736978,2.673955173636492,1.8594267642584574
A4/Fukuda,46907787,-1.6446005772830188,1.8594267642584574
ONS-76,654092,-0.1261556450149646,1.8594267642584574
NCI-H661,6610355,4.759868911507443,1.8594267642584574
Panc 04.03,JQ-1-UNC0638 (2-1 mol-mol),2.939045539650312,1.8594267642584574
G-401,25154868,3.6071608181606063,1.8594267642584574
MDA-MB-453,4788,3.7423511350995255,1.8594267642584574
MDA-MB-157,11960529,3.789984251684095,1.8594267642584574
SCC-9,16720766,1.7269628893506093,1.8594267642584574
NOMO-1,753704,4.4431191000277375,1.8594267642584574
A4/Fukuda,6450551,1.0528971846899622,1.8594267642584574
YAPC,24964624,2.625771283300636,1.8594267642584574
A2780,82146,3.1377115486631273,1.8594267642584574
MDA-MB-157,1566236,1.4232096904008935,1.8594267642584574
LXF 289,25183872,-1.882522005728347,1.8594267642584574
KMRC-1,24753719,4.192591897270876,1.8594267642584574
LoVo,44607530,0.9946707755477716,1.8594267642584574
SBC-5,44632017,0.6241642112624288,1.8594267642584574
SBC-5,23635314,-2.6646956028329223,1.8594267642584574
LXF 289,54619267,4.7435335143288935,1.8594267642584574
BT-549,46199207,3.7007120058669623,1.8594267642584574
KYSE-70,6914657,-2.943523310206574,1.8594267642584574
A2780,89928392,-0.8241966309638568,1.8594267642584574
MDA-MB-453,54618164,4.967166731196573,1.8594267642584574
SNU-81,selumetinib-tretinoin (2-1 mol-mol),-2.852334261178199,1.8594267642584574
NCI-H460,4788,5.894567383019075,1.8594267642584574
DMS 273,24951314,0.5391494064850418,1.8594267642584574
NCI-H460,1750826,3.3189287492303197,1.8594267642584574
CAL-51,2749,1.4482754145936665,1.8594267642584574
OPM-2,1566236,0.7571858740606694,1.8594267642584574
A-673,selumetinib-decitabine (4-1 mol-mol),3.170233971616513,1.8594267642584574
EFO-27,11626560,3.0674086659258646,1.8594267642584574
BT-549,216345,4.357029009920563,1.8594267642584574
KYSE-70,3081361,2.4267899196210982,1.8594267642584574
NCI-H146,156414,1.153076826996135,1.8594267642584574
NCI-H522,135411,0.5669945497970937,1.8594267642584574
BxPC-3,6438330,1.9774707221451924,1.8594267642584574
MDA-MB-453,9903786,4.505035222499518,1.8594267642584574
YAPC,5281321,0.2366473375234088,1.8594267642584574
MDA-MB-157,71304818,1.9463509570918949,1.8594267642584574
BxPC-3,56946209,-3.950691768305054,1.8594267642584574
LOU-NH91,6450551,3.4853298595759687,1.8594267642584574
G-401,1242560,3.581659075050411,1.8594267642584574
MSTO-211H,3854666,2.1662920246080963,1.8594267642584574
NCI-H522,25062766,2.616535601519866,1.8594267642584574
Panc 04.03,3038522,3.0958365698912154,1.8594267642584574
NCI-H460,25183872,2.110783783288614,1.8594267642584574
SCC-9,71304818,2.8421374335972653,1.8594267642584574
SCC-9,65064,5.356580923551092,1.8594267642584574
NCI-H727,25183872,0.4102957812787974,1.8594267642584574
NCI-H460,81146,4.483282466350705,1.8594267642584574
OPM-2,navitoclax-piperlongumine (1-1 mol-mol),0.7945063119799598,1.8594267642584574
MDA-MB-453,54765302,2.0573663082868405,1.8594267642584574
KYSE-70,10302451,3.1884398798129525,1.8594267642584574
LoVo,49793307,-4.412709808216002,1.8594267642584574
SNU-81,36314,-5.848392982376778,1.8594267642584574
A-673,navitoclax-birinapant (1-1 mol-mol),1.618517186072499,1.8594267642584574
Panc 04.03,2733526,4.292486036611722,1.8594267642584574
CA46,9926054,1.6892727173627182,1.8594267642584574
NCI-H522,2746,2.8917767436803414,1.8594267642584574
LOU-NH91,67156097,-3.1227398262817587,1.8594267642584574
NCI-H146,5284329,3.6277290639514455,1.8594267642584574
KMRC-1,644241,4.9037113640465035,1.8594267642584574
A4/Fukuda,60700,-1.3381290141173086,1.8594267642584574
NOMO-1,24753719,4.496099764979975,1.8594267642584574
NOMO-1,9903786,1.612481289648159,1.8594267642584574
LOU-NH91,JQ-1-carboplatin (1-1 mol-mol),1.662362738651182,1.8594267642584574
JM-1,54618771,-0.5043757930015165,1.8594267642584574
G-401,3854666,0.6606077023561356,1.8594267642584574
EFO-27,24978538,3.143555245211511,1.8594267642584574
OVISE,322968,2.654176014952692,1.8594267642584574
EFO-27,alisertib-navitoclax (2-1 mol-mol),2.9537662820479693,1.8594267642584574
FU-OV-1,637858,1.762395691671764,1.8594267642584574
NCI-H460,navitoclax-sorafenib (1-1 mol-mol),2.697352012962362,1.8594267642584574
ONS-76,11626560,1.9844806011562912,1.8594267642584574
LoVo,216345,1.1599721320761718,1.8594267642584574
SNU-449,9926054,1.9385314164963827,1.8594267642584574
HCC1143,568763,-0.6390257750571487,1.8594267642584574
MDA-MB-157,JQ-1-MK-0752 (1-1 mol-mol),3.739596804581883,1.8594267642584574
NCI-H292,72193870,4.439424680926146,1.8594267642584574
NCI-H522,11228183,3.862798460505377,1.8594267642584574
CAL-51,4788,6.061217822513647,1.8594267642584574
LoVo,4521392,4.145025799048703,1.8594267642584574
HSC-4,11626560,2.5873766751252436,1.8594267642584574
NCI-H460,60750,-0.8382921927225392,1.8594267642584574
JM-1,44137675,3.718094845766921,1.8594267642584574
HSC-4,71304818,1.898043557267106,1.8594267642584574
CAL-51,25150857,2.2346870378683934,1.8594267642584574
CA46,2871966,-1.7971239931694716,1.8594267642584574
DMS 273,54454,3.225049529812471,1.8594267642584574
ONS-76,25183872,-0.170903852827654,1.8594267642584574
SNU-61,984333,6.216581141210495,1.8594267642584574
CAL-51,JQ-1-vorinostat (2-1 mol-mol),1.2952868621484117,1.8594267642584574
A2780,71466578,2.665399831677294,1.8594267642584574
HCC1143,docetaxel-tanespimycin (2-1 mol-mol),-1.7966403961348645,1.8594267642584574
CA46,24797083,-0.1839530161688024,1.8594267642584574
CAL-51,135875424,4.33643967165441,1.8594267642584574
NCI-H2171,3689413,-2.7117222930063867,1.8594267642584574
A2780,11396600,2.9320615716687564,1.8594267642584574
SNU-449,navitoclax-PLX-4032 (1-1 mol-mol),3.4557412405701258,1.8594267642584574
G-401,56963564,0.504836775176006,1.8594267642584574
LOU-NH91,44632017,2.871860814691948,1.8594267642584574
CA46,11214940,-0.2735426892992921,1.8594267642584574
NOMO-1,67156097,-2.629595584457773,1.8594267642584574
NOMO-1,26596,-2.074766602044621,1.8594267642584574
JM-1,50905018,4.16446369685189,1.8594267642584574
NCI-H2171,445455,3.811797523558628,1.8594267642584574
EFO-27,16736978,1.8793599511128067,1.8594267642584574
JM-1,54678924,1.2599632015511184,1.8594267642584574
NCI-H460,5281321,2.142807178276493,1.8594267642584574
SNU-449,5738263,4.026622535351311,1.8594267642584574
SCC-9,216239,3.331867398285969,1.8594267642584574
G-401,10410894,3.279247022117546,1.8594267642584574
SNU-61,11222830,1.6415416447740467,1.8594267642584574
CA46,2113511,3.5674790523720317,1.8594267642584574
NCI-H146,72734382,2.9399655016804114,1.8594267642584574
NCI-H522,613753,2.504960527289346,1.8594267642584574
G-401,156414,1.0662464633968871,1.8594267642584574
BxPC-3,5470400,-0.5134005920596514,1.8594267642584574
KMRC-1,1242560,3.860865345198952,1.8594267642584574
BT-549,1242560,4.319126066576065,1.8594267642584574
OPM-2,66577038,2.8274271292709536,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],613753,3.402609507762531,1.8594267642584574
DMS 273,16013152,3.9042510131977353,1.8594267642584574
NCI-H522,448949,1.6947060599097594,1.8594267642584574
MDA-MB-157,5566,3.489209385839125,1.8594267642584574
Panc 04.03,53392493,3.71782736184095,1.8594267642584574
BxPC-3,55508,4.124435576281598,1.8594267642584574
EFO-27,carboplatin-UNC0638 (2-1 mol-mol),4.02907602487195,1.8594267642584574
NCI-H661,4521392,4.344795346058825,1.8594267642584574
JM-1,119607,3.9456515069078,1.8594267642584574
NCI-H292,SNX-2112-bortezomib (250-1 mol-mol),-1.594180190580018,1.8594267642584574
NCI-H460,3385,3.2657114863965573,1.8594267642584574
A2780,327653,2.026169684275287,1.8594267642584574
SBC-5,vorinostat-navitoclax (4-1 mol-mol),1.5319499176143987,1.8594267642584574
MSTO-211H,crizotinib-PLX-4032 (2-1 mol-mol),1.678384538966045,1.8594267642584574
JM-1,4261,-0.3533034531676731,1.8594267642584574
HSC-4,135875424,3.4627713632233537,1.8594267642584574
A2780,44491742,3.4077888459991774,1.8594267642584574
Panc 04.03,135999136,5.549073334475873,1.8594267642584574
SCC-9,57519531,3.918058558817349,1.8594267642584574
LoVo,3815108,2.2685826541267615,1.8594267642584574
DMS 273,71466445,2.157471967137961,1.8594267642584574
NCI-H661,44241473,4.80522256986357,1.8594267642584574
ONS-76,6438330,3.0471678199579206,1.8594267642584574
Panc 04.03,2949965,2.626604824548014,1.8594267642584574
OPM-2,676352,1.691725548140899,1.8594267642584574
SNU-449,16722836,2.5551835494173325,1.8594267642584574
A-673,11152667,-2.304412849002376,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],53232,3.9030972816172262,1.8594267642584574
G-401,151289,0.7906130786084481,1.8594267642584574
OPM-2,serdemetan-SCH-529074 (1-1 mol-mol),1.0013874340560274,1.8594267642584574
LoVo,25195348,3.880726101323461,1.8594267642584574
NCI-H1623,11404337,1.3417738865788873,1.8594267642584574
BT-549,3062316,0.532185160328145,1.8594267642584574
NCI-H146,doxorubicin-navitoclax (2-1 mol-mol),-3.7183112313857216,1.8594267642584574
EFO-27,44185566,3.1194970070950276,1.8594267642584574
A4/Fukuda,16725315,3.095723533871789,1.8594267642584574
LOU-NH91,3854666,2.9087049696787544,1.8594267642584574
NCI-H460,676352,2.985829219207002,1.8594267642584574
MSTO-211H,23725625,2.234746785874409,1.8594267642584574
SCC-9,5351362,1.6846115382104403,1.8594267642584574
JM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1559529879995699,1.8594267642584574
NCI-H522,241158,3.3210308536521156,1.8594267642584574
A-673,10127622,5.418104152685571,1.8594267642584574
MDA-MB-157,serdemetan-SCH-529074 (1-1 mol-mol),2.3164799956967665,1.8594267642584574
G-401,53232,3.5991410971239866,1.8594267642584574
OPM-2,5287969,-2.4106191892149185,1.8594267642584574
SCC-9,637858,3.7694424070181127,1.8594267642584574
NCI-H2171,5282054,2.409902559914623,1.8594267642584574
NCI-H292,1242560,3.487131794973456,1.8594267642584574
KMRC-1,selumetinib-GDC-0941 (4-1 mol-mol),1.816727012202974,1.8594267642584574
CAL-51,3503,3.2899889427654245,1.8594267642584574
DMS 273,selumetinib-BRD-A02303741 (4-1 mol-mol),7.1319495853751045,1.8594267642584574
Panc 04.03,51039095,3.732934843851844,1.8594267642584574
NOMO-1,5329102,1.5937414073922636,1.8594267642584574
ONS-76,1242560,3.484199229378892,1.8594267642584574
G-401,24180719,3.4290114124184568,1.8594267642584574
A-673,11485656,1.6006257465541904,1.8594267642584574
NCI-H460,5278396,3.885794996406102,1.8594267642584574
ONS-76,4788,5.851184911612036,1.8594267642584574
NCI-H661,11234052,4.193192571907383,1.8594267642584574
LoVo,46174525,4.300656487428364,1.8594267642584574
CA46,135875424,2.985562686352135,1.8594267642584574
SNU-81,6610355,3.7225360861185592,1.8594267642584574
MDA-MB-453,JQ-1-MK-0752 (1-1 mol-mol),0.5621675718726626,1.8594267642584574
A-673,1566236,1.6605846703776754,1.8594267642584574
LXF 289,55283,4.7983814176360715,1.8594267642584574
DMS 273,1566236,1.8001113918747356,1.8594267642584574
SCC-9,4477,0.0462068475019735,1.8594267642584574
BxPC-3,439501,-2.27553783948146,1.8594267642584574
G-401,3503,1.5245243202568906,1.8594267642584574
SNU-449,5280436,2.098309971831213,1.8594267642584574
LOU-NH91,119607,5.561970464467383,1.8594267642584574
MSTO-211H,6918328,-0.4462053694736546,1.8594267642584574
A2780,10231331,0.3686619766312378,1.8594267642584574
SNU-449,44137675,3.6126407514409378,1.8594267642584574
Panc 04.03,9866186,0.4755964236535121,1.8594267642584574
JM-1,40482356,5.622716652052393,1.8594267642584574
CAL-51,49766530,0.4609697007955676,1.8594267642584574
G-401,11960529,4.93979495553103,1.8594267642584574
HCC1143,6505803,-0.5233928936461414,1.8594267642584574
KYSE-70,676352,2.557270596786296,1.8594267642584574
A2780,135398516,-0.3122960179418635,1.8594267642584574
NCI-H292,23635314,4.8326715815763395,1.8594267642584574
SNU-449,15547703,3.400796461378631,1.8594267642584574
CA46,navitoclax-piperlongumine (1-1 mol-mol),1.4441341288477034,1.8594267642584574
LXF 289,46843906,2.101940493524925,1.8594267642584574
DMS 273,46174525,4.164871991455526,1.8594267642584574
NCI-H727,selumetinib-decitabine (4-1 mol-mol),-1.5172256962408457,1.8594267642584574
SNU-449,6917907,-5.317414756413243,1.8594267642584574
A2780,4705,2.567744201920244,1.8594267642584574
KYSE-70,73707438,4.323396479680616,1.8594267642584574
NCI-H460,5329102,3.240160570329804,1.8594267642584574
NCI-H661,5282054,3.5253080606128133,1.8594267642584574
NCI-H1623,119607,5.952206355872506,1.8594267642584574
NCI-H522,64971,2.9291780846019413,1.8594267642584574
CAL-51,11222830,1.6762547521470548,1.8594267642584574
A2780,vorinostat-carboplatin (1-1 mol-mol),2.197042842116113,1.8594267642584574
SCC-9,25062766,2.812414712404745,1.8594267642584574
YAPC,31703,-0.7401868256368748,1.8594267642584574
KYSE-70,2858523,3.054228167220651,1.8594267642584574
MDA-MB-453,1242560,3.902800159671119,1.8594267642584574
MSTO-211H,71466380,4.302501611697816,1.8594267642584574
NCI-H2009,3689413,0.5343246791806224,1.8594267642584574
G-401,15547703,3.220896426279267,1.8594267642584574
NCI-H522,11719255,2.5592835843852337,1.8594267642584574
LXF 289,46191454,2.351463869671111,1.8594267642584574
LoVo,71304818,2.0724805960279027,1.8594267642584574
A-673,5311,0.6764453858481513,1.8594267642584574
KMRC-1,11175137,2.246406512349146,1.8594267642584574
MDA-MB-157,568763,-0.4149964884485024,1.8594267642584574
LOU-NH91,11213558,0.661761515775888,1.8594267642584574
CAL-51,2733487,8.211583338705053,1.8594267642584574
LXF 289,16741245,5.010251526780332,1.8594267642584574
SNU-61,24797083,1.0556452382424049,1.8594267642584574
BT-549,44137675,4.586830027774197,1.8594267642584574
CAL-51,15547703,3.503799403292956,1.8594267642584574
JM-1,3136844,3.4340507925237307,1.8594267642584574
NCI-H460,46191454,1.6495265120274705,1.8594267642584574
CAL-51,16722836,0.8083581946159574,1.8594267642584574
FTC-133,25227462,2.318225674680384,1.8594267642584574
A2780,51039095,0.059669762784491,1.8594267642584574
OPM-2,54613361,-1.307423897840743,1.8594267642584574
LOU-NH91,5328940,1.6284519107294106,1.8594267642584574
HSC-4,11640390,4.10313790521596,1.8594267642584574
LoVo,11222830,1.6500045227885836,1.8594267642584574
NCI-H2171,53495165,-2.473385034422452,1.8594267642584574
MDA-MB-453,5281321,-0.6344069396712416,1.8594267642584574
FU-OV-1,9926054,2.079351745951841,1.8594267642584574
G-401,36462,-0.1566510321668276,1.8594267642584574
A-673,JQ-1-carboplatin (1-1 mol-mol),1.1518421458333987,1.8594267642584574
NCI-H1623,11427553,2.6307082318350132,1.8594267642584574
A-673,6918638,-0.1443248090306654,1.8594267642584574
OPM-2,54596490,4.128803973627264,1.8594267642584574
G-401,24753719,3.1602445998928186,1.8594267642584574
FTC-133,selumetinib-MK-2206 (8-1 mol-mol),6.933601402972985,1.8594267642584574
DMS 273,637858,1.5802330029013405,1.8594267642584574
OPM-2,72199292,0.0645754970830883,1.8594267642584574
SNU-449,5328940,1.97588831229785,1.8594267642584574
OVISE,49793307,0.0210083556696064,1.8594267642584574
A-673,11647372,1.3285775791052634,1.8594267642584574
OVISE,6918328,1.4244682512544402,1.8594267642584574
Panc 04.03,25154868,5.1819399857498025,1.8594267642584574
EFO-27,17755052,1.748867275877649,1.8594267642584574
EFO-27,decitabine-navitoclax (2-1 mol-mol),3.595019869203868,1.8594267642584574
SBC-5,375860,-0.6399303579455221,1.8594267642584574
HCC1143,selumetinib-piperlongumine (8-1 mol-mol),2.549848868109157,1.8594267642584574
MDA-MB-157,451668,4.959725465812671,1.8594267642584574
YAPC,54619267,5.29132207947154,1.8594267642584574
OPM-2,36462,1.377546018006998,1.8594267642584574
BxPC-3,3081361,1.7902484572067556,1.8594267642584574
SNU-449,11455910,0.8938620280411973,1.8594267642584574
NCI-H1623,25022340,5.5347014016683875,1.8594267642584574
NCI-H522,409805,3.737006742854017,1.8594267642584574
CAL-51,568763,0.0917223714484538,1.8594267642584574
HSC-4,12001922,2.169357927696289,1.8594267642584574
CA46,2742550,3.5037926309603944,1.8594267642584574
LOU-NH91,11507802,2.1124947170440533,1.8594267642584574
LXF 289,6852167,2.2044562779321635,1.8594267642584574
ONS-76,26596,0.1332187247782509,1.8594267642584574
KYSE-70,9903786,2.353212274658888,1.8594267642584574
DMS 273,10385095,0.5027476993233067,1.8594267642584574
ONS-76,3025986,-0.4351415981508911,1.8594267642584574
MDA-MB-453,89928392,1.7795585771799345,1.8594267642584574
LXF 289,676352,2.537691956872654,1.8594267642584574
OPM-2,navitoclax-gemcitabine (1-1 mol-mol),-1.0437605792762972,1.8594267642584574
HSC-4,135659046,3.804399419736421,1.8594267642584574
OVISE,alisertib-navitoclax (2-1 mol-mol),-0.6471026369576864,1.8594267642584574
SNU-81,6623618,-2.7236989498385733,1.8594267642584574
HSC-4,5282054,3.7951129778884822,1.8594267642584574
MDA-MB-157,sirolimus-bortezomib (250-1 mol-mol),1.4679701866850798,1.8594267642584574
A-673,16219061,2.4523595679466954,1.8594267642584574
SCC-9,123631,1.8109604294388877,1.8594267642584574
A-673,11364421,-5.84995188170368,1.8594267642584574
A-673,216345,3.678855080389337,1.8594267642584574
A-673,439501,-3.092013019617277,1.8594267642584574
NCI-H460,1566236,4.3513012021592505,1.8594267642584574
LOU-NH91,25195348,3.759766884877561,1.8594267642584574
DMS 273,23725625,4.676663171220921,1.8594267642584574
ONS-76,selumetinib-vorinostat (8-1 mol-mol),-1.377626233169706,1.8594267642584574
CAL-51,6852167,2.546662292056567,1.8594267642584574
OPM-2,5738263,2.0935625564909737,1.8594267642584574
SCC-9,5311,1.75647433259966,1.8594267642584574
SNU-81,5291,3.232691727920098,1.8594267642584574
FU-OV-1,262093,2.4810055989466018,1.8594267642584574
LoVo,56949517,2.258326270055845,1.8594267642584574
A4/Fukuda,9825149,-2.050748608979426,1.8594267642584574
CAL-51,53392493,1.8808489153668793,1.8594267642584574
NCI-H522,4521392,3.962796694444569,1.8594267642584574
NOMO-1,navitoclax-birinapant (1-1 mol-mol),-1.0294989244517518,1.8594267642584574
NCI-H2009,11612883,2.3268324416241777,1.8594267642584574
NCI-H292,65064,3.148033598452649,1.8594267642584574
NCI-H292,44589607,3.354505508461316,1.8594267642584574
KMRC-1,462382,0.2791911345900462,1.8594267642584574
A4/Fukuda,5291,3.6218734753047226,1.8594267642584574
NCI-H460,ISOX-bortezomib (250-1 mol-mol),1.7631943110451136,1.8594267642584574
A-673,135440466,1.1776565801361647,1.8594267642584574
Panc 04.03,60700,0.3719609401953118,1.8594267642584574
LOU-NH91,66577038,3.4622279905398052,1.8594267642584574
A2780,24856436,-0.502193855863573,1.8594267642584574
CAL-51,6852167,2.546662292056567,1.8594267642584574
JM-1,5311037,4.072371281952103,1.8594267642584574
NCI-H460,374536,2.933441634270558,1.8594267642584574
NCI-H460,216468,4.763843832635099,1.8594267642584574
SW1463,421610,3.2195561799423804,1.8594267642584574
NCI-H460,439501,-2.362377537788676,1.8594267642584574
NCI-H292,tanespimycin-bortezomib (250-1 mol-mol),-0.1673864119679393,1.8594267642584574
MDA-MB-157,24978538,3.306703195844951,1.8594267642584574
MDA-MB-453,54618795,1.052632381834858,1.8594267642584574
EFO-27,6914657,-5.685084863882177,1.8594267642584574
NCI-H661,9866186,1.9017456959186525,1.8594267642584574
CAL-51,6623618,2.223133904662847,1.8594267642584574
OPM-2,5281672,3.1701528707347015,1.8594267642584574
CAL-51,1716436,3.275997904874087,1.8594267642584574
NOMO-1,25183872,-0.6960845434284378,1.8594267642584574
EFO-27,216239,3.3875560857040887,1.8594267642584574
NOMO-1,54619267,3.207870909981956,1.8594267642584574
NCI-H460,400769,-0.4007490431715684,1.8594267642584574
SNU-61,6610355,3.885584601382451,1.8594267642584574
BT-549,vorinostat-carboplatin (1-1 mol-mol),4.114114464716558,1.8594267642584574
JM-1,10077130,2.0136903876831993,1.8594267642584574
NCI-H661,81146,4.823771143587,1.8594267642584574
LoVo,56946209,-4.467950537911531,1.8594267642584574
NCI-H522,5460769,0.5614535105182378,1.8594267642584574
CA46,9927531,3.0223750820915978,1.8594267642584574
CAL-51,11612883,1.9359641259018452,1.8594267642584574
CAL-51,11427553,2.069280384014222,1.8594267642584574
NCI-H727,5746,2.1304383256196293,1.8594267642584574
MDA-MB-453,16219061,1.5030881414961583,1.8594267642584574
MDA-MB-453,68056272,3.261695748545246,1.8594267642584574
A4/Fukuda,6610216,3.4719570509087445,1.8594267642584574
CAL-51,piperlongumine-MST-312 (1-1 mol-mol),2.124506315707809,1.8594267642584574
SCC-9,107985,-2.37702169012632,1.8594267642584574
MDA-MB-157,23939,3.513284021833553,1.8594267642584574
OPM-2,262093,0.5720462757198622,1.8594267642584574
NCI-H661,5351362,2.412641003608378,1.8594267642584574
BT-549,53495165,-2.465962418573161,1.8594267642584574
A-673,decitabine-carboplatin (1-1 mol-mol),2.7905557903359246,1.8594267642584574
HSC-4,1716436,3.018983829466311,1.8594267642584574
A4/Fukuda,10231331,-0.0070700765814584,1.8594267642584574
OPM-2,25105715,2.7306053213312027,1.8594267642584574
CAL-51,3384730,2.4775948365465905,1.8594267642584574
DMS 273,vorinostat-navitoclax (4-1 mol-mol),0.8220813286666946,1.8594267642584574
KMRC-1,262093,3.6313310555506817,1.8594267642584574
KYSE-70,5311281,3.780874632943925,1.8594267642584574
Panc 04.03,135659046,3.760242578723066,1.8594267642584574
NCI-H460,46199207,3.5033257005335163,1.8594267642584574
CA46,JQ-1-carboplatin (1-1 mol-mol),-0.7040949114758062,1.8594267642584574
NCI-H522,285033,-5.015646919007219,1.8594267642584574
NCI-H1623,31703,-1.093718795909536,1.8594267642584574
CA46,8515,3.648186715161825,1.8594267642584574
A-673,54618164,3.9765209939943857,1.8594267642584574
MDA-MB-453,71304818,1.4463301677266325,1.8594267642584574
SNU-81,656346,0.6811147423088999,1.8594267642584574
A4/Fukuda,JQ-1-vorinostat (2-1 mol-mol),-1.448511600529376,1.8594267642584574
SCC-9,alisertib-navitoclax (2-1 mol-mol),1.3350821103573205,1.8594267642584574
OVISE,71680916,3.981894618274443,1.8594267642584574
LOU-NH91,56963564,0.9665729866263152,1.8594267642584574
NCI-H661,23635314,-2.0342629068452056,1.8594267642584574
LOU-NH91,12001922,2.55699926148122,1.8594267642584574
JM-1,31703,-4.919166892515249,1.8594267642584574
EFO-27,16065773,2.8503557299543063,1.8594267642584574
DMS 273,107970,2.226748766743483,1.8594267642584574
MDA-MB-157,67156097,-2.087594374926874,1.8594267642584574
BxPC-3,JQ-1-UNC0638 (2-1 mol-mol),0.9591872546469856,1.8594267642584574
LOU-NH91,46199207,3.3608515659177147,1.8594267642584574
DMS 273,JQ-1-vorinostat (2-1 mol-mol),0.2212996861992737,1.8594267642584574
BT-549,2871966,1.6191257261573118,1.8594267642584574
BT-549,46926350,-4.493585638609818,1.8594267642584574
OVISE,54626689,4.712933516379989,1.8594267642584574
NCI-H460,119182,0.2489341964189734,1.8594267642584574
MDA-MB-453,7251185,1.8406187352582624,1.8594267642584574
JM-1,4521392,4.181937683636394,1.8594267642584574
LoVo,44589607,1.625549992230134,1.8594267642584574
LXF 289,vorinostat-navitoclax (4-1 mol-mol),1.5886672686618393,1.8594267642584574
A-673,24951314,0.6400096482448101,1.8594267642584574
NCI-H146,selumetinib-GDC-0941 (4-1 mol-mol),2.6749469012990525,1.8594267642584574
A2780,11152667,-1.0749204847082217,1.8594267642584574
BT-549,5329102,2.9790267437316285,1.8594267642584574
G-401,17755052,0.028133790527295,1.8594267642584574
CAL-51,11238147,2.100409816322544,1.8594267642584574
FTC-133,16725315,5.918216987208106,1.8594267642584574
HSC-4,10127622,4.548794444843462,1.8594267642584574
NCI-H2009,JQ-1-MK-0752 (1-1 mol-mol),0.489585373897599,1.8594267642584574
HSC-4,72376,-2.108784759313747,1.8594267642584574
HCC1143,11455910,1.411815978618001,1.8594267642584574
G-401,6610216,3.9425308150709,1.8594267642584574
OPM-2,73707398,-1.391957592490296,1.8594267642584574
Panc 04.03,crizotinib-PLX-4032 (2-1 mol-mol),2.2047528734152655,1.8594267642584574
MSTO-211H,11396600,3.2938939565791765,1.8594267642584574
NCI-H2171,15983966,-6.379176066325201,1.8594267642584574
HCC1143,9903786,3.3387804215378885,1.8594267642584574
JM-1,3385,1.6679469335870958,1.8594267642584574
NCI-H460,SNX-2112-bortezomib (250-1 mol-mol),-0.7287978777704803,1.8594267642584574
JM-1,44487872,4.651129481786086,1.8594267642584574
NOMO-1,439501,-2.35226533453039,1.8594267642584574
Panc 04.03,568763,0.8595160951448656,1.8594267642584574
A-673,15953870,2.6171812575314757,1.8594267642584574
CA46,6917907,-5.812984110767001,1.8594267642584574
A4/Fukuda,11404337,-2.650657466190433,1.8594267642584574
MDA-MB-157,6184667,1.80494393962058,1.8594267642584574
NCI-H2009,JQ-1-vorinostat (2-1 mol-mol),0.1591835457896471,1.8594267642584574
NCI-H522,25102847,2.0692872541383784,1.8594267642584574
EFO-27,2113511,5.820212709586459,1.8594267642584574
Panc 04.03,2729026,3.1546590032208948,1.8594267642584574
MDA-MB-453,9866186,-0.0857862406385878,1.8594267642584574
CA46,44491742,3.801952242992866,1.8594267642584574
MDA-MB-157,16720766,-3.610201854539628,1.8594267642584574
NCI-H522,168313016,4.366007701234683,1.8594267642584574
JM-1,53232,3.389128909220105,1.8594267642584574
ONS-76,24901704,3.4855009095109435,1.8594267642584574
FTC-133,3136844,4.271719807093853,1.8594267642584574
CAL-51,54619267,4.1828818787298765,1.8594267642584574
NCI-H146,17755052,1.2442303799433287,1.8594267642584574
FU-OV-1,2858523,3.1344850445874752,1.8594267642584574
NCI-H292,5280436,4.014624366310106,1.8594267642584574
BT-549,15547703,2.0718927663287703,1.8594267642584574
A2780,25126798,3.236047242798602,1.8594267642584574
Panc 04.03,2945648,3.066534391812563,1.8594267642584574
SCC-9,56963564,0.633234370730304,1.8594267642584574
A4/Fukuda,11507802,0.3746235533355334,1.8594267642584574
Panc 04.03,3025944,4.694936485248253,1.8594267642584574
SBC-5,46398810,3.6562963267762183,1.8594267642584574
JM-1,49793307,-5.3555461291239075,1.8594267642584574
SNU-81,67156097,-1.5845934662844448,1.8594267642584574
A2780,72376,-3.651935268939024,1.8594267642584574
CAL-51,25195348,5.6667768045179905,1.8594267642584574
NOMO-1,10074640,3.0496099519927435,1.8594267642584574
FTC-133,46174525,5.692041239325808,1.8594267642584574
YAPC,409805,4.253424942012428,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],135421197,1.2784797904555276,1.8594267642584574
SNU-61,11626560,1.823906724750755,1.8594267642584574
A-498,16736978,3.6467697702535182,1.8594267642584574
JM-1,9967941,2.969647244173239,1.8594267642584574
MSTO-211H,3815108,2.5678993468563913,1.8594267642584574
KYSE-70,637858,2.812350468450961,1.8594267642584574
A-673,16013152,4.069813049540754,1.8594267642584574
A2780,4521392,3.924686212385386,1.8594267642584574
A2780,23635314,-2.3171748001501635,1.8594267642584574
JM-1,3689413,-3.612287026066889,1.8594267642584574
CA46,navitoclax-PLX-4032 (1-1 mol-mol),3.7945066500570057,1.8594267642584574
OPM-2,64971,2.0053510879561296,1.8594267642584574
LXF 289,9935249,3.315625346230847,1.8594267642584574
Panc 04.03,984333,1.398892433045171,1.8594267642584574
DMS 273,676352,1.7083859345894283,1.8594267642584574
MDA-MB-453,4096211,1.6956492567589403,1.8594267642584574
DMS 273,9903786,1.811418424711566,1.8594267642584574
BxPC-3,3634881,3.024771766376516,1.8594267642584574
ONS-76,54618305,5.4771970245541866,1.8594267642584574
Panc 04.03,44491742,4.30815140156182,1.8594267642584574
A-673,tretinoin-carboplatin (2-1 mol-mol),4.33843308891482,1.8594267642584574
MDA-MB-453,123631,2.1950816453081545,1.8594267642584574
A4/Fukuda,426756,4.168045276817785,1.8594267642584574
CA46,252682,5.8821335535914905,1.8594267642584574
Panc 04.03,2828334,6.268769524950107,1.8594267642584574
EFO-27,135411,0.9008731550993504,1.8594267642584574
LXF 289,15983966,-1.3187435990338214,1.8594267642584574
A4/Fukuda,3384730,1.825152720179272,1.8594267642584574
SCC-9,11404337,-1.771041191231111,1.8594267642584574
SNU-61,6610216,4.086517799339023,1.8594267642584574
LOU-NH91,446155,1.33101507486467,1.8594267642584574
KMRC-1,71466380,4.698779777562497,1.8594267642584574
SNU-61,46398810,2.7474251169458346,1.8594267642584574
NCI-H2009,9826308,-0.026532071259288,1.8594267642584574
NCI-H2009,56946209,-2.630012103472263,1.8594267642584574
HCC1143,46843906,3.1964507186723305,1.8594267642584574
A-673,2742550,4.033526638201744,1.8594267642584574
SNU-81,11507802,0.99367607100598,1.8594267642584574
KMRC-1,11485656,3.5314695534539045,1.8594267642584574
SBC-5,57330099,2.8388792643726295,1.8594267642584574
LXF 289,219104,4.555444774518925,1.8594267642584574
Panc 04.03,9907093,4.451330392346362,1.8594267642584574
DMS 273,19582717,4.273838780275844,1.8594267642584574
SBC-5,3815108,2.9831729144642956,1.8594267642584574
OPM-2,168313016,3.5498730155612863,1.8594267642584574
ONS-76,10427712,4.642311539672088,1.8594267642584574
NCI-H522,54765302,4.051221649365855,1.8594267642584574
JM-1,44620216,4.114569245447781,1.8594267642584574
MDA-MB-453,9887053,5.45770037243801,1.8594267642584574
A4/Fukuda,72193861,-0.8043632874402014,1.8594267642584574
G-401,25102847,1.393287045797279,1.8594267642584574
SBC-5,11507802,0.0977610232609949,1.8594267642584574
JM-1,168313200,1.89690041567587,1.8594267642584574
FTC-133,3634881,3.4388146515237468,1.8594267642584574
NOMO-1,10427712,4.067466468396052,1.8594267642584574
SNU-61,6918328,0.4046547109968232,1.8594267642584574
NCI-H2171,23635314,-3.6505205606038382,1.8594267642584574
SNU-449,6438330,2.777557669825017,1.8594267642584574
JM-1,25161177,3.865095276574429,1.8594267642584574
LOU-NH91,3025986,-0.3413799803632848,1.8594267642584574
HCC1143,53232,5.137172207040132,1.8594267642584574
LOU-NH91,53232,2.5403477328432933,1.8594267642584574
NCI-H1623,24797083,2.165751455730843,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],10074640,3.542423635061651,1.8594267642584574
LOU-NH91,crizotinib-PLX-4032 (2-1 mol-mol),1.9615360492611609,1.8594267642584574
SNU-449,3025986,4.266276949739511,1.8594267642584574
NOMO-1,2858523,2.9127751570608136,1.8594267642584574
A-673,6918736,-0.9753951922870552,1.8594267642584574
A2780,44202524,1.0300821380640774,1.8594267642584574
DMS 273,25154868,4.488535380180048,1.8594267642584574
NCI-H146,navitoclax-gemcitabine (1-1 mol-mol),-4.8472150579078646,1.8594267642584574
BT-549,100016,6.139281322747303,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11609586,3.4054743637312006,1.8594267642584574
SCC-9,148124,-0.9222891029936632,1.8594267642584574
DMS 273,11494412,0.2734180035919979,1.8594267642584574
A-673,ISOX-bortezomib (250-1 mol-mol),0.1019689677537875,1.8594267642584574
A4/Fukuda,selumetinib-decitabine (4-1 mol-mol),-0.8212818207724355,1.8594267642584574
EFO-27,16725315,5.151426492732951,1.8594267642584574
KYSE-70,3689413,0.9447440025313596,1.8594267642584574
A2780,navitoclax-MST-312 (1-1 mol-mol),0.9234968671687596,1.8594267642584574
NCI-H460,285033,-0.7054560098467199,1.8594267642584574
KMRC-1,5311,2.4483949186029794,1.8594267642584574
Panc 04.03,54618164,4.2869772681873695,1.8594267642584574
NCI-H727,676352,2.629502567411482,1.8594267642584574
HSC-4,24779724,5.454925638847944,1.8594267642584574
A2780,23725625,2.4195603562256873,1.8594267642584574
CA46,56946209,-5.9555571874685755,1.8594267642584574
NCI-H146,6252,-1.7817409080320272,1.8594267642584574
SNU-449,44589607,3.7188226068257872,1.8594267642584574
LoVo,969516,2.402995535890804,1.8594267642584574
KMRC-1,carboplatin-etoposide (40-17 mol-mol),4.177751638329711,1.8594267642584574
CAL-51,9935249,3.84795648434564,1.8594267642584574
NCI-H1623,53392493,3.831222645051568,1.8594267642584574
MDA-MB-453,54596490,5.641262539800198,1.8594267642584574
A-498,42642645,1.5845020846141176,1.8594267642584574
FU-OV-1,4788,6.1006518616017615,1.8594267642584574
DMS 273,6852167,2.1769146352356707,1.8594267642584574
LoVo,11612883,2.4190290931093954,1.8594267642584574
A4/Fukuda,54618305,3.964460418875751,1.8594267642584574
NCI-H2009,17755052,1.0629457660851225,1.8594267642584574
EFO-27,5113032,5.5462842201226925,1.8594267642584574
LoVo,9907093,0.4604974674369004,1.8594267642584574
SCC-9,44491742,4.764074483400304,1.8594267642584574
NOMO-1,53392493,1.775943290565707,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],36462,2.9964453818745924,1.8594267642584574
SNU-449,16725315,5.255161508937853,1.8594267642584574
SNU-81,9825149,1.815233140933264,1.8594267642584574
NCI-H522,60700,-0.5552110519793028,1.8594267642584574
NCI-H2009,375860,-0.9754800160336818,1.8594267642584574
OPM-2,44607530,0.8834373674969361,1.8594267642584574
MSTO-211H,2708,3.2234156242084073,1.8594267642584574
OPM-2,15953870,2.653227585048534,1.8594267642584574
DMS 273,11238147,3.12717198165546,1.8594267642584574
OVISE,3062316,1.3579552700407893,1.8594267642584574
NCI-H522,11955716,-2.355417617820864,1.8594267642584574
LXF 289,44486219,3.8558224358877298,1.8594267642584574
NCI-H522,4261,1.255814980012561,1.8594267642584574
SBC-5,11396600,3.6683316442381617,1.8594267642584574
NCI-H727,448949,2.521247711014773,1.8594267642584574
CAL-51,126941,-2.448006630223804,1.8594267642584574
MDA-MB-157,156414,1.5733069512528617,1.8594267642584574
Panc 04.03,selumetinib-BRD-A02303741 (4-1 mol-mol),4.320411537707366,1.8594267642584574
A2780,selumetinib-BRD-A02303741 (4-1 mol-mol),1.4355880611725125,1.8594267642584574
FTC-133,2871966,2.512715884905784,1.8594267642584574
NCI-H460,tanespimycin-gemcitabine (1-1 mol-mol),0.0048174492306964,1.8594267642584574
KYSE-70,168313047,2.1859183661660624,1.8594267642584574
OVISE,serdemetan-SCH-529074 (1-1 mol-mol),2.136633519186749,1.8594267642584574
LoVo,54454,2.7172548619434025,1.8594267642584574
SNU-61,73707398,0.7144154314829279,1.8594267642584574
MSTO-211H,9866186,-1.5986440722967756,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],23582824,0.8636405428481416,1.8594267642584574
BT-549,selumetinib-vorinostat (8-1 mol-mol),4.066811248351909,1.8594267642584574
NCI-H2171,57519531,1.5586354952126105,1.8594267642584574
CAL-51,JQ-1-vorinostat (2-1 mol-mol),1.2952868621484117,1.8594267642584574
NOMO-1,451668,-1.632426084818391,1.8594267642584574
CA46,5282054,2.3254868404716755,1.8594267642584574
MDA-MB-157,54618795,2.0481333451118204,1.8594267642584574
OPM-2,11707110,-2.1571352516283113,1.8594267642584574
CA46,3136844,3.7113001526336338,1.8594267642584574
NCI-H2171,984333,-0.9596445260901963,1.8594267642584574
NCI-H1623,11507802,3.5238050648518136,1.8594267642584574
NCI-H460,46191454,1.6495265120274705,1.8594267642584574
EFO-27,BRD-A02303741-navitoclax (2-1 mol-mol),3.819919815231351,1.8594267642584574
MDA-MB-157,7326481,2.299098205794017,1.8594267642584574
EFO-27,1239801,4.748117996702423,1.8594267642584574
NCI-H460,969516,4.1763077592827225,1.8594267642584574
G-401,44202524,1.447982360696086,1.8594267642584574
A-673,JQ-1-MK-0752 (1-1 mol-mol),1.0252952721702926,1.8594267642584574
NCI-H460,2749,2.5004778765083695,1.8594267642584574
DMS 273,119607,5.531574360726778,1.8594267642584574
FU-OV-1,10074640,3.835416148861087,1.8594267642584574
DMS 273,navitoclax-MST-312 (1-1 mol-mol),0.9055949261710712,1.8594267642584574
MSTO-211H,9911830,2.3480580098381747,1.8594267642584574
SBC-5,135411,0.301348299555382,1.8594267642584574
MDA-MB-453,6610216,3.7821562137745217,1.8594267642584574
SBC-5,2708,2.061546130614232,1.8594267642584574
KYSE-70,11396600,3.829938839575827,1.8594267642584574
OPM-2,vorinostat-navitoclax (4-1 mol-mol),0.1768151572883334,1.8594267642584574
A4/Fukuda,11152667,-2.4230854517211977,1.8594267642584574
SBC-5,36314,-4.885811702708602,1.8594267642584574
DMS 273,9884685,-1.1971048738595964,1.8594267642584574
SNU-61,vorinostat-navitoclax (4-1 mol-mol),2.3944367596721547,1.8594267642584574
NCI-H2009,439501,-2.087429471182781,1.8594267642584574
MDA-MB-157,1716436,1.1718034720311097,1.8594267642584574
ONS-76,216239,1.6729885995968985,1.8594267642584574
NCI-H460,9911830,3.1326305509826824,1.8594267642584574
A-498,2858523,3.0988346297597293,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],51039095,3.29886736232205,1.8594267642584574
OVISE,969516,2.883429877122848,1.8594267642584574
SBC-5,3825829,3.3495967392740953,1.8594267642584574
LOU-NH91,5278396,3.7974378044691495,1.8594267642584574
MSTO-211H,9935249,0.534197831206919,1.8594267642584574
JM-1,9911463,2.675259516581914,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],6184667,3.2761425368749477,1.8594267642584574
SCC-9,60750,4.9910553033212866,1.8594267642584574
SCC-9,387447,-4.584813930042193,1.8594267642584574
SNU-81,25062766,1.4859068805404914,1.8594267642584574
NCI-H661,2708,6.321788786635088,1.8594267642584574
NCI-H460,57519531,1.7606196796007008,1.8594267642584574
KMRC-1,613753,3.207263348750723,1.8594267642584574
KYSE-70,67156097,-2.3379446798215127,1.8594267642584574
OPM-2,10127622,2.4771662101119194,1.8594267642584574
LOU-NH91,5291,3.971687681340124,1.8594267642584574
DMS 273,6918638,-0.6329393875591668,1.8594267642584574
A4/Fukuda,16722836,0.6102638619225811,1.8594267642584574
NCI-H1623,11175137,3.026300100874371,1.8594267642584574
SCC-9,122327,5.629849115039079,1.8594267642584574
CA46,11625818,3.63093624941088,1.8594267642584574
FTC-133,navitoclax-piperlongumine (1-1 mol-mol),0.208088727166438,1.8594267642584574
Panc 04.03,156422,4.828457411788627,1.8594267642584574
DMS 273,5278396,3.2906012116635694,1.8594267642584574
HCC1143,53495165,-2.177337144630303,1.8594267642584574
OPM-2,1641662,3.0681099569104653,1.8594267642584574
A2780,BRD-K27188169-navitoclax (2-1 mol-mol),1.5548908643939203,1.8594267642584574
NCI-H1623,doxorubicin-navitoclax (2-1 mol-mol),-1.3303127155633732,1.8594267642584574
FU-OV-1,navitoclax-MST-312 (1-1 mol-mol),2.560090479517714,1.8594267642584574
A-498,6917907,2.9475757171512575,1.8594267642584574
G-401,10385095,0.8697787767816428,1.8594267642584574
MDA-MB-453,702558,3.1332940697725435,1.8594267642584574
BxPC-3,15547703,0.9056764589340796,1.8594267642584574
A-673,44632017,0.706241354368095,1.8594267642584574
FTC-133,JQ-1-navitoclax (2-1 mol-mol),0.6314108059190333,1.8594267642584574
NCI-H661,11626560,1.806538061239003,1.8594267642584574
SBC-5,9840324,4.760330511699364,1.8594267642584574
NCI-H727,46398810,3.032466795061864,1.8594267642584574
HSC-4,654092,0.2566378579351391,1.8594267642584574
G-401,5978,-3.1887203575088727,1.8594267642584574
A4/Fukuda,11238147,1.0973923844128086,1.8594267642584574
MDA-MB-157,JQ-1-navitoclax (2-1 mol-mol),-0.7190689296194697,1.8594267642584574
NOMO-1,54678924,1.1055951494804663,1.8594267642584574
JM-1,135421197,0.410328587733175,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],5287620,-1.851018785369774,1.8594267642584574
BT-549,216468,4.5222519285579885,1.8594267642584574
NCI-H2009,136227924,2.9896301065010933,1.8594267642584574
SCC-9,2828334,6.128266495621781,1.8594267642584574
LOU-NH91,3025944,4.356407657994756,1.8594267642584574
ONS-76,5329102,2.3644433253395545,1.8594267642584574
DMS 273,53495165,-0.9870251488119351,1.8594267642584574
NCI-H1623,3634881,3.389178636612412,1.8594267642584574
NCI-H1623,446155,4.270765867841268,1.8594267642584574
ONS-76,984333,0.6472143254241693,1.8594267642584574
SBC-5,3081361,3.306292226806483,1.8594267642584574
NCI-H2009,11625818,4.7000574258268255,1.8594267642584574
CA46,24775005,3.732581966598925,1.8594267642584574
SCC-9,11222830,1.8600220042192213,1.8594267642584574
KMRC-1,12003241,-1.418239320082467,1.8594267642584574
SNU-61,613753,3.0121134483838037,1.8594267642584574
NCI-H661,sirolimus-bortezomib (250-1 mol-mol),0.684217370363433,1.8594267642584574
SBC-5,4261,2.0931810634834105,1.8594267642584574
HSC-4,serdemetan-SCH-529074 (1-1 mol-mol),2.5503350460616505,1.8594267642584574
JM-1,445091,4.048660068158945,1.8594267642584574
NCI-H292,44185566,2.325959343920572,1.8594267642584574
SNU-81,6918328,0.0758058419703895,1.8594267642584574
A-498,16659841,6.0591016575330325,1.8594267642584574
NCI-H460,51037431,2.104101453867928,1.8594267642584574
MSTO-211H,5978,-2.861470631068365,1.8594267642584574
SBC-5,6918736,-1.7962623830849138,1.8594267642584574
NCI-H2171,11178236,-6.134942659978268,1.8594267642584574
ONS-76,11427553,2.8550216000544695,1.8594267642584574
JM-1,11234052,3.3092904099829115,1.8594267642584574
NCI-H661,ISOX-bortezomib (250-1 mol-mol),0.8750807194042233,1.8594267642584574
MDA-MB-453,11719255,3.0016884563631057,1.8594267642584574
HSC-4,241158,3.797905223062241,1.8594267642584574
SNU-61,49766530,-2.178873950286192,1.8594267642584574
ONS-76,54454,1.5364254879481318,1.8594267642584574
NCI-H2009,54618164,4.160237516111787,1.8594267642584574
CAL-51,3136844,4.799885860604426,1.8594267642584574
DMS 273,selumetinib-JQ-1 (4-1 mol-mol),2.4189081702185096,1.8594267642584574
SCC-9,46926350,-4.135183666473923,1.8594267642584574
YAPC,5460769,2.316930709954587,1.8594267642584574
YAPC,135411,0.9254838530178896,1.8594267642584574
A-673,11228183,1.918128583172148,1.8594267642584574
MSTO-211H,24856436,-1.8779899697418416,1.8594267642584574
LXF 289,44185566,2.4809324153017265,1.8594267642584574
OVISE,654092,-1.3076939787912127,1.8594267642584574
A2780,6918328,-1.1386748973241003,1.8594267642584574
FU-OV-1,44819697,-2.23904448126328,1.8594267642584574
BT-549,42642645,1.6219324424635808,1.8594267642584574
JM-1,216345,2.231105973795255,1.8594267642584574
G-401,73707398,0.5507155331982622,1.8594267642584574
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793,1.8594267642584574
KMRC-1,16722836,1.9243244677044424,1.8594267642584574
NCI-H1623,135875424,3.67415188779786,1.8594267642584574
NCI-H2009,638278,3.464543124143687,1.8594267642584574
NCI-H727,168313047,2.9561297907786717,1.8594267642584574
SNU-81,439501,-1.707157001292212,1.8594267642584574
MDA-MB-157,11234052,1.0821323764870938,1.8594267642584574
NCI-H727,11364421,1.2179988120980565,1.8594267642584574
BxPC-3,2729026,2.140647578797141,1.8594267642584574
NCI-H292,46224516,2.488403107417036,1.8594267642584574
MSTO-211H,5746,0.1838030897357816,1.8594267642584574
NCI-H727,5280436,4.172163827724594,1.8594267642584574
NCI-H727,9911463,4.409308573364914,1.8594267642584574
LOU-NH91,9907093,4.908801109640004,1.8594267642584574
HSC-4,24772860,-3.179601965562413,1.8594267642584574
MDA-MB-453,10302451,3.3014196832790628,1.8594267642584574
A-673,2945648,0.1856393110329161,1.8594267642584574
G-401,56946209,-5.714614119541748,1.8594267642584574
MSTO-211H,452548,-2.0931551112296742,1.8594267642584574
NCI-H2009,5280436,3.59103147994178,1.8594267642584574
CAL-51,241158,3.781489879449518,1.8594267642584574
FU-OV-1,24772860,-2.86759244210788,1.8594267642584574
DMS 273,54596558,4.317274835352231,1.8594267642584574
DMS 273,71466380,4.5698020131067745,1.8594267642584574
ONS-76,11175137,2.2807611594224975,1.8594267642584574
NCI-H522,136227331,5.948504593030567,1.8594267642584574
KYSE-70,262093,3.701785722517592,1.8594267642584574
KMRC-1,119607,5.885636542486439,1.8594267642584574
CA46,16722836,1.2778374610309875,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],6918878,1.3044693080210874,1.8594267642584574
SNU-61,24772860,-2.9174361907600592,1.8594267642584574
LoVo,322968,3.2361743048313536,1.8594267642584574
NCI-H460,168313047,3.736921155938788,1.8594267642584574
LOU-NH91,123631,3.064358892537756,1.8594267642584574
NCI-H146,10410894,2.10877812565835,1.8594267642584574
OPM-2,107985,-4.911691484457119,1.8594267642584574
HSC-4,4917,3.66079963002401,1.8594267642584574
SBC-5,72376,-1.1693945126287038,1.8594267642584574
KYSE-70,11238147,3.36128873589197,1.8594267642584574
CA46,9935249,0.2545497442771542,1.8594267642584574
SCC-9,135421197,2.7056920215811293,1.8594267642584574
FU-OV-1,123631,2.446979601054181,1.8594267642584574
MSTO-211H,12001922,2.4775669078904397,1.8594267642584574
NCI-H661,3543504,4.269759852401949,1.8594267642584574
FU-OV-1,53495165,2.0201630022514263,1.8594267642584574
NCI-H2009,448949,2.535639173937985,1.8594267642584574
EFO-27,285033,-1.172211692399995,1.8594267642584574
YAPC,5978,3.3733616775717716,1.8594267642584574
BT-549,9911463,4.268645247281358,1.8594267642584574
NCI-H522,2113511,5.298827483301359,1.8594267642584574
SNU-61,1242560,3.7603648536411622,1.8594267642584574
A2780,3503,2.123197367997407,1.8594267642584574
JM-1,262093,0.3077511100871351,1.8594267642584574
DMS 273,11612883,3.047294051558191,1.8594267642584574
A-673,156414,1.4246196000990916,1.8594267642584574
HSC-4,JQ-1-UNC0638 (2-1 mol-mol),5.303785757115223,1.8594267642584574
SNU-81,3385,3.194341332216005,1.8594267642584574
SNU-449,44486219,4.185988120780244,1.8594267642584574
SCC-9,25262965,-0.8228501050995407,1.8594267642584574
NCI-H146,9967941,1.5373910611842192,1.8594267642584574
HCC1143,969516,2.4763079586135546,1.8594267642584574
ONS-76,12003241,-1.3579895274230906,1.8594267642584574
SNU-61,selumetinib-tretinoin (2-1 mol-mol),0.2011452068154318,1.8594267642584574
OPM-2,26596,-3.75281027154887,1.8594267642584574
KMRC-1,11955716,1.3700469468180672,1.8594267642584574
ONS-76,445091,4.207927105180806,1.8594267642584574
CAL-51,ISOX-bortezomib (250-1 mol-mol),1.1183162335023276,1.8594267642584574
NCI-H460,selumetinib-decitabine (4-1 mol-mol),7.324082171117594,1.8594267642584574
JM-1,11964036,0.6346833811859819,1.8594267642584574
MDA-MB-453,24180719,3.640576555720147,1.8594267642584574
NCI-H146,3689413,0.5626872136369616,1.8594267642584574
A-673,5335621,4.03269099593382,1.8594267642584574
FTC-133,44491742,4.538470926749077,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],44607531,1.8642852142992712,1.8594267642584574
LXF 289,23725625,4.938564251049365,1.8594267642584574
OPM-2,11612883,1.2708799210561326,1.8594267642584574
CA46,11485656,1.2289823963881294,1.8594267642584574
SNU-61,227681,2.9666568152307993,1.8594267642584574
NOMO-1,135421197,1.2386186938920458,1.8594267642584574
NCI-H1623,vorinostat-carboplatin (1-1 mol-mol),3.549282836614641,1.8594267642584574
BxPC-3,135421197,1.4419000032460958,1.8594267642584574
CAL-51,66577038,4.134711160885491,1.8594267642584574
BxPC-3,11485656,2.0481416814216375,1.8594267642584574
LOU-NH91,3689413,0.742189593443008,1.8594267642584574
OVISE,crizotinib-PLX-4032 (2-1 mol-mol),2.5474980530955844,1.8594267642584574
JM-1,49766530,-3.0151701370453794,1.8594267642584574
NOMO-1,15983966,-5.011559396504552,1.8594267642584574
HSC-4,24856436,1.7831446753384608,1.8594267642584574
OPM-2,387447,-6.258797979541162,1.8594267642584574
A-673,54765302,3.022220101838166,1.8594267642584574
A-673,5479543,3.2499245267113928,1.8594267642584574
SBC-5,docetaxel-tanespimycin (2-1 mol-mol),-4.858337371172803,1.8594267642584574
A2780,441298,1.2276441630256645,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],4259181,1.1322876173551923,1.8594267642584574
HSC-4,65064,5.180183799352401,1.8594267642584574
OPM-2,3384730,1.6721258053175836,1.8594267642584574
NCI-H522,387447,-5.403881314975521,1.8594267642584574
MDA-MB-157,11640390,1.4666591993417384,1.8594267642584574
CA46,9911463,2.565133854881976,1.8594267642584574
FTC-133,227681,2.0408407851095416,1.8594267642584574
JM-1,285033,-4.464347137363986,1.8594267642584574
KYSE-70,16736978,1.1213704825993671,1.8594267642584574
MSTO-211H,2729026,1.9618514095460544,1.8594267642584574
NCI-H661,24180719,3.917772031076744,1.8594267642584574
NCI-H1623,400769,-1.0076663191396935,1.8594267642584574
YAPC,9840324,5.782457936566159,1.8594267642584574
Panc 04.03,57330099,4.388225142481581,1.8594267642584574
G-401,135659046,3.5574575455214608,1.8594267642584574
A4/Fukuda,148198,-4.99238512913244,1.8594267642584574
CA46,126941,-4.174426911659592,1.8594267642584574
SCC-9,6610355,5.330005746360321,1.8594267642584574
KYSE-70,44185566,2.2395157674699875,1.8594267642584574
NCI-H1623,462382,1.1150663609789129,1.8594267642584574
CAL-51,6914657,-5.067352950634086,1.8594267642584574
A-673,selumetinib-BRD-A02303741 (4-1 mol-mol),7.378712483637354,1.8594267642584574
EFO-27,54618164,4.628305371415217,1.8594267642584574
JM-1,23582824,0.2805180690676545,1.8594267642584574
NCI-H460,44185566,3.2105564381381035,1.8594267642584574
CA46,52912189,-0.9978651387823436,1.8594267642584574
NCI-H2009,9935249,4.414461781647313,1.8594267642584574
NCI-H2009,135928012,4.098076343567735,1.8594267642584574
CAL-51,60750,-3.4379358682898973,1.8594267642584574
MSTO-211H,8515,1.6806311840995682,1.8594267642584574
ONS-76,15983966,-3.1712265481751243,1.8594267642584574
NOMO-1,56946209,-4.862706213909506,1.8594267642584574
NOMO-1,24772860,-3.4546209155075687,1.8594267642584574
FU-OV-1,44185566,3.182046500186311,1.8594267642584574
NCI-H2171,11977753,0.3036523614034643,1.8594267642584574
FTC-133,31703,-0.768913830642622,1.8594267642584574
EFO-27,984333,0.9554706085777084,1.8594267642584574
NCI-H292,5329102,1.7855476735914897,1.8594267642584574
CA46,409805,3.3808362620175187,1.8594267642584574
MSTO-211H,25183872,0.3972499543283658,1.8594267642584574
LOU-NH91,24180719,4.451607655435679,1.8594267642584574
A2780,44185566,1.1999498835751436,1.8594267642584574
JM-1,piperlongumine-MST-312 (1-1 mol-mol),0.8602384647056689,1.8594267642584574
NCI-H2171,6505803,-0.0596794204500112,1.8594267642584574
CA46,66577038,2.896384523521911,1.8594267642584574
NCI-H2009,navitoclax-PLX-4032 (1-1 mol-mol),4.434532653738059,1.8594267642584574
CA46,12003241,-2.799565618947511,1.8594267642584574
NCI-H661,10427712,3.832896992750264,1.8594267642584574
SNU-449,107970,2.557902386411369,1.8594267642584574
Panc 04.03,2874250,5.078270927101478,1.8594267642584574
NCI-H292,54626689,4.661071465435288,1.8594267642584574
NCI-H460,23725625,5.666756485817308,1.8594267642584574
CAL-51,53232,2.8018516258833395,1.8594267642584574
FTC-133,decitabine-navitoclax (2-1 mol-mol),1.1951853583551142,1.8594267642584574
EFO-27,53495165,0.9078503906950024,1.8594267642584574
SNU-81,65064,4.179756271690876,1.8594267642584574
BT-549,3689413,-0.9397914335397376,1.8594267642584574
NCI-H2009,66577038,3.427367822074961,1.8594267642584574
LOU-NH91,10302451,4.426232341068122,1.8594267642584574
CAL-51,168313047,1.9592520089902103,1.8594267642584574
NCI-H292,135411,0.5538002090667975,1.8594267642584574
LXF 289,2874250,5.409057432200043,1.8594267642584574
EFO-27,4261,1.4655103146060633,1.8594267642584574
ONS-76,25150857,2.480326692853007,1.8594267642584574
G-401,11175137,1.9335599830838224,1.8594267642584574
OPM-2,5460769,4.223891374112808,1.8594267642584574
NOMO-1,10385095,1.0593467546243338,1.8594267642584574
LOU-NH91,2126,5.273491801207327,1.8594267642584574
MDA-MB-453,11625818,5.002273286989784,1.8594267642584574
OPM-2,44632017,0.7121474472673729,1.8594267642584574
LoVo,135411,-0.4629764704945864,1.8594267642584574
EFO-27,16722836,2.503686118945589,1.8594267642584574
LOU-NH91,10074640,3.3386477352477715,1.8594267642584574
DMS 273,11719255,4.586791904076426,1.8594267642584574
OPM-2,136227924,1.7425170628423947,1.8594267642584574
YAPC,vorinostat-navitoclax (4-1 mol-mol),1.7986594173334518,1.8594267642584574
KMRC-1,vorinostat-carboplatin (1-1 mol-mol),4.1908249815251075,1.8594267642584574
NCI-H522,2828334,6.021027928266713,1.8594267642584574
KYSE-70,72193861,1.5917149982909504,1.8594267642584574
MSTO-211H,9911463,2.6842905920893108,1.8594267642584574
MDA-MB-453,969516,2.9001694226946153,1.8594267642584574
CAL-51,44632017,0.9975947899898204,1.8594267642584574
LXF 289,10231331,2.4249622135671824,1.8594267642584574
A2780,25195348,2.1109786238814943,1.8594267642584574
NCI-H2171,44202524,1.9759332673432517,1.8594267642584574
Panc 04.03,1641662,4.251343925322988,1.8594267642584574
NCI-H292,54686904,5.52345614596139,1.8594267642584574
DMS 273,7251185,2.13119393000196,1.8594267642584574
LoVo,9956119,3.291456775833892,1.8594267642584574
BxPC-3,11404337,-0.6361724208993981,1.8594267642584574
NCI-H2009,119182,-1.1305543955582442,1.8594267642584574
BxPC-3,selumetinib-JQ-1 (4-1 mol-mol),-2.4444526852208206,1.8594267642584574
NCI-H2009,5278396,3.446569775137936,1.8594267642584574
SNU-61,327653,2.3439595497702985,1.8594267642584574
Panc 04.03,11238147,2.6863632300229936,1.8594267642584574
LOU-NH91,9926054,3.1176474597994908,1.8594267642584574
NCI-H727,5566,3.3170373665309416,1.8594267642584574
SBC-5,25150857,3.1636616713903893,1.8594267642584574
A4/Fukuda,11719255,2.014724282446697,1.8594267642584574
NCI-H460,374536,2.933441634270558,1.8594267642584574
Panc 04.03,135875424,4.739147054003967,1.8594267642584574
NCI-H522,9825149,2.538976142931882,1.8594267642584574
NCI-H522,11964036,1.1738559849313974,1.8594267642584574
NCI-H727,docetaxel-tanespimycin (2-1 mol-mol),-0.2306371483754844,1.8594267642584574
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434,1.8594267642584574
SCC-9,5566,3.224791432055543,1.8594267642584574
NCI-H460,9936388,2.3098343611543415,1.8594267642584574
A-673,salermide-PLX-4032 (12-1 mol-mol),5.197476716146756,1.8594267642584574
NCI-H460,16720766,0.8258921674033131,1.8594267642584574
FTC-133,54618164,4.149608396421597,1.8594267642584574
NCI-H727,5281321,2.7498034475542803,1.8594267642584574
BT-549,31703,-0.610163723442028,1.8594267642584574
JM-1,11609586,0.7887510712984062,1.8594267642584574
MSTO-211H,65628,3.7458295220001,1.8594267642584574
NCI-H661,9887053,5.171148908960024,1.8594267642584574
LXF 289,vorinostat-carboplatin (1-1 mol-mol),3.3134202255532053,1.8594267642584574
G-401,9887053,1.7608751069117703,1.8594267642584574
HSC-4,ISOX-bortezomib (250-1 mol-mol),1.0749923378755126,1.8594267642584574
A-673,7251185,1.3487938120123666,1.8594267642584574
ONS-76,4259181,0.68334491499701,1.8594267642584574
NCI-H292,613753,2.7114183475644857,1.8594267642584574
CA46,tretinoin-navitoclax (4-1 mol-mol),4.197829514755647,1.8594267642584574
JM-1,25126798,3.029145333632086,1.8594267642584574
CAL-51,3815108,3.0623029951861396,1.8594267642584574
SCC-9,16725315,5.212889946477865,1.8594267642584574
NCI-H661,alisertib-navitoclax (2-1 mol-mol),3.068945671773435,1.8594267642584574
NCI-H522,serdemetan-SCH-529074 (1-1 mol-mol),2.019053107898385,1.8594267642584574
LoVo,16722836,0.1488668556579147,1.8594267642584574
A4/Fukuda,25262965,-4.823082336145625,1.8594267642584574
OPM-2,53392493,1.6243275023991692,1.8594267642584574
HSC-4,9926054,2.0278633205902468,1.8594267642584574
SNU-81,9936388,-6.314751034125396,1.8594267642584574
G-401,9823820,1.4384887897470693,1.8594267642584574
YAPC,24753719,5.0641073859888,1.8594267642584574
OPM-2,24772860,-2.8738620885527153,1.8594267642584574
MDA-MB-157,10427712,3.542893078297904,1.8594267642584574
A-498,4259181,1.547873530266754,1.8594267642584574
LXF 289,tanespimycin-bortezomib (250-1 mol-mol),-1.4479595903244196,1.8594267642584574
SBC-5,9927531,4.452264212548339,1.8594267642584574
LXF 289,119607,4.549732560104057,1.8594267642584574
MDA-MB-453,piperlongumine-MST-312 (1-1 mol-mol),1.140334319354309,1.8594267642584574
NCI-H2009,11396600,4.054693544346837,1.8594267642584574
SNU-81,15983966,-3.5187473914136738,1.8594267642584574
Panc 04.03,11494412,3.764008563191269,1.8594267642584574
OPM-2,216345,2.3930113976289364,1.8594267642584574
JM-1,66577038,2.266129645862272,1.8594267642584574
SNU-449,15953870,3.8419288275174326,1.8594267642584574
BT-549,9903786,2.513972936103366,1.8594267642584574
OPM-2,44202524,1.1830318509158162,1.8594267642584574
OVISE,6623618,2.0550481440983153,1.8594267642584574
SNU-449,11657048,5.413893492178721,1.8594267642584574
NCI-H2171,67291369,-0.2342814323553679,1.8594267642584574
MDA-MB-453,UNC0638-navitoclax (1-1 mol-mol),2.401691334113767,1.8594267642584574
NCI-H522,11238147,3.4337502548923404,1.8594267642584574
MDA-MB-453,16065773,1.7584918793826552,1.8594267642584574
LoVo,136227924,4.6796674015936075,1.8594267642584574
LXF 289,3854666,2.0847029854583377,1.8594267642584574
OVISE,984333,-1.5189255907846522,1.8594267642584574
A2780,159324,-2.166969557176003,1.8594267642584574
SCC-9,17755052,1.3521912896367647,1.8594267642584574
OPM-2,9823820,1.0965123517529505,1.8594267642584574
DMS 273,12001922,1.9670879212293255,1.8594267642584574
KMRC-1,24180719,3.956198558970242,1.8594267642584574
KMRC-1,637858,3.0556928718558707,1.8594267642584574
NCI-H2009,6917907,-5.363195379340594,1.8594267642584574
SBC-5,24748573,1.8248605513332548,1.8594267642584574
CAL-51,452548,-0.9080095532304931,1.8594267642584574
BT-549,2858523,3.192172893232417,1.8594267642584574
KMRC-1,219104,4.439460794922528,1.8594267642584574
LXF 289,2858523,3.038787864461457,1.8594267642584574
NCI-H1623,9907093,3.838952634819664,1.8594267642584574
NCI-H460,168313047,3.736921155938788,1.8594267642584574
JM-1,5287969,-2.2665073107333997,1.8594267642584574
NCI-H1623,2828334,5.745033734102683,1.8594267642584574
NCI-H522,53232,3.4340993190045763,1.8594267642584574
MDA-MB-157,24180719,1.846017762198611,1.8594267642584574
NCI-H727,2858523,2.9690043699309094,1.8594267642584574
HSC-4,3384730,1.6775009570022803,1.8594267642584574
MDA-MB-453,66577038,2.2210808109899687,1.8594267642584574
CA46,54619267,3.4754479185856604,1.8594267642584574
BxPC-3,selumetinib-decitabine (4-1 mol-mol),1.0861669276123684,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],3136844,4.175493618298147,1.8594267642584574
DMS 273,89183176,4.012998903778193,1.8594267642584574
LXF 289,89183176,5.264029999533809,1.8594267642584574
HCC1143,25154868,3.6479876335061863,1.8594267642584574
NCI-H460,5566,3.3663694984335533,1.8594267642584574
EFO-27,3384730,3.632582575012134,1.8594267642584574
YAPC,3854666,3.60977300269674,1.8594267642584574
CAL-51,11960529,3.662834723962616,1.8594267642584574
NCI-H522,4096211,1.7167000910654833,1.8594267642584574
LXF 289,46199207,3.0446562724495676,1.8594267642584574
MSTO-211H,44507138,3.561974329612715,1.8594267642584574
BxPC-3,10127622,0.1850831315580212,1.8594267642584574
SNU-81,57519531,3.6375637578947098,1.8594267642584574
NCI-H522,46926350,-4.757002390021422,1.8594267642584574
LXF 289,675434,4.434927450149955,1.8594267642584574
SBC-5,2858523,3.0625939376722147,1.8594267642584574
YAPC,3025986,-1.0818355674515514,1.8594267642584574
G-401,753704,3.840031862409327,1.8594267642584574
NCI-H2171,9933475,1.8341202855706125,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],24821094,4.372062930620609,1.8594267642584574
BT-549,5746,2.744550621458616,1.8594267642584574
MSTO-211H,2733487,6.00734552009151,1.8594267642584574
LoVo,9908783,4.437010992006648,1.8594267642584574
NCI-H2009,46398810,2.5614683956162554,1.8594267642584574
NCI-H292,15983966,2.054572304908195,1.8594267642584574
G-401,46943432,1.6295589064479152,1.8594267642584574
LXF 289,54618771,-0.5375230222620658,1.8594267642584574
NCI-H2009,4261,0.1994590765469732,1.8594267642584574
NCI-H292,119182,-1.3574963176080912,1.8594267642584574
LoVo,675434,4.114717976727459,1.8594267642584574
CAL-51,613753,3.3238399640193177,1.8594267642584574
OVISE,tanespimycin-gemcitabine (1-1 mol-mol),2.9974689860461785,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],9967941,4.297033846683125,1.8594267642584574
MDA-MB-157,7251185,1.2275966709755557,1.8594267642584574
LOU-NH91,168313047,3.5347026371928565,1.8594267642584574
Panc 04.03,11175137,3.811547013287204,1.8594267642584574
YAPC,46191454,1.528991916080322,1.8594267642584574
Panc 04.03,246676,4.5210437514033615,1.8594267642584574
LOU-NH91,107985,-2.204555775629559,1.8594267642584574
JM-1,9884685,0.5602575931973728,1.8594267642584574
KYSE-70,26596,-1.4453873864890578,1.8594267642584574
SBC-5,11238147,3.923057921789592,1.8594267642584574
CAL-51,5351362,1.1872361858703535,1.8594267642584574
CAL-51,148198,-3.728190383000159,1.8594267642584574
MSTO-211H,10074640,2.8901374693183848,1.8594267642584574
CA46,navitoclax-gemcitabine (1-1 mol-mol),-1.1536671772218576,1.8594267642584574
Panc 04.03,54618305,4.994656380487723,1.8594267642584574
HSC-4,9444,4.231424733159592,1.8594267642584574
ONS-76,136227924,2.542073211711186,1.8594267642584574
CA46,navitoclax-MST-312 (1-1 mol-mol),1.8648125815203176,1.8594267642584574
NCI-H2171,JQ-1-UNC0638 (2-1 mol-mol),0.4857053438992066,1.8594267642584574
A-498,4705,4.1964696083385595,1.8594267642584574
NCI-H292,4788,6.000922818610643,1.8594267642584574
A4/Fukuda,selumetinib-vorinostat (8-1 mol-mol),0.52731023294293,1.8594267642584574
A4/Fukuda,168312962,0.589698091471745,1.8594267642584574
MSTO-211H,135421197,0.8053711662366769,1.8594267642584574
G-401,9826308,0.736562536874994,1.8594267642584574
JM-1,44202524,1.2333959484520816,1.8594267642584574
SNU-449,135984461,4.468051833024593,1.8594267642584574
LOU-NH91,UNC0638-navitoclax (1-1 mol-mol),-2.1290518505040854,1.8594267642584574
HSC-4,135999136,1.7584955345229645,1.8594267642584574
HCC1143,6918328,-0.4969866258783406,1.8594267642584574
A4/Fukuda,2871966,-1.2628046939905593,1.8594267642584574
HSC-4,89928392,1.9678897287961257,1.8594267642584574
CA46,7251185,0.9564015595877396,1.8594267642584574
A4/Fukuda,serdemetan-SCH-529074 (1-1 mol-mol),0.8122212024039632,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],5280436,3.538296903160907,1.8594267642584574
LOU-NH91,navitoclax-pluripotin (1-1 mol-mol),-2.6950691306043297,1.8594267642584574
YAPC,9967941,3.379913520192136,1.8594267642584574
Panc 04.03,119607,5.706581209982884,1.8594267642584574
KMRC-1,46926350,-4.153095302049271,1.8594267642584574
OPM-2,JQ-1-MK-0752 (1-1 mol-mol),-1.5972514317296775,1.8594267642584574
OVISE,5287620,-0.8119274098935182,1.8594267642584574
NOMO-1,135440466,1.6123042261647436,1.8594267642584574
A-673,11507802,0.3878845266361032,1.8594267642584574
G-401,tanespimycin-gemcitabine (1-1 mol-mol),-2.3448363007854325,1.8594267642584574
NCI-H2009,3854666,0.912328636385412,1.8594267642584574
SNU-81,2749,0.983670801340458,1.8594267642584574
A4/Fukuda,25105715,3.290295740743095,1.8594267642584574
OVISE,erlotinib-PLX-4032 (2-1 mol-mol),3.714460286615586,1.8594267642584574
ONS-76,salermide-PLX-4032 (12-1 mol-mol),5.250502452848782,1.8594267642584574
CAL-51,9903786,2.1849161121493847,1.8594267642584574
LXF 289,5113032,5.558232749512156,1.8594267642584574
NCI-H522,46224516,2.9506377913569244,1.8594267642584574
FU-OV-1,56649450,4.970206677695459,1.8594267642584574
CA46,erlotinib-PLX-4032 (2-1 mol-mol),3.1947109713205033,1.8594267642584574
MSTO-211H,9887053,4.1066593545259975,1.8594267642584574
CA46,6610355,3.575030613446337,1.8594267642584574
NCI-H522,445643,3.9693726836499863,1.8594267642584574
A-673,46224516,0.8314688808424526,1.8594267642584574
NCI-H661,6918736,-3.5059805921507823,1.8594267642584574
NCI-H522,selumetinib-PLX-4032 (8-1 mol-mol),4.633194208623746,1.8594267642584574
A-673,3825829,3.830298825271896,1.8594267642584574
ONS-76,11396600,3.887590392789339,1.8594267642584574
LXF 289,5282054,3.512278681739004,1.8594267642584574
A-673,54618771,0.7910545462175201,1.8594267642584574
KMRC-1,25062766,1.7411663615582824,1.8594267642584574
EFO-27,71751553,4.378478985868248,1.8594267642584574
EFO-27,10074640,3.872803440374816,1.8594267642584574
ONS-76,24964624,2.710261416606334,1.8594267642584574
LOU-NH91,53392493,2.3846272258457737,1.8594267642584574
CAL-51,46199207,3.548155956826357,1.8594267642584574
DMS 273,227681,4.814934070367145,1.8594267642584574
HSC-4,9908783,6.127900398037499,1.8594267642584574
HSC-4,10184653,-0.7296444895073179,1.8594267642584574
NCI-H292,selumetinib-vorinostat (8-1 mol-mol),2.7823927532205546,1.8594267642584574
NCI-H1623,44185566,3.0587688781610667,1.8594267642584574
KYSE-70,6918328,0.2213620303324437,1.8594267642584574
MDA-MB-453,327653,2.9444810987281533,1.8594267642584574
FTC-133,4259181,2.1331002918337925,1.8594267642584574
NCI-H292,60750,-3.187051343712646,1.8594267642584574
KYSE-70,60700,2.818490002790748,1.8594267642584574
MDA-MB-453,24821094,0.7464785951288041,1.8594267642584574
NCI-H2009,656346,1.3969032628362248,1.8594267642584574
SNU-61,24964624,2.494415785344137,1.8594267642584574
NCI-H661,4261,1.9569329914003135,1.8594267642584574
SNU-449,54618305,4.668068655096509,1.8594267642584574
LoVo,135875424,3.182508442374063,1.8594267642584574
LoVo,6623618,1.7195113979524326,1.8594267642584574
A-498,135398516,3.177268179593805,1.8594267642584574
BxPC-3,26596,-1.629746525957504,1.8594267642584574
NCI-H460,2749,2.5004778765083695,1.8594267642584574
KMRC-1,46398810,3.012918063271682,1.8594267642584574
NCI-H522,5291,3.860595721411624,1.8594267642584574
SNU-449,36462,4.301758862194218,1.8594267642584574
SNU-449,6918837,-1.494845192804234,1.8594267642584574
CA46,11955716,-2.7152267118714204,1.8594267642584574
NCI-H1623,168313200,4.911870039242249,1.8594267642584574
NCI-H2171,10427712,3.6918148562663937,1.8594267642584574
NCI-H522,262093,3.0660845932794656,1.8594267642584574
BT-549,168312962,3.315695506914068,1.8594267642584574
MDA-MB-157,15953870,0.7968689532543627,1.8594267642584574
BxPC-3,carboplatin-etoposide (40-17 mol-mol),4.727119373262846,1.8594267642584574
SNU-61,11364421,-2.983927558247801,1.8594267642584574
SNU-61,3101542,4.3555934573063695,1.8594267642584574
NCI-H460,52947716,-4.997624319891589,1.8594267642584574
CAL-51,44543605,3.919885801001582,1.8594267642584574
NCI-H292,12003241,-1.027467238096921,1.8594267642584574
OVISE,sirolimus-bortezomib (250-1 mol-mol),0.3208269840941957,1.8594267642584574
Panc 04.03,navitoclax-sorafenib (1-1 mol-mol),3.337045495454646,1.8594267642584574
NCI-H292,25154868,5.001413217408079,1.8594267642584574
NCI-H292,36462,2.4286801987130486,1.8594267642584574
HSC-4,navitoclax-gemcitabine (1-1 mol-mol),-4.75214371637746,1.8594267642584574
NCI-H292,159324,3.210621191245253,1.8594267642584574
SNU-81,24978538,1.1236702452048486,1.8594267642584574
A2780,9929138,3.988043631552867,1.8594267642584574
HSC-4,16065773,3.311693132411482,1.8594267642584574
A4/Fukuda,400769,-1.555916482707746,1.8594267642584574
A2780,11977753,-3.718954593203518,1.8594267642584574
FU-OV-1,60700,0.8482129777629449,1.8594267642584574
DMS 273,168312962,2.633531304827929,1.8594267642584574
SCC-9,8515,4.77911141452934,1.8594267642584574
A2780,71680916,3.658218554445846,1.8594267642584574
FU-OV-1,5328940,2.1307155577669143,1.8594267642584574
NCI-H661,42642645,1.2812432760018797,1.8594267642584574
A4/Fukuda,2113511,3.845432548996496,1.8594267642584574
SBC-5,19582717,5.27972019168548,1.8594267642584574
HSC-4,11222830,1.068056053085511,1.8594267642584574
CAL-51,10427712,4.2973287072996085,1.8594267642584574
A4/Fukuda,44185566,1.3030950937163224,1.8594267642584574
ONS-76,5278396,3.742938248744769,1.8594267642584574
MDA-MB-453,46943432,1.9398007817238585,1.8594267642584574
NCI-H727,984333,1.9308701128060968,1.8594267642584574
MDA-MB-157,24889392,2.1225906954298535,1.8594267642584574
FU-OV-1,ISOX-bortezomib (250-1 mol-mol),0.954548859556388,1.8594267642584574
A4/Fukuda,46843906,1.071626560517578,1.8594267642584574
CAL-51,selumetinib-MK-2206 (8-1 mol-mol),3.019475754284589,1.8594267642584574
HCC1143,44241473,5.874360916813842,1.8594267642584574
NCI-H460,vorinostat-navitoclax (4-1 mol-mol),2.672492910118056,1.8594267642584574
EFO-27,6918878,4.955152670116511,1.8594267642584574
CAL-51,5281672,3.9430830045045857,1.8594267642584574
NCI-H146,9915743,-0.2957101551438801,1.8594267642584574
G-401,89928392,0.7343580800154272,1.8594267642584574
SCC-9,navitoclax-piperlongumine (1-1 mol-mol),2.9839395541067515,1.8594267642584574
EFO-27,6184667,5.467001643500489,1.8594267642584574
NCI-H727,3854666,3.6466691501950512,1.8594267642584574
LOU-NH91,9825149,6.244850491409518,1.8594267642584574
NCI-H146,11178236,-6.140205122942071,1.8594267642584574
HCC1143,navitoclax-birinapant (1-1 mol-mol),-1.1255303234100646,1.8594267642584574
ONS-76,448949,2.486443038536461,1.8594267642584574
BT-549,57330099,4.335540938726609,1.8594267642584574
CAL-51,44819697,-1.9765663783606575,1.8594267642584574
SNU-449,5278396,3.499051739077657,1.8594267642584574
LXF 289,9956119,3.057634534881657,1.8594267642584574
A-498,9933475,2.3013420942123655,1.8594267642584574
DMS 273,10074640,2.948045052381196,1.8594267642584574
LOU-NH91,25102847,2.3579155704363206,1.8594267642584574
G-401,5311281,1.6046025374895514,1.8594267642584574
A-673,219104,2.2996165619151507,1.8594267642584574
FU-OV-1,42642645,1.0692746742635495,1.8594267642584574
NCI-H460,135411,0.3374737909082799,1.8594267642584574
CAL-51,6252,-0.2076922850947726,1.8594267642584574
NCI-H1623,selumetinib-JQ-1 (4-1 mol-mol),2.0981342871867903,1.8594267642584574
LXF 289,10296883,3.609856485747645,1.8594267642584574
KMRC-1,54626689,4.972873475873264,1.8594267642584574
A-673,JQ-1-UNC0638 (2-1 mol-mol),0.3202130450215845,1.8594267642584574
HCC1143,1750826,-1.2654463091368686,1.8594267642584574
SNU-449,24785538,2.8069089427026346,1.8594267642584574
LOU-NH91,53495165,1.612116489462364,1.8594267642584574
EFO-27,11609586,3.640431752283184,1.8594267642584574
LoVo,tanespimycin-gemcitabine (1-1 mol-mol),0.1756680673297083,1.8594267642584574
Panc 04.03,104842,-1.0125052126256155,1.8594267642584574
NCI-H522,6610355,5.34603712705315,1.8594267642584574
NCI-H661,11656518,2.215339329496845,1.8594267642584574
NCI-H661,6505803,-0.5859050253944337,1.8594267642584574
NCI-H292,5351362,1.0382380370911135,1.8594267642584574
EFO-27,11612883,3.4595212211892377,1.8594267642584574
FU-OV-1,vorinostat-carboplatin (1-1 mol-mol),2.1636839207385914,1.8594267642584574
HSC-4,10302451,2.384078053411002,1.8594267642584574
NCI-H292,46199207,3.366381535989616,1.8594267642584574
LoVo,262093,2.370412929490009,1.8594267642584574
BxPC-3,445643,4.432772060189362,1.8594267642584574
A-673,carboplatin-UNC0638 (2-1 mol-mol),1.4546927004142935,1.8594267642584574
A4/Fukuda,46224516,1.3171235816864948,1.8594267642584574
JM-1,3854666,0.4999957819555636,1.8594267642584574
NCI-H292,124202324,2.857386903129287,1.8594267642584574
BT-549,1566236,1.7296376770428397,1.8594267642584574
LXF 289,11364421,-2.6687395721676577,1.8594267642584574
NCI-H146,navitoclax-sorafenib (1-1 mol-mol),-1.8992247000680913,1.8594267642584574
FTC-133,148198,-1.6568063805549866,1.8594267642584574
LXF 289,11640390,5.398484732926136,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],24951314,1.1143156240073944,1.8594267642584574
LXF 289,2749,2.818144236178911,1.8594267642584574
NOMO-1,decitabine-carboplatin (1-1 mol-mol),1.4040518072476522,1.8594267642584574
JM-1,135875424,2.019666731209586,1.8594267642584574
SCC-9,4705,2.492131143046821,1.8594267642584574
NCI-H2171,151289,1.4157771037164255,1.8594267642584574
NCI-H522,644241,2.1349742590503427,1.8594267642584574
A-673,445643,4.040507929851862,1.8594267642584574
JM-1,6252,-5.0324479776154885,1.8594267642584574
NCI-H292,208908,4.322795663590344,1.8594267642584574
A-498,2871966,1.0686849145956876,1.8594267642584574
G-401,12001922,1.3873374697674952,1.8594267642584574
DMS 273,44491742,3.7307306463602545,1.8594267642584574
A4/Fukuda,11396600,-8.215434514364686,1.8594267642584574
HSC-4,3689413,2.5472025828962055,1.8594267642584574
MDA-MB-453,4378219,1.7417226469020404,1.8594267642584574
ONS-76,387447,-4.115404850127739,1.8594267642584574
LOU-NH91,656346,1.0077735762311986,1.8594267642584574
A4/Fukuda,3081361,1.810117399969756,1.8594267642584574
NCI-H460,6505803,-0.4074860596498978,1.8594267642584574
NCI-H146,45279963,2.8359939324557706,1.8594267642584574
OPM-2,6184667,1.6391974127027074,1.8594267642584574
HCC1143,148198,-3.881060339055355,1.8594267642584574
A-673,421610,1.6759942643549426,1.8594267642584574
SNU-61,4259181,0.2985440005718957,1.8594267642584574
LXF 289,44819697,0.5606163889857397,1.8594267642584574
KYSE-70,168312962,-0.2970816131627225,1.8594267642584574
NCI-H146,11494412,-1.136229477240518,1.8594267642584574
OPM-2,2746,0.9082445461467812,1.8594267642584574
MDA-MB-157,6918736,-2.3678025624565175,1.8594267642584574
DMS 273,135659046,3.477426326571923,1.8594267642584574
HSC-4,126941,-2.3076253927529127,1.8594267642584574
CAL-51,57519531,1.893237876741888,1.8594267642584574
MDA-MB-157,3038522,4.043799431595376,1.8594267642584574
ONS-76,SNX-2112-bortezomib (250-1 mol-mol),-0.0712128201037348,1.8594267642584574
BxPC-3,54613361,-0.6294380958983512,1.8594267642584574
CA46,25102847,1.8345278315547784,1.8594267642584574
FTC-133,5746,0.3858378554684238,1.8594267642584574
BT-549,10113978,3.95693770646699,1.8594267642584574
A2780,54618771,-0.248592168161829,1.8594267642584574
SNU-61,6917907,-7.995083965311066,1.8594267642584574
ONS-76,3384730,2.185678697527176,1.8594267642584574
LOU-NH91,11228183,0.5456186750940368,1.8594267642584574
MDA-MB-157,25227462,1.286146426910961,1.8594267642584574
Panc 04.03,selumetinib-JQ-1 (4-1 mol-mol),2.1482953038113286,1.8594267642584574
BT-549,439501,-3.1266914034371567,1.8594267642584574
LXF 289,409805,5.2068809837223435,1.8594267642584574
OVISE,148198,-3.4121309130102055,1.8594267642584574
YAPC,262093,3.6115167721531343,1.8594267642584574
NCI-H727,5738263,3.354715168796171,1.8594267642584574
A-673,6918328,-0.9424380212903694,1.8594267642584574
MSTO-211H,navitoclax-piperlongumine (1-1 mol-mol),-1.4716070020924246,1.8594267642584574
JM-1,445643,3.755930816022248,1.8594267642584574
A2780,25154868,3.617715738937927,1.8594267642584574
Panc 04.03,81146,4.4293645850092735,1.8594267642584574
MDA-MB-453,4521392,4.261545411784443,1.8594267642584574
CAL-51,5460769,1.3780575552768597,1.8594267642584574
SNU-81,9926054,1.3093723678717843,1.8594267642584574
CAL-51,2113511,6.39897875596168,1.8594267642584574
NCI-H460,136227924,3.925006850615035,1.8594267642584574
NCI-H522,24856436,0.0798065953372803,1.8594267642584574
SBC-5,9967941,3.629642521259923,1.8594267642584574
A4/Fukuda,462382,-0.2406989279082468,1.8594267642584574
OVISE,11640390,4.491956307789174,1.8594267642584574
NCI-H522,selumetinib-vorinostat (8-1 mol-mol),2.6916205553530843,1.8594267642584574
CAL-51,24180125,2.8082301472193203,1.8594267642584574
LXF 289,25262965,-2.558275633709226,1.8594267642584574
NCI-H2009,9903786,1.8298580590992315,1.8594267642584574
SNU-61,54678924,1.5881868934361725,1.8594267642584574
YAPC,24785538,1.575520805381804,1.8594267642584574
NCI-H2171,676352,1.591250217642193,1.8594267642584574
SCC-9,carboplatin-UNC0638 (2-1 mol-mol),3.5571818540455413,1.8594267642584574
ONS-76,BRD-K27188169-navitoclax (2-1 mol-mol),3.629677877626108,1.8594267642584574
NOMO-1,3689413,-2.5325178418163174,1.8594267642584574
OPM-2,5284373,2.335601496737994,1.8594267642584574
NCI-H661,10127622,4.958480333722226,1.8594267642584574
ONS-76,44185566,2.3053400119978735,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11427553,3.480492721904053,1.8594267642584574
HCC1143,11485656,1.8564802256291268,1.8594267642584574
G-401,613753,2.8041503953296187,1.8594267642584574
MDA-MB-157,11657048,4.26764748298064,1.8594267642584574
ONS-76,24951314,1.2212354664419371,1.8594267642584574
A2780,36462,-2.0824592368546893,1.8594267642584574
FTC-133,vorinostat-carboplatin (1-1 mol-mol),4.046796900888368,1.8594267642584574
OPM-2,72376,-3.1510357921092376,1.8594267642584574
OPM-2,6918328,-2.875264730320658,1.8594267642584574
NCI-H522,decitabine-navitoclax (2-1 mol-mol),4.970964992537572,1.8594267642584574
EFO-27,168312962,3.0506772104926343,1.8594267642584574
NCI-H1623,107985,-2.7226564689550488,1.8594267642584574
MDA-MB-453,46398810,2.51328952557295,1.8594267642584574
SNU-449,49766530,-0.9876450445747244,1.8594267642584574
OPM-2,25102847,1.4573873057147737,1.8594267642584574
G-401,3081361,2.1638535645332664,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],71576739,4.46778033750866,1.8594267642584574
A2780,24951314,0.3580646626980762,1.8594267642584574
SCC-9,2871966,2.1501352130214695,1.8594267642584574
EFO-27,53232,3.845715413797161,1.8594267642584574
A2780,5460769,-5.6757466443406575,1.8594267642584574
Panc 04.03,10322450,4.721553837851545,1.8594267642584574
NCI-H292,selumetinib-JQ-1 (4-1 mol-mol),0.7417417133593783,1.8594267642584574
SNU-449,23582824,0.6769149785817056,1.8594267642584574
LoVo,selumetinib-BRD-A02303741 (4-1 mol-mol),1.3489379302549531,1.8594267642584574
ONS-76,3854666,0.984876663182433,1.8594267642584574
MDA-MB-453,71466578,1.854784458712459,1.8594267642584574
BT-549,piperlongumine-MST-312 (1-1 mol-mol),1.4526674208496635,1.8594267642584574
MDA-MB-453,15547703,3.861172408325267,1.8594267642584574
MDA-MB-157,252682,6.150103454129247,1.8594267642584574
G-401,46398810,1.5664917458517695,1.8594267642584574
NCI-H1623,327653,3.600793829240414,1.8594267642584574
SBC-5,6610355,5.221010400785003,1.8594267642584574
A4/Fukuda,6918878,-0.3411937140873722,1.8594267642584574
SNU-81,3062316,2.330723232319837,1.8594267642584574
OPM-2,9903786,2.6412283094975657,1.8594267642584574
HSC-4,15953870,4.269670192757531,1.8594267642584574
JM-1,984333,-1.6115401451915106,1.8594267642584574
Panc 04.03,46174525,5.826098059849913,1.8594267642584574
NCI-H292,5460769,0.0770188109309223,1.8594267642584574
FTC-133,216345,4.490711794352075,1.8594267642584574
BT-549,alisertib-navitoclax (2-1 mol-mol),-0.0458580768045358,1.8594267642584574
FU-OV-1,5311,1.028726852721831,1.8594267642584574
LoVo,9911830,1.9062113768292104,1.8594267642584574
CA46,23582824,0.075225101675958,1.8594267642584574
JM-1,alisertib-navitoclax (2-1 mol-mol),-3.873969254990661,1.8594267642584574
EFO-27,24797083,1.960036113572856,1.8594267642584574
NCI-H1623,5460769,3.63452416726077,1.8594267642584574
NCI-H661,5311,1.0541651051557333,1.8594267642584574
G-401,119182,-0.7625552993148171,1.8594267642584574
KMRC-1,navitoclax-MST-312 (1-1 mol-mol),0.8819471903820566,1.8594267642584574
ONS-76,11507802,1.2556507557201144,1.8594267642584574
KYSE-70,6918736,-3.61435843984592,1.8594267642584574
NCI-H2009,4788,5.716428228211685,1.8594267642584574
ONS-76,54686904,4.527599605979478,1.8594267642584574
CAL-51,2729026,2.5757432896171517,1.8594267642584574
ONS-76,3689413,-0.2845128895134612,1.8594267642584574
JM-1,676352,1.381688063426603,1.8594267642584574
NCI-H2171,11238147,2.9150011478889795,1.8594267642584574
EFO-27,JQ-1-carboplatin (1-1 mol-mol),5.5199687531263715,1.8594267642584574
Panc 04.03,5738263,4.451939152518209,1.8594267642584574
HCC1143,71304818,2.928848735179534,1.8594267642584574
OPM-2,9826308,-1.153894104617258,1.8594267642584574
OVISE,73707438,4.551111956107329,1.8594267642584574
KMRC-1,448949,2.0346247593103257,1.8594267642584574
NCI-H661,44589607,2.97822499860898,1.8594267642584574
YAPC,3503,2.818608145608573,1.8594267642584574
NCI-H522,3825829,3.960912701697082,1.8594267642584574
NCI-H661,5738263,2.7657344337958687,1.8594267642584574
CAL-51,168312962,1.4117577594763937,1.8594267642584574
CA46,4261,-0.8863355705331979,1.8594267642584574
CAL-51,241158,3.781489879449518,1.8594267642584574
A-673,2874250,4.616954738528679,1.8594267642584574
BT-549,46191454,1.72486803708685,1.8594267642584574
JM-1,6918878,0.0294179493888284,1.8594267642584574
CAL-51,4521392,4.667802355757324,1.8594267642584574
CAL-51,9915743,1.1260994347217144,1.8594267642584574
NCI-H146,46943432,1.2283557348915184,1.8594267642584574
YAPC,168312962,3.6522382892319185,1.8594267642584574
NCI-H522,44493528,4.173254194812623,1.8594267642584574
BT-549,10296883,4.161421407524775,1.8594267642584574
OVISE,11152667,1.81896217810704,1.8594267642584574
G-401,6852167,1.9492633511801831,1.8594267642584574
NCI-H292,168313047,2.7678931286458974,1.8594267642584574
A-673,5329102,0.93841525470917,1.8594267642584574
A-673,11404337,-2.7698937773977033,1.8594267642584574
BxPC-3,11222830,1.6538054387944447,1.8594267642584574
KMRC-1,25102847,3.2500467863275735,1.8594267642584574
MDA-MB-453,400769,-1.402270827463697,1.8594267642584574
OVISE,89928392,2.0483381338479907,1.8594267642584574
MDA-MB-157,136227924,3.402219650297347,1.8594267642584574
SNU-449,JQ-1-UNC0638 (2-1 mol-mol),5.2681139205860354,1.8594267642584574
BxPC-3,5738263,3.0337675506106576,1.8594267642584574
NCI-H292,16741245,5.797273118380107,1.8594267642584574
Panc 04.03,11404337,1.3784278741672673,1.8594267642584574
HSC-4,2130404,3.512147769522711,1.8594267642584574
SBC-5,5329102,3.79532117952851,1.8594267642584574
SNU-449,57519531,5.8010509150022145,1.8594267642584574
KMRC-1,1750826,-1.909836969824086,1.8594267642584574
DMS 273,53245473,3.723579099176344,1.8594267642584574
A4/Fukuda,44137675,1.307300702935143,1.8594267642584574
LoVo,72734382,4.052668353480041,1.8594267642584574
SW1463,57519531,1.6287135351441295,1.8594267642584574
SNU-61,16038120,1.3103584397228891,1.8594267642584574
CAL-51,9926054,2.2227862000004577,1.8594267642584574
KMRC-1,15953870,4.40931040558564,1.8594267642584574
A4/Fukuda,46191454,-2.2780561859524457,1.8594267642584574
EFO-27,6505803,0.9411407576336728,1.8594267642584574
A4/Fukuda,24951314,0.2081517019188384,1.8594267642584574
A-498,10184653,1.9377607214538883,1.8594267642584574
HSC-4,doxorubicin-navitoclax (2-1 mol-mol),-1.2623488821486932,1.8594267642584574
NCI-H522,9911830,2.121034111225194,1.8594267642584574
YAPC,53392493,3.0834263437199705,1.8594267642584574
FU-OV-1,JQ-1-MK-0752 (1-1 mol-mol),1.194664031604259,1.8594267642584574
FTC-133,15547703,3.427766539334031,1.8594267642584574
SBC-5,11404337,1.1992857421773124,1.8594267642584574
NOMO-1,654092,-2.6158486127541343,1.8594267642584574
JM-1,navitoclax-sorafenib (1-1 mol-mol),0.8658356793776997,1.8594267642584574
OPM-2,49793307,-4.879066461483742,1.8594267642584574
JM-1,11717001,4.327873015149225,1.8594267642584574
MSTO-211H,969516,2.440842922513423,1.8594267642584574
NCI-H460,9926054,2.081701465030928,1.8594267642584574
LXF 289,9936388,-5.793518221083613,1.8594267642584574
LoVo,10184653,-0.0525672628767589,1.8594267642584574
G-401,9866186,0.2347893748246883,1.8594267642584574
ONS-76,BRD-K99584050,5.369990310930208,1.8594267642584574
KMRC-1,168312962,3.867746451267385,1.8594267642584574
YAPC,452548,0.3485834104810916,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],selumetinib-navitoclax (8-1 mol-mol),2.9022286191617597,1.8594267642584574
FU-OV-1,6450551,4.626381712180732,1.8594267642584574
EFO-27,carboplatin-etoposide (40-17 mol-mol),3.749556119159122,1.8594267642584574
SNU-449,5978,1.8233754703073703,1.8594267642584574
LOU-NH91,44589607,2.878199319266369,1.8594267642584574
CAL-51,tretinoin-carboplatin (2-1 mol-mol),4.904159369397283,1.8594267642584574
A4/Fukuda,65628,3.8428022223998366,1.8594267642584574
A2780,42611257,2.862805810765337,1.8594267642584574
FTC-133,49867930,5.271360985380777,1.8594267642584574
SNU-61,56946209,-2.5026309203687314,1.8594267642584574
FU-OV-1,3062316,-5.013660753129892,1.8594267642584574
KMRC-1,vorinostat-navitoclax (4-1 mol-mol),1.4468975732833491,1.8594267642584574
NCI-H522,123631,2.114949756755372,1.8594267642584574
NOMO-1,52912189,-0.5265680930430634,1.8594267642584574
HCC1143,selumetinib-tretinoin (2-1 mol-mol),4.123174212921891,1.8594267642584574
CA46,2733526,4.193969711090682,1.8594267642584574
G-401,44819697,-1.6952135460319926,1.8594267642584574
MDA-MB-453,44507138,1.496822662467132,1.8594267642584574
NCI-H2171,9825149,1.181898582623386,1.8594267642584574
OPM-2,8515,3.0418796641091226,1.8594267642584574
Panc 04.03,4096211,3.5665133346619684,1.8594267642584574
KMRC-1,6610216,4.1544949822147,1.8594267642584574
NCI-H460,25150857,3.536831166282903,1.8594267642584574
OPM-2,11977753,-4.6820583055789,1.8594267642584574
G-401,49793307,-5.199300209786212,1.8594267642584574
A2780,1239801,3.465676691044825,1.8594267642584574
Panc 04.03,46398810,3.688960594211219,1.8594267642584574
G-401,65628,4.0909837295628275,1.8594267642584574
BT-549,53232,2.511840395622571,1.8594267642584574
NCI-H727,104842,-0.3454800108905812,1.8594267642584574
NCI-H292,6852167,2.409220580223775,1.8594267642584574
KMRC-1,15547703,4.785371110425684,1.8594267642584574
SCC-9,vorinostat-carboplatin (1-1 mol-mol),4.0549639225779615,1.8594267642584574
BxPC-3,16722836,0.8866010617403134,1.8594267642584574
OPM-2,BRD-A02303741-navitoclax (2-1 mol-mol),2.1588596939971625,1.8594267642584574
LXF 289,168312962,1.364587801939814,1.8594267642584574
G-401,11626560,1.1843690178322546,1.8594267642584574
YAPC,3825829,4.484241364021175,1.8594267642584574
NCI-H2009,46943432,2.8478796444115835,1.8594267642584574
SNU-449,16038120,1.104181711259477,1.8594267642584574
MDA-MB-157,72193861,0.2105280638919307,1.8594267642584574
ONS-76,46191454,1.5088295462826262,1.8594267642584574
LXF 289,439501,-1.653941874457911,1.8594267642584574
MDA-MB-453,54649381,4.094182376460235,1.8594267642584574
EFO-27,11507802,4.116687062031661,1.8594267642584574
ONS-76,crizotinib-PLX-4032 (2-1 mol-mol),2.136807968488312,1.8594267642584574
SNU-81,11427553,2.1196099795437733,1.8594267642584574
SNU-61,54143018,-0.3273600933762652,1.8594267642584574
HSC-4,17755052,1.8179922614483863,1.8594267642584574
EFO-27,2130404,3.4270754566369748,1.8594267642584574
FTC-133,24821094,3.776872089794721,1.8594267642584574
SNU-449,44607531,1.5485785292308227,1.8594267642584574
KYSE-70,24772860,-1.2328668610311222,1.8594267642584574
NCI-H522,11214940,1.077396173859641,1.8594267642584574
SNU-449,1474550,4.524224948734458,1.8594267642584574
LXF 289,44589607,3.4320685896186585,1.8594267642584574
OPM-2,31703,-1.5109362720248076,1.8594267642584574
A4/Fukuda,445455,4.756694709293823,1.8594267642584574
LoVo,71680916,4.224958300762603,1.8594267642584574
KMRC-1,25262965,-3.4791684180939,1.8594267642584574
NCI-H1623,54613361,0.8976129642368637,1.8594267642584574
DMS 273,15547703,2.68216153568037,1.8594267642584574
HCC1143,5311,1.090656828429124,1.8594267642584574
SNU-81,JQ-1-navitoclax (2-1 mol-mol),0.6755199584386623,1.8594267642584574
MSTO-211H,11977753,-3.756718801235006,1.8594267642584574
NCI-H661,51037431,4.262261435001038,1.8594267642584574
EFO-27,25183872,0.6822597295955183,1.8594267642584574
BT-549,docetaxel-tanespimycin (2-1 mol-mol),-6.584782072874471,1.8594267642584574
MDA-MB-453,16659841,4.43927192393091,1.8594267642584574
SNU-449,3854666,3.254678167809475,1.8594267642584574
JM-1,selumetinib-navitoclax (8-1 mol-mol),1.96596855152698,1.8594267642584574
HSC-4,46174525,4.818915916273074,1.8594267642584574
NCI-H727,25062766,3.0095924827905813,1.8594267642584574
EFO-27,9823820,4.474335567240953,1.8594267642584574
CAL-51,4917,3.122174268556499,1.8594267642584574
SCC-9,676352,2.0394457592349093,1.8594267642584574
MSTO-211H,4259181,-0.7585521679245923,1.8594267642584574
Panc 04.03,3854666,3.6180263181428622,1.8594267642584574
A2780,11214940,1.8716907673631955,1.8594267642584574
Panc 04.03,445455,5.108054343544362,1.8594267642584574
SCC-9,SNX-2112-bortezomib (250-1 mol-mol),-2.0018823279326776,1.8594267642584574
DMS 273,3081361,3.0365977955778805,1.8594267642584574
BxPC-3,126941,-2.8667568441276083,1.8594267642584574
EFO-27,6918837,-4.778560341054376,1.8594267642584574
JM-1,9956119,1.3894298966841814,1.8594267642584574
CAL-51,60750,-3.4379358682898973,1.8594267642584574
SNU-449,12001922,2.031450773900583,1.8594267642584574
SNU-81,119182,-3.3799134284972614,1.8594267642584574
CAL-51,6918878,3.0110486558166274,1.8594267642584574
CA46,44819697,-3.819793103454841,1.8594267642584574
OPM-2,46199207,2.048842595102616,1.8594267642584574
JM-1,11977753,-2.0561747941195674,1.8594267642584574
MDA-MB-453,16038120,1.4822204990084098,1.8594267642584574
BT-549,selumetinib-tretinoin (2-1 mol-mol),5.357160165486871,1.8594267642584574
G-401,135928012,4.758772301459146,1.8594267642584574
LoVo,445455,4.556737788306169,1.8594267642584574
FU-OV-1,11964036,-0.3048537688067435,1.8594267642584574
CAL-51,3825829,3.9510679995615257,1.8594267642584574
NOMO-1,66577038,2.985459327680272,1.8594267642584574
YAPC,4259181,0.8211273757017798,1.8594267642584574
BT-549,2708,5.415828272287544,1.8594267642584574
OPM-2,4477,0.1075725295912922,1.8594267642584574
ONS-76,23635314,-1.3572631369234491,1.8594267642584574
Panc 04.03,168313200,2.993774278353398,1.8594267642584574
A2780,25262965,-4.532154518345387,1.8594267642584574
LoVo,24951314,0.8531724175888866,1.8594267642584574
SNU-61,6918837,-2.02709157063253,1.8594267642584574
LOU-NH91,6918878,5.623996708869271,1.8594267642584574
LOU-NH91,16725315,5.120050781978422,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],9866186,0.0174318535432376,1.8594267642584574
NCI-H661,16722836,1.177222753188902,1.8594267642584574
A-498,9935249,3.347418171794467,1.8594267642584574
NCI-H2009,44185566,3.0429431135599607,1.8594267642584574
Panc 04.03,25126798,3.7756614801897377,1.8594267642584574
LOU-NH91,24771867,3.0978851297923895,1.8594267642584574
Panc 04.03,10231331,4.944041434313903,1.8594267642584574
Panc 04.03,9967941,5.787601223768576,1.8594267642584574
HCC1143,11497983,5.345504804401821,1.8594267642584574
MDA-MB-453,6505803,-3.8322805026755806,1.8594267642584574
LXF 289,285033,-1.4335563326434544,1.8594267642584574
NCI-H292,3689413,1.7536313837601494,1.8594267642584574
OVISE,54618771,1.319775250733869,1.8594267642584574
SNU-81,135411,1.0381613293566891,1.8594267642584574
NCI-H2009,451668,5.323035746604961,1.8594267642584574
SNU-81,3689413,1.1974270464491454,1.8594267642584574
FTC-133,5738263,4.07617232189308,1.8594267642584574
NCI-H1623,5291,3.880629558524794,1.8594267642584574
NCI-H727,51039095,2.7124063556691267,1.8594267642584574
DMS 273,262093,2.141936221481062,1.8594267642584574
CAL-51,6918328,0.3807555589851347,1.8594267642584574
A-498,24951314,2.536702379510054,1.8594267642584574
OVISE,135440466,-0.9475229728449716,1.8594267642584574
A2780,11404337,-0.8981705286722745,1.8594267642584574
OVISE,selumetinib-navitoclax (8-1 mol-mol),1.5927997425042688,1.8594267642584574
Panc 04.03,24951314,1.470760951451068,1.8594267642584574
NOMO-1,4705,2.5023829157060926,1.8594267642584574
BxPC-3,176870,2.768163283404042,1.8594267642584574
G-401,11609586,0.8694160359503889,1.8594267642584574
EFO-27,doxorubicin-navitoclax (2-1 mol-mol),0.6327917719948324,1.8594267642584574
NCI-H2009,tanespimycin-gemcitabine (1-1 mol-mol),0.2582692893190324,1.8594267642584574
NCI-H2009,15983966,-3.9047819028388178,1.8594267642584574
JM-1,16659841,2.088291676862089,1.8594267642584574
NCI-H146,5311,-0.0389435386139853,1.8594267642584574
A2780,72734382,3.371521062177298,1.8594267642584574
A-673,2708,2.956024737310482,1.8594267642584574
NCI-H460,11152667,1.2005763717636435,1.8594267642584574
A4/Fukuda,tretinoin-carboplatin (2-1 mol-mol),3.3716994915899945,1.8594267642584574
G-401,60700,-0.931594906554522,1.8594267642584574
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633,1.8594267642584574
NCI-H146,31703,-2.278385754586821,1.8594267642584574
KMRC-1,445643,4.4248475697731005,1.8594267642584574
SNU-61,tanespimycin-gemcitabine (1-1 mol-mol),-0.5770554338848054,1.8594267642584574
KYSE-70,54613361,0.0645626216296427,1.8594267642584574
CAL-51,444795,5.053001195278548,1.8594267642584574
KYSE-70,54619267,5.587983352589812,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],16065773,2.083422102332506,1.8594267642584574
NCI-H522,135984461,5.248212763135773,1.8594267642584574
CA46,10385095,0.6992054873225039,1.8594267642584574
G-401,16038120,0.8239725572719159,1.8594267642584574
A2780,selumetinib-tretinoin (2-1 mol-mol),2.739843613325444,1.8594267642584574
NCI-H1623,6918328,0.1782181011891448,1.8594267642584574
G-401,31703,-2.7567506026552904,1.8594267642584574
OPM-2,11497983,4.2316824511311,1.8594267642584574
NCI-H522,46215462,1.6065433434555243,1.8594267642584574
JM-1,selumetinib-UNC0638 (4-1 mol-mol),2.9715297614660474,1.8594267642584574
A-498,selumetinib-BRD-A02303741 (4-1 mol-mol),2.466660305447313,1.8594267642584574
A-673,16741245,3.6856166817392393,1.8594267642584574
DMS 273,44486219,3.889102530118227,1.8594267642584574
ONS-76,3062316,0.3527292351029743,1.8594267642584574
NCI-H1623,4521392,4.396491619301915,1.8594267642584574
SBC-5,3062316,3.347274022566764,1.8594267642584574
OPM-2,374536,1.7033153768622478,1.8594267642584574
NCI-H292,5291,3.74340966649761,1.8594267642584574
G-401,123631,2.330078370852269,1.8594267642584574
HSC-4,135423438,1.814117839489682,1.8594267642584574
CAL-51,25126798,3.926975819986009,1.8594267642584574
NCI-H727,409805,5.9670224431598875,1.8594267642584574
A-673,4917,1.8117239982797952,1.8594267642584574
DMS 273,57519531,1.9430749026869305,1.8594267642584574
MSTO-211H,vorinostat-carboplatin (1-1 mol-mol),3.1229894172951043,1.8594267642584574
HSC-4,25262965,-0.4495508061813805,1.8594267642584574
OVISE,327653,2.506626214633075,1.8594267642584574
A4/Fukuda,71680916,4.641498651595925,1.8594267642584574
EFO-27,104842,-1.4311942194738418,1.8594267642584574
A-673,11626560,-0.097195247735582,1.8594267642584574
NCI-H146,3384730,2.6214971804948908,1.8594267642584574
MSTO-211H,26596,-0.5653018529577997,1.8594267642584574
JM-1,445455,3.9843646189648863,1.8594267642584574
CAL-51,11427553,2.069280384014222,1.8594267642584574
SNU-61,20959075,-3.60077638491687,1.8594267642584574
LXF 289,25062766,1.8533275351899623,1.8594267642584574
LOU-NH91,24797083,1.602297413523094,1.8594267642584574
CAL-51,24771867,-0.5018492111736887,1.8594267642584574
NOMO-1,44632017,0.9405041708842384,1.8594267642584574
NCI-H146,25195348,0.0229507172684141,1.8594267642584574
A-673,151289,0.5990139557366498,1.8594267642584574
JM-1,72376,-3.929922218649067,1.8594267642584574
NCI-H727,12003241,-0.657143782776601,1.8594267642584574
JM-1,24180125,1.1035620934920058,1.8594267642584574
LoVo,24964624,-0.96112559187181,1.8594267642584574
NCI-H2171,UNC0638-navitoclax (1-1 mol-mol),-0.3565063117120224,1.8594267642584574
OVISE,6610216,4.867128617935935,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],5113032,4.670023295767466,1.8594267642584574
CAL-51,11507802,1.2528060552922216,1.8594267642584574
A4/Fukuda,25227462,-5.883792654516593,1.8594267642584574
BxPC-3,5566,2.8001360517565628,1.8594267642584574
DMS 273,119182,1.6620070398785467,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],3062316,2.514926182355465,1.8594267642584574
NOMO-1,168313200,3.152434526133537,1.8594267642584574
A-673,navitoclax-PLX-4032 (1-1 mol-mol),0.8994506626912233,1.8594267642584574
NCI-H727,24856436,1.7647429516878397,1.8594267642584574
KMRC-1,72734382,5.690666345136703,1.8594267642584574
A-673,56949517,4.212065281653062,1.8594267642584574
BT-549,135421197,3.4062158650675265,1.8594267642584574
DMS 273,vorinostat-carboplatin (1-1 mol-mol),2.6049111550172506,1.8594267642584574
NCI-H1623,10074640,3.727129107489099,1.8594267642584574
YAPC,5329102,2.676937714502371,1.8594267642584574
YAPC,docetaxel-tanespimycin (2-1 mol-mol),2.5986620559096902,1.8594267642584574
NCI-H2009,4917,2.9963488408029417,1.8594267642584574
NCI-H727,44589607,2.894616632949603,1.8594267642584574
G-401,5328940,1.7098947779411977,1.8594267642584574
FTC-133,10410894,5.920528547603018,1.8594267642584574
CAL-51,216468,1.370586512271769,1.8594267642584574
MDA-MB-453,227681,3.97271964535407,1.8594267642584574
A4/Fukuda,5284616,3.229953451024844,1.8594267642584574
NCI-H460,753704,5.635234970240753,1.8594267642584574
NCI-H2009,vorinostat-carboplatin (1-1 mol-mol),1.7172571438659243,1.8594267642584574
SBC-5,crizotinib-PLX-4032 (2-1 mol-mol),2.792734881189652,1.8594267642584574
NCI-H1623,25150857,2.7146098705885127,1.8594267642584574
YAPC,JQ-1-vorinostat (2-1 mol-mol),2.9118979144458548,1.8594267642584574
LOU-NH91,2729026,2.877851429076431,1.8594267642584574
CA46,46191454,-0.333651418813281,1.8594267642584574
FTC-133,65628,4.302527639906617,1.8594267642584574
A2780,72193861,-0.1120033238626439,1.8594267642584574
SCC-9,49793307,-2.052824266331224,1.8594267642584574
BxPC-3,135440466,1.2091890795281053,1.8594267642584574
NCI-H146,11455910,-0.4209962248823531,1.8594267642584574
A-673,46398810,1.6125076634642133,1.8594267642584574
SNU-81,11626927,-0.7774954189098839,1.8594267642584574
JM-1,45279963,2.536030346276664,1.8594267642584574
MDA-MB-157,5746,1.4435337882328911,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],16725315,5.393896472431684,1.8594267642584574
ONS-76,2874250,6.058821088556036,1.8594267642584574
A2780,5284329,2.502098244540034,1.8594267642584574
LoVo,53232,3.084407514553567,1.8594267642584574
ONS-76,navitoclax-PLX-4032 (1-1 mol-mol),4.335120397658034,1.8594267642584574
OPM-2,9927531,3.0625153090482757,1.8594267642584574
SNU-449,44202524,4.173676721592596,1.8594267642584574
SNU-61,124202324,2.5924607447988643,1.8594267642584574
JM-1,SNX-2112-bortezomib (250-1 mol-mol),-3.853804462612268,1.8594267642584574
CAL-51,44819697,-1.9765663783606575,1.8594267642584574
FU-OV-1,2708,5.501261259949465,1.8594267642584574
EFO-27,selumetinib-JQ-1 (4-1 mol-mol),3.927546340306408,1.8594267642584574
SNU-81,16722836,0.5712028725805488,1.8594267642584574
SNU-61,1716436,2.6740680266491763,1.8594267642584574
OPM-2,3854666,0.6659331794855328,1.8594267642584574
DMS 273,71304818,2.423766397759693,1.8594267642584574
OPM-2,44185566,1.967847411757682,1.8594267642584574
SNU-449,25154868,5.089625763576692,1.8594267642584574
JM-1,serdemetan-SCH-529074 (1-1 mol-mol),0.850280297026697,1.8594267642584574
NCI-H661,5281321,0.7671093512543088,1.8594267642584574
SCC-9,44185566,3.0958673753547785,1.8594267642584574
MDA-MB-453,16736978,1.2653262263884038,1.8594267642584574
KYSE-70,9935249,3.427959003246725,1.8594267642584574
MDA-MB-453,11178236,-5.341922221503707,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],168313016,4.590367789402496,1.8594267642584574
EFO-27,24180719,4.15462806748021,1.8594267642584574
NCI-H727,44607531,2.33451518290986,1.8594267642584574
NCI-H292,10410894,3.620691172443616,1.8594267642584574
A4/Fukuda,SNX-2112-bortezomib (250-1 mol-mol),-3.583227894628943,1.8594267642584574
MDA-MB-453,10184653,1.4947310227918462,1.8594267642584574
MDA-MB-453,11228183,3.436796326739784,1.8594267642584574
DMS 273,67291369,1.8884432049214537,1.8594267642584574
NCI-H2171,54619267,3.4799425585632204,1.8594267642584574
MDA-MB-453,448949,2.258073743229602,1.8594267642584574
A2780,135440466,1.248320725279374,1.8594267642584574
NCI-H146,9866186,0.8123633746782326,1.8594267642584574
CAL-51,JQ-1-UNC0638 (2-1 mol-mol),2.957186158032418,1.8594267642584574
A4/Fukuda,10074640,2.009206402328629,1.8594267642584574
KYSE-70,31703,-0.0860185315527888,1.8594267642584574
A-673,11497983,-0.3979292238924095,1.8594267642584574
A2780,12003241,-2.743381978251489,1.8594267642584574
A4/Fukuda,25102847,0.4372365282678318,1.8594267642584574
KMRC-1,11717001,4.773123606238519,1.8594267642584574
FTC-133,36462,0.6793689394766376,1.8594267642584574
SCC-9,23582824,0.351039434592286,1.8594267642584574
BT-549,2729026,3.014205222238777,1.8594267642584574
EFO-27,selumetinib-piperlongumine (8-1 mol-mol),4.5130277383980015,1.8594267642584574
LXF 289,46943432,1.4312531154305732,1.8594267642584574
NCI-H727,11625818,5.425399240643101,1.8594267642584574
HSC-4,44507138,3.308450875381542,1.8594267642584574
A-673,969516,1.3043572294505754,1.8594267642584574
FTC-133,969516,2.842702479050133,1.8594267642584574
HCC1143,11609586,3.6708937391840206,1.8594267642584574
DMS 273,2733487,6.43119993607997,1.8594267642584574
LoVo,10302451,1.0215583424111876,1.8594267642584574
KYSE-70,46174525,4.613744209458669,1.8594267642584574
SBC-5,65628,3.417870630997437,1.8594267642584574
DMS 273,24180125,3.0640550148835812,1.8594267642584574
OVISE,452548,1.282500130328104,1.8594267642584574
BxPC-3,71304818,2.4465042326182247,1.8594267642584574
ONS-76,54143018,0.4309751541382265,1.8594267642584574
OVISE,24856436,2.006053298804951,1.8594267642584574
MDA-MB-453,71729975,-0.0804754192781109,1.8594267642584574
NCI-H1623,65628,4.265717950525356,1.8594267642584574
DMS 273,9927531,4.953960158421894,1.8594267642584574
BxPC-3,426756,6.38858222821808,1.8594267642584574
NCI-H2009,49766530,0.9767616789625324,1.8594267642584574
JM-1,2858523,2.95851246958296,1.8594267642584574
YAPC,9935249,3.6850704434892823,1.8594267642584574
A2780,654092,-1.3080416104753447,1.8594267642584574
OPM-2,6918638,-1.573449675489913,1.8594267642584574
NCI-H2009,alisertib-navitoclax (2-1 mol-mol),-2.130413891599744,1.8594267642584574
SBC-5,25105715,3.9151038194938352,1.8594267642584574
SNU-61,168313047,1.9617236271133212,1.8594267642584574
A4/Fukuda,11317348,1.1392337694005448,1.8594267642584574
NCI-H522,25262965,-1.3157493467877637,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],54618771,0.5185720985561021,1.8594267642584574
LXF 289,docetaxel-tanespimycin (2-1 mol-mol),-5.172665265297567,1.8594267642584574
MSTO-211H,44607530,1.4093785076150551,1.8594267642584574
HSC-4,984333,1.2474358256824072,1.8594267642584574
CAL-51,alisertib-navitoclax (2-1 mol-mol),0.1244503961193178,1.8594267642584574
ONS-76,9967941,2.912852232249919,1.8594267642584574
DMS 273,24753719,4.257561408038297,1.8594267642584574
CAL-51,24772860,-2.425084956958233,1.8594267642584574
MSTO-211H,44632017,1.2059374560785627,1.8594267642584574
NCI-H146,5978,-4.422435519224839,1.8594267642584574
G-401,2746,2.560873344661061,1.8594267642584574
A-498,navitoclax-sorafenib (1-1 mol-mol),1.1504287043269172,1.8594267642584574
NCI-H2009,11152667,-0.3244172236423036,1.8594267642584574
BxPC-3,erlotinib-PLX-4032 (2-1 mol-mol),3.269235353902274,1.8594267642584574
MDA-MB-453,219104,3.605347452429255,1.8594267642584574
KMRC-1,5280436,0.1724698964633139,1.8594267642584574
A-673,25154868,2.9619598302203176,1.8594267642584574
A-673,135999136,4.231524255529223,1.8594267642584574
FU-OV-1,9884685,-0.2158788705773567,1.8594267642584574
NCI-H727,11626560,1.656358651993978,1.8594267642584574
CAL-51,9866186,1.45916914556855,1.8594267642584574
HCC1143,44507138,1.5952303095871043,1.8594267642584574
CA46,9823820,1.6053302041689723,1.8594267642584574
NCI-H522,docetaxel-tanespimycin (2-1 mol-mol),-6.262465399444894,1.8594267642584574
CAL-51,12001922,2.008779489179369,1.8594267642584574
FTC-133,selumetinib-PLX-4032 (8-1 mol-mol),5.295700336992507,1.8594267642584574
NCI-H292,19582717,5.466560288208149,1.8594267642584574
A4/Fukuda,374536,-1.0311095755670416,1.8594267642584574
OPM-2,10113978,1.3298356496360293,1.8594267642584574
SNU-449,9903786,3.696408358539977,1.8594267642584574
JM-1,25195348,3.46638875562813,1.8594267642584574
NCI-H1623,5746,-0.5390712999232294,1.8594267642584574
KYSE-70,71466445,4.079477869375345,1.8594267642584574
NCI-H460,44185566,3.2105564381381035,1.8594267642584574
MSTO-211H,6918837,-2.204195063499652,1.8594267642584574
CAL-51,54613361,0.2180057854442524,1.8594267642584574
A2780,216345,1.0708930445758365,1.8594267642584574
HCC1143,100016,7.122041956726765,1.8594267642584574
NCI-H522,5278396,4.518604091155278,1.8594267642584574
SNU-61,54619267,4.677926252875765,1.8594267642584574
OPM-2,135421197,1.341685947169011,1.8594267642584574
G-401,72193861,1.057396802085585,1.8594267642584574
NCI-H727,15547703,3.504014494953252,1.8594267642584574
NCI-H292,11178236,-4.939590057195551,1.8594267642584574
MDA-MB-453,44241473,4.685974466458818,1.8594267642584574
MSTO-211H,60700,-2.4521642225491065,1.8594267642584574
BxPC-3,SNX-2112-bortezomib (250-1 mol-mol),-2.5266408566121297,1.8594267642584574
NCI-H2171,4096211,1.8093642806404184,1.8594267642584574
NCI-H146,68056272,3.3997347898500063,1.8594267642584574
A2780,984333,-1.5561630492039429,1.8594267642584574
NCI-H2171,5479543,3.509510962528721,1.8594267642584574
ONS-76,6610355,5.379398654611739,1.8594267642584574
G-401,2742550,4.179048555325354,1.8594267642584574
OPM-2,44137675,3.238695939616315,1.8594267642584574
NCI-H661,selumetinib-navitoclax (8-1 mol-mol),5.100563052002661,1.8594267642584574
FU-OV-1,387447,-1.63105242136749,1.8594267642584574
LoVo,3825829,3.571391318080427,1.8594267642584574
JM-1,11404337,-2.1014875230304315,1.8594267642584574
FU-OV-1,9929138,5.415072941349914,1.8594267642584574
SBC-5,5738263,3.46908634421933,1.8594267642584574
KMRC-1,navitoclax-piperlongumine (1-1 mol-mol),1.9271011950938683,1.8594267642584574
G-401,4917,3.172752348635073,1.8594267642584574
A-673,44589607,3.5509265356046305,1.8594267642584574
A-673,selumetinib-navitoclax (8-1 mol-mol),2.703259710676399,1.8594267642584574
CAL-51,2828334,6.190580852669228,1.8594267642584574
MDA-MB-453,BRD-A02303741-navitoclax (2-1 mol-mol),4.399808633782925,1.8594267642584574
SNU-61,67156097,-2.2274361546113854,1.8594267642584574
OPM-2,65628,4.597670741376445,1.8594267642584574
MDA-MB-453,3038522,2.334816038150176,1.8594267642584574
HSC-4,2708,2.9878251305615477,1.8594267642584574
MSTO-211H,selumetinib-JQ-1 (4-1 mol-mol),1.9489551392518472,1.8594267642584574
CA46,54678924,0.940253932332064,1.8594267642584574
SNU-449,11964036,1.3997299371502423,1.8594267642584574
DMS 273,54613361,-0.0987092047967699,1.8594267642584574
SW1463,2749,1.5016847157281326,1.8594267642584574
A2780,4477,0.2147996237825641,1.8594267642584574
NOMO-1,9907093,3.6530797436282434,1.8594267642584574
A-673,54618305,4.212251300263772,1.8594267642584574
LOU-NH91,65064,5.187256751294022,1.8594267642584574
NCI-H2171,72376,-3.3432588050758296,1.8594267642584574
MDA-MB-453,72199292,1.3092335372039157,1.8594267642584574
NCI-H522,107970,1.611650854248594,1.8594267642584574
A-673,444795,4.685959151928419,1.8594267642584574
HSC-4,6505803,0.688410933428746,1.8594267642584574
CA46,11455910,-0.2967360934235351,1.8594267642584574
NCI-H460,6252,1.4342703041264255,1.8594267642584574
BT-549,49793307,-0.000238716840207,1.8594267642584574
CAL-51,68056272,3.9955701948507247,1.8594267642584574
A-498,vorinostat-navitoclax (4-1 mol-mol),0.5641326032533043,1.8594267642584574
A-673,227681,3.19347186106623,1.8594267642584574
BxPC-3,54618771,0.182098153600537,1.8594267642584574
A4/Fukuda,3385,2.3595203579832553,1.8594267642584574
LoVo,36314,1.7018910931264415,1.8594267642584574
BxPC-3,11152667,-1.4400195695513092,1.8594267642584574
SCC-9,3025986,-0.0492814979551807,1.8594267642584574
MDA-MB-453,4259181,0.7923345004369465,1.8594267642584574
Panc 04.03,9927531,5.313421559596226,1.8594267642584574
LoVo,448949,1.89047161937067,1.8594267642584574
KMRC-1,5978,0.0310598033875183,1.8594267642584574
NCI-H292,262093,2.9868554632365556,1.8594267642584574
CAL-51,9884685,-0.2528326244590672,1.8594267642584574
KMRC-1,135421197,2.781168744821282,1.8594267642584574
A2780,56973724,1.317874340119369,1.8594267642584574
A4/Fukuda,46943432,-0.0927442133672991,1.8594267642584574
HSC-4,50905018,4.462883747891921,1.8594267642584574
JM-1,448949,0.7740790697885386,1.8594267642584574
EFO-27,11964036,1.3211691780165964,1.8594267642584574
A4/Fukuda,637858,0.8198578842358093,1.8594267642584574
OPM-2,5282054,2.4375164125334217,1.8594267642584574
ONS-76,637858,2.646425044184718,1.8594267642584574
HSC-4,439501,-1.7709622187792924,1.8594267642584574
KYSE-70,24964624,1.4483005111507754,1.8594267642584574
LOU-NH91,5282054,3.3765969574471315,1.8594267642584574
A-498,selumetinib-UNC0638 (4-1 mol-mol),2.905526592026194,1.8594267642584574
SNU-81,5281321,-4.892530389502709,1.8594267642584574
HCC1143,168312962,3.1559735288767468,1.8594267642584574
JM-1,126941,-4.3883192692313955,1.8594267642584574
SCC-9,54143018,0.8755026739061308,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],5460769,3.958915694045798,1.8594267642584574
SNU-449,1641662,3.672188762237013,1.8594267642584574
NCI-H146,54765302,2.77091239654666,1.8594267642584574
NCI-H146,11427553,2.364557310661393,1.8594267642584574
CAL-51,159324,3.1794720270506307,1.8594267642584574
YAPC,71466445,6.285156806731666,1.8594267642584574
ONS-76,5351362,1.281569720069414,1.8594267642584574
NCI-H292,doxorubicin-navitoclax (2-1 mol-mol),-1.8265545031559949,1.8594267642584574
BxPC-3,6505803,-3.0514917868960767,1.8594267642584574
A-673,45279963,3.7593508340409287,1.8594267642584574
CA46,3465537,3.345448990020783,1.8594267642584574
HCC1143,168313016,5.718985268806146,1.8594267642584574
A-498,400769,-1.6101267353788036,1.8594267642584574
NCI-H2009,10184653,1.0890186290305244,1.8594267642584574
NCI-H522,426756,6.015863149473534,1.8594267642584574
NCI-H2171,44819697,-4.1780638649943675,1.8594267642584574
DMS 273,24785538,0.640909019865508,1.8594267642584574
NCI-H146,6918638,-1.4860665745363582,1.8594267642584574
NOMO-1,3543504,4.095340640265792,1.8594267642584574
NCI-H661,151289,0.3755226510544496,1.8594267642584574
G-401,53495165,-2.4189675718778516,1.8594267642584574
LXF 289,selumetinib-navitoclax (8-1 mol-mol),2.675431188570136,1.8594267642584574
YAPC,6918837,-0.3723714565085887,1.8594267642584574
BT-549,219104,4.096633484715141,1.8594267642584574
LXF 289,24753719,4.56569970094865,1.8594267642584574
CAL-51,25102847,1.94226811064499,1.8594267642584574
A2780,doxorubicin-navitoclax (2-1 mol-mol),-3.696476342878232,1.8594267642584574
OPM-2,54618164,3.637238343412542,1.8594267642584574
MDA-MB-157,2733526,3.146610844933737,1.8594267642584574
KMRC-1,54618164,3.981312375484732,1.8594267642584574
CA46,375860,-0.5712781411665353,1.8594267642584574
G-401,24772860,-1.622851891505981,1.8594267642584574
NCI-H1623,119182,-1.1196330586869003,1.8594267642584574
A-673,984333,-2.7710011035310074,1.8594267642584574
KMRC-1,49793307,-2.5218593870176793,1.8594267642584574
ONS-76,alisertib-navitoclax (2-1 mol-mol),2.05248890000496,1.8594267642584574
DMS 273,11152667,-1.0918930552191226,1.8594267642584574
NCI-H460,44620216,3.8133491956675902,1.8594267642584574
MDA-MB-453,19582717,2.5916230237173696,1.8594267642584574
SNU-61,53495165,-0.6572534585269733,1.8594267642584574
JM-1,6505803,0.12933264701109,1.8594267642584574
SNU-449,60700,1.1315850608054705,1.8594267642584574
CAL-51,676352,2.3367523995253454,1.8594267642584574
LXF 289,89928392,2.4967474535679623,1.8594267642584574
LOU-NH91,11625818,5.704636625331963,1.8594267642584574
MDA-MB-453,156414,0.9469838239648454,1.8594267642584574
OPM-2,462382,-0.5185214646773461,1.8594267642584574
A2780,53392493,1.4842280461046395,1.8594267642584574
DMS 273,9823820,3.9764583445605006,1.8594267642584574
ONS-76,24772860,-0.9083480450936676,1.8594267642584574
KYSE-70,11612883,2.3570058511886396,1.8594267642584574
SCC-9,3854666,1.6335835525169635,1.8594267642584574
KMRC-1,375860,0.0373834100132385,1.8594267642584574
SBC-5,9866186,-0.1944977114504531,1.8594267642584574
NOMO-1,11719255,2.6566855899212944,1.8594267642584574
CAL-51,702558,3.5144984342436563,1.8594267642584574
ONS-76,51039095,3.253449307143194,1.8594267642584574
CAL-51,SNX-2112-bortezomib (250-1 mol-mol),-1.7705274817452763,1.8594267642584574
BT-549,carboplatin-etoposide (40-17 mol-mol),3.0956073566699147,1.8594267642584574
HSC-4,selumetinib-navitoclax (8-1 mol-mol),1.957846901945355,1.8594267642584574
BxPC-3,216468,3.632186197150132,1.8594267642584574
SBC-5,2742550,4.323082293816951,1.8594267642584574
HSC-4,24797083,0.9836127584085878,1.8594267642584574
OVISE,4788,6.030976207458705,1.8594267642584574
LXF 289,11455910,1.909862916296106,1.8594267642584574
SCC-9,16659841,4.917362195715636,1.8594267642584574
G-401,49766530,-2.7444300270308113,1.8594267642584574
HSC-4,6450551,4.030000721690881,1.8594267642584574
CAL-51,6918736,-2.0480142356294637,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],12003241,-1.4246438063204208,1.8594267642584574
SCC-9,4096211,2.914802879806832,1.8594267642584574
EFO-27,168313200,3.5651936579716277,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],100016,6.48277389223573,1.8594267642584574
SCC-9,448949,2.996737074861378,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],54618305,4.342158128597338,1.8594267642584574
NCI-H460,selumetinib-decitabine (4-1 mol-mol),7.324082171117594,1.8594267642584574
NCI-H661,15953870,2.9876041506010003,1.8594267642584574
KMRC-1,6918638,1.621172594092556,1.8594267642584574
Panc 04.03,44489675,4.301555650291772,1.8594267642584574
HSC-4,54143018,5.46718478704898,1.8594267642584574
NCI-H661,11175137,2.5272908163527745,1.8594267642584574
OVISE,piperlongumine-MST-312 (1-1 mol-mol),1.6778401901556628,1.8594267642584574
NCI-H292,24753719,4.2962074219620225,1.8594267642584574
NCI-H146,11228183,-2.941805953111262,1.8594267642584574
MDA-MB-157,65064,3.084719541991811,1.8594267642584574
HSC-4,44491742,4.173988284907792,1.8594267642584574
CA46,9933475,1.582522184359856,1.8594267642584574
JM-1,53245473,3.7598021769733414,1.8594267642584574
CAL-51,navitoclax-gemcitabine (1-1 mol-mol),-3.0464623098161256,1.8594267642584574
KMRC-1,702558,5.7321455674333475,1.8594267642584574
EFO-27,262093,3.0007323703470896,1.8594267642584574
A4/Fukuda,72734382,2.815137004147321,1.8594267642584574
NCI-H727,44185566,2.6786881549102626,1.8594267642584574
OVISE,25062766,3.2029018764111896,1.8594267642584574
HCC1143,JQ-1-carboplatin (1-1 mol-mol),2.533079655753226,1.8594267642584574
CA46,3825829,3.8503527939376583,1.8594267642584574
EFO-27,JQ-1-navitoclax (2-1 mol-mol),3.2464971768878086,1.8594267642584574
BxPC-3,60750,-2.6920891843690273,1.8594267642584574
EFO-27,1566236,1.9834366009012432,1.8594267642584574
LXF 289,53392493,2.5437082258312804,1.8594267642584574
NCI-H460,135421197,3.2510260026522233,1.8594267642584574
JM-1,tanespimycin-gemcitabine (1-1 mol-mol),-5.316937276009384,1.8594267642584574
Panc 04.03,44607531,1.8924568500741572,1.8594267642584574
ONS-76,15547703,3.220128707821482,1.8594267642584574
BxPC-3,123631,1.9141625570683185,1.8594267642584574
NCI-H2009,24180125,3.399696031265864,1.8594267642584574
A-673,19582717,3.777631654850071,1.8594267642584574
FU-OV-1,12003241,-1.039273875540509,1.8594267642584574
SNU-61,409805,4.743067556302579,1.8594267642584574
DMS 273,11364421,-1.741561290091182,1.8594267642584574
Panc 04.03,11214940,1.7867172186781857,1.8594267642584574
NCI-H522,31703,-1.0005486569838078,1.8594267642584574
KYSE-70,5287620,-1.7159794680358271,1.8594267642584574
A2780,11507802,0.380240885087182,1.8594267642584574
ONS-76,54613361,0.8570205233962582,1.8594267642584574
KMRC-1,2729026,3.101959850286169,1.8594267642584574
NCI-H522,136227924,2.2034936459857506,1.8594267642584574
NCI-H661,52912189,3.763222756257729,1.8594267642584574
ONS-76,262093,3.354802573562099,1.8594267642584574
A2780,675434,3.840840752716624,1.8594267642584574
EFO-27,24771867,3.839082818590537,1.8594267642584574
BT-549,44185566,3.1570730526396407,1.8594267642584574
NCI-H2009,89183176,3.352860584382055,1.8594267642584574
A2780,2949965,2.158264003903123,1.8594267642584574
MDA-MB-157,119182,-3.4496410534325093,1.8594267642584574
MDA-MB-453,2949965,2.588847266095094,1.8594267642584574
MDA-MB-453,71576739,4.365206221166654,1.8594267642584574
A-498,11455910,2.747308138802023,1.8594267642584574
A4/Fukuda,448949,1.1686862984883333,1.8594267642584574
OPM-2,10385095,0.6586756349946576,1.8594267642584574
BxPC-3,52912189,1.4214477046132656,1.8594267642584574
JM-1,46907787,-1.9243382261841309,1.8594267642584574
G-401,3385,1.38862488630676,1.8594267642584574
LOU-NH91,24978538,-2.307670841327046,1.8594267642584574
BxPC-3,25262965,-1.1326145626109247,1.8594267642584574
KYSE-70,9915743,1.2522553618909642,1.8594267642584574
A4/Fukuda,42642645,-1.373677794386147,1.8594267642584574
A-673,44202524,1.1944686936342714,1.8594267642584574
FU-OV-1,66577038,3.5319441468561648,1.8594267642584574
SBC-5,BRD-K99584050,5.772271611565925,1.8594267642584574
MSTO-211H,2749,1.2029234831790616,1.8594267642584574
EFO-27,2858523,3.4178086224101527,1.8594267642584574
NCI-H2009,54613361,-1.6701870677586086,1.8594267642584574
CAL-51,11626560,0.7349282975065881,1.8594267642584574
YAPC,446155,3.8433351119798695,1.8594267642584574
KYSE-70,3854666,1.6457032232411275,1.8594267642584574
MDA-MB-157,49836020,-4.4611089332084335,1.8594267642584574
Panc 04.03,10385095,1.3607276101908192,1.8594267642584574
NCI-H522,piperlongumine-MST-312 (1-1 mol-mol),1.211540874463276,1.8594267642584574
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117,1.8594267642584574
NCI-H460,31703,-0.6563705559837907,1.8594267642584574
HSC-4,135421197,2.1482643592466495,1.8594267642584574
KYSE-70,216345,3.953496119268799,1.8594267642584574
NCI-H2009,44259,0.1981246725332563,1.8594267642584574
NCI-H661,24771867,2.8989054210712784,1.8594267642584574
LOU-NH91,89928392,1.577129115434841,1.8594267642584574
SBC-5,44819697,-0.6119786373907494,1.8594267642584574
CAL-51,135398738,4.757337519270393,1.8594267642584574
A2780,11234052,1.762226904306368,1.8594267642584574
EFO-27,5287969,-2.249416082595734,1.8594267642584574
BT-549,sirolimus-bortezomib (250-1 mol-mol),0.3371996014711167,1.8594267642584574
EFO-27,72734382,4.838814549837177,1.8594267642584574
A2780,2126,3.67742533530732,1.8594267642584574
NOMO-1,656346,0.9377734591624955,1.8594267642584574
NCI-H522,439501,-5.784929410118117,1.8594267642584574
NOMO-1,4521392,4.093982124965485,1.8594267642584574
NCI-H2009,452548,-0.9979896146805513,1.8594267642584574
NOMO-1,327653,2.81345515165661,1.8594267642584574
A-673,46191454,-1.7005324627981964,1.8594267642584574
A2780,168312962,0.1167104942518841,1.8594267642584574
HSC-4,11214940,4.953530718305131,1.8594267642584574
KYSE-70,44507138,1.8487883665285316,1.8594267642584574
MDA-MB-453,5566,2.956907653722259,1.8594267642584574
SNU-81,selumetinib-PLX-4032 (8-1 mol-mol),-1.7498226144583562,1.8594267642584574
SNU-449,24753719,4.452712705797618,1.8594267642584574
HSC-4,6184667,2.683776581109496,1.8594267642584574
Panc 04.03,4477,1.027037586587599,1.8594267642584574
CA46,24951314,-0.0442972386064399,1.8594267642584574
MDA-MB-453,JQ-1-vorinostat (2-1 mol-mol),-0.5883390027404639,1.8594267642584574
NCI-H460,637858,3.384702960830197,1.8594267642584574
MSTO-211H,54618164,3.0389284404004795,1.8594267642584574
BxPC-3,135875424,4.118804534986376,1.8594267642584574
LoVo,374536,3.1459286411718055,1.8594267642584574
SBC-5,65064,5.87027592575748,1.8594267642584574
A2780,2708,1.6817262399506028,1.8594267642584574
NCI-H292,11427553,2.7677841547579347,1.8594267642584574
EFO-27,10184653,2.474041422726229,1.8594267642584574
LXF 289,16038120,0.5250135720403194,1.8594267642584574
LoVo,piperlongumine-MST-312 (1-1 mol-mol),2.135338171440717,1.8594267642584574
OVISE,selumetinib-JQ-1 (4-1 mol-mol),1.7685285533186823,1.8594267642584574
LoVo,navitoclax-sorafenib (1-1 mol-mol),2.5511515051305893,1.8594267642584574
BxPC-3,10184653,-0.596247884950306,1.8594267642584574
KMRC-1,54618771,0.2036698487849761,1.8594267642584574
FTC-133,4705,5.547028107549284,1.8594267642584574
A2780,107970,2.1177540249197246,1.8594267642584574
DMS 273,15983966,-4.308041598319055,1.8594267642584574
DMS 273,JQ-1-UNC0638 (2-1 mol-mol),0.3284926048856003,1.8594267642584574
HCC1143,637858,1.5767538824178036,1.8594267642584574
OVISE,753704,5.218614122812972,1.8594267642584574
NCI-H1623,148124,4.04127286799143,1.8594267642584574
NCI-H661,1716436,2.7606212382296205,1.8594267642584574
A2780,5328940,1.6938804432156576,1.8594267642584574
Panc 04.03,doxorubicin-navitoclax (2-1 mol-mol),0.7758881761631229,1.8594267642584574
A-673,52947716,2.7267743407084333,1.8594267642584574
LXF 289,51039095,1.6878089310027404,1.8594267642584574
LoVo,24753719,4.853832341629896,1.8594267642584574
FU-OV-1,16065773,3.3464590574422424,1.8594267642584574
Panc 04.03,439501,0.3022334331499904,1.8594267642584574
NCI-H2009,44137675,2.9238442509206606,1.8594267642584574
SCC-9,24964624,2.350052808289582,1.8594267642584574
BT-549,56946209,-4.178729112607428,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],969516,2.888727843593038,1.8594267642584574
NCI-H460,1716436,4.318712917611328,1.8594267642584574
MSTO-211H,4917,2.9904400598930088,1.8594267642584574
NCI-H2009,5282054,3.436101167626708,1.8594267642584574
FU-OV-1,53232,3.5510277872612903,1.8594267642584574
NCI-H460,3503,2.4668231300278154,1.8594267642584574
CAL-51,6252,-0.2076922850947726,1.8594267642584574
CA46,44607531,1.0933116261411373,1.8594267642584574
NCI-H2171,44589607,1.1207968177639505,1.8594267642584574
ONS-76,selumetinib-PLX-4032 (8-1 mol-mol),-0.2158611974685485,1.8594267642584574
BT-549,5311,2.3943998607281314,1.8594267642584574
SNU-61,44491742,3.859456688826312,1.8594267642584574
JM-1,46943432,-0.1491870155181681,1.8594267642584574
HSC-4,156414,0.4374127066870092,1.8594267642584574
EFO-27,tretinoin-navitoclax (4-1 mol-mol),4.088217515777896,1.8594267642584574
OPM-2,42611257,3.2957467857000404,1.8594267642584574
A2780,136227331,3.7351205807719863,1.8594267642584574
MDA-MB-157,71751553,2.589623955944651,1.8594267642584574
HCC1143,262093,2.740628946324062,1.8594267642584574
NCI-H522,56946209,-5.885513086137786,1.8594267642584574
A2780,67156097,-2.4563073864206633,1.8594267642584574
FU-OV-1,136227924,3.2834953568281597,1.8594267642584574
NCI-H1623,241158,4.3681147628536445,1.8594267642584574
ONS-76,2828334,6.172523844471339,1.8594267642584574
BxPC-3,11625818,4.084435736278963,1.8594267642584574
DMS 273,5281321,-3.764975659067455,1.8594267642584574
KMRC-1,3825829,4.43742858244417,1.8594267642584574
JM-1,5280436,0.8051765864900793,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11175137,3.6620571654650846,1.8594267642584574
MDA-MB-157,9927531,5.35009923211275,1.8594267642584574
OPM-2,56963564,0.1507827744052812,1.8594267642584574
JM-1,9825149,1.1101255190052433,1.8594267642584574
A4/Fukuda,136227924,1.9204852137512072,1.8594267642584574
A-498,sirolimus-bortezomib (250-1 mol-mol),0.4701899983837266,1.8594267642584574
Panc 04.03,16065773,3.1082338307326687,1.8594267642584574
KMRC-1,148198,-3.0121915653316953,1.8594267642584574
NCI-H727,11612883,2.6691234813665226,1.8594267642584574
A-673,25183872,-1.50300168442849,1.8594267642584574
NCI-H292,5470400,0.7410873105484811,1.8594267642584574
SNU-61,24771867,2.3194270269791772,1.8594267642584574
ONS-76,2729026,2.9392891978845626,1.8594267642584574
NCI-H522,54618305,4.230012053256092,1.8594267642584574
MDA-MB-157,6918328,-1.4439105140240134,1.8594267642584574
SCC-9,11609586,3.4579622750703902,1.8594267642584574
NCI-H2009,73707398,1.4628489872410333,1.8594267642584574
BT-549,613753,3.1113642662223913,1.8594267642584574
NCI-H522,11396600,3.374818989992459,1.8594267642584574
A2780,227681,3.163289337051595,1.8594267642584574
SNU-61,42642645,0.1547953205487765,1.8594267642584574
EFO-27,24753719,4.6250624916483405,1.8594267642584574
NCI-H522,1750826,-4.884358581349171,1.8594267642584574
NCI-H460,3854666,3.1385110084048065,1.8594267642584574
Panc 04.03,16736978,2.069266987472695,1.8594267642584574
KYSE-70,135875424,3.720063911223788,1.8594267642584574
NCI-H146,tanespimycin-bortezomib (250-1 mol-mol),-0.2657593294173981,1.8594267642584574
NCI-H727,4369359,4.470803757423574,1.8594267642584574
SNU-61,10296883,3.559313583941647,1.8594267642584574
MSTO-211H,24748573,5.719931334372704,1.8594267642584574
SNU-81,5479543,2.97701110816304,1.8594267642584574
BT-549,2733526,4.582584043539932,1.8594267642584574
A2780,135423438,1.4521240670524396,1.8594267642584574
A-673,24772860,-3.1744597884682997,1.8594267642584574
G-401,15953870,2.2768915791068483,1.8594267642584574
DMS 273,5738263,3.533950076223639,1.8594267642584574
BT-549,SNX-2112-bortezomib (250-1 mol-mol),0.8532729508269209,1.8594267642584574
MSTO-211H,10385095,1.0224754227931234,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],10231331,1.8254668182041616,1.8594267642584574
EFO-27,25062766,1.510659268863457,1.8594267642584574
FTC-133,11612883,4.310092339589411,1.8594267642584574
MDA-MB-453,11455910,-0.0078824359576409,1.8594267642584574
FTC-133,23582824,1.291713189645836,1.8594267642584574
MSTO-211H,6918289,3.158366552983379,1.8594267642584574
CAL-51,9826308,0.5677925602140103,1.8594267642584574
OPM-2,doxorubicin-navitoclax (2-1 mol-mol),-1.5033566295439995,1.8594267642584574
LoVo,JQ-1-UNC0638 (2-1 mol-mol),3.1589551233195428,1.8594267642584574
NCI-H292,25195348,2.925898223014509,1.8594267642584574
NCI-H661,71466380,4.502023854991524,1.8594267642584574
SNU-449,17755052,1.8812917370069304,1.8594267642584574
SCC-9,11977753,0.680369597029185,1.8594267642584574
DMS 273,selumetinib-PLX-4032 (8-1 mol-mol),5.046947236193085,1.8594267642584574
LXF 289,selumetinib-BRD-A02303741 (4-1 mol-mol),3.5296053048894116,1.8594267642584574
JM-1,carboplatin-UNC0638 (2-1 mol-mol),2.589326672729891,1.8594267642584574
OPM-2,56973724,2.552424788495835,1.8594267642584574
ONS-76,24785538,3.425081329750359,1.8594267642584574
OVISE,6914657,-4.467384055269322,1.8594267642584574
CA46,7326481,2.91557869092902,1.8594267642584574
SNU-61,445091,3.84586130327939,1.8594267642584574
SNU-81,387447,-4.728664972971387,1.8594267642584574
A4/Fukuda,613000,-0.1954730319333323,1.8594267642584574
JM-1,54143018,0.7319009489566454,1.8594267642584574
FU-OV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.2027157770718528,1.8594267642584574
MDA-MB-157,tanespimycin-bortezomib (250-1 mol-mol),-1.1455809440560911,1.8594267642584574
NCI-H2009,11222830,1.732127254120576,1.8594267642584574
Panc 04.03,25105715,3.6014191473601236,1.8594267642584574
BxPC-3,3038522,3.5132521338876352,1.8594267642584574
SBC-5,2945648,3.183732803518487,1.8594267642584574
SNU-449,6450551,3.816508101047544,1.8594267642584574
A2780,4261,0.5678575604143293,1.8594267642584574
JM-1,54639665,5.005029028557516,1.8594267642584574
MDA-MB-453,55508,3.100658329893645,1.8594267642584574
FU-OV-1,vorinostat-navitoclax (4-1 mol-mol),1.2627597867759035,1.8594267642584574
OPM-2,71466578,1.093801721105574,1.8594267642584574
DMS 273,219104,2.8685320291275276,1.8594267642584574
MSTO-211H,36314,2.7056254754018,1.8594267642584574
NCI-H661,135999136,1.375733620998009,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],1641662,3.738448071417011,1.8594267642584574
A4/Fukuda,387447,-5.631039688913266,1.8594267642584574
ONS-76,65064,5.2757302482281005,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],JQ-1-MK-0752 (1-1 mol-mol),2.1464995044057606,1.8594267642584574
LXF 289,613753,3.241655631161551,1.8594267642584574
NCI-H661,25262965,-2.0298208680132253,1.8594267642584574
LXF 289,6438330,5.338014468481796,1.8594267642584574
HSC-4,51037431,1.5211622982639597,1.8594267642584574
HCC1143,ISOX-bortezomib (250-1 mol-mol),0.6900085602161256,1.8594267642584574
A-673,613000,2.3658771635142877,1.8594267642584574
A4/Fukuda,135421197,1.440002399326734,1.8594267642584574
G-401,tretinoin-carboplatin (2-1 mol-mol),5.235487615212222,1.8594267642584574
NCI-H522,322968,2.453472191773609,1.8594267642584574
JM-1,702558,3.1195416036187646,1.8594267642584574
NCI-H1623,60700,-0.6326390393669364,1.8594267642584574
KYSE-70,71466578,3.801340757329347,1.8594267642584574
OPM-2,969516,1.7213945625906069,1.8594267642584574
FTC-133,71751553,4.47121108066688,1.8594267642584574
HSC-4,4261,2.7283942469645424,1.8594267642584574
DMS 273,60750,-2.8080851182888096,1.8594267642584574
BT-549,11955716,4.243153956403502,1.8594267642584574
ONS-76,104842,-3.1760610756826826,1.8594267642584574
JM-1,54619267,3.2762986321752656,1.8594267642584574
NCI-H460,11427553,3.3912724357702873,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],4261,0.3806474761357037,1.8594267642584574
KYSE-70,3503,4.330341802091645,1.8594267642584574
LoVo,6505803,-0.2027234925460443,1.8594267642584574
A2780,123631,2.055120977987268,1.8594267642584574
CA46,216345,3.098455032375494,1.8594267642584574
SBC-5,216345,4.3270666561224935,1.8594267642584574
SBC-5,104842,-4.617883126488141,1.8594267642584574
KYSE-70,3025944,3.9400169946897226,1.8594267642584574
JM-1,16725315,3.055633956084052,1.8594267642584574
KYSE-70,3385,2.7043091028991175,1.8594267642584574
SNU-61,241158,3.885428513145571,1.8594267642584574
Panc 04.03,44819697,-0.3269217472163675,1.8594267642584574
LOU-NH91,151289,1.7382502757713727,1.8594267642584574
SW1463,72193861,2.3780707386668563,1.8594267642584574
FU-OV-1,3081361,1.2672435670761582,1.8594267642584574
NCI-H2171,5311,-0.0981787470707459,1.8594267642584574
OVISE,15983966,2.4746719809654474,1.8594267642584574
CA46,56649450,3.397645307363617,1.8594267642584574
G-401,135398516,1.567409789625541,1.8594267642584574
A4/Fukuda,285033,-4.063528792592557,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],31703,0.9691163018023546,1.8594267642584574
SNU-81,2113511,5.998073078967423,1.8594267642584574
SBC-5,984333,1.1242620116457585,1.8594267642584574
DMS 273,31703,-1.0453531837534489,1.8594267642584574
SNU-449,11955716,-1.9372940063200903,1.8594267642584574
JM-1,156414,0.9517000986854224,1.8594267642584574
A-498,5746,0.9967598286589636,1.8594267642584574
CAL-51,168313016,5.819136604546001,1.8594267642584574
SNU-61,doxorubicin-navitoclax (2-1 mol-mol),0.8790870297518688,1.8594267642584574
SNU-449,selumetinib-PLX-4032 (8-1 mol-mol),4.586042131351809,1.8594267642584574
DMS 273,285033,-4.2902604104934685,1.8594267642584574
NCI-H1623,25227462,1.3835292391956049,1.8594267642584574
SNU-449,46199207,3.2102080061749665,1.8594267642584574
NCI-H727,54619267,4.766187279700058,1.8594267642584574
KYSE-70,2729026,2.877153539650856,1.8594267642584574
JM-1,9866186,-1.392842627261666,1.8594267642584574
CA46,9956119,2.2503821303322864,1.8594267642584574
NCI-H1623,10302451,3.5735543079001553,1.8594267642584574
NCI-H460,119607,4.735621464768821,1.8594267642584574
LXF 289,36462,2.912637639845359,1.8594267642584574
HCC1143,208908,2.564266394778906,1.8594267642584574
CA46,doxorubicin-navitoclax (2-1 mol-mol),-1.6756299291036936,1.8594267642584574
HSC-4,10296883,4.12801319058873,1.8594267642584574
NCI-H460,44819697,0.8384181776379687,1.8594267642584574
A-673,644241,3.265724898737132,1.8594267642584574
SBC-5,55283,1.6476943611515316,1.8594267642584574
CAL-51,60700,-0.6497243984818711,1.8594267642584574
NCI-H460,44819697,0.8384181776379687,1.8594267642584574
NCI-H460,2113511,6.407699041859446,1.8594267642584574
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725,1.8594267642584574
NCI-H146,44819697,-3.0409273944044672,1.8594267642584574
CAL-51,2729026,2.5757432896171517,1.8594267642584574
OPM-2,25262965,-5.528707504919602,1.8594267642584574
BxPC-3,67156097,-2.0030489961064664,1.8594267642584574
SNU-61,11455910,1.387165489844305,1.8594267642584574
MDA-MB-157,6252,-1.2956844965038024,1.8594267642584574
BxPC-3,decitabine-navitoclax (2-1 mol-mol),-0.3566314519475204,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.6431753699859777,1.8594267642584574
MSTO-211H,5284616,-7.533473618112548,1.8594267642584574
CAL-51,ISOX-bortezomib (250-1 mol-mol),1.1183162335023276,1.8594267642584574
NCI-H146,11609586,1.562173805318663,1.8594267642584574
A2780,tretinoin-navitoclax (4-1 mol-mol),1.5980580193271057,1.8594267642584574
KMRC-1,9908783,5.060189279561186,1.8594267642584574
OPM-2,3825829,3.9075204590636226,1.8594267642584574
FTC-133,439501,-1.0725688155870328,1.8594267642584574
MDA-MB-157,73707398,-0.5856522541525173,1.8594267642584574
YAPC,71466380,5.668462841036745,1.8594267642584574
YAPC,81146,5.922853011724604,1.8594267642584574
SNU-61,9935249,2.942554259952632,1.8594267642584574
FTC-133,72193861,2.4976681850124516,1.8594267642584574
NCI-H2171,3025944,4.816182739912449,1.8594267642584574
BT-549,6918638,1.3825585614023566,1.8594267642584574
A-673,24180125,1.1732098097274752,1.8594267642584574
KYSE-70,46907787,2.9670215892594793,1.8594267642584574
NCI-H2171,54678924,2.405018759443171,1.8594267642584574
FU-OV-1,15547703,4.297867355017808,1.8594267642584574
EFO-27,49846579,4.098108273885428,1.8594267642584574
HSC-4,24748573,1.230311327364621,1.8594267642584574
BT-549,10427712,4.3521452258648505,1.8594267642584574
EFO-27,126941,-4.256911665013358,1.8594267642584574
NCI-H2009,4096211,1.934112859371262,1.8594267642584574
MDA-MB-157,salermide-PLX-4032 (12-1 mol-mol),3.2199843556039593,1.8594267642584574
NCI-H146,135999136,1.6477982136645704,1.8594267642584574
HSC-4,selumetinib-PLX-4032 (8-1 mol-mol),3.794219924107932,1.8594267642584574
SNU-449,2746,3.928036011173348,1.8594267642584574
CAL-51,11228183,3.6770505489909007,1.8594267642584574
Panc 04.03,123631,3.678186856777378,1.8594267642584574
MDA-MB-453,6184667,2.451074325070958,1.8594267642584574
EFO-27,6438330,1.8682975687900552,1.8594267642584574
NCI-H661,11497983,4.324872079299071,1.8594267642584574
Panc 04.03,637858,2.9634699724220783,1.8594267642584574
SNU-61,168312962,1.49910092402229,1.8594267642584574
NCI-H522,25183872,-1.6150957585419312,1.8594267642584574
A2780,6252,0.4918472463671758,1.8594267642584574
A-673,15547703,3.0802315016781843,1.8594267642584574
NCI-H1623,36462,0.862958596391428,1.8594267642584574
MSTO-211H,44819697,0.327886174428457,1.8594267642584574
CAL-51,tanespimycin-gemcitabine (1-1 mol-mol),-2.7031816507325517,1.8594267642584574
SNU-81,19582717,3.466001022974326,1.8594267642584574
A2780,6610355,3.3735704633901973,1.8594267642584574
SCC-9,119607,6.006958395758143,1.8594267642584574
NCI-H146,11625818,3.4222174762792843,1.8594267642584574
CAL-51,11178236,-3.674192911743539,1.8594267642584574
NCI-H460,168312962,-1.8333752522095308,1.8594267642584574
NCI-H661,4788,4.879892558412017,1.8594267642584574
JM-1,4705,3.374089362448498,1.8594267642584574
LoVo,3634881,2.800959668083557,1.8594267642584574
OPM-2,11178236,-3.008129792299995,1.8594267642584574
CA46,9884685,-1.0270691788705264,1.8594267642584574
MDA-MB-453,44589607,2.562256212112598,1.8594267642584574
SBC-5,54454,2.279469523172582,1.8594267642584574
LoVo,5311,0.3380696500116906,1.8594267642584574
NOMO-1,100016,4.546215242968586,1.8594267642584574
CAL-51,71304818,3.0248956992793565,1.8594267642584574
HCC1143,216345,3.8986832350959792,1.8594267642584574
CAL-51,54618164,4.021329289838694,1.8594267642584574
NCI-H292,135398516,1.6270415918019412,1.8594267642584574
HSC-4,71466445,6.061667629347064,1.8594267642584574
BT-549,51039095,3.595187367514741,1.8594267642584574
MDA-MB-453,26596,-1.0726693130426117,1.8594267642584574
CA46,4259181,0.0375174782651609,1.8594267642584574
SNU-449,sirolimus-bortezomib (250-1 mol-mol),1.1578809609780345,1.8594267642584574
SBC-5,9887053,2.384081187432928,1.8594267642584574
FTC-133,25154868,4.81278236826852,1.8594267642584574
SNU-61,44202524,1.623676041505741,1.8594267642584574
Panc 04.03,6914657,-3.724597953552904,1.8594267642584574
EFO-27,445091,4.884678811382666,1.8594267642584574
SCC-9,54619267,4.260733417129102,1.8594267642584574
LOU-NH91,3815108,3.3787088400125422,1.8594267642584574
NCI-H2171,135875424,2.950178944342904,1.8594267642584574
HSC-4,selumetinib-piperlongumine (8-1 mol-mol),4.641326276625381,1.8594267642584574
LOU-NH91,11404337,-0.9599092047687252,1.8594267642584574
SBC-5,5746,-1.5208844717109098,1.8594267642584574
NCI-H460,135440466,3.295247648571462,1.8594267642584574
OPM-2,1242560,2.912152501304371,1.8594267642584574
CAL-51,erlotinib-PLX-4032 (2-1 mol-mol),3.3535318918945647,1.8594267642584574
BxPC-3,11364421,-1.186359589843585,1.8594267642584574
NOMO-1,11626560,1.0628914473501356,1.8594267642584574
MDA-MB-157,5311281,2.9465431337253065,1.8594267642584574
LoVo,753704,4.37626239298451,1.8594267642584574
LoVo,1317464,3.6287749925486743,1.8594267642584574
LoVo,11626560,0.8234069861143318,1.8594267642584574
SCC-9,60700,0.6764265945588348,1.8594267642584574
YAPC,5351362,2.7486257978183812,1.8594267642584574
KYSE-70,24797083,1.8843278101436565,1.8594267642584574
LXF 289,65064,4.964411921317377,1.8594267642584574
SNU-449,16736978,1.6431800441666105,1.8594267642584574
HSC-4,BRD-A02303741-carboplatin (1-1 mol-mol),4.481505642686289,1.8594267642584574
CAL-51,3062316,-2.5625958708444205,1.8594267642584574
Panc 04.03,49793307,-2.352687994078586,1.8594267642584574
MSTO-211H,10302451,2.2723798321327826,1.8594267642584574
A-673,54619267,3.9525164677601015,1.8594267642584574
G-401,448949,1.8289326894340776,1.8594267642584574
SCC-9,15983966,-4.042628093805887,1.8594267642584574
CA46,3854666,0.2733202158609283,1.8594267642584574
SBC-5,42642645,2.1700569257248734,1.8594267642584574
FTC-133,6184667,4.171777093513536,1.8594267642584574
A-673,3543504,4.433549859321033,1.8594267642584574
CAL-51,409805,3.8515087112009656,1.8594267642584574
SNU-61,5287620,-1.5621550618200195,1.8594267642584574
BT-549,6610216,4.341228931549091,1.8594267642584574
MDA-MB-453,44566777,-0.164341777615228,1.8594267642584574
CAL-51,219104,3.260140555917495,1.8594267642584574
A4/Fukuda,tanespimycin-gemcitabine (1-1 mol-mol),-4.973874531854187,1.8594267642584574
A2780,65064,4.350950935999884,1.8594267642584574
G-401,9803433,5.696660690430479,1.8594267642584574
BT-549,11626560,2.6049019780447473,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],3025944,4.221207920184214,1.8594267642584574
A-673,107970,1.5652885370840817,1.8594267642584574
A-498,46199207,3.6222117747737057,1.8594267642584574
OPM-2,navitoclax-pluripotin (1-1 mol-mol),-2.4334437397089053,1.8594267642584574
BT-549,11364421,-5.683704390961643,1.8594267642584574
G-401,25195348,3.8836243061511215,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],3552672,4.462538243049003,1.8594267642584574
LoVo,24901704,1.9806347162028537,1.8594267642584574
NCI-H2009,11485656,2.228831542035607,1.8594267642584574
NCI-H2171,1750826,-2.946975931831454,1.8594267642584574
MSTO-211H,5738263,2.0448017247583996,1.8594267642584574
SBC-5,2729026,3.0750341046070933,1.8594267642584574
A-673,60700,-2.9578260017137437,1.8594267642584574
KMRC-1,216239,3.2937854483312172,1.8594267642584574
G-401,7251185,1.5631627066286176,1.8594267642584574
NCI-H522,568763,-0.6787143148403639,1.8594267642584574
MDA-MB-453,52912189,0.0253127265648339,1.8594267642584574
NCI-H1623,637858,3.185553411157662,1.8594267642584574
BxPC-3,65064,4.239552039257921,1.8594267642584574
BxPC-3,44202524,1.2355479078044973,1.8594267642584574
HCC1143,10231331,3.1675049490504943,1.8594267642584574
NCI-H727,4917,3.0740580007272125,1.8594267642584574
NCI-H522,46907787,0.5375692456309028,1.8594267642584574
G-401,4261,0.8301994759372666,1.8594267642584574
HSC-4,46398810,3.0881815243810897,1.8594267642584574
NCI-H460,16722836,2.818869820371906,1.8594267642584574
CAL-51,107985,-4.126908547019261,1.8594267642584574
EFO-27,445643,4.157223404562412,1.8594267642584574
NCI-H661,327653,3.5614910429728295,1.8594267642584574
A2780,15547703,2.917961616739491,1.8594267642584574
Panc 04.03,11222830,1.7267772277517466,1.8594267642584574
NCI-H727,445455,6.030056890362138,1.8594267642584574
A-673,72199292,0.9360047714765588,1.8594267642584574
DMS 273,2945648,3.171749675698132,1.8594267642584574
SCC-9,6917907,-5.592045136043938,1.8594267642584574
CAL-51,72193861,0.6423702350358801,1.8594267642584574
SBC-5,5281321,2.671163534426493,1.8594267642584574
NCI-H2009,10231331,-1.9302715463885551,1.8594267642584574
SCC-9,3825829,4.24505295528646,1.8594267642584574
NCI-H661,702558,4.861012061293982,1.8594267642584574
SCC-9,piperlongumine-MST-312 (1-1 mol-mol),2.236566574852554,1.8594267642584574
MSTO-211H,451668,4.9569649646478515,1.8594267642584574
A2780,9908783,4.382006664554736,1.8594267642584574
EFO-27,44566777,0.6667958565864378,1.8594267642584574
SNU-449,11228183,3.721594588319689,1.8594267642584574
MSTO-211H,322968,3.0218271531726897,1.8594267642584574
NCI-H522,135999136,4.552466214525868,1.8594267642584574
BxPC-3,375860,-1.018881063070817,1.8594267642584574
FTC-133,46398810,3.783858454202458,1.8594267642584574
LXF 289,446155,3.7142968943868073,1.8594267642584574
NCI-H146,54619267,2.4574193717136663,1.8594267642584574
JM-1,400769,-1.2746733592438322,1.8594267642584574
BT-549,5328940,1.7912058861852873,1.8594267642584574
NCI-H460,15547703,4.965379127843483,1.8594267642584574
JM-1,10026128,4.426440879951995,1.8594267642584574
LoVo,327653,2.9108064375514604,1.8594267642584574
HSC-4,5329102,2.7247882686097458,1.8594267642584574
BxPC-3,5460769,-0.1362128387149436,1.8594267642584574
SNU-449,148124,1.515559327544478,1.8594267642584574
KYSE-70,24951314,1.3178292218062186,1.8594267642584574
BT-549,11485656,2.9441987555380855,1.8594267642584574
CAL-51,9866186,1.45916914556855,1.8594267642584574
NOMO-1,5278396,3.0205756000124775,1.8594267642584574
LXF 289,JQ-1-vorinostat (2-1 mol-mol),0.5669885048273257,1.8594267642584574
KMRC-1,42642645,1.142476115564406,1.8594267642584574
NCI-H460,100016,5.855223104671776,1.8594267642584574
MDA-MB-157,25062766,0.4624374403471977,1.8594267642584574
MDA-MB-453,107970,2.0242856345207834,1.8594267642584574
DMS 273,16741245,5.579276049340643,1.8594267642584574
BxPC-3,3689413,-0.056748072256038,1.8594267642584574
KYSE-70,25126798,3.963979956832577,1.8594267642584574
A-673,54678924,2.025744293137832,1.8594267642584574
HCC1143,25062766,2.2830484377909492,1.8594267642584574
NCI-H2171,11625818,4.794880990749841,1.8594267642584574
MDA-MB-453,2729026,2.974469204821206,1.8594267642584574
G-401,9933475,0.0956350981602405,1.8594267642584574
NCI-H460,51039095,3.9314979002332535,1.8594267642584574
NCI-H522,219104,3.343081396349963,1.8594267642584574
NCI-H661,56946209,-3.6194559692185018,1.8594267642584574
SNU-81,568763,0.5116878508289208,1.8594267642584574
A-673,67291369,2.4007963238191854,1.8594267642584574
LoVo,3854666,1.417426416420887,1.8594267642584574
MSTO-211H,439501,-1.1644309958543906,1.8594267642584574
SNU-449,285033,1.5882926770841097,1.8594267642584574
CA46,6918878,-0.7300256707111569,1.8594267642584574
NCI-H146,71466445,0.6815814889300492,1.8594267642584574
SBC-5,10385095,2.1758850118167077,1.8594267642584574
A-498,637858,3.4757595298108974,1.8594267642584574
ONS-76,11964036,2.0748582848578865,1.8594267642584574
NCI-H727,16725315,4.353817237787042,1.8594267642584574
G-401,10427712,4.653472001336551,1.8594267642584574
CA46,10127622,5.462644164632326,1.8594267642584574
SNU-449,25161177,4.378304661297746,1.8594267642584574
MDA-MB-157,49766530,-2.405889714389838,1.8594267642584574
FU-OV-1,23582824,0.4003812349581704,1.8594267642584574
FTC-133,24180719,5.041424864241871,1.8594267642584574
CA46,3689413,-3.563387503989764,1.8594267642584574
NCI-H146,JQ-1-carboplatin (1-1 mol-mol),-0.0863429597614012,1.8594267642584574
CAL-51,tanespimycin-gemcitabine (1-1 mol-mol),-2.7031816507325517,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],322968,4.629178663880947,1.8594267642584574
NCI-H522,6918638,0.2628749411775776,1.8594267642584574
EFO-27,10127622,7.049186817655218,1.8594267642584574
MDA-MB-157,400769,-0.9429856644264992,1.8594267642584574
CAL-51,54618164,4.021329289838694,1.8594267642584574
LOU-NH91,9935249,4.429052878520747,1.8594267642584574
NCI-H727,49766530,1.5110740555461553,1.8594267642584574
A-673,9926054,1.7717409858597033,1.8594267642584574
HCC1143,5351362,1.6023771560954885,1.8594267642584574
NOMO-1,54613361,-1.5441782746277026,1.8594267642584574
JM-1,613000,2.2697515166000355,1.8594267642584574
CAL-51,49793307,-3.2015156477281193,1.8594267642584574
NCI-H1623,1750826,-0.130863987039663,1.8594267642584574
OPM-2,JQ-1-UNC0638 (2-1 mol-mol),-3.4645520478530516,1.8594267642584574
NCI-H460,107970,2.752075604137296,1.8594267642584574
SNU-81,JQ-1-vorinostat (2-1 mol-mol),0.90621526316067,1.8594267642584574
CAL-51,46199207,3.548155956826357,1.8594267642584574
NCI-H2171,10074640,2.5219754676966435,1.8594267642584574
A2780,selumetinib-navitoclax (8-1 mol-mol),1.1083480952702989,1.8594267642584574
A-498,JQ-1-carboplatin (1-1 mol-mol),4.434303177287225,1.8594267642584574
JM-1,11238147,1.2374439058156688,1.8594267642584574
SNU-449,54678924,2.162306121493456,1.8594267642584574
NCI-H522,3854666,0.0482767863302698,1.8594267642584574
KMRC-1,selumetinib-JQ-1 (4-1 mol-mol),4.265974961239561,1.8594267642584574
HSC-4,10427712,3.709601221495256,1.8594267642584574
KMRC-1,10296883,4.079927671527966,1.8594267642584574
A-673,46907787,1.1836850249017303,1.8594267642584574
NCI-H460,67156097,3.7191617083219097,1.8594267642584574
Panc 04.03,11364421,2.200002813497647,1.8594267642584574
A2780,57330099,3.934423580004946,1.8594267642584574
KMRC-1,400769,0.144742351180573,1.8594267642584574
LOU-NH91,25062766,1.8056251936091945,1.8594267642584574
NCI-H460,11175137,3.7005840280640374,1.8594267642584574
HSC-4,124202324,2.961748327308983,1.8594267642584574
DMS 273,46191454,0.2871755056280096,1.8594267642584574
LoVo,23582824,-0.7966748622900964,1.8594267642584574
FU-OV-1,24785538,3.56375796516153,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],9911830,2.5852143987743883,1.8594267642584574
CAL-51,216345,2.9520334452605637,1.8594267642584574
KYSE-70,11427553,3.0124804015996185,1.8594267642584574
NCI-H2009,decitabine-navitoclax (2-1 mol-mol),4.93341873674704,1.8594267642584574
DMS 273,selumetinib-vorinostat (8-1 mol-mol),1.928257280185898,1.8594267642584574
A2780,54618164,3.641335469190071,1.8594267642584574
SNU-61,2708,5.501133929338057,1.8594267642584574
CAL-51,702558,3.5144984342436563,1.8594267642584574
CAL-51,11175137,1.2330676481368064,1.8594267642584574
OPM-2,119607,4.667002181538018,1.8594267642584574
BxPC-3,4096211,0.9773140949236826,1.8594267642584574
NCI-H146,2749,0.7789788955457625,1.8594267642584574
LXF 289,16725315,3.2486511295045677,1.8594267642584574
HCC1143,4261,1.976797651434544,1.8594267642584574
SNU-449,11152667,1.3844218204303944,1.8594267642584574
CAL-51,52947716,-4.729660133739893,1.8594267642584574
SBC-5,4477,-0.6853772163114386,1.8594267642584574
A4/Fukuda,44819697,-1.7397384839387715,1.8594267642584574
NCI-H2009,54618771,-0.2233577251443086,1.8594267642584574
LOU-NH91,2733487,6.3296049393179485,1.8594267642584574
G-401,erlotinib-PLX-4032 (2-1 mol-mol),3.757739778609172,1.8594267642584574
NCI-H146,89928392,0.6603214053079605,1.8594267642584574
SW1463,10231331,-1.1566445252598772,1.8594267642584574
MDA-MB-453,11977753,-1.828846421242697,1.8594267642584574
HSC-4,445643,4.123722857917103,1.8594267642584574
EFO-27,42642645,1.7670896576814532,1.8594267642584574
EFO-27,crizotinib-PLX-4032 (2-1 mol-mol),3.36614562688719,1.8594267642584574
BxPC-3,5311281,3.739267965753581,1.8594267642584574
SBC-5,44185566,3.097813648169307,1.8594267642584574
LOU-NH91,5351362,1.6461408289790205,1.8594267642584574
EFO-27,50905018,5.404252445104634,1.8594267642584574
MDA-MB-453,374536,3.68630764751743,1.8594267642584574
G-401,25262965,-3.9564581939856582,1.8594267642584574
CA46,2749,1.009648399882346,1.8594267642584574
SW1463,387447,-4.88012723681038,1.8594267642584574
A4/Fukuda,8515,2.244185004641864,1.8594267642584574
NCI-H1623,24901704,3.7829050158791064,1.8594267642584574
HCC1143,71680916,4.5741598898507565,1.8594267642584574
YAPC,54143018,2.4773688492488892,1.8594267642584574
FU-OV-1,49793307,-0.2872221589202163,1.8594267642584574
Panc 04.03,168312962,4.832441653848414,1.8594267642584574
NCI-H292,11609586,2.9930145326420146,1.8594267642584574
NCI-H727,25150857,2.574637897952517,1.8594267642584574
NCI-H292,6438330,2.681078996624105,1.8594267642584574
OPM-2,12003241,-2.9738714531294232,1.8594267642584574
MSTO-211H,BRD-A02303741-navitoclax (2-1 mol-mol),0.3230364092955163,1.8594267642584574
NCI-H522,151289,0.0217168787144745,1.8594267642584574
NCI-H146,docetaxel-tanespimycin (2-1 mol-mol),-0.2232334336717333,1.8594267642584574
BT-549,11238147,3.2866911979765803,1.8594267642584574
OVISE,9866186,0.5630702781820192,1.8594267642584574
HSC-4,6918328,0.4827098957230251,1.8594267642584574
NCI-H2009,135411,0.2253946709705592,1.8594267642584574
JM-1,10385095,0.4126425157623973,1.8594267642584574
CA46,45279963,3.66447519946476,1.8594267642584574
A-673,44197249,4.247235211402652,1.8594267642584574
A4/Fukuda,selumetinib-navitoclax (8-1 mol-mol),1.1983954877584069,1.8594267642584574
NCI-H661,135440466,2.665416885593315,1.8594267642584574
G-401,168313016,4.483065775660181,1.8594267642584574
BxPC-3,168313047,2.402437406788064,1.8594267642584574
NCI-H661,2746,2.7828270451310786,1.8594267642584574
FU-OV-1,11612883,1.8669069183790803,1.8594267642584574
DMS 273,53232,2.0931635545137266,1.8594267642584574
BxPC-3,9903786,2.126136875029704,1.8594267642584574
NCI-H661,11625818,4.41260734243293,1.8594267642584574
NCI-H522,16659841,2.9113601324358287,1.8594267642584574
OVISE,53232,2.4849914286727426,1.8594267642584574
EFO-27,135440466,3.806006891786582,1.8594267642584574
SNU-449,5746,3.348109332475853,1.8594267642584574
CAL-51,969516,2.948027689121256,1.8594267642584574
FTC-133,11238147,4.273178384451577,1.8594267642584574
NCI-H522,24748573,1.6076101041751254,1.8594267642584574
MDA-MB-453,46224516,2.0758190952131215,1.8594267642584574
LXF 289,6918878,2.1668969721619833,1.8594267642584574
OPM-2,451668,-1.14063259637223,1.8594267642584574
HCC1143,3689413,0.0716522323698814,1.8594267642584574
SBC-5,135398744,6.447254342428179,1.8594267642584574
CAL-51,227681,3.694103991631346,1.8594267642584574
CAL-51,5287620,-2.338247824560234,1.8594267642584574
A2780,3062316,2.0817886994426704,1.8594267642584574
SNU-61,2858523,2.9582475566417195,1.8594267642584574
SNU-61,54649381,3.9147762798202863,1.8594267642584574
A2780,10385095,0.5603604864283975,1.8594267642584574
MDA-MB-157,11152667,0.7570225590856333,1.8594267642584574
ONS-76,400769,-0.3525004301248006,1.8594267642584574
A-673,409805,3.491559756034339,1.8594267642584574
SBC-5,10184653,2.5351322042771356,1.8594267642584574
NCI-H727,66577038,2.8647542032772604,1.8594267642584574
A-498,6505803,4.020571046679738,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11178236,-3.001745406812045,1.8594267642584574
NCI-H522,2708,5.085998334781725,1.8594267642584574
BT-549,45279963,4.047021813577569,1.8594267642584574
LOU-NH91,25183872,2.2713164299079627,1.8594267642584574
FU-OV-1,24797083,1.8707999880079529,1.8594267642584574
SNU-449,44607530,1.456313243054954,1.8594267642584574
MSTO-211H,1566236,2.167071233614174,1.8594267642584574
JM-1,24951314,0.1302219808330525,1.8594267642584574
EFO-27,53392493,1.9151019076026368,1.8594267642584574
FU-OV-1,16725315,4.930691545287574,1.8594267642584574
NCI-H1623,12003241,-0.4868602659209724,1.8594267642584574
SBC-5,148198,-1.371938553790338,1.8594267642584574
BxPC-3,17755052,0.5794893802598977,1.8594267642584574
SNU-61,11485656,2.115016827038527,1.8594267642584574
LXF 289,2729026,2.289348740995074,1.8594267642584574
MSTO-211H,654092,-1.1984807631004837,1.8594267642584574
A-673,5291,3.269854942504113,1.8594267642584574
LOU-NH91,4705,2.8449970854381945,1.8594267642584574
SBC-5,24753719,5.823724927288436,1.8594267642584574
SNU-61,675434,4.254516948181055,1.8594267642584574
A2780,5278396,2.562980728115376,1.8594267642584574
DMS 273,122327,5.509571347430681,1.8594267642584574
A-673,9884685,0.1604809562987641,1.8594267642584574
NCI-H1623,16722836,1.0817030477122866,1.8594267642584574
NCI-H661,67291369,1.7470049727917394,1.8594267642584574
A4/Fukuda,135398516,0.099848878431286,1.8594267642584574
A-673,568763,-0.0608974572236531,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11396600,4.9998303274937115,1.8594267642584574
SNU-81,11178236,-8.196337700198193,1.8594267642584574
OVISE,navitoclax-PLX-4032 (1-1 mol-mol),-1.1204888715090109,1.8594267642584574
A4/Fukuda,46215462,1.453707580765341,1.8594267642584574
HSC-4,6252,1.1187983220422375,1.8594267642584574
HSC-4,3062316,-0.6194675763886993,1.8594267642584574
NCI-H1623,57330099,4.486652982197453,1.8594267642584574
BxPC-3,23635314,-1.513116034089344,1.8594267642584574
OPM-2,46943432,-1.735277326796896,1.8594267642584574
FTC-133,11175137,3.295108533345337,1.8594267642584574
SNU-61,100016,6.106397388471953,1.8594267642584574
MDA-MB-453,446155,5.408001660467943,1.8594267642584574
NCI-H2009,selumetinib-vorinostat (8-1 mol-mol),-1.4945582225586194,1.8594267642584574
MSTO-211H,168313200,3.954855187852925,1.8594267642584574
LoVo,2729026,2.166128688763036,1.8594267642584574
FU-OV-1,73707398,1.0047751906041116,1.8594267642584574
LOU-NH91,44241473,5.33179348194517,1.8594267642584574
YAPC,135440466,2.1529261418392807,1.8594267642584574
KMRC-1,568763,1.1483170277588293,1.8594267642584574
CAL-51,656346,0.8466306406200714,1.8594267642584574
MDA-MB-157,327653,1.3811083957143218,1.8594267642584574
NCI-H460,107985,-2.632533954936978,1.8594267642584574
NCI-H460,135875424,3.211754300989152,1.8594267642584574
BT-549,119607,5.663531776682701,1.8594267642584574
KYSE-70,4261,1.9447398866595849,1.8594267642584574
CAL-51,44543605,3.919885801001582,1.8594267642584574
SCC-9,44566777,0.4714703461280546,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],16722836,2.4867038992166783,1.8594267642584574
EFO-27,10322450,4.618987367546035,1.8594267642584574
LoVo,452548,-1.7762082467733018,1.8594267642584574
G-401,24821094,2.5559581237528097,1.8594267642584574
Panc 04.03,docetaxel-tanespimycin (2-1 mol-mol),-0.4013709222669032,1.8594267642584574
KYSE-70,135999136,5.194226724950964,1.8594267642584574
NCI-H146,6438330,-0.4558524131736901,1.8594267642584574
BxPC-3,31703,-0.5929664629875476,1.8594267642584574
Panc 04.03,5470400,0.9135030177256964,1.8594267642584574
KYSE-70,25150857,2.5963104301055258,1.8594267642584574
OVISE,selumetinib-piperlongumine (8-1 mol-mol),3.917327807535022,1.8594267642584574
A4/Fukuda,439501,-3.252400391503616,1.8594267642584574
SBC-5,107985,-2.339881885950972,1.8594267642584574
NCI-H146,25227462,0.2247724046939956,1.8594267642584574
JM-1,44491742,3.590859136704876,1.8594267642584574
YAPC,6505803,-0.1975849276423945,1.8594267642584574
MDA-MB-453,10113978,3.193218839681212,1.8594267642584574
A-673,16038120,-1.140194872712738,1.8594267642584574
FTC-133,675434,4.640800834602054,1.8594267642584574
MDA-MB-157,439501,-3.062684000428755,1.8594267642584574
SBC-5,10074640,3.660613951501144,1.8594267642584574
DMS 273,3689413,-1.7704206659692223,1.8594267642584574
SCC-9,36462,2.4622585602605493,1.8594267642584574
NCI-H1623,46843906,3.212648418277938,1.8594267642584574
NCI-H2009,676352,1.803439035619831,1.8594267642584574
CAL-51,387447,-3.720200693098244,1.8594267642584574
SNU-61,navitoclax-pluripotin (1-1 mol-mol),0.1014096267424324,1.8594267642584574
CAL-51,44632017,0.9975947899898204,1.8594267642584574
A-673,tanespimycin-bortezomib (250-1 mol-mol),-0.1560084319129122,1.8594267642584574
DMS 273,9936388,3.4086707637717883,1.8594267642584574
NCI-H1623,24180125,3.727544824819635,1.8594267642584574
NOMO-1,969516,2.327280884248625,1.8594267642584574
A4/Fukuda,1750826,-3.1003590099134284,1.8594267642584574
Panc 04.03,5281321,2.674318568781228,1.8594267642584574
FTC-133,176870,5.80195413779655,1.8594267642584574
CAL-51,10113978,3.4506321601115397,1.8594267642584574
SCC-9,selumetinib-vorinostat (8-1 mol-mol),3.604672449855193,1.8594267642584574
MDA-MB-453,sirolimus-bortezomib (250-1 mol-mol),-2.416971902682566,1.8594267642584574
A2780,3385,2.4446535707127537,1.8594267642584574
DMS 273,45279963,3.8289869697511527,1.8594267642584574
OPM-2,11609586,2.7966274513563496,1.8594267642584574
NCI-H1623,26596,-1.1542368606327895,1.8594267642584574
SW1463,5479543,1.0422897086412093,1.8594267642584574
SNU-449,53392493,3.0071956547718113,1.8594267642584574
Panc 04.03,11178236,-2.395899374087587,1.8594267642584574
A2780,selumetinib-GDC-0941 (4-1 mol-mol),-0.1378336599124344,1.8594267642584574
OVISE,BRD-A02303741-navitoclax (2-1 mol-mol),0.9537570528694392,1.8594267642584574
NCI-H460,9866186,0.4176494313944011,1.8594267642584574
FTC-133,53232,1.7186310962422595,1.8594267642584574
BxPC-3,216345,4.279216843902863,1.8594267642584574
A-673,10296883,3.758044639987347,1.8594267642584574
ONS-76,11178236,-3.26201925681368,1.8594267642584574
CAL-51,25062766,1.9168321284868295,1.8594267642584574
NCI-H522,6852167,2.4506568165817777,1.8594267642584574
SNU-61,72193861,1.1230875557226898,1.8594267642584574
ONS-76,vorinostat-navitoclax (4-1 mol-mol),1.54700333580169,1.8594267642584574
BxPC-3,3543504,4.240175882152398,1.8594267642584574
NCI-H661,73707438,4.487630336801632,1.8594267642584574
OVISE,638278,1.1296919637825429,1.8594267642584574
A4/Fukuda,36314,4.126705075384559,1.8594267642584574
SBC-5,10127622,7.037598772691409,1.8594267642584574
MDA-MB-157,selumetinib-decitabine (4-1 mol-mol),4.44139235410904,1.8594267642584574
BxPC-3,49766530,0.5943123243750338,1.8594267642584574
LoVo,54143018,-0.354466194309244,1.8594267642584574
BT-549,44589607,2.161067974853105,1.8594267642584574
LOU-NH91,3136844,4.41334270983783,1.8594267642584574
OPM-2,5311,-0.071810443528602,1.8594267642584574
G-401,JQ-1-MK-0752 (1-1 mol-mol),0.1350272017197765,1.8594267642584574
HCC1143,676352,2.389016147507623,1.8594267642584574
Panc 04.03,11657048,4.4356176445581,1.8594267642584574
NCI-H661,navitoclax-piperlongumine (1-1 mol-mol),2.7076431504633676,1.8594267642584574
DMS 273,doxorubicin-navitoclax (2-1 mol-mol),-0.5717172949913683,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.7027440652786807,1.8594267642584574
NCI-H1623,374536,0.6337427379168257,1.8594267642584574
SNU-61,3825829,4.102120147241808,1.8594267642584574
DMS 273,56649450,3.5073695444545288,1.8594267642584574
CAL-51,24785538,0.7720267524795773,1.8594267642584574
OVISE,16038120,2.1825815777023965,1.8594267642584574
EFO-27,6918328,-0.3264411901724555,1.8594267642584574
FTC-133,3025944,4.352563236352026,1.8594267642584574
A-673,89183176,3.363943107585485,1.8594267642584574
KYSE-70,123631,1.697265417228948,1.8594267642584574
MDA-MB-157,441298,1.9245422363016824,1.8594267642584574
A-673,156422,4.078876073319714,1.8594267642584574
BxPC-3,676352,2.25430531813019,1.8594267642584574
HSC-4,25150857,3.233332545340528,1.8594267642584574
G-401,24856436,-0.0141865957174665,1.8594267642584574
MSTO-211H,49793307,-4.316049670445352,1.8594267642584574
OPM-2,11485656,1.3184852346481954,1.8594267642584574
HSC-4,208908,1.4999275809756432,1.8594267642584574
MDA-MB-453,54613361,-2.035930507333412,1.8594267642584574
G-401,serdemetan-SCH-529074 (1-1 mol-mol),0.8425945982642317,1.8594267642584574
EFO-27,44589607,3.0601109795549295,1.8594267642584574
SNU-61,44493528,4.287806417412906,1.8594267642584574
G-401,11152667,0.9519757620011424,1.8594267642584574
NCI-H2009,5287620,-2.745575302534365,1.8594267642584574
ONS-76,23725625,4.840348822045759,1.8594267642584574
CAL-51,44620216,5.469091994130916,1.8594267642584574
NCI-H460,9903786,4.057661845653794,1.8594267642584574
A-673,11214940,1.1675505170406824,1.8594267642584574
A-673,24964624,2.426022149354347,1.8594267642584574
BxPC-3,9866186,0.8001699279354296,1.8594267642584574
FTC-133,25062766,3.8237771334178903,1.8594267642584574
HSC-4,42642645,1.8060847122685193,1.8594267642584574
HSC-4,11178236,-3.2670379451965164,1.8594267642584574
HCC1143,JQ-1-vorinostat (2-1 mol-mol),1.5570491988867368,1.8594267642584574
NCI-H2009,selumetinib-UNC0638 (4-1 mol-mol),-1.7113919065901229,1.8594267642584574
MDA-MB-157,selumetinib-MK-2206 (8-1 mol-mol),3.246099259686085,1.8594267642584574
NOMO-1,46843906,1.7610241193794407,1.8594267642584574
NCI-H2171,6917907,-6.363958938419671,1.8594267642584574
DMS 273,11707110,5.189560989731051,1.8594267642584574
LoVo,6918328,-0.3156299102516719,1.8594267642584574
HSC-4,vorinostat-carboplatin (1-1 mol-mol),3.405772607796717,1.8594267642584574
NCI-H2009,44632017,1.0717713653211387,1.8594267642584574
DMS 273,11626560,1.283315066012986,1.8594267642584574
MDA-MB-157,11317348,1.0421206228140214,1.8594267642584574
A2780,5311281,0.918852428114819,1.8594267642584574
DMS 273,2113511,5.781557942421417,1.8594267642584574
LOU-NH91,10184653,1.5324310696398793,1.8594267642584574
BT-549,selumetinib-navitoclax (8-1 mol-mol),4.705621989339038,1.8594267642584574
Panc 04.03,73707398,1.757833710000806,1.8594267642584574
JM-1,JQ-1-navitoclax (2-1 mol-mol),-2.0715419523140883,1.8594267642584574
BxPC-3,11455910,2.77826122800999,1.8594267642584574
MDA-MB-453,11955716,-2.2213534191245303,1.8594267642584574
A-673,navitoclax-MST-312 (1-1 mol-mol),0.824497586093143,1.8594267642584574
NCI-H661,3634881,2.923822089210327,1.8594267642584574
NCI-H460,5281672,4.99885948312363,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],JQ-1-UNC0638 (2-1 mol-mol),1.043202454490808,1.8594267642584574
KYSE-70,4259181,-4.187670573846372,1.8594267642584574
BxPC-3,2756,5.8394588105914105,1.8594267642584574
HCC1143,24901704,3.259585605807663,1.8594267642584574
BxPC-3,selumetinib-vorinostat (8-1 mol-mol),-1.5896818639125374,1.8594267642584574
CAL-51,5470400,4.528848471588079,1.8594267642584574
JM-1,10296883,2.092198976716966,1.8594267642584574
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176,1.8594267642584574
NCI-H146,46199207,1.7925573568525552,1.8594267642584574
OPM-2,448949,1.278414281383,1.8594267642584574
NCI-H146,216239,1.510222966819436,1.8594267642584574
HSC-4,9903786,4.262681016067309,1.8594267642584574
ONS-76,57330099,4.261013423315652,1.8594267642584574
NCI-H522,148124,-6.241132033807486,1.8594267642584574
SNU-449,156414,1.8120811787876097,1.8594267642584574
NCI-H2171,2746,1.1013983502046127,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],400769,-1.066885564414268,1.8594267642584574
LXF 289,135398744,6.087135496005038,1.8594267642584574
SNU-449,3689413,-2.168376107627999,1.8594267642584574
A4/Fukuda,5351362,0.320845740356061,1.8594267642584574
A4/Fukuda,446155,1.0805751863544764,1.8594267642584574
CA46,151289,0.6780663351050565,1.8594267642584574
ONS-76,selumetinib-JQ-1 (4-1 mol-mol),-2.481078216030984,1.8594267642584574
NCI-H292,UNC0638-navitoclax (1-1 mol-mol),0.2061924649473525,1.8594267642584574
NCI-H460,11625818,5.428588497019925,1.8594267642584574
A2780,119182,-2.871948238792312,1.8594267642584574
ONS-76,10385095,1.1655527010487017,1.8594267642584574
EFO-27,51037431,5.317639691280149,1.8594267642584574
A-673,72376,-3.645473298633041,1.8594267642584574
MDA-MB-157,24748573,1.7707431454067368,1.8594267642584574
JM-1,6610355,3.6312795132079136,1.8594267642584574
EFO-27,44819697,-1.290536172530674,1.8594267642584574
A2780,5702613,3.197014181878355,1.8594267642584574
A-498,25102847,3.3376740856950335,1.8594267642584574
KMRC-1,3634881,3.321374403116886,1.8594267642584574
OPM-2,3081361,1.5210485339307265,1.8594267642584574
LOU-NH91,3038522,4.554088179549466,1.8594267642584574
SNU-61,216239,1.9834133881004128,1.8594267642584574
FU-OV-1,124202324,1.4335087059128786,1.8594267642584574
NCI-H292,72193861,2.2952018559260363,1.8594267642584574
MDA-MB-453,53495165,1.832682106227088,1.8594267642584574
NCI-H2171,31703,-2.460746582121975,1.8594267642584574
NCI-H460,2729026,3.0609463870825926,1.8594267642584574
SBC-5,9868037,1.591902673624677,1.8594267642584574
LoVo,44632017,0.6073588127957028,1.8594267642584574
JM-1,25262965,-2.478831797463893,1.8594267642584574
SCC-9,148198,-2.735497552895971,1.8594267642584574
CA46,89928392,0.0283947615438792,1.8594267642584574
OVISE,5566,3.518034595538079,1.8594267642584574
HSC-4,5278396,3.3910828172613128,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],462382,0.7838643978728388,1.8594267642584574
KYSE-70,4788,5.890959200463747,1.8594267642584574
SNU-61,serdemetan-SCH-529074 (1-1 mol-mol),2.1746130433144386,1.8594267642584574
Panc 04.03,374536,2.376032280196277,1.8594267642584574
NCI-H661,20959075,-3.3600823520668306,1.8594267642584574
LXF 289,3543504,4.042070583449167,1.8594267642584574
SNU-449,5287620,0.008240040829162,1.8594267642584574
HCC1143,11719255,3.553533872223464,1.8594267642584574
NOMO-1,54618164,3.731990472759892,1.8594267642584574
A4/Fukuda,piperlongumine-MST-312 (1-1 mol-mol),1.0662246579823889,1.8594267642584574
NCI-H1623,5311,1.5946462199665867,1.8594267642584574
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076,1.8594267642584574
LOU-NH91,216468,5.562373540734892,1.8594267642584574
JM-1,9915743,0.8499678141273637,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.7783627662163426,1.8594267642584574
NOMO-1,107985,-4.118574275669005,1.8594267642584574
JM-1,135423438,1.5495237102322077,1.8594267642584574
A-673,24856436,-1.1403661815810562,1.8594267642584574
CAL-51,5282054,3.552468823116285,1.8594267642584574
CAL-51,11178236,-3.674192911743539,1.8594267642584574
G-401,6252,-0.6004387834343344,1.8594267642584574
KMRC-1,4261,3.216149224144429,1.8594267642584574
MSTO-211H,54454,-0.190602208325988,1.8594267642584574
CAL-51,4917,3.122174268556499,1.8594267642584574
HCC1143,54649381,3.828405406955801,1.8594267642584574
EFO-27,25262965,-3.442895730672298,1.8594267642584574
NCI-H522,54626689,4.6269731577498066,1.8594267642584574
KMRC-1,123631,2.4243478642730634,1.8594267642584574
JM-1,JQ-1-vorinostat (2-1 mol-mol),-2.067527251050835,1.8594267642584574
MSTO-211H,6438330,1.6419113469823416,1.8594267642584574
CAL-51,446155,1.9002286289262065,1.8594267642584574
MSTO-211H,25126798,3.885175037199499,1.8594267642584574
KYSE-70,54626689,6.762622459467938,1.8594267642584574
FTC-133,navitoclax-pluripotin (1-1 mol-mol),-1.324010652875928,1.8594267642584574
CA46,4705,3.1649236354970154,1.8594267642584574
LOU-NH91,36314,-6.12634068503974,1.8594267642584574
OPM-2,49766530,-3.767684481967312,1.8594267642584574
NCI-H460,135411,0.3374737909082799,1.8594267642584574
NCI-H2009,6623618,3.0922058987418315,1.8594267642584574
KMRC-1,44185566,3.110367208302614,1.8594267642584574
Panc 04.03,9933475,2.3468691227324965,1.8594267642584574
NCI-H146,25105715,3.2144396386290617,1.8594267642584574
SBC-5,25062766,3.305997596539037,1.8594267642584574
G-401,11364421,-5.069536717957333,1.8594267642584574
OPM-2,1285940,4.143301448340403,1.8594267642584574
NCI-H661,46843906,3.609730466041,1.8594267642584574
JM-1,selumetinib-piperlongumine (8-1 mol-mol),2.3811879474866093,1.8594267642584574
NCI-H292,selumetinib-MK-2206 (8-1 mol-mol),0.2769010439937888,1.8594267642584574
ONS-76,656346,2.4725060186946974,1.8594267642584574
A-498,135421197,2.4500558267656873,1.8594267642584574
YAPC,5280436,4.973863444979394,1.8594267642584574
NCI-H522,53481919,3.906372094667401,1.8594267642584574
CAL-51,448949,2.479839067238928,1.8594267642584574
MSTO-211H,JQ-1-navitoclax (2-1 mol-mol),-0.1744059770900167,1.8594267642584574
NCI-H727,15953870,3.6175866373148713,1.8594267642584574
A4/Fukuda,4378219,1.9024946719152895,1.8594267642584574
ONS-76,374536,5.32668572402577,1.8594267642584574
HCC1143,387447,-2.8902460626215216,1.8594267642584574
A2780,navitoclax-piperlongumine (1-1 mol-mol),1.0612869409921282,1.8594267642584574
OPM-2,3543504,2.699241331915609,1.8594267642584574
G-401,54618305,4.431468655886698,1.8594267642584574
A2780,54649381,3.634529154077109,1.8594267642584574
LXF 289,5287620,-2.3080718171081385,1.8594267642584574
YAPC,637858,2.16601707981449,1.8594267642584574
NCI-H522,9915743,1.083108246388964,1.8594267642584574
KYSE-70,25183872,-0.2407157689495178,1.8594267642584574
NCI-H522,56649450,4.1349782138767655,1.8594267642584574
OPM-2,52947716,0.8847701060718332,1.8594267642584574
SBC-5,124202324,2.6085939591802307,1.8594267642584574
DMS 273,2742550,3.72774264414297,1.8594267642584574
NCI-H522,BRD-A02303741-navitoclax (2-1 mol-mol),5.562601250875811,1.8594267642584574
NCI-H522,44491742,4.766943404170333,1.8594267642584574
MSTO-211H,3503,2.7854032891391163,1.8594267642584574
FTC-133,10427712,4.710340548147587,1.8594267642584574
SW1463,56946209,-2.6004240108086187,1.8594267642584574
KMRC-1,11178236,-3.5821993315226175,1.8594267642584574
NCI-H146,5281672,3.80713040102785,1.8594267642584574
SBC-5,16038120,3.1431644252796835,1.8594267642584574
NCI-H522,421610,1.9391714098470076,1.8594267642584574
DMS 273,9866186,1.1265446059819233,1.8594267642584574
SNU-61,11717001,3.914635952460324,1.8594267642584574
NCI-H522,JQ-1-MK-0752 (1-1 mol-mol),0.1872499419058635,1.8594267642584574
LOU-NH91,44137675,3.1585262513685612,1.8594267642584574
JM-1,5335621,3.4974928376934766,1.8594267642584574
CAL-51,444795,5.053001195278548,1.8594267642584574
SNU-81,68056272,2.81466177200511,1.8594267642584574
MDA-MB-157,23582824,1.002360199735323,1.8594267642584574
CAL-51,44185566,1.8630594392382311,1.8594267642584574
MDA-MB-453,54618771,-0.4179555738274852,1.8594267642584574
MDA-MB-157,16038120,1.7351596622267822,1.8594267642584574
OVISE,44589607,3.8530354372246394,1.8594267642584574
LOU-NH91,navitoclax-MST-312 (1-1 mol-mol),-1.3828767553270485,1.8594267642584574
NCI-H460,400769,-0.4007490431715684,1.8594267642584574
SCC-9,5460769,4.655053652221148,1.8594267642584574
MDA-MB-453,135398516,1.6443590350340722,1.8594267642584574
OPM-2,444795,4.04932788863876,1.8594267642584574
MDA-MB-157,navitoclax-birinapant (1-1 mol-mol),-3.5674569438027977,1.8594267642584574
OVISE,navitoclax-MST-312 (1-1 mol-mol),0.1298249702458385,1.8594267642584574
HSC-4,11656518,1.5757846986297326,1.8594267642584574
MDA-MB-453,navitoclax-pluripotin (1-1 mol-mol),-0.3400363144819007,1.8594267642584574
G-401,3062316,1.3877203939609295,1.8594267642584574
SNU-61,16013152,3.3306050431250056,1.8594267642584574
NCI-H292,4259181,-0.3596950747779806,1.8594267642584574
G-401,6918638,0.0373379560261908,1.8594267642584574
NCI-H460,53232,3.485336782178725,1.8594267642584574
NCI-H292,navitoclax-pluripotin (1-1 mol-mol),-0.7245377190748261,1.8594267642584574
HSC-4,262093,2.780665409693215,1.8594267642584574
LoVo,100016,6.001395250082881,1.8594267642584574
OVISE,2729026,3.0624747536258843,1.8594267642584574
SNU-449,46174525,4.694645250518289,1.8594267642584574
MDA-MB-453,25102847,3.185871702253412,1.8594267642584574
NCI-H661,selumetinib-piperlongumine (8-1 mol-mol),4.143402820216487,1.8594267642584574
LoVo,208908,1.8298234127328137,1.8594267642584574
DMS 273,36462,2.158918041886743,1.8594267642584574
SCC-9,252682,6.244434841835944,1.8594267642584574
CAL-51,3689413,0.5709426612715743,1.8594267642584574
ONS-76,5328940,1.5304760606777814,1.8594267642584574
KYSE-70,46199207,3.0458734214111436,1.8594267642584574
NCI-H2009,sirolimus-bortezomib (250-1 mol-mol),2.102899194038225,1.8594267642584574
NCI-H727,16720766,2.0944103672723577,1.8594267642584574
CAL-51,16741245,4.222373420591208,1.8594267642584574
HSC-4,23939,4.494005895197972,1.8594267642584574
LoVo,60700,-0.3967380120150421,1.8594267642584574
MDA-MB-453,25262965,-0.03783703480807,1.8594267642584574
A-498,374536,-1.3715174839162405,1.8594267642584574
SNU-61,107970,2.0644711824277757,1.8594267642584574
G-401,702558,4.958816468985481,1.8594267642584574
MDA-MB-157,tanespimycin-gemcitabine (1-1 mol-mol),-1.0230607950179071,1.8594267642584574
NOMO-1,16038120,-0.1786929053902652,1.8594267642584574
HSC-4,3543504,3.922868331711394,1.8594267642584574
NCI-H460,vorinostat-carboplatin (1-1 mol-mol),4.479996249659036,1.8594267642584574
SNU-61,10410894,3.2150759349666176,1.8594267642584574
JM-1,2746,0.8560843341026924,1.8594267642584574
NCI-H2009,15547703,2.9018345982556935,1.8594267642584574
A2780,246676,4.314588687253318,1.8594267642584574
CA46,135398738,2.145043320547598,1.8594267642584574
MDA-MB-157,55508,0.9028127001821934,1.8594267642584574
Panc 04.03,71304818,2.709197405012258,1.8594267642584574
MDA-MB-453,53301938,4.664434739240087,1.8594267642584574
A-673,46843906,1.5511639515888018,1.8594267642584574
OPM-2,selumetinib-JQ-1 (4-1 mol-mol),-1.0917216914210384,1.8594267642584574
MDA-MB-453,3543504,4.170014094465671,1.8594267642584574
NCI-H2171,5470400,-1.4637445210918176,1.8594267642584574
NCI-H292,25062766,1.6798511870535655,1.8594267642584574
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055,1.8594267642584574
A4/Fukuda,16736978,-0.5754825114210159,1.8594267642584574
JM-1,2749,0.0460059123026362,1.8594267642584574
SCC-9,46215462,2.815249887965138,1.8594267642584574
SNU-61,24821094,2.5022209832597757,1.8594267642584574
LXF 289,44493528,4.295099384269069,1.8594267642584574
KYSE-70,54649381,4.140433754758901,1.8594267642584574
CA46,JQ-1-navitoclax (2-1 mol-mol),-0.4595467452216603,1.8594267642584574
SNU-61,9826308,1.2155896819085543,1.8594267642584574
NCI-H522,49766530,-2.92412408259348,1.8594267642584574
HCC1143,44493528,4.485488370266477,1.8594267642584574
A2780,sirolimus-bortezomib (250-1 mol-mol),-4.6812912688082555,1.8594267642584574
CAL-51,3081361,1.780158758130264,1.8594267642584574
DMS 273,2746,1.8465116882146249,1.8594267642584574
HCC1143,5282054,3.2164949694146237,1.8594267642584574
LoVo,navitoclax-gemcitabine (1-1 mol-mol),0.8957448181446594,1.8594267642584574
SBC-5,644241,3.9213876276885458,1.8594267642584574
DMS 273,702558,5.649496210085508,1.8594267642584574
NCI-H661,25183872,-0.013752841490686,1.8594267642584574
NCI-H1623,71751553,5.091527890142487,1.8594267642584574
SNU-61,10322450,3.828611192492266,1.8594267642584574
YAPC,44589607,1.444383642816813,1.8594267642584574
FTC-133,426756,4.37678677221598,1.8594267642584574
DMS 273,25062766,2.819032107658894,1.8594267642584574
KYSE-70,375860,-0.042936769343065,1.8594267642584574
NCI-H292,6623618,2.2662127680014708,1.8594267642584574
A2780,3634881,2.2771511965432767,1.8594267642584574
FTC-133,11427553,5.52425857278767,1.8594267642584574
FTC-133,613753,3.41594619216373,1.8594267642584574
DMS 273,5978,-4.4169630962529896,1.8594267642584574
MDA-MB-453,135398738,3.241714649843938,1.8594267642584574
G-401,252682,7.482268639703102,1.8594267642584574
CAL-51,126941,-2.448006630223804,1.8594267642584574
KMRC-1,1716436,3.642710819139985,1.8594267642584574
KMRC-1,9967941,4.338887861114791,1.8594267642584574
ONS-76,serdemetan-SCH-529074 (1-1 mol-mol),2.2978761416603812,1.8594267642584574
A-673,16725315,4.562355532440761,1.8594267642584574
NCI-H661,54613361,-0.43407763491745,1.8594267642584574
NCI-H727,17755052,2.165535951118127,1.8594267642584574
LOU-NH91,4521392,4.279385220000522,1.8594267642584574
NCI-H661,448949,1.832526735111792,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],4788,6.143393528563881,1.8594267642584574
JM-1,24753719,1.6485500810507543,1.8594267642584574
CA46,42642645,0.1424242949920916,1.8594267642584574
A2780,122327,3.970459431332868,1.8594267642584574
LoVo,11609586,1.9215259939554383,1.8594267642584574
NCI-H292,piperlongumine-MST-312 (1-1 mol-mol),3.188802005351175,1.8594267642584574
Panc 04.03,6918328,0.7116207668770654,1.8594267642584574
YAPC,10302451,3.503177254309001,1.8594267642584574
Panc 04.03,262093,3.918875507815306,1.8594267642584574
Panc 04.03,4261,1.8035720705799856,1.8594267642584574
HCC1143,11238147,3.6259374679037943,1.8594267642584574
FU-OV-1,24951314,0.7779749033617789,1.8594267642584574
CA46,135440466,2.9995621349054007,1.8594267642584574
SNU-449,675434,6.334911868299287,1.8594267642584574
G-401,568763,-0.8413074079434755,1.8594267642584574
A4/Fukuda,421610,2.9916322722523425,1.8594267642584574
NCI-H727,11964036,1.415853516680377,1.8594267642584574
SBC-5,53232,3.018737473370281,1.8594267642584574
NCI-H1623,2746,3.1722069840164533,1.8594267642584574
A-673,25102847,1.6240664882379,1.8594267642584574
NCI-H146,71680916,3.9962882248297182,1.8594267642584574
CA46,702558,3.0016875761250383,1.8594267642584574
HSC-4,3465537,2.7025414883497443,1.8594267642584574
SBC-5,15983966,-3.760719305706525,1.8594267642584574
NCI-H661,10184653,-0.0970326303224196,1.8594267642584574
KMRC-1,docetaxel-tanespimycin (2-1 mol-mol),-1.2179749713416546,1.8594267642584574
MDA-MB-453,3634881,3.217596499324366,1.8594267642584574
KMRC-1,54596558,4.448003654736506,1.8594267642584574
SBC-5,6438330,2.801398037891768,1.8594267642584574
DMS 273,11317348,1.436395200538785,1.8594267642584574
MDA-MB-453,241158,3.8848602363142697,1.8594267642584574
CA46,72376,-3.3789820311778764,1.8594267642584574
EFO-27,1242560,3.615097330539702,1.8594267642584574
BxPC-3,51039095,2.7952547650191297,1.8594267642584574
BxPC-3,71466380,5.524538311672043,1.8594267642584574
A2780,49850262,3.28716577139928,1.8594267642584574
EFO-27,148124,2.931737870457193,1.8594267642584574
DMS 273,65064,5.260786534928717,1.8594267642584574
NCI-H727,5328940,1.5210077536616875,1.8594267642584574
SBC-5,20959075,-3.707780876124786,1.8594267642584574
LOU-NH91,5281321,-2.3527775967876097,1.8594267642584574
OVISE,123631,2.580734449711204,1.8594267642584574
BT-549,navitoclax-piperlongumine (1-1 mol-mol),2.0033323756459325,1.8594267642584574
OVISE,56946209,-1.506774361262591,1.8594267642584574
DMS 273,5282054,2.793045570742954,1.8594267642584574
SNU-449,11626560,2.613161578711923,1.8594267642584574
HCC1143,vorinostat-carboplatin (1-1 mol-mol),2.950179443799285,1.8594267642584574
KYSE-70,11214940,1.7563649507227177,1.8594267642584574
Panc 04.03,15953870,4.151399322633975,1.8594267642584574
LXF 289,16736978,1.6084503302226174,1.8594267642584574
MDA-MB-157,60700,-3.9633933148193066,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],25102847,3.88391486543544,1.8594267642584574
NCI-H522,11152667,0.761836671652074,1.8594267642584574
SCC-9,1750826,-1.358939777918893,1.8594267642584574
CAL-51,3854666,1.1494535123186709,1.8594267642584574
CA46,11656518,1.817934601803022,1.8594267642584574
CA46,46843906,1.200591966763502,1.8594267642584574
A4/Fukuda,ISOX-bortezomib (250-1 mol-mol),-0.2493422793699864,1.8594267642584574
CA46,24772860,-2.6679944090404035,1.8594267642584574
G-401,24771867,0.701574094296253,1.8594267642584574
SBC-5,44202524,1.3408029920565403,1.8594267642584574
NCI-H2009,44507138,1.543580962147717,1.8594267642584574
OPM-2,24748573,1.2641689672749945,1.8594267642584574
NCI-H661,3025986,-0.862198206140106,1.8594267642584574
ONS-76,107970,2.339276188405755,1.8594267642584574
BxPC-3,54619267,3.7277591748612866,1.8594267642584574
ONS-76,4917,3.1821597264511863,1.8594267642584574
NOMO-1,44493528,4.211717002525977,1.8594267642584574
SNU-449,421610,4.477929285236737,1.8594267642584574
NCI-H460,4259181,-0.2054535095090753,1.8594267642584574
G-401,327653,2.827166761380022,1.8594267642584574
SNU-449,10302451,2.626140201612578,1.8594267642584574
OPM-2,24964624,1.0133948666397414,1.8594267642584574
NCI-H460,decitabine-carboplatin (1-1 mol-mol),5.711922209034068,1.8594267642584574
SBC-5,441298,0.8643210359830038,1.8594267642584574
NCI-H727,44489367,5.9503570299169875,1.8594267642584574
HSC-4,123631,0.7882754974693414,1.8594267642584574
ONS-76,24753719,3.8801096922841656,1.8594267642584574
A2780,53495165,-2.5208465146636008,1.8594267642584574
SCC-9,135411,1.0456929507985402,1.8594267642584574
A2780,6918878,0.724096247903148,1.8594267642584574
A-498,45279963,3.865048616527305,1.8594267642584574
NCI-H522,51039095,-2.208127710853326,1.8594267642584574
LoVo,5335621,4.644708398315867,1.8594267642584574
HSC-4,46199207,3.2853086951025197,1.8594267642584574
KMRC-1,45279963,3.811973271229391,1.8594267642584574
LXF 289,56946209,-4.292268406284497,1.8594267642584574
OPM-2,24775005,3.1759511003243532,1.8594267642584574
MDA-MB-453,11609586,2.797782394552202,1.8594267642584574
FU-OV-1,JQ-1-carboplatin (1-1 mol-mol),0.7571969377872175,1.8594267642584574
A2780,53481919,3.3933560170788355,1.8594267642584574
G-401,25150857,1.6513368879801875,1.8594267642584574
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055,1.8594267642584574
G-401,126941,-1.029913917257394,1.8594267642584574
FTC-133,JQ-1-MK-0752 (1-1 mol-mol),4.281585420865333,1.8594267642584574
MDA-MB-453,BRD-K55473186,2.6877336742225424,1.8594267642584574
MSTO-211H,5311281,0.6318902138586533,1.8594267642584574
CAL-51,44589607,2.4963130908502107,1.8594267642584574
KMRC-1,11234052,5.10610802043039,1.8594267642584574
OPM-2,erlotinib-PLX-4032 (2-1 mol-mol),3.4874212858880314,1.8594267642584574
HSC-4,5291,4.568554891244716,1.8594267642584574
KYSE-70,3543504,4.273044270546896,1.8594267642584574
NCI-H522,54618164,3.979913879048498,1.8594267642584574
LXF 289,selumetinib-UNC0638 (4-1 mol-mol),2.485737118348581,1.8594267642584574
DMS 273,439501,-3.5888564067388633,1.8594267642584574
MDA-MB-453,122327,4.8881767020652775,1.8594267642584574
A2780,6918837,-3.827695834319955,1.8594267642584574
A4/Fukuda,44489675,3.3968348796203003,1.8594267642584574
NCI-H522,25195348,4.252884841670477,1.8594267642584574
SNU-449,11404337,-0.5921655065432572,1.8594267642584574
MSTO-211H,12003241,-2.79016034960529,1.8594267642584574
A4/Fukuda,selumetinib-PLX-4032 (8-1 mol-mol),2.453113132843287,1.8594267642584574
SNU-61,654092,-1.5451038120184588,1.8594267642584574
NCI-H1623,4705,0.0935418442786881,1.8594267642584574
NCI-H460,3543504,4.388423548450019,1.8594267642584574
NCI-H522,23635314,-4.582316729083318,1.8594267642584574
LXF 289,6918837,-2.0130943060067454,1.8594267642584574
LoVo,31703,-2.470313869470646,1.8594267642584574
MSTO-211H,ISOX-bortezomib (250-1 mol-mol),-0.1802030513255949,1.8594267642584574
FU-OV-1,654092,-1.6613932676517214,1.8594267642584574
OPM-2,60750,-2.943046758118922,1.8594267642584574
Panc 04.03,serdemetan-SCH-529074 (1-1 mol-mol),2.4838177280551057,1.8594267642584574
A4/Fukuda,445643,2.2110077600401996,1.8594267642584574
JM-1,25105715,3.1433974364296526,1.8594267642584574
KYSE-70,9967941,5.193135802047497,1.8594267642584574
Panc 04.03,24748573,2.946919213932378,1.8594267642584574
MDA-MB-453,6918878,0.409116855324534,1.8594267642584574
Panc 04.03,24901704,4.022965674422846,1.8594267642584574
CAL-51,16736978,0.375988055286384,1.8594267642584574
MSTO-211H,sirolimus-bortezomib (250-1 mol-mol),-4.356348785591885,1.8594267642584574
NCI-H727,carboplatin-etoposide (40-17 mol-mol),5.344630715975986,1.8594267642584574
Panc 04.03,462382,1.207122186011881,1.8594267642584574
BxPC-3,568763,0.1839879990612418,1.8594267642584574
A4/Fukuda,11640390,-1.5428779369431247,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],5566,3.137413738775102,1.8594267642584574
NCI-H522,216239,1.926799438191183,1.8594267642584574
G-401,53392493,1.8463111416757765,1.8594267642584574
KMRC-1,241158,4.823138037217212,1.8594267642584574
A-498,5566,2.910612965628124,1.8594267642584574
SNU-61,17755052,2.932810476371255,1.8594267642584574
HSC-4,49793307,-1.7279713732228117,1.8594267642584574
SW1463,49793307,-1.9541064611693424,1.8594267642584574
LXF 289,11964036,0.5627528071719251,1.8594267642584574
FU-OV-1,11228183,2.3859582400300683,1.8594267642584574
EFO-27,5311,0.9089041307391243,1.8594267642584574
SNU-449,44819697,-1.6819344520854818,1.8594267642584574
G-401,JQ-1-UNC0638 (2-1 mol-mol),-0.8221581174940659,1.8594267642584574
A-498,168313307,4.423397924448837,1.8594267642584574
NCI-H522,19582717,4.722348713472889,1.8594267642584574
FU-OV-1,9903786,2.8592788804010936,1.8594267642584574
DMS 273,444795,4.3404236236698495,1.8594267642584574
A2780,56946209,-4.674045280410088,1.8594267642584574
A-498,tretinoin-navitoclax (4-1 mol-mol),1.5109888268131983,1.8594267642584574
A4/Fukuda,3503,1.0521499831923595,1.8594267642584574
SBC-5,6918837,-2.402107568310104,1.8594267642584574
YAPC,23582824,3.2647123156294855,1.8594267642584574
HSC-4,159324,3.192829599869501,1.8594267642584574
ONS-76,54619238,4.4304444652836805,1.8594267642584574
G-401,11228183,5.702662541402335,1.8594267642584574
JM-1,44819697,-3.7816867530650535,1.8594267642584574
SBC-5,54143018,-0.8844414516239579,1.8594267642584574
A4/Fukuda,44589607,1.1710928843495056,1.8594267642584574
ONS-76,44543605,3.8219566402137457,1.8594267642584574
YAPC,15983966,2.0827072702810847,1.8594267642584574
SBC-5,2749,1.818007095297154,1.8594267642584574
FU-OV-1,44487872,4.488734888040304,1.8594267642584574
EFO-27,44197249,3.884486906001317,1.8594267642584574
NCI-H2171,10385095,0.5588950968794439,1.8594267642584574
LXF 289,5351362,2.37199640031851,1.8594267642584574
OPM-2,54618305,3.930022905522119,1.8594267642584574
NCI-H146,327653,2.704686127708374,1.8594267642584574
OVISE,11497983,4.4381003844097595,1.8594267642584574
NCI-H522,11977753,-0.2877362686640902,1.8594267642584574
NCI-H460,JQ-1-vorinostat (2-1 mol-mol),2.751902354538612,1.8594267642584574
NCI-H522,11707110,3.8955176091352857,1.8594267642584574
HSC-4,3676137,3.997252050059137,1.8594267642584574
CA46,BRD-A02303741-navitoclax (2-1 mol-mol),3.6671520767068095,1.8594267642584574
A2780,9840324,5.381878860524984,1.8594267642584574
BT-549,crizotinib-PLX-4032 (2-1 mol-mol),2.4648473849576384,1.8594267642584574
FU-OV-1,6917907,-4.405886494893828,1.8594267642584574
CAL-51,71304818,3.0248956992793565,1.8594267642584574
FU-OV-1,51039095,3.5191953123451096,1.8594267642584574
SNU-449,5470400,0.6313893315276518,1.8594267642584574
MDA-MB-157,6438330,1.1379279588809148,1.8594267642584574
NCI-H727,969516,3.103754409621015,1.8594267642584574
LOU-NH91,439501,-1.197324809082114,1.8594267642584574
FTC-133,sirolimus-bortezomib (250-1 mol-mol),1.8639176688857977,1.8594267642584574
FTC-133,148124,-3.926787463073679,1.8594267642584574
NCI-H146,24901704,3.4954665576646216,1.8594267642584574
NCI-H146,6505803,-0.3489025917214021,1.8594267642584574
BT-549,44819697,3.658602858416661,1.8594267642584574
Panc 04.03,5278396,4.260606427966062,1.8594267642584574
G-401,11647372,0.0479330615057392,1.8594267642584574
EFO-27,71466445,6.412452895571818,1.8594267642584574
NOMO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.002133040962993,1.8594267642584574
SNU-61,selumetinib-UNC0638 (4-1 mol-mol),1.9080621375720417,1.8594267642584574
NOMO-1,1716436,2.6410194121109773,1.8594267642584574
JM-1,navitoclax-pluripotin (1-1 mol-mol),-1.136595381126137,1.8594267642584574
SNU-61,46199207,3.1956978461436014,1.8594267642584574
LXF 289,4261,1.4002862892534345,1.8594267642584574
DMS 273,46843906,2.9019571008738763,1.8594267642584574
SCC-9,25150857,2.532575506870741,1.8594267642584574
NCI-H460,navitoclax-MST-312 (1-1 mol-mol),2.434638176735655,1.8594267642584574
NCI-H727,24785538,-1.326987163467981,1.8594267642584574
NCI-H661,11404337,-0.0954545894437525,1.8594267642584574
MSTO-211H,66577038,3.302731292752764,1.8594267642584574
OVISE,126941,-1.5326684035544371,1.8594267642584574
BT-549,44566777,1.3521548270810906,1.8594267642584574
A2780,3025986,-2.2950808421603983,1.8594267642584574
NCI-H727,16736978,4.598640955798025,1.8594267642584574
JM-1,6610216,3.7780643735318615,1.8594267642584574
MDA-MB-453,168312962,-1.3854623993271444,1.8594267642584574
LoVo,2749,2.494181165729376,1.8594267642584574
OVISE,15547703,4.212246909591729,1.8594267642584574
ONS-76,16736978,2.0849164003870877,1.8594267642584574
MDA-MB-453,1714884,2.9618056579194585,1.8594267642584574
DMS 273,327653,3.1988672985426847,1.8594267642584574
YAPC,2828334,6.193046978626199,1.8594267642584574
CAL-51,10184653,1.4453250777347395,1.8594267642584574
Panc 04.03,9936388,2.385451093408398,1.8594267642584574
NCI-H2009,4477,0.2115452666376647,1.8594267642584574
A2780,322968,2.566344426002007,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],1566236,2.0083001744148596,1.8594267642584574
EFO-27,216345,4.384346641524126,1.8594267642584574
Panc 04.03,UNC0638-navitoclax (1-1 mol-mol),4.190054196085194,1.8594267642584574
LOU-NH91,9956119,4.571782850484356,1.8594267642584574
NCI-H661,1641662,2.9325574972427813,1.8594267642584574
CA46,44493528,3.81061502276679,1.8594267642584574
OPM-2,navitoclax-PLX-4032 (1-1 mol-mol),2.9114134564638037,1.8594267642584574
A2780,11647372,-1.4335547211387447,1.8594267642584574
SCC-9,176870,2.779248818408345,1.8594267642584574
NCI-H2171,JQ-1-vorinostat (2-1 mol-mol),-0.591426926021434,1.8594267642584574
SCC-9,ISOX-bortezomib (250-1 mol-mol),0.3127664498221564,1.8594267642584574
NCI-H2009,25183872,2.394233803753281,1.8594267642584574
BxPC-3,selumetinib-piperlongumine (8-1 mol-mol),1.5279722865269718,1.8594267642584574
FTC-133,selumetinib-JQ-1 (4-1 mol-mol),3.749238444437789,1.8594267642584574
NCI-H727,11222830,1.7878002384813196,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],doxorubicin-navitoclax (2-1 mol-mol),0.7949647024919319,1.8594267642584574
SCC-9,9823820,5.247901285797655,1.8594267642584574
FTC-133,44462760,4.267925011817446,1.8594267642584574
EFO-27,salermide-PLX-4032 (12-1 mol-mol),5.523351402733512,1.8594267642584574
DMS 273,54618164,3.989243888703328,1.8594267642584574
A-673,5470400,-1.9410984929514092,1.8594267642584574
A4/Fukuda,56973724,1.7857996527787343,1.8594267642584574
NOMO-1,5311281,1.2143454060885572,1.8594267642584574
CA46,135423438,1.6657304721140649,1.8594267642584574
HCC1143,5287620,-1.5012475814925117,1.8594267642584574
EFO-27,107970,2.9901836608736883,1.8594267642584574
EFO-27,7251185,1.6138148752584345,1.8594267642584574
LoVo,11214940,1.900565531770479,1.8594267642584574
NCI-H2009,6450551,1.0382100121131883,1.8594267642584574
LoVo,3081361,0.9226789940369008,1.8594267642584574
SBC-5,BRD-A02303741-carboplatin (1-1 mol-mol),4.575375432825298,1.8594267642584574
Panc 04.03,2113511,7.412620584739622,1.8594267642584574
G-401,crizotinib-PLX-4032 (2-1 mol-mol),1.2254709557426715,1.8594267642584574
A2780,42642645,-1.071178701221225,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],46191454,2.186617263372051,1.8594267642584574
G-401,72376,-2.6056367900842745,1.8594267642584574
NCI-H460,54618771,1.6853262233131374,1.8594267642584574
BT-549,selumetinib-piperlongumine (8-1 mol-mol),4.450190552332179,1.8594267642584574
NCI-H1623,60750,-5.650217340343659,1.8594267642584574
BT-549,49766530,-1.005486623843658,1.8594267642584574
NCI-H292,10184653,1.6188231902933972,1.8594267642584574
NCI-H727,5282054,3.939726324876112,1.8594267642584574
Panc 04.03,11485656,3.4698409381110435,1.8594267642584574
NCI-H522,24772860,-1.6489481573528793,1.8594267642584574
NOMO-1,136227331,3.913043208951298,1.8594267642584574
FU-OV-1,984333,0.3323688812243723,1.8594267642584574
LoVo,9911463,2.8816718818913176,1.8594267642584574
NCI-H661,6917907,-5.078778116905793,1.8594267642584574
SNU-81,25102847,1.5499571993593506,1.8594267642584574
CAL-51,159324,3.1794720270506307,1.8594267642584574
A-673,122327,3.9666709409894527,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],72734382,4.304323658475911,1.8594267642584574
KMRC-1,2858523,3.233729541186922,1.8594267642584574
LOU-NH91,9823820,5.384931157369051,1.8594267642584574
NCI-H2171,5287969,-2.1635291246577286,1.8594267642584574
A-673,426756,2.5032328390514365,1.8594267642584574
HSC-4,24964624,2.5086826728272538,1.8594267642584574
NCI-H1623,176870,0.1873243677029567,1.8594267642584574
KMRC-1,7251185,3.109058235493882,1.8594267642584574
NCI-H727,6610216,4.563405769903236,1.8594267642584574
BxPC-3,15983966,-3.8778410742282694,1.8594267642584574
G-401,46843906,1.9398273455018735,1.8594267642584574
NCI-H661,126941,-5.16742432120375,1.8594267642584574
FU-OV-1,5746,2.910322472492285,1.8594267642584574
CAL-51,11609586,1.5077859423552509,1.8594267642584574
NCI-H292,navitoclax-birinapant (1-1 mol-mol),3.1013974556417825,1.8594267642584574
NCI-H1623,23582824,0.0165284592292431,1.8594267642584574
SNU-449,31703,3.0847938162993707,1.8594267642584574
A2780,4788,4.492604658524488,1.8594267642584574
Panc 04.03,25102847,3.783052108341051,1.8594267642584574
FTC-133,selumetinib-decitabine (4-1 mol-mol),6.596226241094775,1.8594267642584574
NCI-H522,5113032,5.82110442960573,1.8594267642584574
KYSE-70,16038120,2.0286855638164054,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],2945648,2.1413236480438544,1.8594267642584574
JM-1,2828334,5.9839290329767945,1.8594267642584574
G-401,16736978,0.7492323653316314,1.8594267642584574
CAL-51,107970,2.299284460939792,1.8594267642584574
NCI-H522,carboplatin-etoposide (40-17 mol-mol),3.969229835066765,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],136227924,3.314624698864007,1.8594267642584574
NCI-H460,51039095,3.9314979002332535,1.8594267642584574
MDA-MB-157,9903786,1.458865596348786,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],selumetinib-UNC0638 (4-1 mol-mol),2.1355082647556127,1.8594267642584574
Panc 04.03,54678924,3.3151598744761626,1.8594267642584574
JM-1,sirolimus-bortezomib (250-1 mol-mol),-0.3513681100208012,1.8594267642584574
ONS-76,25195348,3.7356955751438754,1.8594267642584574
MSTO-211H,71466578,5.31450298723974,1.8594267642584574
CA46,crizotinib-PLX-4032 (2-1 mol-mol),1.0865859048820203,1.8594267642584574
LOU-NH91,10385095,0.9698085069900604,1.8594267642584574
FTC-133,24856436,2.183528137346661,1.8594267642584574
A2780,54613361,-2.0737031658574043,1.8594267642584574
CAL-51,5311,1.4183219405835503,1.8594267642584574
NCI-H522,51037431,4.989409718658752,1.8594267642584574
Panc 04.03,11647372,2.0191280123179824,1.8594267642584574
NCI-H727,327653,3.8552398443183193,1.8594267642584574
OPM-2,9884685,-0.7869928949425254,1.8594267642584574
BT-549,676352,1.8104954024890367,1.8594267642584574
CAL-51,46907787,3.297361866649883,1.8594267642584574
EFO-27,11494412,4.723849828867172,1.8594267642584574
A2780,60700,-2.20534635529039,1.8594267642584574
A-673,5281321,-1.2857978730590742,1.8594267642584574
NCI-H522,navitoclax-birinapant (1-1 mol-mol),2.79987001717094,1.8594267642584574
NCI-H661,6610216,4.875851858170822,1.8594267642584574
NCI-H460,6917907,-4.956095121428261,1.8594267642584574
A4/Fukuda,5460769,3.0365194168079572,1.8594267642584574
BxPC-3,3025944,3.477531707151509,1.8594267642584574
CAL-51,16065773,2.8749329306977853,1.8594267642584574
SBC-5,navitoclax-piperlongumine (1-1 mol-mol),3.0140004933884796,1.8594267642584574
EFO-27,2874250,5.869363689503336,1.8594267642584574
A-673,702558,2.7000584853196936,1.8594267642584574
HCC1143,107985,-3.4652614368177432,1.8594267642584574
SNU-81,navitoclax-piperlongumine (1-1 mol-mol),0.0853232254018234,1.8594267642584574
NCI-H522,3025986,-1.0139106356663683,1.8594267642584574
NCI-H2171,439501,-3.0635131055453924,1.8594267642584574
NCI-H522,444795,5.191031194563041,1.8594267642584574
NCI-H661,53392493,2.28152765608909,1.8594267642584574
Panc 04.03,445643,3.9306423242452673,1.8594267642584574
NCI-H727,selumetinib-piperlongumine (8-1 mol-mol),-1.6426158910123243,1.8594267642584574
NCI-H292,25150857,2.3048085705836563,1.8594267642584574
NCI-H727,25126798,3.836281743476004,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],2708,5.228043564409416,1.8594267642584574
LXF 289,tanespimycin-gemcitabine (1-1 mol-mol),-0.7803553761989187,1.8594267642584574
ONS-76,9887053,4.335145594020597,1.8594267642584574
OPM-2,675434,4.053836549963459,1.8594267642584574
KMRC-1,16725315,5.238650021868635,1.8594267642584574
SNU-449,piperlongumine-MST-312 (1-1 mol-mol),1.362794205944183,1.8594267642584574
A4/Fukuda,151289,0.1986917338936865,1.8594267642584574
SNU-449,ISOX-bortezomib (250-1 mol-mol),2.1712489431250437,1.8594267642584574
NCI-H1623,sirolimus-bortezomib (250-1 mol-mol),0.487688387449291,1.8594267642584574
CA46,selumetinib-UNC0638 (4-1 mol-mol),4.090188755292698,1.8594267642584574
MDA-MB-453,56963564,1.2952259038449256,1.8594267642584574
NCI-H522,65064,5.303150406450188,1.8594267642584574
NCI-H2171,24772860,-3.209318985857815,1.8594267642584574
KMRC-1,104842,1.0931359128213904,1.8594267642584574
NCI-H460,16741245,2.175171044948558,1.8594267642584574
OVISE,4259181,0.909929291036465,1.8594267642584574
HSC-4,46191454,1.405754738797376,1.8594267642584574
KYSE-70,2749,2.2442090130660577,1.8594267642584574
SNU-81,400769,-1.1944669265215293,1.8594267642584574
NCI-H2009,6852167,1.9075911063810396,1.8594267642584574
SBC-5,241158,4.402731015442316,1.8594267642584574
LXF 289,sirolimus-bortezomib (250-1 mol-mol),0.6089213560806236,1.8594267642584574
HSC-4,44185566,3.0805483382503844,1.8594267642584574
FU-OV-1,17755052,0.0450390211671309,1.8594267642584574
KMRC-1,53495165,5.726132279462146,1.8594267642584574
NCI-H146,6184667,1.5836777358218528,1.8594267642584574
NCI-H1623,selumetinib-MK-2206 (8-1 mol-mol),1.9939850846524236,1.8594267642584574
HCC1143,55283,3.9101720152241226,1.8594267642584574
OPM-2,71466445,2.165442844786418,1.8594267642584574
A2780,49867926,3.0666746223408157,1.8594267642584574
LOU-NH91,17755052,2.4120102833965844,1.8594267642584574
MDA-MB-453,49867926,4.180155964726801,1.8594267642584574
Panc 04.03,25183872,0.1973991794911014,1.8594267642584574
CAL-51,9967941,3.511576456928413,1.8594267642584574
SBC-5,6852167,3.965917526242172,1.8594267642584574
NCI-H292,navitoclax-gemcitabine (1-1 mol-mol),-2.2738254252186314,1.8594267642584574
KYSE-70,selumetinib-UNC0638 (4-1 mol-mol),3.25629169074294,1.8594267642584574
NCI-H522,54596558,4.342696772784201,1.8594267642584574
HSC-4,2733526,3.5101027459294425,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],23725625,5.154585398323981,1.8594267642584574
OVISE,decitabine-navitoclax (2-1 mol-mol),0.3462958100091469,1.8594267642584574
MDA-MB-453,4477,-0.2020943624975227,1.8594267642584574
NCI-H2171,72193861,0.5955631718249997,1.8594267642584574
NCI-H292,2828334,6.458495810735601,1.8594267642584574
ONS-76,7326481,1.79748139254514,1.8594267642584574
A-673,44607531,1.457749077960986,1.8594267642584574
NOMO-1,73707438,4.2876330596581305,1.8594267642584574
NCI-H460,60750,-0.8382921927225392,1.8594267642584574
NCI-H522,4259181,-0.2456063667287351,1.8594267642584574
A2780,JQ-1-carboplatin (1-1 mol-mol),-0.3248944310620366,1.8594267642584574
ONS-76,969516,2.910086136195903,1.8594267642584574
YAPC,49850262,3.6789282041181095,1.8594267642584574
SNU-449,44491742,3.9284370838515903,1.8594267642584574
MDA-MB-453,11485656,1.765591398344026,1.8594267642584574
NCI-H460,44607530,3.4043015144880444,1.8594267642584574
OPM-2,56949517,5.349058842742104,1.8594267642584574
SBC-5,216239,1.5582588949606833,1.8594267642584574
NCI-H661,219104,3.9372744940630646,1.8594267642584574
NCI-H460,44484440,3.757520830720006,1.8594267642584574
MDA-MB-453,44462760,5.00879187339522,1.8594267642584574
ONS-76,5281321,-1.2480266745690851,1.8594267642584574
LOU-NH91,5566,3.288881685822646,1.8594267642584574
MSTO-211H,72193861,1.6065459514404858,1.8594267642584574
NCI-H1623,16038120,-0.158474112921266,1.8594267642584574
BxPC-3,11238147,1.751681691561693,1.8594267642584574
YAPC,3025944,4.720838189364642,1.8594267642584574
SNU-61,1239801,4.195034605110225,1.8594267642584574
NCI-H522,11640390,4.472705990017258,1.8594267642584574
OPM-2,11238147,3.2386204402735874,1.8594267642584574
YAPC,16722836,1.8948218470527252,1.8594267642584574
MSTO-211H,4261,1.9115438043118669,1.8594267642584574
BxPC-3,24901704,3.2492386456059266,1.8594267642584574
A2780,2742550,2.799223861459344,1.8594267642584574
LoVo,6918736,-4.296362304597629,1.8594267642584574
NCI-H292,3854666,3.3764205876154074,1.8594267642584574
G-401,11222830,1.5347756238466792,1.8594267642584574
CAL-51,44620216,5.469091994130916,1.8594267642584574
NCI-H146,6918328,-4.616864565737749,1.8594267642584574
SNU-449,100016,6.350050439021361,1.8594267642584574
CAL-51,6438330,3.884194225982375,1.8594267642584574
A4/Fukuda,451668,-0.3897468918932548,1.8594267642584574
NOMO-1,135875424,3.068632733482165,1.8594267642584574
OPM-2,selumetinib-UNC0638 (4-1 mol-mol),2.327180479574148,1.8594267642584574
MDA-MB-453,9907093,5.353373126975176,1.8594267642584574
SNU-81,11404337,-1.7380856142345846,1.8594267642584574
BT-549,3634881,2.142843752657143,1.8594267642584574
SW1463,6918837,-3.406571913442127,1.8594267642584574
HSC-4,6610216,4.241818899552939,1.8594267642584574
G-401,135421197,1.4306754302223277,1.8594267642584574
MSTO-211H,400769,-2.118881346037636,1.8594267642584574
OPM-2,56946209,-6.715247823396851,1.8594267642584574
OPM-2,156414,0.898749748032719,1.8594267642584574
SCC-9,2708,5.420316309291021,1.8594267642584574
BxPC-3,72376,-2.7426383250741786,1.8594267642584574
LXF 289,44607530,1.309750089611443,1.8594267642584574
A4/Fukuda,216468,0.7779788317268376,1.8594267642584574
ONS-76,9936388,2.029236983033262,1.8594267642584574
A4/Fukuda,navitoclax-MST-312 (1-1 mol-mol),0.8742444067839383,1.8594267642584574
A4/Fukuda,15953870,2.701018205920996,1.8594267642584574
A4/Fukuda,3825829,2.918538307685252,1.8594267642584574
NCI-H522,1716436,2.601362471636894,1.8594267642584574
NCI-H460,16725315,5.407057101640495,1.8594267642584574
NCI-H661,969516,2.7370069869182996,1.8594267642584574
SNU-449,9915743,1.6643053553641087,1.8594267642584574
NCI-H522,16219061,2.1788816492377054,1.8594267642584574
NCI-H1623,25126798,4.062693377799547,1.8594267642584574
LoVo,46199207,2.62459096292295,1.8594267642584574
Panc 04.03,2126,5.406308275886939,1.8594267642584574
NCI-H522,702558,5.065903257418961,1.8594267642584574
NCI-H661,44489675,4.0470438340050086,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],409805,6.9502249218901975,1.8594267642584574
CAL-51,11175137,1.2330676481368064,1.8594267642584574
EFO-27,tanespimycin-gemcitabine (1-1 mol-mol),1.7387659506719169,1.8594267642584574
A-498,119607,5.756544485429512,1.8594267642584574
CAL-51,89183176,3.8950338695454088,1.8594267642584574
FTC-133,2828334,5.859070513237425,1.8594267642584574
KMRC-1,135440466,2.425894917183188,1.8594267642584574
NCI-H2009,36314,-5.253596358515139,1.8594267642584574
G-401,11238147,2.0802759078276853,1.8594267642584574
NCI-H661,452548,0.003417557634082,1.8594267642584574
NCI-H292,5282054,4.085287507740134,1.8594267642584574
HCC1143,10385095,1.0799280769088206,1.8594267642584574
A4/Fukuda,11626560,-1.03034976821798,1.8594267642584574
FTC-133,65064,5.375666939367713,1.8594267642584574
BT-549,753704,4.958873098850826,1.8594267642584574
KYSE-70,46224516,2.993089177283032,1.8594267642584574
CA46,11707110,2.876405562319207,1.8594267642584574
LXF 289,11609586,2.9430338892136354,1.8594267642584574
KYSE-70,10296883,3.691258417269261,1.8594267642584574
A2780,tanespimycin-gemcitabine (1-1 mol-mol),-1.0115297721833665,1.8594267642584574
DMS 273,67156097,-2.1294955352549,1.8594267642584574
NCI-H2171,11955716,-2.5749004703466976,1.8594267642584574
LOU-NH91,124202324,3.0671378719618283,1.8594267642584574
A2780,135659046,3.385733838662662,1.8594267642584574
OPM-2,11427553,0.184758700497643,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],46199207,3.748216496798377,1.8594267642584574
OVISE,11427553,3.886061021243629,1.8594267642584574
A2780,24821094,2.7975033336102095,1.8594267642584574
LoVo,10410894,2.092646303934145,1.8594267642584574
CA46,327653,2.398308016277815,1.8594267642584574
NCI-H522,135440466,2.851321997265629,1.8594267642584574
NCI-H661,9903786,4.646166413465223,1.8594267642584574
ONS-76,docetaxel-tanespimycin (2-1 mol-mol),-1.0307664921769042,1.8594267642584574
CA46,11427553,1.0834968953052575,1.8594267642584574
Panc 04.03,6450551,3.8538949310121353,1.8594267642584574
A2780,644241,1.9281614760038184,1.8594267642584574
A2780,3815108,2.053113262637462,1.8594267642584574
NOMO-1,71466380,3.4384411266907295,1.8594267642584574
EFO-27,serdemetan-SCH-529074 (1-1 mol-mol),3.002804413616897,1.8594267642584574
A4/Fukuda,24821094,2.016569070962388,1.8594267642584574
LoVo,3503,2.2987332704820016,1.8594267642584574
LXF 289,46398810,1.8383298322371264,1.8594267642584574
NCI-H146,42642645,1.3339409860624971,1.8594267642584574
A4/Fukuda,navitoclax-pluripotin (1-1 mol-mol),-2.9042967889462408,1.8594267642584574
HCC1143,135984461,4.873829103860087,1.8594267642584574
LoVo,23725625,5.102020281972671,1.8594267642584574
NCI-H2171,4477,0.0540600744484099,1.8594267642584574
Panc 04.03,24964624,3.127575767188385,1.8594267642584574
CA46,676352,1.5563040092860552,1.8594267642584574
ONS-76,135440466,2.234484066901876,1.8594267642584574
EFO-27,31703,1.037291503873681,1.8594267642584574
MDA-MB-157,208908,2.741119640746793,1.8594267642584574
G-401,46191454,0.141864729037356,1.8594267642584574
LoVo,439501,-1.7683171506776545,1.8594267642584574
KYSE-70,vorinostat-carboplatin (1-1 mol-mol),2.3289614094858813,1.8594267642584574
A-498,36314,4.095863504824457,1.8594267642584574
G-401,ISOX-bortezomib (250-1 mol-mol),0.1394395041296586,1.8594267642584574
NCI-H727,9935249,3.73205967923935,1.8594267642584574
KYSE-70,53392493,3.454381994737171,1.8594267642584574
HCC1143,11234052,5.229903952882612,1.8594267642584574
CAL-51,4705,2.903463840875761,1.8594267642584574
MDA-MB-157,56946209,-3.6171244608990905,1.8594267642584574
LoVo,3689413,-0.0015328635235731,1.8594267642584574
NCI-H460,46199207,3.5033257005335163,1.8594267642584574
BxPC-3,135411,0.8341107494370649,1.8594267642584574
NCI-H727,46191454,2.1799448668848105,1.8594267642584574
OPM-2,25195348,0.9238255530721258,1.8594267642584574
SNU-61,JQ-1-UNC0638 (2-1 mol-mol),2.3060253857026343,1.8594267642584574
SNU-61,656346,0.8749051442535513,1.8594267642584574
JM-1,136227924,1.2038413750130548,1.8594267642584574
SNU-449,49867930,4.864159132996777,1.8594267642584574
A2780,2733526,2.8794725769531997,1.8594267642584574
OVISE,23725625,5.908959950408421,1.8594267642584574
BxPC-3,60700,-0.122761385712052,1.8594267642584574
OPM-2,53495165,-4.146839218250571,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],135411,0.5141731800260497,1.8594267642584574
A-673,25227462,-5.829932006274449,1.8594267642584574
KMRC-1,6918328,0.9635513821249304,1.8594267642584574
JM-1,89183176,3.1890961462334335,1.8594267642584574
MSTO-211H,16038120,0.2471942161915729,1.8594267642584574
JM-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.175928698896838,1.8594267642584574
ONS-76,6918878,5.0214366982824306,1.8594267642584574
CA46,60750,-0.9269398092944348,1.8594267642584574
HCC1143,42642645,1.0566197638440329,1.8594267642584574
OPM-2,3503,1.0860674816661569,1.8594267642584574
BxPC-3,11612883,2.2063280154469993,1.8594267642584574
NCI-H522,16065773,1.5488087432962436,1.8594267642584574
A-673,3634881,3.109333818891092,1.8594267642584574
NCI-H2171,71466445,1.378191899492029,1.8594267642584574
SNU-81,JQ-1-UNC0638 (2-1 mol-mol),0.4433096898383019,1.8594267642584574
NCI-H292,17755052,1.3393568867062529,1.8594267642584574
NCI-H522,11427553,1.733163384028149,1.8594267642584574
G-401,selumetinib-JQ-1 (4-1 mol-mol),0.629673615073819,1.8594267642584574
BT-549,24797083,1.6394182791354686,1.8594267642584574
OVISE,6438330,2.2515103089504818,1.8594267642584574
LXF 289,10410894,3.939992216810496,1.8594267642584574
EFO-27,60750,5.390319994108079,1.8594267642584574
BT-549,400769,-1.1296625579443007,1.8594267642584574
SCC-9,2742550,4.1692460597635135,1.8594267642584574
JM-1,5281321,-3.43257780081901,1.8594267642584574
OVISE,24771867,1.656692666128474,1.8594267642584574
SBC-5,3384730,0.0954837515635063,1.8594267642584574
BT-549,navitoclax-sorafenib (1-1 mol-mol),3.9279804703061703,1.8594267642584574
A4/Fukuda,2749,1.141581020051295,1.8594267642584574
G-401,1716436,2.4290804430946547,1.8594267642584574
NCI-H2009,23635314,-2.363129056883172,1.8594267642584574
SNU-449,3081361,2.056588488576824,1.8594267642584574
NCI-H522,969516,2.4900188230240485,1.8594267642584574
MDA-MB-157,11626560,3.460415978238755,1.8594267642584574
NCI-H292,selumetinib-UNC0638 (4-1 mol-mol),2.5678319047053244,1.8594267642584574
HSC-4,11719255,4.924721636143113,1.8594267642584574
KYSE-70,17755052,0.9465092626724514,1.8594267642584574
G-401,25062766,0.8725390828623283,1.8594267642584574
KMRC-1,4477,0.198014478122684,1.8594267642584574
SNU-81,44197249,-2.185783961489413,1.8594267642584574
A-673,10410894,2.502904420433103,1.8594267642584574
ONS-76,6914657,-4.101072641720643,1.8594267642584574
MDA-MB-157,53495165,-1.8622859982145463,1.8594267642584574
Panc 04.03,72734382,5.165438336919353,1.8594267642584574
FU-OV-1,navitoclax-pluripotin (1-1 mol-mol),-0.2689466648852067,1.8594267642584574
CA46,613000,1.1767209163070167,1.8594267642584574
EFO-27,3503,2.721888959468924,1.8594267642584574
SNU-81,decitabine-navitoclax (2-1 mol-mol),0.903824446896739,1.8594267642584574
MSTO-211H,6917907,-6.416473568686441,1.8594267642584574
CAL-51,675434,4.354107922133551,1.8594267642584574
CA46,5278396,3.312720557512005,1.8594267642584574
FU-OV-1,9911463,4.1305925074662575,1.8594267642584574
DMS 273,5328940,1.9629216769229116,1.8594267642584574
LXF 289,54454,1.7599180903835134,1.8594267642584574
A2780,446155,3.1527811730433366,1.8594267642584574
CA46,11222830,0.90552754986452,1.8594267642584574
MDA-MB-157,15547703,2.7177027433879912,1.8594267642584574
A-673,9915743,0.6829950735134661,1.8594267642584574
Panc 04.03,50905018,4.96616490546014,1.8594267642584574
NCI-H146,50905018,3.857703749758686,1.8594267642584574
OPM-2,carboplatin-etoposide (40-17 mol-mol),2.4358856749484596,1.8594267642584574
CA46,148198,-5.7845042531785,1.8594267642584574
BxPC-3,11427553,2.964396595429347,1.8594267642584574
JM-1,17755052,1.8568486472237824,1.8594267642584574
MDA-MB-453,135875424,2.7753375231350104,1.8594267642584574
LoVo,52947716,-5.666189039665748,1.8594267642584574
SNU-81,3543504,4.205084802754879,1.8594267642584574
CAL-51,9887053,4.486783389261201,1.8594267642584574
YAPC,SNX-2112-bortezomib (250-1 mol-mol),0.1222425985645655,1.8594267642584574
FTC-133,6852167,4.78859095347106,1.8594267642584574
SBC-5,46907787,3.799315463541784,1.8594267642584574
SNU-449,6918638,1.2557717528626495,1.8594267642584574
NCI-H2171,6438330,1.125878118169246,1.8594267642584574
ONS-76,15953870,3.841628876209717,1.8594267642584574
KYSE-70,44493528,4.735176242945038,1.8594267642584574
BT-549,71751553,4.2471267374516435,1.8594267642584574
NCI-H2171,46943432,3.4065574915710735,1.8594267642584574
SNU-61,carboplatin-UNC0638 (2-1 mol-mol),3.8198655410363287,1.8594267642584574
A4/Fukuda,135875424,2.943838777845953,1.8594267642584574
SCC-9,25154868,5.2906536290113975,1.8594267642584574
A4/Fukuda,11964036,-0.0142982917472374,1.8594267642584574
NCI-H292,10302451,3.577296661602114,1.8594267642584574
A2780,135999136,1.5930192405329104,1.8594267642584574
NCI-H292,54618164,4.184972812062346,1.8594267642584574
LXF 289,107985,-2.691798131563437,1.8594267642584574
NCI-H522,44137675,3.8599044567005434,1.8594267642584574
CAL-51,3503,3.2899889427654245,1.8594267642584574
A2780,409805,4.989244714218352,1.8594267642584574
HSC-4,71466380,3.6804948915169784,1.8594267642584574
JM-1,6918638,-1.945896791217812,1.8594267642584574
SNU-449,44566777,0.6479277578392284,1.8594267642584574
MSTO-211H,387447,-3.4382078488280063,1.8594267642584574
DMS 273,9915743,1.912374780622189,1.8594267642584574
NCI-H2171,selumetinib-JQ-1 (4-1 mol-mol),1.3266542460733022,1.8594267642584574
NCI-H661,16736978,1.5408428303752983,1.8594267642584574
MSTO-211H,44241473,3.911097970359605,1.8594267642584574
NCI-H460,60700,-0.2314807684970784,1.8594267642584574
A2780,serdemetan-SCH-529074 (1-1 mol-mol),0.9740349619499052,1.8594267642584574
JM-1,227681,1.6891640861629382,1.8594267642584574
G-401,JQ-1-navitoclax (2-1 mol-mol),-0.4060053682032895,1.8594267642584574
NCI-H661,656346,0.6919490200967222,1.8594267642584574
SW1463,5311,0.7635678260369684,1.8594267642584574
NCI-H460,387447,-2.436463262555682,1.8594267642584574
MSTO-211H,navitoclax-MST-312 (1-1 mol-mol),-0.7166631771213113,1.8594267642584574
HSC-4,9825149,2.985341504866837,1.8594267642584574
NCI-H727,25262965,0.7692581364380534,1.8594267642584574
A2780,10077130,2.5506457702723786,1.8594267642584574
BT-549,selumetinib-JQ-1 (4-1 mol-mol),3.8001526734522617,1.8594267642584574
NCI-H661,136227924,2.7818959309662183,1.8594267642584574
SCC-9,446155,1.3937663931747788,1.8594267642584574
BT-549,73707398,1.468839183930599,1.8594267642584574
A-498,navitoclax-PLX-4032 (1-1 mol-mol),0.6341402769109122,1.8594267642584574
CAL-51,6623618,2.223133904662847,1.8594267642584574
LOU-NH91,327653,3.620861790086289,1.8594267642584574
BT-549,67291369,4.3793706620025095,1.8594267642584574
MSTO-211H,docetaxel-tanespimycin (2-1 mol-mol),-6.863228932141716,1.8594267642584574
NCI-H460,3025986,0.3909368316008428,1.8594267642584574
Panc 04.03,11228183,3.2874901590346934,1.8594267642584574
LoVo,25262965,-3.8912736240644694,1.8594267642584574
SBC-5,73707398,1.6541333685248465,1.8594267642584574
NCI-H661,89183176,4.289155461605826,1.8594267642584574
G-401,44241473,4.28251451131172,1.8594267642584574
BT-549,2746,3.8188337512891137,1.8594267642584574
YAPC,25062766,2.237282024435701,1.8594267642584574
LXF 289,20959075,-2.4089188058085,1.8594267642584574
SCC-9,53232,2.1606412524830017,1.8594267642584574
G-401,56649450,1.8227428945555348,1.8594267642584574
MSTO-211H,11222830,1.162959487763126,1.8594267642584574
JM-1,15953870,2.1778700018066144,1.8594267642584574
LoVo,15953870,2.9352023189332703,1.8594267642584574
DMS 273,15953870,3.8128904638275216,1.8594267642584574
G-401,JQ-1-vorinostat (2-1 mol-mol),-0.8769966942019048,1.8594267642584574
CAL-51,1750826,-0.4147302595408071,1.8594267642584574
NCI-H522,9884685,0.1045560296672991,1.8594267642584574
HSC-4,327653,3.5197711195347434,1.8594267642584574
BxPC-3,6918328,-0.2318480121478282,1.8594267642584574
NCI-H661,10074640,2.974634579766932,1.8594267642584574
FTC-133,11178236,-4.398882676695501,1.8594267642584574
CAL-51,6450551,1.9748462748620472,1.8594267642584574
NCI-H522,SNX-2112-bortezomib (250-1 mol-mol),-2.0311318982301665,1.8594267642584574
SCC-9,5978,-3.875351555062552,1.8594267642584574
LOU-NH91,5311,1.697115177859265,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],45279963,4.209581344916876,1.8594267642584574
A4/Fukuda,49766530,-0.1813275565198268,1.8594267642584574
CA46,5978,-7.34958411963843,1.8594267642584574
JM-1,15547703,2.5122126082355227,1.8594267642584574
HSC-4,3038522,3.958216901800584,1.8594267642584574
MDA-MB-453,24901704,3.2296574944609735,1.8594267642584574
SCC-9,23635314,-1.650613607792241,1.8594267642584574
KMRC-1,11612883,3.608500084904783,1.8594267642584574
OVISE,24772860,-1.0102375693918164,1.8594267642584574
A2780,11626560,0.43489025720173,1.8594267642584574
MDA-MB-453,51037431,1.3361098813185686,1.8594267642584574
HSC-4,4705,3.95336427523857,1.8594267642584574
A4/Fukuda,24748573,1.3032837048402657,1.8594267642584574
OPM-2,51039095,-2.6866952618976434,1.8594267642584574
KMRC-1,11609586,2.4412406506497155,1.8594267642584574
ONS-76,11609586,3.485979398565755,1.8594267642584574
LoVo,12003241,-2.8621949377385465,1.8594267642584574
DMS 273,241158,3.177272786345067,1.8594267642584574
KYSE-70,20959075,-2.927604227069557,1.8594267642584574
SNU-61,16722836,1.3959733890222568,1.8594267642584574
SBC-5,89928392,2.3719311856170537,1.8594267642584574
CAL-51,decitabine-navitoclax (2-1 mol-mol),4.2164288882213,1.8594267642584574
A-498,4261,1.667462132250413,1.8594267642584574
SNU-449,23725625,6.429990861305722,1.8594267642584574
A2780,4259181,-1.27299012623329,1.8594267642584574
ONS-76,10127622,-2.1347139098699706,1.8594267642584574
A2780,1641662,2.3828094640764412,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],52912189,1.6859492587685891,1.8594267642584574
Panc 04.03,9549297,5.2530677537073975,1.8594267642584574
MDA-MB-453,53481919,3.1180191774885735,1.8594267642584574
JM-1,56963564,0.0249959117693502,1.8594267642584574
HSC-4,11234052,4.4583786214563865,1.8594267642584574
A-498,SNX-2112-bortezomib (250-1 mol-mol),0.1538165542627618,1.8594267642584574
BxPC-3,119607,5.22613990212802,1.8594267642584574
BxPC-3,5278396,2.866816315326302,1.8594267642584574
LOU-NH91,400769,-0.4518117512524929,1.8594267642584574
A-673,doxorubicin-navitoclax (2-1 mol-mol),-4.20921708976932,1.8594267642584574
FU-OV-1,16722836,-0.0099462763207794,1.8594267642584574
SNU-449,46907787,4.480861537403045,1.8594267642584574
NCI-H292,24748573,1.9235457900331792,1.8594267642584574
NCI-H460,2113511,6.407699041859446,1.8594267642584574
HCC1143,selumetinib-UNC0638 (4-1 mol-mol),1.3639730576271398,1.8594267642584574
NCI-H1623,46174525,4.205988468269685,1.8594267642584574
NCI-H1623,6917907,-5.728045829659389,1.8594267642584574
MDA-MB-453,1641662,3.085427143962118,1.8594267642584574
NOMO-1,3854666,1.0231806307237967,1.8594267642584574
SNU-449,24821094,1.9429996101140543,1.8594267642584574
SNU-449,crizotinib-PLX-4032 (2-1 mol-mol),2.114422576149497,1.8594267642584574
Panc 04.03,216345,4.594435961426402,1.8594267642584574
DMS 273,2708,4.711982190259564,1.8594267642584574
NCI-H2009,navitoclax-MST-312 (1-1 mol-mol),0.6133760469311309,1.8594267642584574
A-673,11222830,1.3107049031534492,1.8594267642584574
SCC-9,219104,4.323236898621614,1.8594267642584574
KYSE-70,11455910,0.6771697782379181,1.8594267642584574
MSTO-211H,9915743,-1.0722844498490078,1.8594267642584574
HCC1143,3062316,0.306898118520016,1.8594267642584574
NCI-H460,11427553,3.3912724357702873,1.8594267642584574
NCI-H1623,675434,4.403585448845777,1.8594267642584574
NCI-H1623,135928012,3.849713333151309,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],73707398,2.4695798871265473,1.8594267642584574
LoVo,serdemetan-SCH-529074 (1-1 mol-mol),1.6319978332110785,1.8594267642584574
KMRC-1,11222830,1.6210071273597368,1.8594267642584574
NCI-H661,44607530,1.6067743901515843,1.8594267642584574
HSC-4,24753719,5.996217074466553,1.8594267642584574
NCI-H1623,44607530,0.6082825778474802,1.8594267642584574
G-401,409805,3.720272745750916,1.8594267642584574
MSTO-211H,24771867,-1.256499005348058,1.8594267642584574
LOU-NH91,100016,8.416108067142021,1.8594267642584574
LOU-NH91,navitoclax-gemcitabine (1-1 mol-mol),-1.5749911209291652,1.8594267642584574
MDA-MB-453,9911830,2.483477791354312,1.8594267642584574
MSTO-211H,216345,2.6222222224733702,1.8594267642584574
A-673,5738263,2.33182798743241,1.8594267642584574
NCI-H292,navitoclax-MST-312 (1-1 mol-mol),1.1730740558558932,1.8594267642584574
CAL-51,16038120,-0.248771562775031,1.8594267642584574
SNU-449,11222830,1.6348775900621026,1.8594267642584574
SBC-5,11656518,1.8588197700646856,1.8594267642584574
LoVo,637858,1.5179613366947162,1.8594267642584574
OPM-2,16065773,1.0643824527623371,1.8594267642584574
LoVo,17759555,2.3197484044750905,1.8594267642584574
LoVo,23635314,-2.3980395881052723,1.8594267642584574
OVISE,241158,2.9923875981017134,1.8594267642584574
LXF 289,6918736,-2.4177135652368476,1.8594267642584574
NCI-H727,24180125,3.0565666249941015,1.8594267642584574
HCC1143,72193861,2.4539335535877607,1.8594267642584574
LXF 289,17755052,1.3903450452706496,1.8594267642584574
SNU-449,24797083,1.6612369643963127,1.8594267642584574
A-673,9903786,1.5948741514342302,1.8594267642584574
FU-OV-1,docetaxel-tanespimycin (2-1 mol-mol),1.25716738994227,1.8594267642584574
SCC-9,3552672,2.2159119862051355,1.8594267642584574
G-401,9903786,2.8038927126182327,1.8594267642584574
CAL-51,36314,1.3238047725901672,1.8594267642584574
A2780,4917,2.608891014350475,1.8594267642584574
BT-549,446155,2.043062772915461,1.8594267642584574
LOU-NH91,2828334,6.123728588021327,1.8594267642584574
SCC-9,89928392,1.8759175792930969,1.8594267642584574
LXF 289,54613361,1.2100808209747431,1.8594267642584574
BT-549,navitoclax-pluripotin (1-1 mol-mol),-0.784652451279203,1.8594267642584574
YAPC,4788,5.944205132488497,1.8594267642584574
NCI-H661,11485656,2.0326011859644075,1.8594267642584574
A4/Fukuda,56649450,0.8497740308893211,1.8594267642584574
JM-1,151289,0.6364544108799082,1.8594267642584574
SNU-449,1566236,1.8764566240908545,1.8594267642584574
NCI-H522,11234052,4.642717967560772,1.8594267642584574
MDA-MB-453,262093,2.6969191096415113,1.8594267642584574
SNU-449,36314,1.881882754123643,1.8594267642584574
FTC-133,3552672,1.929463221662531,1.8594267642584574
DMS 273,44202524,0.9824733163321672,1.8594267642584574
CAL-51,2708,4.939881356462198,1.8594267642584574
NCI-H661,doxorubicin-navitoclax (2-1 mol-mol),-1.1391297012173984,1.8594267642584574
LOU-NH91,44507138,2.849532358816909,1.8594267642584574
A4/Fukuda,24856436,-2.105951383298443,1.8594267642584574
EFO-27,9967941,3.205966960393555,1.8594267642584574
NCI-H460,24964624,3.5490884182562565,1.8594267642584574
A2780,71304818,1.3100858151797232,1.8594267642584574
LoVo,16065773,3.0239362353443195,1.8594267642584574
MDA-MB-157,19582717,3.2682056974125744,1.8594267642584574
G-401,44607531,1.4405644617048554,1.8594267642584574
DMS 273,426756,5.171527401006451,1.8594267642584574
A-673,selumetinib-MK-2206 (8-1 mol-mol),2.344238409661225,1.8594267642584574
A-673,3465537,3.0102553460613626,1.8594267642584574
KYSE-70,135398744,6.338938630156892,1.8594267642584574
NCI-H727,439501,-2.2848783314382133,1.8594267642584574
EFO-27,1750826,-2.462449966677767,1.8594267642584574
NCI-H522,selumetinib-JQ-1 (4-1 mol-mol),1.1620563079754236,1.8594267642584574
NCI-H2171,15547703,3.4091207334536717,1.8594267642584574
BxPC-3,24753719,4.274594841538204,1.8594267642584574
A2780,49846579,2.326369228321655,1.8594267642584574
KMRC-1,135398516,2.513650186922018,1.8594267642584574
LXF 289,12001922,1.5738020993239468,1.8594267642584574
OVISE,107985,-3.603598955800668,1.8594267642584574
FTC-133,crizotinib-PLX-4032 (2-1 mol-mol),3.9800326864083506,1.8594267642584574
MSTO-211H,51039095,-0.728954813106199,1.8594267642584574
MDA-MB-453,24856436,0.153871218683687,1.8594267642584574
OVISE,12003241,-0.8183931153803442,1.8594267642584574
JM-1,219104,1.4868441806857289,1.8594267642584574
KMRC-1,24901704,3.4724240700357414,1.8594267642584574
CAL-51,25105715,4.077363851334658,1.8594267642584574
Panc 04.03,5284616,3.514498334257777,1.8594267642584574
NCI-H2009,446155,3.3217785993510884,1.8594267642584574
NCI-H1623,66577038,3.365380490578284,1.8594267642584574
NCI-H460,72193861,2.1658883750752844,1.8594267642584574
NCI-H522,17755052,3.243909986839396,1.8594267642584574
A4/Fukuda,salermide-PLX-4032 (12-1 mol-mol),4.8455357298985655,1.8594267642584574
LoVo,9936388,-7.372990206557469,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],selumetinib-GDC-0941 (4-1 mol-mol),1.7782951057156742,1.8594267642584574
A2780,46907787,0.387414270491788,1.8594267642584574
A-673,25150857,0.7583223763798244,1.8594267642584574
KYSE-70,11175137,2.267736133904179,1.8594267642584574
KYSE-70,6852167,2.2981101713941814,1.8594267642584574
SNU-61,3081361,2.723820700669796,1.8594267642584574
NCI-H661,6252,2.9131036022991728,1.8594267642584574
NCI-H1623,9903786,3.0418604220511436,1.8594267642584574
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569,1.8594267642584574
NCI-H2009,JQ-1-navitoclax (2-1 mol-mol),-0.3100400196592782,1.8594267642584574
SNU-449,10322450,2.7236273289045942,1.8594267642584574
LXF 289,4096211,2.4023988219433337,1.8594267642584574
SNU-81,10026128,-0.7780702377310673,1.8594267642584574
KYSE-70,6610216,4.087252338732691,1.8594267642584574
MDA-MB-453,44607530,0.880863900568506,1.8594267642584574
NCI-H522,24978538,3.1859390482195216,1.8594267642584574
SBC-5,107970,3.247043743319875,1.8594267642584574
DMS 273,969516,2.584462316279732,1.8594267642584574
MDA-MB-453,5284616,0.7898078062241378,1.8594267642584574
A2780,16720766,0.7344228111589829,1.8594267642584574
OPM-2,25154868,3.783948059993976,1.8594267642584574
DMS 273,44493528,4.2569430545307725,1.8594267642584574
MDA-MB-157,25022340,3.479219964634342,1.8594267642584574
LOU-NH91,15547703,3.808438680736899,1.8594267642584574
CA46,426756,4.77193452473935,1.8594267642584574
DMS 273,2858523,3.0502279484440233,1.8594267642584574
EFO-27,3676137,4.310046032716647,1.8594267642584574
MDA-MB-157,3025986,-1.856662168016076,1.8594267642584574
NCI-H661,tanespimycin-bortezomib (250-1 mol-mol),0.6505677093345705,1.8594267642584574
LOU-NH91,44607531,1.3180545967249335,1.8594267642584574
G-401,46215462,1.5390133747858452,1.8594267642584574
OPM-2,7251185,0.5721351512480617,1.8594267642584574
CAL-51,15953870,3.220977372988981,1.8594267642584574
YAPC,11964036,3.221056153642411,1.8594267642584574
BxPC-3,208908,2.4547812946400502,1.8594267642584574
MDA-MB-157,44589607,1.2787513073565453,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],49766530,0.9963320873999868,1.8594267642584574
NCI-H727,72193861,2.684204612264405,1.8594267642584574
MDA-MB-453,5287969,-1.436813958809434,1.8594267642584574
NCI-H727,15983966,2.109759483394555,1.8594267642584574
KMRC-1,216468,4.973373200756221,1.8594267642584574
SNU-449,52912189,4.380826008996873,1.8594267642584574
SCC-9,46174525,4.3512864598075645,1.8594267642584574
A2780,3011155,5.55303778809739,1.8594267642584574
SBC-5,135999136,5.333154079184271,1.8594267642584574
YAPC,322968,3.8135092450764656,1.8594267642584574
SNU-449,vorinostat-navitoclax (4-1 mol-mol),2.197410731070427,1.8594267642584574
NCI-H146,5328940,1.6811042727449883,1.8594267642584574
CAL-51,168313200,3.900876548563449,1.8594267642584574
DMS 273,1750826,-1.913269562568005,1.8594267642584574
A2780,54618305,3.781380565087532,1.8594267642584574
NOMO-1,9936388,-6.523282887173488,1.8594267642584574
NCI-H460,5282054,4.802373462225767,1.8594267642584574
SBC-5,82146,3.3774942308101785,1.8594267642584574
NCI-H727,56946209,-2.7175198163763232,1.8594267642584574
FTC-133,3062316,3.806169585149848,1.8594267642584574
A2780,9967941,1.4564169862408056,1.8594267642584574
DMS 273,5351362,1.0025978169272032,1.8594267642584574
SCC-9,16038120,1.877705535955449,1.8594267642584574
NCI-H522,6917907,-6.015261010654924,1.8594267642584574
CA46,4477,-0.2706834990523855,1.8594267642584574
NCI-H661,erlotinib-PLX-4032 (2-1 mol-mol),2.455448460706525,1.8594267642584574
SNU-449,11178236,-2.056078636199096,1.8594267642584574
SBC-5,5278396,3.3013936373431996,1.8594267642584574
NCI-H1623,44493528,4.638812765070766,1.8594267642584574
NOMO-1,16720766,-1.891739380903732,1.8594267642584574
G-401,2729026,2.5705443446476828,1.8594267642584574
G-401,6917907,-5.905222634362146,1.8594267642584574
MDA-MB-453,2858523,2.664825786894245,1.8594267642584574
CAL-51,navitoclax-piperlongumine (1-1 mol-mol),2.2643943730886944,1.8594267642584574
LoVo,11427553,2.604805449600099,1.8594267642584574
G-401,11234052,3.7167035951130423,1.8594267642584574
FU-OV-1,168312962,3.576057642182836,1.8594267642584574
JM-1,11228183,-0.9199972643114134,1.8594267642584574
ONS-76,65628,4.406189432641036,1.8594267642584574
Panc 04.03,11964036,1.4501208375942458,1.8594267642584574
YAPC,17759555,4.434513834785858,1.8594267642584574
Panc 04.03,5311,1.931700632460216,1.8594267642584574
NCI-H522,tretinoin-carboplatin (2-1 mol-mol),5.2025586729101185,1.8594267642584574
NOMO-1,49793307,-3.1091933140229,1.8594267642584574
MDA-MB-453,46174525,3.691895458218128,1.8594267642584574
G-401,11977753,-3.640604480016117,1.8594267642584574
A-673,16722836,0.9037523157925,1.8594267642584574
MDA-MB-453,5494449,3.8003034085581993,1.8594267642584574
NCI-H522,25150857,1.47132219158847,1.8594267642584574
OPM-2,5311037,3.4844810711382936,1.8594267642584574
LXF 289,11152667,-0.4789950074309144,1.8594267642584574
CAL-51,9911830,2.6702149728757343,1.8594267642584574
KMRC-1,4378219,2.060133570967863,1.8594267642584574
SNU-61,navitoclax-sorafenib (1-1 mol-mol),1.8672566595023088,1.8594267642584574
CAL-51,156414,1.13799157004995,1.8594267642584574
A4/Fukuda,carboplatin-etoposide (40-17 mol-mol),0.4853632935092173,1.8594267642584574
NCI-H727,89928392,1.7873251449620886,1.8594267642584574
KYSE-70,6918837,-2.6267197721971582,1.8594267642584574
JM-1,135928012,4.176764785732949,1.8594267642584574
NCI-H522,10427712,4.202859541756615,1.8594267642584574
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793,1.8594267642584574
CA46,5470400,3.727677755196873,1.8594267642584574
KMRC-1,navitoclax-pluripotin (1-1 mol-mol),-0.6870292633838142,1.8594267642584574
EFO-27,9936388,3.039710224097925,1.8594267642584574
NCI-H292,54618771,0.019803014891406,1.8594267642584574
KYSE-70,25262965,-2.1035778811550836,1.8594267642584574
ONS-76,selumetinib-piperlongumine (8-1 mol-mol),-1.0642702210035522,1.8594267642584574
MDA-MB-453,11656518,1.9818038641727111,1.8594267642584574
YAPC,5282054,4.005772938817316,1.8594267642584574
SNU-449,24180719,3.8016565421464072,1.8594267642584574
FU-OV-1,15983966,2.2280291717608947,1.8594267642584574
SBC-5,11485656,2.2866280503579812,1.8594267642584574
ONS-76,702558,5.821489397293988,1.8594267642584574
SCC-9,9911463,4.4493328300482995,1.8594267642584574
HSC-4,72193861,2.788231918333871,1.8594267642584574
DMS 273,2126,4.20633218634453,1.8594267642584574
OVISE,46199207,4.361349086507746,1.8594267642584574
Panc 04.03,241158,4.444137488799797,1.8594267642584574
NCI-H460,654092,0.4612941847378306,1.8594267642584574
A4/Fukuda,45279963,1.9027034071047564,1.8594267642584574
NCI-H292,44259,1.4427392496176257,1.8594267642584574
FU-OV-1,17759555,4.190415677120393,1.8594267642584574
SNU-81,3634881,2.620060882721275,1.8594267642584574
NCI-H2009,107970,2.2954238398166344,1.8594267642584574
LoVo,5278396,2.046108484267772,1.8594267642584574
NCI-H146,vorinostat-navitoclax (4-1 mol-mol),-3.3112811386444525,1.8594267642584574
HCC1143,12003241,-0.0421467164139253,1.8594267642584574
Panc 04.03,46926350,-3.8788763459733473,1.8594267642584574
A4/Fukuda,4578,3.815086457915261,1.8594267642584574
CAL-51,9929138,6.421072450841616,1.8594267642584574
CA46,decitabine-navitoclax (2-1 mol-mol),3.2544479904294383,1.8594267642584574
SNU-81,4259181,-0.3131255720640173,1.8594267642584574
KYSE-70,675434,4.695192974207532,1.8594267642584574
A2780,selumetinib-MK-2206 (8-1 mol-mol),0.1736531975308503,1.8594267642584574
A-673,135659046,3.595490040408381,1.8594267642584574
NCI-H522,4578,4.727447650100284,1.8594267642584574
DMS 273,54765302,4.301325739041371,1.8594267642584574
A4/Fukuda,135440466,-0.9873079875011114,1.8594267642584574
LXF 289,24821094,2.4128137194258215,1.8594267642584574
NCI-H460,5746,0.0249012606464236,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11964036,2.7270949198537195,1.8594267642584574
A-498,25062766,2.0793230877467166,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],262093,3.1357995089449058,1.8594267642584574
Panc 04.03,10127622,4.886231353649791,1.8594267642584574
G-401,57330099,4.350194890812272,1.8594267642584574
NCI-H1623,168312962,4.13769742192025,1.8594267642584574
SBC-5,5566,3.1825236444892124,1.8594267642584574
Panc 04.03,9825149,3.055289787116955,1.8594267642584574
BT-549,11507802,2.533090965918468,1.8594267642584574
OPM-2,5951923,4.162321290800766,1.8594267642584574
MDA-MB-453,salermide-PLX-4032 (12-1 mol-mol),3.8592412133005265,1.8594267642584574
NOMO-1,9935249,2.770043096032674,1.8594267642584574
LOU-NH91,11640390,4.567382593568383,1.8594267642584574
MDA-MB-453,135440466,2.739035638886915,1.8594267642584574
HSC-4,644241,2.6183127396598262,1.8594267642584574
MSTO-211H,17755052,-0.0733710656781619,1.8594267642584574
A-498,crizotinib-PLX-4032 (2-1 mol-mol),2.697469324317316,1.8594267642584574
BxPC-3,5281321,-1.5422365883768068,1.8594267642584574
MSTO-211H,9444,4.1850544738080915,1.8594267642584574
LoVo,17755052,-0.1303127354802701,1.8594267642584574
KMRC-1,44137675,2.117874577310701,1.8594267642584574
A4/Fukuda,9911463,2.417745886609146,1.8594267642584574
MSTO-211H,3101542,4.302130070317232,1.8594267642584574
NCI-H146,426756,4.36191990335561,1.8594267642584574
Panc 04.03,44589607,3.8783822611027454,1.8594267642584574
G-401,24901704,2.2796887972749307,1.8594267642584574
MSTO-211H,285033,-3.2380358495287695,1.8594267642584574
BxPC-3,452548,1.628130986083035,1.8594267642584574
SCC-9,9926054,1.898935947612019,1.8594267642584574
MSTO-211H,1750826,-4.930051018535606,1.8594267642584574
NCI-H2171,navitoclax-sorafenib (1-1 mol-mol),0.0359030592746101,1.8594267642584574
HSC-4,216345,4.5807127841732775,1.8594267642584574
LOU-NH91,168312962,3.892175490150028,1.8594267642584574
MSTO-211H,53232,-0.5437095856797647,1.8594267642584574
DMS 273,sirolimus-bortezomib (250-1 mol-mol),0.2700618452232576,1.8594267642584574
EFO-27,5335621,6.264647611417884,1.8594267642584574
CAL-51,1716436,3.275997904874087,1.8594267642584574
NCI-H460,53232,3.485336782178725,1.8594267642584574
MDA-MB-157,54454,1.950382699789776,1.8594267642584574
NCI-H292,44489367,4.492014578968512,1.8594267642584574
KMRC-1,4521392,4.136909747869898,1.8594267642584574
HCC1143,selumetinib-PLX-4032 (8-1 mol-mol),-0.2774552513051289,1.8594267642584574
HSC-4,56649450,2.6853332826773144,1.8594267642584574
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187,1.8594267642584574
BT-549,9926054,1.9687680834705423,1.8594267642584574
SCC-9,9911830,2.3699428367857145,1.8594267642584574
CAL-51,selumetinib-BRD-A02303741 (4-1 mol-mol),6.310844826141485,1.8594267642584574
FU-OV-1,409805,4.026686349090877,1.8594267642584574
BxPC-3,387447,-4.571753731996322,1.8594267642584574
CA46,44486219,3.6158388001945463,1.8594267642584574
EFO-27,135659046,3.7618075322397297,1.8594267642584574
NCI-H661,104842,-3.978937701952532,1.8594267642584574
SBC-5,16741245,1.694771238369721,1.8594267642584574
FU-OV-1,676352,2.7826635655764473,1.8594267642584574
CA46,969516,2.1845952347247306,1.8594267642584574
ONS-76,decitabine-navitoclax (2-1 mol-mol),2.571137533276933,1.8594267642584574
HCC1143,9825149,3.0211594258387486,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11707110,-2.81784904286785,1.8594267642584574
KYSE-70,navitoclax-piperlongumine (1-1 mol-mol),2.418726808753935,1.8594267642584574
MDA-MB-453,selumetinib-UNC0638 (4-1 mol-mol),4.2655945403569815,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11494412,4.241721696176272,1.8594267642584574
MDA-MB-453,676352,1.703646310562033,1.8594267642584574
CAL-51,46191454,0.2698308836515951,1.8594267642584574
Panc 04.03,9823820,5.907522872650916,1.8594267642584574
SNU-81,44259,0.6272555485824429,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],selumetinib-PLX-4032 (8-1 mol-mol),2.814367803640325,1.8594267642584574
EFO-27,445455,4.405247459654703,1.8594267642584574
BT-549,11152667,-0.4620191787747055,1.8594267642584574
HSC-4,23725625,4.12890848458229,1.8594267642584574
BxPC-3,11640390,3.353927872983648,1.8594267642584574
HCC1143,216468,1.9778651637296407,1.8594267642584574
Panc 04.03,49766530,1.2448845141630578,1.8594267642584574
SCC-9,10427712,3.976850957625781,1.8594267642584574
HCC1143,36462,4.303888689757339,1.8594267642584574
NCI-H460,262093,3.3627537421549314,1.8594267642584574
SNU-61,56963564,0.6866306287041547,1.8594267642584574
SNU-449,2858523,3.0307383113048676,1.8594267642584574
KMRC-1,11214940,1.677559369833433,1.8594267642584574
A2780,216239,1.3949646663017006,1.8594267642584574
MDA-MB-157,89183176,3.472749903375588,1.8594267642584574
NCI-H146,11152667,-0.8780602169524299,1.8594267642584574
NCI-H460,9956119,4.485375019847723,1.8594267642584574
CAL-51,vorinostat-carboplatin (1-1 mol-mol),3.249812174722343,1.8594267642584574
A2780,BRD-A02303741-carboplatin (1-1 mol-mol),3.111500594060002,1.8594267642584574
DMS 273,6450551,2.589238729256945,1.8594267642584574
NCI-H2171,5311281,0.8399284053106422,1.8594267642584574
SNU-81,23635314,-3.737654632526069,1.8594267642584574
FTC-133,119182,-0.5312905210850081,1.8594267642584574
A2780,656346,0.4231070640442763,1.8594267642584574
HSC-4,441298,2.8371907900438535,1.8594267642584574
MDA-MB-157,285033,-2.194765851649468,1.8594267642584574
JM-1,73707398,-0.8556338999048841,1.8594267642584574
JM-1,6852167,1.3157742507093588,1.8594267642584574
A2780,11364421,-5.7057574677584295,1.8594267642584574
NCI-H522,54596490,4.410611853984333,1.8594267642584574
NOMO-1,159324,1.6027654254866297,1.8594267642584574
A-673,107985,-4.827881226135439,1.8594267642584574
NCI-H460,piperlongumine-MST-312 (1-1 mol-mol),2.8290325142840036,1.8594267642584574
NCI-H661,5287620,-2.104840782561513,1.8594267642584574
LOU-NH91,119182,4.180997641513534,1.8594267642584574
SBC-5,10113978,4.162999994539472,1.8594267642584574
A-673,252682,5.861850244558702,1.8594267642584574
NCI-H2171,5281321,-4.274427204887198,1.8594267642584574
EFO-27,3854666,3.6632128701571194,1.8594267642584574
A-498,25154868,5.700321852894753,1.8594267642584574
LOU-NH91,JQ-1-vorinostat (2-1 mol-mol),0.7101877793592652,1.8594267642584574
CAL-51,31703,-2.726607914110417,1.8594267642584574
KMRC-1,9840324,5.892638074147807,1.8594267642584574
BxPC-3,49850262,4.227475038244019,1.8594267642584574
JM-1,6450551,1.340572992486765,1.8594267642584574
KMRC-1,148124,2.1112012667960656,1.8594267642584574
MDA-MB-453,navitoclax-gemcitabine (1-1 mol-mol),-2.0425828682575684,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],60700,-0.2980706312028528,1.8594267642584574
NCI-H522,7326481,4.603358487226629,1.8594267642584574
KMRC-1,3025944,4.220614757043024,1.8594267642584574
EFO-27,9935249,3.352272124535396,1.8594267642584574
SNU-449,10296883,3.939630786750968,1.8594267642584574
A-673,42611257,3.360985567795572,1.8594267642584574
MDA-MB-453,156422,3.699160121301749,1.8594267642584574
A4/Fukuda,89928392,-0.3543848103605003,1.8594267642584574
SNU-449,10385095,1.0986031812390589,1.8594267642584574
HCC1143,6438330,1.6030228226948184,1.8594267642584574
MDA-MB-453,3854666,1.8999840682298523,1.8594267642584574
SCC-9,46191454,1.8170261878735936,1.8594267642584574
OPM-2,9825149,0.9763440152106764,1.8594267642584574
NCI-H661,vorinostat-carboplatin (1-1 mol-mol),2.835829919183064,1.8594267642584574
BxPC-3,25150857,2.298115585090939,1.8594267642584574
OVISE,selumetinib-vorinostat (8-1 mol-mol),2.514826548203033,1.8594267642584574
NCI-H2171,25227462,0.3993487036849301,1.8594267642584574
JM-1,24748573,1.2692721555493711,1.8594267642584574
EFO-27,selumetinib-navitoclax (8-1 mol-mol),4.865349283387626,1.8594267642584574
JM-1,doxorubicin-navitoclax (2-1 mol-mol),-4.099692246271054,1.8594267642584574
KYSE-70,5281321,-0.9979352327108848,1.8594267642584574
NCI-H460,11507802,2.848054270429628,1.8594267642584574
SCC-9,4259181,1.940043087837339,1.8594267642584574
ONS-76,135421197,2.4329108516652775,1.8594267642584574
CAL-51,52947716,-4.729660133739893,1.8594267642584574
JM-1,123631,2.636256127990424,1.8594267642584574
HCC1143,1641662,3.4150871228937563,1.8594267642584574
NCI-H292,8515,4.694095877434875,1.8594267642584574
SNU-449,71304818,1.9790204353457292,1.8594267642584574
A2780,5566,2.7251077604344696,1.8594267642584574
EFO-27,82146,5.16738023752069,1.8594267642584574
NCI-H727,107985,-2.9799734550318204,1.8594267642584574
CAL-51,446155,1.9002286289262065,1.8594267642584574
SNU-61,4378219,2.193359587578685,1.8594267642584574
NCI-H522,1641662,3.4912081270508293,1.8594267642584574
FTC-133,44607530,3.0000417574370157,1.8594267642584574
A-673,448949,0.8158812974066569,1.8594267642584574
LOU-NH91,20959075,-3.4746906487579494,1.8594267642584574
SNU-449,5113032,5.017862259712187,1.8594267642584574
NCI-H522,6450551,3.1458433056927295,1.8594267642584574
SNU-449,16659841,4.200866251374559,1.8594267642584574
NCI-H460,409805,5.4278006548731295,1.8594267642584574
MSTO-211H,46943432,4.749068259324704,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],6918638,-0.5937755297048425,1.8594267642584574
ONS-76,navitoclax-MST-312 (1-1 mol-mol),0.8596431807362984,1.8594267642584574
SCC-9,11455910,1.869884665357408,1.8594267642584574
Panc 04.03,613753,3.3040029053289772,1.8594267642584574
OPM-2,6918736,-1.006954953557461,1.8594267642584574
A2780,3854666,-0.0414990172822217,1.8594267642584574
FTC-133,25183872,2.254027462535002,1.8594267642584574
MDA-MB-157,387447,-4.079240132125457,1.8594267642584574
SNU-449,54618771,0.9697829427454708,1.8594267642584574
Panc 04.03,selumetinib-GDC-0941 (4-1 mol-mol),1.425782410580866,1.8594267642584574
MDA-MB-157,72376,-2.1484578807410553,1.8594267642584574
SBC-5,5287620,-1.4097460130546278,1.8594267642584574
FU-OV-1,54649381,4.3760479468817675,1.8594267642584574
NCI-H2009,26596,-1.5885219134108934,1.8594267642584574
A-673,66577038,2.223533674143975,1.8594267642584574
SBC-5,6918878,2.928817535111611,1.8594267642584574
OPM-2,11640390,0.8264429779628358,1.8594267642584574
NCI-H460,3503,2.4668231300278154,1.8594267642584574
SBC-5,156422,4.2102641448485345,1.8594267642584574
ONS-76,216345,3.2166812322741043,1.8594267642584574
BT-549,15983966,-4.218963036377602,1.8594267642584574
A4/Fukuda,3038522,1.5780319148667876,1.8594267642584574
BT-549,23582824,0.5256314804740283,1.8594267642584574
NCI-H146,2871966,-2.058689249756004,1.8594267642584574
OVISE,17755052,3.2346427318945263,1.8594267642584574
OVISE,44819697,-1.8576377458936848,1.8594267642584574
SNU-449,46398810,3.267032406348896,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],4917,3.7649934219972727,1.8594267642584574
A2780,11228183,2.2113347222865123,1.8594267642584574
NCI-H1623,piperlongumine-MST-312 (1-1 mol-mol),2.715053183810439,1.8594267642584574
NCI-H661,tanespimycin-gemcitabine (1-1 mol-mol),-0.3480588357963589,1.8594267642584574
SNU-81,46398810,0.3023493978041217,1.8594267642584574
KYSE-70,11152667,0.5949086715112851,1.8594267642584574
LoVo,73707386,4.416344333605744,1.8594267642584574
NCI-H522,5746,0.3558137383480795,1.8594267642584574
NCI-H460,135421197,3.2510260026522233,1.8594267642584574
MDA-MB-453,11507802,1.551744908234443,1.8594267642584574
A-673,4096211,1.8222389073608836,1.8594267642584574
NCI-H727,136227924,3.2179651731130585,1.8594267642584574
NCI-H460,16065773,2.454458456288103,1.8594267642584574
SNU-61,24901704,3.3171528895384115,1.8594267642584574
NCI-H292,11612883,2.84187428422206,1.8594267642584574
NCI-H2171,9907093,4.086146580877247,1.8594267642584574
NCI-H522,3634881,3.092168984490579,1.8594267642584574
G-401,9915743,0.7240748800691799,1.8594267642584574
SNU-61,46843906,2.645147040347038,1.8594267642584574
SNU-81,73707386,1.6277005390789234,1.8594267642584574
NCI-H1623,4261,0.4244365105903193,1.8594267642584574
FU-OV-1,selumetinib-vorinostat (8-1 mol-mol),1.6178932175124687,1.8594267642584574
OVISE,1750826,-3.1689535405206715,1.8594267642584574
OVISE,25183872,-0.2641805795712313,1.8594267642584574
MDA-MB-157,753704,5.007751734334353,1.8594267642584574
CAL-51,54618771,0.0049145289548569,1.8594267642584574
NCI-H661,25195348,2.4001868352132445,1.8594267642584574
KMRC-1,3689413,-1.8207429228817171,1.8594267642584574
HSC-4,650361,3.951915492066197,1.8594267642584574
KYSE-70,10427712,2.9549225300897977,1.8594267642584574
SNU-61,selumetinib-GDC-0941 (4-1 mol-mol),0.6805559460270842,1.8594267642584574
OPM-2,11717001,3.8340096164502135,1.8594267642584574
NCI-H727,11214940,2.165075102098245,1.8594267642584574
KMRC-1,11404337,1.3121470144090095,1.8594267642584574
MDA-MB-453,24951314,-0.4314694021522904,1.8594267642584574
SCC-9,135398516,3.38372398158662,1.8594267642584574
KMRC-1,11977753,-0.1874629547163491,1.8594267642584574
NCI-H2009,25062766,1.439977805675878,1.8594267642584574
NCI-H2171,6918638,-1.5146784294865197,1.8594267642584574
Panc 04.03,3081361,3.5741960453568464,1.8594267642584574
BxPC-3,73707398,1.0061551215696194,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11364421,0.8746857299268361,1.8594267642584574
BT-549,11404337,-0.1293922368150601,1.8594267642584574
SCC-9,5281321,1.285660121438517,1.8594267642584574
SNU-81,104842,-4.044454085478647,1.8594267642584574
CAL-51,6610216,4.7761200098267365,1.8594267642584574
JM-1,9933475,1.5625695981291614,1.8594267642584574
NCI-H727,11485656,2.2939690780404423,1.8594267642584574
A2780,426756,4.623757394028108,1.8594267642584574
A2780,5311,0.5155233924036543,1.8594267642584574
NCI-H146,11707110,3.3128142773805176,1.8594267642584574
MDA-MB-157,11977753,-1.6055696025393866,1.8594267642584574
A4/Fukuda,11494412,-1.359408079628026,1.8594267642584574
KYSE-70,selumetinib-GDC-0941 (4-1 mol-mol),1.855556078867097,1.8594267642584574
LoVo,11977753,-2.85765012298846,1.8594267642584574
FU-OV-1,56963564,3.5833852081145836,1.8594267642584574
NOMO-1,375860,-0.5184264862355304,1.8594267642584574
EFO-27,3136844,4.472321824110979,1.8594267642584574
MDA-MB-157,selumetinib-BRD-A02303741 (4-1 mol-mol),5.186273377251054,1.8594267642584574
NCI-H292,168312962,3.5892294654935726,1.8594267642584574
CAL-51,44607530,2.3415901962162855,1.8594267642584574
EFO-27,2949965,3.1309950522818277,1.8594267642584574
DMS 273,carboplatin-UNC0638 (2-1 mol-mol),3.439220302346012,1.8594267642584574
A4/Fukuda,12001922,1.2276815023009988,1.8594267642584574
CAL-51,24951314,1.3730048574034712,1.8594267642584574
A4/Fukuda,135928012,2.23734461349398,1.8594267642584574
SNU-81,10127622,-3.2164123245129095,1.8594267642584574
MDA-MB-157,navitoclax-PLX-4032 (1-1 mol-mol),-2.380477221349832,1.8594267642584574
NCI-H2171,decitabine-navitoclax (2-1 mol-mol),-1.124671467486642,1.8594267642584574
OPM-2,122327,3.690232587907526,1.8594267642584574
NCI-H522,5329102,1.9502496806074603,1.8594267642584574
NCI-H2171,9903786,1.7901794952315444,1.8594267642584574
HCC1143,SNX-2112-bortezomib (250-1 mol-mol),-0.3762551319629964,1.8594267642584574
YAPC,676352,2.46422610000008,1.8594267642584574
NCI-H292,44507138,1.692325111571909,1.8594267642584574
SNU-449,2945648,2.540265867455936,1.8594267642584574
MDA-MB-157,navitoclax-gemcitabine (1-1 mol-mol),-2.3120540291625766,1.8594267642584574
A-673,3136844,3.9161258830055736,1.8594267642584574
OPM-2,151289,0.8971834485048114,1.8594267642584574
LoVo,219104,3.1119995266948237,1.8594267642584574
NCI-H1623,9936388,-4.968103162812744,1.8594267642584574
DMS 273,11485656,2.8704893197930272,1.8594267642584574
LoVo,73707398,0.5951327141059009,1.8594267642584574
NCI-H2009,135421197,1.5480281661357902,1.8594267642584574
NCI-H1623,409805,3.8984511674912943,1.8594267642584574
CAL-51,1750826,-0.4147302595408071,1.8594267642584574
MDA-MB-453,54143018,-0.7571444922765344,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1580465121550203,1.8594267642584574
HSC-4,54619267,4.093335991980471,1.8594267642584574
BxPC-3,4378219,2.0321108717651426,1.8594267642584574
NCI-H292,5978,-1.7096488796134024,1.8594267642584574
A2780,71466380,3.7792629508428783,1.8594267642584574
MSTO-211H,44589607,1.2735087838172758,1.8594267642584574
NOMO-1,54143018,-1.1216489579847602,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],1750826,-0.1499809417024857,1.8594267642584574
A-673,46174525,2.7075701285598375,1.8594267642584574
NCI-H661,3854666,2.0669995151297633,1.8594267642584574
NCI-H1623,322968,2.7878661836218863,1.8594267642584574
Panc 04.03,52947716,3.0713971775620448,1.8594267642584574
DMS 273,9840324,6.645778367521572,1.8594267642584574
NCI-H460,15547703,4.965379127843483,1.8594267642584574
FTC-133,11228183,0.2445093238012437,1.8594267642584574
NCI-H522,9935249,3.002706281912375,1.8594267642584574
NOMO-1,6610216,4.0700997553747325,1.8594267642584574
A4/Fukuda,46199207,1.9027513858957976,1.8594267642584574
EFO-27,16659841,4.389988364450653,1.8594267642584574
LXF 289,JQ-1-carboplatin (1-1 mol-mol),0.2436296236972278,1.8594267642584574
CA46,11977753,-4.21997551918338,1.8594267642584574
OPM-2,tretinoin-navitoclax (4-1 mol-mol),3.1299009016579253,1.8594267642584574
SBC-5,54613361,-1.7173374464522142,1.8594267642584574
MDA-MB-157,16065773,0.9216763205067852,1.8594267642584574
NCI-H1623,selumetinib-BRD-A02303741 (4-1 mol-mol),6.385895152539582,1.8594267642584574
SNU-81,44137675,1.234825635215107,1.8594267642584574
OVISE,9929138,5.66720682434708,1.8594267642584574
Panc 04.03,16725315,5.278537246983346,1.8594267642584574
A4/Fukuda,6438330,0.8804707138455458,1.8594267642584574
NCI-H292,984333,1.6058463338689488,1.8594267642584574
NOMO-1,11396600,3.3888037624860674,1.8594267642584574
SNU-81,24964624,0.6434241987426411,1.8594267642584574
BT-549,11964036,1.9997330886235436,1.8594267642584574
A-673,135411,0.3370419809316401,1.8594267642584574
NCI-H1623,10296883,4.489600285768525,1.8594267642584574
NCI-H292,2733526,4.552154891253422,1.8594267642584574
YAPC,6914657,-3.2827547721856423,1.8594267642584574
BT-549,selumetinib-GDC-0941 (4-1 mol-mol),2.833725023206459,1.8594267642584574
NCI-H2009,327653,3.1880644035572825,1.8594267642584574
CAL-51,3384730,2.4775948365465905,1.8594267642584574
FTC-133,3689413,-0.3036251064519336,1.8594267642584574
MDA-MB-453,11964036,0.3676608059270313,1.8594267642584574
NCI-H2009,5281321,-2.3281539094269843,1.8594267642584574
FU-OV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.708642246881296,1.8594267642584574
LoVo,654092,0.3814222362545946,1.8594267642584574
MDA-MB-453,50905018,4.488581944485688,1.8594267642584574
HSC-4,selumetinib-UNC0638 (4-1 mol-mol),3.54677113858736,1.8594267642584574
OPM-2,46215462,1.142494911690201,1.8594267642584574
SCC-9,navitoclax-PLX-4032 (1-1 mol-mol),4.098864709147574,1.8594267642584574
A4/Fukuda,5329102,0.822909221294871,1.8594267642584574
A4/Fukuda,11228183,1.827405863351363,1.8594267642584574
Panc 04.03,5460769,2.0457621674825224,1.8594267642584574
MDA-MB-157,9933475,1.5029335433067268,1.8594267642584574
A-673,12003241,-2.2168793422392103,1.8594267642584574
NCI-H460,54618164,4.49670945938676,1.8594267642584574
NCI-H292,11656518,2.099021496243428,1.8594267642584574
SCC-9,51039095,3.242385267473305,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],24753719,5.1478478816318685,1.8594267642584574
SBC-5,3634881,3.763213110876527,1.8594267642584574
SCC-9,984333,1.3591962563360305,1.8594267642584574
CAL-51,72193861,0.6423702350358801,1.8594267642584574
SNU-449,6610216,3.892858260461962,1.8594267642584574
HCC1143,6918837,-2.8885170378203995,1.8594267642584574
DMS 273,10427712,3.7833762157010655,1.8594267642584574
SBC-5,ISOX-bortezomib (250-1 mol-mol),0.5037473854516791,1.8594267642584574
LoVo,8515,2.0502092932288543,1.8594267642584574
ONS-76,5311281,3.0534152046102507,1.8594267642584574
EFO-27,100016,6.711163327148508,1.8594267642584574
A-498,6610216,4.284288503720797,1.8594267642584574
SNU-449,docetaxel-tanespimycin (2-1 mol-mol),0.921733403174168,1.8594267642584574
G-401,71466578,3.958692091033976,1.8594267642584574
A2780,2749,1.2168739363641357,1.8594267642584574
LXF 289,23635314,-2.0420734326640253,1.8594267642584574
LXF 289,24901704,2.332916050939017,1.8594267642584574
LoVo,9887053,2.8676927346989265,1.8594267642584574
OPM-2,6918837,-6.102124609605729,1.8594267642584574
NOMO-1,72734382,3.160209893803666,1.8594267642584574
A2780,44507138,1.3155442648841038,1.8594267642584574
NCI-H661,9915743,-0.8538809858854721,1.8594267642584574
SW1463,168313047,-3.1836020137929246,1.8594267642584574
SNU-81,55283,4.080745185244615,1.8594267642584574
YAPC,159324,3.323857793241652,1.8594267642584574
HCC1143,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9300366262923152,1.8594267642584574
SNU-449,JQ-1-carboplatin (1-1 mol-mol),4.503532877258194,1.8594267642584574
A-673,31703,-3.778183583095139,1.8594267642584574
OPM-2,439501,-4.648238189793765,1.8594267642584574
A2780,452548,-4.864509732913544,1.8594267642584574
CA46,71304818,1.9606514180280712,1.8594267642584574
LoVo,25150857,3.1045912764862056,1.8594267642584574
KMRC-1,selumetinib-vorinostat (8-1 mol-mol),4.1266329667576915,1.8594267642584574
OVISE,446155,3.256033609420766,1.8594267642584574
SBC-5,54626689,4.608121703383126,1.8594267642584574
DMS 273,11497983,-3.3171386440582467,1.8594267642584574
BT-549,46398810,3.037551805065761,1.8594267642584574
KYSE-70,44819697,2.67312291481412,1.8594267642584574
DMS 273,10113978,3.3411401717417135,1.8594267642584574
YAPC,11178236,-2.1853000629740342,1.8594267642584574
EFO-27,89928392,2.3405290602814586,1.8594267642584574
NCI-H727,3062316,3.1124899612632135,1.8594267642584574
MSTO-211H,9825149,1.7087798179810727,1.8594267642584574
OPM-2,25062766,1.526966504091227,1.8594267642584574
LoVo,24797083,1.0858534416002044,1.8594267642584574
MDA-MB-157,11612883,1.9249665557248452,1.8594267642584574
MDA-MB-453,24978538,2.762094535978925,1.8594267642584574
A-673,55283,2.8138583621562288,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],5282054,4.302238331478781,1.8594267642584574
OPM-2,11228183,2.227238978219669,1.8594267642584574
SNU-449,11640390,3.8548607423510384,1.8594267642584574
NCI-H522,5281321,-1.0736628447197911,1.8594267642584574
NCI-H460,25126798,4.092385726400508,1.8594267642584574
JM-1,9887053,1.8224498727300744,1.8594267642584574
MDA-MB-453,3689413,0.605092083526794,1.8594267642584574
BT-549,322968,4.038930181616003,1.8594267642584574
G-401,969516,2.4612878169829067,1.8594267642584574
FU-OV-1,10127622,2.361983631252389,1.8594267642584574
G-401,5738263,2.503403034491448,1.8594267642584574
MDA-MB-453,5328940,1.6011356292327752,1.8594267642584574
HSC-4,25105715,3.6888708464756337,1.8594267642584574
G-401,5291,3.6897209629580616,1.8594267642584574
SNU-81,148198,-1.0516438667772403,1.8594267642584574
FU-OV-1,25183872,1.8271723160300688,1.8594267642584574
NCI-H460,navitoclax-piperlongumine (1-1 mol-mol),3.830586656387486,1.8594267642584574
JM-1,9935249,0.9666917954448688,1.8594267642584574
JM-1,44607531,1.0390724505323097,1.8594267642584574
BT-549,5566,3.2694223641451887,1.8594267642584574
LXF 289,637858,2.285720521187594,1.8594267642584574
SNU-81,56946209,-4.781557694686043,1.8594267642584574
FU-OV-1,89928392,1.4286122200262183,1.8594267642584574
MSTO-211H,doxorubicin-navitoclax (2-1 mol-mol),-1.8407653022035375,1.8594267642584574
CAL-51,54618359,4.544084907505638,1.8594267642584574
LoVo,15983966,-3.091518031584947,1.8594267642584574
CA46,5746,0.6077367646083516,1.8594267642584574
CAL-51,2733487,8.211583338705053,1.8594267642584574
NCI-H522,4705,3.8595388748644375,1.8594267642584574
A4/Fukuda,5284329,2.3119801528783244,1.8594267642584574
DMS 273,ISOX-bortezomib (250-1 mol-mol),0.050266361305609,1.8594267642584574
OPM-2,6505803,-0.5489645461029444,1.8594267642584574
NCI-H146,11955716,-2.61946993472624,1.8594267642584574
Panc 04.03,19582717,5.125237161512837,1.8594267642584574
LXF 289,9926054,2.043368643335034,1.8594267642584574
BT-549,136227924,3.266068806496957,1.8594267642584574
LOU-NH91,24901704,2.9181520482303585,1.8594267642584574
A2780,11167602,1.1290528312474395,1.8594267642584574
HCC1143,15983966,0.2074313732487278,1.8594267642584574
G-401,piperlongumine-MST-312 (1-1 mol-mol),1.0766364038162666,1.8594267642584574
JM-1,2871966,-2.1290689366468354,1.8594267642584574
FU-OV-1,6852167,2.292876265150526,1.8594267642584574
MSTO-211H,31703,-2.679199045886266,1.8594267642584574
BxPC-3,5335621,4.830409945539455,1.8594267642584574
SNU-81,6438330,3.0600940001891863,1.8594267642584574
CAL-51,6918878,3.0110486558166274,1.8594267642584574
LXF 289,6610355,4.558728947318035,1.8594267642584574
KYSE-70,12001922,1.7900886800743383,1.8594267642584574
BxPC-3,60168763,4.708123265391542,1.8594267642584574
CAL-51,44137675,3.485867182081199,1.8594267642584574
SBC-5,carboplatin-UNC0638 (2-1 mol-mol),4.8107215741986105,1.8594267642584574
NCI-H460,216345,3.827300936034388,1.8594267642584574
NCI-H522,15953870,3.615553645162116,1.8594267642584574
A-673,46199207,3.2534509529249176,1.8594267642584574
SCC-9,10127622,7.404435857651999,1.8594267642584574
Panc 04.03,11977753,1.829262770264154,1.8594267642584574
HCC1143,168313047,3.0210205197435935,1.8594267642584574
EFO-27,3465537,3.52414234339403,1.8594267642584574
A-498,462382,4.566729065673536,1.8594267642584574
FTC-133,45279963,4.126382655862848,1.8594267642584574
G-401,71751553,4.092007605377758,1.8594267642584574
MDA-MB-453,119607,3.891659451485504,1.8594267642584574
MDA-MB-453,3384730,-0.7236289420344145,1.8594267642584574
SNU-61,6184667,2.8549853776409937,1.8594267642584574
NOMO-1,23635314,-2.3321691272104697,1.8594267642584574
SNU-81,54618164,-0.3986435357924686,1.8594267642584574
NCI-H727,65064,3.1010913931031867,1.8594267642584574
CAL-51,44607531,1.640429423812436,1.8594267642584574
CAL-51,72376,-2.938334648898351,1.8594267642584574
NCI-H522,126941,-2.655181013676553,1.8594267642584574
ONS-76,3025944,4.431691617199171,1.8594267642584574
NCI-H460,25154868,3.4600493825904564,1.8594267642584574
FTC-133,71304818,3.18789827914798,1.8594267642584574
CAL-51,151289,0.6583498849401344,1.8594267642584574
LXF 289,11238147,3.4273419568352006,1.8594267642584574
BT-549,BRD-A02303741-carboplatin (1-1 mol-mol),5.675509495895237,1.8594267642584574
KYSE-70,702558,6.39879445367054,1.8594267642584574
CAL-51,124202324,2.033990287468598,1.8594267642584574
MSTO-211H,46907787,2.574686905184434,1.8594267642584574
MSTO-211H,4521392,4.029667841571139,1.8594267642584574
EFO-27,ISOX-bortezomib (250-1 mol-mol),0.3269008359156463,1.8594267642584574
A2780,9549297,1.1491610880845489,1.8594267642584574
NCI-H2171,tanespimycin-bortezomib (250-1 mol-mol),-0.2558464529397277,1.8594267642584574
NCI-H2009,2729026,1.97459320968498,1.8594267642584574
HSC-4,5311,1.8002123285320597,1.8594267642584574
YAPC,135398738,5.4751822545753415,1.8594267642584574
Panc 04.03,285033,-1.1400173305697017,1.8594267642584574
OPM-2,decitabine-carboplatin (1-1 mol-mol),3.56587263318402,1.8594267642584574
A4/Fukuda,71466578,0.6387062903604859,1.8594267642584574
CAL-51,135398738,4.757337519270393,1.8594267642584574
A2780,selumetinib-PLX-4032 (8-1 mol-mol),1.6060841409900903,1.8594267642584574
A-498,24785538,3.3641680302296564,1.8594267642584574
HSC-4,452548,-1.2537746146037845,1.8594267642584574
NOMO-1,6918837,-4.687337521865761,1.8594267642584574
A2780,6505803,-1.803583295606165,1.8594267642584574
YAPC,387447,-2.999100837413036,1.8594267642584574
NCI-H292,25183872,-0.4983801682636667,1.8594267642584574
NCI-H1623,44137675,2.921297693984664,1.8594267642584574
LoVo,46843906,2.381362357237743,1.8594267642584574
MDA-MB-157,5281321,-2.46264909171439,1.8594267642584574
NCI-H292,44137675,3.1459685562862707,1.8594267642584574
KYSE-70,navitoclax-MST-312 (1-1 mol-mol),1.2159582620106,1.8594267642584574
JM-1,5470400,3.917661049847631,1.8594267642584574
NCI-H522,52912189,0.1662181985496506,1.8594267642584574
MDA-MB-157,15983966,-4.787780953616188,1.8594267642584574
CAL-51,10322450,3.881825194853649,1.8594267642584574
CAL-51,6918837,-3.0563476396929703,1.8594267642584574
NCI-H661,54639126,4.507619035006863,1.8594267642584574
NCI-H661,5311281,4.526772174839299,1.8594267642584574
NCI-H460,selumetinib-MK-2206 (8-1 mol-mol),3.864749533949913,1.8594267642584574
LXF 289,3025986,-0.453776319374568,1.8594267642584574
Panc 04.03,25262965,-1.014076783670677,1.8594267642584574
MDA-MB-453,5746,3.800897853250581,1.8594267642584574
SBC-5,15953870,3.487984127844562,1.8594267642584574
HSC-4,decitabine-navitoclax (2-1 mol-mol),3.5629592535507557,1.8594267642584574
OVISE,3025986,-0.0395702470459638,1.8594267642584574
FTC-133,5311,2.4215013743463647,1.8594267642584574
NCI-H2171,11485656,1.3701169509015756,1.8594267642584574
A4/Fukuda,5282054,2.418862118344995,1.8594267642584574
NCI-H1623,25102847,3.8675819706398418,1.8594267642584574
OPM-2,984333,-0.0237710386013994,1.8594267642584574
FTC-133,387447,-3.6414317999651336,1.8594267642584574
BT-549,5311281,2.333978253730499,1.8594267642584574
OVISE,16720766,3.986904391501256,1.8594267642584574
NOMO-1,11612883,1.4996443311921075,1.8594267642584574
NCI-H146,5282054,2.6062567229872924,1.8594267642584574
SBC-5,6917907,0.6114763356012877,1.8594267642584574
NCI-H727,24951314,2.050368453430269,1.8594267642584574
MDA-MB-157,613753,2.6621381248494456,1.8594267642584574
JM-1,44486219,4.06629583721778,1.8594267642584574
CA46,285033,-4.358161131916293,1.8594267642584574
A-673,9952709,2.6406542482442545,1.8594267642584574
BxPC-3,124202324,2.2278087185314694,1.8594267642584574
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569,1.8594267642584574
A-673,6852167,1.8255345198368305,1.8594267642584574
NCI-H146,6610355,3.561762383324193,1.8594267642584574
NOMO-1,46215462,1.6253213091786816,1.8594267642584574
CA46,439501,-3.521132637790176,1.8594267642584574
KMRC-1,5329102,1.6227643750477536,1.8594267642584574
MDA-MB-453,568763,0.1355288059345826,1.8594267642584574
NCI-H2009,15953870,4.632669867834425,1.8594267642584574
G-401,16725315,3.2068580834321048,1.8594267642584574
SNU-81,25154868,4.054299809836995,1.8594267642584574
SNU-61,2742550,3.576212598776706,1.8594267642584574
BxPC-3,44589607,1.722183316619471,1.8594267642584574
SNU-61,3025986,-0.1307165413786875,1.8594267642584574
NCI-H1623,3062316,1.6941172744123574,1.8594267642584574
ONS-76,16115403,-5.005393778847352,1.8594267642584574
LXF 289,12003241,-2.348837864712453,1.8594267642584574
DMS 273,168313016,5.378851860414917,1.8594267642584574
CA46,54765302,3.694944477545822,1.8594267642584574
MDA-MB-453,vorinostat-navitoclax (4-1 mol-mol),-0.1886705997266854,1.8594267642584574
A2780,10113978,1.7525717433500034,1.8594267642584574
OVISE,9911463,4.4041109725525525,1.8594267642584574
ONS-76,44589607,2.6985455021272573,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],9887053,4.376213721678965,1.8594267642584574
FU-OV-1,JQ-1-vorinostat (2-1 mol-mol),0.8626774662663057,1.8594267642584574
NCI-H522,JQ-1-UNC0638 (2-1 mol-mol),-1.3225503189993402,1.8594267642584574
A2780,26596,-4.32263985415392,1.8594267642584574
SNU-449,53481919,3.639889931386733,1.8594267642584574
A-673,135875424,2.9734448822107886,1.8594267642584574
A-673,49867926,4.049605811998934,1.8594267642584574
MSTO-211H,16720766,-0.9979081980160748,1.8594267642584574
MDA-MB-157,24785538,1.324170410962965,1.8594267642584574
CAL-51,107970,2.299284460939792,1.8594267642584574
OVISE,11178236,-4.082767785475175,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],374536,0.8021830219773941,1.8594267642584574
A4/Fukuda,25154868,2.544294393199085,1.8594267642584574
CAL-51,46191454,0.2698308836515951,1.8594267642584574
NOMO-1,136227924,2.5449106490851263,1.8594267642584574
KMRC-1,24821094,3.705597482955712,1.8594267642584574
A2780,5282054,2.567919090275208,1.8594267642584574
NCI-H2009,11404337,-0.0657811746758558,1.8594267642584574
HSC-4,409805,5.399675964474335,1.8594267642584574
LoVo,24772860,-3.380615847351667,1.8594267642584574
MDA-MB-453,54626689,4.438407624810902,1.8594267642584574
G-401,104842,-3.837747012299513,1.8594267642584574
BT-549,135440466,3.2033555971359267,1.8594267642584574
MDA-MB-157,docetaxel-tanespimycin (2-1 mol-mol),-4.4000012039018594,1.8594267642584574
NCI-H460,5280436,4.847067650781305,1.8594267642584574
NCI-H727,10385095,1.3903964913374658,1.8594267642584574
NCI-H727,262093,2.950291125725139,1.8594267642584574
CA46,25227462,-5.088225796968986,1.8594267642584574
HCC1143,439501,-0.7374061663212956,1.8594267642584574
MSTO-211H,10113978,1.403014421240365,1.8594267642584574
SNU-449,72734382,5.7131640484247805,1.8594267642584574
MSTO-211H,tanespimycin-gemcitabine (1-1 mol-mol),-0.5272277437526489,1.8594267642584574
MSTO-211H,selumetinib-decitabine (4-1 mol-mol),3.004409574636068,1.8594267642584574
BxPC-3,24772860,-3.1359973170310993,1.8594267642584574
LoVo,5281321,-2.272723057934536,1.8594267642584574
FU-OV-1,crizotinib-PLX-4032 (2-1 mol-mol),1.9353082171221765,1.8594267642584574
MDA-MB-453,10427712,3.2513664008238874,1.8594267642584574
Panc 04.03,53495165,2.8699642151767746,1.8594267642584574
FU-OV-1,54619267,4.302850520300199,1.8594267642584574
MSTO-211H,24964624,0.1425074184859401,1.8594267642584574
G-401,135875424,3.147536590476696,1.8594267642584574
ONS-76,selumetinib-tretinoin (2-1 mol-mol),-0.7324247564116871,1.8594267642584574
A-673,selumetinib-UNC0638 (4-1 mol-mol),2.386430695912322,1.8594267642584574
MDA-MB-157,9967941,1.858403940770751,1.8594267642584574
LoVo,ISOX-bortezomib (250-1 mol-mol),0.9349202186753368,1.8594267642584574
NCI-H292,11497983,4.544493181272098,1.8594267642584574
HSC-4,3011155,4.427149856421904,1.8594267642584574
NCI-H1623,17755052,0.7357373094762232,1.8594267642584574
SNU-61,navitoclax-piperlongumine (1-1 mol-mol),1.6755715296131175,1.8594267642584574
BxPC-3,5746,0.9856415477525818,1.8594267642584574
OPM-2,24901704,1.9220236520558196,1.8594267642584574
MSTO-211H,2858523,3.0747353868294627,1.8594267642584574
BT-549,107970,2.9169966931039113,1.8594267642584574
NCI-H292,135875424,4.14052752249008,1.8594267642584574
LOU-NH91,107970,2.5070848864255093,1.8594267642584574
MDA-MB-453,6918328,-2.060631340343386,1.8594267642584574
KMRC-1,44566777,-0.0538941449270197,1.8594267642584574
HCC1143,17755052,1.15684078766818,1.8594267642584574
Panc 04.03,9956119,4.202347043107845,1.8594267642584574
G-401,54613361,-0.5160099475891917,1.8594267642584574
NCI-H460,6918837,-0.9355989207233988,1.8594267642584574
SCC-9,10302451,2.205114392498864,1.8594267642584574
BT-549,24856436,0.2415814283223239,1.8594267642584574
Panc 04.03,25150857,3.139734816867742,1.8594267642584574
A-498,9866186,-1.262750837313692,1.8594267642584574
SW1463,11497983,4.077621288565615,1.8594267642584574
LoVo,124202324,1.6089295836770297,1.8594267642584574
JM-1,46215462,1.389060279673689,1.8594267642584574
A-673,2729026,1.806074207860909,1.8594267642584574
MSTO-211H,241158,2.290519528489604,1.8594267642584574
A4/Fukuda,6917907,-6.123586781218294,1.8594267642584574
NCI-H460,11485656,2.6212830818798065,1.8594267642584574
A2780,135875424,2.703796648613349,1.8594267642584574
NCI-H292,10127622,7.746640801358069,1.8594267642584574
DMS 273,9887053,1.8082863610482875,1.8594267642584574
EFO-27,426756,4.432789586131128,1.8594267642584574
MDA-MB-453,2749,0.298775024907787,1.8594267642584574
NCI-H460,11222830,2.8861636193629323,1.8594267642584574
NCI-H460,119182,0.2489341964189734,1.8594267642584574
MSTO-211H,676352,2.2606828184976955,1.8594267642584574
HSC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.9348378913345816,1.8594267642584574
SNU-81,16736978,0.587276282018702,1.8594267642584574
BxPC-3,10113978,2.7603674185652536,1.8594267642584574
SCC-9,6505803,-0.8932206272709824,1.8594267642584574
HSC-4,122327,4.034102983304833,1.8594267642584574
MDA-MB-157,107985,-3.8805729202788304,1.8594267642584574
HCC1143,5566,3.096162587379626,1.8594267642584574
BT-549,5738263,2.4683192628765753,1.8594267642584574
A-498,3854666,2.914304878080617,1.8594267642584574
SNU-449,navitoclax-pluripotin (1-1 mol-mol),0.5416887924611083,1.8594267642584574
ONS-76,73707398,1.7098056225756528,1.8594267642584574
A2780,10322450,2.9165978660974545,1.8594267642584574
CA46,3062316,1.4079672687586804,1.8594267642584574
HSC-4,selumetinib-MK-2206 (8-1 mol-mol),1.8625647516668664,1.8594267642584574
BT-549,71466380,5.5332032048485065,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],navitoclax-MST-312 (1-1 mol-mol),1.2670160922961198,1.8594267642584574
KYSE-70,24180719,3.52071426185984,1.8594267642584574
BT-549,10385095,1.777553004720717,1.8594267642584574
JM-1,4259181,-0.0762731042787348,1.8594267642584574
BxPC-3,12003241,-1.7282705692868598,1.8594267642584574
LXF 289,9840324,4.681234496405457,1.8594267642584574
KYSE-70,17759555,3.816264723168541,1.8594267642584574
NCI-H292,9911830,2.887423578139022,1.8594267642584574
HSC-4,9840324,5.223554072523372,1.8594267642584574
G-401,selumetinib-UNC0638 (4-1 mol-mol),3.413545127228383,1.8594267642584574
A2780,9915743,1.3754925129164983,1.8594267642584574
NCI-H2009,10302451,1.2105403110698565,1.8594267642584574
JM-1,tretinoin-navitoclax (4-1 mol-mol),0.3453404774126501,1.8594267642584574
ONS-76,9935249,3.5330143946083874,1.8594267642584574
BT-549,11427553,2.4752578658091524,1.8594267642584574
G-401,148198,-4.717755806624399,1.8594267642584574
NCI-H661,JQ-1-UNC0638 (2-1 mol-mol),3.1332466289853884,1.8594267642584574
NCI-H460,5351362,3.0809857123464037,1.8594267642584574
BxPC-3,5978,-3.126756112961715,1.8594267642584574
OPM-2,11396600,1.8817984525619431,1.8594267642584574
A-673,5328940,0.9058407904985936,1.8594267642584574
LoVo,16720766,-0.1141862087465287,1.8594267642584574
LoVo,11404337,-0.8407014552816361,1.8594267642584574
JM-1,11455910,-0.0097968256607179,1.8594267642584574
A2780,54686904,3.0280150906907206,1.8594267642584574
G-401,selumetinib-decitabine (4-1 mol-mol),1.9675825066475652,1.8594267642584574
SNU-449,9956119,3.198924280342594,1.8594267642584574
OPM-2,SNX-2112-bortezomib (250-1 mol-mol),-3.9902018365290752,1.8594267642584574
SNU-81,60700,-1.0304958014583914,1.8594267642584574
SBC-5,navitoclax-PLX-4032 (1-1 mol-mol),2.6386672409141756,1.8594267642584574
Panc 04.03,216468,3.559067681626077,1.8594267642584574
OVISE,46398810,3.0089868889673426,1.8594267642584574
MDA-MB-453,11494412,1.83607541398336,1.8594267642584574
NOMO-1,409805,3.6617718212828874,1.8594267642584574
BT-549,25062766,0.9643791751629904,1.8594267642584574
FTC-133,446155,0.3759987857405991,1.8594267642584574
KMRC-1,23635314,0.7760380281113136,1.8594267642584574
SW1463,15953870,3.283482316204368,1.8594267642584574
LoVo,46943432,3.050109964187685,1.8594267642584574
HSC-4,46907787,5.727789952108257,1.8594267642584574
BT-549,navitoclax-MST-312 (1-1 mol-mol),1.130665765716481,1.8594267642584574
FTC-133,135440466,5.15132472260749,1.8594267642584574
SW1463,568763,0.7789022422759734,1.8594267642584574
JM-1,25150857,0.7748927856999902,1.8594267642584574
A4/Fukuda,71304818,1.5363144884487692,1.8594267642584574
HCC1143,tanespimycin-gemcitabine (1-1 mol-mol),0.1249858816054574,1.8594267642584574
NCI-H661,24785538,4.2805678056942,1.8594267642584574
FTC-133,5282054,4.434007222498336,1.8594267642584574
A2780,613000,1.210736664046428,1.8594267642584574
SNU-449,6852167,2.6501635563943977,1.8594267642584574
NCI-H1623,5280436,2.3425513929901043,1.8594267642584574
SNU-61,11625818,5.738401007397874,1.8594267642584574
NCI-H146,selumetinib-tretinoin (2-1 mol-mol),5.090146461709555,1.8594267642584574
G-401,selumetinib-BRD-A02303741 (4-1 mol-mol),3.259716171612134,1.8594267642584574
G-401,11396600,3.403558125152034,1.8594267642584574
LoVo,11396600,2.965288622606591,1.8594267642584574
YAPC,5311,2.641039705119952,1.8594267642584574
HSC-4,168313047,3.0036663016787015,1.8594267642584574
LXF 289,135440466,1.0541158239349229,1.8594267642584574
FTC-133,navitoclax-PLX-4032 (1-1 mol-mol),5.2980010762745415,1.8594267642584574
SW1463,16720766,2.9834843450585193,1.8594267642584574
Panc 04.03,2708,5.3340089352485816,1.8594267642584574
MSTO-211H,11612883,1.8196539401694043,1.8594267642584574
G-401,219104,1.9483296496250493,1.8594267642584574
OVISE,3854666,4.260793298508907,1.8594267642584574
JM-1,327653,2.4402793258430786,1.8594267642584574
SNU-449,984333,0.3609894515007521,1.8594267642584574
NCI-H146,40482356,6.02837292181762,1.8594267642584574
NCI-H2009,selumetinib-navitoclax (8-1 mol-mol),-2.134794996272836,1.8594267642584574
HSC-4,9952709,2.643320259436509,1.8594267642584574
CA46,71680916,4.255070441315874,1.8594267642584574
MSTO-211H,119182,-3.3068023354733156,1.8594267642584574
HSC-4,4788,5.270141450772874,1.8594267642584574
MDA-MB-453,11612883,2.003650622053601,1.8594267642584574
A-498,2729026,3.0720683032694827,1.8594267642584574
CAL-51,135659046,3.6035863494873137,1.8594267642584574
A-673,16736978,0.9204710311128564,1.8594267642584574
SNU-61,selumetinib-navitoclax (8-1 mol-mol),-0.634937533687344,1.8594267642584574
G-401,5335621,4.041162639386401,1.8594267642584574
NCI-H292,11647372,0.0082735983152987,1.8594267642584574
NCI-H661,46191454,1.844409109204796,1.8594267642584574
NCI-H460,439501,-2.362377537788676,1.8594267642584574
NCI-H146,BRD-A02303741-navitoclax (2-1 mol-mol),-1.9757799692204725,1.8594267642584574
JM-1,navitoclax-birinapant (1-1 mol-mol),0.1360362208330573,1.8594267642584574
A4/Fukuda,5328940,-0.5379688872377596,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],65628,4.3030211924112125,1.8594267642584574
LOU-NH91,25126798,3.943021506059378,1.8594267642584574
CAL-51,56963564,0.4281851677964957,1.8594267642584574
Panc 04.03,24785538,2.964340727211602,1.8594267642584574
SNU-449,56963564,1.9660320048352,1.8594267642584574
SBC-5,156414,2.5142262290401516,1.8594267642584574
FU-OV-1,46398810,1.7086224401878771,1.8594267642584574
MDA-MB-157,426756,4.156862898324412,1.8594267642584574
G-401,4521392,4.161493335374481,1.8594267642584574
OVISE,36462,4.611657944155446,1.8594267642584574
SCC-9,serdemetan-SCH-529074 (1-1 mol-mol),2.940999186382139,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11955716,-2.128476517967918,1.8594267642584574
CAL-51,5351362,1.1872361858703535,1.8594267642584574
CAL-51,119182,-1.323881847361974,1.8594267642584574
NCI-H522,24753719,5.009376195679754,1.8594267642584574
JM-1,tretinoin-carboplatin (2-1 mol-mol),2.443432654603248,1.8594267642584574
HCC1143,9915743,0.7364353129897024,1.8594267642584574
NCI-H460,navitoclax-piperlongumine (1-1 mol-mol),3.830586656387486,1.8594267642584574
NCI-H522,24889392,3.251100273050004,1.8594267642584574
LoVo,11178236,-1.6059359070935737,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],44462760,4.900478491796212,1.8594267642584574
CA46,23725625,5.582899861703026,1.8594267642584574
NCI-H460,25154868,3.4600493825904564,1.8594267642584574
CAL-51,36462,0.7338920585832341,1.8594267642584574
EFO-27,5281321,-1.9543223460886947,1.8594267642584574
LXF 289,11612883,1.9814919247106189,1.8594267642584574
HCC1143,2828334,6.454192166435682,1.8594267642584574
A4/Fukuda,3854666,-0.0838776105349313,1.8594267642584574
CA46,10322450,2.6264913036213606,1.8594267642584574
NCI-H2009,51039095,1.8360035457780568,1.8594267642584574
BxPC-3,10231331,0.6961573218104748,1.8594267642584574
LOU-NH91,56649450,2.5557041031897705,1.8594267642584574
G-401,216239,1.6826916037000108,1.8594267642584574
CAL-51,carboplatin-UNC0638 (2-1 mol-mol),3.3460163341878726,1.8594267642584574
HCC1143,5281321,0.7613054606946723,1.8594267642584574
EFO-27,72376,-1.8608022629783372,1.8594267642584574
NCI-H2171,19582717,3.772812394316534,1.8594267642584574
MDA-MB-453,10074640,2.421510718072182,1.8594267642584574
G-401,11317348,2.32763680059041,1.8594267642584574
FU-OV-1,selumetinib-tretinoin (2-1 mol-mol),-1.802800887870168,1.8594267642584574
NCI-H146,2729026,1.2131739481587438,1.8594267642584574
OPM-2,46907787,-3.368300500627006,1.8594267642584574
HSC-4,navitoclax-sorafenib (1-1 mol-mol),2.0260640638250154,1.8594267642584574
KYSE-70,15547703,3.259406085484829,1.8594267642584574
NCI-H522,107985,-4.282222583037789,1.8594267642584574
A4/Fukuda,9933475,1.717973727652582,1.8594267642584574
CAL-51,6505803,-1.1525670311484852,1.8594267642584574
HCC1143,5329102,2.41968992927328,1.8594267642584574
MDA-MB-453,46215462,2.7539180673476986,1.8594267642584574
LoVo,151289,0.7390860710542093,1.8594267642584574
SCC-9,10296883,4.238304408621306,1.8594267642584574
LOU-NH91,54454,2.054793401572522,1.8594267642584574
A4/Fukuda,9884685,-2.10728676228506,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],107985,-2.8907916820196156,1.8594267642584574
JM-1,11317348,1.0457451678280252,1.8594267642584574
MDA-MB-157,5287620,-1.8230093056434509,1.8594267642584574
FU-OV-1,24821094,1.823018038350918,1.8594267642584574
Panc 04.03,15547703,3.067090198790942,1.8594267642584574
DMS 273,568763,0.8680081273298318,1.8594267642584574
KMRC-1,16038120,1.697027615564608,1.8594267642584574
A4/Fukuda,11214940,3.3298423014633585,1.8594267642584574
LoVo,168313016,4.599216339831628,1.8594267642584574
JM-1,3011155,4.445867330482826,1.8594267642584574
NOMO-1,135411,-0.3073928829727976,1.8594267642584574
A2780,24772860,-3.463956246093966,1.8594267642584574
MSTO-211H,11625818,2.0984197145893853,1.8594267642584574
FU-OV-1,219104,2.911303350256359,1.8594267642584574
SBC-5,JQ-1-navitoclax (2-1 mol-mol),3.919217693519999,1.8594267642584574
SBC-5,49793307,2.0795512515040144,1.8594267642584574
CA46,53232,2.437328600755792,1.8594267642584574
EFO-27,24901704,4.244323432217726,1.8594267642584574
CA46,2746,0.9501634288999758,1.8594267642584574
Panc 04.03,selumetinib-navitoclax (8-1 mol-mol),2.4072445179954665,1.8594267642584574
MDA-MB-453,selumetinib-GDC-0941 (4-1 mol-mol),1.2517967202260842,1.8594267642584574
HSC-4,sirolimus-bortezomib (250-1 mol-mol),1.2607817332731768,1.8594267642584574
NCI-H661,9956119,3.313685900900753,1.8594267642584574
SW1463,44185566,1.4171512734588314,1.8594267642584574
FU-OV-1,3384730,4.633609637548597,1.8594267642584574
SW1463,3384730,2.9539510373394458,1.8594267642584574
MDA-MB-453,3825829,3.844348445708714,1.8594267642584574
SNU-81,selumetinib-GDC-0941 (4-1 mol-mol),-2.7364127388649937,1.8594267642584574
Panc 04.03,400769,-0.067858138339059,1.8594267642584574
CAL-51,445643,4.334473435217703,1.8594267642584574
EFO-27,156414,2.3785601677308215,1.8594267642584574
NCI-H2009,4259181,1.0344432117954978,1.8594267642584574
MSTO-211H,16722836,0.7655247341289007,1.8594267642584574
SNU-81,11364421,-4.012430935720713,1.8594267642584574
CAL-51,selumetinib-piperlongumine (8-1 mol-mol),4.057759894730394,1.8594267642584574
A-673,2746,1.857945511282164,1.8594267642584574
OVISE,navitoclax-sorafenib (1-1 mol-mol),0.9257424766739848,1.8594267642584574
NCI-H460,135398516,4.13019906717736,1.8594267642584574
BT-549,25183872,-0.4430920052505824,1.8594267642584574
JM-1,49846579,-3.8749150343559498,1.8594267642584574
NCI-H522,10127622,6.598645867237379,1.8594267642584574
OPM-2,446155,0.7744505725193765,1.8594267642584574
G-401,10296883,3.7583450228982342,1.8594267642584574
DMS 273,1716436,3.74376938939547,1.8594267642584574
SNU-449,serdemetan-SCH-529074 (1-1 mol-mol),2.2114452533334212,1.8594267642584574
NCI-H522,44566777,-0.9754694174653856,1.8594267642584574
MDA-MB-453,53393127,2.113910519669698,1.8594267642584574
FTC-133,49793307,1.1308238833509443,1.8594267642584574
OPM-2,carboplatin-UNC0638 (2-1 mol-mol),3.55532531474596,1.8594267642584574
A-673,135928012,2.926877088120134,1.8594267642584574
NCI-H661,5280436,4.871704282803626,1.8594267642584574
NCI-H661,docetaxel-tanespimycin (2-1 mol-mol),-5.324368950628822,1.8594267642584574
JM-1,5282054,2.3244175489984573,1.8594267642584574
JM-1,9549297,1.5955396397117223,1.8594267642584574
NCI-H460,11507802,2.848054270429628,1.8594267642584574
A-673,387447,-4.940230504934896,1.8594267642584574
LoVo,89928392,0.5944678691764933,1.8594267642584574
SNU-449,navitoclax-MST-312 (1-1 mol-mol),1.1854227296029016,1.8594267642584574
BxPC-3,doxorubicin-navitoclax (2-1 mol-mol),-1.6348135682657186,1.8594267642584574
NCI-H2171,67156097,-2.093355563734418,1.8594267642584574
CAL-51,9929138,6.421072450841616,1.8594267642584574
NCI-H522,11609586,2.3447481698139545,1.8594267642584574
JM-1,56946209,-6.537344033049601,1.8594267642584574
MSTO-211H,54649381,3.373909346349482,1.8594267642584574
A-673,4261,1.089626824326701,1.8594267642584574
SNU-61,56649450,4.501229591303133,1.8594267642584574
EFO-27,5738263,4.449588569174732,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],60750,2.8463966167693515,1.8594267642584574
EFO-27,462382,1.6036436678954449,1.8594267642584574
BT-549,24180719,4.750015939259711,1.8594267642584574
HSC-4,73707398,0.9895931551524366,1.8594267642584574
LXF 289,52912189,-0.1394416798850269,1.8594267642584574
DMS 273,BRD-A02303741-navitoclax (2-1 mol-mol),4.151780169779293,1.8594267642584574
NCI-H2009,31703,-0.97323545782719,1.8594267642584574
NCI-H2009,219104,3.953506929532588,1.8594267642584574
A2780,11626927,5.568414170846121,1.8594267642584574
NCI-H1623,navitoclax-pluripotin (1-1 mol-mol),-0.2970825131911801,1.8594267642584574
Panc 04.03,4788,6.095957987809042,1.8594267642584574
OPM-2,4259181,-0.0185783035827133,1.8594267642584574
LOU-NH91,9915743,1.51930479588737,1.8594267642584574
G-401,2828334,5.836351566381613,1.8594267642584574
LXF 289,3689413,0.4542816941401804,1.8594267642584574
DMS 273,selumetinib-GDC-0941 (4-1 mol-mol),1.852942012782467,1.8594267642584574
SBC-5,119182,0.2964340092945935,1.8594267642584574
JM-1,2729026,2.071801783442454,1.8594267642584574
SNU-81,11214940,1.7135053171337324,1.8594267642584574
SBC-5,439501,-2.4874901722547977,1.8594267642584574
OPM-2,46174525,3.627220507837432,1.8594267642584574
A-498,tanespimycin-bortezomib (250-1 mol-mol),1.6557393213217402,1.8594267642584574
FTC-133,selumetinib-vorinostat (8-1 mol-mol),4.335548645422765,1.8594267642584574
NCI-H2009,3062316,-2.678423554108453,1.8594267642584574
HSC-4,6438330,1.0116267584860468,1.8594267642584574
A2780,1317464,4.304763369285543,1.8594267642584574
G-401,3025944,3.816605103301755,1.8594267642584574
NOMO-1,9915743,0.4758643096003905,1.8594267642584574
CAL-51,9877608,5.917079709597661,1.8594267642584574
LoVo,71466380,3.017013363980257,1.8594267642584574
HCC1143,53392493,2.60613854373917,1.8594267642584574
A-673,6918837,-5.129930095166698,1.8594267642584574
SNU-61,60700,1.2670278964841577,1.8594267642584574
OVISE,6918837,-1.5846953199834826,1.8594267642584574
NCI-H727,11609586,3.3120945172723917,1.8594267642584574
CA46,tretinoin-carboplatin (2-1 mol-mol),4.700900152183415,1.8594267642584574
NCI-H1623,5281672,4.562545083615407,1.8594267642584574
NCI-H2009,6918328,-0.9509353973047906,1.8594267642584574
LOU-NH91,vorinostat-carboplatin (1-1 mol-mol),3.369896826709664,1.8594267642584574
OVISE,16722836,2.434488476233433,1.8594267642584574
JM-1,10127622,5.153041805169496,1.8594267642584574
NCI-H1623,252682,6.46254793762087,1.8594267642584574
JM-1,53392493,1.8440760854554048,1.8594267642584574
MDA-MB-157,168312962,1.1798186112423137,1.8594267642584574
YAPC,44819697,-1.3460219164430964,1.8594267642584574
KMRC-1,44607531,1.585622780528836,1.8594267642584574
NCI-H2171,6918878,0.0284372668850805,1.8594267642584574
MDA-MB-453,44607531,1.359301388322155,1.8594267642584574
ONS-76,11485656,2.5953354109263262,1.8594267642584574
MDA-MB-157,135398516,1.565807276365399,1.8594267642584574
A2780,24753719,3.5545225878481745,1.8594267642584574
NCI-H661,6918328,-0.1140400883450083,1.8594267642584574
JM-1,4578,4.1991230056704785,1.8594267642584574
A4/Fukuda,9903786,0.7546004224414102,1.8594267642584574
CAL-51,11485656,2.6541256228973773,1.8594267642584574
NCI-H292,24964624,2.911439833663599,1.8594267642584574
NCI-H661,6918837,-3.3797686305940156,1.8594267642584574
EFO-27,71304818,3.2919872626583486,1.8594267642584574
MSTO-211H,4705,2.457156821386339,1.8594267642584574
DMS 273,107985,-4.548014092027974,1.8594267642584574
SNU-61,2729026,2.4451253635155106,1.8594267642584574
JM-1,60700,-2.9904484465209036,1.8594267642584574
SNU-449,JQ-1-MK-0752 (1-1 mol-mol),5.5892167281424285,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11640390,3.7299689357319257,1.8594267642584574
SNU-449,24856436,4.072390930567189,1.8594267642584574
NCI-H460,159324,4.0462841352482855,1.8594267642584574
NCI-H2009,11175137,2.49599907102206,1.8594267642584574
A-673,208908,1.851861192467165,1.8594267642584574
BxPC-3,25183872,-1.12027566647844,1.8594267642584574
EFO-27,5328940,2.731901822530229,1.8594267642584574
HSC-4,135398516,2.2759469773851224,1.8594267642584574
HSC-4,11647372,1.1815136799972823,1.8594267642584574
CA46,16038120,1.1324791438314847,1.8594267642584574
MDA-MB-453,9868037,1.568237926564538,1.8594267642584574
A-673,446155,1.1478268834845686,1.8594267642584574
A2780,5479543,3.565203320915574,1.8594267642584574
MDA-MB-157,10322450,5.067042624032479,1.8594267642584574
NCI-H2171,JQ-1-carboplatin (1-1 mol-mol),1.7298129528217236,1.8594267642584574
MDA-MB-157,9915743,0.9957990206413116,1.8594267642584574
A4/Fukuda,219104,2.2512696330904447,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],10410894,5.33973414369723,1.8594267642584574
SBC-5,12001922,2.404615034975172,1.8594267642584574
A-673,51037431,1.861905373589415,1.8594267642584574
A2780,637858,1.382423379201008,1.8594267642584574
NCI-H2171,BRD-A02303741-navitoclax (2-1 mol-mol),-0.1592201049133759,1.8594267642584574
A2780,9884685,-1.5939943621043984,1.8594267642584574
JM-1,5311,-0.0672732572458771,1.8594267642584574
CA46,15547703,2.518572103836232,1.8594267642584574
BxPC-3,54618164,4.016743819691475,1.8594267642584574
BT-549,2749,3.5786970568950913,1.8594267642584574
SNU-81,73707398,1.1294477244846828,1.8594267642584574
SNU-61,docetaxel-tanespimycin (2-1 mol-mol),-4.617294417621486,1.8594267642584574
A-673,55508,3.3138750706926157,1.8594267642584574
SNU-449,carboplatin-etoposide (40-17 mol-mol),5.135900435909966,1.8594267642584574
MDA-MB-453,23725625,4.029710365908802,1.8594267642584574
A4/Fukuda,4261,-0.9007526332595048,1.8594267642584574
NCI-H727,446155,4.65589483782911,1.8594267642584574
NCI-H1623,44486219,4.206804435599472,1.8594267642584574
MDA-MB-453,441298,1.8295928982069447,1.8594267642584574
SNU-449,54454,2.520106415523585,1.8594267642584574
A2780,387447,-4.368237522415053,1.8594267642584574
MSTO-211H,11152667,-3.5300772231011703,1.8594267642584574
SNU-449,25195348,3.622170031481097,1.8594267642584574
MDA-MB-157,322968,2.1225136411127545,1.8594267642584574
A2780,168313200,1.7543183926879495,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],24797083,2.1636765251680625,1.8594267642584574
SNU-449,5329102,2.0099859216843075,1.8594267642584574
NCI-H2009,322968,4.70725114827159,1.8594267642584574
KYSE-70,16722836,1.4327625680833322,1.8594267642584574
MDA-MB-157,11609586,1.0926317538630208,1.8594267642584574
FU-OV-1,10231331,3.398558944555642,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],168313200,3.953722308471172,1.8594267642584574
NCI-H292,docetaxel-tanespimycin (2-1 mol-mol),-3.440758677710888,1.8594267642584574
LOU-NH91,11238147,4.007302405058718,1.8594267642584574
LOU-NH91,49766530,0.361985362717411,1.8594267642584574
YAPC,9444,4.346283036692295,1.8594267642584574
NCI-H522,15547703,3.471643136947843,1.8594267642584574
NCI-H522,375860,-0.630771500248647,1.8594267642584574
CA46,119182,-4.388833865288787,1.8594267642584574
OPM-2,10410894,2.9147321100270593,1.8594267642584574
CAL-51,erlotinib-PLX-4032 (2-1 mol-mol),3.3535318918945647,1.8594267642584574
NCI-H727,selumetinib-GDC-0941 (4-1 mol-mol),-1.3460907005826803,1.8594267642584574
OPM-2,docetaxel-tanespimycin (2-1 mol-mol),-6.145766231617617,1.8594267642584574
NCI-H2171,4261,0.9024779156039784,1.8594267642584574
NCI-H1623,25262965,-3.228781743363827,1.8594267642584574
NCI-H2171,navitoclax-gemcitabine (1-1 mol-mol),-4.23755685830139,1.8594267642584574
MSTO-211H,10427712,4.183883954719584,1.8594267642584574
EFO-27,navitoclax-birinapant (1-1 mol-mol),3.2392186746278244,1.8594267642584574
A-498,9967941,4.3277437867326025,1.8594267642584574
HCC1143,25183872,-1.001460572121427,1.8594267642584574
NCI-H522,crizotinib-PLX-4032 (2-1 mol-mol),2.133335771815486,1.8594267642584574
CAL-51,17755052,0.5283491907817935,1.8594267642584574
SW1463,44137675,3.7114847318755806,1.8594267642584574
BT-549,5278396,3.375604766419473,1.8594267642584574
NCI-H292,3025986,-0.8794264876923694,1.8594267642584574
NCI-H2171,3825829,3.727904622873516,1.8594267642584574
EFO-27,327653,2.4330037956805133,1.8594267642584574
NCI-H460,637858,3.384702960830197,1.8594267642584574
G-401,5746,-1.2143401521495898,1.8594267642584574
A2780,5281321,-0.7497434400684011,1.8594267642584574
NCI-H460,409805,5.4278006548731295,1.8594267642584574
MSTO-211H,alisertib-navitoclax (2-1 mol-mol),-1.8568151112874771,1.8594267642584574
SNU-81,11964036,-0.3940350311201446,1.8594267642584574
OPM-2,53232,1.210133300080481,1.8594267642584574
A-498,216468,3.41587450505901,1.8594267642584574
LoVo,6852167,1.8421975016001388,1.8594267642584574
SNU-449,53325874,4.456238471946744,1.8594267642584574
FU-OV-1,10296883,4.259179003182187,1.8594267642584574
LoVo,3136844,3.7568853791466608,1.8594267642584574
HSC-4,637858,2.398043952194309,1.8594267642584574
NCI-H522,9927531,4.749051096908956,1.8594267642584574
MSTO-211H,53392493,1.8202473930982712,1.8594267642584574
Panc 04.03,11626560,2.20525660125161,1.8594267642584574
EFO-27,11178236,-5.208504296414087,1.8594267642584574
SBC-5,3503,1.24841833111282,1.8594267642584574
G-401,11640390,2.8162749001609417,1.8594267642584574
NCI-H727,selumetinib-UNC0638 (4-1 mol-mol),-1.3488333019368446,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],46843906,3.578406808206158,1.8594267642584574
FTC-133,54454,1.7579296666098376,1.8594267642584574
MSTO-211H,54613361,-0.4311183648022992,1.8594267642584574
G-401,5282054,2.6200467258422235,1.8594267642584574
NCI-H727,135440466,0.3181577925646752,1.8594267642584574
SCC-9,6852167,2.7106856908699255,1.8594267642584574
NCI-H2009,124202324,1.390796248932456,1.8594267642584574
SCC-9,54618771,0.4910288003516506,1.8594267642584574
A-673,9826308,0.1905391916215918,1.8594267642584574
KYSE-70,446155,3.830415114438346,1.8594267642584574
CAL-51,vorinostat-navitoclax (4-1 mol-mol),1.6210592416983378,1.8594267642584574
CA46,10296883,3.259152671675197,1.8594267642584574
NCI-H661,159324,2.633762936698375,1.8594267642584574
FU-OV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4708101541145827,1.8594267642584574
LXF 289,5328940,2.0490491787199687,1.8594267642584574
KYSE-70,400769,-0.6610715268602807,1.8594267642584574
BxPC-3,9911463,3.950256717526944,1.8594267642584574
MDA-MB-157,119607,5.813382396653367,1.8594267642584574
NCI-H727,168312962,2.354698653601169,1.8594267642584574
G-401,67156097,-1.3508759360204068,1.8594267642584574
HSC-4,53232,3.536415160688875,1.8594267642584574
BT-549,9866186,1.9395157417186848,1.8594267642584574
A2780,46174525,3.809782337657401,1.8594267642584574
NCI-H661,24797083,0.8737198077858661,1.8594267642584574
OPM-2,107970,1.3408908225452507,1.8594267642584574
HCC1143,3038522,3.729990546362485,1.8594267642584574
JM-1,5746,-1.3315669786621744,1.8594267642584574
OPM-2,9935249,1.874633336412032,1.8594267642584574
A4/Fukuda,10302451,3.353566161735505,1.8594267642584574
SBC-5,1641662,2.7360117188732684,1.8594267642584574
CAL-51,25183872,-0.1080661998677032,1.8594267642584574
HCC1143,72734382,3.642829686089203,1.8594267642584574
SCC-9,67156097,-0.5297515363076177,1.8594267642584574
LOU-NH91,17759555,3.0310153631552295,1.8594267642584574
FTC-133,selumetinib-GDC-0941 (4-1 mol-mol),4.492269110406249,1.8594267642584574
FTC-133,6252,3.0791801983523297,1.8594267642584574
NCI-H146,10026128,3.971012402354388,1.8594267642584574
HCC1143,327653,2.9245812810780745,1.8594267642584574
NCI-H661,selumetinib-JQ-1 (4-1 mol-mol),2.8735822394027335,1.8594267642584574
BxPC-3,docetaxel-tanespimycin (2-1 mol-mol),-4.5492420076102045,1.8594267642584574
SNU-449,SNX-2112-bortezomib (250-1 mol-mol),0.2827290486356496,1.8594267642584574
A2780,71466445,2.121500658196736,1.8594267642584574
FTC-133,11640390,4.129780643497309,1.8594267642584574
NCI-H661,66577038,3.3791675548307225,1.8594267642584574
A4/Fukuda,89183176,1.286008536767452,1.8594267642584574
KYSE-70,49793307,-3.275020883815728,1.8594267642584574
NCI-H2171,36314,-6.271125424872196,1.8594267642584574
G-401,5351362,1.1066788885055705,1.8594267642584574
NOMO-1,44507138,0.557170216692965,1.8594267642584574
CAL-51,56649450,1.7310987503885624,1.8594267642584574
MDA-MB-453,100016,6.0730906594859215,1.8594267642584574
NCI-H1623,6852167,1.7873387390250663,1.8594267642584574
A-673,16659841,2.6132078541729404,1.8594267642584574
OPM-2,67291369,1.773293288142809,1.8594267642584574
OVISE,374536,3.768512931442208,1.8594267642584574
CAL-51,11238147,2.100409816322544,1.8594267642584574
YAPC,11175137,3.2313352651289327,1.8594267642584574
NCI-H522,ISOX-bortezomib (250-1 mol-mol),0.0474854277983787,1.8594267642584574
OVISE,10427712,4.5158462716299415,1.8594267642584574
EFO-27,5351362,1.1790960486008195,1.8594267642584574
NCI-H292,6505803,0.1482155149138876,1.8594267642584574
SNU-61,vorinostat-carboplatin (1-1 mol-mol),3.629887150631109,1.8594267642584574
DMS 273,71680916,4.789726238699708,1.8594267642584574
CA46,10184653,1.13668363671425,1.8594267642584574
SBC-5,49867926,4.30527508614513,1.8594267642584574
LoVo,11238147,1.4038592423826672,1.8594267642584574
MDA-MB-157,11427553,2.127814795485051,1.8594267642584574
SNU-61,11178236,-3.475859478717308,1.8594267642584574
SBC-5,piperlongumine-MST-312 (1-1 mol-mol),2.5701291604117045,1.8594267642584574
FU-OV-1,11214940,1.6800576649286882,1.8594267642584574
LoVo,9903786,0.6551100591729495,1.8594267642584574
NCI-H1623,135411,0.3784026464220375,1.8594267642584574
LoVo,3062316,-2.119304437973892,1.8594267642584574
NCI-H661,46174525,4.042428757819544,1.8594267642584574
SBC-5,51037431,0.5420283127367359,1.8594267642584574
A-498,3689413,-0.327867250415736,1.8594267642584574
DMS 273,selumetinib-UNC0638 (4-1 mol-mol),4.157627757757485,1.8594267642584574
CAL-51,54649381,3.902782783768603,1.8594267642584574
A4/Fukuda,16038120,-3.113498344638628,1.8594267642584574
A-673,135398516,1.4288802928040978,1.8594267642584574
NOMO-1,135398744,6.340708200805823,1.8594267642584574
KYSE-70,216468,2.031191966418552,1.8594267642584574
A2780,67291369,1.1130592599106983,1.8594267642584574
NCI-H2009,654092,0.0283248260105453,1.8594267642584574
NCI-H661,UNC0638-navitoclax (1-1 mol-mol),4.1455150469586535,1.8594267642584574
NCI-H146,navitoclax-PLX-4032 (1-1 mol-mol),-2.8852479543284617,1.8594267642584574
SNU-61,11612883,3.050953505253589,1.8594267642584574
SNU-61,5746,1.3298489283886064,1.8594267642584574
KYSE-70,124202324,2.186627813347476,1.8594267642584574
SNU-449,carboplatin-UNC0638 (2-1 mol-mol),4.161475175536438,1.8594267642584574
BxPC-3,409805,3.7922849099240734,1.8594267642584574
A4/Fukuda,3552672,1.9607713184754867,1.8594267642584574
KYSE-70,9907093,3.6347338213446454,1.8594267642584574
SNU-61,12003241,0.1572719330395487,1.8594267642584574
HSC-4,322968,4.636798889333657,1.8594267642584574
LXF 289,selumetinib-vorinostat (8-1 mol-mol),2.464198116249673,1.8594267642584574
CAL-51,16115403,-4.643171700082743,1.8594267642584574
LOU-NH91,2746,5.002248002286792,1.8594267642584574
A2780,3543504,4.147653095225295,1.8594267642584574
NCI-H661,25126798,3.9237728184770946,1.8594267642584574
DMS 273,4521392,4.235410021964807,1.8594267642584574
BxPC-3,49836020,-2.380895293574403,1.8594267642584574
NCI-H146,JQ-1-vorinostat (2-1 mol-mol),-0.8208901447975969,1.8594267642584574
OPM-2,3689413,-4.501811354570108,1.8594267642584574
Panc 04.03,selumetinib-piperlongumine (8-1 mol-mol),4.132461761791421,1.8594267642584574
NCI-H727,navitoclax-gemcitabine (1-1 mol-mol),1.335724896470854,1.8594267642584574
NCI-H460,5328940,3.322075361136407,1.8594267642584574
ONS-76,25126798,4.148768722347094,1.8594267642584574
OPM-2,57519531,1.419627244644159,1.8594267642584574
BxPC-3,20959075,-3.864209289368053,1.8594267642584574
OVISE,54618164,4.29678583267412,1.8594267642584574
YAPC,10074640,3.068654585130056,1.8594267642584574
BxPC-3,5287620,-2.837282092833542,1.8594267642584574
SNU-81,24785538,-0.3807988804027284,1.8594267642584574
NCI-H292,5287620,-2.1513248285430997,1.8594267642584574
NCI-H146,104842,-5.965892600420639,1.8594267642584574
NCI-H1623,selumetinib-vorinostat (8-1 mol-mol),2.11860807065236,1.8594267642584574
KMRC-1,17755052,1.9475900469511016,1.8594267642584574
NCI-H2171,24856436,-0.4096039036242957,1.8594267642584574
NCI-H2009,11364421,-4.013811791110126,1.8594267642584574
MDA-MB-157,5470400,0.4579153499304774,1.8594267642584574
HCC1143,51039095,3.6749130279746938,1.8594267642584574
G-401,11964036,0.0453230579510409,1.8594267642584574
NOMO-1,1641662,3.174576963224712,1.8594267642584574
MSTO-211H,25102847,1.842661618149511,1.8594267642584574
A-673,9908783,4.713034696547774,1.8594267642584574
BT-549,71680916,6.0821013857398745,1.8594267642584574
JM-1,11719255,1.4438675590466743,1.8594267642584574
HSC-4,2874250,5.810325396532396,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],25227462,1.022239632483553,1.8594267642584574
NCI-H460,654092,0.4612941847378306,1.8594267642584574
OPM-2,5328940,0.8145180628284293,1.8594267642584574
A4/Fukuda,44202524,1.0259860145116777,1.8594267642584574
G-401,11213558,0.7886605378704363,1.8594267642584574
OVISE,135984461,1.6429740508824469,1.8594267642584574
NOMO-1,11964036,-1.1045639043109698,1.8594267642584574
CA46,6184667,1.8666466805539537,1.8594267642584574
NCI-H460,9903786,4.057661845653794,1.8594267642584574
BxPC-3,25102847,2.0998558206838913,1.8594267642584574
SCC-9,5470400,0.9401931564199802,1.8594267642584574
ONS-76,5284329,2.36276815665719,1.8594267642584574
DMS 273,25227462,-3.883072621079263,1.8594267642584574
A-673,42642645,-0.8052568071576633,1.8594267642584574
A4/Fukuda,9549297,1.6255879909683784,1.8594267642584574
FU-OV-1,11427553,3.01783779671809,1.8594267642584574
SNU-61,5328940,1.147707594205283,1.8594267642584574
HSC-4,5281321,1.7816899121848235,1.8594267642584574
KYSE-70,656346,0.9492660515895844,1.8594267642584574
NCI-H1623,72734382,4.853935764849827,1.8594267642584574
MSTO-211H,67156097,-3.635314822435898,1.8594267642584574
MDA-MB-453,637858,1.2138352699902215,1.8594267642584574
CAL-51,56963564,0.4281851677964957,1.8594267642584574
A-673,10113978,2.507382463710335,1.8594267642584574
YAPC,2946601,6.339465197306548,1.8594267642584574
NCI-H2171,ISOX-bortezomib (250-1 mol-mol),-0.1667670458768617,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],2858523,3.3395777905719872,1.8594267642584574
HSC-4,65628,3.12205826618997,1.8594267642584574
HCC1143,227681,3.1373347590378335,1.8594267642584574
A-673,53301938,4.3782771731899555,1.8594267642584574
G-401,66577038,2.320880294749871,1.8594267642584574
NCI-H661,9884685,0.1767392095869446,1.8594267642584574
SNU-449,6184667,3.7989058233577566,1.8594267642584574
OPM-2,24951314,0.2222837933942169,1.8594267642584574
LXF 289,56963564,0.2991276479966406,1.8594267642584574
HCC1143,11364421,-2.85203888888326,1.8594267642584574
NCI-H292,9936388,-1.1579069678838152,1.8594267642584574
G-401,10231331,2.894718734978725,1.8594267642584574
CAL-51,89928392,1.068329558331595,1.8594267642584574
NCI-H2171,53392493,1.8740494203136608,1.8594267642584574
A-673,136227331,4.241984110268528,1.8594267642584574
NCI-H727,11717001,2.7053596974758594,1.8594267642584574
A2780,16219061,2.814782356526162,1.8594267642584574
SCC-9,54454,3.1137155512464596,1.8594267642584574
YAPC,12003241,-0.7644111057992425,1.8594267642584574
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187,1.8594267642584574
SNU-81,5335621,4.181800470543683,1.8594267642584574
CAL-51,5329102,2.0492492410301484,1.8594267642584574
NCI-H146,10385095,0.6869778017915235,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],53392493,3.4798204288234165,1.8594267642584574
SCC-9,2113511,6.3303497429476625,1.8594267642584574
ONS-76,2708,5.792421817961339,1.8594267642584574
SNU-449,11485656,3.58452534173841,1.8594267642584574
A-673,46215462,1.2771489946566346,1.8594267642584574
FTC-133,285033,-1.2963608176743802,1.8594267642584574
SCC-9,6184667,3.279451062583292,1.8594267642584574
NCI-H146,16722836,0.0677462505380894,1.8594267642584574
NCI-H661,44137675,3.7576040576240257,1.8594267642584574
NCI-H1623,11612883,1.5649574760969076,1.8594267642584574
LOU-NH91,3825829,4.327670981782257,1.8594267642584574
SCC-9,5287969,-2.1272191034883874,1.8594267642584574
Panc 04.03,10410894,3.886544188244091,1.8594267642584574
NCI-H146,135398516,1.5035346569298091,1.8594267642584574
A-498,4096211,4.004902569915099,1.8594267642584574
OVISE,104842,-0.680714151991963,1.8594267642584574
SCC-9,135440466,2.439160969941936,1.8594267642584574
ONS-76,10322450,3.321198163736043,1.8594267642584574
SNU-449,81146,6.119223793669881,1.8594267642584574
JM-1,148124,-7.840698833354439,1.8594267642584574
BT-549,5460769,6.35928800843138,1.8594267642584574
MDA-MB-157,969516,1.7670354115722269,1.8594267642584574
LXF 289,5278396,2.6487510770020104,1.8594267642584574
ONS-76,100016,6.019166856387977,1.8594267642584574
A4/Fukuda,11707110,-3.666992219196893,1.8594267642584574
JM-1,6438330,0.1685207017328377,1.8594267642584574
SBC-5,navitoclax-sorafenib (1-1 mol-mol),1.4051935643931297,1.8594267642584574
BT-549,10074640,3.6929061121608577,1.8594267642584574
A4/Fukuda,46926350,-6.021657358635238,1.8594267642584574
SNU-81,selumetinib-JQ-1 (4-1 mol-mol),-1.924488986117384,1.8594267642584574
SNU-81,4917,2.3748179961814375,1.8594267642584574
A4/Fukuda,119607,3.918640768426122,1.8594267642584574
HSC-4,613753,3.3632883902358715,1.8594267642584574
DMS 273,135411,0.7219297948054574,1.8594267642584574
KMRC-1,46907787,3.729545872280723,1.8594267642584574
LXF 289,44489675,4.904101073680104,1.8594267642584574
BxPC-3,6918736,-1.9181543280529496,1.8594267642584574
KYSE-70,65064,5.1318583658275205,1.8594267642584574
HSC-4,25062766,1.8609848482730849,1.8594267642584574
SW1463,15983966,1.3055923116721375,1.8594267642584574
HCC1143,11396600,3.529486359294858,1.8594267642584574
SCC-9,45279963,4.124125049817703,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],docetaxel-tanespimycin (2-1 mol-mol),0.3001853485414289,1.8594267642584574
NCI-H661,5113032,4.99918939361245,1.8594267642584574
LXF 289,17759555,2.434653643868842,1.8594267642584574
DMS 273,46926350,-4.333780789364997,1.8594267642584574
OPM-2,46224516,2.1207785622277373,1.8594267642584574
A4/Fukuda,9908783,4.281950187885367,1.8594267642584574
A4/Fukuda,1716436,2.785785051354721,1.8594267642584574
KMRC-1,54454,2.958009627513852,1.8594267642584574
HSC-4,73707371,4.771220465805862,1.8594267642584574
KYSE-70,9911830,3.1951659700149886,1.8594267642584574
KYSE-70,tanespimycin-gemcitabine (1-1 mol-mol),0.2674613674270346,1.8594267642584574
HSC-4,16720766,-1.6245250648624636,1.8594267642584574
OPM-2,11964036,0.2409704368173301,1.8594267642584574
LXF 289,3038522,4.104388560491244,1.8594267642584574
A2780,49793307,-3.5064247630527494,1.8594267642584574
MDA-MB-157,12003241,-1.4339892472843776,1.8594267642584574
MSTO-211H,53495165,-2.281905985837366,1.8594267642584574
MDA-MB-453,24797083,1.319210590833939,1.8594267642584574
HSC-4,25126798,3.2488654911973196,1.8594267642584574
BxPC-3,3854666,3.4835595653471167,1.8594267642584574
HSC-4,176870,2.813832788377266,1.8594267642584574
DMS 273,tanespimycin-bortezomib (250-1 mol-mol),1.3026014961511128,1.8594267642584574
MDA-MB-157,alisertib-navitoclax (2-1 mol-mol),-2.615500389933575,1.8594267642584574
YAPC,135398744,6.484368053683043,1.8594267642584574
MDA-MB-453,51039095,2.709903892694302,1.8594267642584574
CAL-51,24821094,3.2618915388877023,1.8594267642584574
NCI-H522,1239801,3.903810420887451,1.8594267642584574
KYSE-70,7251185,4.369311092923008,1.8594267642584574
CAL-51,navitoclax-birinapant (1-1 mol-mol),5.691707887303523,1.8594267642584574
G-401,60750,-4.380742093252711,1.8594267642584574
YAPC,11404337,0.4717703732171429,1.8594267642584574
MDA-MB-157,9826308,-1.0851482905673768,1.8594267642584574
MDA-MB-157,25262965,0.470934001928582,1.8594267642584574
FU-OV-1,10427712,2.3896052276409887,1.8594267642584574
CAL-51,285033,-2.914004430070481,1.8594267642584574
CA46,246676,4.699933053014099,1.8594267642584574
A-498,9926054,1.5026788619071982,1.8594267642584574
LXF 289,44632017,2.313535350982782,1.8594267642584574
NCI-H727,3689413,0.3749801507161196,1.8594267642584574
SNU-449,1716436,3.0856052265463023,1.8594267642584574
LOU-NH91,24951314,1.380037957351277,1.8594267642584574
SNU-81,46191454,-1.5874627182763832,1.8594267642584574
KMRC-1,119182,-0.1449504353389931,1.8594267642584574
NCI-H522,9823820,3.261618834820585,1.8594267642584574
NCI-H460,11178236,-2.300904923417752,1.8594267642584574
A2780,5738263,3.096886997462696,1.8594267642584574
NCI-H661,carboplatin-etoposide (40-17 mol-mol),2.8210696568936786,1.8594267642584574
BT-549,5287969,-2.055370090828861,1.8594267642584574
BT-549,11609586,2.735581966533724,1.8594267642584574
OPM-2,1317464,3.5924971065959244,1.8594267642584574
NCI-H146,54639701,4.038686865533554,1.8594267642584574
LOU-NH91,3384730,3.7773271912609623,1.8594267642584574
YAPC,11152667,0.3482753398657929,1.8594267642584574
SNU-449,702558,5.257858019653286,1.8594267642584574
MDA-MB-157,selumetinib-tretinoin (2-1 mol-mol),1.8981533797930392,1.8594267642584574
FTC-133,6438330,2.249518605035186,1.8594267642584574
NCI-H727,12001922,1.7281936629666887,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],9903786,4.3108216230747685,1.8594267642584574
HSC-4,60750,-5.118377280037083,1.8594267642584574
SNU-61,1566236,1.9599867850180668,1.8594267642584574
NCI-H460,5282054,4.802373462225767,1.8594267642584574
DMS 273,6610216,4.172124776089646,1.8594267642584574
NCI-H727,6852167,3.356078560596427,1.8594267642584574
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591,1.8594267642584574
SNU-61,445455,4.539446073708065,1.8594267642584574
DMS 273,3062316,3.60345807305724,1.8594267642584574
MDA-MB-157,9956119,2.310937024804907,1.8594267642584574
OPM-2,135423438,0.9866001177758746,1.8594267642584574
Panc 04.03,16722836,2.845252730089092,1.8594267642584574
MDA-MB-453,9936388,0.6028011486270662,1.8594267642584574
A-673,68056272,3.7833857366006094,1.8594267642584574
HCC1143,16722836,1.2433455264432278,1.8594267642584574
DMS 273,72193861,0.4647891664131632,1.8594267642584574
DMS 273,navitoclax-birinapant (1-1 mol-mol),3.616691876772055,1.8594267642584574
Panc 04.03,11396600,3.73844061007523,1.8594267642584574
NCI-H522,6505803,-3.5272214952237344,1.8594267642584574
CA46,56963564,-0.0544830399645368,1.8594267642584574
A-673,9825149,0.7138432506885886,1.8594267642584574
NCI-H1623,2871966,1.4286416314522286,1.8594267642584574
SNU-449,4096211,1.9400565485658428,1.8594267642584574
CAL-51,44137675,3.485867182081199,1.8594267642584574
MDA-MB-157,375860,0.0174110406826079,1.8594267642584574
MSTO-211H,327653,2.467891014920142,1.8594267642584574
A4/Fukuda,selumetinib-JQ-1 (4-1 mol-mol),-0.1942413967070371,1.8594267642584574
CA46,11178236,-6.883102305003874,1.8594267642584574
NCI-H661,5291,3.8370923902638063,1.8594267642584574
FTC-133,25262965,1.6757685209235111,1.8594267642584574
SNU-449,24771867,3.0453458349703793,1.8594267642584574
HCC1143,9911830,2.6182666070844447,1.8594267642584574
SNU-61,44185566,2.430559307269213,1.8594267642584574
SNU-449,445091,4.4459202939225815,1.8594267642584574
LXF 289,123631,1.612545473594554,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],44493528,4.389573022277453,1.8594267642584574
SNU-61,637858,1.6436621136217924,1.8594267642584574
MSTO-211H,3025944,3.596075182431598,1.8594267642584574
SNU-81,11612883,1.8877401103471,1.8594267642584574
A-673,52912189,-0.9448854486243604,1.8594267642584574
NCI-H727,613753,3.184500780825273,1.8594267642584574
BxPC-3,24856436,-0.8809901773698104,1.8594267642584574
SNU-61,3038522,3.6960216122526943,1.8594267642584574
KMRC-1,374536,2.325099751463231,1.8594267642584574
CAL-51,54613361,0.2180057854442524,1.8594267642584574
CAL-51,10385095,1.0305027810027567,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],71466445,2.906568419759945,1.8594267642584574
LXF 289,5281321,-2.4870532876216487,1.8594267642584574
SNU-449,10184653,1.7910926490151993,1.8594267642584574
SNU-81,9887053,2.281153151762533,1.8594267642584574
KYSE-70,11485656,2.2230455690794404,1.8594267642584574
CAL-51,439501,-2.444412450902406,1.8594267642584574
A4/Fukuda,72967,3.695839205584607,1.8594267642584574
NCI-H1623,navitoclax-MST-312 (1-1 mol-mol),2.6356568038196175,1.8594267642584574
BT-549,57519531,1.7866000969199525,1.8594267642584574
YAPC,9911830,4.0093640169179325,1.8594267642584574
KYSE-70,54143018,-0.2928055682999507,1.8594267642584574
ONS-76,6852167,3.4771955261396252,1.8594267642584574
CA46,216468,1.7849524837603168,1.8594267642584574
KYSE-70,71304818,1.8226881659751617,1.8594267642584574
SNU-449,10427712,4.716616821408685,1.8594267642584574
KYSE-70,11364421,-0.2598881855214042,1.8594267642584574
SCC-9,46199207,3.715699147831311,1.8594267642584574
OVISE,tretinoin-navitoclax (4-1 mol-mol),1.2267801901076945,1.8594267642584574
SNU-81,selumetinib-navitoclax (8-1 mol-mol),-4.808792251277437,1.8594267642584574
NCI-H522,45279963,2.975445810656792,1.8594267642584574
NCI-H727,44137675,3.902640688581202,1.8594267642584574
CAL-51,doxorubicin-navitoclax (2-1 mol-mol),-2.632738790580408,1.8594267642584574
CAL-51,3854666,1.1494535123186709,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],7251185,3.190616991183446,1.8594267642584574
NCI-H2009,81146,6.16166931928307,1.8594267642584574
LoVo,135440466,2.5900307411888357,1.8594267642584574
G-401,445455,4.8654155018395535,1.8594267642584574
NCI-H1623,15547703,3.108106821400364,1.8594267642584574
SCC-9,322968,4.6886309532040435,1.8594267642584574
MDA-MB-157,23635314,-3.347178711973772,1.8594267642584574
CA46,49793307,-4.01311922110524,1.8594267642584574
CAL-51,53495165,0.3298774405260949,1.8594267642584574
SNU-449,54618164,4.194291334344069,1.8594267642584574
LOU-NH91,11178236,-2.353397629942184,1.8594267642584574
A2780,5284616,-6.357248921927095,1.8594267642584574
OVISE,11404337,1.793635825025173,1.8594267642584574
HSC-4,216239,1.6239220207771676,1.8594267642584574
NCI-H1623,208908,0.8939149685214822,1.8594267642584574
NCI-H146,25161177,3.485806465133522,1.8594267642584574
YAPC,6918328,1.93910137978286,1.8594267642584574
EFO-27,3038522,3.6669358154068097,1.8594267642584574
DMS 273,25262965,-3.6359475061731534,1.8594267642584574
SNU-81,9803433,4.184314019267332,1.8594267642584574
SBC-5,5351362,3.2358684618056164,1.8594267642584574
NCI-H661,9826308,-0.3578866099027624,1.8594267642584574
CA46,462382,0.6475442737717811,1.8594267642584574
SNU-449,168313200,1.9091128501610053,1.8594267642584574
SBC-5,613753,3.3291324843640497,1.8594267642584574
HCC1143,24797083,1.671403596818138,1.8594267642584574
NCI-H522,11625818,5.118334572164132,1.8594267642584574
Panc 04.03,446155,2.4976903608369994,1.8594267642584574
NOMO-1,2733487,3.664178503465112,1.8594267642584574
CA46,11494412,-0.1540181126177876,1.8594267642584574
KMRC-1,168313200,3.9547474801247455,1.8594267642584574
BT-549,12003241,-0.9663956127583828,1.8594267642584574
MDA-MB-453,53232,4.528141583720988,1.8594267642584574
Panc 04.03,BRD-A02303741-carboplatin (1-1 mol-mol),4.551523048928573,1.8594267642584574
A4/Fukuda,selumetinib-piperlongumine (8-1 mol-mol),1.1723483513994604,1.8594267642584574
BT-549,7251185,2.7032329014559555,1.8594267642584574
YAPC,72734382,4.459010686131963,1.8594267642584574
NCI-H2171,navitoclax-birinapant (1-1 mol-mol),-1.0975266283205345,1.8594267642584574
LoVo,10113978,1.9718639606113115,1.8594267642584574
G-401,9884685,-1.463173781220529,1.8594267642584574
NCI-H460,969516,4.1763077592827225,1.8594267642584574
CAL-51,docetaxel-tanespimycin (2-1 mol-mol),-4.362144159711312,1.8594267642584574
NCI-H522,10302451,3.5044820085806645,1.8594267642584574
SNU-61,10127622,0.6703048084308344,1.8594267642584574
DMS 273,216239,1.7826696655906364,1.8594267642584574
NCI-H2171,24785538,-0.9958553447114444,1.8594267642584574
OPM-2,2945648,2.5610378238786367,1.8594267642584574
JM-1,5278396,3.0111139094733987,1.8594267642584574
A-673,11625818,4.166556040788123,1.8594267642584574
MSTO-211H,23582824,0.616921606097025,1.8594267642584574
CAL-51,11977753,-3.094424679361229,1.8594267642584574
OPM-2,55283,2.954343465689474,1.8594267642584574
SCC-9,445091,4.9115801471194365,1.8594267642584574
FTC-133,11609586,3.5175505098064113,1.8594267642584574
DMS 273,16065773,2.5819171284899873,1.8594267642584574
NCI-H661,16725315,3.2574493912109315,1.8594267642584574
ONS-76,3825829,4.014711164490238,1.8594267642584574
NCI-H2009,613753,3.3208706433892483,1.8594267642584574
OVISE,72376,-0.0680425204905225,1.8594267642584574
Panc 04.03,1566236,3.6247050899799698,1.8594267642584574
KMRC-1,10385095,1.0697515150450725,1.8594267642584574
MDA-MB-157,6918638,0.523436976846598,1.8594267642584574
SNU-61,10231331,-0.1396530061474971,1.8594267642584574
SBC-5,67156097,-2.1260485275267684,1.8594267642584574
HCC1143,16720766,1.508740109375584,1.8594267642584574
SNU-449,5311281,1.2425771495660034,1.8594267642584574
EFO-27,15547703,3.36481674718985,1.8594267642584574
LOU-NH91,selumetinib-BRD-A02303741 (4-1 mol-mol),5.795599914262683,1.8594267642584574
HCC1143,71466445,2.406598865609875,1.8594267642584574
HCC1143,11625818,4.1599423197543395,1.8594267642584574
LoVo,67156097,-2.753278115102512,1.8594267642584574
NOMO-1,3385,1.8227638422939128,1.8594267642584574
JM-1,11494412,0.2153546786296628,1.8594267642584574
SNU-449,3384730,4.130527031297823,1.8594267642584574
KMRC-1,2871966,0.6996568641549454,1.8594267642584574
MDA-MB-157,2126,3.382661447598077,1.8594267642584574
SBC-5,444795,4.741830288065925,1.8594267642584574
CAL-51,135398516,1.449392214756173,1.8594267642584574
CAL-51,selumetinib-UNC0638 (4-1 mol-mol),4.646662024517227,1.8594267642584574
FTC-133,11626560,4.477282693511418,1.8594267642584574
NCI-H2171,135411,0.036573209368321,1.8594267642584574
NCI-H522,5479543,3.719555600198391,1.8594267642584574
NCI-H2009,selumetinib-GDC-0941 (4-1 mol-mol),-2.07577936678547,1.8594267642584574
SNU-81,44494148,1.061827805146114,1.8594267642584574
OVISE,119607,5.735286818250817,1.8594267642584574
CA46,4578,4.451375135730711,1.8594267642584574
FU-OV-1,navitoclax-piperlongumine (1-1 mol-mol),2.023653307095543,1.8594267642584574
MDA-MB-453,148198,-6.384072425395857,1.8594267642584574
CAL-51,44491742,5.152478206660974,1.8594267642584574
G-401,6438330,1.230579919692557,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],2749,1.6658310830765266,1.8594267642584574
KMRC-1,2746,4.901784458568857,1.8594267642584574
SW1463,3025986,0.7137013515595916,1.8594267642584574
NCI-H727,54618164,4.079418853402711,1.8594267642584574
CA46,9907093,3.753589195065423,1.8594267642584574
CA46,1750826,-4.755590130007624,1.8594267642584574
G-401,135411,0.5966957307940325,1.8594267642584574
NCI-H727,9825149,0.533141934304371,1.8594267642584574
NCI-H2009,168312962,3.455210391348572,1.8594267642584574
NCI-H522,25154868,4.970187113391964,1.8594267642584574
HSC-4,3503,2.6271988960037502,1.8594267642584574
SNU-449,54619267,4.584813130836932,1.8594267642584574
CAL-51,44507138,2.6477043136390637,1.8594267642584574
CAL-51,24753719,3.9981702522006257,1.8594267642584574
SBC-5,16725315,4.9617798252058165,1.8594267642584574
CAL-51,123631,2.4616591372530605,1.8594267642584574
A2780,56963564,-1.0587892817911606,1.8594267642584574
LoVo,119182,-3.2827225124554804,1.8594267642584574
A-498,3503,2.8872062971439436,1.8594267642584574
ONS-76,navitoclax-sorafenib (1-1 mol-mol),1.6529923050445217,1.8594267642584574
FU-OV-1,9915743,0.5010130642537969,1.8594267642584574
LOU-NH91,6917907,-5.4115573726076125,1.8594267642584574
A4/Fukuda,322968,1.909418940393303,1.8594267642584574
LoVo,selumetinib-vorinostat (8-1 mol-mol),-0.5614711347851936,1.8594267642584574
HSC-4,54618164,4.183236352259565,1.8594267642584574
SNU-81,navitoclax-MST-312 (1-1 mol-mol),0.1255158725803597,1.8594267642584574
MSTO-211H,89928392,0.2675284607275224,1.8594267642584574
MSTO-211H,16741245,3.31564558456852,1.8594267642584574
FU-OV-1,969516,2.7898134338200093,1.8594267642584574
FTC-133,9840324,5.72186430729165,1.8594267642584574
FU-OV-1,2828334,6.23308188240882,1.8594267642584574
JM-1,docetaxel-tanespimycin (2-1 mol-mol),-7.819980451052631,1.8594267642584574
NCI-H146,25062766,0.9164062509537028,1.8594267642584574
MDA-MB-453,44197249,5.538441394278097,1.8594267642584574
NCI-H292,25126798,3.8121795120859865,1.8594267642584574
NCI-H2009,49793307,-2.1832388254663746,1.8594267642584574
ONS-76,446155,1.9434822335598465,1.8594267642584574
NCI-H460,613753,5.368273372553464,1.8594267642584574
NCI-H1623,375860,-0.2497324332058591,1.8594267642584574
NCI-H292,135440466,1.1809367948500966,1.8594267642584574
DMS 273,24821094,3.2786522000090974,1.8594267642584574
CA46,1566236,0.9666867201201066,1.8594267642584574
LXF 289,6914657,-2.1957863105134474,1.8594267642584574
BxPC-3,68056272,4.30573170491611,1.8594267642584574
CA46,24856436,-0.7056093623802927,1.8594267642584574
SCC-9,136227924,3.721677265331546,1.8594267642584574
BT-549,5281672,6.431065394953252,1.8594267642584574
KMRC-1,136227924,2.9529226708788734,1.8594267642584574
A2780,46224516,3.0956757820489966,1.8594267642584574
OPM-2,2871966,-0.6940984937409527,1.8594267642584574
NCI-H522,44607530,1.256897748575463,1.8594267642584574
YAPC,135421197,1.6415717791988456,1.8594267642584574
Panc 04.03,11609586,3.1950022878003375,1.8594267642584574
YAPC,285033,-1.734058118132599,1.8594267642584574
EFO-27,25161177,4.775691091389994,1.8594267642584574
MDA-MB-453,285033,-3.584093663874095,1.8594267642584574
YAPC,135398516,2.168624804585352,1.8594267642584574
BT-549,10184653,2.4120945582019098,1.8594267642584574
SNU-61,322968,3.1681402320576924,1.8594267642584574
CAL-51,9911463,4.251278022142156,1.8594267642584574
NCI-H661,119607,4.8407678671423975,1.8594267642584574
Panc 04.03,navitoclax-pluripotin (1-1 mol-mol),0.6568791219760653,1.8594267642584574
CA46,16720766,0.453567173389679,1.8594267642584574
CAL-51,11404337,-1.4033364127444676,1.8594267642584574
SBC-5,9911463,4.310936662946409,1.8594267642584574
NCI-H727,2828334,5.890997909388885,1.8594267642584574
JM-1,104842,-7.303088314363844,1.8594267642584574
NCI-H460,5335621,5.645903220513178,1.8594267642584574
MDA-MB-157,ISOX-bortezomib (250-1 mol-mol),0.8277419655011916,1.8594267642584574
HSC-4,12003241,-0.0373048915881231,1.8594267642584574
MDA-MB-157,53301938,4.15898814375023,1.8594267642584574
MDA-MB-453,25150857,2.1104930677980964,1.8594267642584574
HSC-4,25183872,-0.8460464512297751,1.8594267642584574
CA46,46907787,-0.8110179268567884,1.8594267642584574
LXF 289,5311,1.216776445363927,1.8594267642584574
NOMO-1,6610355,3.932739350210071,1.8594267642584574
CAL-51,11222830,1.6762547521470548,1.8594267642584574
HSC-4,9915743,0.765957034876682,1.8594267642584574
SBC-5,72193861,-0.1091418694351138,1.8594267642584574
NCI-H460,60700,-0.2314807684970784,1.8594267642584574
SNU-449,tanespimycin-bortezomib (250-1 mol-mol),1.8616843727931585,1.8594267642584574
SNU-449,2729026,2.998695944617882,1.8594267642584574
A-673,6914657,-9.096845778146204,1.8594267642584574
EFO-27,64971,3.389505323176025,1.8594267642584574
MDA-MB-157,44137675,2.4962707088889524,1.8594267642584574
A-673,374536,-2.1767869041067462,1.8594267642584574
NCI-H522,24951314,1.0216385721244754,1.8594267642584574
JM-1,16038120,-0.8379540118722992,1.8594267642584574
SNU-449,25126798,3.9846076439311258,1.8594267642584574
JM-1,9444,3.0857992205099616,1.8594267642584574
NCI-H2009,selumetinib-MK-2206 (8-1 mol-mol),-2.109665042041408,1.8594267642584574
A-673,327653,2.521292352419487,1.8594267642584574
MDA-MB-453,5470400,0.9814504444661803,1.8594267642584574
KMRC-1,71751553,4.436686890494674,1.8594267642584574
FU-OV-1,52947716,3.0881190342895626,1.8594267642584574
A2780,selumetinib-piperlongumine (8-1 mol-mol),1.4682842142884078,1.8594267642584574
JM-1,3825829,3.3725964609251005,1.8594267642584574
G-401,6918328,-1.3062418496747916,1.8594267642584574
OPM-2,136227331,3.7431952210756014,1.8594267642584574
OVISE,5281321,-1.443802792924895,1.8594267642584574
CAL-51,6450551,1.9748462748620472,1.8594267642584574
DMS 273,387447,-5.016212668564022,1.8594267642584574
OPM-2,5278396,3.463635489570463,1.8594267642584574
ONS-76,445643,3.769289821936489,1.8594267642584574
OVISE,676352,3.019558255819343,1.8594267642584574
OPM-2,126941,-4.73900193491969,1.8594267642584574
MDA-MB-453,11404337,-0.3002498088297632,1.8594267642584574
NOMO-1,24797083,1.0415171353084307,1.8594267642584574
NCI-H522,374536,3.894183139895475,1.8594267642584574
A-673,6252,-1.7615808961584718,1.8594267642584574
LXF 289,9915743,1.5678711489122208,1.8594267642584574
DMS 273,72734382,4.203397510599988,1.8594267642584574
NCI-H522,selumetinib-tretinoin (2-1 mol-mol),5.363366003063694,1.8594267642584574
A4/Fukuda,BRD-K55473186,4.020373973875239,1.8594267642584574
FU-OV-1,6505803,0.8019489696335256,1.8594267642584574
NCI-H292,10074640,3.1247192788252134,1.8594267642584574
A-673,3854666,0.8608139997201792,1.8594267642584574
EFO-27,637858,1.802850970746332,1.8594267642584574
MSTO-211H,123631,1.7071024302486195,1.8594267642584574
OPM-2,54619267,3.38914180731132,1.8594267642584574
SCC-9,11612883,3.4111633177056992,1.8594267642584574
MSTO-211H,BRD-K55473186,4.0690738661382175,1.8594267642584574
CA46,25154868,4.248651634430963,1.8594267642584574
LOU-NH91,6918837,-1.6936529516603684,1.8594267642584574
OPM-2,9911830,2.101419447334853,1.8594267642584574
BT-549,6438330,1.5528656655176645,1.8594267642584574
EFO-27,11647372,2.575313315468432,1.8594267642584574
SNU-61,568763,-0.2886838000487807,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],selumetinib-tretinoin (2-1 mol-mol),1.4034944184327462,1.8594267642584574
Panc 04.03,5282054,4.5317440773242925,1.8594267642584574
YAPC,53232,3.166937959197618,1.8594267642584574
SCC-9,44486219,3.972056382599232,1.8594267642584574
NCI-H460,104842,-2.7771726159534773,1.8594267642584574
BxPC-3,4788,5.831531206482249,1.8594267642584574
KMRC-1,753704,4.9867166993089365,1.8594267642584574
MDA-MB-157,71729975,1.9097389430207852,1.8594267642584574
MDA-MB-157,46398810,3.5828771462995666,1.8594267642584574
ONS-76,42642645,1.3507577274785498,1.8594267642584574
EFO-27,9956119,4.364890218263242,1.8594267642584574
SNU-61,49850262,3.504538311157692,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],135999136,4.538916733621322,1.8594267642584574
MDA-MB-453,9967941,2.180105496017499,1.8594267642584574
OPM-2,409805,3.1459770002319023,1.8594267642584574
BxPC-3,11214940,1.4945762019529478,1.8594267642584574
CAL-51,71466445,4.7818956768695715,1.8594267642584574
YAPC,44137675,4.160217990140765,1.8594267642584574
A2780,3465537,2.6217509140821247,1.8594267642584574
SNU-449,135398744,6.632733291537939,1.8594267642584574
A4/Fukuda,676352,1.592410759121419,1.8594267642584574
NCI-H522,5566,3.055916396278747,1.8594267642584574
SBC-5,6252,1.1660150864515155,1.8594267642584574
NCI-H460,65064,5.803776096144955,1.8594267642584574
NCI-H727,sirolimus-bortezomib (250-1 mol-mol),1.838886799564678,1.8594267642584574
KMRC-1,60700,1.5998244644110848,1.8594267642584574
MDA-MB-453,72734382,3.580352840578633,1.8594267642584574
FTC-133,BRD-K55473186,4.331616686106064,1.8594267642584574
NCI-H661,3062316,-1.6378145648450078,1.8594267642584574
NCI-H661,11977753,-1.2976183269776842,1.8594267642584574
KYSE-70,4477,1.3887255745641551,1.8594267642584574
A2780,15953870,2.2934332620703457,1.8594267642584574
SBC-5,44589607,3.2873586375678627,1.8594267642584574
NCI-H2009,3634881,3.6058977960867233,1.8594267642584574
A2780,5951923,4.306994873236267,1.8594267642584574
HSC-4,11152667,-1.532358108136572,1.8594267642584574
OVISE,3543504,4.513312782724499,1.8594267642584574
CAL-51,676352,2.3367523995253454,1.8594267642584574
LXF 289,100016,7.121965810949268,1.8594267642584574
OVISE,JQ-1-vorinostat (2-1 mol-mol),2.753881285057562,1.8594267642584574
KMRC-1,4096211,2.4789291220770053,1.8594267642584574
NCI-H522,2949965,1.5154466163896825,1.8594267642584574
G-401,613000,2.0341288465268397,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],3634881,3.579575013653745,1.8594267642584574
FU-OV-1,46907787,-0.0188806347407138,1.8594267642584574
NCI-H1623,selumetinib-GDC-0941 (4-1 mol-mol),0.8054769318526331,1.8594267642584574
NCI-H522,9926054,1.815484319665427,1.8594267642584574
EFO-27,9866186,1.214213380462077,1.8594267642584574
DMS 273,446155,1.3230843960440628,1.8594267642584574
EFO-27,136227924,3.515702384882397,1.8594267642584574
NCI-H522,25161177,5.347457629837048,1.8594267642584574
BT-549,107985,-4.157404914346088,1.8594267642584574
CA46,vorinostat-carboplatin (1-1 mol-mol),1.5433198119850344,1.8594267642584574
CAL-51,984333,0.1261860025273146,1.8594267642584574
NCI-H2009,60700,0.1880080174398503,1.8594267642584574
CAL-51,135421197,1.6266864976107616,1.8594267642584574
MDA-MB-453,54619267,4.30313846005301,1.8594267642584574
NCI-H727,72376,-1.9917966726836325,1.8594267642584574
A4/Fukuda,54618771,0.259551202975953,1.8594267642584574
HCC1143,5280436,2.2824596389444567,1.8594267642584574
FTC-133,168313200,3.883948141330694,1.8594267642584574
LOU-NH91,11427553,1.5999683226177923,1.8594267642584574
LoVo,5287620,-2.196691557023958,1.8594267642584574
LOU-NH91,11222830,1.619786635706389,1.8594267642584574
SNU-81,ISOX-bortezomib (250-1 mol-mol),0.4477556870323437,1.8594267642584574
ONS-76,44507138,2.3475098717107685,1.8594267642584574
EFO-27,12001922,2.6878207164132517,1.8594267642584574
HSC-4,25102847,2.881629074853979,1.8594267642584574
A-673,4477,0.9527863024115504,1.8594267642584574
YAPC,119607,5.457421403002251,1.8594267642584574
SNU-449,11364421,1.172419453845969,1.8594267642584574
FTC-133,1566236,2.958331107997485,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],6852167,4.10667945313068,1.8594267642584574
A2780,9956119,3.341179703016576,1.8594267642584574
A2780,421610,3.3194399172740296,1.8594267642584574
MSTO-211H,11656518,-2.9147381038014095,1.8594267642584574
YAPC,carboplatin-etoposide (40-17 mol-mol),3.290819811015708,1.8594267642584574
ONS-76,5282054,3.726244399490591,1.8594267642584574
BT-549,JQ-1-vorinostat (2-1 mol-mol),2.606631722875188,1.8594267642584574
SNU-449,1750826,-2.5268598200751504,1.8594267642584574
HSC-4,56949517,4.34052816497715,1.8594267642584574
BxPC-3,alisertib-navitoclax (2-1 mol-mol),-2.4786410081497223,1.8594267642584574
LXF 289,11175137,1.607203821415342,1.8594267642584574
LoVo,400769,-0.9988261077541156,1.8594267642584574
SNU-449,9823820,4.446865909721317,1.8594267642584574
A2780,23582824,-1.3073183780043152,1.8594267642584574
LOU-NH91,24821094,3.1074025746804854,1.8594267642584574
NCI-H2171,1566236,1.862945078393334,1.8594267642584574
SBC-5,alisertib-navitoclax (2-1 mol-mol),-0.5027212648938616,1.8594267642584574
SNU-81,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.6771468011681286,1.8594267642584574
LXF 289,3815108,3.5075214319549683,1.8594267642584574
SCC-9,6918638,0.4192666549800527,1.8594267642584574
LoVo,54626689,4.759845357486115,1.8594267642584574
HSC-4,9956119,3.775946121479013,1.8594267642584574
Panc 04.03,carboplatin-UNC0638 (2-1 mol-mol),4.7376936577432405,1.8594267642584574
JM-1,2708,2.6994993672471774,1.8594267642584574
A2780,151289,-0.0035192392559562,1.8594267642584574
JM-1,135440466,2.1821804764998785,1.8594267642584574
SNU-449,JQ-1-vorinostat (2-1 mol-mol),1.642225062280099,1.8594267642584574
SCC-9,100016,6.423023301160456,1.8594267642584574
MDA-MB-453,24180125,2.9500133631526477,1.8594267642584574
MDA-MB-157,6610216,4.481014218943506,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11152667,-0.80003376539758,1.8594267642584574
MDA-MB-157,216239,2.048111671637324,1.8594267642584574
ONS-76,72376,-2.745447792813742,1.8594267642584574
YAPC,56946209,-4.683971162846982,1.8594267642584574
LXF 289,11977753,-2.1467130480879217,1.8594267642584574
A-673,46926350,-6.171938943197618,1.8594267642584574
SNU-81,44490293,1.2258782245734428,1.8594267642584574
A-673,3384730,1.4382839107098095,1.8594267642584574
HSC-4,5328940,0.4436918358674775,1.8594267642584574
MDA-MB-453,15953870,2.92470748098227,1.8594267642584574
ONS-76,44487061,4.494085272908884,1.8594267642584574
MSTO-211H,656346,1.1626228980727835,1.8594267642584574
NCI-H522,72376,-2.490005030905514,1.8594267642584574
A2780,2945648,2.954770875487345,1.8594267642584574
OPM-2,49867926,3.883283056469906,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],285033,0.1322577754861078,1.8594267642584574
FU-OV-1,2729026,1.7636424043101242,1.8594267642584574
A-673,5351362,0.6290025594893434,1.8594267642584574
NCI-H727,crizotinib-PLX-4032 (2-1 mol-mol),1.979940863489789,1.8594267642584574
NOMO-1,3384730,0.781590014898287,1.8594267642584574
A2780,753704,5.064252843259393,1.8594267642584574
LOU-NH91,104842,-1.007764649763801,1.8594267642584574
SCC-9,selumetinib-PLX-4032 (8-1 mol-mol),4.645114234652884,1.8594267642584574
NCI-H661,135398738,5.197398941249139,1.8594267642584574
OPM-2,11213558,0.5330056992590615,1.8594267642584574
SCC-9,216345,4.596520649168519,1.8594267642584574
LXF 289,73707398,1.5723760999376108,1.8594267642584574
KYSE-70,148198,-2.193158047226166,1.8594267642584574
LoVo,5281672,4.34355838965171,1.8594267642584574
NCI-H292,3081361,1.6323755734101046,1.8594267642584574
NCI-H292,969516,2.7034021602074207,1.8594267642584574
BxPC-3,carboplatin-UNC0638 (2-1 mol-mol),3.4079462645676815,1.8594267642584574
DMS 273,56963564,0.2331753873879126,1.8594267642584574
CAL-51,168313047,1.9592520089902103,1.8594267642584574
CA46,2949965,2.263314804434843,1.8594267642584574
G-401,135423438,1.541142645334712,1.8594267642584574
OVISE,16741245,2.37455837119256,1.8594267642584574
CA46,3634881,2.7183374991781903,1.8594267642584574
HSC-4,11427553,3.1625220487182193,1.8594267642584574
BT-549,selumetinib-UNC0638 (4-1 mol-mol),5.0457009484631365,1.8594267642584574
G-401,168313200,3.793890782777564,1.8594267642584574
A-673,3689413,-2.493408888485536,1.8594267642584574
OVISE,JQ-1-navitoclax (2-1 mol-mol),0.6695486858757606,1.8594267642584574
A-673,3062316,1.882423163055416,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],44185566,2.9642149554045,1.8594267642584574
FU-OV-1,49766530,-1.0180111021842635,1.8594267642584574
NCI-H1623,4259181,0.7011384719609343,1.8594267642584574
NOMO-1,11427553,1.1686106553832942,1.8594267642584574
JM-1,25102847,1.7356230100982195,1.8594267642584574
A2780,219104,2.8403974518726938,1.8594267642584574
SBC-5,2113511,4.3346082595960045,1.8594267642584574
BxPC-3,navitoclax-birinapant (1-1 mol-mol),-2.5138239615221907,1.8594267642584574
A-498,JQ-1-vorinostat (2-1 mol-mol),1.7562292819472516,1.8594267642584574
BT-549,44607530,1.0072782741331217,1.8594267642584574
FTC-133,56946209,-2.082875590070058,1.8594267642584574
SBC-5,49766530,2.674414744921775,1.8594267642584574
NCI-H727,1750826,-0.0055354600789778,1.8594267642584574
SNU-449,2749,2.680740017346485,1.8594267642584574
YAPC,46843906,3.8406256643083214,1.8594267642584574
OVISE,3503,3.051689922997692,1.8594267642584574
BxPC-3,tanespimycin-bortezomib (250-1 mol-mol),-1.7059064780517903,1.8594267642584574
A4/Fukuda,24901704,2.035809268681581,1.8594267642584574
SNU-449,2949965,2.551789087127138,1.8594267642584574
MSTO-211H,65064,5.509158922836103,1.8594267642584574
NCI-H460,753704,5.635234970240753,1.8594267642584574
BT-549,9907093,5.687861442777729,1.8594267642584574
SNU-449,89928392,1.7008506784074908,1.8594267642584574
KYSE-70,piperlongumine-MST-312 (1-1 mol-mol),2.4573232964304506,1.8594267642584574
LOU-NH91,675434,4.5447066201437325,1.8594267642584574
CA46,5351362,0.7524287969492447,1.8594267642584574
BT-549,3025944,4.080638158593822,1.8594267642584574
SW1463,57330099,3.693611547578868,1.8594267642584574
HSC-4,16722836,1.7684769334825834,1.8594267642584574
G-401,4096211,1.4243357241965535,1.8594267642584574
Panc 04.03,6610216,4.328711123736605,1.8594267642584574
KMRC-1,5287620,-2.779883294896464,1.8594267642584574
BxPC-3,119182,-1.1309049402050737,1.8594267642584574
G-401,135999136,2.1711954992798987,1.8594267642584574
KYSE-70,285033,-2.195981319752621,1.8594267642584574
NCI-H1623,selumetinib-decitabine (4-1 mol-mol),5.307511276565798,1.8594267642584574
KYSE-70,44607531,3.0404164934883733,1.8594267642584574
SCC-9,6918878,3.402250236896725,1.8594267642584574
MDA-MB-453,5282054,2.7696083041072237,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],46398810,3.3659833177824563,1.8594267642584574
BxPC-3,57519531,2.3630144255947045,1.8594267642584574
NCI-H2171,56949517,4.289308734480345,1.8594267642584574
Panc 04.03,54619267,4.1321899610425215,1.8594267642584574
G-401,11485656,1.708547873036538,1.8594267642584574
A-673,6917907,-5.646852280462545,1.8594267642584574
NOMO-1,71304818,2.372593058500035,1.8594267642584574
MSTO-211H,11214940,0.3292815706978371,1.8594267642584574
HSC-4,1750826,0.4564084690350189,1.8594267642584574
HSC-4,426756,6.131320111521982,1.8594267642584574
SCC-9,12001922,2.463166865850559,1.8594267642584574
CAL-51,656346,0.8466306406200714,1.8594267642584574
NCI-H661,49793307,-1.6947898398784864,1.8594267642584574
MSTO-211H,6450551,1.5186693992042568,1.8594267642584574
LXF 289,navitoclax-piperlongumine (1-1 mol-mol),2.4157701472871005,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],JQ-1-navitoclax (2-1 mol-mol),1.3966963569100277,1.8594267642584574
NCI-H460,73707398,3.251551904382877,1.8594267642584574
CAL-51,168313016,5.819136604546001,1.8594267642584574
NCI-H292,119607,5.8072644572840915,1.8594267642584574
SNU-81,31703,-2.2099083949209715,1.8594267642584574
A-673,11719255,3.0296971336672627,1.8594267642584574
HSC-4,9911830,2.7717739782698563,1.8594267642584574
CAL-51,44589607,2.4963130908502107,1.8594267642584574
FU-OV-1,24180125,2.037807307003979,1.8594267642584574
EFO-27,3634881,3.530057446917586,1.8594267642584574
MSTO-211H,25262965,-3.426128826799908,1.8594267642584574
LOU-NH91,3543504,4.266458043071255,1.8594267642584574
KMRC-1,sirolimus-bortezomib (250-1 mol-mol),0.3840144129269961,1.8594267642584574
NCI-H2171,23582824,0.048802245172864,1.8594267642584574
SCC-9,11507802,1.3688807961315366,1.8594267642584574
MDA-MB-453,selumetinib-BRD-A02303741 (4-1 mol-mol),6.9656310639147305,1.8594267642584574
CAL-51,65628,4.560195683913681,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],56649450,3.837346847556256,1.8594267642584574
CA46,6505803,0.7805822725654986,1.8594267642584574
KYSE-70,327653,3.7336437717951103,1.8594267642584574
NCI-H2171,11494412,-0.1110474347644453,1.8594267642584574
LXF 289,6918328,-0.239589445073231,1.8594267642584574
CAL-51,24951314,1.3730048574034712,1.8594267642584574
OPM-2,tretinoin-carboplatin (2-1 mol-mol),4.37691141446878,1.8594267642584574
A4/Fukuda,2858523,2.415383768636832,1.8594267642584574
NCI-H522,753704,4.098243268802601,1.8594267642584574
A4/Fukuda,11625818,2.700159842549232,1.8594267642584574
MDA-MB-157,2949965,2.5406478696331587,1.8594267642584574
ONS-76,409805,3.962852167855045,1.8594267642584574
NCI-H146,439501,-3.5641402563292393,1.8594267642584574
CAL-51,24856436,-0.3083697359271743,1.8594267642584574
SBC-5,31703,-1.5086983052531706,1.8594267642584574
NCI-H522,10184653,0.5663226513641079,1.8594267642584574
NCI-H522,135421197,1.9700795220087195,1.8594267642584574
A-673,alisertib-navitoclax (2-1 mol-mol),-1.8576644604152912,1.8594267642584574
NCI-H1623,46398810,3.5623335184860196,1.8594267642584574
A-673,216468,-1.1121166448103192,1.8594267642584574
BxPC-3,2708,4.650566781622339,1.8594267642584574
SNU-81,6184667,-0.6614889419446587,1.8594267642584574
NOMO-1,168312962,2.6221164331885003,1.8594267642584574
MDA-MB-453,16720766,-0.5495005772629474,1.8594267642584574
NCI-H522,9956119,4.024745164263863,1.8594267642584574
NCI-H1623,135440466,0.8012621152288821,1.8594267642584574
CA46,3025944,4.264528242833472,1.8594267642584574
CAL-51,71466380,3.802692276073616,1.8594267642584574
Panc 04.03,11656518,3.295682085422899,1.8594267642584574
SNU-61,JQ-1-MK-0752 (1-1 mol-mol),2.077081766151821,1.8594267642584574
LOU-NH91,16720766,0.888730139062919,1.8594267642584574
HCC1143,selumetinib-MK-2206 (8-1 mol-mol),0.0669797287296957,1.8594267642584574
JM-1,57519531,1.1574190263295916,1.8594267642584574
CAL-51,vorinostat-navitoclax (4-1 mol-mol),1.6210592416983378,1.8594267642584574
MSTO-211H,148198,-2.180219295506665,1.8594267642584574
SCC-9,4521392,4.43257578464979,1.8594267642584574
FTC-133,2746,3.487652314498242,1.8594267642584574
LoVo,44819697,3.398153390084315,1.8594267642584574
Panc 04.03,122327,5.490637645011104,1.8594267642584574
BxPC-3,25154868,5.007679584209566,1.8594267642584574
NCI-H661,3503,2.324538290067321,1.8594267642584574
NCI-H727,54618771,2.7901712320729333,1.8594267642584574
A2780,10302451,4.067201499125142,1.8594267642584574
A4/Fukuda,5281321,-4.090150251628595,1.8594267642584574
Panc 04.03,24771867,4.398084543376112,1.8594267642584574
CA46,241158,1.6221144264981358,1.8594267642584574
SBC-5,26596,-2.1907470722084414,1.8594267642584574
A-498,11625818,3.6553151033235904,1.8594267642584574
G-401,9911830,0.6760173642929876,1.8594267642584574
CA46,123631,1.9024335998312112,1.8594267642584574
LoVo,104842,-3.39586805089817,1.8594267642584574
OPM-2,5479543,3.226492982806864,1.8594267642584574
HCC1143,6623618,3.4930934009716226,1.8594267642584574
NCI-H2009,46199207,3.041674504763304,1.8594267642584574
NCI-H661,49766530,1.1318827683023138,1.8594267642584574
CAL-51,1641662,3.5457804017420744,1.8594267642584574
ONS-76,44819697,-0.7397391051726983,1.8594267642584574
BxPC-3,57330099,4.21152658046839,1.8594267642584574
MSTO-211H,3038522,3.865174160499475,1.8594267642584574
LXF 289,71466380,3.888647536265504,1.8594267642584574
CA46,5479543,2.004846411807367,1.8594267642584574
OPM-2,9907093,3.786753386665246,1.8594267642584574
NCI-H522,54613361,-1.014694822148615,1.8594267642584574
NCI-H2171,25195348,2.4042641753284872,1.8594267642584574
LOU-NH91,9911463,4.226439837654448,1.8594267642584574
JM-1,6918736,-2.112176013423493,1.8594267642584574
OPM-2,89183176,2.1177805080987633,1.8594267642584574
OPM-2,135875424,2.796643273298537,1.8594267642584574
HCC1143,24964624,2.836653438175677,1.8594267642584574
DMS 273,44566777,1.254196350489733,1.8594267642584574
NCI-H522,49867926,4.17523654199276,1.8594267642584574
LoVo,72193861,-0.0557430791680942,1.8594267642584574
YAPC,selumetinib-GDC-0941 (4-1 mol-mol),2.7150403374869856,1.8594267642584574
LXF 289,selumetinib-JQ-1 (4-1 mol-mol),1.3410904156119008,1.8594267642584574
SNU-61,374536,-1.8297483787291275,1.8594267642584574
CA46,44566777,-1.0409480025289963,1.8594267642584574
JM-1,54613361,-0.7111924625528845,1.8594267642584574
LoVo,25154868,3.829103546750207,1.8594267642584574
A4/Fukuda,15547703,2.4441609561923547,1.8594267642584574
KMRC-1,10074640,3.6694615069556886,1.8594267642584574
NCI-H2171,2729026,2.1337054337121466,1.8594267642584574
CA46,JQ-1-vorinostat (2-1 mol-mol),-0.7880767442206768,1.8594267642584574
HCC1143,68056272,4.744387863321378,1.8594267642584574
CAL-51,navitoclax-MST-312 (1-1 mol-mol),1.7959249408216948,1.8594267642584574
NCI-H2009,44607531,0.9822487023795796,1.8594267642584574
KYSE-70,89183176,4.766828638924323,1.8594267642584574
SBC-5,25154868,3.0138435145006155,1.8594267642584574
A-498,11719255,3.5352993104723245,1.8594267642584574
SCC-9,208908,2.838235608451249,1.8594267642584574
SW1463,2126,3.781949624288532,1.8594267642584574
SBC-5,5311,0.7694897344457827,1.8594267642584574
BxPC-3,11609586,2.766108761160721,1.8594267642584574
CA46,71466380,3.212448709653588,1.8594267642584574
FTC-133,25126798,4.495223588633032,1.8594267642584574
JM-1,44632017,0.8586744690995054,1.8594267642584574
A4/Fukuda,navitoclax-sorafenib (1-1 mol-mol),1.3354427361603598,1.8594267642584574
SNU-449,4917,3.4001304631059965,1.8594267642584574
JM-1,135984461,1.552881480804892,1.8594267642584574
NCI-H2009,969516,2.7623608328977314,1.8594267642584574
SCC-9,104842,-1.437225086828998,1.8594267642584574
CAL-51,73707398,0.7053044464230985,1.8594267642584574
KMRC-1,67156097,2.0694443843024173,1.8594267642584574
SNU-449,135411,1.1071215925884743,1.8594267642584574
A4/Fukuda,72376,-3.4342601152101473,1.8594267642584574
CAL-51,54619238,5.308906879487735,1.8594267642584574
SBC-5,5282054,4.370273963099393,1.8594267642584574
SNU-81,vorinostat-carboplatin (1-1 mol-mol),3.3031492334396977,1.8594267642584574
OVISE,5328940,2.3935755372069676,1.8594267642584574
SNU-449,BRD-A02303741-carboplatin (1-1 mol-mol),6.10453045453208,1.8594267642584574
A2780,24779724,4.3340331177123765,1.8594267642584574
A-673,400769,-0.9976419565742564,1.8594267642584574
MDA-MB-453,3081361,2.1431734647577496,1.8594267642584574
A4/Fukuda,123631,1.573225246333458,1.8594267642584574
A-498,46224516,5.193995490382977,1.8594267642584574
CA46,5738263,2.2696720462337456,1.8594267642584574
DMS 273,16722836,2.1308156944151833,1.8594267642584574
KYSE-70,119607,5.065055719995064,1.8594267642584574
MDA-MB-157,637858,0.0650158223638603,1.8594267642584574
KMRC-1,24180125,3.3952911821821052,1.8594267642584574
A4/Fukuda,9935249,-4.132944592984893,1.8594267642584574
A4/Fukuda,9915743,-0.3554458205966057,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],56946209,-4.301528027920143,1.8594267642584574
FU-OV-1,11222830,1.8946229471337992,1.8594267642584574
SNU-81,BRD-K27188169-navitoclax (2-1 mol-mol),2.560233422856499,1.8594267642584574
NCI-H522,24775005,3.057250054087749,1.8594267642584574
NCI-H522,15983966,4.053677978120726,1.8594267642584574
DMS 273,25102847,1.54508352242066,1.8594267642584574
A4/Fukuda,44543605,3.1271044447490235,1.8594267642584574
CAL-51,44507138,2.6477043136390637,1.8594267642584574
SNU-61,16725315,5.215969195263621,1.8594267642584574
EFO-27,448949,1.7491267397814168,1.8594267642584574
A-673,5280436,1.8974559090481808,1.8594267642584574
MDA-MB-453,24779724,5.606505141806212,1.8594267642584574
SCC-9,carboplatin-etoposide (40-17 mol-mol),3.166154009244092,1.8594267642584574
G-401,alisertib-navitoclax (2-1 mol-mol),-1.5256164798687666,1.8594267642584574
NCI-H522,216345,3.499198551341706,1.8594267642584574
BT-549,25022340,3.398199457605664,1.8594267642584574
SCC-9,23725625,6.300420686237622,1.8594267642584574
MSTO-211H,54619267,2.133098694540018,1.8594267642584574
NCI-H146,JQ-1-UNC0638 (2-1 mol-mol),-1.369706115362065,1.8594267642584574
A-498,148198,-1.0809020747576437,1.8594267642584574
SNU-449,10127622,5.039458046327855,1.8594267642584574
CAL-51,1641662,3.5457804017420744,1.8594267642584574
MDA-MB-453,5291,3.622613892398656,1.8594267642584574
A-673,168312962,-0.712468254461992,1.8594267642584574
SNU-61,52912189,0.4386789975034979,1.8594267642584574
LXF 289,2828334,5.402872149224608,1.8594267642584574
BxPC-3,374536,3.0351492595764347,1.8594267642584574
EFO-27,9825149,3.71226874457915,1.8594267642584574
NCI-H727,216345,4.166745514794161,1.8594267642584574
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117,1.8594267642584574
A2780,156414,1.0391092981452308,1.8594267642584574
BxPC-3,11647372,-0.5523773269560157,1.8594267642584574
NOMO-1,10296883,3.647443685498321,1.8594267642584574
LOU-NH91,60750,2.5426597160889823,1.8594267642584574
NCI-H460,16038120,2.547350732010626,1.8594267642584574
ONS-76,123631,2.7486777230854176,1.8594267642584574
OVISE,9903786,4.69480560533159,1.8594267642584574
HSC-4,168312962,-1.5337410071263893,1.8594267642584574
NOMO-1,421610,4.35383474826381,1.8594267642584574
NCI-H661,4917,2.840246866325883,1.8594267642584574
LXF 289,3634881,3.11935208210029,1.8594267642584574
EFO-27,9911830,3.273850069923984,1.8594267642584574
A2780,46215462,1.4920420325768875,1.8594267642584574
MSTO-211H,11234052,3.0252233847843515,1.8594267642584574
NCI-H522,2842253,4.095670069869479,1.8594267642584574
A-673,3385,3.2869772752619033,1.8594267642584574
MSTO-211H,46398810,1.7478948810000858,1.8594267642584574
ONS-76,49850262,3.849158291733923,1.8594267642584574
MDA-MB-157,11507802,-0.5781039838427031,1.8594267642584574
A2780,24978538,0.9309197302054482,1.8594267642584574
BxPC-3,24180719,3.164671730334926,1.8594267642584574
NCI-H146,676352,1.7139908333138,1.8594267642584574
A-673,82146,3.820966427179324,1.8594267642584574
NCI-H2009,46174525,3.5250507211438107,1.8594267642584574
EFO-27,10302451,6.465018307145316,1.8594267642584574
A-673,135984461,3.9402009784769745,1.8594267642584574
HCC1143,4521392,4.180219407268625,1.8594267642584574
A2780,5351362,1.3372825777001471,1.8594267642584574
EFO-27,10296883,4.235346466258499,1.8594267642584574
SNU-61,25150857,2.1451887473522295,1.8594267642584574
LXF 289,25150857,2.4132050810476,1.8594267642584574
KYSE-70,135440466,2.892957215680813,1.8594267642584574
MDA-MB-453,11222830,1.1155100991132725,1.8594267642584574
A2780,6918289,-5.622064624678881,1.8594267642584574
OPM-2,445455,3.93427157933256,1.8594267642584574
EFO-27,15953870,3.8448280803188233,1.8594267642584574
A4/Fukuda,4917,1.915641979161103,1.8594267642584574
YAPC,44185566,2.6271326170179248,1.8594267642584574
SNU-449,3634881,3.3285371967859128,1.8594267642584574
OPM-2,44566777,-0.9514063433103236,1.8594267642584574
NCI-H2171,docetaxel-tanespimycin (2-1 mol-mol),-7.650275881256593,1.8594267642584574
MDA-MB-157,4259181,-0.4671059045276012,1.8594267642584574
SNU-81,11656518,-0.0512259493867009,1.8594267642584574
NCI-H522,11494412,-0.7022253688217924,1.8594267642584574
A2780,selumetinib-decitabine (4-1 mol-mol),1.5025491201295178,1.8594267642584574
CA46,24180719,4.114109141176105,1.8594267642584574
MDA-MB-157,82146,3.0360891700929984,1.8594267642584574
G-401,23635314,-3.865618451368766,1.8594267642584574
LoVo,42642645,0.0146125142547242,1.8594267642584574
HSC-4,9826308,3.3704185574061456,1.8594267642584574
NCI-H292,176870,4.643600229240446,1.8594267642584574
ONS-76,44202524,1.6130278410730936,1.8594267642584574
KYSE-70,9911463,3.4914249269651307,1.8594267642584574
NCI-H146,24779724,4.32606530761132,1.8594267642584574
LoVo,44493528,4.114958638118981,1.8594267642584574
CAL-51,44486219,4.943814728636009,1.8594267642584574
HCC1143,serdemetan-SCH-529074 (1-1 mol-mol),1.8750312876622353,1.8594267642584574
MDA-MB-453,8515,4.14044832994183,1.8594267642584574
A-498,tanespimycin-gemcitabine (1-1 mol-mol),3.605685519475067,1.8594267642584574
FTC-133,56963564,0.7376209226585526,1.8594267642584574
MDA-MB-157,11494412,-1.4760508995443156,1.8594267642584574
SNU-449,4261,2.5462586921108197,1.8594267642584574
MSTO-211H,984333,0.926178476056404,1.8594267642584574
SCC-9,1641662,3.777884166860496,1.8594267642584574
HSC-4,2949965,3.8536489984175097,1.8594267642584574
NCI-H2009,5566,2.98031688083636,1.8594267642584574
HCC1143,16741245,3.781249389530293,1.8594267642584574
CA46,67156097,-2.616833441535583,1.8594267642584574
SNU-449,vorinostat-carboplatin (1-1 mol-mol),4.005391500954191,1.8594267642584574
G-401,55283,4.120501166008349,1.8594267642584574
A-673,11977753,-4.8378783477247875,1.8594267642584574
BT-549,637858,2.0216713295762614,1.8594267642584574
MDA-MB-453,5287620,-1.4808110009700917,1.8594267642584574
BxPC-3,46907787,0.03250860780982,1.8594267642584574
NCI-H661,44819697,-3.610310878099198,1.8594267642584574
Panc 04.03,vorinostat-carboplatin (1-1 mol-mol),3.8664916709741792,1.8594267642584574
LOU-NH91,BRD-K27188169-navitoclax (2-1 mol-mol),-1.3161602950159492,1.8594267642584574
BxPC-3,46191454,0.7426288337003383,1.8594267642584574
MDA-MB-453,322968,3.088283756332906,1.8594267642584574
NCI-H1623,16736978,1.234327001570643,1.8594267642584574
KYSE-70,1641662,3.490090790744947,1.8594267642584574
A2780,5470400,5.365026906170319,1.8594267642584574
NCI-H522,23582824,0.9084599252004664,1.8594267642584574
OPM-2,BRD-A02303741-carboplatin (1-1 mol-mol),5.621987253531824,1.8594267642584574
MDA-MB-157,23725625,0.2462467633250468,1.8594267642584574
SNU-61,44632017,1.0979359106396418,1.8594267642584574
ONS-76,8515,4.109060881613791,1.8594267642584574
BT-549,erlotinib-PLX-4032 (2-1 mol-mol),4.9890831311831665,1.8594267642584574
HSC-4,54626689,4.284935050666877,1.8594267642584574
SCC-9,42642645,1.380036396261508,1.8594267642584574
LOU-NH91,9866186,2.5706791809917258,1.8594267642584574
MDA-MB-453,3552672,1.8646445353613752,1.8594267642584574
LXF 289,11507802,1.7765111516543377,1.8594267642584574
KYSE-70,107985,-3.298359335305578,1.8594267642584574
G-401,53325874,4.831157164763357,1.8594267642584574
NCI-H460,5746,0.0249012606464236,1.8594267642584574
MSTO-211H,11213558,-0.8326933060339966,1.8594267642584574
KYSE-70,56963564,0.3897414986371327,1.8594267642584574
FU-OV-1,11485656,3.4521578130267336,1.8594267642584574
A4/Fukuda,56963564,-0.5107551488404702,1.8594267642584574
A-498,51039095,3.6847311434926535,1.8594267642584574
BxPC-3,44486219,3.8860987116797703,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],24856436,1.4266113819026696,1.8594267642584574
OPM-2,piperlongumine-MST-312 (1-1 mol-mol),0.9476168525414524,1.8594267642584574
HSC-4,44819697,-1.3561318696958864,1.8594267642584574
LOU-NH91,selumetinib-PLX-4032 (8-1 mol-mol),3.969843428334973,1.8594267642584574
A2780,148198,-4.120801514793353,1.8594267642584574
YAPC,36462,2.246335150310725,1.8594267642584574
NCI-H460,10184653,3.574651577310896,1.8594267642584574
CAL-51,navitoclax-gemcitabine (1-1 mol-mol),-3.0464623098161256,1.8594267642584574
LOU-NH91,54678924,3.1162234647683205,1.8594267642584574
ONS-76,11214940,1.2536021206371053,1.8594267642584574
SCC-9,9907093,4.490912734248418,1.8594267642584574
NCI-H661,11964036,1.3116184134954847,1.8594267642584574
CAL-51,135411,0.595745817277345,1.8594267642584574
EFO-27,613753,3.260816470325069,1.8594267642584574
A-673,73707398,-0.4228078892765429,1.8594267642584574
YAPC,25262965,-0.9761970914901598,1.8594267642584574
LXF 289,31703,0.1888440469000175,1.8594267642584574
A-673,44486219,3.969252294689724,1.8594267642584574
HCC1143,135875424,3.1375636080090925,1.8594267642584574
NCI-H661,241158,4.406370209729512,1.8594267642584574
A-673,17755052,1.3895683648511998,1.8594267642584574
LXF 289,4788,5.213081732847737,1.8594267642584574
NCI-H522,5738263,2.340773324031017,1.8594267642584574
SCC-9,4788,5.928282303581182,1.8594267642584574
JM-1,46843906,0.1108259550663182,1.8594267642584574
CAL-51,9967941,3.511576456928413,1.8594267642584574
Panc 04.03,5746,1.7282227653726634,1.8594267642584574
JM-1,444795,2.4559914793227597,1.8594267642584574
A2780,25183872,-0.9660294253312856,1.8594267642584574
NCI-H460,ISOX-bortezomib (250-1 mol-mol),1.7631943110451136,1.8594267642584574
A-498,12001922,2.3665933531109564,1.8594267642584574
NCI-H522,selumetinib-decitabine (4-1 mol-mol),5.680021227414058,1.8594267642584574
NCI-H460,3384730,3.247736649900264,1.8594267642584574
NCI-H292,9884685,1.805947993429832,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],82146,3.3691200384154456,1.8594267642584574
NCI-H2009,25126798,3.423512143516965,1.8594267642584574
A-673,67156097,-2.6530750558799268,1.8594267642584574
A-673,selumetinib-JQ-1 (4-1 mol-mol),0.7422634242763538,1.8594267642584574
NCI-H1623,11364421,1.5638784569997608,1.8594267642584574
OVISE,65064,5.3042455172619345,1.8594267642584574
CAL-51,11485656,2.6541256228973773,1.8594267642584574
EFO-27,navitoclax-MST-312 (1-1 mol-mol),1.1101378003165483,1.8594267642584574
G-401,135984461,4.271777659576195,1.8594267642584574
A2780,11960529,3.87105656281655,1.8594267642584574
OVISE,168312962,-1.1497759256084987,1.8594267642584574
SNU-449,25062766,2.0173338536366776,1.8594267642584574
CA46,44462760,4.878030903037556,1.8594267642584574
SNU-449,126941,-4.267074342641938,1.8594267642584574
BxPC-3,55283,0.3092833280624811,1.8594267642584574
MDA-MB-453,2708,5.180783048838842,1.8594267642584574
EFO-27,441298,3.357031616162376,1.8594267642584574
A-673,25195348,4.457358631051988,1.8594267642584574
OPM-2,285033,-4.309653599496783,1.8594267642584574
FTC-133,156414,2.701071854154092,1.8594267642584574
NCI-H2171,sirolimus-bortezomib (250-1 mol-mol),0.0870413029192065,1.8594267642584574
A-673,vorinostat-navitoclax (4-1 mol-mol),0.758498532756487,1.8594267642584574
SNU-449,219104,4.193064059209751,1.8594267642584574
SNU-61,387447,-3.847354855280633,1.8594267642584574
ONS-76,89928392,2.125505613903981,1.8594267642584574
DMS 273,10296883,4.130929131041443,1.8594267642584574
SCC-9,71466380,4.753733846444339,1.8594267642584574
CAL-51,11234052,5.18044926966805,1.8594267642584574
FTC-133,135875424,4.265925786122884,1.8594267642584574
NCI-H292,135398738,5.91070825601545,1.8594267642584574
NCI-H2009,24785538,-2.0037312151285462,1.8594267642584574
KMRC-1,5281321,-2.040334048066586,1.8594267642584574
OPM-2,9926054,1.8132463747821628,1.8594267642584574
NOMO-1,44607530,2.1799605259844914,1.8594267642584574
BxPC-3,104842,-2.6661298782325265,1.8594267642584574
JM-1,decitabine-carboplatin (1-1 mol-mol),-2.2469818975584004,1.8594267642584574
A-498,1716436,3.6890609174990057,1.8594267642584574
NCI-H522,252682,6.061888172888063,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],219104,4.304261518356908,1.8594267642584574
CAL-51,409805,3.8515087112009656,1.8594267642584574
SNU-449,676352,1.7938896042567478,1.8594267642584574
NOMO-1,72193861,0.7304873005319745,1.8594267642584574
FU-OV-1,5566,3.32118213388136,1.8594267642584574
YAPC,piperlongumine-MST-312 (1-1 mol-mol),2.5050103055031356,1.8594267642584574
CAL-51,5291,4.8235616489491635,1.8594267642584574
NCI-H1623,73707398,1.8898657972875643,1.8594267642584574
G-401,navitoclax-PLX-4032 (1-1 mol-mol),3.453832495837289,1.8594267642584574
A2780,54619267,2.083839750794981,1.8594267642584574
A4/Fukuda,25150857,1.0832866246256998,1.8594267642584574
SCC-9,25195348,3.9019221273063858,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],4521392,4.2393817604075705,1.8594267642584574
NCI-H2009,20959075,-3.4439076637996076,1.8594267642584574
HSC-4,navitoclax-birinapant (1-1 mol-mol),2.9615241748083907,1.8594267642584574
YAPC,135875424,4.215334227700636,1.8594267642584574
NCI-H522,vorinostat-carboplatin (1-1 mol-mol),3.5371010286521827,1.8594267642584574
LOU-NH91,2708,7.798658787946165,1.8594267642584574
MDA-MB-157,54613361,-1.9100924648361528,1.8594267642584574
YAPC,613753,3.436227254149273,1.8594267642584574
G-401,26596,-1.5666727843222663,1.8594267642584574
A2780,124202324,1.685811695923782,1.8594267642584574
BT-549,52912189,4.655826026030035,1.8594267642584574
OPM-2,6438330,0.5735051923287856,1.8594267642584574
ONS-76,49766530,-0.8397126534273769,1.8594267642584574
A-673,24180719,3.918829940752815,1.8594267642584574
A-673,72734382,3.862779655203366,1.8594267642584574
JM-1,46926350,-6.131969810114727,1.8594267642584574
A-498,216239,2.9738940537308203,1.8594267642584574
NOMO-1,54618771,-0.7336388686704796,1.8594267642584574
A4/Fukuda,25126798,3.529395374343333,1.8594267642584574
NCI-H522,16013152,4.870026952980287,1.8594267642584574
NCI-H1623,JQ-1-vorinostat (2-1 mol-mol),1.274501215342979,1.8594267642584574
ONS-76,6918328,0.1573953751573411,1.8594267642584574
LOU-NH91,1566236,3.241690914019502,1.8594267642584574
HCC1143,2858523,3.0390361797055276,1.8594267642584574
BT-549,71304818,3.5849392152335713,1.8594267642584574
MDA-MB-453,49867930,4.991198207309722,1.8594267642584574
LOU-NH91,4261,2.7247094190978007,1.8594267642584574
NCI-H522,52947716,2.6251827866590385,1.8594267642584574
NCI-H661,6852167,3.3441449371697205,1.8594267642584574
NCI-H292,16736978,2.16203795839555,1.8594267642584574
SNU-449,637858,2.172600125936458,1.8594267642584574
SBC-5,16720766,-1.9276845300945755,1.8594267642584574
ONS-76,piperlongumine-MST-312 (1-1 mol-mol),1.8657254357935973,1.8594267642584574
NCI-H661,2828334,5.966055284777512,1.8594267642584574
EFO-27,9884685,1.4230112837032636,1.8594267642584574
OPM-2,25227462,-6.0467342682230445,1.8594267642584574
A-673,3038522,2.0400506341720237,1.8594267642584574
HSC-4,54686904,4.85379149564711,1.8594267642584574
A4/Fukuda,969516,2.117405484631732,1.8594267642584574
MSTO-211H,JQ-1-UNC0638 (2-1 mol-mol),2.4218751645526573,1.8594267642584574
LOU-NH91,6610216,4.701575628194421,1.8594267642584574
NCI-H661,24856436,-1.6135015308236011,1.8594267642584574
LoVo,6252,1.008875569338637,1.8594267642584574
CAL-51,5281672,3.9430830045045857,1.8594267642584574
YAPC,25183872,-0.4840811687838853,1.8594267642584574
NCI-H2171,11222830,1.3474519729527985,1.8594267642584574
SBC-5,16722836,3.112579400078665,1.8594267642584574
FU-OV-1,3689413,-2.180005064661593,1.8594267642584574
JM-1,6914657,-7.803103466538306,1.8594267642584574
A4/Fukuda,11222830,1.361211164053787,1.8594267642584574
OPM-2,24180719,3.7347961717129383,1.8594267642584574
A2780,50905018,3.503420862443992,1.8594267642584574
LXF 289,168313016,5.746715572468322,1.8594267642584574
MDA-MB-453,2874250,4.390759253530558,1.8594267642584574
NCI-H146,3543504,3.2112662755133616,1.8594267642584574
MSTO-211H,9956119,3.2798548332341246,1.8594267642584574
NOMO-1,11152667,-1.8753376491976492,1.8594267642584574
NCI-H292,241158,3.585722962787503,1.8594267642584574
SCC-9,52912189,3.371588298050412,1.8594267642584574
A-673,15983966,-8.138595470092604,1.8594267642584574
OPM-2,JQ-1-navitoclax (2-1 mol-mol),-3.008224254673695,1.8594267642584574
NCI-H146,5287969,-2.632266530811145,1.8594267642584574
A4/Fukuda,44632017,0.3391160528514481,1.8594267642584574
CA46,1242560,2.637858421223904,1.8594267642584574
CAL-51,serdemetan-SCH-529074 (1-1 mol-mol),1.9102886426753127,1.8594267642584574
NCI-H727,10184653,0.8809089143232124,1.8594267642584574
MSTO-211H,6918736,-4.031815262851263,1.8594267642584574
Panc 04.03,54454,4.748257983656133,1.8594267642584574
BxPC-3,tanespimycin-gemcitabine (1-1 mol-mol),-1.8536024337573052,1.8594267642584574
SNU-449,6918328,2.053547134624907,1.8594267642584574
A4/Fukuda,262093,3.0357368226896178,1.8594267642584574
ONS-76,6918837,-2.636307015456442,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],6918837,-4.6352405483445525,1.8594267642584574
ONS-76,107985,-3.307412021608342,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],10302451,3.9774689486836383,1.8594267642584574
OPM-2,42642645,-0.4905470491794313,1.8594267642584574
FTC-133,16722836,3.262117509304611,1.8594267642584574
SNU-449,123631,2.9179285945779183,1.8594267642584574
OPM-2,644241,1.6900050339542656,1.8594267642584574
HSC-4,1242560,3.572222416741055,1.8594267642584574
NCI-H292,123631,3.5457837677726833,1.8594267642584574
HSC-4,2842253,4.76622062087716,1.8594267642584574
NCI-H2009,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.4079843447100908,1.8594267642584574
Panc 04.03,3689413,0.3957464459941977,1.8594267642584574
NCI-H460,135398516,4.13019906717736,1.8594267642584574
NCI-H460,5311,2.161812802665503,1.8594267642584574
SNU-61,11238147,3.2212717665721375,1.8594267642584574
YAPC,sirolimus-bortezomib (250-1 mol-mol),1.6566311249890242,1.8594267642584574
HCC1143,44607531,1.4024247683472026,1.8594267642584574
NCI-H727,5351362,1.1476230363651536,1.8594267642584574
KMRC-1,6852167,3.0099217565414693,1.8594267642584574
MDA-MB-157,5311,0.9088479539093504,1.8594267642584574
CA46,BRD-A02303741-carboplatin (1-1 mol-mol),6.48045136918117,1.8594267642584574
HCC1143,crizotinib-PLX-4032 (2-1 mol-mol),1.506008388614785,1.8594267642584574
SNU-449,3025944,4.153676005178765,1.8594267642584574
A-673,23635314,-4.460908555858267,1.8594267642584574
JM-1,5351362,0.3312371174067021,1.8594267642584574
DMS 273,24901704,3.9468378622372264,1.8594267642584574
MDA-MB-453,9911463,3.8683390626627454,1.8594267642584574
OVISE,60700,1.357326318980797,1.8594267642584574
FTC-133,448949,3.317946341403347,1.8594267642584574
LoVo,5566,2.507145044552918,1.8594267642584574
DMS 273,9967941,3.979035067958665,1.8594267642584574
LOU-NH91,16038120,-0.2213795856096394,1.8594267642584574
NCI-H1623,11977753,-1.4500330036408269,1.8594267642584574
NCI-H522,JQ-1-navitoclax (2-1 mol-mol),0.228465095222191,1.8594267642584574
NCI-H460,31703,-0.6563705559837907,1.8594267642584574
A-673,9866186,-0.4052980916556575,1.8594267642584574
OVISE,31703,0.0982732174518241,1.8594267642584574
HCC1143,124202324,1.6321362493528402,1.8594267642584574
G-401,4705,3.1032512954578415,1.8594267642584574
NOMO-1,3025986,-1.4139862297409005,1.8594267642584574
CAL-51,navitoclax-pluripotin (1-1 mol-mol),-0.5264654943286647,1.8594267642584574
NOMO-1,148198,-5.33573798573566,1.8594267642584574
A2780,9907093,2.8643649893432106,1.8594267642584574
HSC-4,44607531,1.5153971496977892,1.8594267642584574
LXF 289,2746,3.190299829163617,1.8594267642584574
MDA-MB-453,4261,0.3032353935433951,1.8594267642584574
BxPC-3,656346,-0.1234429100103727,1.8594267642584574
Panc 04.03,BRD-K55473186,5.259619810258457,1.8594267642584574
BxPC-3,sirolimus-bortezomib (250-1 mol-mol),-0.2731425990324966,1.8594267642584574
CAL-51,3385,3.064238699960593,1.8594267642584574
BT-549,675434,4.287026263227802,1.8594267642584574
LOU-NH91,9868037,3.6278868560603574,1.8594267642584574
G-401,400769,-0.955062013548762,1.8594267642584574
SNU-449,44185566,2.80206906512974,1.8594267642584574
DMS 273,613753,3.2268993277161524,1.8594267642584574
FTC-133,9911830,2.8814152307979946,1.8594267642584574
KMRC-1,selumetinib-navitoclax (8-1 mol-mol),3.760872598946533,1.8594267642584574
FTC-133,462382,1.2436445575195818,1.8594267642584574
SNU-449,selumetinib-vorinostat (8-1 mol-mol),3.605779113828276,1.8594267642584574
NOMO-1,9884685,0.4754269892492985,1.8594267642584574
FU-OV-1,44589607,2.6910555486326397,1.8594267642584574
CA46,11228183,3.2150932794291975,1.8594267642584574
G-401,24797083,1.4378353960151609,1.8594267642584574
OPM-2,4705,3.10353547990691,1.8594267642584574
SCC-9,49766530,0.4117706354329887,1.8594267642584574
DMS 273,44819697,-0.9932488797546292,1.8594267642584574
NCI-H661,56963564,-1.1338494929069671,1.8594267642584574
NCI-H727,25154868,4.680199730171404,1.8594267642584574
MDA-MB-453,56649450,1.3470223737131497,1.8594267642584574
CAL-51,54678924,3.225490994604415,1.8594267642584574
NCI-H292,vorinostat-navitoclax (4-1 mol-mol),3.14329221790471,1.8594267642584574
NCI-H522,56963564,-0.3134921987801757,1.8594267642584574
JM-1,10322450,2.576608882705072,1.8594267642584574
KYSE-70,sirolimus-bortezomib (250-1 mol-mol),0.1222740684138433,1.8594267642584574
A-673,24748573,1.962021648564739,1.8594267642584574
LoVo,24785538,0.3940436885335026,1.8594267642584574
NCI-H292,135421197,1.1571557888211337,1.8594267642584574
SCC-9,19582717,4.601399638975327,1.8594267642584574
NCI-H2009,5311281,-0.1357038590739554,1.8594267642584574
BT-549,24951314,1.7605147679012945,1.8594267642584574
CAL-51,10302451,1.350542324147247,1.8594267642584574
HCC1143,10127622,3.54698748679943,1.8594267642584574
NCI-H460,44589607,4.73035444754351,1.8594267642584574
LXF 289,10113978,1.6721223719755247,1.8594267642584574
YAPC,5566,3.1204203259985044,1.8594267642584574
NCI-H522,135423438,2.202740699610144,1.8594267642584574
MDA-MB-453,5280436,1.8692407341233208,1.8594267642584574
BxPC-3,400769,-1.094495387384235,1.8594267642584574
MDA-MB-453,57330099,4.336922942952946,1.8594267642584574
DMS 273,24964624,-0.4885915334424611,1.8594267642584574
LXF 289,JQ-1-UNC0638 (2-1 mol-mol),0.6373974931870546,1.8594267642584574
A2780,11964036,-0.2399638951327319,1.8594267642584574
BxPC-3,56963564,-0.5407215297938537,1.8594267642584574
A-673,9907093,4.212541297476806,1.8594267642584574
EFO-27,11427553,3.591439679350591,1.8594267642584574
MDA-MB-453,439501,-3.002845657836036,1.8594267642584574
LOU-NH91,11485656,3.2972382499502935,1.8594267642584574
MDA-MB-453,25161177,4.057301598200359,1.8594267642584574
NCI-H460,54143018,2.5592633032091956,1.8594267642584574
MDA-MB-453,53325874,4.468628295310174,1.8594267642584574
CAL-51,71466380,3.802692276073616,1.8594267642584574
NCI-H1623,4788,5.98570816019398,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],448949,2.472966773294446,1.8594267642584574
Panc 04.03,11707110,4.882480457753906,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],6450551,4.167380741941181,1.8594267642584574
NCI-H2009,JQ-1-UNC0638 (2-1 mol-mol),1.1366258852040196,1.8594267642584574
SNU-61,285033,-2.2323165928541746,1.8594267642584574
A2780,25150857,2.724824774969284,1.8594267642584574
SCC-9,tanespimycin-bortezomib (250-1 mol-mol),-0.5584640053775825,1.8594267642584574
SW1463,36314,3.0951531870893523,1.8594267642584574
A2780,2858523,2.134868506415456,1.8594267642584574
NCI-H460,3825829,4.446795399525052,1.8594267642584574
A2780,1750826,-0.9954774428329844,1.8594267642584574
NCI-H661,carboplatin-UNC0638 (2-1 mol-mol),4.544203960519617,1.8594267642584574
MSTO-211H,selumetinib-MK-2206 (8-1 mol-mol),1.2523786732506748,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],vorinostat-navitoclax (4-1 mol-mol),2.52102368660606,1.8594267642584574
A4/Fukuda,JQ-1-carboplatin (1-1 mol-mol),-0.863856573463552,1.8594267642584574
MSTO-211H,107985,-3.699787970340743,1.8594267642584574
SNU-81,navitoclax-birinapant (1-1 mol-mol),-3.02925999333472,1.8594267642584574
DMS 273,10302451,4.121656528900648,1.8594267642584574
CAL-51,262093,2.862241975448649,1.8594267642584574
DMS 273,4261,-0.2104746005525494,1.8594267642584574
MDA-MB-453,148124,-4.8335014079709975,1.8594267642584574
G-401,11178236,-6.653209761704985,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],24964624,3.1300744088166312,1.8594267642584574
MDA-MB-157,262093,2.565616950913742,1.8594267642584574
MSTO-211H,9868037,1.9157833543052896,1.8594267642584574
HSC-4,5280436,3.1415705358429884,1.8594267642584574
MSTO-211H,10231331,1.7809441814393978,1.8594267642584574
NCI-H2171,969516,2.758162928931276,1.8594267642584574
HCC1143,10184653,0.277782870066905,1.8594267642584574
A-673,4788,5.851137286094999,1.8594267642584574
OVISE,11364421,1.999223974612241,1.8594267642584574
NCI-H661,44202524,1.2385989199848235,1.8594267642584574
NCI-H460,3062316,3.704520183651484,1.8594267642584574
NCI-H1623,44607531,0.8047036576600745,1.8594267642584574
OPM-2,9956119,3.674575368535915,1.8594267642584574
OVISE,carboplatin-UNC0638 (2-1 mol-mol),3.0965224412296743,1.8594267642584574
NCI-H146,54618305,4.054654997899016,1.8594267642584574
OPM-2,11507802,0.0988268127526858,1.8594267642584574
CAL-51,10385095,1.0305027810027567,1.8594267642584574
CAL-51,carboplatin-etoposide (40-17 mol-mol),1.6376184164581593,1.8594267642584574
A-673,71466380,3.8107210551169577,1.8594267642584574
A-673,10427712,3.6867963290416346,1.8594267642584574
DMS 273,56946209,-5.704769625352934,1.8594267642584574
A2780,53301938,-5.924783673466769,1.8594267642584574
MDA-MB-453,3025944,3.940846865776467,1.8594267642584574
NCI-H146,9840324,5.546223512080725,1.8594267642584574
HCC1143,3815108,2.289037887638348,1.8594267642584574
NCI-H460,11625818,5.428588497019925,1.8594267642584574
HSC-4,salermide-PLX-4032 (12-1 mol-mol),5.175495928614886,1.8594267642584574
SNU-61,123631,1.7897165257078365,1.8594267642584574
HCC1143,73707398,0.6963565440176983,1.8594267642584574
FU-OV-1,24964624,0.6948307959675745,1.8594267642584574
BxPC-3,89928392,1.339609071089843,1.8594267642584574
MSTO-211H,carboplatin-etoposide (40-17 mol-mol),1.373265530821681,1.8594267642584574
NCI-H661,46398810,2.545394900571619,1.8594267642584574
NCI-H661,17755052,1.4228000150725233,1.8594267642584574
CAL-51,10427712,4.2973287072996085,1.8594267642584574
NCI-H661,208908,1.9265593878348335,1.8594267642584574
LXF 289,71466578,4.726723075051965,1.8594267642584574
A-673,selumetinib-vorinostat (8-1 mol-mol),2.071525628595549,1.8594267642584574
KMRC-1,46224516,3.1277122869876064,1.8594267642584574
JM-1,2113511,3.632981632735763,1.8594267642584574
LOU-NH91,2113511,6.175446639496144,1.8594267642584574
A4/Fukuda,6918837,-6.1208599704470865,1.8594267642584574
FU-OV-1,11640390,5.4167064390474335,1.8594267642584574
SBC-5,44607531,2.697205944866836,1.8594267642584574
OVISE,71304818,3.3064642565645572,1.8594267642584574
OPM-2,11152667,-1.3080541002664456,1.8594267642584574
NCI-H146,3552672,1.604439194031644,1.8594267642584574
CAL-51,12001922,2.008779489179369,1.8594267642584574
SBC-5,969516,3.68635139774897,1.8594267642584574
KMRC-1,alisertib-navitoclax (2-1 mol-mol),1.4545717666785216,1.8594267642584574
CA46,53495165,-3.0280125025934495,1.8594267642584574
SW1463,60750,0.1610513612263897,1.8594267642584574
FU-OV-1,46215462,1.830231092617303,1.8594267642584574
ONS-76,49793307,-2.5280436252167733,1.8594267642584574
NOMO-1,11404337,-0.1001889231988697,1.8594267642584574
SW1463,123631,0.5150504925697384,1.8594267642584574
A2780,44819697,-3.3662473846109333,1.8594267642584574
A-673,44491742,3.844993574977925,1.8594267642584574
NOMO-1,5280436,3.413613220161409,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],9911463,4.136675560401034,1.8594267642584574
BxPC-3,2858523,2.8297817429760945,1.8594267642584574
A2780,445091,3.798794327077476,1.8594267642584574
OPM-2,11647372,1.2733466761832082,1.8594267642584574
CA46,71751553,4.222934016329145,1.8594267642584574
G-401,44486219,4.1772416968228505,1.8594267642584574
NCI-H522,9826308,0.3930789830124517,1.8594267642584574
CAL-51,5566,3.271951139375183,1.8594267642584574
G-401,89183176,4.003742825914683,1.8594267642584574
NOMO-1,12003241,-0.5951695723430065,1.8594267642584574
MDA-MB-157,2708,2.34132544783096,1.8594267642584574
YAPC,10410894,3.466680540940763,1.8594267642584574
HCC1143,65064,3.71051637258464,1.8594267642584574
EFO-27,2746,3.149760082978987,1.8594267642584574
LoVo,216468,2.992200557668688,1.8594267642584574
DMS 273,3025944,4.590997145359233,1.8594267642584574
NCI-H661,15983966,-5.492856258402122,1.8594267642584574
BxPC-3,selumetinib-tretinoin (2-1 mol-mol),-1.7965498046170116,1.8594267642584574
CAL-51,2708,4.939881356462198,1.8594267642584574
HCC1143,11175137,3.393081010308343,1.8594267642584574
CA46,42611257,2.680269393096826,1.8594267642584574
ONS-76,68056272,2.9147642388168675,1.8594267642584574
Panc 04.03,2871966,2.8539977368648275,1.8594267642584574
CAL-51,25062766,1.9168321284868295,1.8594267642584574
FU-OV-1,52912189,0.1271866873311006,1.8594267642584574
EFO-27,73707371,4.965139584704115,1.8594267642584574
SNU-449,24951314,2.758293516562198,1.8594267642584574
NCI-H522,sirolimus-bortezomib (250-1 mol-mol),0.2435604528916691,1.8594267642584574
A4/Fukuda,135999136,4.178898868342667,1.8594267642584574
Panc 04.03,sirolimus-bortezomib (250-1 mol-mol),1.3597378595777716,1.8594267642584574
HSC-4,119182,0.0150561689419209,1.8594267642584574
LXF 289,68056272,4.660756431297166,1.8594267642584574
LoVo,selumetinib-navitoclax (8-1 mol-mol),1.0965034655670265,1.8594267642584574
SNU-61,31703,0.3335579072308824,1.8594267642584574
SCC-9,9915743,1.0040050158500469,1.8594267642584574
NCI-H460,446155,3.79922347841428,1.8594267642584574
MSTO-211H,51037431,1.7350128995421004,1.8594267642584574
OPM-2,73707438,4.146852269482474,1.8594267642584574
MDA-MB-453,9926054,1.6596725660557576,1.8594267642584574
FU-OV-1,selumetinib-decitabine (4-1 mol-mol),7.280025082931535,1.8594267642584574
MDA-MB-157,126941,-4.13859012935224,1.8594267642584574
NCI-H522,doxorubicin-navitoclax (2-1 mol-mol),-0.6296252861358815,1.8594267642584574
MDA-MB-453,24785538,3.5897722779252383,1.8594267642584574
JM-1,24978538,0.0218307924501431,1.8594267642584574
SCC-9,selumetinib-BRD-A02303741 (4-1 mol-mol),5.354085868822434,1.8594267642584574
DMS 273,3503,1.4004718919159695,1.8594267642584574
NCI-H460,JQ-1-vorinostat (2-1 mol-mol),2.751902354538612,1.8594267642584574
NCI-H2009,9926054,2.181635437582939,1.8594267642584574
KYSE-70,23725625,6.518030965677853,1.8594267642584574
CA46,2729026,2.6315261399645755,1.8594267642584574
OPM-2,135398516,1.2750707316498222,1.8594267642584574
SNU-449,42642645,1.3579889941817174,1.8594267642584574
HCC1143,25126798,4.15297730422149,1.8594267642584574
KMRC-1,9933475,1.7755712843428362,1.8594267642584574
G-401,12003241,-2.103305079214356,1.8594267642584574
A-498,5113032,5.384850868352965,1.8594267642584574
NCI-H2009,6918736,-2.2815319513344896,1.8594267642584574
NCI-H292,11455910,1.285235050416197,1.8594267642584574
NOMO-1,24889392,4.281820029392572,1.8594267642584574
HSC-4,4259181,1.301377168384764,1.8594267642584574
NCI-H2171,73707371,5.940029655461802,1.8594267642584574
A-498,5329102,2.2449182254359843,1.8594267642584574
JM-1,51037431,4.238886241129638,1.8594267642584574
A-673,56973724,1.675633920325915,1.8594267642584574
MDA-MB-157,BRD9876-MK-1775 (4-1 mol-mol),0.1874852527806031,1.8594267642584574
MDA-MB-157,136227331,3.870321503168366,1.8594267642584574
A-673,navitoclax-gemcitabine (1-1 mol-mol),-4.77481524796036,1.8594267642584574
KYSE-70,selumetinib-JQ-1 (4-1 mol-mol),2.626623407119128,1.8594267642584574
OPM-2,7326481,2.643641332780412,1.8594267642584574
NCI-H146,135423438,2.8528911509997137,1.8594267642584574
BT-549,36314,1.6954100357352504,1.8594267642584574
A2780,11717001,3.193837101204412,1.8594267642584574
NCI-H2171,136227924,2.167829841056951,1.8594267642584574
NCI-H292,selumetinib-navitoclax (8-1 mol-mol),1.0361315723218127,1.8594267642584574
NCI-H460,11152667,1.2005763717636435,1.8594267642584574
JM-1,462382,-0.3688196944858197,1.8594267642584574
SNU-61,262093,2.836545473910542,1.8594267642584574
FU-OV-1,10385095,1.480245925499038,1.8594267642584574
SCC-9,72193861,2.3270498811162508,1.8594267642584574
NCI-H661,1242560,4.217168015363727,1.8594267642584574
CAL-51,984333,0.1261860025273146,1.8594267642584574
NCI-H522,navitoclax-pluripotin (1-1 mol-mol),-0.4896519907045426,1.8594267642584574
MDA-MB-157,SNX-2112-bortezomib (250-1 mol-mol),-2.8250293733048615,1.8594267642584574
BT-549,374536,3.1184462544943363,1.8594267642584574
NCI-H1623,11640390,0.1271923003977441,1.8594267642584574
HSC-4,387447,-4.060952426407354,1.8594267642584574
MDA-MB-157,5311037,2.9595373739718087,1.8594267642584574
MDA-MB-453,navitoclax-sorafenib (1-1 mol-mol),1.523284542572191,1.8594267642584574
YAPC,3543504,4.3832051547821855,1.8594267642584574
SNU-449,tanespimycin-gemcitabine (1-1 mol-mol),2.625273627898756,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11222830,1.840895437487006,1.8594267642584574
NCI-H1623,9866186,-0.0100221274837169,1.8594267642584574
SNU-449,4788,5.842775682236554,1.8594267642584574
Panc 04.03,5287620,-2.39349186702993,1.8594267642584574
MDA-MB-157,11717001,3.389932991765854,1.8594267642584574
NCI-H2009,216468,1.7077485468094884,1.8594267642584574
HSC-4,24821094,3.2038955653523713,1.8594267642584574
A-673,4578,4.214026417190043,1.8594267642584574
KMRC-1,135875424,5.075329697898493,1.8594267642584574
G-401,11612883,1.6387860096052431,1.8594267642584574
HSC-4,156422,5.249929789072156,1.8594267642584574
NCI-H522,2742550,2.7952007563166203,1.8594267642584574
NCI-H522,400769,-0.9806645547005408,1.8594267642584574
NCI-H2009,selumetinib-PLX-4032 (8-1 mol-mol),-1.4525193887521055,1.8594267642584574
NCI-H661,46199207,2.8133245189521054,1.8594267642584574
A2780,10184653,1.3482388837291208,1.8594267642584574
SCC-9,24856436,1.519847806890015,1.8594267642584574
NCI-H460,2729026,3.0609463870825926,1.8594267642584574
LXF 289,11222830,2.2114905387790755,1.8594267642584574
KMRC-1,46215462,1.6205494448376236,1.8594267642584574
SCC-9,tanespimycin-gemcitabine (1-1 mol-mol),-0.581626900680549,1.8594267642584574
OPM-2,421610,2.2409150931042072,1.8594267642584574
KMRC-1,serdemetan-SCH-529074 (1-1 mol-mol),2.70640431324625,1.8594267642584574
CAL-51,119607,5.291790266428237,1.8594267642584574
CAL-51,24753719,3.9981702522006257,1.8594267642584574
KMRC-1,25154868,5.3943697684741805,1.8594267642584574
Panc 04.03,89928392,1.6805018731496522,1.8594267642584574
SNU-61,25126798,4.129245799651812,1.8594267642584574
NCI-H522,UNC0638-navitoclax (1-1 mol-mol),4.115450321285854,1.8594267642584574
HSC-4,11977753,4.574500022269399,1.8594267642584574
NCI-H727,4477,0.5438785176620984,1.8594267642584574
CA46,5335621,3.676802077981384,1.8594267642584574
JM-1,322968,1.8634300837521185,1.8594267642584574
CAL-51,46907787,3.297361866649883,1.8594267642584574
OVISE,doxorubicin-navitoclax (2-1 mol-mol),-1.2556065332393784,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],71680916,4.48717515696629,1.8594267642584574
NCI-H522,53495165,-1.820766752755188,1.8594267642584574
MSTO-211H,11626560,1.3885064506517848,1.8594267642584574
SBC-5,262093,2.1741934315953726,1.8594267642584574
MSTO-211H,52912189,3.1066961080068123,1.8594267642584574
HSC-4,568763,1.3764913265299208,1.8594267642584574
LoVo,sirolimus-bortezomib (250-1 mol-mol),0.1095810263563626,1.8594267642584574
DMS 273,25195348,3.734209419300899,1.8594267642584574
Panc 04.03,5951923,4.37213064077745,1.8594267642584574
FU-OV-1,439501,-0.5556149973103641,1.8594267642584574
A2780,BRD-A02303741-navitoclax (2-1 mol-mol),1.977156193717172,1.8594267642584574
LXF 289,168313047,4.113002678801054,1.8594267642584574
SCC-9,67291369,5.015060977849177,1.8594267642584574
OPM-2,5351362,0.2459388559982981,1.8594267642584574
FTC-133,11485656,4.087051585535102,1.8594267642584574
HSC-4,46843906,4.814917111969106,1.8594267642584574
CA46,51039095,1.651262767418978,1.8594267642584574
NCI-H522,2945648,3.0823392214986343,1.8594267642584574
MDA-MB-453,selumetinib-piperlongumine (8-1 mol-mol),3.1080333616625713,1.8594267642584574
YAPC,9911463,3.901904463732921,1.8594267642584574
DMS 273,11977753,-2.475673354763999,1.8594267642584574
SNU-449,46191454,5.774811831739998,1.8594267642584574
NCI-H661,25062766,2.1967321973268294,1.8594267642584574
A-498,53301938,4.241910990361246,1.8594267642584574
Panc 04.03,10302451,3.874200048588579,1.8594267642584574
A-673,16065773,1.4559751864460968,1.8594267642584574
NCI-H1623,135398516,1.607867961646436,1.8594267642584574
FTC-133,60700,-2.7194012548196,1.8594267642584574
NCI-H661,3384730,1.2254103498827775,1.8594267642584574
SCC-9,168313200,4.072126418899639,1.8594267642584574
OPM-2,25150857,1.3601106429565517,1.8594267642584574
NCI-H292,3385,4.509781783210997,1.8594267642584574
NOMO-1,227681,3.177880686522457,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.9740491797534947,1.8594267642584574
OPM-2,46191454,-0.9534482392265864,1.8594267642584574
NCI-H522,3081361,1.6470006965888542,1.8594267642584574
CA46,374536,0.6029387131655304,1.8594267642584574
SCC-9,selumetinib-UNC0638 (4-1 mol-mol),3.717663096766538,1.8594267642584574
DMS 273,4705,3.496116762813734,1.8594267642584574
A4/Fukuda,17755052,-0.6813796549781841,1.8594267642584574
SNU-81,24180125,-1.7131691030529954,1.8594267642584574
Panc 04.03,969516,3.706271998961216,1.8594267642584574
CAL-51,15547703,3.503799403292956,1.8594267642584574
NCI-H460,24951314,1.96669984187411,1.8594267642584574
SBC-5,446155,1.3486611419477716,1.8594267642584574
Panc 04.03,6184667,3.768891848670565,1.8594267642584574
MDA-MB-157,4096211,2.1957324566584715,1.8594267642584574
CAL-51,15983966,-4.387912760170627,1.8594267642584574
NCI-H2171,49793307,-5.547674326636965,1.8594267642584574
MDA-MB-453,31703,-1.1483878700266144,1.8594267642584574
KMRC-1,24785538,2.687509195601708,1.8594267642584574
SNU-61,JQ-1-carboplatin (1-1 mol-mol),3.4608261029865615,1.8594267642584574
FU-OV-1,54618164,4.603510021761196,1.8594267642584574
YAPC,5287620,-1.8729921135671632,1.8594267642584574
NCI-H661,16065773,2.6852778174065435,1.8594267642584574
CA46,5329102,1.3169898780971163,1.8594267642584574
OVISE,66577038,3.7859124338920065,1.8594267642584574
LOU-NH91,57519531,4.764819520424852,1.8594267642584574
LOU-NH91,448949,2.461672905148464,1.8594267642584574
LXF 289,10427712,4.0701965709145504,1.8594267642584574
CAL-51,9915743,1.1260994347217144,1.8594267642584574
NCI-H2009,11609586,4.059888202416809,1.8594267642584574
SBC-5,60700,-1.8327808511007615,1.8594267642584574
NCI-H2009,SNX-2112-bortezomib (250-1 mol-mol),-2.754596306388576,1.8594267642584574
OVISE,24951314,2.5954730551837386,1.8594267642584574
KMRC-1,66577038,2.9827052655036206,1.8594267642584574
LXF 289,36314,1.2391029615263165,1.8594267642584574
NCI-H292,44607531,0.4181911293940362,1.8594267642584574
KYSE-70,219104,3.9271840577372705,1.8594267642584574
NCI-H460,71304818,2.359856693071434,1.8594267642584574
SNU-81,4477,1.0310003158688126,1.8594267642584574
A2780,1716436,1.933630716197044,1.8594267642584574
LOU-NH91,11964036,1.2476019563081622,1.8594267642584574
SBC-5,9936388,-5.234314033557506,1.8594267642584574
KMRC-1,24964624,2.351358467802262,1.8594267642584574
MSTO-211H,73707438,4.334782721865043,1.8594267642584574
MDA-MB-453,73707438,3.778137609083601,1.8594267642584574
EFO-27,49793307,-1.9052761294403429,1.8594267642584574
G-401,71680916,4.434691555895244,1.8594267642584574
MSTO-211H,3634881,2.531877742135044,1.8594267642584574
NCI-H292,42642645,0.8145779285410705,1.8594267642584574
OPM-2,168313200,1.8002020874491595,1.8594267642584574
NCI-H2009,53232,2.115043522086945,1.8594267642584574
SNU-449,9825149,2.659052538489635,1.8594267642584574
CAL-51,25105715,4.077363851334658,1.8594267642584574
MDA-MB-157,53232,1.9030895496471385,1.8594267642584574
NCI-H727,2708,6.607150814967448,1.8594267642584574
A-673,carboplatin-etoposide (40-17 mol-mol),0.9497431982903584,1.8594267642584574
NCI-H1623,44632017,1.5464636141196502,1.8594267642584574
SCC-9,sirolimus-bortezomib (250-1 mol-mol),0.9662100185478,1.8594267642584574
FTC-133,selumetinib-tretinoin (2-1 mol-mol),5.415389433541197,1.8594267642584574
SCC-9,3689413,-0.5284639903905319,1.8594267642584574
NCI-H460,23725625,5.666756485817308,1.8594267642584574
NCI-H460,100016,5.855223104671776,1.8594267642584574
NCI-H2009,24771867,-1.6305331500245923,1.8594267642584574
SBC-5,9952709,3.0525329755213466,1.8594267642584574
SNU-449,5566,3.0151612646695822,1.8594267642584574
NOMO-1,9926054,1.6113291347040215,1.8594267642584574
EFO-27,11404337,1.0583908830182924,1.8594267642584574
A2780,54626689,3.943205764450006,1.8594267642584574
A4/Fukuda,168313200,2.9572494196719723,1.8594267642584574
LoVo,5460769,-2.1468642890382412,1.8594267642584574
NCI-H661,25102847,2.378632231655901,1.8594267642584574
A4/Fukuda,9866186,-0.2462641713744652,1.8594267642584574
MSTO-211H,selumetinib-piperlongumine (8-1 mol-mol),2.1949656994292455,1.8594267642584574
KYSE-70,36314,1.2189527676950276,1.8594267642584574
BT-549,2828334,6.061535937537666,1.8594267642584574
NOMO-1,25262965,-2.043358942198166,1.8594267642584574
LXF 289,25195348,5.284501520866742,1.8594267642584574
CA46,451668,2.285623139838705,1.8594267642584574
SNU-61,24856436,-0.371488374536367,1.8594267642584574
NCI-H460,crizotinib-PLX-4032 (2-1 mol-mol),2.8016371489501593,1.8594267642584574
SCC-9,44137675,3.491154886377157,1.8594267642584574
BT-549,151289,0.9825598768305964,1.8594267642584574
JM-1,49836020,4.6064946369246025,1.8594267642584574
YAPC,54618771,0.5686030675412354,1.8594267642584574
SCC-9,24772860,-2.0717241396099473,1.8594267642584574
A-673,10385095,1.0544598585596625,1.8594267642584574
SNU-449,216468,4.54901774756382,1.8594267642584574
SNU-61,67291369,4.2845115751683736,1.8594267642584574
FU-OV-1,5291,4.051520848138153,1.8594267642584574
LoVo,12001922,1.64420677630862,1.8594267642584574
NCI-H661,3815108,3.885074716587427,1.8594267642584574
JM-1,374536,-1.2279479926310035,1.8594267642584574
LoVo,tretinoin-carboplatin (2-1 mol-mol),5.63935886980119,1.8594267642584574
NOMO-1,4788,5.067002306940809,1.8594267642584574
SNU-61,24748573,1.6967337473161408,1.8594267642584574
BxPC-3,16720766,0.4925277259578197,1.8594267642584574
EFO-27,46215462,2.714023108610326,1.8594267642584574
SNU-61,selumetinib-JQ-1 (4-1 mol-mol),-2.0822040932557564,1.8594267642584574
SCC-9,31703,-1.2436349312067534,1.8594267642584574
A2780,5335621,4.014990109441054,1.8594267642584574
EFO-27,4917,3.7917867214450096,1.8594267642584574
A2780,9926054,1.5482217772077662,1.8594267642584574
A4/Fukuda,3689413,-1.7998697854540155,1.8594267642584574
OPM-2,6610216,3.8953919440086575,1.8594267642584574
NCI-H522,6918328,0.2751454024017333,1.8594267642584574
LoVo,60750,-4.161283305326802,1.8594267642584574
LXF 289,15547703,4.3915240757493565,1.8594267642584574
HSC-4,55283,3.529343210540244,1.8594267642584574
MDA-MB-453,6436223,-6.0469700747965325,1.8594267642584574
OVISE,54619267,4.300185321056238,1.8594267642584574
CA46,12001922,1.4868064190708767,1.8594267642584574
SNU-61,53392493,2.2959575452819543,1.8594267642584574
CA46,alisertib-navitoclax (2-1 mol-mol),-0.3203128616100632,1.8594267642584574
G-401,44137675,2.141460704144857,1.8594267642584574
NOMO-1,9825149,1.4944850939332062,1.8594267642584574
CAL-51,4788,6.061217822513647,1.8594267642584574
HSC-4,119607,3.948608575005578,1.8594267642584574
NOMO-1,ISOX-bortezomib (250-1 mol-mol),0.07871384473645,1.8594267642584574
LXF 289,4477,1.125394938272502,1.8594267642584574
JM-1,11657048,4.676495506604394,1.8594267642584574
G-401,10302451,3.1015289114526774,1.8594267642584574
HCC1143,31703,-0.2055424786168501,1.8594267642584574
HCC1143,374536,1.384467639208202,1.8594267642584574
Panc 04.03,10184653,2.983159460505767,1.8594267642584574
NCI-H2009,crizotinib-PLX-4032 (2-1 mol-mol),1.3104929839779844,1.8594267642584574
MDA-MB-453,9915743,0.2126089191242519,1.8594267642584574
HCC1143,4477,1.746819852748151,1.8594267642584574
LoVo,44486219,3.9526381308541025,1.8594267642584574
ONS-76,135875424,3.856833286433643,1.8594267642584574
SCC-9,24797083,1.144476664186746,1.8594267642584574
OPM-2,4096211,1.0315429789467454,1.8594267642584574
OPM-2,selumetinib-piperlongumine (8-1 mol-mol),2.005304394078306,1.8594267642584574
SNU-81,25262965,-1.8265758424412304,1.8594267642584574
KYSE-70,44137675,3.4677446622108925,1.8594267642584574
NCI-H1623,3854666,1.505587442259218,1.8594267642584574
HSC-4,10385095,0.4573663196580717,1.8594267642584574
EFO-27,107985,-2.474640150808475,1.8594267642584574
NCI-H2009,6610216,3.953101400309774,1.8594267642584574
SNU-61,135421197,1.1046098427392648,1.8594267642584574
HCC1143,4259181,-0.4991941409006941,1.8594267642584574
BxPC-3,16038120,0.5924635925282854,1.8594267642584574
NCI-H661,135875424,2.4725937826628006,1.8594267642584574
SCC-9,9866186,1.319539660579235,1.8594267642584574
LXF 289,24964624,1.3940062455599875,1.8594267642584574
HCC1143,vorinostat-navitoclax (4-1 mol-mol),1.2828606463085703,1.8594267642584574
HCC1143,6610216,3.638345017281011,1.8594267642584574
G-401,2949965,1.5385484234582818,1.8594267642584574
BxPC-3,49793307,-3.2953922214008697,1.8594267642584574
A4/Fukuda,5287969,-2.571307610380136,1.8594267642584574
A-673,6184667,1.935989865778159,1.8594267642584574
NCI-H2171,24821094,2.9775477594317743,1.8594267642584574
NCI-H2009,67156097,-1.7347724318553324,1.8594267642584574
A4/Fukuda,409805,3.596796639089143,1.8594267642584574
JM-1,5738263,2.278112606764228,1.8594267642584574
SBC-5,2828334,5.980106592077389,1.8594267642584574
BxPC-3,107985,-2.51349631829315,1.8594267642584574
G-401,11427553,1.555705840809683,1.8594267642584574
G-401,10113978,1.710663554595952,1.8594267642584574
NCI-H661,16013152,4.678017706607999,1.8594267642584574
A4/Fukuda,11497983,-1.0595923666648657,1.8594267642584574
NCI-H522,10296883,3.751667506317718,1.8594267642584574
HCC1143,6610355,4.569348514461763,1.8594267642584574
SCC-9,56946209,-4.978704692275232,1.8594267642584574
LOU-NH91,54613361,0.2217026048603205,1.8594267642584574
Panc 04.03,ISOX-bortezomib (250-1 mol-mol),0.266400908707645,1.8594267642584574
G-401,42642645,-0.5846467586678221,1.8594267642584574
SNU-449,selumetinib-GDC-0941 (4-1 mol-mol),2.576796761551289,1.8594267642584574
NCI-H727,5287620,-1.579053209750056,1.8594267642584574
FTC-133,16038120,2.9212616737408896,1.8594267642584574
SCC-9,11626560,2.4253223939520976,1.8594267642584574
Panc 04.03,2742550,4.347188786942969,1.8594267642584574
OPM-2,15547703,2.634316496996711,1.8594267642584574
NCI-H522,10074640,3.1231046963753686,1.8594267642584574
HSC-4,2945648,2.59041604505869,1.8594267642584574
NCI-H661,vorinostat-navitoclax (4-1 mol-mol),1.2789358142207048,1.8594267642584574
MSTO-211H,10127622,2.776094640706434,1.8594267642584574
FTC-133,serdemetan-SCH-529074 (1-1 mol-mol),3.1500157786176777,1.8594267642584574
NCI-H661,2858523,3.1395656938248124,1.8594267642584574
A-673,56946209,-5.889509916794497,1.8594267642584574
CAL-51,44185566,1.8630594392382311,1.8594267642584574
YAPC,51039095,2.046611375354791,1.8594267642584574
OPM-2,4261,-0.9911458583810344,1.8594267642584574
BT-549,969516,2.601131538014171,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],tretinoin-navitoclax (4-1 mol-mol),-2.5028847208859637,1.8594267642584574
A-498,55508,4.21947279006693,1.8594267642584574
SNU-449,71466380,4.63195087543953,1.8594267642584574
MSTO-211H,selumetinib-BRD-A02303741 (4-1 mol-mol),2.4025987585573363,1.8594267642584574
A-673,11707110,3.906892758790242,1.8594267642584574
NCI-H460,54649381,4.173104904963283,1.8594267642584574
KYSE-70,5282054,4.279196842795529,1.8594267642584574
G-401,119607,4.5837417334889885,1.8594267642584574
YAPC,24856436,1.898811352025064,1.8594267642584574
CAL-51,5460769,1.3780575552768597,1.8594267642584574
NOMO-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0823481762060787,1.8594267642584574
CA46,400769,-1.5476292313826252,1.8594267642584574
SNU-449,19582717,4.423938746946012,1.8594267642584574
KMRC-1,46191454,1.86757619496812,1.8594267642584574
MDA-MB-453,45279963,3.011106079512325,1.8594267642584574
BT-549,25150857,2.011062957026122,1.8594267642584574
BxPC-3,navitoclax-pluripotin (1-1 mol-mol),-1.3920803089523777,1.8594267642584574
NCI-H2009,135999136,4.285465393980956,1.8594267642584574
LXF 289,984333,0.880488465949386,1.8594267642584574
NCI-H146,11238147,0.964491846183422,1.8594267642584574
Panc 04.03,5287969,-1.8253556910298991,1.8594267642584574
NCI-H292,654092,0.1209701484650686,1.8594267642584574
MDA-MB-453,9927531,3.885109165752666,1.8594267642584574
NCI-H522,44819697,-2.38793523497331,1.8594267642584574
LOU-NH91,11364421,-1.522672653311712,1.8594267642584574
NOMO-1,4477,1.0767445259598296,1.8594267642584574
LoVo,148198,-1.1147075342847712,1.8594267642584574
SBC-5,54619267,3.782844847718682,1.8594267642584574
BxPC-3,vorinostat-carboplatin (1-1 mol-mol),1.8300641490410745,1.8594267642584574
NCI-H2171,46224516,1.006764214935909,1.8594267642584574
SNU-61,55283,2.411692675664504,1.8594267642584574
ONS-76,navitoclax-birinapant (1-1 mol-mol),1.131765862858429,1.8594267642584574
BxPC-3,vorinostat-navitoclax (4-1 mol-mol),1.2956332154746788,1.8594267642584574
G-401,135398738,4.751845538055463,1.8594267642584574
A2780,24889392,2.5877097444926265,1.8594267642584574
CAL-51,3081361,1.780158758130264,1.8594267642584574
MSTO-211H,3025986,-0.6925850648320051,1.8594267642584574
NCI-H1623,10231331,4.737119210946733,1.8594267642584574
LXF 289,60750,-4.482846219959503,1.8594267642584574
JM-1,19582717,1.6871405928140415,1.8594267642584574
MDA-MB-453,24775005,1.4926368241852035,1.8594267642584574
JM-1,10074640,2.5195149680920657,1.8594267642584574
A-673,2749,0.4791921848862392,1.8594267642584574
ONS-76,9911463,3.87028315643254,1.8594267642584574
A2780,3136844,3.626688956130205,1.8594267642584574
LOU-NH91,2945648,3.130856585594597,1.8594267642584574
NCI-H146,52912189,0.5266703058361273,1.8594267642584574
A2780,156422,3.602973007130472,1.8594267642584574
LXF 289,969516,2.6399649875984355,1.8594267642584574
NCI-H146,25154868,-1.0719819424572428,1.8594267642584574
YAPC,1641662,3.645861677961698,1.8594267642584574
LOU-NH91,136227331,3.865245001267085,1.8594267642584574
YAPC,46224516,2.408657893134071,1.8594267642584574
JM-1,46199207,1.915427322474508,1.8594267642584574
G-401,54618164,3.8592700204433807,1.8594267642584574
A-673,53232,1.7702469915903785,1.8594267642584574
SBC-5,6918289,2.991753308414544,1.8594267642584574
MDA-MB-453,selumetinib-MK-2206 (8-1 mol-mol),2.1996282854374303,1.8594267642584574
NCI-H522,24797083,1.396487413816628,1.8594267642584574
YAPC,11238147,2.574935183805209,1.8594267642584574
BT-549,9444,3.939814284899288,1.8594267642584574
NCI-H460,11364421,0.3566052665939138,1.8594267642584574
LXF 289,23582824,0.8647594683412683,1.8594267642584574
FTC-133,89928392,1.8077600838169707,1.8594267642584574
NCI-H661,15547703,3.600649740500543,1.8594267642584574
JM-1,8515,3.19981027650634,1.8594267642584574
LXF 289,25102847,1.656353256373218,1.8594267642584574
NCI-H1623,11626560,2.1087636260711333,1.8594267642584574
NOMO-1,2729026,1.9247353379999697,1.8594267642584574
A2780,carboplatin-etoposide (40-17 mol-mol),-0.855870041276873,1.8594267642584574
OPM-2,60700,-1.448416790812607,1.8594267642584574
NCI-H292,9825149,1.7347241761388297,1.8594267642584574
KMRC-1,6918878,5.2070030404450485,1.8594267642584574
SBC-5,4259181,0.3536055110585087,1.8594267642584574
KMRC-1,71466578,5.804397104747809,1.8594267642584574
JM-1,selumetinib-MK-2206 (8-1 mol-mol),3.384959636780238,1.8594267642584574
SCC-9,54596490,5.620994411748341,1.8594267642584574
MSTO-211H,42642645,-0.4763575861779333,1.8594267642584574
DMS 273,4378219,3.0463884183789336,1.8594267642584574
FTC-133,SNX-2112-bortezomib (250-1 mol-mol),2.186622613691835,1.8594267642584574
MDA-MB-453,11626560,2.2881538301476696,1.8594267642584574
BT-549,46215462,1.7261150757919093,1.8594267642584574
SNU-449,45279963,4.011305658965759,1.8594267642584574
HSC-4,selumetinib-BRD-A02303741 (4-1 mol-mol),4.233119251645935,1.8594267642584574
MSTO-211H,serdemetan-SCH-529074 (1-1 mol-mol),1.7679544322052605,1.8594267642584574
A-673,10302451,3.0176041071951345,1.8594267642584574
CAL-51,5280436,3.749440064194485,1.8594267642584574
OPM-2,23582824,0.3145394278485406,1.8594267642584574
JM-1,5287620,-0.1298713463901946,1.8594267642584574
MDA-MB-157,3503,1.1658051797362206,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],9926054,2.0094388483046757,1.8594267642584574
SNU-61,16741245,4.568608723382813,1.8594267642584574
SNU-449,54626689,4.585589968636992,1.8594267642584574
G-401,49867930,6.047675909857249,1.8594267642584574
HCC1143,46199207,3.122692827276537,1.8594267642584574
OPM-2,445643,3.4082912819673536,1.8594267642584574
DMS 273,54618771,0.8675837195237585,1.8594267642584574
NCI-H1623,71304818,2.8160491805212615,1.8594267642584574
MDA-MB-157,16659841,3.727147143419768,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],44566777,1.6377443255416146,1.8594267642584574
MDA-MB-453,1750826,0.6003684780059517,1.8594267642584574
NCI-H1623,5281321,-0.5392861044239732,1.8594267642584574
MDA-MB-453,613753,2.5060803116052357,1.8594267642584574
MDA-MB-453,2871966,-0.7610622755396385,1.8594267642584574
MSTO-211H,5281321,-2.386258436411726,1.8594267642584574
KMRC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.854846859119752,1.8594267642584574
FU-OV-1,44137675,3.1043101525841377,1.8594267642584574
NCI-H2171,285033,-3.2427052076981693,1.8594267642584574
FTC-133,alisertib-navitoclax (2-1 mol-mol),-1.780189218062184,1.8594267642584574
NCI-H727,5311,2.2708816030438816,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],6505803,-0.0377469333531859,1.8594267642584574
A2780,5746,0.8697095475366516,1.8594267642584574
NCI-H2171,53232,2.7429596689347875,1.8594267642584574
EFO-27,5291,4.106816055599409,1.8594267642584574
MDA-MB-453,9933475,1.6213532539721074,1.8594267642584574
OPM-2,5281321,-3.721370442971226,1.8594267642584574
SBC-5,25183872,-1.21590268467039,1.8594267642584574
SBC-5,452548,-1.978558467437607,1.8594267642584574
NCI-H522,5351362,1.1598735323390523,1.8594267642584574
MSTO-211H,3552672,1.7334798735784387,1.8594267642584574
A2780,10427712,3.0744297357135557,1.8594267642584574
LOU-NH91,409805,5.248055334811583,1.8594267642584574
JM-1,5460769,0.6255065324989537,1.8594267642584574
NCI-H292,9967941,4.033073764451828,1.8594267642584574
NCI-H727,16038120,-0.1646423801756905,1.8594267642584574
NCI-H460,16038120,2.547350732010626,1.8594267642584574
LXF 289,241158,4.717778097263283,1.8594267642584574
OPM-2,46398810,1.9487214127979129,1.8594267642584574
A2780,selumetinib-JQ-1 (4-1 mol-mol),-1.37978583005038,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],135440466,3.6704227989419738,1.8594267642584574
CAL-51,9884685,-0.2528326244590672,1.8594267642584574
LoVo,44607531,1.302221694572025,1.8594267642584574
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434,1.8594267642584574
MSTO-211H,56963564,1.234327129960966,1.8594267642584574
MDA-MB-453,73707398,1.1537227860078607,1.8594267642584574
BxPC-3,5329102,1.9407746673909456,1.8594267642584574
HSC-4,5287620,-1.917371788332746,1.8594267642584574
FTC-133,11152667,-0.4786534736280033,1.8594267642584574
NCI-H146,9935249,1.0600603569941576,1.8594267642584574
YAPC,2729026,2.7496252904978293,1.8594267642584574
SNU-449,71751553,4.402646349497825,1.8594267642584574
HCC1143,9926054,1.808099247882512,1.8594267642584574
Panc 04.03,448949,2.534760210414342,1.8594267642584574
NCI-H661,5566,3.151274839096282,1.8594267642584574
FTC-133,6610355,5.440540243356366,1.8594267642584574
JM-1,16741245,4.187666128361383,1.8594267642584574
SBC-5,navitoclax-birinapant (1-1 mol-mol),2.2573957245834246,1.8594267642584574
LXF 289,107970,2.2922723928752307,1.8594267642584574
Panc 04.03,54626689,4.659724899973851,1.8594267642584574
MSTO-211H,16736978,0.1439838744803616,1.8594267642584574
MDA-MB-453,151289,1.613318506724072,1.8594267642584574
CAL-51,carboplatin-etoposide (40-17 mol-mol),1.6376184164581593,1.8594267642584574
CA46,6918638,-2.155597959241919,1.8594267642584574
ONS-76,selumetinib-UNC0638 (4-1 mol-mol),0.4414887098860544,1.8594267642584574
A4/Fukuda,53495165,-3.058270414187161,1.8594267642584574
DMS 273,135984461,4.327877942465965,1.8594267642584574
OPM-2,89928392,0.3187576395153793,1.8594267642584574
NCI-H1623,10385095,1.1256497169747182,1.8594267642584574
ONS-76,11717001,3.327449083785458,1.8594267642584574
LoVo,6610216,4.332472846182503,1.8594267642584574
NCI-H292,16722836,1.3558361632896196,1.8594267642584574
MSTO-211H,135440466,1.110539790918092,1.8594267642584574
BxPC-3,9868037,2.7194108471732243,1.8594267642584574
CA46,2874250,4.668483912698598,1.8594267642584574
MSTO-211H,11238147,2.1702387480753393,1.8594267642584574
JM-1,44607530,1.0639194271383936,1.8594267642584574
NCI-H460,navitoclax-sorafenib (1-1 mol-mol),2.697352012962362,1.8594267642584574
ONS-76,2749,5.1102698724547375,1.8594267642584574
CAL-51,36462,0.7338920585832341,1.8594267642584574
CAL-51,6610216,4.7761200098267365,1.8594267642584574
KYSE-70,3062316,0.8461927752800795,1.8594267642584574
LOU-NH91,285033,0.7293222441785373,1.8594267642584574
A2780,11485656,1.5628347007454235,1.8594267642584574
A-673,26596,-3.820628112159822,1.8594267642584574
KYSE-70,44632017,1.4611535882953923,1.8594267642584574
NCI-H2171,702558,3.801125308495619,1.8594267642584574
MSTO-211H,23635314,-1.96294908215212,1.8594267642584574
SNU-81,5746,1.2061469752663514,1.8594267642584574
KMRC-1,4788,5.9167994505540475,1.8594267642584574
CAL-51,15983966,-4.387912760170627,1.8594267642584574
CA46,49867930,4.292641096024632,1.8594267642584574
HSC-4,11455910,0.337268703123225,1.8594267642584574
YAPC,5281672,4.680001258160183,1.8594267642584574
SBC-5,5978,-3.632907311761228,1.8594267642584574
NCI-H460,3825829,4.446795399525052,1.8594267642584574
MDA-MB-157,9444,2.0478202605503206,1.8594267642584574
OPM-2,UNC0638-navitoclax (1-1 mol-mol),2.0554805477116207,1.8594267642584574
SBC-5,46191454,2.9096163569547,1.8594267642584574
CA46,644241,2.374325583681648,1.8594267642584574
EFO-27,erlotinib-PLX-4032 (2-1 mol-mol),3.67875442693599,1.8594267642584574
FTC-133,252682,6.679184103041344,1.8594267642584574
SCC-9,56649450,2.7319907342568275,1.8594267642584574
CA46,5311,-0.1889513685103653,1.8594267642584574
OVISE,9967941,3.747669270164806,1.8594267642584574
KMRC-1,5328940,2.3844062156656256,1.8594267642584574
NCI-H146,9825149,1.1795040286889695,1.8594267642584574
SNU-81,445091,-0.9408785363266468,1.8594267642584574
FU-OV-1,6610216,4.742914927321441,1.8594267642584574
A2780,56949517,4.37203598237815,1.8594267642584574
EFO-27,119607,5.664089470896734,1.8594267642584574
ONS-76,57519531,2.0495811593793105,1.8594267642584574
MDA-MB-157,42642645,0.4106458170856017,1.8594267642584574
CA46,135421197,1.13174100448049,1.8594267642584574
LOU-NH91,11719255,2.9529273796726394,1.8594267642584574
A-673,9967941,2.0264988474191377,1.8594267642584574
A-673,23582824,0.2073680927392712,1.8594267642584574
CAL-51,374536,3.1977545561189347,1.8594267642584574
SNU-449,5311,2.373513113952619,1.8594267642584574
SCC-9,11178236,-3.8920346249942264,1.8594267642584574
SNU-61,71680916,4.248107596602719,1.8594267642584574
BT-549,4578,4.840393866327907,1.8594267642584574
JM-1,56973724,1.572059771180543,1.8594267642584574
BT-549,6184667,4.320802676068414,1.8594267642584574
OPM-2,6918878,0.2719026340750923,1.8594267642584574
HSC-4,9967941,3.0274642479334215,1.8594267642584574
G-401,6610355,3.5029306645068696,1.8594267642584574
Panc 04.03,1750826,0.308709425359425,1.8594267642584574
KYSE-70,6610355,4.961596413135767,1.8594267642584574
A-673,24775005,3.310963685757038,1.8594267642584574
SNU-81,208908,2.232815974371363,1.8594267642584574
LXF 289,ISOX-bortezomib (250-1 mol-mol),0.4085036355152772,1.8594267642584574
NCI-H727,3543504,4.299187359877464,1.8594267642584574
SCC-9,11152667,-0.1233430086603879,1.8594267642584574
A2780,208908,2.5004436475537974,1.8594267642584574
SBC-5,tanespimycin-bortezomib (250-1 mol-mol),1.6745298572430678,1.8594267642584574
A4/Fukuda,44607531,1.1783204907000706,1.8594267642584574
ONS-76,54649381,4.0197495944656465,1.8594267642584574
A4/Fukuda,31703,-2.1013190360416147,1.8594267642584574
EFO-27,46398810,2.9967281863964867,1.8594267642584574
JM-1,119182,-5.01139227406357,1.8594267642584574
NCI-H2171,25183872,-2.065345244597309,1.8594267642584574
SCC-9,53392493,3.3396857977581917,1.8594267642584574
ONS-76,44259,0.6373390659589321,1.8594267642584574
NCI-H661,72376,-3.040643961037913,1.8594267642584574
KYSE-70,11609586,2.827625452517046,1.8594267642584574
NCI-H727,3025944,4.64192894764355,1.8594267642584574
NCI-H460,262093,3.3627537421549314,1.8594267642584574
MDA-MB-157,tretinoin-navitoclax (4-1 mol-mol),4.215736518135254,1.8594267642584574
NCI-H292,11396600,3.7365966834404225,1.8594267642584574
OPM-2,11626560,0.8852338363333486,1.8594267642584574
MDA-MB-453,24772860,-3.354356853525474,1.8594267642584574
BxPC-3,168312962,2.7485538585474547,1.8594267642584574
KMRC-1,46199207,3.449143967158838,1.8594267642584574
MDA-MB-157,2729026,3.2437974205657816,1.8594267642584574
LoVo,4259181,0.2045859597859785,1.8594267642584574
KYSE-70,5329102,1.9375891375175784,1.8594267642584574
EFO-27,3025944,4.337116030950391,1.8594267642584574
EFO-27,2742550,4.50908635993052,1.8594267642584574
A2780,6610216,3.3472253004646593,1.8594267642584574
LOU-NH91,docetaxel-tanespimycin (2-1 mol-mol),-3.5084138300894625,1.8594267642584574
EFO-27,24856436,4.205894943099943,1.8594267642584574
Panc 04.03,9444,4.565679465533194,1.8594267642584574
ONS-76,72193861,2.0006819721723197,1.8594267642584574
MSTO-211H,445643,1.8400808237063873,1.8594267642584574
CAL-51,8515,3.5852991976047863,1.8594267642584574
OVISE,25150857,3.4132003431569524,1.8594267642584574
KMRC-1,tanespimycin-gemcitabine (1-1 mol-mol),2.381825597611343,1.8594267642584574
OPM-2,JQ-1-carboplatin (1-1 mol-mol),-2.077921094958442,1.8594267642584574
OVISE,5746,2.6308159153246047,1.8594267642584574
A4/Fukuda,168313016,2.0147776130358253,1.8594267642584574
LOU-NH91,54686904,4.160622905506427,1.8594267642584574
LOU-NH91,8515,5.2113767400480775,1.8594267642584574
NCI-H727,73707398,1.5620380856857303,1.8594267642584574
OPM-2,16722836,0.349034656527362,1.8594267642584574
NCI-H2009,119607,5.663513162505294,1.8594267642584574
G-401,11707110,-1.5866495763270043,1.8594267642584574
SCC-9,439501,-2.6581193485563737,1.8594267642584574
NCI-H2171,4259181,0.2390230285316857,1.8594267642584574
MDA-MB-157,45279963,1.9862312593637983,1.8594267642584574
LXF 289,6610216,3.700752852024682,1.8594267642584574
NCI-H2009,9936388,-6.076047204085024,1.8594267642584574
ONS-76,11612883,3.1090836160489417,1.8594267642584574
SNU-61,969516,2.346236032939849,1.8594267642584574
HCC1143,3025986,-1.3091092061734078,1.8594267642584574
NCI-H146,46398810,1.4219775291726766,1.8594267642584574
HSC-4,BRD-A02303741-navitoclax (2-1 mol-mol),3.4165254570204953,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],5287969,-2.1782985548113336,1.8594267642584574
HSC-4,9887053,4.087399127765092,1.8594267642584574
JM-1,11178236,-8.647638887964375,1.8594267642584574
LOU-NH91,24856436,2.045063798311017,1.8594267642584574
JM-1,4477,0.6485766089343484,1.8594267642584574
MDA-MB-157,31703,-2.5361356877609142,1.8594267642584574
NCI-H1623,carboplatin-UNC0638 (2-1 mol-mol),3.4805064241678627,1.8594267642584574
NCI-H661,54619267,3.8937949591354486,1.8594267642584574
LOU-NH91,sirolimus-bortezomib (250-1 mol-mol),1.6256279429010452,1.8594267642584574
CAL-51,135398516,1.449392214756173,1.8594267642584574
CA46,4917,3.2539126844885757,1.8594267642584574
A-673,4705,3.2416788332737454,1.8594267642584574
CA46,carboplatin-UNC0638 (2-1 mol-mol),3.486985389348746,1.8594267642584574
NCI-H661,107985,-3.0533673433660393,1.8594267642584574
G-401,navitoclax-gemcitabine (1-1 mol-mol),-3.419368467159671,1.8594267642584574
NCI-H727,322968,3.201201930682186,1.8594267642584574
MDA-MB-453,9823820,3.844639760703811,1.8594267642584574
CAL-51,44202524,1.5528850010053556,1.8594267642584574
MDA-MB-157,BRD-A02303741-navitoclax (2-1 mol-mol),-1.256832531766744,1.8594267642584574
NCI-H522,216468,3.814024876197808,1.8594267642584574
MSTO-211H,selumetinib-GDC-0941 (4-1 mol-mol),1.2827616524915244,1.8594267642584574
FTC-133,46191454,4.521976640758756,1.8594267642584574
A-673,tanespimycin-gemcitabine (1-1 mol-mol),-3.600781620367816,1.8594267642584574
NCI-H460,3385,3.2657114863965573,1.8594267642584574
SBC-5,4917,3.6947166304022465,1.8594267642584574
SNU-449,241158,4.010766929552104,1.8594267642584574
SBC-5,676352,1.191452976157089,1.8594267642584574
FU-OV-1,11626560,1.6217924510760422,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],12001922,1.85954377189608,1.8594267642584574
JM-1,23635314,-4.012358401321602,1.8594267642584574
MSTO-211H,24978538,-1.489482683206989,1.8594267642584574
A-673,6438330,1.8412388803722883,1.8594267642584574
LOU-NH91,selumetinib-vorinostat (8-1 mol-mol),2.951111508603088,1.8594267642584574
SNU-449,11719255,4.899085715446655,1.8594267642584574
SBC-5,3025986,0.415316224839701,1.8594267642584574
YAPC,439501,-1.3344819600707327,1.8594267642584574
NCI-H292,25262965,-1.3774761624707286,1.8594267642584574
OVISE,4261,2.633875372862392,1.8594267642584574
SCC-9,24951314,2.365472705935838,1.8594267642584574
CAL-51,57519531,1.893237876741888,1.8594267642584574
SNU-449,4521392,4.287622659497221,1.8594267642584574
SNU-61,136227924,2.341371828887226,1.8594267642584574
HCC1143,24772860,-1.4749293698634824,1.8594267642584574
BT-549,11178236,-2.7962989267365828,1.8594267642584574
G-401,322968,2.2957138552590264,1.8594267642584574
DMS 273,322968,3.714238246037839,1.8594267642584574
NCI-H460,135875424,3.211754300989152,1.8594267642584574
SNU-449,8515,3.796953450261519,1.8594267642584574
EFO-27,3689413,-2.375877948841856,1.8594267642584574
SBC-5,46224516,4.445568719663603,1.8594267642584574
SCC-9,285033,-1.0227924755741569,1.8594267642584574
MDA-MB-157,vorinostat-navitoclax (4-1 mol-mol),-2.302516692171374,1.8594267642584574
YAPC,6610216,4.2275333940091215,1.8594267642584574
DMS 273,26596,-2.1961333269229173,1.8594267642584574
NCI-H460,15953870,5.00315267734786,1.8594267642584574
JM-1,16065773,2.0826903108024646,1.8594267642584574
CA46,5280436,1.6785665289286047,1.8594267642584574
SNU-61,sirolimus-bortezomib (250-1 mol-mol),1.753090501474884,1.8594267642584574
JM-1,navitoclax-piperlongumine (1-1 mol-mol),-0.2702753374722612,1.8594267642584574
NCI-H522,40482356,5.076444098213918,1.8594267642584574
SNU-449,72193861,2.670314458690751,1.8594267642584574
A-673,44185566,1.862123250313604,1.8594267642584574
MSTO-211H,6623618,1.8328237574963773,1.8594267642584574
NCI-H661,9868037,2.6835007144938032,1.8594267642584574
NCI-H522,9903786,3.9217135447784783,1.8594267642584574
A2780,2828334,5.5086207374667175,1.8594267642584574
FTC-133,9887053,4.335569761437092,1.8594267642584574
Panc 04.03,3503,2.292907505320521,1.8594267642584574
A-498,126941,-2.1438583463370495,1.8594267642584574
A-673,sirolimus-bortezomib (250-1 mol-mol),-6.228363606010268,1.8594267642584574
OPM-2,2130404,2.9720984033823896,1.8594267642584574
HCC1143,10427712,3.6655746579836497,1.8594267642584574
EFO-27,148198,-4.612142049540045,1.8594267642584574
MSTO-211H,25195348,2.7607409792089186,1.8594267642584574
NCI-H460,11455910,1.4134750909778395,1.8594267642584574
LOU-NH91,selumetinib-piperlongumine (8-1 mol-mol),4.488619060244233,1.8594267642584574
NCI-H727,11640390,0.8742840152576016,1.8594267642584574
EFO-27,51039095,3.8168650627357903,1.8594267642584574
OPM-2,148198,-4.827513159673032,1.8594267642584574
CAL-51,10113978,3.4506321601115397,1.8594267642584574
NCI-H2009,71304818,2.93523377765095,1.8594267642584574
A4/Fukuda,24772860,-3.4983689572797307,1.8594267642584574
NCI-H460,6918837,-0.9355989207233988,1.8594267642584574
MDA-MB-453,3503,1.4691071846699333,1.8594267642584574
EFO-27,135398516,1.6834680726831996,1.8594267642584574
A2780,19582717,2.5113952618702102,1.8594267642584574
SNU-61,6918289,4.130324820008196,1.8594267642584574
SNU-81,navitoclax-pluripotin (1-1 mol-mol),-1.399520137964588,1.8594267642584574
MDA-MB-157,448949,1.9498713128669924,1.8594267642584574
NCI-H727,675434,4.719754403481023,1.8594267642584574
KMRC-1,11152667,-0.0604913513883814,1.8594267642584574
ONS-76,9926054,2.5108803232151304,1.8594267642584574
G-401,tanespimycin-bortezomib (250-1 mol-mol),-1.7315974865132566,1.8594267642584574
CAL-51,44491742,5.152478206660974,1.8594267642584574
NCI-H1623,5278396,3.5068270087169022,1.8594267642584574
DMS 273,3634881,3.2856933751991844,1.8594267642584574
NCI-H146,23582824,-0.1302486758765051,1.8594267642584574
NCI-H522,salermide-PLX-4032 (12-1 mol-mol),5.39637133830604,1.8594267642584574
A-673,11175137,1.5552265537901524,1.8594267642584574
A-673,4378219,1.9880690032317576,1.8594267642584574
NCI-H661,5460769,1.0320957244219937,1.8594267642584574
NCI-H522,selumetinib-BRD-A02303741 (4-1 mol-mol),6.687730464329683,1.8594267642584574
NCI-H146,2746,0.8652413173737366,1.8594267642584574
NCI-H1623,11955716,5.690110889982477,1.8594267642584574
JM-1,46224516,0.3128269384104456,1.8594267642584574
NCI-H2009,docetaxel-tanespimycin (2-1 mol-mol),-5.612671071914989,1.8594267642584574
A2780,11317348,0.9115498056774632,1.8594267642584574
NCI-H661,9911830,2.711917815790479,1.8594267642584574
CAL-51,44202524,1.5528850010053556,1.8594267642584574
BT-549,4096211,1.216432091282546,1.8594267642584574
FTC-133,6918328,0.7944971797491694,1.8594267642584574
CAL-51,9911830,2.6702149728757343,1.8594267642584574
SCC-9,selumetinib-GDC-0941 (4-1 mol-mol),0.7797361148156482,1.8594267642584574
NCI-H146,BRD-K55473186,3.591565624419444,1.8594267642584574
ONS-76,doxorubicin-navitoclax (2-1 mol-mol),-1.5086467428383314,1.8594267642584574
SNU-81,16720766,0.0913844680975832,1.8594267642584574
LOU-NH91,46215462,2.06389335978863,1.8594267642584574
MDA-MB-453,navitoclax-PLX-4032 (1-1 mol-mol),2.982075726164247,1.8594267642584574
CAL-51,5978,-2.6819752982341463,1.8594267642584574
CAL-51,5278396,3.885366261927898,1.8594267642584574
HSC-4,4477,1.1301199037714704,1.8594267642584574
HSC-4,25195348,4.125902627491381,1.8594267642584574
NCI-H661,227681,4.255095664751994,1.8594267642584574
NCI-H292,24951314,1.8411912809473163,1.8594267642584574
NCI-H522,3543504,4.389197316233122,1.8594267642584574
NCI-H460,452548,0.6919333948360032,1.8594267642584574
SNU-61,25105715,3.603411279706935,1.8594267642584574
NCI-H727,navitoclax-pluripotin (1-1 mol-mol),-0.0549082702470221,1.8594267642584574
SW1463,11175137,3.4916395483032256,1.8594267642584574
SBC-5,6914657,-3.351925471283153,1.8594267642584574
JM-1,65064,5.210865559450395,1.8594267642584574
OPM-2,9967941,3.958466181768741,1.8594267642584574
KMRC-1,969516,2.336566526495707,1.8594267642584574
MSTO-211H,15983966,-3.5322347663594016,1.8594267642584574
OPM-2,9952709,2.422518614873216,1.8594267642584574
NOMO-1,16741245,4.369418152152245,1.8594267642584574
DMS 273,16659841,4.479005871158747,1.8594267642584574
CAL-51,selumetinib-decitabine (4-1 mol-mol),5.605446855061176,1.8594267642584574
JM-1,46398810,2.06860116520361,1.8594267642584574
NCI-H661,12003241,-1.8871798966926587,1.8594267642584574
CA46,docetaxel-tanespimycin (2-1 mol-mol),-7.203765496579748,1.8594267642584574
FU-OV-1,10184653,3.943218547538411,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],25126798,4.131561769072402,1.8594267642584574
OPM-2,156422,3.8836640353636382,1.8594267642584574
BxPC-3,JQ-1-vorinostat (2-1 mol-mol),0.8253599744929256,1.8594267642584574
SNU-449,56649450,3.812927022122559,1.8594267642584574
CAL-51,119607,5.291790266428237,1.8594267642584574
LOU-NH91,selumetinib-UNC0638 (4-1 mol-mol),4.70852852885549,1.8594267642584574
BT-549,148124,3.591112191677911,1.8594267642584574
A2780,216468,0.3493873836888674,1.8594267642584574
MDA-MB-453,176870,4.531738011413092,1.8594267642584574
FTC-133,docetaxel-tanespimycin (2-1 mol-mol),-1.4229742664151317,1.8594267642584574
LXF 289,24180125,2.8590757937383517,1.8594267642584574
G-401,4259181,0.5796012369716917,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],71751553,4.339346911330044,1.8594267642584574
SNU-81,alisertib-navitoclax (2-1 mol-mol),-2.6757706059542445,1.8594267642584574
JM-1,54618305,4.117087010604098,1.8594267642584574
NCI-H522,16736978,1.523319728114192,1.8594267642584574
NCI-H522,36462,3.1215227661343925,1.8594267642584574
HSC-4,400769,-0.948607557046086,1.8594267642584574
FU-OV-1,piperlongumine-MST-312 (1-1 mol-mol),2.3913949476666243,1.8594267642584574
YAPC,20959075,1.1991758721406616,1.8594267642584574
A-498,5328940,1.8314953095149151,1.8594267642584574
YAPC,9915743,1.8269757962027744,1.8594267642584574
SNU-81,54613361,-2.01246069716893,1.8594267642584574
CA46,navitoclax-pluripotin (1-1 mol-mol),-1.6931023620468224,1.8594267642584574
OPM-2,1716436,2.6292767753294437,1.8594267642584574
Panc 04.03,3025986,-1.5275729109481309,1.8594267642584574
NCI-H661,25150857,2.764254958619497,1.8594267642584574
MSTO-211H,JQ-1-carboplatin (1-1 mol-mol),2.423353722828544,1.8594267642584574
LOU-NH91,5746,1.403252091596802,1.8594267642584574
MSTO-211H,UNC0638-navitoclax (1-1 mol-mol),-1.567850255531391,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],2729026,3.1482483825414698,1.8594267642584574
NCI-H146,135398738,5.0513404057578155,1.8594267642584574
MDA-MB-453,25227462,0.3575965628816619,1.8594267642584574
NCI-H460,2858523,3.1665522277325575,1.8594267642584574
SNU-449,9866186,1.4050575476777012,1.8594267642584574
CAL-51,54686904,4.850424917483252,1.8594267642584574
LoVo,53392493,2.4765619401689154,1.8594267642584574
LXF 289,24951314,1.0119406639366386,1.8594267642584574
NCI-H661,JQ-1-carboplatin (1-1 mol-mol),3.6496372437464992,1.8594267642584574
NCI-H1623,5329102,1.790138577011996,1.8594267642584574
HCC1143,selumetinib-vorinostat (8-1 mol-mol),1.9962314127216017,1.8594267642584574
NCI-H292,3815108,3.432884993584308,1.8594267642584574
OPM-2,400769,-3.2268127368380215,1.8594267642584574
MDA-MB-157,9823820,1.002295209558588,1.8594267642584574
MDA-MB-453,vorinostat-carboplatin (1-1 mol-mol),1.132828187068375,1.8594267642584574
YAPC,135999136,4.461108174764027,1.8594267642584574
A-498,71680916,6.416494665581045,1.8594267642584574
BT-549,252682,5.865498031558929,1.8594267642584574
NCI-H522,2130404,2.4549438882602463,1.8594267642584574
BT-549,60750,3.345812478570961,1.8594267642584574
A2780,55508,1.942124594025635,1.8594267642584574
BT-549,3136844,5.53345832245052,1.8594267642584574
A-673,SNX-2112-bortezomib (250-1 mol-mol),-3.639662214518592,1.8594267642584574
NCI-H522,135398516,2.766899162932887,1.8594267642584574
Panc 04.03,45279963,4.427260741974604,1.8594267642584574
MDA-MB-157,107970,2.1200224507121868,1.8594267642584574
DMS 273,24180719,3.915275581303962,1.8594267642584574
Panc 04.03,71680916,5.172010716636655,1.8594267642584574
DMS 273,44632017,0.8019003224742934,1.8594267642584574
NCI-H292,5311281,4.174884455345005,1.8594267642584574
NCI-H2171,9549297,1.2348443580878434,1.8594267642584574
NCI-H661,135398516,2.0112722508641525,1.8594267642584574
A4/Fukuda,6918328,-3.9252329494253586,1.8594267642584574
SBC-5,selumetinib-vorinostat (8-1 mol-mol),2.6526809527728603,1.8594267642584574
A-673,5284616,-2.8220877865693996,1.8594267642584574
A-498,11222830,1.898532346529896,1.8594267642584574
SNU-81,44589607,-1.0723208776906596,1.8594267642584574
SCC-9,54596558,4.378159430294897,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],11404337,-0.1256073852846617,1.8594267642584574
OPM-2,56649450,1.6365959554779024,1.8594267642584574
JM-1,2945648,1.8231052373320176,1.8594267642584574
Panc 04.03,6852167,3.6951209581653743,1.8594267642584574
OPM-2,5311281,1.024044758253736,1.8594267642584574
SCC-9,9967941,4.677287493278682,1.8594267642584574
CAL-51,11609586,1.5077859423552509,1.8594267642584574
SNU-61,9911463,3.407728451470452,1.8594267642584574
LOU-NH91,BRD-A02303741-navitoclax (2-1 mol-mol),0.4254312881757893,1.8594267642584574
KMRC-1,72193861,2.923138623905541,1.8594267642584574
SCC-9,168313016,4.940700460648117,1.8594267642584574
NCI-H1623,46215462,1.70222177248337,1.8594267642584574
MDA-MB-157,6505803,-0.678815881739905,1.8594267642584574
A-673,25062766,1.5933001652207863,1.8594267642584574
NCI-H522,148198,-5.538025476960186,1.8594267642584574
KMRC-1,11625818,4.222506706272698,1.8594267642584574
LoVo,10074640,2.9851259451828476,1.8594267642584574
NCI-H1623,12001922,2.89915315578861,1.8594267642584574
NCI-H460,107970,2.752075604137296,1.8594267642584574
HSC-4,10322450,4.749470049467763,1.8594267642584574
A4/Fukuda,JQ-1-navitoclax (2-1 mol-mol),-1.310646692558982,1.8594267642584574
CAL-51,65628,4.560195683913681,1.8594267642584574
LoVo,selumetinib-tretinoin (2-1 mol-mol),0.1717915474841797,1.8594267642584574
SCC-9,2746,3.644005246156997,1.8594267642584574
JM-1,107985,-4.195149425063274,1.8594267642584574
NCI-H146,119607,3.9951566487227823,1.8594267642584574
JM-1,44566777,-1.1129943275867182,1.8594267642584574
SBC-5,11167602,1.6319389998554443,1.8594267642584574
LOU-NH91,9936388,-6.294191236399446,1.8594267642584574
SNU-61,135875424,3.609444893060012,1.8594267642584574
NCI-H292,6917907,-6.008612763335491,1.8594267642584574
G-401,19582717,3.4233639988307623,1.8594267642584574
LXF 289,46174525,4.3838011857350585,1.8594267642584574
SW1463,10184653,-0.9517511422842978,1.8594267642584574
SCC-9,7251185,3.4755501931610486,1.8594267642584574
OPM-2,4788,3.799883557086963,1.8594267642584574
MSTO-211H,selumetinib-UNC0638 (4-1 mol-mol),2.638630251212758,1.8594267642584574
OPM-2,selumetinib-navitoclax (8-1 mol-mol),2.2674041559669917,1.8594267642584574
DMS 273,JQ-1-navitoclax (2-1 mol-mol),1.419130204387569,1.8594267642584574
NCI-H460,387447,-2.436463262555682,1.8594267642584574
NCI-H522,3465537,1.2201304719285595,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],JQ-1-carboplatin (1-1 mol-mol),2.0139488398740637,1.8594267642584574
OVISE,11228183,1.089434907795814,1.8594267642584574
HCC1143,sirolimus-bortezomib (250-1 mol-mol),-0.8248046184342958,1.8594267642584574
NOMO-1,10410894,2.884775843935945,1.8594267642584574
NCI-H522,3062316,1.3416096793720445,1.8594267642584574
NCI-H522,5328940,1.3898569828081493,1.8594267642584574
OVISE,6917907,-2.8614664806523975,1.8594267642584574
DMS 273,53392493,1.951320459884087,1.8594267642584574
BxPC-3,44259,0.1590720374324279,1.8594267642584574
CAL-51,17755052,0.5283491907817935,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),4.856399530140112,1.8594267642584574
NCI-H661,676352,2.2217693895783115,1.8594267642584574
LXF 289,452548,0.2436004430663324,1.8594267642584574
LoVo,6438330,1.2087527750724023,1.8594267642584574
OPM-2,16736978,1.1906517256258733,1.8594267642584574
DMS 273,89928392,1.202164769006387,1.8594267642584574
CA46,3543504,2.8823298921776717,1.8594267642584574
SBC-5,11427553,4.187017651849035,1.8594267642584574
CAL-51,67156097,-2.385254348530768,1.8594267642584574
FTC-133,23725625,5.526585624025884,1.8594267642584574
BT-549,25227462,1.1552638438270102,1.8594267642584574
SNU-81,374536,-2.2172994025671877,1.8594267642584574
MSTO-211H,navitoclax-pluripotin (1-1 mol-mol),-2.948162650279317,1.8594267642584574
BT-549,65064,5.372588334008338,1.8594267642584574
NOMO-1,135398738,0.7085728369009435,1.8594267642584574
A-673,44566777,0.6818018070798556,1.8594267642584574
OVISE,42642645,1.7980918591344808,1.8594267642584574
CA46,637858,0.8997823848237061,1.8594267642584574
NCI-H292,9877608,5.923265260718527,1.8594267642584574
DMS 273,11964036,0.5570994002779035,1.8594267642584574
FTC-133,44137675,6.176024086140045,1.8594267642584574
BxPC-3,9926054,1.7603137158224154,1.8594267642584574
DMS 273,5311,0.3077166337368,1.8594267642584574
SNU-61,36314,2.631499046696298,1.8594267642584574
EFO-27,6917907,-5.745836009999857,1.8594267642584574
OPM-2,11455910,0.7503761469114726,1.8594267642584574
NCI-H1623,24785538,-1.341558176424811,1.8594267642584574
SNU-449,462382,1.3667681892704822,1.8594267642584574
G-401,8515,3.316277000480566,1.8594267642584574
SNU-449,25102847,2.813788740655036,1.8594267642584574
BT-549,JQ-1-UNC0638 (2-1 mol-mol),2.8120688111855845,1.8594267642584574
ONS-76,11404337,-0.4259392266769182,1.8594267642584574
KMRC-1,49766530,-0.1675164065777726,1.8594267642584574
HSC-4,24785538,3.772420906085344,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],119607,5.94570045924447,1.8594267642584574
KYSE-70,73707398,2.029692143461395,1.8594267642584574
NCI-H1623,2729026,3.210868522276231,1.8594267642584574
ONS-76,selumetinib-MK-2206 (8-1 mol-mol),-0.5692436577416031,1.8594267642584574
FTC-133,56649450,4.4227260509908275,1.8594267642584574
NCI-H727,3815108,3.498449156165097,1.8594267642584574
FU-OV-1,448949,2.8154029654914137,1.8594267642584574
FU-OV-1,168313200,1.721890351327649,1.8594267642584574
HSC-4,107985,-2.2656284906222144,1.8594267642584574
NCI-H2009,44241473,6.22803294537171,1.8594267642584574
CAL-51,46843906,2.776329873296567,1.8594267642584574
NCI-H1623,56946209,-3.1229213094171895,1.8594267642584574
FU-OV-1,3825829,3.720797122696784,1.8594267642584574
LXF 289,10385095,0.5776298837700374,1.8594267642584574
KMRC-1,4259181,1.968851453570829,1.8594267642584574
G-401,11494412,0.2825252149996007,1.8594267642584574
KYSE-70,6918878,2.8589087884624673,1.8594267642584574
CA46,44185566,1.786162700750641,1.8594267642584574
LoVo,54618164,3.038824107117225,1.8594267642584574
NOMO-1,16722836,0.125485002235246,1.8594267642584574
A4/Fukuda,44486219,1.5854911698245977,1.8594267642584574
LOU-NH91,10127622,4.686411868973226,1.8594267642584574
KMRC-1,387447,-4.945508167403058,1.8594267642584574
NCI-H146,54618164,3.6762408834701423,1.8594267642584574
KMRC-1,5351362,3.133883590343709,1.8594267642584574
NCI-H2171,54765302,2.983840848305476,1.8594267642584574
KMRC-1,16013152,4.7431155582488325,1.8594267642584574
SNU-61,71304818,2.3861681407496125,1.8594267642584574
JM-1,selumetinib-vorinostat (8-1 mol-mol),2.137722454720046,1.8594267642584574
SW1463,2708,3.597321448088185,1.8594267642584574
CA46,vorinostat-navitoclax (4-1 mol-mol),0.373580583037546,1.8594267642584574
FTC-133,piperlongumine-MST-312 (1-1 mol-mol),3.9575841468826383,1.8594267642584574
SBC-5,445643,4.051401497201939,1.8594267642584574
A4/Fukuda,241158,1.407426277414268,1.8594267642584574
NOMO-1,6852167,1.234836949550939,1.8594267642584574
A-673,9887053,2.3565868011684956,1.8594267642584574
SNU-61,6450551,3.0035817833604783,1.8594267642584574
OPM-2,24771867,-0.0082042750480303,1.8594267642584574
NOMO-1,11507802,1.1250810428603863,1.8594267642584574
CAL-51,2828334,6.190580852669228,1.8594267642584574
OPM-2,selumetinib-PLX-4032 (8-1 mol-mol),2.3146569091496847,1.8594267642584574
KMRC-1,44489675,3.6404436921550607,1.8594267642584574
FU-OV-1,23725625,5.156277829802871,1.8594267642584574
NCI-H1623,navitoclax-gemcitabine (1-1 mol-mol),-5.01790230865627,1.8594267642584574
OVISE,439501,-2.343202219776273,1.8594267642584574
CAL-51,5281321,-0.4656602142962174,1.8594267642584574
DMS 273,151289,0.7083247440682101,1.8594267642584574
MSTO-211H,9903786,1.212702371904443,1.8594267642584574
LXF 289,135421197,2.6553019911408056,1.8594267642584574
NCI-H146,24771867,1.252264036368602,1.8594267642584574
CAL-51,136227924,2.079284078064279,1.8594267642584574
NCI-H522,3689413,-4.273368850016072,1.8594267642584574
NCI-H460,46907787,4.3372157131836255,1.8594267642584574
NCI-H146,25183872,-1.3449770735764903,1.8594267642584574
CAL-51,selumetinib-MK-2206 (8-1 mol-mol),3.019475754284589,1.8594267642584574
CAL-51,9887053,4.486783389261201,1.8594267642584574
NCI-H460,107985,-2.632533954936978,1.8594267642584574
YAPC,65064,4.247853222703643,1.8594267642584574
SCC-9,9884685,0.522968392230544,1.8594267642584574
SNU-61,6852167,3.859693430343892,1.8594267642584574
NCI-H292,400769,-0.4441855968341354,1.8594267642584574
EFO-27,24748573,3.2354879524418347,1.8594267642584574
CA46,65628,4.372814936384242,1.8594267642584574
NOMO-1,1750826,-5.797741098147838,1.8594267642584574
LOU-NH91,135440466,0.9387697781897782,1.8594267642584574
MSTO-211H,11427553,1.7459714847796464,1.8594267642584574
SNU-61,9903786,2.1391845181717373,1.8594267642584574
JM-1,9952709,2.333856130884211,1.8594267642584574
YAPC,44507138,4.423761616669373,1.8594267642584574
OPM-2,selumetinib-vorinostat (8-1 mol-mol),1.6127891772049152,1.8594267642584574
NCI-H727,10231331,-2.105430518957453,1.8594267642584574
NCI-H661,navitoclax-gemcitabine (1-1 mol-mol),-0.9367360763965996,1.8594267642584574
LoVo,6610355,3.962139785065475,1.8594267642584574
LOU-NH91,16065773,1.5129164046929433,1.8594267642584574
NCI-H292,51039095,2.62578521626359,1.8594267642584574
NCI-H2009,135398516,3.792403018557381,1.8594267642584574
Panc 04.03,44566777,0.5187219827219705,1.8594267642584574
NOMO-1,285033,-2.4289999699368923,1.8594267642584574
LOU-NH91,doxorubicin-navitoclax (2-1 mol-mol),-1.426641258307621,1.8594267642584574
KYSE-70,51039095,3.5490987853947247,1.8594267642584574
NCI-H460,36462,3.103581216464206,1.8594267642584574
MDA-MB-157,216345,3.882260039310166,1.8594267642584574
NCI-H522,104842,-1.8805759610000512,1.8594267642584574
FU-OV-1,72376,-3.2802123060842283,1.8594267642584574
HCC1143,selumetinib-GDC-0941 (4-1 mol-mol),1.964789015650302,1.8594267642584574
NCI-H661,5978,-4.21717720873681,1.8594267642584574
A-498,54619267,3.764771843303345,1.8594267642584574
SCC-9,53495165,0.7472636588137463,1.8594267642584574
MSTO-211H,9823820,1.3460489687603958,1.8594267642584574
EFO-27,11222830,1.8018026478898377,1.8594267642584574
JM-1,11612883,1.345048153552996,1.8594267642584574
NCI-H146,carboplatin-etoposide (40-17 mol-mol),0.3222331814864832,1.8594267642584574
EFO-27,12003241,-1.7336155023360622,1.8594267642584574
SNU-449,969516,2.7263398794742972,1.8594267642584574
NCI-H146,4259181,0.4591034911128469,1.8594267642584574
NOMO-1,24901704,1.738276567126731,1.8594267642584574
BxPC-3,54619238,5.160880582862859,1.8594267642584574
SBC-5,654092,0.9915803206550192,1.8594267642584574
MDA-MB-453,71751553,4.5545018888168185,1.8594267642584574
MDA-MB-157,5978,-4.802538048228265,1.8594267642584574
CAL-51,24964624,1.6704816041215405,1.8594267642584574
LOU-NH91,5280436,5.173335280456015,1.8594267642584574
EFO-27,53481919,4.175905541374054,1.8594267642584574
ONS-76,6610216,4.821554065133985,1.8594267642584574
JM-1,53495165,-3.850144918627292,1.8594267642584574
YAPC,16065773,2.864044457230109,1.8594267642584574
SNU-449,51039095,3.650396552732121,1.8594267642584574
NCI-H661,71466445,2.1620252686029646,1.8594267642584574
A4/Fukuda,984333,-0.4165614363108865,1.8594267642584574
JM-1,4096211,0.9764948319580444,1.8594267642584574
SNU-449,44197249,4.950419501644914,1.8594267642584574
NCI-H460,11178236,-2.300904923417752,1.8594267642584574
MDA-MB-453,12001922,1.470906003655458,1.8594267642584574
NCI-H460,44620216,3.8133491956675902,1.8594267642584574
A-673,119182,-1.0392852637873304,1.8594267642584574
NCI-H727,11178236,-2.542459533585497,1.8594267642584574
NCI-H1623,erlotinib-PLX-4032 (2-1 mol-mol),-0.1422885712238643,1.8594267642584574
A4/Fukuda,753704,3.7176461109746897,1.8594267642584574
SW1463,168312962,2.678519281942756,1.8594267642584574
KMRC-1,SNX-2112-bortezomib (250-1 mol-mol),0.0767950067042666,1.8594267642584574
OPM-2,227681,1.827584998281281,1.8594267642584574
HCC1143,3081361,2.3254724072420316,1.8594267642584574
CAL-51,44607531,1.640429423812436,1.8594267642584574
HCC1143,322968,3.187805633465504,1.8594267642584574
FTC-133,9911463,4.36756965003986,1.8594267642584574
SNU-61,159324,1.5880493113453718,1.8594267642584574
NCI-H2171,5738263,2.6832104272478188,1.8594267642584574
CA46,49867926,4.142181337076857,1.8594267642584574
SNU-81,BRD-A02303741-navitoclax (2-1 mol-mol),0.8522567387086551,1.8594267642584574
HSC-4,44589607,3.345116081225748,1.8594267642584574
EFO-27,11485656,3.240498776862908,1.8594267642584574
SNU-81,23725625,1.2739024793065858,1.8594267642584574
A4/Fukuda,9911830,0.8865121451383732,1.8594267642584574
NCI-H1623,JQ-1-UNC0638 (2-1 mol-mol),2.6843347454635604,1.8594267642584574
NCI-H292,9866186,0.3072921576740348,1.8594267642584574
NCI-H460,54143018,2.5592633032091956,1.8594267642584574
A2780,4378219,4.7769256594107254,1.8594267642584574
NCI-H1623,44566777,3.7111231324950102,1.8594267642584574
CAL-51,10074640,3.192334769578339,1.8594267642584574
RCM-1 [Human rectal adenocarcinoma],71466380,4.350719813683452,1.8594267642584574
CAL-51,60700,-0.6497243984818711,1.8594267642584574
HCC1143,12001922,1.8011931254041345,1.8594267642584574
NCI-H727,638278,3.5555642892396744,1.8594267642584574
LOU-NH91,72376,-0.6247816475402558,1.8594267642584574
EFO-27,4578,4.426476303141277,1.8594267642584574
HCC1143,119607,4.074424413991316,1.8594267642584574
JM-1,selumetinib-decitabine (4-1 mol-mol),-2.432451496880968,1.8594267642584574
OPM-2,selumetinib-GDC-0941 (4-1 mol-mol),1.4008173274482878,1.8594267642584574
NCI-H727,159324,3.364651085509472,1.8594267642584574
NCI-H1623,5287620,-2.020641279124402,1.8594267642584574
CAL-51,4261,2.4552246887350417,1.8594267642584574
JM-1,3543504,2.821603823672808,1.8594267642584574
SNU-81,11497983,2.4691665919847514,1.8594267642584574
G-401,5113032,4.898905985161468,1.8594267642584574
MDA-MB-157,52912189,4.238554807379722,1.8594267642584574
G-401,selumetinib-navitoclax (8-1 mol-mol),2.1097176548583407,1.8594267642584574
KYSE-70,10410894,6.372300696648814,1.8594267642584574
LXF 289,54618164,3.0378434141224617,1.8594267642584574
SNU-61,11214940,-0.337645985307237,1.8594267642584574
ONS-76,11364421,-0.3098764345335473,1.8594267642584574
KYSE-70,5978,-0.772629381148284,1.8594267642584574
Panc 04.03,53232,3.444660782403792,1.8594267642584574
FTC-133,46926350,-4.117104249862265,1.8594267642584574
